Strain	ACE2_binding_site_mutations	DMS_Class_1	DMS_Class_2	DMS_Class_3	DMS_convalescent_serum	GISAID Clade	S1 mutations	Clade	Country	Country of exposure	Admin Division	Division of exposure	Host	location	Originating Lab	PANGO Lineage	Region	Region of exposure	Submitting Lab	url	Collection Data	Author	Accession	Age	Sex
Wuhan/Hu-1/2019						L		19A	Asia	China	Asia	Hubei	Human	Asia	National Institute for Communicable Disease Control and Prevention (ICDC) Chinese Center for Disease Control and Prevention (China CDC)	B	Asia	Asia	National Institute for Communicable Disease Control and Prevention (ICDC) Chinese Center for Disease Control and Prevention (China CDC)		2019-12-26	Zhang et al (https://dx.doi.org/10.1038/s41586-020-2008-3)	[object Object]		
Wuhan/WH01/2019						L		19A	Asia	China	Asia	Hubei	Human	Asia	General Hospital of Central Theater Command of People's Liberation Army of China	B	Asia	Asia	BGI & Institute of Microbiology, Chinese Academy of Sciences & Shandong First Medical University & Shandong Academy of Medical Sciences & General Hospital of Central Theater Command of People's Liberation Army of China		2019-12-26	Weijun Chen et al (https://dx.doi.org/10.1016/S0140-6736(20)30251-8)	[object Object]	44	Male
Sweden/01/2020						O		19A	Sweden	Sweden	Sweden	Småland	Human	Jönköping	Unit for Laboratory Development and Technology Transfer, Public Health Agency of Sweden	B	Europe	Europe	Unit for Laboratory Development and Technology Transfer, Public Health Agency of Sweden		2020-02-07	Bengner et al (https://dx.doi.org/10.2807/1560-7917.ES.2020.25.13.2000305)	[object Object]		
mink/Netherlands/NB02_03KS/2020	1.00	0.06	0.01		0.04	L	2.00	19A	Netherlands	Netherlands	Netherlands	North Brabant	Mink		Virology, Wageningen Bioveterinary Research	B.11	Europe	Europe	Virology, Wageningen Bioveterinary Research		2020-04-29	van der Poel et al (https://dx.doi.org/10.2807/1560-7917.ES.2020.25.23.2001005)	[object Object]		
Japan/DP0152/2020						O		19A	Asia	Japan	Asia	Japan	Human	Asia	Japanese Quarantine Stations	B	Asia	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases		2020-02-15	Tsuyoshi Sekizuka et al A (https://dx.doi.org/10.1101/2020.03.23.20041970)	[object Object]		
Spain/EX-ISCIII-201258/2020						V		19A	Spain	Spain	Spain	Extremadura	Human		Hospital Infanta Cristina	B	Europe	Europe	Instituto de Salud Carlos III		2020-02-29	Iglesias-Caballero et al	[object Object]	20	Female
Spain/AR-IBV-2444/2020						V		19A	Spain	Spain	Spain	Aragon	Human	Teruel	Servicio de Microbiología, Hospital Miguel Servet, Zaragoza	B	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2020-03-24	Antonio Rezusta López et al	[object Object]	59	Female
Switzerland/SH-ETHZ-100808/2020						V	1.00	19A	Switzerland	Switzerland	Switzerland	Schaffhausen	Human		Viollier AG	B.40	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-03-26	Christian Beisel et al	[object Object]		
Russia/StPetersburg-82005/2020						V		19A	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.28	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-24	Sergey A. Bodnev et al	[object Object]	35	Male
Qatar/QA-QU_02-2-44/2020						V		19A	Asia	Qatar	Asia	Doha	Human	Asia	Ministry of Public Health / Hamad Medical Corporation	B.36	Asia	Asia	Biomedical Research Center (BRC), Qatar University / Qatar Genome Project (QGP)		2020-03-13	BRC: Fatiha M. Benslimane et al	[object Object]	58	Female
Qatar/QA-WCMQ_FD15506511/2020						V	1.00	19A	Asia	Qatar	Asia	Doha	Human	Asia	Ministry of Public Health / Hamad Medical Corporation	B	Asia	Asia	Weill Cornell Medical College - Qatar (WCM-Q), Genomics Core Laboratory / Qatar Genome Project (QGP)		2020-04-24	WCMQ: Ayeda A. Ahmed et al	[object Object]	32	Male
Brunei/3/2020						O		19A	Asia	Brunei	Asia	Brunei	Human	Asia	National Virology Reference Laboratory	B.6	Asia	Asia	National Public Health Laboratory, National Centre for Infectious Diseases		2020-03-11	Mak Tze Minn et al	[object Object]	5	Male
India/MH-NIV-6311/2020						O		19A	Asia	India	Asia	Maharashtra	Human	Asia	NIV Influenza	B.6	Asia	Asia	NIV Influenza		2020-03-30	Potdar V et al	[object Object]	68	Male
Malaysia/MGI-MAEPS41/2020						O		19A	Asia	Malaysia	Asia	Selangor	Human	Asia	Malaysia Genome Institute	B.6.2	Asia	Asia	Malaysia Genome Institute		2020-06-03	Mohd Noor Mat Isa et al	[object Object]		Male
Pakistan/KP-RMI-01/2020						O		19A	Asia	Pakistan	Asia	Pakistan	Human	Asia	Genomic Sciences, Rehman Medical Institute	B.6	Asia	Asia	Genomic Sciences, Rehman Medical Institute		2020-04-01	Ali et al	[object Object]		
Singapore/680/2020						O		19A	Asia	Singapore	Asia	Singapore	Human	Asia	National Public Health Laboratory, National Centre for Infectious Diseases	B.6	Asia	Asia	National Public Health Laboratory, National Centre for Infectious Diseases		2020-06-22	Mak TM et al	[object Object]	53	Male
Singapore/1338/2020						O		19A	Asia	Singapore	Asia	Singapore	Human	Asia	Department of Laboratory Medicine, Tan Tock Seng Hospital	B.6.6	Asia	Asia	Department of Laboratory Medicine, Tan Tock Seng Hospital		2020-06-04	Chen YYC et al	[object Object]	36	Male
Singapore/1342/2020						O		19A	Asia	Singapore	Asia	Singapore	Human	Asia	Department of Laboratory Medicine, Tan Tock Seng Hospital	B.6.6	Asia	Asia	Department of Laboratory Medicine, Tan Tock Seng Hospital		2020-06-07	Chen YYC et al	[object Object]	37	Male
Zambia/ZMB-67/2020						O		19A	Africa	Zambia	Africa	Lusaka	Human	Africa	University of Zambia, School of Veterinary Medicine	B.6	Africa	Africa	UNZAVET and PATH		2020-03-20	Mulenga Mwenda-Chimfwembe et al	[object Object]	60	Female
PapuaNewGuinea/3/2020						O		19A	Oceania	Papua New Guinea	Oceania	Papua New Guinea	Human	Oceania	Central Public Health Laboratory	B.6.8	Oceania	Oceania	National Public Health Laboratory, National Centre for Infectious Diseases		2020-08-21	Tze Minn Mak et al	[object Object]	49	Male
PapuaNewGuinea/7/2020						O		19A	Oceania	Papua New Guinea	Oceania	Papua New Guinea	Human	Oceania	Central Public Health Laboratory	B.6.8	Oceania	Oceania	National Public Health Laboratory, National Centre for Infectious Diseases		2020-08-29	Tze Minn Mak et al	[object Object]	41	Female
Tunisia/7899/2020						O		19A	Africa	Tunisia	Africa	Tunis	Human	Africa	1-Laboratory of Microbiology, National Reference Lab, Charles Nicolle Hospital; 2-University of Tunis ElManar, Faculty of Medicine of Tunis, LR99ES09, Tunis, Tunisia	B.4	Africa	Africa	1-Clinical and Experimental Pharmacology Lab, LR16SP02, National Center of Pharmacovigilance, University of Tunis El Manar, Tunis, Tunisia. 2-Neurodegenerative diseases and psychiatric troubles, LR18SP03, Razi Hospital, University of Tunis El Manar, Tunis, Tunisia. 3- Ministry of Health, National Observatory of New and Emerging Diseases, 1006, Tunis, Tunisia		2020-04-06	Ilhem Boutiba-Ben Boubaker et al	[object Object]	79	Female
Kazakhstan/NCB-1/2020						O		19A	Asia	Kazakhstan	Asia	Nur-Sultan	Human	Asia	Laboratory of Applied Genetics	B.4.1	Asia	Asia	RSE "National Center for Biotechnology"		2020-03-22	Alexandr Shevtsov et al	[object Object]		
Oman/RESP-20-837/2020						O		19A	Asia	Oman	Asia	Muscat	Human	Asia	Oman-NIC	B.4	Asia	Asia	Oman-NIC		2020-02-24	Samira Al-Maruqi et al	[object Object]	42	Female
SriLanka/COV38/2020						O		19A	Asia	Sri Lanka	Asia	Sri Lanka	Human	Asia	Centre for Dengue Research	B.4	Asia	Asia	Centre for Dengue Research		2020-03-16	Chandima Jeewandara et al A (https://dx.doi.org/10.21203/rs.3.rs-44134/v1)	[object Object]	33	Male
Canada/BC_17397/2020						O		19A	North America	Iran	North America	Iran	Human	North America	BCCDC Public Health Laboratory	B.4	North America	Asia	BCCDC Public Health Laboratory		2020-02-28	Harrigan et al	[object Object]	57	
Iran/PN2179/2020						O	1.00	19A	Asia	Iran	Asia	Iran	Human	Asia	Pasteur Institute of Iran	B.4	Asia	Asia	Rapid Response Team		2020-03-26	Mahboobeh Rafigh et al	[object Object]		Female
Taiwan/CGMH-CGU-04/2020						O		19A	Asia	Taiwan	Asia	Taiwan	Human	Asia	Laboratory Medicine	B.4	Asia	Asia	Department of Laboratory Medicine, Lin-Kou Chang Gung Memorial Hospital, Taoyuan, Taiwan		2020-02-27	Kuo-Chien Tsao et al A (https://dx.doi.org/10.1080/22221751.2020.1782271)	[object Object]		Female
Taiwan/CGMH-CGU-21/2020						O	1.00	19A	Asia	Taiwan	Asia	Taiwan	Human	Asia	Laboratory Medicine	B.4	Asia	Asia	Department of Laboratory Medicine, Lin-Kou Chang Gung Memorial Hospital, Taoyuan, Taiwan		2020-02-29	Kuo-Chien Tsao et al B	[object Object]		Female
Iran/Urmia-715U/2020						O		19A	Asia	Iran	Asia	Urmia	Human	Asia	National Influenza Center, Virology Department	B.4	Asia	Asia	National Influenza Center		2020-05-06	J Yavarian et al	[object Object]		Male
NewZealand/20VR0174/2020						O		19A	Oceania	Iran	Oceania	Iran	Human	Oceania	Auckland Hospital	B.4	Oceania	Asia	Institute of Environmental Science and Research (ESR)		2020-02-27	Matt Storey et al A (https://dx.doi.org/10.1101/2020.03.15.992818)	[object Object]		Female
Iraq/BAS-2/2020						O		19A	Asia	Iraq	Asia	Iraq	Human	Asia	Department of Biology, University of Basrah	B.4	Asia	Asia	Department of Biology, University of Basrah		2020-10-01	Abu-Ali et al	[object Object]		
Kuwait/KU17/2020						O		19A	Asia	Kuwait	Asia	Kuwait	Human	Asia	Dasman Diabetes Institute	B.4	Asia	Asia	Dasman Diabetes Institute		2020-03-02	Fahd Al-Mulla et al	[object Object]		
Thailand/Bangkok-0085/2020						S		19B	Asia	Thailand	Asia	Bangkok	Human	Asia	Ramathibodi Hospital	A.6	Asia	Asia	COVID-19 Network Investigations (CONI) Alliance		2020-04-03	Elizabeth Batty et al	[object Object]		
England/02/2020						S		19B	United Kingdom	China	United Kingdom	Hubei	Human		Respiratory Virus Unit, Microbiology Services Colindale, Public Health England	B	Europe	Asia	Respiratory Virus Unit, Microbiology Services Colindale, Public Health England		2020-01-29	Monica Galiano et al (https://virological.org/t/preliminary-analysis-of-sars-cov-2-importation-establishment-of-uk-transmission-lineages/507)	[object Object]	23	Male
Japan/TY-WK-521/2020						S		19B	Asia	Japan	Asia	Tokyo	Human	Asia	Dept. of Virology III, National Institute of Infectious Diseases	A	Asia	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases		2020-01-31	Tsuyoshi Sekizuka et al B	[object Object]		
Vietnam/PIHCM-14/2020						S		19B	Asia	Vietnam	Asia	Ho Chi Minh City	Human	Asia	Pasteur Institute in Ho Chi Minh city	A	Asia	Asia	Department of Microbiology and Immunology - Pasteur Institute in Ho Chi Minh city		2020-01-31	Cao Minh Thắng et al	[object Object]	73	Male
Australia/TAS166/2020						S		19B	Oceania	Australia	Oceania	Tasmania	Human	Oceania	Royal Hobart Hospital Microbiology Department	A.2.2	Oceania	Oceania	MDU-PHL		2020-05-01	Cooley L. et al	[object Object]		
Israel/CVL-n4295/2020						S		19B	Asia	Israel	Asia	Tel Aviv District	Human	Asia	Israel Central Virology laboratory	A.2	Asia	Asia	Israel Central Virology laboratory		2020-03-12	Neta Zuckerman et al	[object Object]		
Spain/RI-ISCIII-201277/2020						S		19B	Spain	Spain	Spain	La Rioja ES	Human		Hospital San Pedro	A.2	Europe	Europe	Instituto de Salud Carlos III		2020-02-29	Iglesias-Caballero et al	[object Object]	41	Male
Netherlands/LI-RIVM-10096/2020						S	1.00	19B	Netherlands	Netherlands	Netherlands	Limburg	Human		Dutch COVID-19 response team	A.2	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2020-03-13	Adam Meijer et al	[object Object]		
Panama/334611/2020						S		19B	North America	Panama	North America	Panama Center	Human	North America	Gorgas Memorial Laboratory of Health Studies	A.2.4	North America	North America	Gorgas Memorial Laboratory of Health Studies		2020-03-31	Danilo Franco et al (https://www.medrxiv.org/content/10.1101/2020.07.31.20160929v1)	[object Object]	23	Male
NewZealand/20VR1297/2020						S		19B	Oceania	New Zealand	Oceania	Auckland	Human	Oceania	Middlemore Hospital	A.2	Oceania	Oceania	Institute of Environmental Science and Research (ESR)		2020-03-20	Matt Storey et al B	[object Object]		
Netherlands/Limburg_9/2020						S		19B	Netherlands	Netherlands	Netherlands	Limburg	Human		Dutch COVID-19 response team	A.2	Europe	Europe	Erasmus Medical Center		2020-03-20	Bas Oude Munnink et al	[object Object]		
Kazakhstan/16173/2020						S		19B	Asia	Kazakhstan	Asia	Nur-Sultan	Human	Asia	RSE "National Center for Biotechnology"	A.2	Asia	Asia	RSE "National Center for Biotechnology"		2020-05-14	Alexandr Shevtsov et al	[object Object]	50	Female
Spain/PV-IBV-000692/2020						S		19B	Spain	Spain	Spain	Basque Country	Human	Vitoria-Gasteiz	Hospital Universitario Araba. Vitoria-Gasteiz,	A.2	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2020-02-29	Silvia Hernáez Crespo et al	[object Object]	42	Female
Vietnam/PIHCM-305/2020						S		19B	Asia	Vietnam	Asia	Ho Chi Minh City	Human	Asia	Pasteur Institute in Ho Chi Minh city	A.2	Asia	Asia	Department of Microbiology and Immunology - Pasteur Institute in Ho Chi Minh city		2020-03-18	Phạm Duy Quang et al	[object Object]	50	Female
Honduras/19179/2021		0.01	0.05	0.05	0.06	S	3.00	19B	North America	Honduras	North America	Honduras	Human	North America	Red - Regional de Vigilancia Genómica del COVID-19	A.2.5	North America	North America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2021-02-18	Paola Resende et al	[object Object]	30	
CostaRica/INC-0662/2021		0.01	0.05	0.05	0.06	S	3.00	19B	North America	Costa Rica	North America	San Jose	Human	North America	AREA DE SALUD ZAPOTE-CATEDRAL - CLINICA DR. CARLOS DURAN	A.2.5.1	North America	North America	Inciensa, Instituto Costarricense de InvestigaciOn y Enseñanza en NutriciOn y Salud		2021-05-22	Francisco Duarte et al	[object Object]	67	Female
CostaRica/HNN-0391/2021		0.01	0.05	0.05	0.06	S	4.00	19B	North America	Costa Rica	North America	Heredia	Human	North America		A.2.5.1	North America	North America	Inciensa, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud		2021-02-17	Pérez-Corrales C et al	[object Object]	34	Male
CostaRica/INC-0525/2021		0.01	0.05	0.05	0.06	S	6.00	19B	North America	Costa Rica	North America	Puntarenas	Human	North America	HOSPITAL DR. FERNANDO ESCALANTE PRADILLA	A.2.5.1	North America	North America	Inciensa, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud		2021-03-25	Francisco Duarte et al	[object Object]	21	Male
SintMaarten/SX-RIVM-23081/2021		0.01	0.05	0.05	0.06	S	3.00	19B	North America	Sint Maarten	North America	Sint Maarten	Human	North America	Dutch COVID-19 response team	A.2.5	North America	North America	National Institute for Public Health and the Environment (RIVM)		2021-02-27	Adam Meijer et al	[object Object]	31	
Ecuador/USFQ-1458/2021		0.02	0.05	0.06	0.07	S	3.00	19B	South America	Ecuador	South America	Carchi	Human	South America	Institute of Microbiology, Universidad San Francisco de Quito	A.2.5	South America	South America	Institute of Microbiology, Universidad San Francisco de Quito		2021-05-27	Juan José Guadalupe et al	[object Object]		Male
Ecuador/USFQ-1465/2021		0.02	0.05	0.06	0.07	S	3.00	19B	South America	Ecuador	South America	Santo Domingo de los Tsachilas	Human	South America	Institute of Microbiology, Universidad San Francisco de Quito	A.2.5	South America	South America	Institute of Microbiology, Universidad San Francisco de Quito		2021-05-21	Monica Becerra-Wong et al	[object Object]	49	Male
Suriname/SR-137/2021		0.01	0.05	0.05	0.06	S	3.00	19B	South America	Suriname	South America	Suriname	Human	South America	Central Laboratory, Bureau of Public Health (BOG) and Academic Hospital Paramaribo	A.2.5	South America	South America	Erasmus Medical Center		2021-03-27	Bas B Oude Munnink et al	[object Object]		
CostaRica/INC-0644/2021		0.01	0.05	0.05	0.06	S	3.00	19B	North America	Costa Rica	North America	Puntarenas	Human	North America	AREA DE SALUD OSA	A.2.5	North America	North America	Inciensa, Instituto Costarricense de InvestigaciOn y Enseñanza en NutriciOn y Salud		2021-05-14	Francisco Duarte et al	[object Object]	41	Female
CostaRica/INC-0324/2021		0.01	0.05	0.05	0.06	S	3.00	19B	North America	Costa Rica	North America	Limon	Human	North America	HOSPITAL DR. TONY FACIO CASTRO	A.2.5	North America	North America	Inciensa, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud		2021-02-12	Francisco Duarte et al	[object Object]	64	Male
CostaRica/INC-0426/2021		0.01	0.05	0.06	0.08	S	4.00	19B	North America	Costa Rica	North America	Limon	Human	North America	HOSPITAL DR. TONY FACIO CASTRO	A.2.5	North America	North America	Inciensa, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud		2021-02-27	Francisco Duarte et al	[object Object]	55	Male
Uganda/UG027/2020						S		19B	Africa	Uganda	Africa	Uganda	Human	Africa	Uganda Central Public Health Lab and Uganda Virus Research Institute	A	Africa	Africa	MRC/UVRI & LSHTM Uganda Research Unit		2020-04-04	Matthew Cotten et al	[object Object]		
Germany/HH-hpi-p2416/2020						S		19B	Germany	Germany	Germany	Hamburg	Human		University Medical Center Hamburg Eppendorf	A	Europe	Europe	Heinrich Pette Institute, Leibniz Institute for Experimental Virology		2020-04-21	Alexis Robitaille et al	[object Object]		
Ghana/UHAS-G541/2020						S		19B	Africa	Ghana	Africa	Volta	Human	Africa	UHAS COVID-19 Lab	A	Africa	Africa	UHAS COVID-19 Lab		2020-06-12	Kwabena O. Duedu et al	[object Object]	30	Male
Coted-Ivoire/COV-BKE2497/bc92/2021		0.01	0.05	0.05	0.06	S	3.00	19B	Africa	Côte d'Ivoire	Africa	Niakara	Human	Africa	Molecular diagnostic unit for viral haemorrhagic fevers and emerging viruses, Bouaké CHU Laboratory	A.21	Africa	Africa	Molecular diagnostic unit for viral haemorrhagic fevers and emerging viruses, Bouaké CHU Laboratory		2021-03-05	Chantal Akoua-Koffi et al	[object Object]	79	Male
BurkinaFaso/2411/2020		0.01	0.22	0.05	0.07	S	2.00	19B	Africa	Burkina Faso	Africa	Hauts-Bassins	Human	Africa	Laboratoire de Microbiologie CHU Souro Sanou	A.21	Africa	Africa	Centre Muraz		2020-09-11	Abdoul-Salam Ouedraogo et al	[object Object]	35	Female
Senegal/SN-IR1-0015705/2020		0.01	0.22	0.05	0.07	S	2.00	19B	Africa	Senegal	Africa	Dakar	Human	Africa	Institute for Health Research, Epidemiological Surveillance and Training (IRESSEF)	A.21	Africa	Africa	Abbott Laboratories		2020-12-31	Souleymane Mboup et al	[object Object]	66	Male
Zambia/ZMB-1241/2020						S		19B	Africa	Zambia	Africa	Lusaka	Human	Africa	University of Zambia, School of Veterinary Medicine	A	Africa	Africa	UNZAVET and PATH		2020-04-07	Mulenga Mwenda-Chimfwembe et al	[object Object]	58	Male
Uganda/UG374/2021		0.01	0.01		0.02	S	5.00	19B	Africa	Uganda	Africa	Uganda	Human	Africa	MRC/UVRI & LSHTM Uganda Research Unit, Central Public Health Laboratories	A.23.1	Africa	Africa	MRC/UVRI & LSHTM Uganda Research Unit, Central Public Health Laboratories		2021-02-27	Matthew Cotten et al	[object Object]		
Rwanda/NRLNAT1014/2020		0.01	0.01	0.01	0.04	S	6.00	19B	Africa	Rwanda	Africa	Kigali	Human	Africa	Nucleic Acid Testing, National Reference Laboratory	A.23.1	Africa	Africa	GIGA Medical Genomics		2020-12-15	Yvan Butera et al	[object Object]	32	Female
Rwanda/BH74397RD/2020		0.01	0.01	0.01	0.04	S	6.00	19B	Africa	Rwanda	Africa	Rwanda	Human	Africa	National Reference Laboratory	A.23.1	Africa	Africa	National Reference Laboratory		2021-02-13	Enatha Mukantwari et al	[object Object]	48	Male
Uganda/MAKCHScov30/2021		0.01	0.01		0.02	S	7.00	19B	Africa	Uganda	Africa	Central Uganda	Human	Africa	Integrated Biorepository of H3Africa Uganda – IBRH3AU	A.23.1	Africa	Africa	Molecular Biology Laboratory		2021-01-13	Savannah Mwesigwa et al	[object Object]	50	Male
Uganda/UG335/2020		0.01	0.01		0.02	S	5.00	19B	Africa	Uganda	Africa	Uganda	Human	Africa	MRC/UVRI & LSHTM Uganda Research Unit	A.23.1	Africa	Africa	Where sequence data have been generated and submitted to GISAID		2020-12-22	Matthew Cotten et al	[object Object]		
Russia/LIP-CRIE-L188D0005b/2021		0.01	0.01		0.02	S	5.00	19B	Russia	Russia	Lipetsk	Lipetsk	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	A.23.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-20	Samojlov A.E. et al	[object Object]	81	Male
Rwanda/NRLNAT4034/2021		0.01	0.01		0.02	S	4.00	19B	Africa	Rwanda	Africa	Kigali	Human	Africa	Nucleic Acid Testing, National Reference Laboratory	A.23.1	Africa	Africa	GIGA Medical Genomics		2021-03-23	Yvan Butera et al	[object Object]	28	Male
Rwanda/NRLNAT4033/2021		0.01	0.01		0.02	S	5.00	19B	Africa	Rwanda	Africa	Kigali	Human	Africa	Nucleic Acid Testing, National Reference Laboratory	A.23.1	Africa	Africa	GIGA Medical Genomics		2021-03-23	Yvan Butera et al	[object Object]	23	Male
Italy/SIC-AOUP-UNIPA_59342/2021		0.01	0.01		0.02	S	4.00	19B	Italy	Italy	Italy	Sicily	Human		Laboratorio di Riferimento Regionale della Sicilia Occidentale per l’Emergenza COVID-19	A.23.1	Europe	Europe	Laboratorio di Riferimento Regionale della Sicilia Occidentale per l’Emergenza COVID-19		2021-02-24	Fabio Tramuto et al	[object Object]	26	Male
Gabon/ITM-K011/2020						S		19B	Africa	Gabon	Africa	Libreville	Human	Africa	Centre de Recherches Medicales de Lambarene (CERMEL)	A	Africa	Africa	Department of Emerging Infectious Diseases, Institute of Tropical Medicine, Nagasaki University		2020-03-22	Haruka Abe et al	[object Object]		
Russia/Kabardino-Balkaria-80503/2020						S		19B	Russia	Russia	Kabardino-Balkaria	Kabardino-Balkaria	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	A	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-23	Sergey A. Bodnev et al	[object Object]	52	Female
Russia/Kabardino-Balkaria-80501/2020						S		19B	Russia	Russia	Kabardino-Balkaria	Kabardino-Balkaria	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	A	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-23	Oleg V. Pyankov et al	[object Object]	37	Female
Ghana/3176_S11/2020						S		19B	Africa	Ghana	Africa	Greater Accra	Human	Africa	NMIMR, Department of Virology	A	Africa	Africa	WACCBIP, University of Ghana		2020-03-30	Joyce M. Ngoi et al	[object Object]	28	Female
Tunisia/SP-0157/2021	1.00	0.08	0.05	0.06	0.10	S	5.00	19B	Africa	Tunisia	Africa	Tunis	Human	Africa	Pasteur Institute - Laboratory of Clinical Virology	A.27	Africa	Africa	Pasteur Institute - Laboratory of Clinical Virology		2021-02-07	Wasfi Fares et al	[object Object]	17	Male
Coted-Ivoire/BKE-2022-bc17/2021	1.00	0.08	0.05	0.06	0.10	S	5.00	19B	Africa	Côte d'Ivoire	Africa	Bouaké	Human	Africa	Molecular diagnostic unit for viral haemorrhagic fevers and emerging viruses, Bouaké CHU Laboratory	A.27	Africa	Africa	Molecular diagnostic unit for viral haemorrhagic fevers and emerging viruses, Bouaké CHU Laboratory		2021-02-12	Chantal Akoua-Koffi et al	[object Object]	57	Male
BurkinaFaso/2-009/2020						S		19B	Africa	Burkina Faso	Africa	Hauts-Bassins	Human	Africa	Laboratoire de Microbiologie CHU Souro Sanou	A	Africa	Africa	Centre Muraz		2020-05-08	Abdoul-Salam Ouedraogo et al	[object Object]	50	Male
BurkinaFaso/2-012/2020						S		19B	Africa	Burkina Faso	Africa	Hauts-Bassins	Human	Africa	Laboratoire de Microbiologie CHU Souro Sanou	A	Africa	Africa	Centre Muraz		2020-05-10	Abdoul-Salam Ouedraogo et al	[object Object]	54	Female
Bahrain/NPS-9/2021	1.00	0.07	0.01	0.01	0.04	S	3.00	19B	Asia	Bahrain	Asia	Bahrain	Human	Asia	Communicable Disease Laboratory, Public Health Directorate	A.28	Asia	Asia	Communicable Disease Laboratory, Public Health Directorate		2021-05-04	Alwasti et al	[object Object]		
Turkey/CTF_04032021_M028/2021	1.00	0.07	0.01	0.01	0.04	S	3.00	19B	Turkey	Turkey	Turkey	Istanbul	Human		IU-Cerrahpasa, Cerrahpasa School of Medicine, COVID-19 Lab	A.28	Europe	Europe	IU-Cerrahpasa, Cerrahpasa School of Medicine, COVID-19 Lab		2021-03-04	Mert Kuskucu et al	[object Object]		Female
Qatar/QA-QU_16-E9/2020						O	2.00	19B	Asia	Qatar	Asia	Doha	Human	Asia	Ministry of Public Health / Hamad Medical Corporation	A	Asia	Asia	Biomedical Research Center (BRC), Qatar University / Qatar Genome Project (QGP)		2020-12-29	BRC: Fatiha M. Benslimane et al	[object Object]	23	Male
Coted-Ivoire/BKE0355/2020						S	1.00	19B	Africa	Côte d'Ivoire	Africa	Bouaké	Human	Africa	Molecular diagnostic unit for viral haemorrhagic fevers and emerging viruses, Bouaké CHU Laboratory	A.19	Africa	Africa	Project group Epidemology of Highly Pathogenic Microorganisms, Robert Koch-Institute		2020-06-29	Chantal Akoua-Koffi et al	[object Object]	23	Male
BurkinaFaso/2-032-1197/2020						S	1.00	19B	Africa	Burkina Faso	Africa	Hauts-Bassins	Human	Africa	Laboratoire de Microbiologie CHU Souro Sanou	A.19	Africa	Africa	Centre Muraz		2020-07-25	Abdoul-Salam Ouedraogo et al	[object Object]	51	Male
BurkinaFaso/3567/2020						S	1.00	19B	Africa	Burkina Faso	Africa	Hauts-Bassins	Human	Africa	Laboratoire de Microbiologie CHU Souro Sanou	A.19	Africa	Africa	Centre Muraz		2020-10-09	Abdoul-Salam Ouedraogo et al	[object Object]	68	Male
Coted-Ivoire/COV-BKE1972/bc38/2021						S	3.00	19B	Africa	Côte d'Ivoire	Africa	Niakara	Human	Africa	Molecular diagnostic unit for viral haemorrhagic fevers and emerging viruses, Bouaké CHU Laboratory	A.19	Africa	Africa	Molecular diagnostic unit for viral haemorrhagic fevers and emerging viruses, Bouaké CHU Laboratory		2021-02-08	Chantal Akoua-Koffi et al	[object Object]	44	Female
Coted-Ivoire/COV-BKE2337/bc19/2021						S	3.00	19B	Africa	Côte d'Ivoire	Africa	Niakara	Human	Africa	Molecular diagnostic unit for viral haemorrhagic fevers and emerging viruses, Bouaké CHU Laboratory	A.19	Africa	Africa	Molecular diagnostic unit for viral haemorrhagic fevers and emerging viruses, Bouaké CHU Laboratory		2021-02-20	Chantal Akoua-Koffi et al	[object Object]	51	Female
Malaysia/MKAK-CL-2020-5047/2020						L		19A	Asia	Malaysia	Asia	Selangor	Human	Asia	National Public Health Laboratory	B	Asia	Asia	Malaysia Genome Institute		2020-01-24	Mohd Noor Mat Isa et al	[object Object]	65	Female
Malaysia/MKAK-CL-2020-5045/2020						L		19A	Asia	Malaysia	Asia	Selangor	Human	Asia	National Public Health Laboratory	B	Asia	Asia	Malaysia Genome Institute		2020-01-24	Mohd Noor Mat Isa et al	[object Object]	11	Male
Nepal/61/2020						L		19A	Asia	China	Asia	Hubei	Human	Asia	National Influenza Centre, National Public Health Laboratory, Kathmandu, Nepal	B	Asia	Asia	The University of Hong Kong		2020-01-13	Ranjit Sah et al (http://biorxiv.org/lookup/doi/10.1101/2020.04.01.019463)	[object Object]	32	Male
Cambodia/0012/2020						L		19A	Asia	China	Asia	Hubei	Human	Asia	Virology Unit, Institut Pasteur du Cambodge.	B	Asia	Asia	Virology Unit, Institut Pasteur du Cambodge (Sequencing done by: Jessica E Manning/Jennifer A Bohl at Malaria and Vector Research Research Laboratory, National Institute of Allergy and Infectious Diseases and Vida Ahyong from Chan-Zuckerberg Biohub)		2020-01-27	Erik A Karlsson et al (https://dx.doi.org/10.2807/1560-7917.ES.2020.25.13.2000305)	[object Object]	60	Male
Germany/HE-FFM5/2020						L	1.00	19A	Germany	Germany	Germany	Hesse	Human	Frankfurt	Goethe University Hospital Frankfurt	B.3	Europe	Europe	Institute for Medical Virology, Goethe University Hospital Frankfurt		2020-03-02	Tuna Toptan et al	[object Object]	42	Female
Austria/CeMM0002/2020						L		19A	Austria	Austria	Austria	Vienna	Human		Center for Virology, Medical University of Vienna	B.3	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2020-02-26	Alexandra Popa et al (https://www.biorxiv.org/content/10.1101/2020.07.15.204339v1)	[object Object]	73	Male
Denmark/DCGC-1679/2020						L		19A	Denmark	Denmark	Denmark	Midtjylland	Human		Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Denmark	B.3	Europe	Europe	Albertsen lab, Department of Chemistry and Bioscience, Aalborg University, Denmark		2020-03-09	Danish Covid-19 Genome Consortia et al	[object Object]		
Wales/PHWC-26A7F/2020						L		19A	United Kingdom	United Kingdom	United Kingdom	Wales	Human		Wales Specialist Virology Centre	B.3.1	Europe	Europe	Public Health Wales Microbiology Cardiff		2020-03-30	Catherine Moore et al A (https://virological.org/t/preliminary-analysis-of-sars-cov-2-importation-establishment-of-uk-transmission-lineages/507)	[object Object]	49	Female
France/ARA-739/2020						L		19A	France	France	France	Auvergne-Rhône-Alpes	Human	Contamines	CNR Virus des Infections Respiratoires - France SUD	B	Europe	Europe	CNR Virus des Infections Respiratoires - France SUD		2020-02-08	Bal et al (https://dx.doi.org/10.1016/j.cmi.2020.03.020)	[object Object]	56	Female
Japan/OS-20-07-1/2020						L		19A	Asia	China	Asia	Hubei	Human	Asia	Dept. of Pathology, National Institute of Infectious Diseases	B	Asia	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases		2020-01-23	Tsuyoshi Sekizuka et al C (https://dx.doi.org/10.2807/1560-7917.ES.2020.25.13.2000305)	[object Object]		Female
Curacao/CW-RIVM-10093/2020						L		19A	South America	Curacao	South America	Curacao	Human	South America	Dutch COVID-19 response team	B.27	South America	South America	National Institute for Public Health and the Environment (RIVM)		2020-03-10	Adam Meijer et al	[object Object]	53	Male
Curacao/CW-RIVM-10309/2020						L		19A	South America	Curacao	South America	Curacao	Human	South America	Dutch COVID-19 response team	B.27	South America	South America	National Institute for Public Health and the Environment (RIVM)		2020-03-10	Adam Meijer et al	[object Object]	67	Male
USA/CA-CDPH016/2020						L		19A	North America	USA	North America	California	Human	North America	California Department of Public Health	B	North America	North America	California Department of Public Health		2020-02-28	CDPH IDLB COVIDNet et al	[object Object]		
Netherlands/Flevoland_2/2020						O		19A	Netherlands	Netherlands	Netherlands	Flevoland	Human		Dutch COVID-19 response team	B	Europe	Europe	Erasmus Medical Center		2020-03-25	Bas Oude Munnink et al	[object Object]		
UnitedArabEmirates/skmc-205223/2020						L	1.00	19A	Asia	United Arab Emirates	Asia	United Arab Emirates	Human	Asia	Sheikh Khalifa Medical City	B.53	Asia	Asia	Molecular/Surveillance lab Sheikh Khalifa Medical City		2020-04-19	Amirtharaj Francis et al	[object Object]	13	Male
Singapore/210/2020						L		19A	Asia	Singapore	Asia	Singapore	Human	Asia	National Public Health Laboratory, National Centre for Infectious Diseases	B	Asia	Asia	National Public Health Laboratory, National Centre for Infectious Diseases		2020-03-09	Mak TM et al	[object Object]	71	Male
UnitedArabEmirates/skmc-01319674/2020						O		19A	Asia	United Arab Emirates	Asia	United Arab Emirates	Human	Asia	Sheikh Khalifa Medical City	B	Asia	Asia	Molecular/Surveillance lab Sheikh Khalifa Medical City		2020-02-28	Amirtharaj Francis et al	[object Object]	47	Male
Hangzhou/HZCDC6111/2020						O		19A	Asia	China	Asia	Zhejiang	Human	Asia	Hangzhou Center for Diseases Control and Prevention	B	Asia	Asia	Hangzhou Center for Diseases Control and Prevention		2020-03-05	Jun Li et al	[object Object]	39	Female
Austria/Graz-MUG7/2020						O	1.00	19A	Austria	Austria	Austria	Styria	Human		Diagnostic- and Research Institute of Pathology, Medical University of Graz	B	Europe	Europe	Diagnostic- and Research Institute of Pathology, Medical University of Graz		2020-04-06	Karl Kashofer et al (https://www.biorxiv.org/content/10.1101/2020.07.15.204339v1)	[object Object]	79	Male
Malaysia/UNIMAS-0358/2020						G	1.00	19A	Asia	Malaysia	Asia	Malaysia	Human	Asia	Ministry of Health Hospitals	B.1	Asia	Asia	Institute of Health and Community Medicine		2020-04-03	David Perera et al	[object Object]	28	Female
Sweden/20-50133/2020						G	1.00	20A	Sweden	Sweden	Sweden	Varmland	Human		Klinisk mikrobiologi Orebro	B.1	Europe	Europe	The Public Health Agency of Sweden		2020-03-06	Martin Sundqvist et al	[object Object]	46	Male
DRC/16191/2020						G	1.00	20A	Africa	Democratic Republic of the Congo	Africa	Kinshasa	Human	Africa	Viral Respiratory Lab, National Institute for Biomedical Research (INRB)	B.1.6	Africa	Africa	Pathogen Sequencing Lab, National Institute for Biomedical Research (INRB)		2020-06-03	Placide Mbala-Kingebeni et al A	[object Object]	47	Female
Belgium/MBLG75700/2020						G	1.00	20A	Belgium	Belgium	Belgium	Brabant Wallon	Human		Cliniques universitaires Saint-Luc	B.1.6	Europe	Europe	UCLouvain/IREC/MBLG		2020-04-06	Jean Ruelle et al	[object Object]	36	Female
Rwanda/NRLNAT2049/2020						G	1.00	20A	Africa	Rwanda	Africa	Kigali	Human	Africa	Nucleic Acid Testing, National Reference Laboratory	B.1.380	Africa	Africa	GIGA Medical Genomics		2020-08-29	Yvan Butera et al	[object Object]	63	Male
Rwanda/NRLNAT2009/2020						G	1.00	20A	Africa	Rwanda	Africa	Kigali	Human	Africa	Nucleic Acid Testing, National Reference Laboratory	B.1.380	Africa	Africa	GIGA Medical Genomics		2020-06-10	Yvan Butera et al	[object Object]	33	Female
France/NOR-N1620/2020						G	1.00	20A	France	France	France	Normandie	Human	Rouen	Centre Hositalier Universitaire de Rouen Laboratoire de Virologie	B.1	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2020-02-26	Mélnie Albert et al (https://dx.doi.org/10.1101/2020.04.24.059576)	[object Object]		
Germany/un-ChVir-W1069-5703/2020						G	1.00	20A	Germany	Germany	Germany	Germany	Human		Charité Universitätsmedizin Berlin, Institut für Virologie/Labor Berlin	B.1	Europe	Europe	Charité Universitätsmedizin Berlin, Institut für Virologie		2020-04-01	Victor M Corman et al	[object Object]		
SriLanka/COV91/2020						G	1.00	20A	Asia	Sri Lanka	Asia	Sri Lanka	Human	Asia	Centre for Dengue Research	B.1	Asia	Asia	Centre for Dengue Research		2020-03-19	Chandima Jeewandara et al A (https://dx.doi.org/10.21203/rs.3.rs-44134/v1)	[object Object]	37	Male
Russia/MUR-RII-MH6309S/2020						G	2.00	20A	Russia	Russia	Murmansk	Murmansk	Human	Severomorsk	HELIX LLC	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-11	Andrey Komissarov et al A	[object Object]	42	Female
Crimea/SRC-80603/2020						G	1.00	20A	Ukraine	Ukraine	Ukraine	Crimea	Human	Crimea	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-23	Sergey A. Bodnev et al	[object Object]	40	Male
Germany/SH-ChVir3038/2020						O	1.00	20A	Germany	Germany	Germany	Schleswig-Holstein	Human		A. Krumbholz, Labor Dr. Krause und Kollegen MVZ GmbH, Kiel	B.1.8	Europe	Europe	Charité Universitätsmedizin Berlin, Institut für Virologie		2020-03-17	Victor M Corman et al	[object Object]		
mink/Netherlands/NB-EMC-20-34/2020						G	1.00	20A	Netherlands	Netherlands	Netherlands	Limburg	Mink		Dutch COVID-19 response team	B.1.8	Europe	Europe	Erasmus Medical Center		2020-07-09	OH consortium et al	[object Object]		
mink/Netherlands/NB-EMC-21-20/2020						G	2.00	20A	Netherlands	Netherlands	Netherlands	Limburg	Mink		Dutch COVID-19 response team	B.1.8	Europe	Europe	Erasmus Medical Center		2020-07-09	OH consortium et al	[object Object]		
mink/Netherlands/NB-EMC-53-9/2020	1.00	0.21	0.12		0.09	G	4.00	20A	Netherlands	Netherlands	Netherlands	Limburg	Mink		Dutch COVID-19 response team	B.1.8	Europe	Europe	Erasmus Medical Center		2020-09-16	OH consortium et al	[object Object]		
Peru/LIM-INS-112/2020						G	2.00	20A	South America	Peru	South America	Lima	Human	South America	Instituto Nacional de Salud	B.1.205	South America	South America	Laboratorio de Infecciones Respiratorias Agudas		2020-05-04	Eduardo Juscamayta Lopez et al	[object Object]	55	Female
Germany/BW-UKT-a112/2020						G	1.00	20A	Germany	Germany	Germany	Baden-Wuerttemberg	Human		Institute of Medical Genetics and Applied Genomics	B.1	Europe	Europe	Institute of Medical Genetics and Applied Genomics		2020-05-14	Caspar Gross et al	[object Object]		
Belgium/rega-0414490/2020						G	1.00	20A	Belgium	Belgium	Belgium	Nivelles	Human	Tubize	UZ Leuven, National Reference Laboratory for Coronaviruses, Laboratory Medicine, Leuven, Belgium	B.1	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-04-14	Tony Wawina-Bokalanga et al	[object Object]	43	Female
Russia/Moscow-64601/2020						G	1.00	20A	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-13	Oleg V. Pyankov et al	[object Object]	36	Male
Russia/Sverdlovsk-71905/2020						G	1.00	20A	Russia	Russia	Sverdlovsk	Sverdlovsk	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-19	Sergey A. Bodnev et al	[object Object]	36	Female
Canada/BC-BCCDC-5571/2020						G	1.00	20A	North America	Canada	North America	British Columbia	Human	North America	BCCDC Public Health Laboratory	B.1.128	North America	North America	BCCDC Public Health Laboratory		2020-10-03	Prystajecky Natalie et al	[object Object]		
Ecuador/USFQ-533/2020						G	1.00	20A	South America	Ecuador	South America	Sucumbios	Human	South America	Institute of Microbiology, Universidad San Francisco de Quito	B.1	South America	South America	Institute of Microbiology, Universidad San Francisco de Quito		2020-11-30	Belén Prado-Vivar et al	[object Object]		
Norway/2461/2020						G	1.00	20A	Norway	Norway	Norway	Vestland	Human		Haugesund Hospital, laboratory for Medical Microbiology	B.1	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2020-04-01	Kathrine Stene-Johansen et al	[object Object]		
Bulgaria/40/2020						G	1.00	20A	Bulgaria	Bulgaria	Bulgaria	Sofia	Human		National Reference Laboratory "Influenza and acute respiratory diseases"	B.1	Europe	Europe	NRL-HIV		2020-04-19	Ivan Ivanov et al	[object Object]	93	Female
Bangladesh/DNAS-CPH-isl-479/2020						G	2.00	20A	Asia	Bangladesh	Asia	Bangladesh	Human	Asia	NGS Lab, DNA SOLUTION LTD.	B.1	Asia	Asia	NGS Lab, DNA SOLUTION LTD.		2020-04-29	Khan et al	[object Object]		
Hungary/SRC-03597w/2020						G	1.00	20A	Hungary	Hungary	Hungary	Szeged	Human		Virological Research Group, Szentágothai Research Centre	B.1	Europe	Europe	Bioinformatics Research Group, Szentágothai Research Centre		2020-03-28	Péter Urbán et al	[object Object]	33	Male
Netherlands/OV-EMC-52/2020						G	1.00	20A	Netherlands	Netherlands	Netherlands	Overijssel	Human		Dutch COVID-19 response team	B.1.220	Europe	Europe	Erasmus Medical Center		2020-05-04	Bas Oude Munnink et al	[object Object]		
Russia/Sverdlovsk-71903/2020						G	1.00	20A	Russia	Russia	Sverdlovsk	Sverdlovsk	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-19	Oleg V. Pyankov et al	[object Object]	48	Female
Switzerland/UR-ETHZ-170004/2020						G	1.00	20A	Switzerland	Switzerland	Switzerland	Uri	Human		Viollier AG	B.1.146	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-06-26	Christian Beisel et al	[object Object]		
Switzerland/GR-ETHZ-210075/2020						G	2.00	20A	Switzerland	Switzerland	Switzerland	Graubünden	Human		Viollier AG	B.1.146	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-07-22	Christian Beisel et al	[object Object]		
Cameroon/Douala-20V-3050/2020						G	1.00	20A	Africa	Cameroon	Africa	Douala	Human	Africa	Centre Pasteur du Cameroun	B.1.147	Africa	Africa	Institut Pasteur de Dakar		2020-03-26	Njouom Richard et al	[object Object]	32	Female
Belize/BZ-CML-TCMC-BZ034-1220/2020						G	1.00	20A	North America	Belize	North America	Belize	Human	North America	Central Medical Laboratory	B.1.147	North America	North America	Texas Children's Microbiome Center		2020-12-28	Ruth Ann Luna et al	[object Object]	68	Male
Belize/BZ-CML-TCMC-BZ014-1020/2020						G	2.00	20A	North America	Belize	North America	Belize	Human	North America	Central Medical Laboratory	B.1.147	North America	North America	Texas Children's Microbiome Center		2020-10-21	Ruth Ann Luna et al	[object Object]	39	Male
Belize/BZ-CML-TCMC-BZ020-1220/2020						G	2.00	20A	North America	Belize	North America	Belize	Human	North America	Central Medical Laboratory	B.1.147	North America	North America	Texas Children's Microbiome Center		2020-12-13	Ruth Ann Luna et al	[object Object]	33	Male
Belgium/ITM_C2184_2/2020						G	1.00	20A	Belgium	Democratic Republic of the Congo	Belgium	Democratic Republic of the Congo	Human		Queen Astrid Military Hospital	B.1.214	Europe	Africa	Institute of Tropical Medicine		2020-06-02	Philippe Selhorst et al	[object Object]	55	Male
Angola/CERI-KRISP-K013648/2021		0.01	0.06	0.04	0.07	G	4.00	20A	Africa	Angola	Africa	Luanda	Human	Africa	Instituto Nacional de Investigação em Saúde	B.1.214.2	Africa	Africa	CERI, Centre for Epidemic Response and Innvoation, Stellenbosch University and KRISP, KZN Research Innovation and Sequencing Platform, UKZN.		2021-03-12	Morais J et al	[object Object]	62	Female
Belgium/UZA-UA-2021-010000/2021		0.01	0.06	0.04	0.07	G	3.00	20A	Belgium	Belgium	Belgium	Veurne	Human	Beveren	Labo Klinische Biologie, UZA	B.1.214.2	Europe	Europe	Labo Klinische Biologie, UZA		2021-03-03	Marie Le Mercier et al	[object Object]	83	Female
Belgium/UZA-UA-CV2086267512/2021		0.01	0.06	0.04	0.07	G	3.00	20A	Belgium	Belgium	Belgium	Turnhout	Human	Herselt	Platform BIS UZA/UAntwerpen	B.1.214.2	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-06	Jasmine Coppens et al	[object Object]	6	Male
Switzerland/GR-ETHZ-490701/2021		0.01	0.02	0.11	0.02	G	3.00	20A	Switzerland	Switzerland	Switzerland	Graubünden	Human		Viollier AG	B.1.221	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-02-11	Chaoran Chen et al	[object Object]		
Spain/VC-IBV-99016697/2021						G	2.00	20A	Spain	Spain	Spain	Comunitat Valenciana	Human	Alicante	Hospital General Universitario de Alicante - Instituto de Investigación Sanitaria y Biomédica de Alicante	B.1.221	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2021-01-26	Maripaz Ventero Martín et al	[object Object]	88	Female
Spain/VC-IBV-98024551/2021						G	2.00	20A	Spain	Spain	Spain	Comunitat Valenciana	Human	Villena	Laboratorio de Microbiología. Hospital General Universitario de Elda, Alicante	B.1.221	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2021-02-08	Mª Isabel Gascón Ros et al	[object Object]	85	Female
CzechRepublic/NRL_11876/2020						G	2.00	20A	Czech Republic	Czech Republic	Czech Republic	Liberec Region	Human	Vratislavice nad Nisou	The National Institute of Public Health	B.1.221	Europe	Europe	State Veterinary Institute Prague		2020-12-18	Nagy et al	[object Object]	58	Male
Slovakia/112860160M/2020						G	2.00	20A	Slovakia	Slovakia	Slovakia	Nitra	Human		Department of Genetics, Medirex	B.1.221	Europe	Europe	Laboratory of Genomics and Bioinformatics, Comenius University Science Park		2020-11-28	Tatiana Sedláčková et al	[object Object]	70	Female
Belgium/ULG-10425/2020						G	2.00	20A	Belgium	Belgium	Belgium	Liège	Human		Department of Clinical Microbiology	B.1.221	Europe	Europe	GIGA Medical Genomics		2020-08-14	Keith Durkin et al	[object Object]	59	Male
Norway/2751/2021						G	3.00	20A	Norway	Norway	Norway	Trondelag	Human		Department of Medical Microbiology, St. Olavs hospital	B.1.221	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-01-21	Kathrine Stene-Johansen et al	[object Object]		
Belgium/rega-4914/2021						G	2.00	20A	Belgium	Belgium	Belgium	Waremme	Human	Omal	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.221	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2021-03-08	Tony Wawina-Bokalanga et al	[object Object]	47	Male
Belgium/rega-1875/2020						G	3.00	20A	Belgium	Belgium	Belgium	Kortrijk	Human		KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.221	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-12-24	Tony Wawina-Bokalanga et al	[object Object]	87	Male
Austria/CeMM2328/2020						G	2.00	20A	Austria	Austria	Austria	Vorarlberg	Human	Bludenz	Austrian Agency for Health and Food Safety (AGES)	B.1.221	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2020-11-13	Lukas Endler et al	[object Object]	74	Male
Belgium/rega-2668/2021						G	2.00	20A	Belgium	Belgium	Belgium	Turnhout	Human		KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.221	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2021-01-25	Tony Wawina-Bokalanga et al	[object Object]	26	Female
Switzerland/TI-ETHZ-410127/2020						G	2.00	20A	Switzerland	Switzerland	Switzerland	Ticino	Human		Viollier AG	B.1.221	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-12-17	Chaoran Chen et al	[object Object]		
Switzerland/LU-ETHZ-531334/2020						G	2.00	20A	Switzerland	Switzerland	Switzerland	Lucerne	Human		Viollier AG	B.1.221	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-11-07	Chaoran Chen et al	[object Object]		
Suriname/SR-22/2020						G	2.00	20A	South America	Suriname	South America	Suriname	Human	South America	Academic Hospital Paramaribo	B.1.219	South America	South America	Erasmus Medical Center		2020-06-25	Bas Oude Munnink et al	[object Object]		
Suriname/SR-31/2020						G	2.00	20A	South America	Suriname	South America	Suriname	Human	South America	Academic Hospital Paramaribo	B.1.219	South America	South America	Erasmus Medical Center		2020-06-25	Bas Oude Munnink et al	[object Object]		
France/BRE-8935/2020						G	2.00	20A	France	France	France	Hauts de France	Human	Santes	Hospital	B.1.219	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2020-07-29	Sylvie Behillil et al	[object Object]		
Belgium/rega-0804744/2020						G	2.00	20A	Belgium	Belgium	Belgium	Turnhout	Human	Herentals	UZ Leuven, National Reference Laboratory for Coronaviruses, Laboratory Medicine, Leuven, Belgium	B.1.219	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-08-04	Tony Wawina-Bokalanga et al	[object Object]	65	Male
Suriname/SR-83/2020						G	2.00	20A	South America	Suriname	South America	Suriname	Human	South America	Central Laboratory, Bureau of Public Health (BOG) and Academic Hospital Paramaribo	B.1.219	South America	South America	Erasmus Medical Center		2020-08-10	Bas B Oude Munnink et al	[object Object]		
Suriname/SR-40/2020						G	2.00	20A	South America	Suriname	South America	Suriname	Human	South America	Academic Hospital Paramaribo	B.1.219	South America	South America	Erasmus Medical Center		2020-06-26	Bas Oude Munnink et al	[object Object]		
Guinea/CERFIG-1337/2020						G	1.00	20A	Africa	Guinea	Africa	Conakry	Human	Africa	Centre de Recherche et de Formation en Infectiologie Guinée	B.1	Africa	Africa	TransVIHMI, IRD/INSERM/Monpellier University		2020-06-09	Alpha Kabinet KEITA et al	[object Object]	60	Female
Guinea/CERFIG-1340/2020						G	1.00	20A	Africa	Guinea	Africa	Conakry	Human	Africa	Centre de Recherche et de Formation en Infectiologie Guinée	B.1	Africa	Africa	TransVIHMI, IRD/INSERM/Monpellier University		2020-06-09	Alpha Kabinet KEITA et al	[object Object]	22	Female
Switzerland/BL-UHB-42179281/2020						G	1.00	20A	Switzerland	Switzerland	Switzerland	Basel-Land	Human		University Hospital Basel, Clinical Virology	B.1	Europe	Europe	University Hospital Basel, Clinical Bacteriology		2020-03-06	Madlen Stange et al	[object Object]		Female
France/GES-8815/2020						G	1.00	20A	France	France	France	Grand Est	Human	Maizières Les Metz	Hospital	B.1	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2020-04-30	Sylvie Behillil et al	[object Object]	94	Male
Serbia/Subotica-101360605/2020						G	1.00	20A	Serbia	Serbia	Serbia	North Bačka District	Human	Subotica	Scientific Veterinary Institute Novi Sad	B.1	Europe	Europe	Veterinary Specialized Institute "Kraljevo", Serbia		2020-05-05	Vidanovic et al	[object Object]		
Poland/NIPH-NIH_ECDC-040/2021						G	1.00	20A	Poland	Poland	Poland	Mazowieckie	Human	Warszawa	National Institute of Public Health - National Institute of Hygiene	B.1.213	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-01-28	Wołkowicz Tomasz et al	[object Object]	60	Male
Switzerland/VD-ETHZ-100171/2020						G	1.00	20A	Switzerland	Switzerland	Switzerland	Vaud	Human		Viollier AG	B.1	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-03-16	Christian Beisel et al	[object Object]		
Belgium/ULG-10198/2020						G	1.00	20A	Belgium	Belgium	Belgium	Liège	Human		Department of Clinical Microbiology	B.1	Europe	Europe	GIGA Medical Genomics		2020-05-23	Keith Durkin et al	[object Object]	91	
Morocco/FMP-183/2020						G	1.00	20A	Africa	Morocco	Africa	Sidi Lahcen	Human	Africa	Laboratoire Central de Virologie	B.1	Africa	Africa	Laboratoire de Biotechnologie		2020-08-08	Mouna Ouadghiri et al	[object Object]	59	Male
Mexico/CMX-InDRE-13/2020						G	1.00	20A	North America	Mexico	North America	Mexico City	Human	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)	B.1.609	North America	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)		2020-03-21	Araiza-Rodriguez Adnan et al	[object Object]	56	Male
Zhejiang/OS6/2020						G	1.00	20A	Asia	China	Asia	Zhejiang	Human	Asia		B.1	Asia	Asia	Department of Microbiology		2020-03-24	Gao et al	[object Object]		
Guatemala/CDC-1227/2020						O	1.00	20A	North America	Guatemala	North America	Guatemala	Human	North America	Guatemala Ministry of Public Health	B.1	North America	North America	Pathogen Discovery, Respiratory Viruses Branch, Division of Viral Diseases, Centers for Disease Control and Prevention		2020-03-13	Ying Tao et al	[object Object]	27	Male
Bolivia/26955/2020						G	1.00	20A	South America	Bolivia	South America	Tarija	Human	South America	Centro Nacional de Enfermedades Tropicales (CENETROP)	B.1.600	South America	South America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-04-20	Paola Resende et al	[object Object]		
Spain/MD-IBV-004988/2020						G	2.00	20A	Spain	Spain	Spain	Madrid	Human		Hospital General Universitario Gregorio Marañón	B.1	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2020-06-11	Laura Pérez-Lago et al	[object Object]	32	Female
Spain/MD-HLP-90/2020						G	1.00	20A	Spain	Spain	Spain	Madrid	Human		Hospital Universitario La Paz	B.1	Europe	Europe	Hospital Universitario La Paz		2020-05-02	María Rodríguez et al	[object Object]	92	Male
Austria/CeMM1322/2020						G	1.00	20A	Austria	Austria	Austria	Vienna	Human		Center for Virology, Medical University of Vienna	B.1.224	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2020-04-30	Lukas Endler et al	[object Object]		Male
Russia/SAR-RARI-5473/2020	1.00	0.10	0.35	0.01	0.29	G	7.00	20A	Russia	Russia	Saratov	Saratov	Human		Mikrobiologie, RARI	B.1	Europe	Europe	Mikrobiologie, RARI		2020-08-11	Krasnov et al	[object Object]		
Lebanon/LAU-R136/2020						G	2.00	20A	Asia	Lebanon	Asia	Lebanon	Human	Asia	School of Pharmacy	B.1.398	Asia	Asia	School of Pharmacy		2020-10-01	Ahmed Kandeil et al	[object Object]		
Lebanon/LAU-R59/2020						G	2.00	20A	Asia	Lebanon	Asia	Lebanon	Human	Asia	School of Pharmacy	B.1.398	Asia	Asia	School of Pharmacy		2020-06-01	Ahmed Kandeil et al	[object Object]		
Hungary/SRC-01136/2020						G	1.00	20A	Hungary	Hungary	Hungary	Baranya County	Human		Virological Research Group, Szentágothai Research Centre	B.1	Europe	Europe	Bioinformatics Research Group, Szentágothai Research Centre		2020-04-02	Péter Urbán et al	[object Object]	27	Male
Russia/StPetersburg-RII8380S/2020						G	1.00	20A	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-04-22	Andrey Komissarov et al B (https://dx.doi.org/10.1101/2020.07.14.20150979)	[object Object]	54	Female
Colombia/GVI-157321/2020						G	1.00	20A	South America	Colombia	South America	Boyaca	Human	South America	Instituto Nacional de Salud, Bogotá, Colombia	B.1.420	South America	South America	Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia Instituto Nacional de Salud, Bogotá, Colombia Icahn School of Medicine at Mount Sinai, New York, USA		2020-06-22	Luz Helena Patiño et al	[object Object]	19	Female
Colombia/DC-C100/2020						G	1.00	20A	South America	Colombia	South America	Bogota	Human	South America	Centro de Estudio de Enfermedades Autoinmunes (CREA), Universidad del Rosario, Bogota, Colombia	B.1.420	South America	South America	Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia		2020-10-10	Juan-Manuel Anaya et al	[object Object]	54	Male
Romania/ROSV_12646/2020						G	1.00	20A	Romania	Romania	Romania	Suceava	Human		Emergency County Hospital Suceava	B.1.180	Europe	Europe	Stefan cel Mare, University Metagenomics lab		2020-06-10	Lobiuc Andrei et al.	[object Object]	80	Male
Romania/ROSV_12619/2020						G	1.00	20A	Romania	Romania	Romania	Suceava	Human		Suceava County Emergency Hospital	B.1.180	Europe	Europe	"Stefan cel Mare" University Metagenomics Lab		2020-06-09	Lobiuc Andrei et al	[object Object]	77	Male
USA/AZ-TG664533/2020						G	2.00	20A	North America	USA	North America	Arizona	Human	North America	Sonora Quest Laboratories, Laboratory Sciences of Arizona	B.1.243	North America	North America	TGen North		2020-04-20	Jolene Bowers et al	[object Object]		
SouthKorea/KCDC2660/2020						G	1.00	20A	Asia	South Korea	Asia	South Korea	Human	Asia	Center for Laboratory Control of Infectious Diseases, Korea Centers for Diseases Control and Prevention	B.1.243	Asia	Asia	Center for Laboratory Control of Infectious Diseases, Korea Centers for Diseases Control and Prevention		2020-05-16	Junyoung Kim et al	[object Object]	40	Male
Barbados/50397/2020						G	2.00	20A	North America	Barbados	North America	Barbados	Human	North America	Caribbean Public Health Agency	B.1.243	North America	North America	Carrington Lab, Department of PreClinical Sciences, Building 36, First Floor Biochemistry Unit, Faculty of Medical Sciences, The University of the West Indies		2020-12-24	Nikita S. D. Sahadeo et al	[object Object]		
SouthKorea/KDCA1359/2020						G	2.00	20A	Asia	USA	Asia	USA	Human	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency	B.1.243	Asia	North America	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency		2020-09-09	Ae Kyung Park et al	[object Object]	41	Male
Switzerland/ZH-ETHZ-230039/2020		0.01	0.01		0.02	G	2.00	20A	Switzerland	Switzerland	Switzerland	Zürich	Human		Viollier AG	B.1.236	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-08-04	Christian Beisel et al	[object Object]		
Russia/NGR-RII-MH14689S/2021						G	1.00	20A	Russia	Russia	Novgorod	Novgorod	Human	Veliky Novgorod	HELIX LLC	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]	66	Male
Switzerland/SH-ETHZ-331377/2020						G	1.00	20A	Switzerland	Switzerland	Switzerland	Schaffhausen	Human		Viollier AG	B.1	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-10-21	Christian Beisel et al	[object Object]		
Guatemala/33872/2020						G	1.00	20A	North America	Guatemala	North America	Guatemala	Human	North America	Laboratorio Nacional de Salud	B.1	North America	North America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-09-19	Paola Resende et al	[object Object]	36	
USA/MD-MDH-0515/2020						G	1.00	20A	North America	USA	North America	Maryland	Human	North America	Maryland Public Health Laboratory	B.1.240	North America	North America	Maryland Public Health Laboratory		2020-11-30	Maryland Department of Health Laboratories Administration et al	[object Object]		
Aruba/AW-RIVM-11740/2021						G	1.00	20A	South America	Aruba	South America	Aruba	Human	South America	Dutch COVID-19 response team	B.1.240.1	South America	South America	National Institute for Public Health and the Environment (RIVM)		2021-02-01	Adam Meijer et al	[object Object]		
Bahamas/33829/2020						G	1.00	20A	North America	Bahamas	North America	Bahamas	Human	North America	Reference Laboratory of the Ministry of Health	B.1.240	North America	North America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-09-03	Paola Resende et al	[object Object]		
Bahamas/33830/2020						G	1.00	20A	North America	Bahamas	North America	Bahamas	Human	North America	Reference Laboratory of the Ministry of Health	B.1.240	North America	North America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-09-02	Paola Resende et al	[object Object]		
Bahamas/33833/2020						G	1.00	20A	North America	Bahamas	North America	Bahamas	Human	North America	Reference Laboratory of the Ministry of Health	B.1.240	North America	North America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-10-19	Paola Resende et al	[object Object]		
Russia/StPetersburg-RII6061S/2020						G	1.00	20A	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-04-15	Andrey Komissarov et al B (https://dx.doi.org/10.1101/2020.07.14.20150979)	[object Object]	25	Male
Russia/Pskov-83602/2020						G	1.00	20A	Russia	Russia	Pskov Oblast	Pskov Oblast	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-25	Oleg V. Pyankov et al	[object Object]	57	Male
Hungary/MBL-469/2020						G	1.00	20A	Hungary	Hungary	Hungary	Balassagyarmat	Human		Virological Research Group, Szentágothai Research Centre	B.1	Europe	Europe	Bioinformatics Research Group, Szentágothai Research Centre		2020-03-27	Péter Urbán et al	[object Object]	36	Female
Russia/Omsk-89001/2020						G	1.00	20A	Russia	Russia	Omsk	Omsk	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-04-01	Sergey A. Bodnev et al	[object Object]	35	Female
Spain/GA-IBV-002757/2020						G	1.00	20A	Spain	Spain	Spain	Galicia	Human	Rianjo	Hospital Clínico Universitario de Santiago de Compostela	B.1	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2020-04-07	José Javier Costa Alcalde et al	[object Object]	86	Female
Guatemala/33880/2020						G	1.00	20A	North America	Guatemala	North America	Guatemala	Human	North America	Laboratorio Nacional de Salud	B.1	North America	North America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-10-08	Paola Resende et al	[object Object]	39	
Guatemala/33893/2020						G	1.00	20A	North America	Guatemala	North America	Guatemala	Human	North America	Laboratorio Nacional de Salud	B.1.189	North America	North America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-11-04	Paola Resende et al	[object Object]	7	
Spain/AR-IBV-98008080/2020						G	1.00	20A	Spain	Spain	Spain	Aragon	Human	Zaragoza ES	Servicio de Microbiología, Hospital Miguel Servet, Zaragoza	B.1.416.1	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2020-09-30	Antonio Rezusta López et al	[object Object]	57	Male
Gambia/4985/2021		0.01	0.05	0.05	0.06	G	2.00	20A	Africa	Gambia	Africa	Kombo	Human	Africa	MRCG at LSHTM Genomics lab	B.1.416	Africa	Africa	MRCG at LSHTM Genomics lab		2021-01-19	Abdul Karim sesay et al	[object Object]	19	Male
Gambia/GC19-3802/2020						G	2.00	20A	Africa	Gambia	Africa	Kombo	Human	Africa	MRCG at LSHTM Genomics lab	B.1.416	Africa	Africa	MRCG at LSHTM Genomics lab		2020-07-27	Abdul Karim sesay et al	[object Object]	36	Male
Senegal/SN-TH-TIV-0890/2020						G	1.00	20A	Africa	Senegal	Africa	Thies	Human	Africa	Institute for Health Research, Epidemiological Surveillance and Training (IRESSEF)	B.1.416	Africa	Africa	Abbott Laboratories		2020-07-01	Souleymane Mboup et al	[object Object]	40	Male
Gambia/14228/2021						G	1.00	20A	Africa	Gambia	Africa	Kombo	Human	Africa	MRCG at LSHTM Genomics lab	B.1.416	Africa	Africa	MRCG at LSHTM Genomics lab		2021-02-19	Abdul Karim sesay et al	[object Object]	19	Male
Switzerland/UR-ETHZ-130001/2020						G	1.00	20A	Switzerland	Switzerland	Switzerland	Uri	Human		Viollier AG	B.1	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-05-05	Christian Beisel et al	[object Object]		
EquatorialGuinea/46787/2020						G	1.00	20A	Africa	Equatorial Guinea	Africa	Litoral	Human	Africa	Laboratorio de Investigaciones de Baney	B.1.192	Africa	Africa	University Hospital Basel, Clinical Bacteriology		2020-08-02	Carlos Cortes et al	[object Object]	34	Male
EquatorialGuinea/28098/2020						G	1.00	20A	Africa	Equatorial Guinea	Africa	Bioko Norte	Human	Africa	Laboratorio de Investigaciones de Baney	B.1.192	Africa	Africa	University Hospital Basel, Clinical Bacteriology		2020-06-29	Carlos Cortes et al	[object Object]	19	Female
EquatorialGuinea/50236/2020						G	1.00	20A	Africa	Equatorial Guinea	Africa	Bioko Norte	Human	Africa	Laboratorio de Investigaciones de Baney	B.1.192	Africa	Africa	University Hospital Basel, Clinical Bacteriology		2020-08-14	Carlos Cortes et al	[object Object]	30	Male
EquatorialGuinea/47001/2020						G	1.00	20A	Africa	Equatorial Guinea	Africa	Bioko Norte	Human	Africa	Laboratorio de Investigaciones de Baney	B.1	Africa	Africa	"Swiss Tropical and Public Health Institute"		2020-08-04	"Carlos Cortes et al	[object Object]	4	Female
EquatorialGuinea/67342/2020						G	1.00	20A	Africa	Equatorial Guinea	Africa	Equatorial Guinea	Human	Africa	Laboratorio de Investigaciones de Baney	B.1.192	Africa	Africa	Swiss Tropical and Public Health Institute		2020-11-04	Salome Hosch et al	[object Object]		
EquatorialGuinea/49973/2020						G	1.00	20A	Africa	Equatorial Guinea	Africa	Litoral	Human	Africa	Laboratorio de Investigaciones de Baney	B.1.192	Africa	Africa	"Swiss Tropical and Public Health Institute"		2020-08-13	"Carlos Cortes et al	[object Object]	85	Female
EquatorialGuinea/25536/2020						G	1.00	20A	Africa	Equatorial Guinea	Africa	Bioko Norte	Human	Africa	Laboratorio de Investigaciones de Baney	B.1.192	Africa	Africa	University Hospital Basel, Clinical Bacteriology		2020-06-25	Carlos Cortes et al	[object Object]	58	Male
Netherlands/Friesland_6/2020						G	1.00	20A	Netherlands	Netherlands	Netherlands	Friesland	Human		Dutch COVID-19 response team	B.1.190	Europe	Europe	Erasmus Medical Center		2020-03-28	Bas Oude Munnink et al	[object Object]		
Norway/2415/2020						G	1.00	20A	Norway	Norway	Norway	Vestland	Human		Foerde Hospital, Department of Microbiology	B.1.610	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2020-04-03	Kathrine Stene-Johansen et al	[object Object]		
Peru/LIM-INS-335/2020						G	1.00	20A	South America	Peru	South America	Lima	Human	South America	Laboratorio de Referencia Nacional de Virus Respiratorio. Instituto Nacional de Salud Perú	B.1.610	South America	South America	Laboratorio de Referencia Nacional de Enteropatógenos. Instituto Nacional de Salud del Perú		2020-03-16	Ronnie Gavilan Chavez et al	[object Object]		
Colombia/VAC-GVI-97223/2020						G	1.00	20A	South America	Colombia	South America	Valle del Cauca	Human	South America	Instituto Nacional de Salud, Bogotá, Colombia	B.1	South America	South America	Grupo de Investigaciones Microbiológicas-UR (GIMUR), Departamento de Biología, Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia Instituto Nacional de Salud, Bogotá, Colombia Icahn School of Medicine at Mount Sinai, New York, USA		2020-04-06	Juan David Ramírez et al (https://www.medrxiv.org/content/10.1101/2020.06.11.20125799v1)	[object Object]	39	Female
France/NAQ-SC597/2020						G	2.00	20A	France	France	France	Nouvelle-Aquitaine	Human	Poitiers	CHU Poitiers	B.1	Europe	Europe	CNR Virus des Infections Respiratoires - France SUD		2020-05-12	Antonin Bal et al	[object Object]		Female
Poland/PL_MCB_1/2020						G	1.00	20A	Poland	Poland	Poland	Poland	Human		Human Genome Variation Research Group, Malopolska Centre of Biotechnology	B.1.187	Europe	Europe	Human Genome Variation Research Group, Malopolska Centre of Biotechnology		2020-04-23	Kowalski et al	[object Object]		
Turkey/IST-GLAB-323/2020						G	1.00	20A	Turkey	Turkey	Turkey	Istanbul	Human		Genomic Laboratory (GLAB) (Conjoint lab of Health Directorate of Istanbul and Istanbul Technical University)	B.1	Europe	Europe	Genomic Laboratory (GLAB), Istanbul Technical University		2020-06-23	Ilker Karacan et al	[object Object]	59	Male
France/CVL-IPP03587/2021	1.00	0.01	0.01	0.02	0.03	G	2.00	20A	France	France	France	Centre-Val de Loire	Human	Tours	Hopital	B.1.258	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2021-02-01	Marion Barbet et al	[object Object]	85	
Romania/Constanta_423037/2021	1.00	0.01	0.01	0.02	0.03	G	2.00	20A	Romania	Romania	Romania	Constanta	Human		Laboratory for Respiratory Viruses, Cantacuzino National Military-Medical Institute for Research and Development	B.1.258.3	Europe	Europe	Cantacuzino Institute Virology		2021-02-11	Luiza Ustea et al	[object Object]	17	Male
Ireland/WX-NVRL-71IRL95961/2020	1.00	0.01	0.01	0.02	0.03	G	2.00	20A	Ireland	Ireland	Ireland	Wexford	Human		National Virus Reference Laboratory	B.1.258.2	Europe	Europe	National Virus Reference Laboratory		2020-07-31	Michael Carr et al	[object Object]		Female
Ireland/WH-NVRL-73IRL31042/2020	1.00	0.01	0.01	0.02	0.03	G	2.00	20A	Ireland	Ireland	Ireland	Westmeath	Human		National Virus Reference Laboratory	B.1.258.2	Europe	Europe	National Virus Reference Laboratory		2020-09-07	Michael Carr et al	[object Object]		Male
NorthMacedonia/ZMC-37582/2020	1.00	0.01	0.01	0.02	0.03	G	2.00	20A	North Macedonia	North Macedonia	North Macedonia	North Macedonia	Human		Laboratory of Genetics and Personalized Medicine, Zan Mitrev Clinic	B.1.258	Europe	Europe	Laboratory of Genetics and Personalized Medicine, Zan Mitrev Clinic		2020-11-18	Kungulovski G. et al.	[object Object]	24	Male
Italy/TAA-1900444866/2021	1.00	0.01	0.01	0.02	0.03	G	3.00	20A	Italy	Italy	Italy	Trentino-Alto Adige	Human	Autonomous Province of Bolzano	Azienda Sanitaria dell’Alto Adige Laboratorio Aziendale di Microbiologia e Virologia	B.1.258	Europe	Europe	Istituto di Genomica Applicata		2021-01-24	Elisabetta Pagani et al	[object Object]	14	Female
Sweden/2A37418130099/2021	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	Sweden	Sweden	Sweden	Norrbotten	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.258.22	Europe	Europe	The Public Health Agency of Sweden		2021-03-03	Maximilian Riess et al	[object Object]		
Hungary/US-32620w/2020	1.00	0.01	0.01	0.02	0.03	G	3.00	20A	Hungary	Hungary	Hungary	Bács-Kiskun County	Human		University of Szeged, Institute of Clinical Microbiology	B.1.258	Europe	Europe	National Laboratory of Virology, Szentágothai Research Centre		2020-09-02	Endre Gábor Tóth et al	[object Object]	55	Female
Croatia/HRV000_266/2021	1.00	0.01	0.01	0.02	0.05	G	4.00	20A	Croatia	Croatia	Croatia	Sibenik-Knin County	Human		Public Health Institute of Šibenik-Knin County	B.1.258	Europe	Europe	Croatian Institute of Public Health		2021-01-12	Irena Tabain et al	[object Object]	34	Male
Switzerland/BL-ETHZ-260075/2020	1.00	0.01	0.01	0.02	0.03	G	3.00	20A	Switzerland	Switzerland	Switzerland	Basel-Land	Human		Viollier AG	B.1.258	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-08-25	Christian Beisel et al	[object Object]		
Slovenia/5C-006202-KP/2021	1.00	0.01	0.01	0.02	0.03	G	3.00	20A	Slovenia	Slovenia	Slovenia	Obalnokraska	Human		National Laboratory for Health, Environment and Food	B.1.258	Europe	Europe	CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-01-27	Jernej Kovač et al	[object Object]	70	Female
Croatia/1948/2021	1.00	0.01	0.01	0.02	0.03	GR	3.00	20A	Croatia	Croatia	Croatia	Primorje-Gorski Kotar County	Human		Clinical Hospital Center Rijeka	B.1.1	Europe	Europe	Croatian Institute of Public Health		2021-01-20	Irena Tabain et al	[object Object]	60	Male
Sweden/20-53817/2020	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	Sweden	Sweden	Sweden	Varmland	Human		Laboratoriemedicin, Klinisk mikrobiologi	B.1.258	Europe	Europe	The Public Health Agency of Sweden		2020-12-22	Department of Microbiology et al	[object Object]	53	Female
Croatia/1151/2021	1.00	0.01	0.01	0.02	0.03	G	3.00	20A	Croatia	Croatia	Croatia	Croatia	Human		Uversity hospital Dubrava	B.1.258	Europe	Europe	Croatian Institute of Public Health		2021-02-27	Irena Tabain et al	[object Object]	71	Female
Liechtenstein/UHB-4176656001/2020	1.00	0.01	0.01	0.02	0.03	G	3.00	20A	Liechtenstein	Liechtenstein	Liechtenstein	Eschen	Human		Labormedizinisches Zentrum Dr Risch	B.1.258	Europe	Europe	University Hospital Basel, Clinical Bacteriology		2020-12-31	Tim Roloff et al	[object Object]		Male
CzechRepublic/NRL_9179-1/2020	1.00	0.01	0.01	0.02	0.03	G	3.00	20A	Czech Republic	Czech Republic	Czech Republic	Liberec Region	Human	Kolin	The National Institute of Public Health	B.1.258	Europe	Europe	State Veterinary Institute Prague		2020-09-19	Nagy et al	[object Object]	19	Male
Iceland/3057/2021	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	Iceland	Iceland	Iceland	Reykjavik	Human		deCODE genetics	B.1.258	Europe	Europe	deCODE genetics		2021-01-03	Daniel F Gudbjartsson et al	[object Object]	23	Female
Belgium/ULG-11890/2020	1.00	0.01	0.01	0.02	0.03	G	3.00	20A	Belgium	Belgium	Belgium	Namur	Human	Boignée	University of Liège COVID-19 testing center	B.1.258	Europe	Europe	GIGA Medical Genomics		2020-11-12	Keith Durkin et al	[object Object]	59	Male
Austria/CeMM1784/2020	1.00	0.01	0.01	0.02	0.03	G	3.00	20A	Austria	Austria	Austria	Austria	Human		Austrian Agency for Health and Food Safety (AGES)	B.1.258	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2020-12-03	Lukas Endler et al	[object Object]	53	
Belgium/ULG-11924/2020	1.00	0.01	0.01	0.02	0.03	G	3.00	20A	Belgium	Belgium	Belgium	Aalst	Human	Denderleeuw	University of Liège COVID-19 testing center	B.1.258	Europe	Europe	GIGA Medical Genomics		2020-10-27	Keith Durkin et al	[object Object]	47	Female
France/BRE-IPP03973/2021	1.00	0.01	0.01	0.02	0.03	G	3.00	20A	France	France	France	Bretagne	Human	Brest	Hopital	B.1.258	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2021-01-18	Marion Barbet et al	[object Object]		
Slovenia/MB08-26497/2021	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	Slovenia	Slovenia	Slovenia	Podravska	Human		National Laboratory for Health, Environment and Food	B.1.258.17	Europe	Europe	CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-01-26	Jernej Kovač et al	[object Object]	56	Male
Italy/FVG-Salus_TS-4/2021	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	Italy	Italy	Italy	Friuli Venezia Giulia	Human	Trieste	SC (UCO) Igiene e Sanità Pubblica (funzione integrata con SC Microbiologia e Virologia) e Laboratory of Molecular Virology of the International Centre for Genetic Engineering and Biotechnology (ICGEB)	B.1.258.24	Europe	Europe	ARGO Laboratorio Genomica ed Epigenomica		2021-02-04	Licastro D et al	[object Object]	56	Female
Italy/FVG-ASUGI-10-run7/2021	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	Italy	Italy	Italy	Friuli Venezia Giulia	Human	Trieste	SC (UCO) Igiene e Sanità Pubblica (funzione integrata con SC Microbiologia e Virologia) e Az. Ospedaliero-Universitaria Udine	B.1.258.17	Europe	Europe	ARGO Laboratorio Genomica ed Epigenomica		2021-03-23	Licastro D et al	[object Object]	64	Female
Slovenia/90-025527-NM/2021	1.00	0.01	0.01	0.02	0.03	G	5.00	20A	Slovenia	Slovenia	Slovenia	Jugovzhodna	Human		National Laboratory for Health, Environment and Food, OMM, Novo mesto	B.1.258.17	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-05-20	Sandra Janezic et al	[object Object]	36	Male
Russia/KAM-CRIE-L188K0775u/2021	1.00	0.01	0.01	0.02	0.03	O	3.00	20A	Russia	Russia	Kamchatka Krai	Kamchatka Krai	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.258.17	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-10	Samoilov AE et al	[object Object]	28	Male
Slovenia/90-008191-NM/2021	1.00	0.01	0.01	0.02	0.06	G	5.00	20A	Slovenia	Slovenia	Slovenia	Posavska	Human		National Laboratory for Health, Environment and Food, OMM, Novo mesto	B.1.258.17	Europe	Europe	CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-02-17	Jernej Kovač et al	[object Object]	29	Male
Norway/08365/2021	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	Norway	Norway	Norway	Viken	Human		Ostfold Hospital Trust - Kalnes, Centre for Laboratory Medicine, Section for gene technology and infection serology	B.1.258.17	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-03-27	Kathrine Stene-Johansen et al	[object Object]		
Slovenia/5C-023234-KP/2021	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	Slovenia	Slovenia	Slovenia	Primorskonotranjska	Human		National Laboratory for Health, Environment and Food, OMM, Koper	B.1.258.17	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-04-22	Sandra Janezic et al	[object Object]	42	Female
Sweden/SE00227183/2021	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	Sweden	Sweden	Sweden	Vastmanland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.258.17	Europe	Europe	The Public Health Agency of Sweden		2021-02-08	Swedish national genomic surveillance program of SARS-CoV-2 et al	[object Object]		
Sweden/3923132364/2021	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	Sweden	Sweden	Sweden	Sormland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.258.17	Europe	Europe	The Public Health Agency of Sweden		2021-02-19	Swedish national genomic surveillance program of SARS-CoV-2 et al	[object Object]		
Liechtenstein/UHB-4168696501/2020	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	Liechtenstein	Liechtenstein	Liechtenstein	Mauren	Human		Labormedizinisches Zentrum Dr Risch	B.1.258.17	Europe	Europe	University Hospital Basel, Clinical Bacteriology		2020-11-16	Tim Roloff et al	[object Object]		Male
Switzerland/FR-ETHZ-490629/2021	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	Switzerland	Switzerland	Switzerland	Fribourg	Human		Viollier AG	B.1.258.17	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-02-09	Chaoran Chen et al	[object Object]		
Austria/CeMM4771/2021	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	Austria	Austria	Austria	Carinthia	Human	Villach-Land	ILV Kärnten	B.1.258.17	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-02-15	Lukas Endler et al	[object Object]	39	Female
Austria/CeMM5521/2021	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	Austria	Austria	Austria	Upper Austria	Human	Wels-Stadt	Klinikum Wels-Grieskirchen	B.1.258.17	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-03-06	Lukas Endler et al	[object Object]	56	Male
Austria/CeMM5545/2021	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	Austria	Austria	Austria	Upper Austria	Human	Wels-Stadt	Klinikum Wels-Grieskirchen	B.1.258.17	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-03-07	Lukas Endler et al	[object Object]	51	Male
Serbia/Belgrade-6014890803/2021	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	Serbia	Serbia	Serbia	Belgrade	Human		Institute of Virology, Vaccines and Sera "Torlak"	B.1.258.17	Europe	Europe	Institute of microbiology and Immunology, Faculty of Medicine, University of Belgrade		2021-03-08	Knezevic et al	[object Object]		
NorthMacedonia/33607/2021	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	North Macedonia	North Macedonia	North Macedonia	Southeastern Region	Human	Strumica	General Hospital - Strumica	B.1.258.17	Europe	Europe	Research Center for Genetic Engineering and Biotechnology "Georgi D. Efremov” , Macedonian Academy of Sciences and Arts		2021-02-05	Aleksandar J. Dimovski et al	[object Object]	82	Male
NorthMacedonia/33952/2021	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	North Macedonia	North Macedonia	North Macedonia	Eastern Region MK	Human	Shtip	General Hospital - Shtip	B.1.258.17	Europe	Europe	Research Center for Genetic Engineering and Biotechnology "Georgi D. Efremov” , Macedonian Academy of Sciences and Arts		2021-02-08	Aleksandar J. Dimovski et al	[object Object]	62	Male
NorthMacedonia/8969/2021	1.00	0.01	0.01	0.02	0.03	G	4.00	20A	North Macedonia	North Macedonia	North Macedonia	Kavadarci	Human		Laboratory of virology and molecular diagnostics	B.1.258.17	Europe	Europe	Laboratory of virology and molecular diagnostics		2021-02-08	Kuzmanovska Maja et al	[object Object]	25	Male
Egypt/MASRI-025/2020						GH	1.00	20A	Africa	Egypt	Africa	Egypt	Human	Africa	Medical Ain Shams Research Institute (MASRI), Ain Shams University	B.1	Africa	Africa	Medical Ain Shams Research Institute (MASRI), Ain Shams University		2020-05-10	Hesham Elghazaly et al	[object Object]	39	Female
DominicanRepublic/ICGEB_UNIBE051/2020						GH	1.00	20A	North America	Dominican Republic	North America	Dominican Republic	Human	North America	Universidad Iberoamericana, Instituto de Medicina Tropical & Salud Global	B.1	North America	North America	International Centre for Genetic Engineering and Biotechnology (ICGEB) and ARGO Open Lab Platform		2020-03-01	Robert Paulino-Ramirez et al	[object Object]		Female
Russia/StPetersburg-RII3524VR4/2020						GH	1.00	20A	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-03-15	Andrey Komissarov et al A	[object Object]		
Nigeria/OS589-CV46/2020		0.01	0.01		0.01	GH	3.00	20A	Africa	Nigeria	Africa	Osun State	Human	Africa	Nigeria Centre for Disease Control (NCDC)	B.1.22	Africa	Africa	African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria		2020-05-29	Oluniyi P.E. et al A (https://virological.org/t/new-sars-cov-2-genomes-from-nigeria-reveals-dominance-of-viruses-with-spike-protein-mutation-d614g-and-additional-virus-lineages-in-circulation/527)	[object Object]		
Netherlands/Gelderland_83/2020						GH	1.00	20A	Netherlands	Netherlands	Netherlands	Gelderland	Human		Dutch COVID-19 response team	B.1.22	Europe	Europe	Erasmus Medical Center		2020-05-19	Bas Oude Munnink et al	[object Object]		
Germany/HB-hpi-p1695/2020						GH	1.00	20A	Germany	Germany	Germany	Bremen	Human		University Medical Center Hamburg Eppendorf	B.1.22	Europe	Europe	Heinrich Pette Institute, Leibniz Institute for Experimental Virology		2020-03-18	Alexis Robitaille et al	[object Object]		
Germany/HH-HPI-p2847/2020						O	1.00	20A	Germany	Germany	Germany	Hamburg	Human		University Medical Center Hamburg Eppendorf	B.1.22	Europe	Europe	Heinrich Pette Institute, Leibniz Institute for Experimental Virology		2020-10-01	Alexis Robitaille et al	[object Object]		
Curacao/CW-RIVM-21704/2020						GH	1.00	20A	South America	Curacao	South America	Curacao	Human	South America	Dutch COVID-19 response team	B.1.22.1	South America	South America	National Institute for Public Health and the Environment (RIVM)		2020-10-13	Adam Meijer et al	[object Object]	65	
Curacao/CW-RIVM-21713/2020						GH	1.00	20A	South America	Curacao	South America	Curacao	Human	South America	Dutch COVID-19 response team	B.1.22.1	South America	South America	National Institute for Public Health and the Environment (RIVM)		2020-12-18	Adam Meijer et al	[object Object]	92	
Curacao/CW-RIVM-21734/2020						GH	1.00	20A	South America	Curacao	South America	Curacao	Human	South America	Dutch COVID-19 response team	B.1.22.1	South America	South America	National Institute for Public Health and the Environment (RIVM)		2020-12-26	Adam Meijer et al	[object Object]	72	
Curacao/CW-RIVM-28001/2021						GH	1.00	20A	South America	Curacao	South America	Curacao	Human	South America	Dutch COVID-19 response team	B.1	South America	South America	National Institute for Public Health and the Environment (RIVM)		2021-01-07	Adam Meijer et al	[object Object]	66	
Ethiopia/ICGEB-S14/2021	1.00	0.01	0.01	0.02	0.03	GH	2.00	20A	Africa	Ethiopia	Africa	Addis Ababa	Human	Africa	Ethiopian Biotechnology Institute (EBTI)	B.1.480	Africa	Africa	International Centre for Genetic Engineering and Biotechnology (ICGEB) and ARGO Open Lab for Genome Sequencing		2021-02-04	Molalegne Bitew et al	[object Object]	30	Male
Guadeloupe/IPP06246/2021		0.01	0.01		0.02	GH	5.00	20A	North America	Guadeloupe	North America	Les Abymes	Human	North America	Outre mer	B.1	North America	North America	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2021-02-26	Marion Barbet et al	[object Object]	39	Male
Russia/CHU-CRIE-L188C0577b/2021						O	2.00	20A	Russia	Russia	Сhukotka Region	Сhukotka Region	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-30	Samojlov A.E. et al	[object Object]	17	Female
Russia/CHU-CRIE-L188C0573b/2021						GR	5.00	20A	Russia	Russia	Сhukotka Region	Сhukotka Region	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.291	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-02	Samojlov A.E. et al	[object Object]	67	Female
Russia/CHU-CRIE-L188C0575b/2021						GR	4.00	20A	Russia	Russia	Сhukotka Region	Сhukotka Region	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-02	Samojlov A.E. et al	[object Object]	57	Male
SriLanka/CK89939/2021						O	2.00	20A	Asia	Sri Lanka	Asia	Colombo	Human	Asia	Centre for Dengue Research and AICBU, Department of Immunology and Molecular Medicine	B.1.411	Asia	Asia	Centre for Dengue Research and AICBU, Department of Immunology and Molecular Medicine		2021-02-03	Chandima Jeewandara et al B	[object Object]	30	Male
SriLanka/cov3563/2020						GH	1.00	20A	Asia	Sri Lanka	Asia	Colombo	Human	Asia	Centre for Dengue Research, Department of Immunology and Molecular Medicine	B.1.411	Asia	Asia	Centre for Dengue Research, Department of Immunology and Molecular Medicine		2020-11-02	Chandima Jeewandara et al B	[object Object]	43	Male
SriLanka/NP47/2020						O	1.00	20A	Asia	Sri Lanka	Asia	Western Province	Human	Asia	Centre for Dengue Research and AICBU, Department of Immunology and Molecular Medicine	B.1.411	Asia	Asia	Centre for Dengue Research and AICBU, Department of Immunology and Molecular Medicine		2020-12-30	Chandima Jeewandara et al B	[object Object]		Male
Germany/TH-IIMK-CaSe-6/2020						GH	1.00	20A	Germany	Germany	Germany	Thuringia	Human		Jena University Hospital, Institute for Infectious Diseases and Infection Control	B.1.22	Europe	Europe	Institute of infectious medicine & hospital hygiene, CaSe-Group		2020-05-19	Spott et al	[object Object]		
Botswana/R8B59_BHP_AAA23108/2020						G	1.00	20A	Africa	Botswana	Africa	Gaborone	Human	Africa	Botswana Harvard HIV Reference Laboratory	B.1	Africa	Africa	Botswana Harvard HIV Reference Laboratory		2020-09-25	Sikhulile Dorcas Maruapula et al	[object Object]	25	Female
Aruba/AW-RIVM-10115/2020						GH	1.00	20A	South America	Aruba	South America	Aruba	Human	South America	Dutch COVID-19 response team	B.1	South America	South America	National Institute for Public Health and the Environment (RIVM)		2020-03-20	Adam Meijer et al	[object Object]	31	Female
Congo/UKT-015/2020						GH	1.00	20A	Africa	Republic of the Congo	Africa	Brazzaville	Human	Africa	Fondation Congolaise pour la recherche medicale (FCRM)	B.1.544	Africa	Africa	NGS Competence Center Tübingen, Institut für Medizinische Mikrobiologie und Hygiene, Universitätsklinikum Tübingen		2020-06-25	Angel Angelov et al	[object Object]		
Bahamas/33827/2020						GH	1.00	20A	North America	Bahamas	North America	Bahamas	Human	North America	Reference Laboratory of the Ministry of Health	B.1	North America	North America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-08-03	Paola Resende et al	[object Object]		
Russia/Khabarovsk-71403/2020						GH	1.00	20A	Russia	Russia	Khabarovsk	Khabarovsk	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-19	Sergey A. Bodnev et al	[object Object]	52	Female
Ethiopia/39650/2020						O	1.00	20A	Africa	Ethiopia	Africa	Addis Ababa	Human	Africa	HIV Molecular Laboratory, Ethiopian Public Health Institute, Ethiopia	B.1	Africa	Africa	HIV molecular lab, Ethiopian Public Health Institute, Ethiopian		2020-11-16	Weldemariam et al	[object Object]	31	Male
Ethiopia/ICGEB-S15/2021						GH	2.00	20A	Africa	Ethiopia	Africa	Addis Ababa	Human	Africa	Ethiopian Biotechnology Institute (EBTI)	B.1	Africa	Africa	International Centre for Genetic Engineering and Biotechnology (ICGEB) and ARGO Open Lab for Genome Sequencing		2021-05-01	Molalegne Bitew et al	[object Object]	24	Female
Congo/UKT-002/2020						GH	1.00	20A	Africa	Republic of the Congo	Africa	Brazzaville	Human	Africa	Fondation Congolaise pour la recherche medicale (FCRM)	B.1.277	Africa	Africa	NGS Competence Center Tübingen, Institut für Medizinische Mikrobiologie und Hygiene, Universitätsklinikum Tübingen		2020-07-04	Angel Angelov et al	[object Object]	27	Female
France/IDF_HB_112004049802/2020						GH	1.00	20A	France	France	France	Ile de France	Human		Hôpital Bichat Claude Bernard, Laboratoire de Virologie	B.1	Europe	Europe	IAME UMR1137 Inserm, Université de Paris, Hôpital Bichat		2020-04-10	Antoine Bridier-Nahmias et al	[object Object]		
Bermuda/51482/2020						GH	1.00	20A	South America	Bermuda	South America	Bermuda	Human	South America	The Caribbean Public Health Agency	B.1	South America	South America	Carrington Lab, Department of PreClinical Sciences, Faculty of Medical Sciences, The University of the West Indies		2020-12-19	Nikita S. D. Sahadeo et al	[object Object]		
Malta/BAL-Sliema-9/2020						GH	1.00	20A	Malta	Malta	Malta	Malta	Human		Laboratory, The Bio Arte Limited	B.1.389	Europe	Europe	Laboratory, The Bio Arte Limited		2020-09-07	Biazzo et al	[object Object]		
Ireland/KK-NVRL-73IRL21709/2020						GH	1.00	20A	Ireland	Ireland	Ireland	Kilkenny	Human		National Virus Reference Laboratory	B.1	Europe	Europe	National Virus Reference Laboratory		2020-09-04	Michael Carr et al	[object Object]		Female
France/PAC-IHU-0817/2020						GH	1.00	20A	France	France	France	Provence-Alpes-Côte d'Azur	Human	Marseille	MEPHI, Aix Marseille University	B.1	Europe	Europe	MEPHI, Aix Marseille University		2020-05-05	Anthony LEVASSEUR et al	[object Object]		
Norway/CS-23/2020						GH	1.00	20A	Norway	Norway	Norway	Viken	Human		Dept. of Microbiology and Infection Control, Akershus University Hospital HF	B.1	Europe	Europe	Dept. of Microbiology and Infection Control, Akershus University Hospital HF		2020-05-04	Hege Vangstein Aamot et al	[object Object]		
Bahrain/340564387_S8_L001/2020						GH	1.00	20A	Asia	Bahrain	Asia	Bahrain	Human	Asia	Communicable Disease Laboratory, Public Health Directorate	B.1.281	Asia	Asia	Communicable Disease Laboratory, Public Health Directorate		2020-08-25	AlWasti et al	[object Object]		
Turkey/HSGM-4706/2020						GH	1.00	20A	Turkey	France	Turkey	France	Human		Ministry of Health Turkey	B.1	Europe	Europe	Ministry of Health Turkey		2020-03-17	Fatma Bayrakdar et al A (https://dx.doi.org/10.1101/2020.05.15.095794)	[object Object]	72	Male
Belgium/rega-0611919/2020						GH	1.00	20A	Belgium	Belgium	Belgium	Halle-Vilvoorde	Human	Overijse	UZ Leuven, National Reference Laboratory for Coronaviruses, Laboratory Medicine, Leuven, Belgium	B.1	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-06-11	Tony Wawina-Bokalanga et al	[object Object]	41	Male
Pakistan/NIH-80/2020						GH	1.00	20A	Asia	Pakistan	Asia	Islamabad	Human	Asia	Department of Virology	B.1	Asia	Asia	Department of Virology		2020-07-07	Massab Umair et al	[object Object]	17	Male
Italy/MAR-UnivPM21_49798/2020						GH	1.00	20A	Italy	Italy	Italy	Marche	Human		Virology Laboratory, Department of Biomedical Sciences and Public Health, University Politecnica delle Marche	B.1	Europe	Europe	Virology and Legal Medicine Laboratories, Department of Biomedical Sciences and Public Health, University Politecnica delle Marche		2020-06-17	Sara Caucci et al	[object Object]	38	Male
Russia/PEN-RARI-953/2020						GH	1.00	20A	Russia	Russia	Penza	Penza	Human		Mikrobiologie, RARI	B.1	Europe	Europe	Mikrobiologie, RARI		2020-04-08	Krasnov et al	[object Object]		
DRC/81/2020						GH	1.00	20A	Africa	Democratic Republic of the Congo	Africa	Kinshasa	Human	Africa	Viral Respiratory Lab, National Institute for Biomedical Research (INRB)	B.1.9.5	Africa	Africa	Pathogen Sequencing Lab, National Institute for Biomedical Research (INRB)		2020-03-18	Placide Mbala-Kingebeni et al B (https://virological.org/t/phylogenetic-analysis-of-sars-cov-2-in-drc/528)	[object Object]		Male
Turkey/Istanbul-BezmCoV1/2020						GH	1.00	20A	Turkey	Turkey	Turkey	Istanbul	Human		Bezmialem Vakif University, Dept Microbiology, Medical School, Fatih, Istanbul, Turkey	B.1.9.5	Europe	Europe	Bezmialem Vakif University, Medical School & Beykoz Institute of Life Sciences & Biotechnology		2020-03-24	Mehmet Z. Doymaz et al	[object Object]	2	Female
Turkey/KU-004/2020						GH	1.00	20A	Turkey	Turkey	Turkey	Kars Province	Human		Kafkas University, Faculty of Medicine, Department of Medical Microbiology	B.1.9.5	Europe	Europe	Kafkas University, Faculty of Medicine, Department of Medical Microbiology		2020-05-01	Murat Karamese et al	[object Object]	35	Male
USA/VA-DCLS-0489/2020						GH	1.00	20A	North America	USA	North America	Virginia	Human	North America	Virginia DCLS	B.1.9.2	North America	North America	Virginia DCLS		2020-05-12	Virginia DCLS et al	[object Object]		
Kashgar/IVDC-01-01/2020						GH	1.00	20A	Asia	China	Asia	Xinjiang	Human	Asia	National Institute for Viral Disease Control and Prevention, China CDC	B.1.9	Asia	Asia	National Institute for Viral Disease Control and Prevention, China CDC		2020-10-30	Xiang Zhao et al	[object Object]	26	Female
Turkey/CTF_14062020_054/2020						O		20A	Turkey	Turkey	Turkey	Marmara	Human		IU-Cerrahpasa, Cerrahpasa School of Medicine, COVID-19 Lab	B.1.9	Europe	Europe	IU-Cerrahpasa, Cerrahpasa School of Medicine, COVID-19 Lab		2020-06-14	Mert Kuskucu et al	[object Object]		
Serbia/Titel-059642304/2020						GH	1.00	20A	Serbia	Serbia	Serbia	South Bačka District	Human	Titel	Scientific Veterinary Institute Novi Sad	B.1	Europe	Europe	Veterinary Specialized Institute "Kraljevo", Serbia		2020-04-22	Vidanovic et al	[object Object]		
Russia/KGD-RII-MH7195S/2020						GH	1.00	20A	Russia	Russia	Kaliningrad Region	Kaliningrad Region	Human	Kaliningrad	WHO National Influenza Centre Russian Federation	B.1.164	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-30	Andrey Komissarov et al A	[object Object]	44	Male
Canada/ABPHL-03419/2021						GH	4.00	20A	North America	Canada	North America	Alberta	Human	North America	Alberta Precision Labs (APL)	B.1	North America	North America	Public Health Agency of Canada (PHAC) National Microbiology Laboratory		2021-02-01	Buss et al	[object Object]		
Canada/Qc-LSPQ-L00232710/2020						GH	1.00	20A	North America	Canada	North America	Quebec	Human	North America	Centre de SSS D'Arthabaska-et-de-l'érable - Hôtel-Dieu	B.1	North America	North America	Laboratoire de santé publique du Québec		2020-03-22	Sandrine Moreira et al	[object Object]	57	Male
USA/DE-DHSS-F956562/2020						GH	1.00	20A	North America	USA	North America	Delaware	Human	North America	Delaware Public Health Laboratory	B.1.439	North America	North America	Delaware Public Health Laboratory		2020-05-27	Gregory Hovan et al	[object Object]		
Bulgaria/21BG-NC_A000076/2020						GH	1.00	20A	Bulgaria	Bulgaria	Bulgaria	Pazardzhik	Human		National Center of Infectious and Parasitic Diseases	B.1	Europe	Europe	National Center of Infectious and Parasitic Diseases		2020-11-25	Alexiev et al	[object Object]	79	Female
India/UP-NBRI-N40-TCQ729/2020						GH	1.00	20A	Asia	India	Asia	Uttar Pradesh	Human	Asia	King Georges Medical University	B.1	Asia	Asia	CSIR-National Botanical Research Institute		2020-03-28	Priti Prasad et al	[object Object]	54	Male
Kuwait/SKS00111-JAH/2020						GH	1.00	20A	Asia	Kuwait	Asia	Al Asimah	Human	Asia	MOH - Jaber Al-Ahmad Hospital (Innovation Research Laboratory)	B.1.441	Asia	Asia	MOH - Jaber Al-Ahmad Hospital (Innovation Research Laboratory)		2020-12-26	Salman Al-Sabah et al	[object Object]		
Serbia/Sabac-000202104/2020						GH	1.00	20A	Serbia	Serbia	Serbia	Sabac	Human		Veterinary Specialized Instute "Nis"	B.1	Europe	Europe	Veterinary Specialized Institute "Sabac", Serbia		2020-04-20	Vidanovic et al	[object Object]		
Venezuela/20MZ/2020						GH	1.00	20A	South America	Venezuela	South America	Zulia	Human	South America	INHRR	B.1.111	South America	South America	Laboratorio de Virología Molecular		2020-05-25	Loureiro CL et al	[object Object]		
Colombia/ANT-CWOHC-VG-SEC00033G/2021						GH	2.00	20A	South America	Colombia	South America	Antioquia	Human	South America	UDEA	B.1.111	South America	South America	Universidad Nacional de Colombia - Laboratorio Genómico One Health		2021-01-01	Daniel O. Maldonado-Perez et al	[object Object]	76	Male
TrinidadandTobago/TT1327/2020						GH	1.00	20A	South America	Trinidad and Tobago	South America	Trinidad and Tobago	Human	South America	Trinidad Public Health Laboratory	B.1.111	South America	South America	Carrington Lab, Department of PreClinical Sciences, Faculty of Medical Sciences, The University of the West Indies		2020-08-28	Nikita S. D. Sahadeo et al	[object Object]	38	Male
TrinidadandTobago/TT4707/2020						GH	2.00	20A	South America	Trinidad and Tobago	South America	Trinidad and Tobago	Human	South America	Trinidad Public Health Laboratory	B.1.111	South America	South America	Carrington Lab, Department of PreClinical Sciences, Faculty of Medical Sciences, The University of the West Indies		2020-09-02	Nikita S. D. Sahadeo et al	[object Object]	27	Male
TrinidadandTobago/TT44092/2020						GH	2.00	20A	South America	Trinidad and Tobago	South America	Trinidad and Tobago	Human	South America	The Caribbean Public Health Agency	B.1.111	South America	South America	Carrington Lab, Department of PreClinical Sciences, Faculty of Medical Sciences, The University of the West Indies		2020-11-26	Nikita S. D. Sahadeo et al	[object Object]		
TrinidadandTobago/0845/2020						GH	3.00	20A	South America	Trinidad and Tobago	South America	Trinidad and Tobago	Human	South America	Trinidad Public Health Laboratory	B.1.111	South America	South America	Carrington Lab, Department of PreClinical Sciences, Faculty of Medical Sciences, The University of the West Indies		2020-12-01	Nikita S. D. Sahadeo et al	[object Object]		
TrinidadandTobago/39213/2020						GH	2.00	20A	South America	Trinidad and Tobago	South America	Trinidad and Tobago	Human	South America	The Caribbean Public Health Agency	B.1.111	South America	South America	Carrington Lab, Department of PreClinical Sciences, Faculty of Medical Sciences, The University of the West Indies		2020-10-27	Nikita S. D. Sahadeo et al	[object Object]		
SaudiArabia/832279/2020						GH	1.00	20A	Asia	Saudi Arabia	Asia	Jeddah	Human	Asia	Special Infectious Agents Unit	B.1	Asia	Asia	Special Infectious Agents Unit		2020-03-15	Azhar et al	[object Object]		
Indonesia/JK-FKUPNVJ-07/2020						GH	1.00	20A	Asia	Indonesia	Asia	Jakarta	Human	Asia	RSUD Pasarminggu	B.1.470	Asia	Asia	Stem Cell Lab, Universitas Pembangunan Nasional Veteran Jakarta (UPNVJ)		2020-11-27	Andri Pramesyanti Pramono et al	[object Object]	51	Male
Indonesia/JK-FKUPNVJ-08/2020						GR	2.00	20A	Asia	Indonesia	Asia	Jakarta	Human	Asia	RSUD Pasarminggu	B.1.1.398	Asia	Asia	Stem Cell Lab, Universitas Pembangunan Nasional Veteran Jakarta (UPNVJ)		2020-11-27	Andri Pramesyanti Pramono et al	[object Object]	51	Female
Pakistan/NIH-40/2020						GH	2.00	20A	Asia	Pakistan	Asia	Karachi	Human	Asia	Department of Virology	B.1.471	Asia	Asia	Department of Virology		2020-12-12	Massab Umair et al	[object Object]	38	Male
Ghana/WACCBIP-GS485/2020						GH	1.00	20A	Africa	Ghana	Africa	Greater Accra	Human	Africa	West African Centre for Cell Biology of Infectious Pathogen, University of Ghana, Legon	B.1	Africa	Africa	WACCBIP, University of Ghana, Volta Road, Legon, Accra		2020-09-03	Collins M. Morang'a et al	[object Object]	53	Male
Malaysia/UNIMAS-B139/2021	1.00	0.01	0.01	0.02	0.03	GH	3.00	20A	Asia	Malaysia	Asia	Sarawak	Human	Asia	Borneo Medical Centre	AU.2	Asia	Asia	Institute of Health and Community Medicine		2021-02-03	Chan Chia Jui et al	[object Object]	21	Male
PapuaNewGuinea/QLD-PNG-31/2021	1.00	0.01	0.01	0.02	0.03	GH	4.00	20A	Oceania	Papua New Guinea	Oceania	Papua New Guinea	Human	Oceania	PHV-FSS	B.1	Oceania	Oceania	PHV-FSS		2021-04-01	Son Nguyen et al	[object Object]		
PapuaNewGuinea/PNG103/2021	1.00	0.01	0.01	0.02	0.03	GH	2.00	20A	Oceania	Papua New Guinea	Oceania	Papua New Guinea	Human	Oceania	Queensland Medical Laboratories	AU.1	Oceania	Oceania	Victorian Infectious Diseases Reference Laboratory (VIDRL) and the Melbourne Diagnostic Unit Public Health Laboratory (MDU-PHL)		2021-02-05	Palou et al	[object Object]	36	Male
PapuaNewGuinea/PNG098/2021	1.00	0.01	0.01	0.02	0.03	GH	2.00	20A	Oceania	Papua New Guinea	Oceania	Papua New Guinea	Human	Oceania	Queensland Medical Laboratories	AU.1	Oceania	Oceania	Victorian Infectious Diseases Reference Laboratory (VIDRL) and the Melbourne Diagnostic Unit Public Health Laboratory (MDU-PHL)		2021-02-05	Palou et al	[object Object]	46	Male
PapuaNewGuinea/PNG099/2021	1.00	0.01	0.01	0.02	0.03	GH	2.00	20A	Oceania	Papua New Guinea	Oceania	Papua New Guinea	Human	Oceania	Queensland Medical Laboratories	AU.1	Oceania	Oceania	Victorian Infectious Diseases Reference Laboratory (VIDRL) and the Melbourne Diagnostic Unit Public Health Laboratory (MDU-PHL)		2021-02-05	Palou et al	[object Object]	38	Male
Russia/Chechenya-83801/2020		0.01	0.01		0.04	GH	2.00	20A	Russia	Russia	Chechen Republic	Chechen Republic	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-26	Oleg V. Pyankov et al	[object Object]	29	Male
Turkey/33-Ankara-GUMV-50642/2020						GH	3.00	20A	Turkey	Turkey	Turkey	Ankara	Human		Gazi University Faculty of Medicine, Medical Virology Laboratory	B.1.469	Europe	Europe	Gazi University Faculty of Medicine, Medical Virology Laboratory		2020-11-20	Erdem Şahin et al	[object Object]		
Indonesia/JI-ITDua-12009NTv/2020						GH	1.00	20A	Asia	Indonesia	Asia	East Java	Human	Asia	Universitas Airlangga Hospital	B.1.470	Asia	Asia	Institute of Tropical Disease, Universitas Airlangga		2020-05-23	Jezzy R Dewantari et al	[object Object]	55	Male
Indonesia/JB-EIJK263/2021						GH	3.00	20A	Asia	Indonesia	Asia	West Java	Human	Asia	RS Medirossa Cikarang	B.1.470	Asia	Asia	Eijkman Institute for Molecular Biology, Ministry of Research and Technology/National Agency for Research and Innovation		2021-02-02	Willy Agustine et al	[object Object]	28	Male
Nigeria/BE-CV243/2020						GH	1.00	20A	Africa	Nigeria	Africa	Benue State	Human	Africa	Nigeria Centre for Disease Control (NCDC)	B.1.467	Africa	Africa	African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria		2020-07-05	Oluniyi P.E. et al B	[object Object]	58	Male
Malaysia/NPHL_98435/2020						GH	1.00	20A	Asia	Malaysia	Asia	Melaka	Human	Asia	National Public Health Laboratory Malaysia	B.1.466	Asia	Asia	National Public Health Laboratory Malaysia		2020-06-09	Noorliza MN et al	[object Object]	23	Male
Jordan/AM-ALSR-2579/2020						GH	1.00	20A	Asia	Jordan	Asia	Amman	Human	Asia	Biolab Diagnostic Laboratories	B.1.466	Asia	Asia	Andersen lab at Scripps Research		2020-07-04	Issa Abu-Dayyeh et al	[object Object]		
Jordan/AM-ALSR-2586/2020						GH	1.00	20A	Asia	Jordan	Asia	Amman	Human	Asia	Biolab Diagnostic Laboratories	B.1.466	Asia	Asia	Andersen lab at Scripps Research		2020-07-04	Issa Abu-Dayyeh et al	[object Object]		
Indonesia/JK-LIPI026/2020						GH	1.00	20A	Asia	Indonesia	Asia	Jakarta	Human	Asia	Klinik Apotek Dein, Jakarta, Indonesia	B.1.459	Asia	Asia	Biosafety Level-3 Laboratory, Indonesian Institute of Sciences (LIPI)		2020-07-15	Andri Wardiana et al	[object Object]	46	Male
Pakistan/NIH-27/2020						GH	1.00	20A	Asia	Pakistan	Asia	Islamabad	Human	Asia	Department of Virology	B.1.471	Asia	Asia	Department of Virology		2020-11-24	Massab Umair et al	[object Object]	60	Male
Nigeria/NI-CV235/2020						GH	1.00	20A	Africa	Nigeria	Africa	Niger State	Human	Africa	Nigeria Centre for Disease Control (NCDC)	B.1.462	Africa	Africa	African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria		2020-05-31	Oluniyi P.E. et al B	[object Object]	15	Male
Ireland/MO-NVRL-20IRL11349/2020						GH	1.00	20A	Ireland	Ireland	Ireland	Mayo	Human		National Virus Reference Laboratory	B.1.562	Europe	Europe	National Virus Reference Laboratory		2020-12-15	Michael Carr et al	[object Object]		Male
SaudiArabia/KAUST-JEDDAH471/2020						GH	1.00	20A	Asia	Saudi Arabia	Asia	Jeddah	Human	Asia	Pathogen Genomics Lab King Abdullah University of Science and Technology(KAUST)	B.1	Asia	Asia	Pathogen Genomics Lab King Abdullah University of Science and Technology(KAUST)		2020-08-04	Fadwa Alofi et al	[object Object]	43	Male
Singapore/1536/2020						GH	2.00	20A	Asia	Indonesia	Asia	Indonesia	Human	Asia	National Public Health Laboratory, National Centre for Infectious Diseases	B.1.36.19	Asia	Asia	National Public Health Laboratory, National Centre for Infectious Diseases		2020-12-28	Tze Minn Mak et al	[object Object]	44	Female
Mozambique/INS-K007934/2020						GH	3.00	20A	Africa	Mozambique	Africa	Maputo	Human	Africa	Instituto Nacional de Saude (INS), Mozambique	B.1.36.31	Africa	Africa	KRISP, KZN Research Innovation and Sequencing Platform		2020-12-24	Nalia Ismael et al	[object Object]		Male
Iran/3533/2020						O	3.00	20A	Asia	Iran	Asia	Iran	Human	Asia	Human Genetic Research Center, Kawsar Biotech Company	B.1.36.7	Asia	Asia	Kawsar Biotech Company		2020-10-10	Khosravi et al	[object Object]		
Bangladesh/NGRI-R3-16/2020						GH	2.00	20A	Asia	Bangladesh	Asia	Chattogram	Human	Asia	NSTU COVID-19 Diagnostic Center	B.1.36.8	Asia	Asia	NSU Genome Research Institute (NGRI)		2020-10-25	Maqsud Hossain et al	[object Object]		Male
Canada/MB-NML-1136/2020						GH	3.00	20A	North America	Canada	North America	Manitoba	Human	North America	Cadham Provincial Laboratory	B.1.36.8	North America	North America	National Microbiology Laboratory (NML)		2020-08-03	Anna Majer et al	[object Object]		Male
Canada/MB-NML-1566/2020						GH	2.00	20A	North America	Canada	North America	Manitoba	Human	North America	Cadham Provincial laboratory	B.1.36.8	North America	North America	National Microbiology Laboratory (NML)		2020-08-18	Anna Majer et al	[object Object]		Female
HongKong/VB20209003/2020						GH	1.00	20A	Asia	Hong Kong	Asia	Hong Kong	Human	Asia	Hong Kong Department of Health	B.1.36.27	Asia	Asia	School of Public Health, The University of Hong Kong		2020-10-06	Daniel Chu et al	[object Object]	36	Female
HongKong/HKU-201216-252/2020						GH	1.00	20A	Asia	Hong Kong	Asia	Hong Kong	Human	Asia	Department of Microbiology, The University of Hong Kong	B.1.36	Asia	Asia	Department of Microbiology, The University of Hong Kong		2020-10-14	Kelvin K.W. To et al	[object Object]		
HongKong/HKU-201216-345/2020						GH	1.00	20A	Asia	Hong Kong	Asia	Hong Kong	Human	Asia	Department of Microbiology, The University of Hong Kong	B.1.36	Asia	Asia	Department of Microbiology, The University of Hong Kong		2020-11-25	Kelvin K.W. To et al	[object Object]		
HongKong/HKPU-08514/2020		0.01	0.01		0.02	GH	2.00	20A	Asia	Hong Kong	Asia	Hong Kong	Human	Asia	Department of Health Technology and Informatics, The Hong Kong Polytechnic University	B.1.36	Asia	Asia	Department of Health Technology and Informatics, The Hong Kong Polytechnic University		2020-12-26	Gilman Kit-Hang Siu et al	[object Object]	83	Female
Norway/4462/2020						GH	2.00	20A	Norway	Norway	Norway	Vestland	Human		Haukeland University Hospital, Department of Medical Microbiology	B.1.36.1	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2020-10-19	Kathrine Stene-Johansen et al	[object Object]		
India/TG-CCMB-AW016/2020		0.01	0.01	0.04	0.02	GH	2.00	20A	Asia	India	Asia	Telangana	Human	Asia	CSIR-Centre for Cellular and Molecular Biology	B.1.36.29	Asia	Asia	CSIR-Centre for Cellular and Molecular Biology-INSACOG		2020-11-13	Payel Mukherjee et al	[object Object]	57	Male
Pakistan/JRCGR-KHI35/2020						GH	2.00	20A	Asia	Pakistan	Asia	Karachi	Human	Asia	Jamil-ur-Rahman Center for Genome Research, Dr. Panjwani Center for Molecular Medicine and Drug Research	B.1.36	Asia	Asia	Jamil-ur-Rahman Center for Genome Research, Dr. Panjwani Center for Molecular Medicine and Drug Research		2020-08-10	Shakeel et al	[object Object]		
Ireland/LM-NVRL-71IRL07120/2020						GH	1.00	20A	Ireland	Ireland	Ireland	Leitrim	Human		National Virus Reference Laboratory	B.1.36.22	Europe	Europe	National Virus Reference Laboratory		2020-07-07	Michael Carr et al	[object Object]		Male
Ireland/LK-NVRL-72IRL34726/2020						GH	1.00	20A	Ireland	Ireland	Ireland	Limerick	Human		National Virus Reference Laboratory	B.1.36.22	Europe	Europe	National Virus Reference Laboratory		2020-08-15	Michael Carr et al	[object Object]		Male
Finland/31ES18AD11/2020						GH	2.00	20A	Finland	Finland	Finland	Uusimaa	Human		Department of Virology and Immunology, University of Helsinki and Helsinki University Hospital, Huslab Finland	B.1.36.22	Europe	Europe	Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland		2020-08-31	Teemu Smura et al	[object Object]	10	Male
Finland/THL-202102241/2021						GH	3.00	20A	Finland	Finland	Finland	Finland	Human		TYKS, Kliininen mikrobiologia	B.1.36.22	Europe	Europe	Expert Microbiology, National Institute for Health and Welfare		2021-01-20	Soile Blomqvist et al	[object Object]	6	Female
Afghanistan/IMB15490/2021		0.01	0.05	0.05	0.06	GH	3.00	20A	Asia	Afghanistan	Asia	Afghanistan	Human	Asia	Bundeswehr Institute of Microbiology	B.1.36	Asia	Asia	Bundeswehr Institute of Microbiology		2021-01-21	Markus Antwerpen et al	[object Object]		
Thailand/phitsanulok-MT0115/2020						GH	1.00	20A	Asia	Thailand	Asia	Phitsanulok	Human	Asia	Regional medical sciences center 2 Phitsanulok	B.1.36.16	Asia	Asia	National Institute of Health, Department of Medical Sciences, Ministry of Public Health, Thailand		2020-10-26	Pilailuk Okada et al	[object Object]		
Myanmar/DSMRC-007/2021						GH	2.00	20A	Asia	Myanmar	Asia	Myanmar	Human	Asia	Special Operations Medical Research Division, Defence Services Medical Research Centre	B.1.36.16	Asia	Asia	Special Operations Medical Research Division, Defence Services Medical Research Centre		2021-01-09	Oo et al	[object Object]		
Thailand/Bangkok-PH7928/2020						GH	1.00	20A	Asia	Thailand	Asia	Bangkok	Human	Asia	World Medical Hospital	B.1.36.16	Asia	Asia	National Institute of Health, Department of Medical Sciences, Ministry of Public Health, Thailand		2020-09-14	Pilailuk Okada et al	[object Object]		
Jordan/AM-ALSR-2585/2020						GH	1.00	20A	Asia	Jordan	Asia	Amman	Human	Asia	Biolab Diagnostic Laboratories	B.1	Asia	Asia	Andersen lab at Scripps Research		2020-06-21	Issa Abu-Dayyeh et al	[object Object]		
Tunisia/11-MHT_9/2020		0.01			0.01	GH	2.00	20A	Africa	Tunisia	Africa	Tunis	Human	Africa	Department of Virology, Principal Military Hospital of Instruction of Tunis	B.1.160	Africa	Africa	Bundeswehr Institute of Microbiology		2020-09-13	Susann Handrick et al	[object Object]	53	Female
Portugal/PT1839/2020		0.01			0.01	GH	2.00	20A	Portugal	Portugal	Portugal	Portugal	Human		Instituto Nacional de Saude (INSA)	B.1.160	Europe	Europe	Instituto Nacional de Saude (INSA)		2020-11-10	Borges et al	[object Object]		
Switzerland/BS-UHB-42403143/2020		0.01			0.01	GH	2.00	20A	France	France	France	Grand Est	Human	Rosenau	University Hospital Basel, Clinical Virology	B.1.160	Europe	Europe	University Hospital Basel, Clinical Bacteriology		2020-08-20	Tim Roloff et al	[object Object]		Male
France/CVL-IPP03771/2021		0.01			0.01	GH	3.00	20A	France	France	France	Centre-Val de Loire	Human	Orléans	Hopital	B.1.160	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2021-02-15	Marion Barbet et al	[object Object]	63	Female
France/CVL-IPP9550/2020		0.01			0.01	GH	3.00	20A	France	France	France	Pays de la Loire	Human	Angers	Hospital	B.1.160	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2020-10-27	Marion Barbet et al	[object Object]	41	Male
Switzerland/BL-UHB-42504426/2020		0.01			0.01	GH	2.00	20A	Switzerland	Switzerland	Switzerland	Basel-Stadt	Human	Basel	University Hospital Basel, Clinical Virology	B.1.177.43	Europe	Europe	University Hospital Basel, Clinical Bacteriology		2020-10-26	Tim Roloff et al	[object Object]		Male
Hungary/UD-58207/2020		0.01			0.01	GH	2.00	20A	Hungary	Hungary	Hungary	Szabolcs-Szatmár-Bereg County	Human		University of Debrecen, Department of Medical Microbiology	B.1.160	Europe	Europe	National Laboratory of Virology, Szentágothai Research Centre		2020-09-03	Endre Gábor Tóth et al	[object Object]	17	Male
Hungary/HM-0121-57/2021		0.01			0.01	GH	3.00	20A	Hungary	Hungary	Hungary	Jász-Nagykun-Szolnok County	Human		Hungarian Defence Forces Military Medical Centre	B.1.160	Europe	Europe	National Laboratory of Virology, Szentágothai Research Centre		2021-01-21	Endre Gábor Tóth et al	[object Object]	42	Female
Hungary/UD-90279/2020		0.01			0.01	GH	3.00	20A	Hungary	Hungary	Hungary	Borsod-Abaúj-Zemplén County	Human		University of Debrecen, Department of Medical Microbiology	B.1.160	Europe	Europe	National Laboratory of Virology, Szentágothai Research Centre		2020-10-04	Endre Gábor Tóth et al	[object Object]	42	Male
Hungary/7299_18/2021		0.01			0.01	GH	4.00	20A	Hungary	Hungary	Hungary	Heves County	Human		National Public Health Center, COVID Laboratory	B.1.160	Europe	Europe	National Public Health Center, National Biosafety Laboratory		2021-02-12	Bernadett Pályi et al	[object Object]	78	Female
Hungary/SRC-2140/2020		0.01			0.01	GH	2.00	20A	Hungary	Hungary	Hungary	Baranya County	Human		National Laboratory of Virology, Szentágothai Research Centre	B.1.160	Europe	Europe	National Laboratory of Virology, Szentágothai Research Centre		2020-10-20	Endre Gábor Tóth et al	[object Object]	43	Male
Hungary/US-60505w/2020		0.01			0.01	GH	2.00	20A	Hungary	Hungary	Hungary	Bács-Kiskun County	Human		University of Szeged, Institute of Clinical Microbiology	B.1.160	Europe	Europe	National Laboratory of Virology, Szentágothai Research Centre		2020-10-02	Endre Gábor Tóth et al	[object Object]	54	Female
Sweden/20-53531/2020		0.01			0.01	GH	2.00	20A	Sweden	Sweden	Sweden	Jonkoping	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.160	Europe	Europe	The Public Health Agency of Sweden		2020-11-25	Maximilian Riess et al	[object Object]		Female
Slovakia/CeMM4317/2021		0.01			0.01	GH	3.00	20A	Slovakia	Slovakia	Slovakia	Trenčín	Human		Public Health Authority of the Slovak Republic	B.1.160	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-02-03	Lukas Endler et al	[object Object]	46	Male
Italy/CeMM1592/2020		0.01			0.01	GH	2.00	20A	Italy	Italy	Italy	Trentino-Alto Adige	Human	Autonomous Province of Bolzano	Pharmgenetix GmbH	B.1.160	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2020-11-09	Lukas Endler et al	[object Object]	28	Male
Suriname/SR-124/2021		0.01			0.01	GH	2.00	20A	South America	Suriname	South America	Suriname	Human	South America	Central Laboratory, Bureau of Public Health (BOG) and Academic Hospital Paramaribo	B.1.160	South America	South America	Erasmus Medical Center		2021-01-22	Bas B Oude Munnink et al	[object Object]		
Reunion/PIMIT_03265/2021		0.01			0.01	GH	2.00	20A	France	France	France	France	Human		CHOR	B.1.160.18	Europe	Europe	UMR PIMIT		2021-03-10	Dr David A Wilkinson et al	[object Object]	62	Male
France/HDF-100001598287/2021		0.01			0.01	GH	2.00	20A	France	France	France	Hauts de France	Human		Synlab Haut de France	B.1.160.26	Europe	Europe	UMR 8199/1283 EGID		2021-02-13	Derhourhi Mehdi et al	[object Object]		
Belgium/UZA-UA-47128367/2021		0.01			0.01	O	3.00	20A	Belgium	Belgium	Belgium	Belgium	Human		Algemeen Medisch Laboratorium	B.1.160	Europe	Europe	UAntwerp, Laboratory of Medical Microbiology		2021-02-10	Basil Britto Xavier et al	[object Object]	48	Female
Spain/PV-ISCIII-213328/2021		0.01			0.01	GH	2.00	20A	Spain	Spain	Spain	Pais Vasco	Human		HOSPITAL TXAGORRITXU	B.1.160	Europe	Europe	Instituto de Salud Carlos III		2021-04-07	Sandonís et al	[object Object]	58	Female
Netherlands/LI-EMC-87/2020		0.01			0.01	GH	2.00	20A	Netherlands	Netherlands	Netherlands	Limburg	Human		Dutch COVID-19 response team	B.1.160	Europe	Europe	Erasmus Medical Center		2020-09-22	Bas Oude Munnink et al	[object Object]		
BosniaandHerzegovina/KCUS21606/2021		0.01			0.01	GH	2.00	20A	Bosnia and Herzegovina	Bosnia and Herzegovina	Bosnia and Herzegovina	Ilijas	Human		Clinical Center, University of Sarajevo; Unit for Clinical Microbiology	B.1.160	Europe	Europe	Clinical Center, University of Sarajevo; Unit for Clinical Microbiology		2021-02-25	Irma Salimović-Bešić et al	[object Object]	52	Female
Netherlands/ZH-EMC-989/2020		0.01			0.01	GH	2.00	20A	Netherlands	Netherlands	Netherlands	South Holland	Human		Dutch COVID-19 response team	B.1.160	Europe	Europe	Erasmus Medical Center		2020-11-13	Bas Oude Munnink et al	[object Object]		
Netherlands/DR-RIVM-16059/2021		0.01			0.01	GH	3.00	20A	Netherlands	Netherlands	Netherlands	Drenthe	Human		Dutch COVID-19 response team	B.1.160	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-02-23	Adam Meijer et al	[object Object]	26	
France/PDL-IPP11466/2020		0.01			0.01	GH	2.00	20A	France	France	France	Pays de la Loire	Human	Angers	Hospital	B.1.160	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2020-11-04	Marion Barbet et al	[object Object]	32	Female
Switzerland/FR-ETHZ-340036/2020		0.01			0.01	GH	2.00	20A	Switzerland	Switzerland	Switzerland	Fribourg	Human		Viollier AG	B.1.160.11	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-10-23	Christian Beisel et al	[object Object]		
NorthMacedonia/34379/2021		0.01			0.01	GH	2.00	20A	North Macedonia	North Macedonia	North Macedonia	Northeastern Region MK	Human	Kumanovo	General Hospital - Kumanovo	B.1.160.16	Europe	Europe	Research Center for Genetic Engineering and Biotechnology "Georgi D. Efremov” , Macedonian Academy of Sciences and Arts		2021-02-13	Aleksandar J. Dimovski et al	[object Object]	1	Male
Switzerland/GR-ETHZ-470859/2021		0.01			0.01	GH	2.00	20A	Switzerland	Switzerland	Switzerland	Graubünden	Human		Viollier AG	B.1.160.15	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-01-26	Chaoran Chen et al	[object Object]		
Switzerland/VD-ETHZ-360047/2020		0.01			0.01	GH	2.00	20A	Switzerland	Switzerland	Switzerland	Vaud	Human		Viollier AG	B.1.160	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-11-10	Christian Beisel et al	[object Object]		
Switzerland/JU-ETHZ-431022/2020		0.01			0.01	GH	3.00	20A	Switzerland	Switzerland	Switzerland	Jura	Human		Viollier AG	B.1.160.32	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-12-28	Christian Beisel et al	[object Object]		
Cameroon/CV441/2020		0.01			0.01	GH	2.00	20A	Africa	Cameroon	Africa	Yaoundé	Human	Africa	National Public Health Laboratory, Cameroon	B.1.160	Africa	Africa	African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University		2020-11-17	Oluniyi P.E. et al B	[object Object]	58	Female
Belgium/rega-10191275/2020		0.01			0.01	GH	2.00	20A	Belgium	Belgium	Belgium	Mons	Human	Nimy	UZ Leuven, National Reference Laboratory for Coronaviruses, Laboratory Medicine, Leuven, Belgium	B.1.160	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-10-19	Tony Wawina-Bokalanga et al	[object Object]	19	Female
Denmark/DCGC-7080/2020		0.01			0.01	GH	2.00	20A	Denmark	Denmark	Denmark	Sjaelland	Human		Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Denmark	B.1.160.8	Europe	Europe	Albertsen lab, Department of Chemistry and Bioscience, Aalborg University, Denmark		2020-10-12	Danish Covid-19 Genome Consortia et al	[object Object]		
Sweden/SE00224629/2021		0.01			0.01	GH	3.00	20A	Sweden	Sweden	Sweden	Gavleborgs Lan	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.160	Europe	Europe	The Public Health Agency of Sweden		2021-02-08	Swedish national genomic surveillance program of SARS-CoV-2 et al	[object Object]		
Sweden/21-50631/2021		0.01			0.01	GH	2.00	20A	Sweden	Sweden	Sweden	Kronoberg	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.160	Europe	Europe	The Public Health Agency of Sweden		2021-01-27	Maximilian Riess et al	[object Object]	45	Female
Belgium/SJ4151092/2020		0.01			0.01	GH	2.00	20A	Belgium	Belgium	Belgium	Veurne	Human	De Panne	AZ St.Jan Brugge-Oostende	B.1.160	Europe	Europe	AZ SINT-JAN BRUGGE		2020-12-30	Marijke Reynders et al	[object Object]	76	Male
Austria/CeMM3774/2021		0.01			0.01	GH	2.00	20A	Austria	Austria	Austria	Vorarlberg	Human	Bregenz	Center for Virology, Medical University of Vienna	B.1.160	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-02-05	Lukas Endler et al	[object Object]	50	Female
France/CVL-IPP9518/2020		0.01			0.01	GH	2.00	20A	France	France	France	Pays de la Loire	Human	Nantes	General practitioner office	B.1.160	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2020-10-26	Marion Barbet et al	[object Object]	26	Male
Tahiti/HCL021013314001/2021		0.01			0.01	GH	2.00	20A	Oceania	French Polynesia	Oceania	Windward Islands	Human	Oceania	C H DE LA POLYNESIE FRANCAISE	B.1.160	Oceania	Oceania	CNR Virus des Infections Respiratoires - France SUD		2021-01-06	Antonin Bal et al	[object Object]	43	Male
Tahiti/HCL021013320801/2021		0.01			0.01	GH	2.00	20A	Oceania	French Polynesia	Oceania	Windward Islands	Human	Oceania	C H DE LA POLYNESIE FRANCAISE	B.1.160	Oceania	Oceania	CNR Virus des Infections Respiratoires - France SUD		2021-01-06	Antonin Bal et al	[object Object]	57	Male
Senegal/328/2020						GH	1.00	20C	Africa	Senegal	Africa	Thies	Human	Africa	Institut Pasteur Dakar	B.1	Africa	Africa	Institut Pasteur de Dakar		2020-03-17	Ndongo Dia et al	[object Object]	56	Female
Israel/CVL-n1852/2020						GH	1.00	20C	Asia	Israel	Asia	North District	Human	Asia	Israel Central Virology Laboratory	B.1.362	Asia	Asia	Israel National Consortium for SARS-CoV-2 sequencing		2020-08-13	Neta Zuckerman et al	[object Object]		
France/PDL-1643/2020						GH	1.00	20C	France	France	France	Pays de la Loire	Human	Nantes	Centre Hospitalier Régional Universitaire de Nantes Laboratoire de Virologie	B.1	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2020-02-26	Mélnie Albert et al (https://dx.doi.org/10.1101/2020.04.24.059576)	[object Object]	59	Female
Russia/Chelyabinsk-85311/2020						GH	2.00	20C	Russia	Russia	Chelyabinsk	Chelyabinsk	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-28	Sergey A. Bodnev et al	[object Object]	55	Male
Denmark/DCGC-1580/2020						GH	1.00	20C	Denmark	Denmark	Denmark	Syddanmark	Human		Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Denmark	B.1.428	Europe	Europe	Albertsen lab, Department of Chemistry and Bioscience, Aalborg University, Denmark		2020-04-13	Danish Covid-19 Genome Consortia et al	[object Object]		
Norway/2404/2020						GH	1.00	20C	Norway	Norway	Norway	Vestfold Og Telemark	Human		Vestfold Hospital, Toensberg Department of Microbiology	B.1	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2020-03-30	Kathrine Stene-Johansen et al	[object Object]		
Russia/Sverdlovsk-71904/2020						GH	1.00	20C	Russia	Russia	Sverdlovsk	Sverdlovsk	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1.513	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-19	Sergey A. Bodnev et al	[object Object]	47	Male
Russia/StPetersburg-RII3997/2020						GH	2.00	20C	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-03-18	Andrey Komissarov et al B (https://dx.doi.org/10.1101/2020.07.14.20150979)	[object Object]	70	Female
Bahamas/33823/2020						GH	1.00	20C	North America	Bahamas	North America	Bahamas	Human	North America	Reference Laboratory of the Ministry of Health	B.1	North America	North America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-04-19	Paola Resende et al	[object Object]		
Coted-Ivoire/COV-BKE1145/bc61/2020						GH	2.00	20C	Africa	Côte d'Ivoire	Africa	Niakara	Human	Africa	Molecular diagnostic unit for viral haemorrhagic fevers and emerging viruses, Bouaké CHU Laboratory	B.1	Africa	Africa	Molecular diagnostic unit for viral haemorrhagic fevers and emerging viruses, Bouaké CHU Laboratory		2020-10-19	Chantal Akoua-Koffi et al	[object Object]	43	Female
Switzerland/BS-42252201/2020						GH	1.00	20C	Switzerland	Switzerland	Switzerland	Basel-Stadt	Human		University Hospital Basel, Clinical Virology	B.1	Europe	Europe	University Hospital Basel, Clinical Bacteriology		2020-05-01	Madlen Stange et al	[object Object]		Male
Russia/SAR-RARI-1150/2020						GH	1.00	20C	Russia	Russia	Saratov	Saratov	Human		Mikrobiologie, RARI	B.1	Europe	Europe	Mikrobiologie, RARI		2020-04-13	Krasnov et al	[object Object]		
Russia/Krasnodar-80902/2020						GH	1.00	20C	Russia	Russia	Krasnodar	Krasnodar	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-23	Oleg V. Pyankov et al	[object Object]	38	Male
Russia/Orenburg-80305/2020						GH	1.00	20C	Russia	Russia	Orenburg	Orenburg	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-23	Sergey A. Bodnev et al	[object Object]	32	Male
Algeria/G0860_2262/2020						GH	1.00	20C	Africa	Algeria	Africa	Boufarik	Human	Africa	NIC Viral Respiratory Unit - Institut Pasteur of Algeria	B.1	Africa	Africa	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2020-03-02	Mélanie Albert et al	[object Object]	41	Male
Tunisia/ADAGE-24758/2020						GH	1.00	20C	Africa	Tunisia	Africa	Sfax	Human	Africa	Laboratoire de Microbiologie- CHU Habib Bourguiba – Sfax adresse	B.1.597	Africa	Africa	Laboratoire des Procédés de Criblage Moléculaire et Cellulaire-Centre de Biotechnologie de Sfax		2020-11-08	Souissi et al	[object Object]		
Algeria/G38882-8853/2020						GH	1.00	20C	Africa	Algeria	Africa	Bouira	Human	Africa	NIC Viral Respiratory Unit - Institut Pasteur of Algeria	B.1.597	Africa	Africa	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2020-06-20	Mélanie Albert et al	[object Object]	52	Male
Switzerland/UR-ETHZ-100832/2020						GH	1.00	20C	Switzerland	Switzerland	Switzerland	Uri	Human		Viollier AG	B.1.356	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-03-25	Christian Beisel et al	[object Object]		
Belgium/rega-0501633/2020						GH	1.00	20C	Belgium	Belgium	Belgium	Tournai-Mouscron	Human	Mouscron	UZ Leuven, National Reference Laboratory for Coronaviruses, Laboratory Medicine, Leuven, Belgium	B.1.12	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-05-01	Tony Wawina-Bokalanga et al	[object Object]	27	Female
France/IDF_HB_112004007059/2020						GH	1.00	20C	France	France	France	Ile de France	Human		Hôpital Bichat Claude Bernard, Laboratoire de Virologie	B.1	Europe	Europe	IAME UMR1137 Inserm, Université de Paris, Hôpital Bichat		2020-04-02	Antoine Bridier-Nahmias et al	[object Object]	49	Male
Benin/501/2020						GH	1.00	20C	Africa	Benin	Africa	Cotonou	Human	Africa	Laboratoire des Fièvres Hémorragiques Virales du Benin	B.1.356	Africa	Africa	Charité-Universitätsmedizin Berlin		2020-03-17	Yadouleton et al (https://www.medrxiv.org/content/10.1101/2020.06.29.20140749v1)	[object Object]	61	Female
Netherlands/Drenthe_3/2020						GH	1.00	20C	Netherlands	Netherlands	Netherlands	Drenthe	Human		Dutch COVID-19 response team	B.1.356	Europe	Europe	Erasmus Medical Center		2020-04-06	Bas Oude Munnink et al	[object Object]		
Jamaica/JM-CDC-6603/2020						GH	1.00	20C	North America	Jamaica	North America	Jamaica	Human	North America	Jamaica Ministry of Health and Wellness	B.1	North America	North America	Pathogen Discovery, Respiratory Viruses Branch, Division of Viral Diseases, Centers for Disease Control and Prevention		2020-03-16	Yan Li et al	[object Object]	79	Male
Israel/2086033/2020						GH	2.00	20C	Asia	Israel	Asia	Jerusalem District	Human	Asia	Clinical Virology Unit, Hadassah Hebrew University Medical Center	B.1	Asia	Asia	Stern Lab		2020-04-01	Stern Lab et al (https://dx.doi.org/10.1101/2020.05.21.20104521)	[object Object]	61	Female
SierraLeone/KGH-G-8548/2020						GH	1.00	20C	Africa	Sierra Leone	Africa	Sierra Leone	Human	Africa	Kenema Government Hospital, Ministry of Health and Sanitation	B.1	Africa	Africa	Kenema Government Hospital, Ministry of Health and Sanitation		2020-03-30	Goba et al	[object Object]		
Poland/PL_P36/2020						GH	1.00	20C	Poland	Poland	Poland	Wielkopolskie	Human	Kalisz	1. ViroGenetics - BSL3 Laboratory of Virology, Małopolska Centre of Biotechnology, Jagiellonian University; 2. II Department of Internal Medicine, Faculty of Medicine, Jagiellonian University Medical College; 3. Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny (NIZP-PZH)	B.1.343	Europe	Europe	1. ViroGenetics - BSL3 Laboratory of Virology, Małopolska Centre of Biotechnology, Jagiellonian University; 2. II Department of Internal Medicine, Faculty of Medicine, Jagiellonian University Medical College; 3. Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny (NIZP-PZH).		2020-03-15	Katarzyna Pancer et al	[object Object]	86	Male
SouthKorea/KDCA0674/2020						GH	1.00	20C	Asia	South Korea	Asia	South Korea	Human	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency	B.1.497	Asia	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency		2020-08-15	Ae Kyung Park et al	[object Object]	49	Male
Serbia/Pancevo-037181504/2020						GH	1.00	20C	Serbia	Serbia	Serbia	South Banat District	Human	Pancevo	Scientific Veterinary Institute Novi Sad	B.1	Europe	Europe	Veterinary Specialized Institute "Kraljevo", Serbia		2020-04-14	Vidanovic et al	[object Object]		
Argentina/PAIS-H0069/2020						O	2.00	20C	South America	Argentina	South America	Santa Fe	Human	South America	Centro de Tecnología en Salud Pública de la Universidad Nacional de Rosario	B.1.499	South America	South America	Laboratorio Mixto de Biotecnología Acuática (LMBA) on behalf of 'Proyecto Argentino Interinstitucional de genomica de SARS-CoV-2' (PAIS Consortium)		2020-10-16	Joaquín Ezpeleta et al	[object Object]	57	Male
Paraguay/iics_8630/2021		0.01	0.01		0.01	GH	2.00	20C	South America	Paraguay	South America	Central	Human	South America	IICS-UNA	B.1.499	South America	South America	IICS-UNA		2021-02-01	Magaly Martinez et al	[object Object]		Male
Argentina/PAIS-D0079/2020						GH	1.00	20C	South America	Argentina	South America	Tierra del Fuego	Human	South America	Laboratorio del Hospital Regional Ushuaia Gdor. Ernesto Campos	B.1.499	South America	South America	Nodo de Secuenciación Tierra del Fuego - Hospital Regional Ushuaia - Centro Austral De Investigaciones Científicas - Universidad Nacional De Tierra Del Fuego on behalf of 'Proyecto Argentino Interinstitucional de genomica de SARS-CoV-2' (PAIS Consortium)		2020-10-09	Carina Andrea De Roccis et al	[object Object]	28	Female
Russia/Sakhalin-84401/2020						GH	1.00	20C	Russia	Russia	Sakhalin	Sakhalin	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-27	Oleg V. Pyankov et al	[object Object]	78	Female
CzechRepublic/NRL-5607/2020						GH	1.00	20C	Czech Republic	Czech Republic	Czech Republic	Central Bohemian Region	Human	Mladá Boleslav	National Institute of Public Health (Czech Republic)	B.1	Europe	Europe	State Veterinary Institute Prague		2020-03-30	Nagy et al	[object Object]	57	Female
SouthKorea/KCDC2138/2020						GH	1.00	20C	Asia	South Korea	Asia	South Korea	Human	Asia	Division of Viral Diseases, Center for Laboratory Control of Infectious Diseases, Korea Centers for Diseases Control and Prevention	B.1	Asia	Asia	Division of Viral Diseases, Center for Laboratory Control of Infectious Diseases, Korea Centers for Diseases Control and Prevention		2020-03-20	Jeong-Min Kim et al	[object Object]	28	Male
SouthKorea/KDCA1385/2020						GH	1.00	20C	Asia	USA	Asia	USA	Human	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency	B.1.265	Asia	North America	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency		2020-09-01	Ae Kyung Park et al	[object Object]	43	Male
Cameroun/Yaounde-21V-07093/2021						GH	2.00	20G	Africa	Cameroon	Africa	Yaoundé	Human	Africa	Centre Pasteur du Cameroun	B.1.2	Africa	Africa	Institut Pasteur de Dakar		2021-02-10	Njouom Richard et al	[object Object]	64	Female
Taiwan/CGMH-CGU-33/2020						GH	1.00	20G	Asia	Taiwan	Asia	Taiwan	Human	Asia	Laboratory Medicine	B.1.2	Asia	Asia	Department of Laboratory Medicine, Lin-Kou Chang Gung Memorial Hospital, Taoyuan, Taiwan		2020-10-04	Kuo-Chien Tsao et al B	[object Object]		Male
HongKong/HKU-210308-Imp8/2020						GH	1.00	20G	Asia	Hong Kong	Asia	Hong Kong	Human	Asia	Department of Microbiology, The University of Hong Kong	B.1.2	Asia	Asia	Department of Microbiology, The University of Hong Kong		2020-12-23	Kelvin K.W. To et al	[object Object]		
Grenada/51132/2021						GH	1.00	20G	South America	Grenada	South America	Grenada	Human	South America	The Caribbean Public Health Agency	B.1.2	South America	South America	Carrington Lab, Department of PreClinical Sciences, Faculty of Medical Sciences, The University of the West Indies		2021-01-06	Nikita S. D. Sahadeo et al	[object Object]		
SaintVincentandtheGrenadines/53389/2021						GH	2.00	20G	South America	Saint Vincent and the Grenadines	South America	Saint Vincent and the Grenadines	Human	South America	The Caribbean Public Health Agency	B.1.2	South America	South America	Carrington Lab, Department of PreClinical Sciences, Faculty of Medical Sciences, The University of the West Indies		2021-01-29	Nikita S. D. Sahadeo et al	[object Object]		
Mexico/AGS-InDRE-83/2020						GH	1.00	20G	North America	Mexico	North America	Aguascalientes	Human	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)	B.1.2	North America	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)		2020-11-02	Gisela Barrera-Badillo et al	[object Object]	26	Female
Germany/MV-Cento-COV7/2020						GH	1.00	20C	Germany	Germany	Germany	Mecklenburg-Vorpommern	Human	Rostock	Centogene AG	B.1	Europe	Europe	Centogene AG		2020-03-26	Prof. Dr. Peter Bauer et al	[object Object]	35	Female
Morocco/RMPS-05/2020						GH	1.00	20C	Africa	Morocco	Africa	Morocco	Human	Africa	LNR National Reference Laboratory, Mohammed VI University of Health Sciences	B.1	Africa	Africa	Medical Biotechnology Laboratory, Rabat Medical and Pharmacy School, Mohammed The Vth University in Rabat		2020-03-30	Meriem LAAMARTI et al A (https://www.biorxiv.org/content/10.1101/2020.06.30.181123v1)	[object Object]		
Kenya/C32519/2020						GH	1.00	20C	Africa	Kenya	Africa	Taita Taveta	Human	Africa	KEMRI-Wellcome Trust Research Programme/KEMRI-CGMR-C Kilifi	B.1	Africa	Africa	KEMRI-Wellcome Trust Research Programme/KEMRI-CGMR-C Kilifi		2020-07-14	Githinji et al	[object Object]	42	Male
Russia/Krasnoyarsk-66501/2020						GH	1.00	20C	Russia	Russia	Krasnoyarsk	Krasnoyarsk	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-13	Oleg V. Pyankov et al	[object Object]	35	Male
Sweden/20-50371/2020						GH	1.00	20C	Sweden	Sweden	Sweden	Kalmar	Human		Kalmar klinisk mikrobiologi	B.1	Europe	Europe	The Public Health Agency of Sweden		2020-03-16	Oskar Karlsson Lindsjo et al	[object Object]	54	Male
Russia/Novosibirsk-RII27316S/2020						GH	1.00	20C	Russia	Russia	Novosibirsk	Novosibirsk	Human		Department of Experimental Modeling and Pathogenesis of Infectious Diseases	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-05-04	Andrey Komissarov et al A	[object Object]	47	Male
Belgium/rega-0512550/2020						GH	1.00	20C	Belgium	Belgium	Belgium	Dendermonde	Human	Zele	UZ Leuven, National Reference Laboratory for Coronaviruses, Laboratory Medicine, Leuven, Belgium	B.1	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-05-12	Tony Wawina-Bokalanga et al	[object Object]	80	Male
Russia/Moscow_PMVL-9/2020						GH	1.00	20C	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Influenza etiology and epidemiology laboratory	B.1	Europe	Europe	Pathogenic Microorganisms Variability Laboratory		2020-04-08	Alexey Shchetinin et al	[object Object]	71	Male
Somalia/CV1175/2020						GH	1.00	20C	Africa	Somalia	Africa	Benadir	Human	Africa	National Institute of Health (NIH) - Federal Government of Somalia	B.1	Africa	Africa	African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer’s University		2020-04-26	Olawoye et al	[object Object]	23	Female
Sweden/20-07768/2020						GH	1.00	20C	Sweden	Sweden	Sweden	Jonkoping	Human		Aneby VC	B.1	Europe	Europe	The Public Health Agency of Sweden		2020-04-23	Ken Granath et al	[object Object]	86	Male
Sweden/20-51780/2020						GH	1.00	20C	Sweden	Sweden	Sweden	Vastmanland	Human		Kungsors VC	B.1	Europe	Europe	The Public Health Agency of Sweden		2020-05-28	Oskar Karlsson Lindsjo et al	[object Object]	39	Female
Russia/RYA-CRIE-L188S0156bh/2021						G	3.00	20C	Russia	Russia	Ryazan	Ryazan	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-24	Samoilov A.E. et al	[object Object]	35	Female
Greece/190/2020						GH	1.00	20C	Greece	Greece	Greece	Crete	Human		Laboratory of Clinical Virology	B.1.36.1	Europe	Europe	Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)		2020-09-14	Emmanouil Athanasiadis et al	[object Object]		
Germany/BY-RKI-I-013845/2020						GH	1.00	20C	Germany	Germany	Germany	Bavaria	Human		Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit (LGL)	B.1	Europe	Europe	Robert Koch Institute		2020-05-12	?	[object Object]		
Panama/GMI-PA580700/2020						GH	2.00	20C	North America	Panama	North America	Panama Oeste	Human	North America	Gorgas Memorial Laboratory of Health Studies	B.1	North America	North America	Gorgas Memorial Laboratory of Health Studies		2020-12-05	Yamilka Diaz et al	[object Object]	22	Male
Russia/ORL-RII-MH9331S/2020						G	1.00	20C	Russia	Russia	Oryol	Oryol	Human	Oryol	HELIX LLC	B.1.320	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-12	Andrey Komissarov et al A	[object Object]	30	Female
Georgia/Tb-22208/2020						GH	1.00	20C	Asia	Georgia	Asia	Tbilisi	Human	Asia	Department for Virology, Molecular Biology and Genome Research, R. G. Lugar Center for Public Health Research, National Center for Disease Control and Public Health (NCDC) of Georgia.	B.1	Asia	Asia	Department for Virology, Molecular Biology and Genome Research, R. G. Lugar Center for Public Health Research, National Center for Disease Control and Public Health (NCDC) of Georgia.		2020-05-29	Giorgi Tomashvili et al	[object Object]		Female
Canada/BC-BCCDC-3071/2020						GH	1.00	20C	North America	Canada	North America	British Columbia	Human	North America	BCCDC Public Health Laboratory	B.1.573	North America	North America	BCCDC Public Health Laboratory		2020-08-09	Prystajecky Natalie et al	[object Object]		
CostaRica/INC-0072/2020						GH	1.00	20C	North America	Costa Rica	North America	Alajuela	Human	North America	Area De Salud Alajuela Norte - Clinica Dr. Marcial Rodriguez	B.1.291	North America	North America	Inciensa, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud		2020-06-19	Francisco Duarte et al	[object Object]	27	Male
CostaRica/HNN-0359/2020						GH	1.00	20C	North America	Costa Rica	North America	Heredia	Human	North America	Inciensa, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud	B.1.291	North America	North America	Inciensa, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud		2020-05-31	Cristian Peréz-Corrales et al	[object Object]	40	Female
SaintLucia/LCA47897/2020						GH	2.00	20C	North America	Saint Lucia	North America	Saint Lucia	Human	North America	Caribbean Public Health Agency	B.1.369	North America	North America	Carrington Lab, Department of PreClinical Sciences, Faculty of Medical Sciences, The University of the West Indies		2020-12-23	Nikita S. D. Sahadeo et al	[object Object]		
Russia/ROS-RII-MH3425S/2020						GH	1.00	20C	Russia	Russia	Rostov	Rostov	Human	Kamensk-Shakhtinsky	HELIX LLC	B.1.264.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-06	Andrey Komissarov et al A	[object Object]	64	Male
Ecuador/UEES-INTERLAB-6660295/2021		0.04	0.34		0.24	GH	4.00	21F (Iota)	South America	Ecuador	South America	Los Rios EC	Human	South America	INTERLAB	B.1.526	South America	South America	Omics Sciences Laboratory		2021-05-27	Derly Andrade Molina et al	[object Object]	58	Male
Ecuador/UEES-HLV-20/2021		0.04	0.34		0.24	GH	4.00	21F (Iota)	South America	Ecuador	South America	Cañar	Human	South America	Hospital Luis Vernaza	B.1.526	South America	South America	Omics Sciences Laboratory		2021-05-26	Derly Andrade Molina et al	[object Object]	76	Female
DominicanRepublic/Yale-5416/2021		0.01	0.05	0.05	0.06	GH	6.00	20C	North America	Dominican Republic	North America	Dominican Republic	Human	North America	IMTSAG	B.1.526.1	North America	North America	Grubaugh Lab - Yale School of Public Health		2021-02-05	Joseph Fauver et al	[object Object]		
USA/MT-CDC-LC0064516/2021		0.01	0.05	0.05	0.06	GH	6.00	20C	North America	USA	North America	Montana	Human	North America	Laboratory Corporation of America	B.1.526.1	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-18	Dakota Howard et al	[object Object]	69	Female
USA/MD-HP06216/2021		0.01	0.05	0.05	0.06	GH	7.00	20C	North America	USA	North America	Maryland	Human	North America	Johns Hopkins Hospital Department of Pathology	B.1.526.1	North America	North America	Johns Hopkins Hospital Department of Pathology		2021-06-01	C. Paul Morris et al	[object Object]	45	Female
Russia/NGR-RII-MH17233S/2021		0.01	0.05	0.05	0.06	GH	5.00	20C	Russia	Russia	Novgorod	Novgorod	Human	Chudovo	HELIX LLC	B.1.526.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-13	Andrey Komissarov et al A	[object Object]	42	Male
Russia/SPE-RII-MH17271S/2021		0.01	0.05	0.05	0.06	GH	5.00	20C	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.526.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-13	Andrey Komissarov et al A	[object Object]	19	Male
Haiti/18256/2021		0.01	0.06	0.07	0.05	GH	3.00	20C	North America	Haiti	North America	Haiti	Human	North America	Laboratoire National de Santé Publique – LNSP (HAITI - LNSP)	B.1.575	North America	North America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2021-02-01	Paola Resende et al	[object Object]	45	
Spain/CM-IBV-98019324/2021		0.01	0.06	0.07	0.05	GH	3.00	20C	Spain	Spain	Spain	Castilla la Mancha	Human	Guadalajara	Hospital Universitario de Guadalajara	B.1.575.1	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2021-02-04	Alejandro González Praetorius y Mariela Martínez Ramírez et al	[object Object]	63	Male
Bonaire/BQ-RIVM-15965/2021		0.01	0.06	0.07	0.05	GH	3.00	20C	South America	Bonaire	South America	Bonaire	Human	South America	Dutch COVID-19 response team	B.1.575	South America	South America	National Institute for Public Health and the Environment (RIVM)		2021-02-24	Adam Meijer et al	[object Object]	37	
Bonaire/BQ-RIVM-16950/2021		0.01	0.06	0.07	0.05	GH	3.00	20C	South America	Bonaire	South America	Bonaire	Human	South America	Dutch COVID-19 response team	B.1.575	South America	South America	National Institute for Public Health and the Environment (RIVM)		2021-02-26	Adam Meijer et al	[object Object]	25	
Mexico/MIC-InDRE_FB15010_S2519/2021						GH	1.00	21C (Epsilon)	North America	Mexico	North America	Michoacan	Human	North America	LESP Michoacan	B.1.429	North America	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)		2021-05-17	Claudia Wong-Arambula et al	[object Object]	52	Male
USA/CA-CZB-30123/2021		0.01	0.05	0.05	0.06	GH	3.00	21C (Epsilon)	North America	USA	North America	California	Human	North America	County of San Luis Obispo Public Health Laboratory	B.1.427	North America	North America	Chan-Zuckerberg Biohub		2021-02-08	CZB Cliahub Consortium et al	[object Object]		
Anguilla/60300/2021		0.01	0.05	0.05	0.06	GH	4.00	21C (Epsilon)	South America	Anguilla	South America	Anguilla	Human	South America	The Caribbean Public Health Agency	B.1.427	South America	South America	Carrington Lab, Department of PreClinical Sciences, Faculty of Medical Sciences, The University of the West Indies		2021-03-19	Nikita S. D. Sahadeo et al	[object Object]		
Tunisia/23-MHT_15/2020						GH	1.00	20C	Africa	Tunisia	Africa	Bizerte	Human	Africa	Department of Virology, Principal Military Hospital of Instruction of Tunis	B.1.428.2	Africa	Africa	Bundeswehr Institute of Microbiology		2020-09-14	Susann Handrick et al	[object Object]	31	Female
Qatar/QA-WCMQ_FD18190051/2020						GH	1.00	20C	Asia	Qatar	Asia	Doha	Human	Asia	Ministry of Public Health / Hamad Medical Corporation	B.1.428	Asia	Asia	Weill Cornell Medical College - Qatar (WCM-Q), Genomics Core Laboratory / Qatar Genome Project (QGP)		2020-07-10	WCMQ: Ayeda A. Ahmed et al	[object Object]	45	Male
Qatar/QA-QU_12-11-A12/2020						GH	1.00	20C	Asia	Qatar	Asia	Doha	Human	Asia	Ministry of Public Health / Hamad Medical Corporation	B.1.428	Asia	Asia	Biomedical Research Center (BRC), Qatar University / Qatar Genome Project (QGP)		2020-11-15	BRC: Fatiha M. Benslimane et al	[object Object]	28	Male
Qatar/QA-QU_12-8-D10/2020						GH	2.00	20C	Asia	Qatar	Asia	Doha	Human	Asia	Ministry of Public Health / Hamad Medical Corporation	B.1.428	Asia	Asia	Biomedical Research Center (BRC), Qatar University / Qatar Genome Project (QGP)		2020-08-07	BRC: Fatiha M. Benslimane et al	[object Object]	12	Female
Qatar/QA-WCMQ_FD17059314/2020						GH	2.00	20C	Asia	Qatar	Asia	Doha	Human	Asia	Ministry of Public Health / Hamad Medical Corporation	B.1.428	Asia	Asia	Weill Cornell Medical College - Qatar (WCM-Q), Genomics Core Laboratory / Qatar Genome Project (QGP)		2020-06-02	WCMQ: Ayeda A. Ahmed et al	[object Object]		
Qatar/QA-QU_12-10-D1/2020						GH	2.00	20C	Asia	Qatar	Asia	Doha	Human	Asia	Ministry of Public Health / Hamad Medical Corporation	B.1.428	Asia	Asia	Biomedical Research Center (BRC), Qatar University / Qatar Genome Project (QGP)		2020-10-07	BRC: Fatiha M. Benslimane et al	[object Object]	42	Male
Qatar/QA-WCMQ_FD18163096/2020						GH	2.00	20C	Asia	Qatar	Asia	Doha	Human	Asia	Ministry of Public Health / Hamad Medical Corporation	B.1.428	Asia	Asia	Weill Cornell Medical College - Qatar (WCM-Q), Genomics Core Laboratory / Qatar Genome Project (QGP)		2020-08-20	WCMQ: Ayeda A. Ahmed et al	[object Object]	36	Male
Qatar/QA-WCMQ_FD18163131/2020						GH	2.00	20C	Asia	Qatar	Asia	Doha	Human	Asia	Ministry of Public Health / Hamad Medical Corporation	B.1.428	Asia	Asia	Weill Cornell Medical College - Qatar (WCM-Q), Genomics Core Laboratory / Qatar Genome Project (QGP)		2020-08-13	WCMQ: Ayeda A. Ahmed et al	[object Object]	40	Female
Qatar/QA-QU_12-11-F12/2020						GH	2.00	20C	Asia	Qatar	Asia	Doha	Human	Asia	Ministry of Public Health / Hamad Medical Corporation	B.1.428	Asia	Asia	Biomedical Research Center (BRC), Qatar University / Qatar Genome Project (QGP)		2020-11-21	BRC: Fatiha M. Benslimane et al	[object Object]	35	Female
Curacao/CW-RIVM-19607/2021		0.04	0.34		0.24	GH	3.00	20C	South America	Curacao	South America	Curacao	Human	South America	Dutch COVID-19 response team	B.1	South America	South America	National Institute for Public Health and the Environment (RIVM)		2021-03-10	Adam Meijer et al	[object Object]	23	
Spain/AR-IBV-98021778/2021		0.04	0.34		0.24	GH	3.00	20C	Spain	Spain	Spain	Aragon	Human	Zaragoza ES	Servicio de Microbiología, Hospital Miguel Servet, Zaragoza	B.1	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2021-02-15	Antonio Rezusta López et al	[object Object]	64	Female
Curacao/CW-RIVM-31692/2021	1.00	0.12	0.36	0.12	0.30	GH	8.00	20C	South America	Curacao	South America	Curacao	Human	South America	Dutch COVID-19 response team	B.1.623	South America	South America	National Institute for Public Health and the Environment (RIVM)		2021-04-28	Adam Meijer et al	[object Object]	18	
Curacao/CW-RIVM-35060/2021	1.00	0.12	0.36	0.12	0.30	GH	9.00	20C	South America	Curacao	South America	Curacao	Human	South America	Dutch COVID-19 response team	B.1.621	South America	South America	National Institute for Public Health and the Environment (RIVM)		2021-05-15	Adam Meijer et al	[object Object]	34	
Mexico/ROO-InDRE_FB16364_S2612/2021	1.00	0.12	0.36	0.12	0.30	GH	8.00	20C	North America	Mexico	North America	Quintana Roo	Human	North America	LESP Quintana Roo	B.1.621	North America	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)		2021-05-17	Claudia Wong-Arambula et al	[object Object]	70	Female
Spain/MC-ISCIII-214684/2021	1.00	0.12	0.36	0.12	0.30	GH	8.00	20C	Spain	Spain	Spain	Murcia	Human		HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA	B.1.621	Europe	Europe	Instituto de Salud Carlos III		2021-04-30	Sandonís et al	[object Object]	24	Male
Cameroon/Ebolowa-20v-13102/2020						G	1.00	20C	Africa	Cameroon	Africa	Ebolowa	Human	Africa	Centre Pasteur du Cameroun	B.1	Africa	Africa	Institut Pasteur de Dakar		2020-05-12	Njouom Richard et al	[object Object]	27	Male
Russia/TA-KFU_109/2020						G	1.00	20C	Russia	Russia	Tatarstan	Tatarstan	Human	Kazan	Kazan Federal University, Academic Consortium	B.1	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-09-14	Vladislav Babenko et al	[object Object]	77	Male
Angola/KRISP-K011703/2020		0.01	0.05	0.05	0.06	G	3.00	20C	Africa	Angola	Africa	Luanda	Human	Africa	Instituto Nacional de Investigação em Saúde	C.16	Africa	Africa	KRISP, KZN Research Innovation and Sequencing Platform		2020-12-30	Morais J et al	[object Object]	26	Male
Angola/CERI-KRISP-K013679/2020						G	1.00	20C	Africa	Angola	Africa	Luanda	Human	Africa	Instituto Nacional de Investigação em Saúde	B.1	Africa	Africa	CERI, Centre for Epidemic Response and Innvoation, Stellenbosch University and KRISP, KZN Research Innovation and Sequencing Platform, UKZN.		2020-09-30	Morais J et al	[object Object]	21	Male
Turkey/CTF_01042021_M044/2021		0.05	0.35	0.05	0.26	G	4.00	20C	Turkey	Turkey	Turkey	Istanbul	Human		IU-Cerrahpasa, Cerrahpasa School of Medicine, COVID-19 Lab	B.1.619	Europe	Europe	IU-Cerrahpasa, Cerrahpasa School of Medicine, COVID-19 Lab		2021-04-01	Mert Kuskucu et al	[object Object]		Male
Belgium/ULG-15197/2021		0.05	0.35	0.05	0.26	G	4.00	20C	Belgium	Belgium	Belgium	Luxembourg BE	Human		SYNLAB	B.1.619	Europe	Europe	GIGA Medical Genomics		2021-04-26	Keith Durkin et al	[object Object]	39	Female
France/BRE-IPP13108/2021		0.05	0.35	0.05	0.26	G	4.00	20C	France	France	France	Bretagne	Human	Chateaulin	Labo Analyses Med	B.1.619	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2021-05-25	Marion Barbet et al	[object Object]	61	Female
Togo/C6813/2021		0.04	0.34		0.24	G	7.00	21D (Eta)	Africa	Togo	Africa	Golfe	Human	Africa	Laboratoire Biolim/FSS/UL	B.1.525	Africa	Africa	Unité Mixte Internationale TransVIHMI (UMI 233 IRD – U1175 INSERM - Université de Montpellier) IRD (Institut de recherche pour le développement)		2021-02-11	Mounerou SALOU et al	[object Object]	49	Female
Nigeria/CV1332/2021		0.04	0.34		0.24	G	7.00	21D (Eta)	Africa	Nigeria	Africa	Rivers	Human	Africa	Nigeria Centre for Disease Control (NCDC)	B.1.525	Africa	Africa	African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer’s University		2021-02-13	Olawoye et al	[object Object]	56	Male
Bangladesh/BCSIR-NILMRC-718/2021		0.04	0.34		0.24	G	7.00	21D (Eta)	Asia	Bangladesh	Asia	Dhaka	Human	Asia	National Institute of Laboratory Medicine and Referral Center	B.1.525	Asia	Asia	Genomic Research Lab, BCSIR		2021-03-16	Md. Murshed Hasan Sarkar et al	[object Object]	23	Female
SouthSudan/UG415/2021		0.04	0.34		0.24	G	8.00	21D (Eta)	Africa	South Sudan	Africa	South Sudan	Human	Africa	National Public Health Laboratory, Ministry of Health, Ministry of Health, Republic of South Sudan	B.1.525	Africa	Africa	South Sudan Ministry of Health, WHO South Sudan, MRC/UVRI & LSHTM Uganda Research Unit		2021-03-15	Joseph Francis Wamala et al	[object Object]		
Italy/SIC-CQRC-21016098/2021		0.04	0.34		0.24	G	8.00	21D (Eta)	Italy	Italy	Italy	Sicily	Human	Palermo	CQRC_QUALITY CONTROL CHEMICAL BIOLOGICAL RISK_AOOR Villa Sofia Cervello Palermo	B.1	Europe	Europe	CQRC_QUALITY CONTROL CHEMICAL BIOLOGICAL RISK_AOOR Villa Sofia Cervello Palermo		2021-03-08	Di Gaudio et al	[object Object]	31	Male
Italy/MOL-ISE21040237233/2021		0.04	0.34		0.24	G	7.00	21D (Eta)	Italy	Italy	Italy	Molise	Human	Isernia	P.O.CARDARELLI	B.1.525	Europe	Europe	P.O.CARDARELLI		2021-04-25	Scutellà M et al	[object Object]	27	Male
Nigeria/CV954/2021		0.04	0.34		0.24	G	7.00	21D (Eta)	Africa	Nigeria	Africa	Abuja	Human	Africa	Nigerian Centre for Disease Control (NCDC)	B.1.525	Africa	Africa	African Centre of Excellence for Genomics of Infectious Diseases, Redeemer’s University		2021-01-13	Olawoye et al	[object Object]	50	Female
Norway/7297/2021		0.04	0.34		0.24	G	8.00	21D (Eta)	Norway	Norway	Norway	More Og Romsdal	Human		Department of Medical Microbiology - section Molde, Molde Hospital	B.1.525	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-03-17	Kathrine Stene-Johansen et al	[object Object]		
Nigeria/NCDC-FCT-11G/2021		0.04	0.34		0.24	G	7.00	21D (Eta)	Africa	Nigeria	Africa	Federal Capital Territory	Human	Africa	Nigeria Centre For Disease Control	B.1.525	Africa	Africa	National reference Laboratory, NCDC, Gaduwa, Abuja		2021-02-08	Dr Ndodo Nnaemeka et al	[object Object]	23	Female
Mali/INSP634/2021		0.04	0.34		0.24	G	7.00	21D (Eta)	Africa	Mali	Africa	Bamako	Human	Africa	INSP-Bamako	B.1.2	Africa	Africa	Malaria Research and Training Center		2021-04-04	Antoine Dara et al	[object Object]	65	Male
Nigeria/NCDC-FCT-8Q/2021		0.04	0.34		0.24	G	7.00	21D (Eta)	Africa	Nigeria	Africa	Abuja	Human	Africa	EHA Clinics	B.1.525	Africa	Africa	National Reference Laboratory, Nigeria Centre for Disease Control		2021-04-02	Dr Ndodo Nnaemeka et al	[object Object]	39	Male
Nigeria/NCDC-FCT-10T/2021		0.04	0.34		0.24	G	7.00	21D (Eta)	Africa	Nigeria	Africa	Abuja	Human	Africa	Demy Health	B.1.525	Africa	Africa	National Reference Laboratory, Nigeria Centre for Disease Control		2021-05-17	Dr Ndodo Nnaemeka et al	[object Object]	14	Male
France/PAC-HCL021099889201/2021		0.04	0.34		0.24	G	8.00	21D (Eta)	France	France	France	Provence-Alpes-Côte d'Azur	Human	Marseille	HIA LAVERAN	B.1.525	Europe	Europe	CNR Virus des Infections Respiratoires - France SUD		2021-06-01	Antonin Bal et al	[object Object]	23	Male
France/PAC-HCL021099895801/2021		0.04	0.34		0.24	G	8.00	21D (Eta)	France	France	France	Provence-Alpes-Côte d'Azur	Human	Marseille	HIA LAVERAN	B.1.525	Europe	Europe	CNR Virus des Infections Respiratoires - France SUD		2021-06-01	Antonin Bal et al	[object Object]	23	Male
France/COR-HCL021094223901/2021		0.04	0.34		0.24	G	8.00	21D (Eta)	France	France	France	Corse	Human	Sarrola-Carcopino	LABORATORIE DE LA GRAVONA	B.1.525	Europe	Europe	CNR Virus des Infections Respiratoires - France SUD		2021-05-17	Antonin Bal et al	[object Object]	31	Male
Russia/SPE-RII-32798S/2021		0.04	0.34		0.24	G	7.00	21D (Eta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.525	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-23	Andrey Komissarov et al A	[object Object]	73	Male
SouthSudan/UG422/2021		0.04	0.34		0.24	G	7.00	21D (Eta)	Africa	South Sudan	Africa	South Sudan	Human	Africa	National Public Health Laboratory, Ministry of Health, Ministry of Health, Republic of South Sudan	B.1.525	Africa	Africa	South Sudan Ministry of Health, WHO South Sudan, MRC/UVRI & LSHTM Uganda Research Unit		2021-02-05	Joseph Francis Wamala et al	[object Object]		
Gabon/CERMEL-X0187/2021	1.00	0.11	0.35	0.01	0.28	GH	3.00	20C	Africa	Gabon	Africa	Lambarene	Human	Africa	Centre de Recherches Médicales de Lambaréné (CERMEL)	B.1	Africa	Africa	Centre de Recherches Médicales de Lambaréné (CERMEL)		2021-02-10	Gédéon Prince Manouana et al	[object Object]	44	Female
Gabon/CERMEL-X0347/2021	1.00	0.11	0.35	0.01	0.28	GH	3.00	20C	Africa	Gabon	Africa	Lambarene	Human	Africa	Centre de Recherches Médicales de Lambaréné (CERMEL)	B.1	Africa	Africa	Centre de Recherches Médicales de Lambaréné (CERMEL)		2021-02-13	Gédéon Prince Manouana et al	[object Object]	31	Male
Angola/CERI-KRISP-K013423/2020	2.00	0.23	0.36	0.01	0.31	GH	5.00	20H (Beta, V2)	Africa	Angola	Africa	Luanda	Human	Africa	Instituto Nacional de Investigação em Saúde	B.1.351	Africa	Africa	CERI, Centre for Epidemic Response and Innvoation, Stellenbosch University and KRISP, KZN Research Innovation and Sequencing Platform, UKZN.		2020-08-25	Morais J et al	[object Object]	48	Male
Malawi/CERI-KRISP-K015336/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Africa	Malawi	Africa	Malawi	Human	Africa	National HIV Reference Laboratory, Ministry of Health, Public Health Institute of Malawi	B.1.351	Africa	Africa	KRISP, KZN Research Innovation and Sequencing Platform		2021-02-23	Mvula B et al	[object Object]	50	Male
Mozambique/INS-K011832/2020	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Africa	Mozambique	Africa	Maputo	Human	Africa	Instituto Nacional de Saude (INS), Mozambique	B.1.351	Africa	Africa	KRISP, KZN Research Innovation and Sequencing Platform		2020-11-03	Nalia Ismael et al	[object Object]	37	Female
Zimbabwe/CERI-KRISP-K011670/2020	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Africa	Zimbabwe	Africa	Masvingo	Human	Africa	National Microbiology Reference Laboratory, Ministry of Health, Harare, Zimbabwe	B.1.351	Africa	Africa	CERI, Centre for Epidemic Response and Innvoation, Stellenbosch University and KRISP, KZN Research Innovation and Sequencing Platform, UKZN.		2020-11-30	Air Comodor Dr J. Chimedza et al	[object Object]	34	Female
Mozambique/MZ-L-IBV-97025463/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Africa	Mozambique	Africa	Maputo	Human	Africa	Centro de Investigação em Saúde de Manhiça (CISM) & ISGlobal, Institut de Salut Global de Barcelona	B.1.351	Africa	Africa	Instituto de Biomedicina de València - CSIC		2021-02-28	Alfredo Mayor et al	[object Object]		Female
Botswana/BOT361367/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Africa	Botswana	Africa	Maun	Human	Africa	National Health Laboratory	B.1.351	Africa	Africa	Botswana Institute for Technology Research and Innovation		2021-02-05	Kefentse Arnold Tumedi et al	[object Object]	41	Female
Japan/IC-1283/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Asia	Philippines	Asia	Philippines	Human	Asia	SARS-CoV-2 testing team, National Institute of Infectious Diseases	B.1.351	Asia	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases		2021-05-16	Tsuyoshi Sekizuka et al B	[object Object]		
HongKong/HKPU-00186/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Asia	Hong Kong	Asia	Hong Kong	Human	Asia	Department of Health Technology and Informatics, The Hong Kong Polytechnic University	B.1.351	Asia	Asia	Department of Health Technology and Informatics, The Hong Kong Polytechnic University		2021-05-07	Cheng et al	[object Object]		
Zambia/ZMB-V65182/2020	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Africa	Zambia	Africa	Livingstone	Human	Africa	University of Zambia, School of Veterinary Medicine	B.1.351	Africa	Africa	UNZAVET and PATH		2020-12-01	Mulenga Mwenda-Chimfwembe et al	[object Object]	43	Female
Rwanda/NRLNAT4031/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Africa	Rwanda	Africa	Kigali	Human	Africa	Nucleic Acid Testing, National Reference Laboratory	B.1.351	Africa	Africa	GIGA Medical Genomics		2021-03-23	Yvan Butera et al	[object Object]	28	Female
Greece/54766/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Greece	Greece	Greece	Epirus	Human		Clinical and Basic Functional Sciences, Department of Microbiology	B.1.351	Europe	Europe	Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)		2021-01-22	Emmanouil Athanasiadis et al	[object Object]		Male
Greece/54170/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Greece	Greece	Greece	Epirus	Human		Clinical and Basic Functional Sciences, Department of Microbiology	B.1.351	Europe	Europe	Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)		2021-02-09	Emmanouil Athanasiadis et al	[object Object]		
Africa/NICD-N6518/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Africa	South Africa	Africa	Northern Cape	Human	Africa	KIMBERLEY LABORATORY	B.1.351	Africa	Africa	National Institute for Communicable Diseases of the National Health Laboratory Service		2021-03-19	Amoako DG et al	[object Object]	54	Female
NewZealand/21MV0043/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Oceania	New Zealand	Oceania	Auckland	Human	Oceania	Middlemore Hospital	B.1.351	Oceania	Oceania	Institute of Environmental Science and Research (ESR)		2021-02-03	Xiaoyun Ren et al	[object Object]		Female
Botswana/R06B50_BHP_AAB23985/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Africa	Botswana	Africa	Gaborone	Human	Africa	Botswana Harvard HIV Reference Laboratory	B.1.351	Africa	Africa	Botswana Harvard HIV Reference Laboratory		2021-03-11	Sikhulile Moyo et al	[object Object]	26	Male
SouthAfrica/KRISP-K012124/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Africa	South Africa	Africa	KwaZulu-Natal	Human	Africa	National Health Laboratory Service, South Africa	B.1.351	Africa	Africa	KRISP, KZN Research Innovation and Sequencing Platform		2021-03-15	Giandhari J et al	[object Object]	25	Male
Malawi/CERI-KRISP-K015259/2021	2.00	0.23	0.36	0.01	0.31	GH	9.00	20H (Beta, V2)	Africa	Malawi	Africa	Malawi	Human	Africa	National HIV Reference Laboratory, Ministry of Health, Public Health Institute of Malawi	B.1.351	Africa	Africa	CERI, Centre for Epidemic Response and Innvoation, Stellenbosch University and KRISP, KZN Research Innovation and Sequencing Platform, UKZN.		2021-03-05	Mvula B et al	[object Object]	26	Male
SouthAfrica/NHLS-UCT-GS-B399/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Africa	South Africa	Africa	Western Cape Province	Human	Africa	2 Military Hospital wc MAA	B.1.351	Africa	Africa	NHLS/UCT		2021-03-26	Arash Iranzadeh et al	[object Object]	42	Female
Russia/SPE-RII-MH15726S/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	33	Female
Ireland/RN-NVRL-21IRL39307/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Ireland	Ireland	Ireland	Roscommon	Human		National Virus Reference Laboratory	B.1.351	Europe	Europe	National Virus Reference Laboratory		2021-02-03	Zoe Yandle et al	[object Object]		Female
Ireland/RN-NVRL-21IRL40378/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Ireland	Ireland	Ireland	Roscommon	Human		National Virus Reference Laboratory	B.1.351	Europe	Europe	National Virus Reference Laboratory		2021-02-10	Zoe Yandle et al	[object Object]		Female
Belgium/rega-3360/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Belgium	Belgium	Belgium	Sint-Niklaas	Human	Kieldrecht	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.351	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2021-02-16	Tony Wawina-Bokalanga et al	[object Object]	46	Female
Russia/MOW-CRIE-D187L0061b/2021	1.00	0.11	0.35	0.01	0.28	GH	3.00	20H (Beta, V2)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.351	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-13	Samoilov A.E. et al	[object Object]	51	Female
Coted-Ivoire/COV-BKE2486/bc56/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Africa	Côte d'Ivoire	Africa	Niakara	Human	Africa	Molecular diagnostic unit for viral haemorrhagic fevers and emerging viruses, Bouaké CHU Laboratory	B.1.351	Africa	Africa	Molecular diagnostic unit for viral haemorrhagic fevers and emerging viruses, Bouaké CHU Laboratory		2021-03-06	Chantal Akoua-Koffi et al	[object Object]	55	Male
Zimbabwe/CERI-KRISP-K011513/2021	2.00	0.23	0.36	0.01	0.31	G	8.00	20H (Beta, V2)	Africa	Zimbabwe	Africa	Harare	Human	Africa	National Microbiology Reference Laboratory, Ministry of Health, Harare, Zimbabwe	B.1.351	Africa	Africa	CERI, Centre for Epidemic Response and Innvoation, Stellenbosch University and KRISP, KZN Research Innovation and Sequencing Platform, UKZN.		2021-02-02	Air Comodor Dr J. Chimedza et al	[object Object]	36	Male
Mozambique/INS-K011862/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Africa	Mozambique	Africa	Maputo	Human	Africa	Instituto Nacional de Saude (INS), Mozambique	B.1.351	Africa	Africa	KRISP, KZN Research Innovation and Sequencing Platform		2021-02-22	Nalia Ismael et al	[object Object]	69	Male
Malawi/CERI-KRISP-K015338/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Africa	Malawi	Africa	Malawi	Human	Africa	National HIV Reference Laboratory, Ministry of Health, Public Health Institute of Malawi	B.1.351	Africa	Africa	KRISP, KZN Research Innovation and Sequencing Platform		2021-02-19	Mvula B et al	[object Object]	28	Female
Australia/SA0727/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Oceania	Australia	Oceania	South Australia	Human	Oceania	SA Pathology	B.1.351	Oceania	Oceania	SA Pathology		2021-05-23	Caitlin Selway et al	[object Object]		Male
Reunion/HCL021099132301/2021	2.00	0.23	0.36	0.01	0.31	GH	9.00	20H (Beta, V2)	France	France	France	Réunion	Human	Saint-Denis de la Réunion	CERBALLIANCE REUNION	B.1.351.2	Europe	Europe	CNR Virus des Infections Respiratoires - France SUD		2021-05-25	Antonin Bal et al	[object Object]	43	Male
Madagascar/IPM-02260/2021	2.00	0.23	0.36	0.01	0.31	GH	9.00	20H (Beta, V2)	Africa	Madagascar	Africa	Boeny	Human	Africa	Virology Unit, Institut Pasteur de Madagascar	B.1.351.2	Africa	Africa	Virology Unit, Institut Pasteur de Madagascar		2021-03-01	Christian Ranaivoson et al	[object Object]	28	Male
Madagascar/IPM-02257/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Africa	Madagascar	Africa	Boeny	Human	Africa	Virology Unit, Institut Pasteur de Madagascar	B.1.351.2	Africa	Africa	Virology Unit, Institut Pasteur de Madagascar		2021-03-01	Christian Ranaivoson et al	[object Object]	39	Male
Reunion/PIMIT_06017/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	France	France	France	France	Human		REUNILAB	B.1.351.2	Europe	Europe	UMR PIMIT		2021-03-29	Dr David A Wilkinson et al	[object Object]	68	Male
Madagascar/IPM-02219/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Africa	Madagascar	Africa	Diana	Human	Africa	Virology Unit, Institut Pasteur de Madagascar	B.1.351.2	Africa	Africa	Virology Unit, Institut Pasteur de Madagascar		2021-02-22	Christian Ranaivoson et al	[object Object]	22	Male
Madagascar/IPM-02259/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Africa	Madagascar	Africa	Boeny	Human	Africa	Virology Unit, Institut Pasteur de Madagascar	B.1.351.2	Africa	Africa	Virology Unit, Institut Pasteur de Madagascar		2021-03-01	Christian Ranaivoson et al	[object Object]	46	Female
Bangladesh/BCSIR-NILMRC-774/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Asia	Bangladesh	Asia	B.Baria	Human	Asia	National Institute of Laboratory Medicine and Referral Center	B.1.351.3	Asia	Asia	Genomic Research Lab, BCSIR		2021-05-18	Md. Murshed Hasan Sarkar et al	[object Object]	45	Female
Bangladesh/BCSIR-NILMRC-758/2021	1.00	0.12	0.35	0.02	0.31	O	8.00	20H (Beta, V2)	Asia	Bangladesh	Asia	Chattogram	Human	Asia	National Institute of Laboratory Medicine and Referral Center	B.1.351.3	Asia	Asia	Genomic Research Lab, BCSIR		2021-05-18	Md. Murshed Hasan Sarkar et al	[object Object]	50	Female
Bangladesh/BCSIR-NILMRC-761/2021	2.00	0.23	0.36	0.01	0.31	O	9.00	20H (Beta, V2)	Asia	Bangladesh	Asia	Chattogram	Human	Asia	National Institute of Laboratory Medicine and Referral Center	B.1.351	Asia	Asia	Genomic Research Lab, BCSIR		2021-05-18	Md. Murshed Hasan Sarkar et al	[object Object]	24	Male
Bangladesh/ideSHi-N-1483/2021	2.00	0.23	0.36	0.01	0.31	GH	9.00	20H (Beta, V2)	Asia	Bangladesh	Asia	Dhaka	Human	Asia	Institute for Developing Science and Health Initiatives (ideSHi)	B.1.351.3	Asia	Asia	Institute for Developing Science and Health Initiatives (ideSHi)		2021-03-29	Hassan Afrad et al	[object Object]	52	Male
Bangladesh/BCSIR-NILMRC-730/2021	2.00	0.23	0.36	0.01	0.31	GH	9.00	20H (Beta, V2)	Asia	Bangladesh	Asia	Dhaka	Human	Asia	National Institute of Laboratory Medicine and Referral Center	B.1.351.3	Asia	Asia	Genomic Research Lab, BCSIR		2021-03-16	Md. Maruf Ahmed Molla et al	[object Object]	46	Male
Bangladesh/CHRF-0210/2021	2.00	0.23	0.36	0.01	0.31	GH	9.00	20H (Beta, V2)	Asia	Bangladesh	Asia	Barishal	Human	Asia	Child Health Research Foundation	B.1.351.3	Asia	Asia	Child Health Research Foundation		2021-03-27	CHRF Bangladesh Genomics Team et al	[object Object]	62	Male
Bangladesh/CHRF-0192/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Asia	Bangladesh	Asia	Dhaka	Human	Asia	Child Health Research Foundation	B.1.351.3	Asia	Asia	Child Health Research Foundation		2021-03-21	CHRF Bangladesh Genomics Team et al	[object Object]	32	Male
Jordan/AM-Biolab013/2021	2.00	0.23	0.36	0.01	0.31	GH	9.00	20H (Beta, V2)	Asia	Jordan	Asia	Amman	Human	Asia	Biolab Diagnostic Laboratories	B.1.351.3	Asia	Asia	Biolab Diagnostic Laboratories		2021-03-07	Issa Abu-Dayyeh et al	[object Object]		
Bangladesh/CHRF-0348/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Asia	Bangladesh	Asia	Sylhet	Human	Asia	Child Health Research Foundation	B.1.351.3	Asia	Asia	Child Health Research Foundation		2021-05-26	CHRF Bangladesh Genomics Team et al	[object Object]	37	Male
Belgium/CHUNamur13290645/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Belgium	Belgium	Belgium	Luxembourg BE	Human		Arlon	B.1.351	Europe	Europe	Plateforme de testing Namuroise		2021-03-29	Céline Maschietto et al	[object Object]	57	Female
CzechRepublic/NRL_8083/2021	2.00	0.23	0.36	0.01	0.31	GH	9.00	20H (Beta, V2)	Czech Republic	Czech Republic	Czech Republic	Moravian-Silesian Region	Human	Ostrava	National Institute of Public Health	B.1.351	Europe	Europe	State Veterinary Institute Prague		2021-05-17	Nagy et al	[object Object]	46	Male
EquatorialGuinea/78388/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Africa	Equatorial Guinea	Africa	Equatorial Guinea	Human	Africa	Laboratorio de Investigaciones de Baney	B.1.351	Africa	Africa	Swiss Tropical and Public Health Institute		2021-04-01	Salome Hosch et al	[object Object]		
Mozambique/MZ-L-IBV-97025340/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Africa	Mozambique	Africa	Maputo	Human	Africa	Centro de Investigação em Saúde de Manhiça (CISM) & ISGlobal, Institut de Salut Global de Barcelona	B.1.351	Africa	Africa	Instituto de Biomedicina de València - CSIC		2021-02-01	Alfredo Mayor et al	[object Object]	39	Male
Belgium/AZDelta-14642-2110R/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Belgium	Belgium	Belgium	Tournai-Mouscron	Human	Houthem	AZDelta	B.1.351	Europe	Europe	AZDelta		2021-03-17	Geert Martens et al	[object Object]		
Belgium/AZDelta-19810A/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Belgium	Belgium	Belgium	Kortrijk	Human	Wevelgem	AZDelta	B.1.351	Europe	Europe	AZDelta		2021-02-11	Geert Martens et al	[object Object]	22	Female
Belgium/AZDelta/14429-2108R/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Belgium	Belgium	Belgium	Roeselare	Human		AZDelta	B.1.351.3	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-03-05	Geert Martens et al	[object Object]		
Belgium/AZDelta-06722-2109R/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Belgium	Belgium	Belgium	Diksmuide	Human		AZDelta	B.1.351	Europe	Europe	AZDelta		2021-03-01	Geert Martens et al	[object Object]		
Belgium/AZDelta-03029-2110R/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Belgium	Belgium	Belgium	Brugge	Human	Zedelgem	AZDelta	B.1.351.3	Europe	Europe	AZDelta		2021-03-08	Geert Martens et al	[object Object]		
Belgium/AZDelta/14645-2108R/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Belgium	Belgium	Belgium	Oostende	Human	Gistel	AZDelta	B.1.351	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-03-05	Geert Martens et al	[object Object]		
Belgium/AZDelta/20051-2108R/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Belgium	Belgium	Belgium	Oostende	Human	Gistel	AZDelta	B.1.351	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-03-05	Geert Martens et al	[object Object]		
Russia/MOS-CRIE-L106D2348b/2021	2.00	0.23	0.36	0.01	0.31	GH	7.00	20H (Beta, V2)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.351	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-07	Samojlov A.E. et al	[object Object]	68	Female
Russia/AMU-RII-MH18376S/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Russia	Russia	Amur Region	Amur Region	Human	Svobodny (Amur)	SOGAZ PROFMEDICINA LLC	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-04	Andrey Komissarov et al A	[object Object]	28	Male
Russia/SPE-RII-MH17226S/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-06	Andrey Komissarov et al A	[object Object]	78	Female
Eswatini/N4796/2021	2.00	0.24	0.36	0.02	0.32	GH	9.00	20H (Beta, V2)	Africa	Eswatini	Africa	Hhohho	Human	Africa	Lobamba	B.1.351	Africa	Africa	National Institute for Communicable Diseases of the National Health Laboratory Service		2021-02-23	Maphalala GP et al	[object Object]	36	Female
Eswatini/N4806/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Africa	Eswatini	Africa	Manzini	Human	Africa	TLC	B.1.351	Africa	Africa	National Institute for Communicable Diseases of the National Health Laboratory Service		2021-03-04	Maphalala GP et al	[object Object]	41	Male
Eswatini/N4805/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Africa	Eswatini	Africa	Mbabane	Human	Africa	Mbabane Public Health	B.1.351	Africa	Africa	National Institute for Communicable Diseases of the National Health Laboratory Service		2021-03-23	Maphalala GP et al	[object Object]	4	Male
Russia/MOW-CRIE-D187L7/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Russia	Tanzania	Moscow Oblast	Tanzania	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.351	Europe	Africa	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-02-15	Samoilov AE et al	[object Object]	42	Male
Malawi/KRISP-K010254/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Africa	Malawi	Africa	Southern Region MW	Human	Africa	National HIV Reference Laboratory, Ministry of Health, Public Health Institute of Malawi	B.1.351	Africa	Africa	KRISP, KZN Research Innovation and Sequencing Platform		2021-01-21	Mvula B et al	[object Object]	32	Female
Rwanda/NRLNAT3065/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Africa	Rwanda	Africa	Kigali	Human	Africa	Nucleic Acid Testing, National Reference Laboratory	B.1.351	Africa	Africa	GIGA Medical Genomics		2021-02-05	Yvan Butera et al	[object Object]	21	Female
Romania/VL-6119/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Romania	Romania	Romania	Valcea	Human		Ilfov County Emergency Clinical Hospital	B.1.351	Europe	Europe	National Institute of Infectious Diseases-Prof. Dr. Matei Bals Molecular Diagnostics Laboratory		2021-03-24	Corina Casangiu et al	[object Object]	69	Female
Russia/MOW-CRIE-L188K0250u/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.351	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-11	Samoilov AE et al	[object Object]	29	Female
Russia/BEL-RII-MH17672S/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-29	Andrey Komissarov et al A	[object Object]	28	
Thailand/CU-SI2107327-NT/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Asia	Tanzania	Asia	Tanzania	Human	Asia	Thai Red Cross Emerging Infectious Diseases Health Science Centre, Chulalongkorn Hospital, Faculty of Medicine, Chulalongkorn University	B.1.351	Asia	Africa	Thai Red Cross Emerging Infectious Diseases Center and Faculty of Medicine, Chulalongkorn University		2021-02-12	Rome Buathong et al	[object Object]	66	Female
Russia/SVE-RII-MH15058S/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Shadrinsk	UMMC-Health	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-13	Andrey Komissarov et al A	[object Object]	40	Male
CzechRepublic/NRL_4744/2021	2.00	0.23	0.36	0.01	0.31	GH	8.00	20H (Beta, V2)	Czech Republic	Czech Republic	Czech Republic	Karlovy Vary	Human		National Institute of Public Health	B.1.351	Europe	Europe	State Veterinary Institute Prague		2021-03-05	Nagy et al	[object Object]	59	Female
Switzerland/TG-ETHZ-100239/2020						G	1.00	20A	Switzerland	Switzerland	Switzerland	Thurgau	Human		Viollier AG	B.1	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-03-18	Christian Beisel et al	[object Object]		
Croatia/1560_Split/2020						G	1.00	20A	Croatia	Croatia	Croatia	Split	Human		University Hospital for Infectious Diseases "Dr. Fran Mihaljević", Research Unit	B.1	Europe	Europe	University of Zagreb, Centre for research and knowledge transfer in biotechnology		2020-03-18	Ivan-Christian Kurolt et al	[object Object]	25	Male
Russia/Tver-72601/2020						G	1.00	20A	Russia	Russia	Tver	Tver	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-19	Sergey A. Bodnev et al	[object Object]	58	Female
Denmark/DCGC-1824/2020						G	2.00	20A	Denmark	Denmark	Denmark	Sjaelland	Human		Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Denmark	B.1.179	Europe	Europe	Albertsen lab, Department of Chemistry and Bioscience, Aalborg University, Denmark		2020-03-30	Danish Covid-19 Genome Consortia et al	[object Object]		
Denmark/DCGC-1526/2020						G	1.00	20A	Denmark	Denmark	Denmark	Sjaelland	Human		Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Denmark	B.1.179	Europe	Europe	Albertsen lab, Department of Chemistry and Bioscience, Aalborg University, Denmark		2020-06-08	Danish Covid-19 Genome Consortia et al	[object Object]		
Denmark/DCGC-1207/2020						G	1.00	20A	Denmark	Denmark	Denmark	Hovedstaden	Human		Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Denmark	B.1.179	Europe	Europe	Albertsen lab, Department of Chemistry and Bioscience, Aalborg University, Denmark		2020-05-25	Danish Covid-19 Genome Consortia et al	[object Object]		
Croatia/AU-S10new/2020						G	1.00	20A	Croatia	Croatia	Croatia	Istria	Human		Institute for Public Health	B.1	Europe	Europe	Laboratory for advanced genomics		2020-04-09	Filip Rokić et al	[object Object]	31	Female
Georgia/Tb/2020						G	1.00	20A	Asia	Georgia	Asia	Tbilisi	Human	Asia	R. G. Lugar Center for Public Health Research, National Center for Disease Control and Public Health (NCDC) of Georgia.	B.1.91	Asia	Asia	R. G. Lugar Center for Public Health Research, National Center for Disease Control and Public Health (NCDC) of Georgia.		2020-03-13	Adam Kotorashvili et al	[object Object]	35	Male
Slovenia/5027/2020						G	2.00	20A	Slovenia	Slovenia	Slovenia	Slovenia	Human		Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana	B.1	Europe	Europe	Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana		2020-03-08	Samo Zakotnik et al	[object Object]	74	Male
Poland/PL_P40/2020						G	1.00	20A	Poland	Poland	Poland	Warminsko-Mazurskie	Human	Olsztyn	1. ViroGenetics - BSL3 Laboratory of Virology, Małopolska Centre of Biotechnology, Jagiellonian University; 2. II Department of Internal Medicine, Faculty of Medicine, Jagiellonian University Medical College; 3. Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny (NIZP-PZH)	B.1	Europe	Europe	1. ViroGenetics - BSL3 Laboratory of Virology, Małopolska Centre of Biotechnology, Jagiellonian University; 2. II Department of Internal Medicine, Faculty of Medicine, Jagiellonian University Medical College; 3. Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny (NIZP-PZH).		2020-03-05	Katarzyna Pancer et al	[object Object]	63	Female
Russia/Samara-73406/2020						G	1.00	20A	Russia	Russia	Samara	Samara	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-20	Oleg V. Pyankov et al	[object Object]	22	Male
Kuwait/KU006/2020						O	1.00	20A	Asia	Italy	Asia	Italy	Human	Asia	Jaber Al Ahmad Al Sabah Hospital	B.1	Asia	Europe	Dasman diabetes Institute		2020-03-15	Fahd Al-Mulla et al	[object Object]	37	Male
SaintMartin/IPG-7354/2020						G	1.00	20A	North America	Saint Martin	North America	Saint Martin	Human	North America	Institut Pasteur de la Guadeloupe	B.1	North America	North America	Institut Pasteur de la Guadeloupe		2020-04-02	Marion Barbet et al	[object Object]	50	Male
Malaysia/IMR_WC342772/2020						G	1.00	20A	Asia	Malaysia	Asia	Malaysia	Human	Asia	Institute for Medical Research, Infectious Disease Research Centre, National Institutes of Health, Ministry of Health Malaysia	B.1.524	Asia	Asia	Institute for Medical Research, Infectious Disease Research Centre, National Institutes of Health, Ministry of Health Malaysia		2020-12-14	Suppiah J et al	[object Object]	34	Female
Russia/SPE-RII-MH14300S/2021						GV	2.00	20A	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-01-18	Andrey Komissarov et al A	[object Object]	23	Female
Russia/SVE-RII-MH16165S/2021						G	2.00	20A	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-28	Andrey Komissarov et al A	[object Object]	72	Male
Belgium/rega-1626/2021						G	2.00	20A	Belgium	Belgium	Belgium	Tournai-Mouscron	Human	Mouscron	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2021-01-03	Tony Wawina-Bokalanga et al	[object Object]	16	Female
Germany/SH-ChVir20024/2020						G	1.00	20A	Germany	Germany	Germany	Schleswig-Holstein	Human		A. Krumbholz, Labor Dr. Krause und Kollegen MVZ GmbH, Kiel	B.1.88.1	Europe	Europe	Charité Universitätsmedizin Berlin, Institut für Virologie		2020-11-05	Victor M Corman et al	[object Object]		
Bulgaria/21BG-NC_A000022/2020		0.01	0.01		0.01	G	2.00	20A	Bulgaria	Bulgaria	Bulgaria	Montana BG	Human		National Center of Infectious and Parasitic Diseases	B.1	Europe	Europe	National Center of Infectious and Parasitic Diseases		2020-12-09	Alexiev et al	[object Object]	67	Female
Kenya/C64798/2020						G	1.00	20A	Africa	Kenya	Africa	Taita Taveta	Human	Africa	KEMRI-Wellcome Trust Research Programme/KEMRI-CGMR-C Kilifi	B.1	Africa	Africa	KEMRI-Wellcome Trust Research Programme/KEMRI-CGMR-C Kilifi		2020-10-14	Githinji et al	[object Object]	10	Female
Kenya/C3216/2020						G	1.00	20A	Africa	Kenya	Africa	Kenya	Human	Africa	KEMRI-CGMR-C	B.1	Africa	Africa	KEMRI-Wellcome Trust Research Programme/KEMRI-CGMR-C Kilifi		2020-04-28	Githinji G. et al 2020 et al (https://virological.org/t/introduction-and-local-transmission-of-sars-cov-2-cases-in-kenya/497)	[object Object]		Male
Panama/GMI-PA462137/2020		0.01	0.01		0.01	G	2.00	20A	North America	Panama	North America	San Miguelito	Human	North America	Gorgas Memorial Laboratory of Health Studies	B.1	North America	North America	Gorgas Memorial Laboratory of Health Studies		2020-08-17	Yamilka Diaz et al	[object Object]	5	Female
Kenya/C23589/2020						G	1.00	20A	Africa	Kenya	Africa	Mombasa	Human	Africa	KEMRI-Wellcome Trust Research Programme/KEMRI-CGMR-C Kilifi	B.1	Africa	Africa	KEMRI-Wellcome Trust Research Programme/KEMRI-CGMR-C Kilifi		2020-06-24	Githinji et al	[object Object]	34	Female
Netherlands/ZE-EMC-53/2020						G	1.00	20A	Netherlands	Netherlands	Netherlands	Zeeland	Human		Dutch COVID-19 response team	B.1	Europe	Europe	Erasmus Medical Center		2020-06-01	Bas Oude Munnink et al	[object Object]		
Haiti/34042/2020						G	2.00	20A	North America	Haiti	North America	Haiti	Human	North America	Laboratoire National de Santé Publique – LNSP (HAITI - LNSP)	B.1.126	North America	North America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-12-24	Paola Resende et al	[object Object]		
Malaysia/UNIMAS-1589/2020						G	1.00	20A	Asia	Malaysia	Asia	Sarawak	Human	Asia	Ministry of Health Hospitals	B.1	Asia	Asia	Institute of Health and Community Medicine		2020-04-13	David Perera et al	[object Object]	68	Male
Ireland/WD-NVRL-20IRL80814/2020						G	1.00	20A	Ireland	Ireland	Ireland	Waterford	Human		National Virus Reference Laboratory	B.1	Europe	Europe	National Virus Reference Laboratory		2020-04-18	Michael Carr et al	[object Object]		Female
Italy/TUS-UOS-15/2020						G	1.00	20A	Italy	Italy	Italy	Tuscany	Human	Siena	Dipartimento di Biotecnologie Mediche, University of Siena	B.1	Europe	Europe	Dipartimento di Biotecnologie Mediche, University of Siena		2020-05-14	Cusi et al	[object Object]		
DRC/10502/2020						G	1.00	20A	Africa	Democratic Republic of the Congo	Africa	Nord Kivu	Human	Africa	Viral Respiratory Lab, National Institute for Biomedical Research (INRB)	B.1	Africa	Africa	Pathogen Sequencing Lab, National Institute for Biomedical Research (INRB)		2020-05-20	Placide Mbala-Kingebeni et al A	[object Object]	28	Male
CzechRepublic/NRL-6847-2/2020						G	1.00	20A	Czech Republic	Czech Republic	Czech Republic	Usti nad Labem	Human	Litomerice	The National Institute of Public Health	B.1	Europe	Europe	State Veterinary Institute Prague		2020-05-10	Nagy et al	[object Object]	66	Female
Peru/CAL-INS-662/2020						G	1.00	20A	South America	Peru	South America	Callao	Human	South America	Laboratorio de Referencia Nacional de Virus Respiratorio. Instituto Nacional de Salud Perú	B.1	South America	South America	Laboratorio de Referencia Nacional de Enteropatógenos. Instituto Nacional de Salud del Perú		2020-05-08	Ronnie Gavilan Chavez et al	[object Object]		
Gabon/CERMEL-S0814/2021						G	1.00	20A	Africa	Gabon	Africa	Lambarene	Human	Africa	Centre de Recherches Médicales de Lambaréné (CERMEL)	B.1.112	Africa	Africa	Centre de Recherches Médicales de Lambaréné (CERMEL)		2020-07-25	Gédéon Prince Manouana et al	[object Object]	33	Male
Botswana/R8B12_BHP_AAB8086/2020						G	1.00	20A	Africa	Botswana	Africa	Gaborone	Human	Africa	Botswana Harvard HIV Reference Laboratory	B.1.1.54	Africa	Africa	Botswana Harvard HIV Reference Laboratory		2020-11-30	Sikhulile Wonderful T. Choga et al	[object Object]	40	Female
env/Austria/CeMM4228/2021						G	2.00	20A	Austria	Austria	Austria	Salzburg	Environment		Department of Microbiology, University Innsbruck	B.1	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-02-07	Lukas Endler et al	[object Object]		
Ecuador/USFQ-1510/2021						G	1.00	20A	South America	Ecuador	South America	Pichincha	Human	South America	Institute of Microbiology, Universidad San Francisco de Quito	B.1	South America	South America	Institute of Microbiology, Universidad San Francisco de Quito		2021-06-05	Belén Prado-Vivar et al	[object Object]		Female
Russia/MOW-RII-MH15904/2021		0.01			0.01	G	2.00	20A	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Rublevo	Pathogenic Microorganisms Variability Laboratory	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-02	Andrey Komissarov et al A	[object Object]	78	Male
SouthAfrica/KRISP-0041/2020						G	1.00	20A	Africa	South Africa	Africa	KwaZulu-Natal	Human	Africa	NHLS-IALCH	B.1	Africa	Africa	KRISP, KZN Research Innovation and Sequencing Platform		2020-03-25	Giandhari J et al	[object Object]	78	Female
SaintMartin/IPG-7348/2020						G	1.00	20A	North America	Saint Martin	North America	Saint Martin	Human	North America	Institut Pasteur de la Guadeloupe	B.1	North America	North America	Institut Pasteur de la Guadeloupe		2020-03-28	Marion Barbet et al	[object Object]	54	Male
Cuba/USAFSAM-S031/2020						G	2.00	20A	North America	Cuba	North America	Cuba	Human	North America	Public Health, United States Air Force School of Aerospace Medicine	B.1.378	North America	North America	Public Health, United States Air Force School of Aerospace Medicine		2020-03-24	Fries et al	[object Object]	63	Male
Bahamas/33821/2020						G	1.00	20A	North America	Bahamas	North America	Bahamas	Human	North America	Reference Laboratory of the Ministry of Health	B.1.378	North America	North America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-03-31	Paola Resende et al	[object Object]		
Bahamas/33820/2020						G	1.00	20A	North America	Bahamas	North America	Bahamas	Human	North America	Reference Laboratory of the Ministry of Health	B.1.378	North America	North America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-03-29	Paola Resende et al	[object Object]		
Russia/StPetersburg-RII4326S/2020						G	1.00	20A	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-03-25	Andrey Komissarov et al B (https://dx.doi.org/10.1101/2020.07.14.20150979)	[object Object]	36	Male
Tunisia/ADAGE-15425/2020		0.01	0.01		0.02	G	2.00	20A	Africa	Tunisia	Africa	Sfax	Human	Africa	Laboratoire de Microbiologie- CHU Habib Bourguiba – Sfax adresse	B.1	Africa	Africa	Laboratoire des Procédés de Criblage Moléculaire et Cellulaire-Centre de Biotechnologie de Sfax		2020-09-21	Souissi et al	[object Object]		
Russia/MOS-RII-MH16254S/2021						O	3.00	20E (EU1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Balashikha	HELIX LLC	B.1.177	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-26	Andrey Komissarov et al A	[object Object]	50	Male
Morocco/FMP-57/2020						GV	2.00	20E (EU1)	Africa	Morocco	Africa	Temara	Human	Africa	Laboratoire Biolife	B.1.177	Africa	Africa	Laboratoire de Biotechnologie		2020-12-21	Mouna Ouadghiri et al	[object Object]	29	Female
Italy/MAR-UnivPM34_55760/2020						GV	3.00	20E (EU1)	Italy	Italy	Italy	Marche	Human		Virology Laboratory, Department of Biomedical Sciences and Public Health, University Politecnica delle Marche	B.1.177.33	Europe	Europe	Virology and Legal Medicine Laboratories, Department of Biomedical Sciences and Public Health, University Politecnica delle Marche		2020-10-09	Sara Caucci et al	[object Object]	7	Female
Ireland/MH-NVRL-20IRL82653/2020						GV	3.00	20E (EU1)	Ireland	Ireland	Ireland	Meath	Human		National Virus Reference Laboratory	B.1.177.39	Europe	Europe	National Virus Reference Laboratory		2020-10-05	Michael Carr et al	[object Object]		Male
Switzerland/VS-ETHZ-410082/2020						GV	2.00	20E (EU1)	Switzerland	Switzerland	Switzerland	Valais	Human		Viollier AG	B.1.177.44	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-12-17	Chaoran Chen et al	[object Object]		
Switzerland/GR-SNRCI-4719/2020						GV	2.00	20E (EU1)	Switzerland	Switzerland	Switzerland	Graubünden	Human		Swiss National Reference Centre for Influenza	B.1.177.44	Europe	Europe	Swiss National Reference Centre for Influenza		2020-10-19	Ana Rita Gonçalves Cabecinhas et al	[object Object]	49	
Netherlands/NB-RIVM-20273/2020						GV	2.00	20E (EU1)	Netherlands	Netherlands	Netherlands	North Brabant	Human		Dutch COVID-19 response team	B.1.177	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2020-11-26	Adam Meijer et al	[object Object]	76	
Denmark/DCGC-47808/2021						GV	2.00	20E (EU1)	Denmark	Denmark	Denmark	Midtjylland	Human		Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark	B.1.177.12	Europe	Europe	Aalborg University		2021-02-08	Danish Covid-19 Genome Consortium et al	[object Object]		
Croatia/472/2021						GV	2.00	20E (EU1)	Croatia	Croatia	Croatia	Istria	Human		Public Health Institute of Istra County	B.1.177.35	Europe	Europe	Croatian Institute of Public Health		2021-02-15	Irena Tabain et al	[object Object]	85	Male
Austria/CeMM7825/2020						GV	2.00	20E (EU1)	Austria	Austria	Austria	Lower Austria	Human	Hainfeld	Department of Laboratory Medicine, Division of Clinical Virology, University of Medicine, Vienna	B.1.177	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2020-11-30	Lukas Endler et al	[object Object]	48	Male
Norway/3186/2020						GV	2.00	20E (EU1)	Norway	Norway	Norway	Nordland	Human		Nordland Hospital - Bodo, Laboratory Department, Molecular Biology Unit	B.1.177	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2020-08-21	'Kathrine Stene-Johansen et al	[object Object]		
Switzerland/ZH-ETHZ-571166/2020						GV	3.00	20E (EU1)	Switzerland	Switzerland	Switzerland	Zürich	Human		Viollier AG	B.1.177	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zurich		2020-12-17	Chaoran Chen et al	[object Object]		
Belgium/rega-10191287/2020						GV	2.00	20E (EU1)	Belgium	Belgium	Belgium	Turnhout	Human	Veerle	UZ Leuven, National Reference Laboratory for Coronaviruses, Laboratory Medicine, Leuven, Belgium	B.1.177	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-10-19	Tony Wawina-Bokalanga et al	[object Object]	24	Male
Spain/VC-IBV-98016258/2021						GV	3.00	20E (EU1)	Spain	Spain	Spain	Comunitat Valenciana	Human	Benidorm	Laboratorio de Microbiología, Hospital Marina Baixa, Villajoyosa	B.1.177	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2021-01-28	Mónica Parra Grande et al	[object Object]	4	Female
Greece/12J/2020						GV	3.00	20E (EU1)	Greece	Greece	Greece	Crete	Human		Laboratory of Clinical Virology	B.1.177	Europe	Europe	Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)		2020-12-14	Emmanouil Athanasiadis et al	[object Object]		
Belgium/rega-09231006/2020						GV	2.00	20E (EU1)	Belgium	Belgium	Belgium	Mechelen	Human	Leest	UZ Leuven, National Reference Laboratory for Coronaviruses, Laboratory Medicine, Leuven, Belgium	B.1.177	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-09-23	Tony Wawina-Bokalanga et al	[object Object]	42	Male
Germany/BW-RKI-I-040138/2021						GV	3.00	20E (EU1)	Germany	Germany	Germany	Baden-Wuerttemberg	Human		Universitätsklinikum Heidelberg	B.1.177	Europe	Europe	Robert Koch Institute		2021-01-21	?	[object Object]		
Austria/CeMM2607/2020						GV	2.00	20E (EU1)	Austria	Austria	Austria	Tyrol	Human	Innsbruck	Institut für Virologie am Department für Hygiene, Mikrobiologie und Public Health	B.1.177	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2020-11-11	Lukas Endler et al	[object Object]	47	Male
Italy/CAM-TIGEM-1567/2020						GV	3.00	20E (EU1)	Italy	Italy	Italy	Campania	Human		Istituto Zooprofilattico Sperimentale del Mezzogiorno	B.1.177	Europe	Europe	TIGEM		2020-12-18	Antonio Grimaldi et al	[object Object]	40	Female
Switzerland/BL-ETHZ-480535/2021						GV	3.00	20E (EU1)	Switzerland	Switzerland	Switzerland	Basel-Land	Human		Viollier AG	B.1.177	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-02-02	Chaoran Chen et al	[object Object]		
Netherlands/FR-RIVM-17000/2021						GV	5.00	20E (EU1)	Netherlands	Netherlands	Netherlands	Friesland	Human		Dutch COVID-19 response team	B.1.177	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-02-17	Adam Meijer et al	[object Object]	31	
Switzerland/un-UHB-42500893/2020						GV	4.00	20E (EU1)	Switzerland	Switzerland	Switzerland	Jura	Human	Boncourt	University Hospital Basel, Clinical Virology	B.1.177	Europe	Europe	University Hospital Basel, Clinical Bacteriology		2020-10-23	Tim Roloff et al	[object Object]		Male
Italy/BAS-CRGS-3/2021		0.04	0.34		0.24	GV	6.00	20E (EU1)	Italy	Italy	Italy	Basilicata	Human		1.AO Universitaria 'S. Giovanni di Dio e Ruggi D'Aragona, Scuola Medica Salernitana' Hospital / 2.UOC di Virologia e Microbiologia, Università della Campania 'L. Vanvitelli' / 3.AO Universitaria 'Federico II' Napoli Hospital / 4.AORN 'San Giuseppe Moscati' Avellino Hospital / 5.AO 'San Pio - presidio G. Rummo' Benevento Hospital / 6.AO 'Sant'Anna e San Sebastiano' Caserta Hospital / 7.PO 'Maria Santissima Addolorata' Eboli Hospital / 8.Biogem Istituto di Ricerche Genetiche / 9. U.O.C. di Genetica Medica e di Laboratorio A.O.R.N., Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli, Napoli / 10. Centro di riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture (PZ) / 11. Presidio Ospedaliero di Agropoli, Agropoli (SA).	B.1.177.88	Europe	Europe	1. Genome Research Center for Health (CRGS) / 2. Laboratory of Molecular Medicine and Genomics(LMMGe) / 3. Center for Research in Pure and Applied Mathematics (CRMPA)		2021-01-21	Giorgio Giurato (Corresponding Author) et al	[object Object]		
Sweden/20-53267/2020						GV	4.00	20E (EU1)	Sweden	Sweden	Sweden	Vasternorrland	Human		Mikrobiologen	B.1.177.82	Europe	Europe	The Public Health Agency of Sweden		2020-10-26	Department of Microbiology et al	[object Object]	60	Female
Sweden/20-53886/2020						GV	3.00	20E (EU1)	Sweden	Sweden	Sweden	Sweden	Human			B.1.177.82	Europe	Europe	The Public Health Agency of Sweden		2020-12-14	Department of Microbiology et al	[object Object]	24	Male
Norway/0291/2021						GV	4.00	20E (EU1)	Norway	Norway	Norway	More Og Romsdal	Human		Department of Medical Microbiology - section Molde, Molde Hospital	B.1.177.82	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-01-04	Kathrine Stene-Johansen et al	[object Object]		
Sweden/21-51096/2021						O	4.00	20E (EU1)	Sweden	Sweden	Sweden	Norrbotten	Human		The Public Health Agency of Sweden	B.1.177.82	Europe	Europe	The Public Health Agency of Sweden		2021-02-08	Oskar Karlsson Lindsjo et al	[object Object]	19	Female
Italy/LAZ-INMI-135/2020						GV	4.00	20E (EU1)	Italy	Italy	Italy	Lazio	Human		National Institute for Infectious Diseases, INMI, "L. Spallanzani" IRCCS	B.1.177.83	Europe	Europe	National Institute for Infectious Diseases, INMI, "L. Spallanzani" IRCCS		2020-12-22	F Messina et al	[object Object]	89	Female
Italy/MAR-AMC-201207264-AN/2020						GV	5.00	20E (EU1)	Italy	Italy	Italy	Marche	Human		Laboratorio di Diagnostica Molecolare	B.1.177.83	Europe	Europe	Virology Laboratory, Scientific Department, Army Medical Center		2020-12-07	Silvia Fillo et al	[object Object]		
Germany/SL-SU-30046678/2021						GV	4.00	20E (EU1)	Germany	Germany	Germany	Saarland	Human		Virology, Universitätsklinikum des Saarlandes	B.1.177	Europe	Europe	Epigenetics, Saarland University		2021-01-29	Kathrin Kattler et al	[object Object]	80	Female
Sweden/20-13158/2021						GV	4.00	20E (EU1)	Sweden	Sweden	Sweden	Sweden	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.177	Europe	Europe	The Public Health Agency of Sweden		2021-01-28	Maximilian Riess et al	[object Object]		
Belgium/rega-4508/2021						GV	4.00	20E (EU1)	Belgium	Belgium	Belgium	Verviers	Human		KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.177	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2021-02-09	Tony Wawina-Bokalanga et al	[object Object]	39	Male
Italy/SAR-AOUSS-1/2021						GV	3.00	20E (EU1)	Italy	Italy	Italy	Sardinia	Human		S.C. Microbiologia e Virologia Laboratorio Virologia -Speciale Centro Influenza - AOU di Sassari - Viale san Pietro 43/B Palazzo Infettivologia	B.1.177.75	Europe	Europe	Laboratorio specialistico UOC Ematologia - Ospedale "San Francesco" - ATS-ASSL Nuoro		2021-02-03	Piras Giovanna et al	[object Object]	78	Male
Belgium/rega-10191267/2020						GV	2.00	20E (EU1)	Belgium	Belgium	Belgium	Antwerpen	Human	Berchem	UZ Leuven, National Reference Laboratory for Coronaviruses, Laboratory Medicine, Leuven, Belgium	B.1.177.32	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-10-19	Tony Wawina-Bokalanga et al	[object Object]	19	Male
Spain/CL-IBV-99016868/2020						GV	2.00	20E (EU1)	Spain	Spain	Spain	Castilla y Leon	Human	Leon	Universidad de León	B.1.177.32	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2020-09-29	Ana Carvajal et al	[object Object]	29	Female
Switzerland/SG-ETHZ-490440/2021						GV	2.00	20E (EU1)	Switzerland	Switzerland	Switzerland	Sankt Gallen	Human		Viollier AG	B.1.177.10	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-02-06	Christian Beisel et al	[object Object]		
Spain/RI-IBV-99016035/2021						GV	2.00	20E (EU1)	Spain	Spain	Spain	La Rioja ES	Human	Lardero	Centro de Investigación Biomédica de La Rioja - Hospital San Pedro Logroño	B.1.177	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2021-01-04	María de Toro et al	[object Object]	91	Male
Switzerland/ZH-ETHZ-370107/2020						GV	2.00	20E (EU1)	Switzerland	Switzerland	Switzerland	Zürich	Human		Viollier AG	B.1.177.71	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-11-15	Chaoran Chen et al	[object Object]		
Germany/BY-MVP-000002683/2020						GV	3.00	20E (EU1)	Germany	Germany	Germany	Bavaria	Human	Munich	Max von Pettenkofer Institute, Virology, National Reference Center for Retroviruses, LMU Munich	B.1	Europe	Europe	Laboratory for Functional Genome Analysis; Dept. Genomics; Gene Center of the LMU Munich		2020-12-24	Max Muenchhoff et al	[object Object]	80	
Vietnam/PIHCM-1564/2020						GV	2.00	20E (EU1)	Asia	Vietnam	Asia	Ho Chi Minh City	Human	Asia	Pasteur Institute in Ho Chi Minh city	B.1.177	Asia	Asia	Department of Microbiology and Immunology - Pasteur Institute in Ho Chi Minh city		2020-12-24	Manh Huy Dao et al	[object Object]	29	Male
Portugal/PT1743/2020						GV	3.00	20E (EU1)	Portugal	Portugal	Portugal	Portugal	Human		Instituto Nacional de Saude (INSA)	Y.1	Europe	Europe	Instituto Nacional de Saude (INSA)		2020-11-09	Borges et al	[object Object]		
Cameroon/CV420/2020						GV	2.00	20E (EU1)	Africa	Cameroon	Africa	Yaoundé	Human	Africa	National Public Health Laboratory, Cameroon	W.1	Africa	Africa	African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University		2020-10-26	Oluniyi P.E. et al B	[object Object]	65	Male
Spain/CN-IBV-97024949/2020						GV	2.00	20E (EU1)	Spain	Spain	Spain	Canary Islands	Human	Las Palmas de Gran Canaria	Hospital Universitario de Gran Canaria Dr. Negrín	B.1.177.53	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2020-09-04	M. Carmen Pérez González et al	[object Object]	41	Male
Sweden/21-00348/2020						GV	2.00	20E (EU1)	Sweden	Sweden	Sweden	Blekinge	Human		Klinisk mikrobiologi	B.1.177	Europe	Europe	The Public Health Agency of Sweden		2020-10-30	Anna-Malin Linde et al	[object Object]	54	Female
Belgium/rega-10131360/2020						GV	3.00	20E (EU1)	Belgium	Belgium	Belgium	Leuven	Human		UZ Leuven, National Reference Laboratory for Coronaviruses, Laboratory Medicine, Leuven, Belgium	B.1.177.81	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-10-13	Tony Wawina-Bokalanga et al	[object Object]	50	Male
Germany/HH-ChVir21479/2020						GV	2.00	20E (EU1)	Germany	Germany	Germany	Hamburg	Human		A. Krumbholz, Labor Dr. Krause und Kollegen MVZ GmbH, Kiel	B.1.177.81	Europe	Europe	Charité Universitätsmedizin Berlin, Institut für Virologie		2020-12-18	Victor M Corman et al	[object Object]		
Germany/un-RKI-I-017093/2021						GV	2.00	20E (EU1)	Germany	Germany	Germany	Germany	Human		St. Marien-Hospital Hamm	B.1.177	Europe	Europe	Robert Koch Institute		2021-02-08	?	[object Object]		
Taiwan/NTU59/2021						GV	4.00	20E (EU1)	Asia	France	Asia	France	Human	Asia	Department of Laboratory Medicine, National Taiwan University Hospital	B.1.177.81	Asia	Europe	Microbial Genomics Core Lab, National Taiwan University Centers of Genomic and Precision Medicine		2021-02-10	Shiou-Hwei Yeh et al	[object Object]		Female
Italy/VEN-IZSVe-20RS2165-6_RO/2020						GV	2.00	20E (EU1)	Italy	Italy	Italy	Veneto	Human	Rovigo	ULSS 5 Polesana	B.1.177.51	Europe	Europe	Istituto Zooprofilattico Sperimentale delle Venezie		2020-11-25	Adelaide Milani et al	[object Object]	38	Male
Norway/1741/2021						GV	3.00	20E (EU1)	Norway	Norway	Norway	Innlandet	Human		Innlandet Hospital Trust, Division Lillehammer, Department for Medical Microbiology	B.1.177	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-01-23	Kathrine Stene-Johansen et al	[object Object]		
Spain/CL-COV00405/2021						GV	2.00	20E (EU1)	Spain	Spain	Spain	Castilla y Leon	Human		SARS-CoV-2 Sequencing Castilla y Leon-Spain Consortium	B.1.177.50	Europe	Europe	SARS-CoV-2 Sequencing Castilla y Leon-Spain Consortium		2021-02-04	Antonio Orduña-Domingo et al	[object Object]		
Spain/CT-HUVH-41240/2021						GV	2.00	20E (EU1)	Spain	Spain	Spain	Catalunya	Human		Hospital Universitari Vall d'Hebron - Vall d'Hebron Institut de Recerca	B.1.177	Europe	Europe	Hospital Universitari Vall d'Hebron - Vall d'Hebron Institut de Recerca		2021-01-15	Cristina Andrés et al	[object Object]	46	Female
Spain/CL-IBV-98012111/2020						GV	2.00	20E (EU1)	Spain	Spain	Spain	Castilla y Leon	Human	Valladolid	Hospital Clínico Universitario de Valladolid-Hospital Universitario Río Hortega	B.1.177	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2020-12-28	Antonio Orduña-Domingo et al	[object Object]	76	Female
Spain/MD-IBV-98018322/2021						GV	2.00	20E (EU1)	Spain	Spain	Spain	Madrid	Human	Madrid	Servicio de Microbiología. Hospital Ramón y Cajal. (CIBERESP)	B.1.177	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2021-02-04	Jose Mª González-Alba et al	[object Object]	50	Female
Denmark/DCGC-27542/2020						GV	2.00	20E (EU1)	Denmark	Denmark	Denmark	Syddanmark	Human		Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark	B.1.177.21	Europe	Europe	Albertsen Lab, Department of Chemistry and Bioscience, Aalborg University, Denmark		2020-12-21	Danish Covid-19 Genome Consortium et al	[object Object]		
Lithuania/ID7411/2021						GV	2.00	20E (EU1)	Lithuania	Lithuania	Lithuania	Utena Apskritis	Human		Vilnius university hospital Santaros Klinikos, Center of Laboratory Medicine	B.1.177	Europe	Europe	Vilnius university hospital Santaros Klinikos, Center of Laboratory Medicine		2021-01-14	Ingrida Olendraite et al	[object Object]	77	Female
Belgium/rega-1569/2020						GV	2.00	20E (EU1)	Belgium	Belgium	Belgium	Sint-Niklaas	Human	Lokeren	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.177.77	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-12-23	Tony Wawina-Bokalanga et al	[object Object]	87	Male
Ireland/KE-NVRL-73IRL48809/2020						GV	2.00	20E (EU1)	Ireland	Ireland	Ireland	Kildare	Human		National Virus Reference Laboratory	B.1.177.55	Europe	Europe	National Virus Reference Laboratory		2020-09-10	Michael Carr et al	[object Object]		Female
Ireland/MO-NVRL-75IRL73163/2020						GV	2.00	20E (EU1)	Ireland	Ireland	Ireland	Mayo	Human		National Virus Reference Laboratory	B.1.177.54	Europe	Europe	National Virus Reference Laboratory		2020-10-12	Michael Carr et al	[object Object]		Female
Ireland/SO-NVRL-76IRL31614/2020						GV	2.00	20E (EU1)	Ireland	Ireland	Ireland	Sligo	Human		National Virus Reference Laboratory	B.1.177.54	Europe	Europe	National Virus Reference Laboratory		2020-10-18	Michael Carr et al	[object Object]		Male
Ireland/CO-NVRL-78IRL70434/2020						GV	2.00	20E (EU1)	Ireland	Ireland	Ireland	Cork	Human		National Virus Reference Laboratory	B.1.177.54	Europe	Europe	National Virus Reference Laboratory		2020-11-22	Michael Carr et al	[object Object]		Male
Ireland/MO-NVRL-76IRL31264/2020						GV	2.00	20E (EU1)	Ireland	Ireland	Ireland	Mayo	Human		National Virus Reference Laboratory	B.1.177.54	Europe	Europe	National Virus Reference Laboratory		2020-10-18	Michael Carr et al	[object Object]		Male
Ireland/MN-NVRL-20IRL82789/2020						GV	2.00	20E (EU1)	Ireland	Ireland	Ireland	Monaghan	Human		National Virus Reference Laboratory	B.1.177.54	Europe	Europe	National Virus Reference Laboratory		2020-10-05	Michael Carr et al	[object Object]		Female
Iraq/HTh20210602_111/2020						GV	3.00	20E (EU1)	Asia	Iraq	Asia	Al-Najaf-Al-Ashraf	Human	Asia	The teaching Baghdad hospital	B.1.177.80	Asia	Asia	PCR lab		2020-12-14	Abdulhussein Thaer et al	[object Object]	37	Male
Sweden/20-53006/2020						GV	3.00	20E (EU1)	Sweden	Sweden	Sweden	Orebro	Human		Orebro klinisk mikrobiologi	B.1.177	Europe	Europe	The Public Health Agency of Sweden		2020-09-28	Department of Microbiology et al	[object Object]	43	Female
Ireland/CE-NVRL-81IRL08770/2020						GV	4.00	20E (EU1)	Ireland	Ireland	Ireland	Clare	Human		National Virus Reference Laboratory	B.1.177.67	Europe	Europe	National Virus Reference Laboratory		2020-12-27	Michael Carr et al	[object Object]		Female
Ireland/G-NVRL-78IRL79027/2020						GV	4.00	20E (EU1)	Ireland	Ireland	Ireland	Galway	Human		National Virus Reference Laboratory	B.1.177.66	Europe	Europe	National Virus Reference Laboratory		2020-11-23	Michael Carr et al	[object Object]		Male
Ireland/WW-NVRL-AIIDV1424v1-2/2020						GV	4.00	20E (EU1)	Ireland	Ireland	Ireland	Wicklow	Human		National Virus Reference Laboratory	B.1.177.66	Europe	Europe	Irish Coronavirus Sequencing Consortium - Teagasc Moorepark		2020-11-29	Alejandro Abner Garcia Leon et al	[object Object]		Female
Ireland/LM-NVRL-83IRL58177/2021						GV	3.00	20E (EU1)	Ireland	Ireland	Ireland	Leitrim	Human		National Virus Reference Laboratory	B.1.177.58	Europe	Europe	National Virus Reference Laboratory		2021-01-14	Michael Carr et al	[object Object]		Male
Germany/SL-SU-181/2020						GV	3.00	20E (EU1)	Germany	Germany	Germany	Saarland	Human		Virology, Universitätsklinikum des Saarlandes	B.1.177	Europe	Europe	Epigenetics, Saarland University		2020-11-18	Kathrin Kattler et al	[object Object]	88	Female
Germany/BB-RKI-I-033689/2021						GV	3.00	20E (EU1)	Germany	Germany	Germany	Brandenburg	Human		Klinikum Ernst von Bergmann gemeinnützige GmbH - stationärer Bereich	B.1.177.86	Europe	Europe	Robert Koch Institute		2021-01-20	?	[object Object]		
Norway/4617/2020						GV	3.00	20E (EU1)	Norway	Norway	Norway	Vestland	Human		Foerde Hospital, Department of Microbiology	B.1.177.60	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2020-09-30	Kathrine Stene-Johansen et al	[object Object]		
Lithuania/LSMULKKGMMK4C92/2021						GV	3.00	20E (EU1)	Lithuania	Lithuania	Lithuania	Prienai	Human		Medicina practica laboratorija	B.1.177.60	Europe	Europe	Lithuanian University of Health Sciences Hospital, Department of Genetics and Molecular Medicine		2021-02-09	Rasa Ugenskiene et al	[object Object]		
Finland/TRE23196_6/2021						O	1.00	20E (EU1)	Finland	Finland	Finland	Kanta-Häme	Human		Fimlab Laboratories	B.1.177.60	Europe	Europe	Fimlab Laboratories		2021-03-22	Leena Huhti et al	[object Object]		
Lithuania/ID7577/2021						G	4.00	20E (EU1)	Lithuania	Lithuania	Lithuania	Telsiai Apskritis	Human		Vilnius university hospital Santaros Klinikos, Center of Laboratory Medicine	B.1.177.60	Europe	Europe	Vilnius university hospital Santaros Klinikos, Center of Laboratory Medicine		2021-01-19	Gytis Dudas et al	[object Object]	24	Female
Estonia/150872/2021						GV	3.00	20E (EU1)	Estonia	Estonia	Estonia	Estonia	Human		Laboratory of Communicable Diseases	B.1.177	Europe	Europe	1. Laboratory of Communicable Diseases (Estonia); 2. Eurofins Genomics Europe Sequencing GmbH		2021-02-08	Liidia Dotsenko et al	[object Object]	35	Male
Lithuania/T-1193/2020						GV	3.00	20E (EU1)	Lithuania	Lithuania	Lithuania	Vilnius	Human		Vilnius University Hospital Santaros Klinikos, Vilnius University	B.1.177.60	Europe	Europe	Institute of Biotechnology, Life Sciences Center, Vilnius University		2020-11-15	Emilija Vasiliunaite et al	[object Object]	59	Male
Lithuania/T_1023/2020						GV	3.00	20E (EU1)	Lithuania	Lithuania	Lithuania	Klaipedos Apskritis	Human		Vilnius University Hospital Santaros Klinikos, Vilnius University	B.1.177.60	Europe	Europe	Institute of Biotechnology, Life Sciences Center, Vilnius University		2020-11-12	Emilija Vasiliunaite et al	[object Object]	33	Male
Sweden/20-51854/2020		0.01			0.01	G	2.00	20A	Sweden	Sweden	Sweden	Vasternorrland	Human		Klinisk mikrobiologi Vasternorrland	B.1.227	Europe	Europe	The Public Health Agency of Sweden		2020-06-01	Oskar Karlsson Lindsjo et al	[object Object]	51	Female
Denmark/DCGC-12727/2020		0.01			0.01	G	2.00	20A	Denmark	Denmark	Denmark	Midtjylland	Human		Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark	B.1.127	Europe	Europe	Albertsen Lab, Department of Chemistry and Bioscience, Aalborg University, Denmark		2020-11-16	Danish Covid-19 Genome Consortium et al	[object Object]		
Kenya/C73519/2020						G	2.00	20A	Africa	Kenya	Africa	Kilifi	Human	Africa	KEMRI-Wellcome Trust Research Programme/KEMRI-CGMR-C Kilifi	B.1.530	Africa	Africa	KEMRI-Wellcome Trust Research Programme/KEMRI-CGMR-C Kilifi		2020-11-24	Githinji et al	[object Object]		Female
Mexico/QUE-InDRE_FB16167_S2569/2021						G	5.00	20A	North America	Mexico	North America	Queretaro	Human	North America	LESP Queretaro	B.1.301	North America	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)		2021-05-19	Claudia Wong-Arambula et al	[object Object]	50	Male
Mexico/GUA-InDRE_FB16213_S2581/2021						G	5.00	20A	North America	Mexico	North America	Guanajuato	Human	North America	LESP Guanajuato	B.1	North America	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)		2021-05-17	Claudia Wong-Arambula et al	[object Object]	24	Female
CentralAfricanRepublic/226/2021		0.05	0.35	0.01	0.26	G	10.00	20A	Africa	Central African Republic	Africa	Bayanga	Human	Africa	WWF Bayanga field laboratory	B.1.620	Africa	Africa	Robert Koch Institute		2021-03-25	S. Calvignac-Spencer et al	[object Object]		
CentralAfricanRepublic/266/2021		0.05	0.35	0.01	0.26	G	10.00	20A	Africa	Central African Republic	Africa	Bayanga	Human	Africa	WWF Bayanga field laboratory	B.1.620	Africa	Africa	WWF Bayanga field laboratory		2021-04-12	S. Calvignac-Spencer et al	[object Object]		
Lithuania/MB24459/2021		0.05	0.35	0.01	0.26	G	10.00	20A	Lithuania	Lithuania	Lithuania	Utena Apskritis	Human		National Public Health Surveillance Laboratory	B.1.620	Europe	Europe	National Public Health Surveillance Laboratory		2021-03-31	Lukas Zemaitis et al	[object Object]	76	Male
SintMaarten/SX-RIVM-23089/2021		0.05	0.40	0.06	0.32	G	7.00	21B (Kappa)	North America	Sint Maarten	North America	Sint Maarten	Human	North America	Dutch COVID-19 response team	B.1.617.1	North America	North America	National Institute for Public Health and the Environment (RIVM)		2021-03-19	Adam Meijer et al	[object Object]	44	
HongKong/HKPU-11669/2021		0.05	0.39	0.06	0.30	G	7.00	21B (Kappa)	Asia	Hong Kong	Asia	Hong Kong	Human	Asia	Department of Health Technology and Informatics, The Hong Kong Polytechnic University	B.1.617.1	Asia	Asia	Department of Health Technology and Informatics, The Hong Kong Polytechnic University		2021-04-18	Gilman Kit-Hang Siu et al	[object Object]	33	Male
Ireland/KY-NVRL-30IRL20527/2021		0.05	0.39	0.06	0.30	G	7.00	21B (Kappa)	Ireland	Ireland	Ireland	Kerry	Human		National Virus Reference Laboratory	B.1.617.1	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Male
Ireland/TA-NVRL-30IRL32145/2021		0.05	0.39	0.06	0.30	G	7.00	21B (Kappa)	Ireland	Ireland	Ireland	Tipperary	Human		National Virus Reference Laboratory	B.1.617.1	Europe	Europe	National Virus Reference Laboratory		2021-05-18	Zoe Yandle et al	[object Object]		Female
Russia/SPE-RII-32716S/2021		0.05	0.39	0.06	0.30	G	8.00	20A	Russia	India	Saint-Petersburg	India	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1	Europe	Asia	WHO National Influenza Centre Russian Federation		2021-04-22	Andrey Komissarov et al A	[object Object]	45	Male
Argentina/INEI104264/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	South America	France	South America	France	Human	South America	Servicio Virosis Respiratorias-Departamento Virología-INEI	B.1.617.2	South America	Europe	Instituto Nacional Enfermedades Infecciosas C.G.Malbran		2021-04-24	Baumeister E. et al	[object Object]	10	
Vietnam/VN5722/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Asia	Vietnam	Asia	Kien Giang	Human	Asia	National Hospital for Tropical Diseases	B.1.617.2	Asia	Asia	Oxford University Clinical Research Unit, Hanoi, Vietnam		2021-04-22	Pham Ngoc Thach et al	[object Object]	23	Male
USA/TX-CDC-FG-036625/2021		0.06	0.39	0.06	0.31	G	10.00	21A (Delta)	North America	USA	North America	Texas	Human	North America	Fulgent Genetics	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-06-01	Dakota Howard et al	[object Object]	56	Male
SouthAfrica/NICD-R01891/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Africa	South Africa	Africa	Gauteng	Human	Africa	Ampath Laboratories	B.1.617.2	Africa	Africa	National Institute for Communicable Diseases of the National Health Laboratory Service		2021-05-06	Amoako DG et al	[object Object]	46	Male
Netherlands/NH-RIVM-37231/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Netherlands	Netherlands	Netherlands	North Holland	Human		Dutch COVID-19 response team	B.1.617.2	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-27	Adam Meijer et al	[object Object]	25	
Austria/CeMM9500/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Austria	Austria	Austria	Tyrol	Human	Innsbruck	Austrian Agency for Health and Food Safety (AGES)	B.1.617.2	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-05-13	Lukas Endler et al	[object Object]		
Austria/CeMM9667/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Austria	Austria	Austria	Tyrol	Human	Innsbruck	Austrian Agency for Health and Food Safety (AGES)	B.1.617.2	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-05-20	Lukas Endler et al	[object Object]	36	Male
Mexico/ROO-InDRE_FB16368_S2369/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	Mexico	North America	Quintana Roo	Human	North America	LESP Quintana Roo	B.1.617.2	North America	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)		2021-05-17	Claudia Wong-Arambula et al	[object Object]	51	Female
Switzerland/VS-ICH-2210558303/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Switzerland	Switzerland	Switzerland	Valais	Human		Valais Hospital, Central Institute	B.1.617.2	Europe	Europe	Valais Hospital, Central Institute		2021-05-25	Alexis Dumoulin et al	[object Object]		
Bahrain/NPS-6/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Asia	Bahrain	Asia	Bahrain	Human	Asia	Communicable Disease Laboratory, Public Health Directorate	B.1.258	Asia	Asia	Communicable Disease Laboratory, Public Health Directorate		2021-05-03	Alwasti et al	[object Object]		
Bahrain/NPS-4/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Asia	Bahrain	Asia	Bahrain	Human	Asia	Communicable Disease Laboratory, Public Health Directorate	B.1	Asia	Asia	Communicable Disease Laboratory, Public Health Directorate		2021-05-20	Alwasti et al	[object Object]		
Australia/SA0735/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Oceania	Australia	Oceania	South Australia	Human	Oceania	SA Pathology	B.1	Oceania	Oceania	SA Pathology		2021-06-02	Caitlin Selway et al	[object Object]		Female
Singapore/962/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Asia	Singapore	Asia	Singapore	Human	Asia	Singapore General Hospital	B.1.617.2	Asia	Asia	Singapore General Hospital		2021-05-23	Nurdyana Abdul Rahman et al	[object Object]	19	Female
Anguilla/64390/2021		0.01	0.05	0.06	0.07	G	5.00	21A (Delta)	United Kingdom	United Kingdom	United Kingdom	Anguilla	Human		The Caribbean Public Health Agency	B.1.617.2	Europe	Europe	Carrington Lab, Department of PreClinical Sciences, Faculty of Medical Sciences, The University of the West Indies		2021-04-20	Nikita S. D. Sahadeo et al	[object Object]		
Austria/CeMM10885/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Austria	Austria	Austria	Salzburg	Human		Austrian Agency for Health and Food Safety (AGES)	B.1.617.2	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-05-24	Lukas Endler et al	[object Object]	29	Male
Bahrain/NPS/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Asia	Bahrain	Asia	Bahrain	Human	Asia	Communicable Disease Laboratory, Public Health Directorate	B.1.617.2	Asia	Asia	Communicable Disease Laboratory, Public Health Directorate		2021-05-16	Alwasti et al	[object Object]		
Belgium/Jessa_55-2122-000438/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Belgium	Belgium	Belgium	Limburg BE	Human		Jessa	B.1.617.2	Europe	Europe	Jessa		2021-06-02	Berden et al. on behalf of the Jessa_cmdLab et al	[object Object]	45	Male
USA/WI-CDC-ASC210065515/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	USA	North America	Wisconsin	Human	North America	Aegis Sciences Corporation	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-21	Dakota Howard et al	[object Object]	50	Male
USA/WI-CDC-ASC210064748/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	USA	North America	Wisconsin	Human	North America	Aegis Sciences Corporation	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-18	Dakota Howard et al	[object Object]	27	Male
Germany/NI-RKI-I-172382/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Germany	Germany	Germany	Niedersachsen	Human		Procomcure Biotech Germany GmbH	B.1.617.2	Europe	Europe	Robert Koch Institute		2021-06-02	?	[object Object]		
USA/WI-UW-5228/2021	1.00	0.14	0.06	0.06	0.10	GV	11.00	21A (Delta)	North America	USA	North America	Wisconsin	Human	North America	University of Wisconsin-Madison AIDS Vaccine Research Laboratories	AY.1	North America	North America	University of Wisconsin-Madison AIDS Vaccine Research Laboratories		2021-05-18	Gage Moreno et al	[object Object]		
USA/CA-CDC-FG-036366/2021	1.00	0.14	0.06	0.06	0.10	G	11.00	21A (Delta)	North America	USA	North America	California	Human	North America	Fulgent Genetics	AY.1	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-06-01	Dakota Howard et al	[object Object]	32	Female
Wales/MILK-16067DF/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	United Kingdom	United Kingdom	United Kingdom	Wales	Human		Lighthouse Lab in Milton Keynes	B.1.617.2	Europe	Europe	Wellcome Sanger Institute for the COVID-19 Genomics UK (COG-UK) Consortium		2021-06-02	The Lighthouse Lab in Milton Keynes et al	[object Object]		
Wales/MILK-16068AF/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	United Kingdom	United Kingdom	United Kingdom	Wales	Human		Lighthouse Lab in Milton Keynes	B.1.617.2	Europe	Europe	Wellcome Sanger Institute for the COVID-19 Genomics UK (COG-UK) Consortium		2021-06-02	The Lighthouse Lab in Milton Keynes et al	[object Object]		
USA/AR-CDC-QDX25164556/2021		0.01	0.05	0.06	0.07	G	10.00	21A (Delta)	North America	USA	North America	Arkansas	Human	North America	Quest Diagnostics Incorporated	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-19	Dakota Howard et al	[object Object]	30	Male
USA/NY-PRL-2021_0603_00A13/2021		0.01	0.05	0.06	0.07	G	10.00	21A (Delta)	North America	USA	North America	New York	Human	North America	Pandemic Response Lab - NYC	B.1.530	North America	North America	Pandemic Response Lab, R&D		2021-06-01	Henry Lee et al	[object Object]	33	Male
NewZealand/21MV0414/2021		0.01	0.05	0.06	0.07	G	10.00	21A (Delta)	Oceania	New Zealand	Oceania	Auckland	Human	Oceania	LabPLUS	B.1.617.2	Oceania	Oceania	Institute of Environmental Science and Research (ESR)		2021-05-06	Rachel Boyle et al	[object Object]		Male
USA/AL-CDC-ASC210065960/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	USA	North America	Alabama	Human	North America	Aegis Sciences Corporation	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-22	Dakota Howard et al	[object Object]	3	Male
Sweden/20271399P/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Sweden	Sweden	Sweden	Varmland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.617.2	Europe	Europe	The Public Health Agency of Sweden		2021-05-18	Maximilian Riess et al	[object Object]		
Belgium/MBLGPF797073/2021		0.01	0.05	0.06	0.07	G	10.00	21A (Delta)	Belgium	Belgium	Belgium	Brussels	Human		Cliniques universitaires Saint-Luc	B.1.617.2	Europe	Europe	UCLouvain/IREC/MBLG		2021-06-01	Jean Ruelle et al	[object Object]	31	Female
Belgium/MBLGPF239739/2021		0.01	0.05	0.06	0.07	G	10.00	21A (Delta)	Belgium	Belgium	Belgium	Brussels	Human		Cliniques universitaires Saint-Luc	B.1.617.2	Europe	Europe	UCLouvain/IREC/MBLG		2021-06-03	Jean Ruelle et al	[object Object]	9	Female
Belgium/Aalst-OLVZ-8128669/2021		0.01	0.05	0.06	0.07	G	10.00	21A (Delta)	Belgium	Belgium	Belgium	Aalst	Human	Lede	OLVZ Aalst	B.1.617.2	Europe	Europe	OLVZ Aalst		2021-05-26	Astrid Holderbeke et al	[object Object]	41	Female
Belgium/CHUNamur13404861/2021		0.02	0.06	0.06	0.09	G	12.00	21A (Delta)	Belgium	Belgium	Belgium	Namur	Human		Plateforme de testing Namuroise	B.1.617.2	Europe	Europe	Plateforme de testing Namuroise		2021-05-29	Lesly Nyinkeu Kemamen et al	[object Object]	7	Female
Belgium/CHUNamur13404860/2021		0.02	0.06	0.06	0.09	G	12.00	21A (Delta)	Belgium	Belgium	Belgium	Namur	Human		Plateforme de testing Namuroise	B.1.617.2	Europe	Europe	Plateforme de testing Namuroise		2021-05-29	Lesly Nyinkeu Kemamen et al	[object Object]	32	Female
Belgium/UZA-UA-31129188/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Belgium	Belgium	Belgium	Halle-Vilvoorde	Human	Relegem	LHUB-ULB	B.1.617.2	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-03	Marie Le Mercier et al	[object Object]		Male
Belgium/ULG-16098/2021		0.01	0.05	0.06	0.07	G	10.00	21A (Delta)	Belgium	Belgium	Belgium	Vlaams-Brabant	Human		University of Liège COVID-19 testing center	B.1.617.2	Europe	Europe	GIGA Medical Genomics		2021-05-25	Keith Durkin et al	[object Object]	10	Female
Belgium/CHUNamur13394297/2021		0.01	0.05	0.06	0.07	G	10.00	21A (Delta)	Belgium	Belgium	Belgium	Namur	Human		Plateforme de testing Namuroise	B.1.617.2	Europe	Europe	Plateforme de testing Namuroise		2021-05-24	Lesly Nyinkeu Kemamen et al	[object Object]	8	Female
Belgium/CHUNamur13394298/2021		0.01	0.05	0.06	0.07	G	10.00	21A (Delta)	Belgium	Belgium	Belgium	Namur	Human		Plateforme de testing Namuroise	B.1.617.2	Europe	Europe	Plateforme de testing Namuroise		2021-05-24	Lesly Nyinkeu Kemamen et al	[object Object]	5	Male
Sweden/10082173/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Sweden	Sweden	Sweden	Stockholm	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.617.2	Europe	Europe	The Public Health Agency of Sweden		2021-05-21	Maximilian Riess et al	[object Object]		
Australia/SA0728/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Oceania	Australia	Oceania	South Australia	Human	Oceania	SA Pathology	B.1.617.2	Oceania	Oceania	SA Pathology		2021-05-24	Caitlin Selway et al	[object Object]		Male
Netherlands/NH-RIVM-37580/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Netherlands	Netherlands	Netherlands	North Holland	Human		Dutch COVID-19 response team	B.1.617.2	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-27	Adam Meijer et al	[object Object]	27	
Indonesia/JK-GSILab-495480/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Asia	Indonesia	Asia	Jakarta	Human	Asia	Genomik Solidaritas Indonesia Laboratorium	B.1.617.2	Asia	Asia	Genomik Solidaritas Indonesia Laboratorium		2021-06-01	Carissa Sintca Wijaya et al	[object Object]	5	Male
Germany/SH-ChVir25702_12/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Germany	Germany	Germany	Schleswig-Holstein	Human		A. Krumbholz, Labor Dr. Krause und Kollegen MVZ GmbH, Kiel	B.1.617.2	Europe	Europe	Charité Universitätsmedizin Berlin, Institut für Virologie		2021-06-05	Victor M Corman et al	[object Object]		
Vietnam/VN5748/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Asia	Vietnam	Asia	Yen Bai	Human	Asia	National Hospital for Tropical Diseases	B.1.617.2	Asia	Asia	Oxford University Clinical Research Unit, Hanoi, Vietnam		2021-04-24	Pham Ngoc Thach et al	[object Object]	49	Male
Vietnam/HCMC-05109069-05/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Asia	Vietnam	Asia	Ho Chi Minh City	Human	Asia	OUCRU	B.1.617.2	Asia	Asia	OUCRU		2021-05-21	Nguyen Van Vinh Chau et al	[object Object]	34	Female
USA/MA-MASPHL-03859/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	North America	USA	North America	Massachusetts	Human	North America	Massachusetts State Public Health Laboratory	B.1.617.2	North America	North America	Massachusetts State Public Health Laboratory		2021-05-20	Andrew Lang et al	[object Object]		
Brazil/MG-FUNED-303-21/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	South America	India	South America	India	Human	South America	Fundação Ezequiel Dias	B.1.617.2	South America	Asia	Coordenação Geral de Laboratórios de Saúde Pública (CGLAB/DAEVS/SVS/MS)		2021-05-22	Vagner Fonseca et al	[object Object]	33	Male
Iran/S1216/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Asia	Iran	Asia	Yazd	Human	Asia	COVID-19 National Reference Laboratory, Pasteur Institute of Iran.	B.1.617.2	Asia	Asia	Genetics Research Center, University of Social Welfare and Rehabilitation Sciences		2021-04-28	Zohreh Fattahi et al	[object Object]	30	Male
NewZealand/21MV0410/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Oceania	New Zealand	Oceania	Auckland	Human	Oceania	LabPLUS	B.1.617.2	Oceania	Oceania	Institute of Environmental Science and Research (ESR)		2021-05-04	Rachel Boyle et al	[object Object]		Male
USA/MO-CDC-LC0067565/2021	1.00	0.04	0.12	0.06	0.11	G	9.00	21A (Delta)	North America	USA	North America	Missouri	Human	North America	Laboratory Corporation of America	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-23	Dakota Howard et al	[object Object]	10	Female
Greece/V781/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Greece	Greece	Greece	Greece	Human		National Public Health Organization	B.1	Europe	Europe	Institute of Applied Biosciences, Centre for Research and Technology Hellas		2021-04-26	Anastasia Chatzidimitriou et al.	[object Object]		
CzechRepublic/NRL_7252_21/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Czech Republic	Czech Republic	Czech Republic	Central Bohemian Region	Human		National Institute of Public Health	B.1.617.2	Europe	Europe	National Institute of Public Health		2021-05-06	Helena Jirincova et al	[object Object]	21	Female
USA/CA-CDC-FG-036356/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	USA	North America	California	Human	North America	Fulgent Genetics	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-31	Dakota Howard et al	[object Object]	40	Male
USA/AZ-TG908155/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	USA	North America	Arizona	Human	North America	TGen North	B.1.617.2	North America	North America	TGen North		2021-05-20	"Jolene Bowers et al	[object Object]		
Uganda/UG468/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Africa	Uganda	Africa	Uganda	Human	Africa	MRC/UVRI & LSHTM Uganda Research Unit	B.1.617.2	Africa	Africa	MRC/UVRI & LSHTM Uganda Research Unit		2021-04-25	Matthew Cotten et al	[object Object]		
Pakistan/NIH-Sam4/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Asia	Pakistan	Asia	Islamabad	Human	Asia	Department of Virology	B.1.617.2	Asia	Asia	Department of Virology		2021-05-23	Massab Umair et al	[object Object]	52	Male
USA/MA-CDC-QDX25207960/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	USA	North America	Massachusetts	Human	North America	Quest Diagnostics Incorporated	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-19	Dakota Howard et al	[object Object]	8	Female
USA/MA-CDC-QDX25207961/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	USA	North America	Massachusetts	Human	North America	Quest Diagnostics Incorporated	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-19	Dakota Howard et al	[object Object]	51	Male
Spain/IB-HUSE-00701/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Spain	Spain	Spain	Balear Islands	Human		HOSPITAL CAN MISSES	B.1.617.2	Europe	Europe	HOSPITAL UNIVERSITARIO SON ESPASES		2021-05-28	Servicio de Microbiología et al	[object Object]	30	Male
Indonesia/JK-NIHRD-WGS03472/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Asia	Indonesia	Asia	Jakarta	Human	Asia	RSPI Prof. Dr. Sulianti Saroso	B.1.617.2	Asia	Asia	National Institute of Health Research and Development		2021-05-04	Hana Apsari Pawestri et al	[object Object]	29	Female
Malaysia/IMR_WC275195/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Asia	Malaysia	Asia	Malaysia	Human	Asia	Institute for Medical Research, Infectious Disease Research Centre, National Institutes of Health, Ministry of Health Malaysia	B.1.617.2	Asia	Asia	Institute for Medical Research, Infectious Disease Research Centre, National Institutes of Health, Ministry of Health Malaysia		2021-05-18	Suppiah J et al	[object Object]	37	Male
Spain/VC-IBV-98028793/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Spain	Spain	Spain	Comunitat Valenciana	Human	Alboraia	Servicio de Microbiología. Hospital Clínico Universitario de Valencia	B.1.617.2	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2021-05-22	David Navarro Ortega et al	[object Object]	24	Male
Germany/HB-RKI-I-141806/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Germany	Germany	Germany	Bremen	Human		Labor Dr. Schumacher MVZ	B.1.617.2	Europe	Europe	Robert Koch Institute		2021-04-29	?	[object Object]		
Canada/MB-NML-86730/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	Canada	North America	Manitoba	Human	North America	MB-Cadham Provincial laboratory	B.1.617.2	North America	North America	National Microbiology Laboratory (NML)		2021-05-17	Anna Majer et al	[object Object]	32	Female
Australia/SA0731/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Oceania	Australia	Oceania	South Australia	Human	Oceania	SA Pathology	B.1.617.2	Oceania	Oceania	SA Pathology		2021-05-31	Caitlin Selway et al	[object Object]		Male
Indonesia/JK-NIHRD-WGS03473/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Asia	Indonesia	Asia	Jakarta	Human	Asia	RSPI Prof. Dr. Sulianti Saroso	B.1.617.2	Asia	Asia	National Institute of Health Research and Development		2021-05-04	Hana Apsari Pawestri et al	[object Object]	27	Male
USA/CA-CDC-ASC210106245/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	North America	USA	North America	California	Human	North America	Aegis Sciences Corporation	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-29	Dakota Howard et al	[object Object]	21	Female
USA/CA-CDC-ASC210105874/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	North America	USA	North America	California	Human	North America	Aegis Sciences Corporation	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-27	Dakota Howard et al	[object Object]	41	Male
Botswana/R13B57_BHP_121047442/2021	1.00	0.14	0.06	0.06	0.10	G	9.00	21A (Delta)	Africa	Botswana	Africa	Gaborone	Human	Africa	Diagnofirm Medical Laboratories	B.1	Africa	Africa	Botswana Harvard HIV Reference Laboratory		2021-04-28	Sikhulile Moyo et al	[object Object]	49	Male
Botswana/R14B1_BHP_AAB39500/2021		0.01	0.05	0.06	0.07	G	4.00	21A (Delta)	Africa	Botswana	Africa	Gaborone	Human	Africa	Botswana Harvard HIV Reference Laboratory	B.1.617.2	Africa	Africa	Botswana Harvard HIV Reference Laboratory		2021-05-10	Sikhulile Moyo et al	[object Object]	45	Male
Russia/TVE-CRIE-L188K0270/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	United Arab Emirates	Tver	United Arab Emirates	Human		Federal Budget Health Care Institution "Center of Hygiene and Epidemiology in Tver region"	B.1.617.2	Europe	Asia	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-07	Samoilov AE et al	[object Object]	15	Male
Uganda/UG469/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Africa	Uganda	Africa	Uganda	Human	Africa	MRC/UVRI & LSHTM Uganda Research Unit	B.1.617.1	Africa	Africa	MRC/UVRI & LSHTM Uganda Research Unit		2021-04-20	Matthew Cotten et al	[object Object]		
Uganda/UG470/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Africa	Uganda	Africa	Uganda	Human	Africa	MRC/UVRI & LSHTM Uganda Research Unit	B.1.617.2	Africa	Africa	MRC/UVRI & LSHTM Uganda Research Unit		2021-04-21	Matthew Cotten et al	[object Object]		
Pakistan/NIH-Sam7/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Asia	Pakistan	Asia	Pakistan	Human	Asia	Department of Virology	B.1.617.2	Asia	Asia	Department of Virology		2021-05-17	Massab Umair et al	[object Object]	53	Female
Morocco/CNRST-IND01/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Africa	Morocco	Africa	Casablanca	Human	Africa	Institut Pasteur du Maroc	B.1.617.2	Africa	Africa	Functional Genomics platform/CNRST		2021-04-22	Melloul Marouane et al	[object Object]	47	Male
Pakistan/NIH-Sam3/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Asia	Pakistan	Asia	Islamabad	Human	Asia	Department of Virology	B.1.617.2	Asia	Asia	Department of Virology		2021-05-27	Massab Umair et al	[object Object]	20	Male
Japan/IC-1295/2021		0.01	0.05	0.06	0.07	G	6.00	21A (Delta)	Asia	Afghanistan	Asia	Afghanistan	Human	Asia	SARS-CoV-2 testing team, National Institute of Infectious Diseases	B.1	Asia	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases		2021-05-18	Tsuyoshi Sekizuka et al B	[object Object]		
Thailand/CU-A21289-NT/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Asia	Thailand	Asia	Thailand	Human	Asia	Thai Red Cross Emerging Infectious Diseases Clinical Center and Faculty of Medicine, Chulalongkorn University	B.1.617.2	Asia	Asia	Thai Red Cross Emerging Infectious Diseases Clinical Center and Faculty of Medicine, Chulalongkorn University		2021-05-23	Opass Putcharoen et al	[object Object]	56	Female
Spain/GA-CHUVI-33977540/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Spain	Spain	Spain	Galicia	Human	Vigo	Microbiology Department. Complexo Hospitalario Universitario de Vigo	B.1	Europe	Europe	Microbiology Department. Complexo Hospitalario Universitario de Vigo		2021-05-13	Alfaya N et al	[object Object]	27	Male
Australia/NSW1590/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Oceania	Australia	Oceania	New South Wales	Human	Oceania	South Eastern Area Laboratory Services (SEALS)	B.1.617.2	Oceania	Oceania	NSW Health Pathology - Institute of Clinical Pathology and Medical Research; Westmead Hospital; University of Sydney		2021-05-26	CIDM-PH et al.	[object Object]		
Ireland/RN-NVRL-90IRL35899/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Ireland	Ireland	Ireland	Roscommon	Human		National Virus Reference Laboratory	B.1.617.2	Europe	Europe	National Virus Reference Laboratory		2021-05-02	Zoe Yandle et al	[object Object]		Female
Bangladesh/IEDCR-OIS-0016/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Asia	India	Asia	India	Human	Asia	Institute of Epidemiology, Disease Control and Research (IEDCR)	B.1.604	Asia	Asia	IEDCR-ideSHi-icddr,b		2021-05-12	Hassan Afrad et al	[object Object]	50	Female
Switzerland/SO-ETHZ-640189/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Switzerland	Switzerland	Switzerland	Solothurn	Human		Viollier AG	B.1.617.2	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-05-21	Chaoran Chen et al	[object Object]		
Italy/APU-IZSPB-1317PT/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Italy	Italy	Italy	Apulia	Human	Brindisi	Presidio di Brindisi Di Summa - Perrino	B.1.617.2	Europe	Europe	Istituto Zooprofilattico Sperimentale della Puglia e della Basilicata		2021-05-26	Parisi A. et al	[object Object]	20	Female
Italy/APU-IZSPB-1329PT/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Italy	Italy	Italy	Apulia	Human	Lecce	Ospedale Santa Caterina Novella	B.1.617.2	Europe	Europe	Istituto Zooprofilattico Sperimentale della Puglia e della Basilicata		2021-05-27	Parisi A. et al	[object Object]	9	Female
USA/NY-PRL-2021_0603_00A20/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	USA	North America	New York	Human	North America	Pandemic Response Lab - NYC	B.1.617.2	North America	North America	Pandemic Response Lab, R&D		2021-06-02	Henry Lee et al	[object Object]	27	Female
HongKong/HKPU-11713/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Asia	Hong Kong	Asia	Hong Kong	Human	Asia	Department of Health Technology and Informatics, The Hong Kong Polytechnic University	B.1.617.2	Asia	Asia	Department of Health Technology and Informatics, The Hong Kong Polytechnic University		2021-04-22	Gilman Kit-Hang Siu et al	[object Object]	45	Male
Ireland/L-NVRL-22IRL38881/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Ireland	Ireland	Ireland	Leinster	Human		National Virus Reference Laboratory	B.1.617.2	Europe	Europe	National Virus Reference Laboratory		2021-04-22	Zoe Yandle et al	[object Object]		Female
Malaysia/IMR_SB68524/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Asia	Malaysia	Asia	Malaysia	Human	Asia	Sungai Buloh Hospital	B.1.617.2	Asia	Asia	Institute for Medical Research, Infectious Disease Research Centre, National Institutes of Health, Ministry of Health Malaysia		2021-04-28	Suppiah J et al	[object Object]	40	Male
Russia/SPE-RII-32759S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	India	Saint-Petersburg	India	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Asia	WHO National Influenza Centre Russian Federation		2021-04-22	Andrey Komissarov et al A	[object Object]	31	Female
Russia/SPE-RII-32758S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	India	Saint-Petersburg	India	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Asia	WHO National Influenza Centre Russian Federation		2021-04-22	Andrey Komissarov et al A	[object Object]	44	Male
Russia/SPE-RII-34739S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	31	Female
Russia/SPE-RII-34612S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	55	Male
Russia/SPE-RII-35100S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	64	Female
Russia/SPE-RII-35117S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	83	Female
Bangladesh/IEDCR-JS003/2021		0.01	0.05	0.06	0.07	G	6.00	21A (Delta)	Asia	India	Asia	India	Human	Asia	Institute of Epidemiology, Disease Control and Research (IEDCR)	B.1.617.2	Asia	Asia	Institute for Developing Science and Health Initiatives (ideSHi)		2021-04-28	Hassan Afrad et al	[object Object]	23	Male
Bangladesh/BCSIR-NILMRC-757/2021		0.01	0.01		0.01	G	7.00	21A (Delta)	Asia	Bangladesh	Asia	Chattogram	Human	Asia	National Institute of Laboratory Medicine and Referral Center	B.1.617.2	Asia	Asia	Genomic Research Lab, BCSIR		2021-05-18	Md. Murshed Hasan Sarkar et al	[object Object]	22	Female
Pakistan/NIH-Sam1/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Asia	Pakistan	Asia	Islamabad	Human	Asia	Department of Virology	B.1.617.2	Asia	Asia	Department of Virology		2021-05-22	Massab Umair et al	[object Object]	38	Female
Romania/B-14515/2021		0.01	0.05	0.06	0.07	G	6.00	21A (Delta)	Romania	Romania	Romania	Bucharest	Human		National Institute of Infectious Diseases-Prof. Dr. Matei Bals Molecular Diagnostics Laboratory	B.1.617.2	Europe	Europe	National Institute of Infectious Diseases-Prof. Dr. Matei Bals Molecular Diagnostics Laboratory		2021-05-18	Corina Casangiu et al	[object Object]	35	Male
Bangladesh/IEDCR-OIS-0036/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Asia	India	Asia	India	Human	Asia	Institute of Epidemiology, Disease Control and Research (IEDCR)	B.1.617.2	Asia	Asia	IEDCR-ideSHi-icddr,b		2021-05-22	Hassan Afrad et al	[object Object]	28	Male
Bangladesh/IEDCR-V-20/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Asia	Bangladesh	Asia	Rajshahi	Human	Asia	Institute of Epidemiology, Disease Control and Research (IEDCR)	B.1.617.2	Asia	Asia	IEDCR-ideSHi-icddr,b		2021-05-17	Hassan Afrad et al	[object Object]	30	Male
Bangladesh/IEDCR-OIS-98/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Asia	Bangladesh	Asia	Dhaka	Human	Asia	Institute of Epidemiology, Disease Control and Research (IEDCR)	B.1.617.2	Asia	Asia	IEDCR-ideSHi-icddr,b		2021-05-27	Hassan Afrad et al	[object Object]	30	Male
Bangladesh/IEDCR-OIS-0070/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Asia	India	Asia	India	Human	Asia	Institute of Epidemiology, Disease Control and Research (IEDCR)	B.1.617.2	Asia	Asia	IEDCR-ideSHi-icddr,b		2021-05-18	Hassan Afrad et al	[object Object]	46	Male
USA/PA-CDC-LC0063059/2021	1.00	0.08	0.06	0.06	0.11	GR	10.00	21A (Delta)	North America	USA	North America	Pennsylvania	Human	North America	Laboratory Corporation of America	B.1.1	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-22	Dakota Howard et al	[object Object]	85	Male
USA/AR-CDC-LC0067427/2021		0.01	0.05	0.06	0.07	GR	8.00	21A (Delta)	North America	USA	North America	Arkansas	Human	North America	Laboratory Corporation of America	B.1.1.451	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-22	Dakota Howard et al	[object Object]	26	Male
Norway/12808/2021		0.01	0.01		0.01	G	7.00	21A (Delta)	Norway	Norway	Norway	Oslo	Human		Unilabs Laboratory Medicine	B.1.617.1	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-05-17	Kathrine Stene-Johansen et al	[object Object]		
Indonesia/JK-NIHRD-WGS02504/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Asia	Indonesia	Asia	Jakarta	Human	Asia	PKC Jagakarsa	B.1.617.2	Asia	Asia	National Institute of Health Research and Development		2021-04-03	Vivi Setiawaty et al	[object Object]	32	Female
Germany/HH-RKI-I-165968/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Germany	Germany	Germany	Hamburg	Human		Labor Dr. Heidrich & Kollegen MVZ GmbH Hamburg	B.1.617.2	Europe	Europe	Robert Koch Institute		2021-05-18	?	[object Object]		
Germany/HH-RKI-I-171229/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Germany	Germany	Germany	Hamburg	Human		Labor Dr. Heidrich & Kollegen MVZ GmbH Hamburg	B.1.617.2	Europe	Europe	Robert Koch Institute		2021-05-26	?	[object Object]		
Qatar/QA.QU_18.12.D8/2021		0.01	0.05	0.06	0.07	G	5.00	21A (Delta)	Asia	Qatar	Asia	Doha	Human	Asia	Ministry of Public Health / Hamad Medical Corporation	B.1.617.2	Asia	Asia	Biomedical Research Center (BRC), Qatar University / Qatar Genome Project (QGP)		2021-04-19	BRC: Fatiha M. Benslimane et al	[object Object]	43	Male
Germany/MV-RKI-I-097414/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Germany	Germany	Germany	Mecklenburg-Vorpommern	Human		Centogene; Dr. Bauer Laboratoriums GmbH	B.1.617.2	Europe	Europe	Robert Koch Institute		2021-04-15	?	[object Object]		
India/TG-CCMB-CIA2863/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Asia	India	Asia	Telangana	Human	Asia	CSIR-Centre for Cellular and Molecular Biology	B.1.617.2	Asia	Asia	CSIR-Centre for Cellular and Molecular Biology-INSACOG		2021-05-13	Tulasi Nagabandi et al	[object Object]	20	Female
India/TG-CCMB-CIA2649/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Asia	India	Asia	Telangana	Human	Asia	CSIR-Centre for Cellular and Molecular Biology	B.1.617.2	Asia	Asia	CSIR-Centre for Cellular and Molecular Biology-INSACOG		2021-05-09	Lamuk Zaveri et al	[object Object]	61	Male
Germany/ST-RKI-I-168941/2021	1.00	0.08	0.06	0.06	0.11	G	8.00	21A (Delta)	Germany	Germany	Germany	Saxony-Anhalt	Human		Med. Labor Prof. Schenk Dr. Ansorge & Kollegen	B.1.617.2	Europe	Europe	Robert Koch Institute		2021-06-01	?	[object Object]		
Russia/SPE-RII-35357S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-25	Andrey Komissarov et al A	[object Object]	60	Male
Indonesia/JT-UGM-2118347/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Asia	Indonesia	Asia	Central Java	Human	Asia	RSUD dr. LOEKMONO HADI	B.1.617.2	Asia	Asia	Genetics Working Group (Pokja Genetik) Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada (FK-KMK UGM); Disease Investigation Center Wates Ministry of Agriculture Indonesia; Department of Microbiology FK-KMK UGM; Laboratorium Diagnostik Yayasan Tahija World Mosquito Program (WMP) Yogyakarta Center for Tropical Medicine FK-KMK UGM; Integrated Research Center FK-KMK UGM; Department of Computer Science and Electronics FMIPA UGM; RSUP Dr. Sardjito		2021-05-31	Gunadi et al	[object Object]	56	Male
Indonesia/JT-UGM-2118346/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Asia	Indonesia	Asia	Central Java	Human	Asia	RSUD dr. LOEKMONO HADI	B.1.617.2	Asia	Asia	Genetics Working Group (Pokja Genetik) Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada (FK-KMK UGM); Disease Investigation Center Wates Ministry of Agriculture Indonesia; Department of Microbiology FK-KMK UGM; Laboratorium Diagnostik Yayasan Tahija World Mosquito Program (WMP) Yogyakarta Center for Tropical Medicine FK-KMK UGM; Integrated Research Center FK-KMK UGM; Department of Computer Science and Electronics FMIPA UGM; RSUP Dr. Sardjito		2021-05-31	Gunadi et al	[object Object]	26	Female
USA/CO-CDC-LC0064506/2021						O	5.00	21A (Delta)	North America	USA	North America	Colorado	Human	North America	Laboratory Corporation of America	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-21	Dakota Howard et al	[object Object]	46	Male
USA/CO-CDC-FG-036637/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	USA	North America	Colorado	Human	North America	Fulgent Genetics	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-06-01	Dakota Howard et al	[object Object]	28	Female
USA/CO-CDPHE-2101112583/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	USA	North America	Colorado	Human	North America	Colorado Department of Public Health and Environment	B.1.617.2	North America	North America	Colorado Department of Public Health and Environment		2021-05-17	Laura Bankers et al	[object Object]		
USA/UT-CDC-LC0060397/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	USA	North America	Utah	Human	North America	Laboratory Corporation of America	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-18	Dakota Howard et al	[object Object]	36	Male
Australia/QLD1901/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Oceania	Australia	Oceania	Queensland	Human	Oceania	PHV-FSS	B.1.617.2	Oceania	Oceania	PHV-FSS		2021-05-25	Son Nguyen et al	[object Object]		
SouthAfrica/604162775/2021		0.01	0.05	0.06	0.07	O	8.00	21A (Delta)	Africa	South Africa	Africa	Gauteng	Human	Africa	Pathcare-Vermaak Centurion	B.1.617.2	Africa	Africa	National Institute for Communicable Diseases of the National Health Laboratory Service		2021-04-24	Amoako DG et al	[object Object]	67	Female
USA/NV-CDC-LC0060395/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	USA	North America	Nevada	Human	North America	Laboratory Corporation of America	B.1	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-18	Dakota Howard et al	[object Object]	35	Female
USA/KS-KHEL-2040/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	USA	North America	Kansas	Human	North America	Wichita State University- Molecular Diagonstic lab	B.1.617.2	North America	North America	Kansas Health and Environmental Lab		2021-05-25	Katherine Wiggins et al	[object Object]	2	Male
Spain/CT-HUGTiPR017JX0A3/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Spain	Spain	Spain	Catalunya	Human	Arenys de Munt	Microbiology Department, Laboratori Clínic Metropolitana Nord. Hospital Universitari Germans Trias i Pujol.	B.1.617.2	Europe	Europe	Can Ruti SARS-CoV-2 Sequencing Hub (HUGTiP/IrsiCaixa/IGTP)		2021-05-13	Marc Noguera-Julian et al	[object Object]	56	Female
Australia/NSW1619/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Oceania	Australia	Oceania	New South Wales	Human	Oceania	South Eastern Area Laboratory Services (SEALS)	B.1.617.2	Oceania	Oceania	NSW Health Pathology - Institute of Clinical Pathology and Medical Research; Westmead Hospital; University of Sydney		2021-05-09	CIDM-PH et al.	[object Object]		
Italy/FVG-ASUGI_4_S4_Run10/2021		0.02	0.06	0.06	0.09	G	10.00	21A (Delta)	Italy	Italy	Italy	Friuli Venezia Giulia	Human	Trieste	SC (UCO) Igiene e Sanità Pubblica (funzione integrata con SC Microbiologia e Virologia)	B.1.617.2	Europe	Europe	ARGO Laboratorio Genomica ed Epigenomica		2021-04-02	Licastro D et al	[object Object]	49	Male
Belgium/Aalst-OLVZ-8132346/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Belgium	Belgium	Belgium	Halle-Vilvoorde	Human	Sint-Katherina-Lombeek	OLVZ Aalst	B.1.617.2	Europe	Europe	OLVZ Aalst		2021-05-28	Astrid Holderbeke et al	[object Object]	41	Male
Belgium/ULG-16390/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Belgium	Belgium	Belgium	Brabant Wallon	Human		University of Liège COVID-19 testing center	B.1.617.2	Europe	Europe	GIGA Medical Genomics		2021-06-07	Keith Durkin et al	[object Object]	49	Female
Australia/NSW-R0238/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Oceania	Australia	Oceania	New South Wales	Human	Oceania	New South Wales Health Pathology Royal Prince Alfred Hospital	B.1	Oceania	Oceania	Microbiology RPAH		2021-04-29	Foster et al	[object Object]		
Wales/PHWC-PYFOKA/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	United Kingdom	United Kingdom	United Kingdom	Wales	Human		Originating lab: Wales Specialist Virology Centre Sequencing lab: Pathogen Genomics Unit	B.1.617.2	Europe	Europe	Public Health Wales Microbiology Cardiff Wales Specialist Virology Centre		2021-05-27	Catherine Moore et al B	[object Object]		
Scotland/QEUH-15973D0/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	United Kingdom	United Kingdom	United Kingdom	Scotland	Human		Lighthouse Lab in Glasgow	B.1.617.2	Europe	Europe	Wellcome Sanger Institute for the COVID-19 Genomics UK (COG-UK) Consortium		2021-05-18	Harper VanSteenhouse et al	[object Object]		
Wales/PLYM-160EC32/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	United Kingdom	United Kingdom	United Kingdom	Wales	Human		Lighthouse Laboratory Plymouth	B.1.617.2	Europe	Europe	Wellcome Sanger Institute for the COVID-19 Genomics UK (COG-UK) Consortium		2021-06-02	Lighthouse Laboratory Plymouth et al	[object Object]		
NewZealand/21MV0439/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Oceania	New Zealand	Oceania	Auckland	Human	Oceania	LabPLUS	B.1.617.2	Oceania	Oceania	Institute of Environmental Science and Research (ESR)		2021-05-17	Rachel Boyle et al	[object Object]		Male
Finland/TRE26521_7/2021		0.01	0.05	0.06	0.07	O	7.00	21A (Delta)	Finland	Finland	Finland	Ostrobothnia	Human	Vaasa	Fimlab Laboratories	B.1.617.1	Europe	Europe	Fimlab Laboratories		2021-05-22	Minna Paloniemi et al	[object Object]	39	Male
Reunion/PIMIT_07848/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	France	France	France	France	Human		CHOR	B.1.617.2	Europe	Europe	UMR PIMIT		2021-05-04	Dr David A Wilkinson et al	[object Object]	40	Male
Reunion/CHU_7210509854/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	France	France	France	France	Human		CHU de la Réunion - Nord	B.1.617.2	Europe	Europe	Laboratoire de virologie, CNR arbovirus Associé, Chu de la Réunion		2021-05-18	Etienne Frumence et al	[object Object]	40	Male
Switzerland/GE-HUG-34332764/2021	1.00	0.14	0.06	0.06	0.10	O	9.00	21A (Delta)	Switzerland	Switzerland	Switzerland	Geneva	Human		University Hospitals of Geneva, Laboratory of Virology	AY.1	Europe	Europe	HUG, Laboratory of Virology and the Health2030 Genome Center		2021-05-31	Samuel Cordey et al	[object Object]		
Switzerland/GE-HUG-34349017/2021	1.00	0.14	0.06	0.06	0.10	G	11.00	21A (Delta)	Switzerland	Switzerland	Switzerland	Geneva	Human		University Hospitals of Geneva, Laboratory of Virology	AY.1	Europe	Europe	HUG, Laboratory of Virology and the Health2030 Genome Center		2021-06-01	Samuel Cordey et al	[object Object]		
USA/IN-CDC-LC0063294/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	North America	USA	North America	Indiana	Human	North America	Laboratory Corporation of America	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-17	Dakota Howard et al	[object Object]	68	Female
Germany/SN-RKI-I-141984/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Germany	Germany	Germany	Saxony	Human		Bioscientia Labor Wermsdorf	B.1.617.2	Europe	Europe	Robert Koch Institute		2021-04-29	?	[object Object]		
France/NAQ-Poitiers_9900268856/2021		0.01	0.05	0.06	0.07	O	6.00	21A (Delta)	France	France	France	Nouvelle-Aquitaine	Human	Angouleme	Laboffice	B.1.617.2	Europe	Europe	CHU Poitiers		2021-05-22	Caroline MICHAUD et al	[object Object]	79	Male
Belgium/UZA-UA-CV2054459289/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Belgium	Belgium	Belgium	Leuven	Human	Langdorp	Platform BIS UZA/UAntwerpen	B.1.617.2	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-21	Marie Le Mercier et al	[object Object]	68	Male
Switzerland/ZH-UZH-IMV-456d9cb0/2021	1.00	0.13	0.10	0.06	0.13	G	8.00	21A (Delta)	Switzerland	Switzerland	Switzerland	Zürich	Human		UniversitätsSpital Zürich 009	B.1.617.2	Europe	Europe	Institute of Medical Virology		2021-05-18	Verena Kufner et al	[object Object]		
Germany/HE-RKI-I-172114/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Germany	Germany	Germany	Hesse	Human		CENTOGENE Frankfurt Laboratory: Niederlassung Industriepark Höchst	B.1.617.2	Europe	Europe	Robert Koch Institute		2021-06-01	?	[object Object]		
Germany/SN-RKI-I-165397/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Germany	Germany	Germany	Saxony	Human		Bioscientia Labor Wermsdorf	B.1.617.2	Europe	Europe	Robert Koch Institute		2021-05-18	?	[object Object]		
Germany/BY-RKI-I-173072/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Germany	Germany	Germany	Bavaria	Human		SYNLAB MVZ Weiden	B.1.617.2	Europe	Europe	Robert Koch Institute		2021-06-02	?	[object Object]		
Spain/CT-HUVH-E16085/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Spain	Spain	Spain	Catalunya	Human		Hospital Universitari Vall d'Hebron - Vall d'Hebron Institut de Recerca	B.1.617.2	Europe	Europe	Hospital Universitari Vall d'Hebron - Vall d'Hebron Institut de Recerca		2021-06-03	Cristina Andrés et al	[object Object]	20	Male
Mexico/MEX-INMEGEN-05-05-85/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	Mexico	North America	Estado de Mexico	Human	North America	Salud Digna	B.1.617.2	North America	North America	Instituto Nacional de Medicina Genomica		2021-05-22	Hidalgo-Miranda A et al	[object Object]	38	Female
Ireland/C-NVRL-30IRL39113/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Ireland	Ireland	Ireland	Cork	Human		National Virus Reference Laboratory	B.1.617.2	Europe	Europe	National Virus Reference Laboratory		2021-05-19	Zoe Yandle et al	[object Object]		Female
Spain/CT-HUVH-E03988/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Spain	Spain	Spain	Catalunya	Human		Hospital Universitari Vall d'Hebron - Vall d'Hebron Institut de Recerca	B.1.617.2	Europe	Europe	Hospital Universitari Vall d'Hebron - Vall d'Hebron Institut de Recerca		2021-06-03	Cristina Andrés et al	[object Object]	56	Male
Germany/BE-RKI-I-142025/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Germany	Germany	Germany	Berlin	Human		Labor 28 MVZ GmbH	B.1.617.2	Europe	Europe	Robert Koch Institute		2021-04-28	?	[object Object]		
Russia/SPE-RII-34626S/2021						G	6.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	62	Female
Russia/SPE-RII-34023S/2021		0.01	0.01		0.01	G	7.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-11	Andrey Komissarov et al A	[object Object]	57	Male
Russia/SPE-RII-MH17346S/2021		0.04	0.34		0.24	G	6.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.617.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-03	Andrey Komissarov et al A	[object Object]	35	Male
USA/NV-CDC-LC0060424/2021		0.01	0.01		0.01	G	7.00	21A (Delta)	North America	USA	North America	Nevada	Human	North America	Laboratory Corporation of America	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-17	Dakota Howard et al	[object Object]	6	Male
Russia/SPE-RII-MH18452S/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	38	Female
DRC/16344/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Africa	Democratic Republic of the Congo	Africa	Kinshasa	Human	Africa	Viral Respiratory Lab, National Institute for Biomedical Research (INRB)	B.1.617.2	Africa	Africa	Pathogen Sequencing Lab, National Institute for Biomedical Research (INRB)		2021-05-03	Placide Mbala-Kingebeni et al A	[object Object]	66	Female
SouthKorea/KDCA4628/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Asia	Singapore	Asia	Singapore	Human	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency	B.1.617.2	Asia	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency		2021-05-25	Ae Kyung Park et al	[object Object]	36	Male
SouthKorea/KDCA4629/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Asia	Singapore	Asia	Singapore	Human	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency	B.1.617.2	Asia	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency		2021-05-28	Ae Kyung Park et al	[object Object]	36	Male
NewZealand/21MV0425/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Oceania	New Zealand	Oceania	Auckland	Human	Oceania	LabPLUS	B.1.617.2	Oceania	Oceania	Institute of Environmental Science and Research (ESR)		2021-05-18	Rachel Boyle et al	[object Object]		Female
Germany/HH-RKI-I-165983/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Germany	Germany	Germany	Hamburg	Human		Labor Dr. Heidrich & Kollegen MVZ GmbH Hamburg	B.1.617.2	Europe	Europe	Robert Koch Institute		2021-05-17	?	[object Object]		
Germany/NW-RKI-I-172675/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Germany	Germany	Germany	North Rhine Westphalia	Human		Eurofins MVZ Labor Gelsenkirchen	B.1.617.2	Europe	Europe	Robert Koch Institute		2021-06-07	?	[object Object]		
Russia/SPE-RII-35349S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-25	Andrey Komissarov et al A	[object Object]	44	Female
Russia/SPE-RII-35136S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-22	Andrey Komissarov et al A	[object Object]	70	Female
Russia/SPE-RII-34449S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-15	Andrey Komissarov et al A	[object Object]	23	Female
Russia/SPE-RII-34615S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	73	Female
Russia/SPE-RII-34886S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	65	Male
Russia/SPE-RII-35277S/2021		0.01	0.05	0.06	0.07	G	10.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]	74	Male
Russia/SPE-RII-35314S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-22	Andrey Komissarov et al A	[object Object]	9	Female
Russia/SPE-RII-35160S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-23	Andrey Komissarov et al A	[object Object]	83	Female
Russia/SPE-RII-35103S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	50	Male
Italy/SAR-Cagliari253/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Italy	Italy	Italy	Sardinia	Human		Laboratorio HUB -Azienda Ospedaliero Universitaria - AOU – Cagliari	B.1.617.2	Europe	Europe	Laboratorio SPOKE Biologia Molecolare -Azienda Ospedaliero Universitaria - AOU – Cagliari		2021-05-25	Germano Orrù et al	[object Object]	49	Female
Germany/HE-RKI-I-171959/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	Germany	Germany	Germany	Hesse	Human		CENTOGENE Frankfurt Laboratory: Niederlassung Industriepark Höchst	B.1.617.2	Europe	Europe	Robert Koch Institute		2021-05-29	?	[object Object]		
Russia/SPE-RII-35622S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-26	Andrey Komissarov et al A	[object Object]	59	Male
Russia/SPE-RII-35086S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	93	Female
Russia/SPE-RII-35294S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]	32	Male
Russia/SPE-RII-35107S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	31	Male
Russia/SPE-RII-34015S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-11	Andrey Komissarov et al A	[object Object]	62	Female
Russia/SPE-RII-MH17366S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-08	Andrey Komissarov et al A	[object Object]	30	Male
Russia/SPE-RII-34429S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-14	Andrey Komissarov et al A	[object Object]	39	Female
Russia/SPE-RII-34902S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	64	Male
Russia/SPE-RII-34422S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-14	Andrey Komissarov et al A	[object Object]	73	Female
Russia/SPE-RII-MH18425S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	34	Female
Russia/SPE-RII-34869S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-20	Andrey Komissarov et al A	[object Object]	27	Male
Russia/SPE-RII-34632S/2021		0.01	0.05	0.05	0.06	G	7.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	56	Female
Russia/SPE-RII-35369S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-25	Andrey Komissarov et al A	[object Object]	24	Female
Russia/SPE-RII-35359S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	A	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-25	Andrey Komissarov et al A	[object Object]	67	Female
Russia/SPE-RII-35263S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]	43	Female
Russia/SPE-RII-MH17352S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-06	Andrey Komissarov et al A	[object Object]	57	Female
Russia/SPE-RII-MH18188S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	57	Female
Russia/SPE-RII-35119S/2021		0.01	0.05	0.06	0.07	O	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	57	Female
Russia/SPE-RII-35135S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-22	Andrey Komissarov et al A	[object Object]	34	Male
Russia/SPE-RII-35347S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-25	Andrey Komissarov et al A	[object Object]	32	Male
Russia/SPE-RII-35162S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-23	Andrey Komissarov et al A	[object Object]	62	Male
Russia/SPE-RII-35161S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-23	Andrey Komissarov et al A	[object Object]	62	Male
Russia/SPE-RII-34659S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-16	Andrey Komissarov et al A	[object Object]	61	Female
Russia/SPE-RII-MH17830S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	34	Male
Russia/SPE-RII-34681S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	43	Female
Russia/SPE-RII-34638S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	22	Female
Russia/SPE-RII-34621S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	20	Female
Russia/SPE-RII-35241S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]	66	Female
Russia/SPE-RII-34870S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	31	Male
Russia/SPE-RII-MH18164S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	72	Female
Russia/SPE-RII-MH17819S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	28	Male
Russia/SPE-RII-34911S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-20	Andrey Komissarov et al A	[object Object]	53	Female
Russia/SPE-RII-34878S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	61	Female
USA/NY-CDC-FG-036604/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	USA	North America	New York	Human	North America	Fulgent Genetics	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-26	Dakota Howard et al	[object Object]	52	Female
Russia/SPE-RII-MH18156S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	33	Female
Russia/SPE-RII-34887S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	25	Male
Russia/SPE-RII-35134S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-22	Andrey Komissarov et al A	[object Object]	82	Female
Russia/SPE-RII-34034S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-11	Andrey Komissarov et al A	[object Object]	62	Male
Russia/SPE-RII-34430S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-15	Andrey Komissarov et al A	[object Object]	62	Female
Russia/SPE-RII-MH17373S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-10	Andrey Komissarov et al A	[object Object]	57	Female
Russia/SPE-RII-MH17832S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	30	Female
Russia/SPE-RII-33925S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-11	Andrey Komissarov et al A	[object Object]	25	Male
Russia/SPE-RII-MH17374S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-10	Andrey Komissarov et al A	[object Object]	21	Female
USA/NJ-CDC-LC0061439/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	USA	North America	New Jersey	Human	North America	Laboratory Corporation of America	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-13	Dakota Howard et al	[object Object]	68	Male
Russia/SPE-RII-34522S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	40	Male
Russia/SPE-RII-34706S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	62	Female
Russia/SPE-RII-35293S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	A	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]	54	Male
Russia/SPE-RII-35352S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-25	Andrey Komissarov et al A	[object Object]	55	Male
Russia/SPE-RII-34960S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	21	Male
Russia/SPE-RII-34963S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	20	Female
Russia/SPE-RII-34707S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	72	Female
Russia/SPE-RII-34907S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	67	Female
Russia/SPE-RII-MH18455S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-22	Andrey Komissarov et al A	[object Object]	34	Female
Russia/SPE-RII-MH18456S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-22	Andrey Komissarov et al A	[object Object]	44	Female
Russia/SPE-RII-35373S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-26	Andrey Komissarov et al A	[object Object]	51	Male
Russia/SPE-RII-34899S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	85	Female
Germany/BW-RKI-I-172282/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Germany	Germany	Germany	Baden-Wuerttemberg	Human		Eurofins LifeCodexx GmbH	B.1.617.2	Europe	Europe	Robert Koch Institute		2021-05-16	?	[object Object]		
Germany/BE-ChVir-LB-210604-4599/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Germany	Germany	Germany	Berlin	Human		Labor Berlin Charité Vivantes GmbH / Institut für Virologie	B.1.617.2	Europe	Europe	Charité Universitätsmedizin Berlin, Institut für Virologie/Labor Berlin		2021-05-31	Peter Menzel et al	[object Object]		
Germany/BE-RKI-I-172752/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Germany	Germany	Germany	Berlin	Human		MDI Limbach Berlin GmbH; MVZ Labor Berlin	B.1.617.2	Europe	Europe	Robert Koch Institute		2021-06-01	?	[object Object]		
Russia/SPE-RII-35170S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-23	Andrey Komissarov et al A	[object Object]	39	Female
Russia/SPE-RII-35667S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-27	Andrey Komissarov et al A	[object Object]	22	Female
Russia/SPE-RII-35693S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-27	Andrey Komissarov et al A	[object Object]	20	Male
Russia/SPE-RII-35681S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-27	Andrey Komissarov et al A	[object Object]	24	Male
Russia/SPE-RII-35704S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-27	Andrey Komissarov et al A	[object Object]	43	Male
Russia/SPE-RII-MH17825S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	8	Male
Russia/SPE-RII-35629S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-27	Andrey Komissarov et al A	[object Object]	35	Female
Japan/IC-1053/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Asia	United Kingdom	Asia	United Kingdom	Human	Asia	SARS-CoV-2 testing team, National Institute of Infectious Diseases	B.1.617.2	Asia	Europe	Pathogen Genomics Center, National Institute of Infectious Diseases		2021-04-16	Tsuyoshi Sekizuka et al B	[object Object]		
USA/MD-CDC-LC0067105/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	USA	North America	Maryland	Human	North America	Laboratory Corporation of America	B.1.617.2	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-29	Dakota Howard et al	[object Object]	10	Male
Russia/VLG-RII-MH18440S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Vologda	Vologda	Human	Cherepovets	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-20	Andrey Komissarov et al A	[object Object]	36	Female
Russia/SPE-RII-MH18445S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	31	Male
USA/WA-CDC-UW21051787103/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	North America	USA	North America	Washington	Human	North America	UW Virology Lab	B.1.617.2	North America	North America	UW Virology Lab		2021-05-17	Pavitra Roychoudhury et al	[object Object]		
USA/WA-CDC-UW21051745917/2021		0.01	0.05	0.06	0.07	G	7.00	21A (Delta)	North America	USA	North America	Washington	Human	North America	UW Virology Lab	B.1.617.2	North America	North America	UW Virology Lab		2021-05-17	Pavitra Roychoudhury et al	[object Object]		
USA/NY-PRL-2021_0503_00A19/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	North America	USA	North America	New York	Human	North America	Pandemic Response Lab - NYC	B.1.617.2	North America	North America	Pandemic Response Lab, R&D		2021-04-30	Henry Lee et al	[object Object]	2	Male
England/QEUH-16281AC/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	United Kingdom	United Kingdom	United Kingdom	England	Human		Lighthouse Lab in Glasgow	B.1.617.2	Europe	Europe	Wellcome Sanger Institute for the COVID-19 Genomics UK (COG-UK) Consortium		2021-06-03	Harper VanSteenhouse et al	[object Object]		
England/NORT-1BC1D33/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	United Kingdom	United Kingdom	United Kingdom	England	Human		Northumbria University / South Tees Hospitals NHS Foundation Trust / North Cumbria Integrated Care NHS Foundation Trust / North Tees and Hartlepool NHS Foundation Trust / Newcastle Hospitals NHS Foundation Trust	B.1.617.2	Europe	Europe	COVID-19 Genomics UK (COG-UK) Consortium		2021-05-18	Darren L Smith et al	[object Object]		
Scotland/QEUH-161844C/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	United Kingdom	United Kingdom	United Kingdom	Scotland	Human		Lighthouse Lab in Glasgow	B.1.617.2	Europe	Europe	Wellcome Sanger Institute for the COVID-19 Genomics UK (COG-UK) Consortium		2021-06-02	Harper VanSteenhouse et al	[object Object]		
England/QEUH-15E9032/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	United Kingdom	United Kingdom	United Kingdom	England	Human		Lighthouse Lab in Glasgow	B.1.617.2	Europe	Europe	Wellcome Sanger Institute for the COVID-19 Genomics UK (COG-UK) Consortium		2021-05-29	Harper VanSteenhouse et al	[object Object]		
Netherlands/NB-RIVM-35912/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Netherlands	Netherlands	Netherlands	North Brabant	Human		Dutch COVID-19 response team	B.1.617.2	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-20	Adam Meijer et al	[object Object]	24	
Russia/SPE-RII-35078S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-22	Andrey Komissarov et al A	[object Object]	19	Female
Russia/SPE-RII-35104S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	A	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	35	Female
Russia/SPE-RII-35190S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]		Male
Russia/SPE-RII-35654S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-27	Andrey Komissarov et al A	[object Object]	17	Male
Russia/SPE-RII-35197S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	A	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]		Male
Russia/SPE-RII-35647S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-27	Andrey Komissarov et al A	[object Object]	16	Male
Russia/SPE-RII-35188S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]		Male
Russia/SPE-RII-35205S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]		Male
Russia/SPE-RII-35199S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]		Male
Russia/SPE-RII-35645S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-27	Andrey Komissarov et al A	[object Object]	16	Male
Russia/SPE-RII-35646S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-27	Andrey Komissarov et al A	[object Object]	16	Male
Russia/SPE-RII-35644S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-27	Andrey Komissarov et al A	[object Object]	17	Male
Russia/SPE-RII-35652S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-27	Andrey Komissarov et al A	[object Object]	17	Male
Russia/SPE-RII-35182S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]		Male
Russia/SPE-RII-35183S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]		Male
Russia/SPE-RII-34547S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	16	Male
Russia/SPE-RII-34554S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	16	Male
Russia/SPE-RII-MH17324S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-06	Andrey Komissarov et al A	[object Object]	38	Male
Russia/SPE-RII-35275S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-25	Andrey Komissarov et al A	[object Object]	45	Female
Russia/SPE-RII-34715S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	54	Male
Russia/SPE-RII-35154S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]	60	Female
Russia/SPE-RII-34890S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.530	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	31	Female
Russia/SPE-RII-MH18158S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	60	Female
Russia/SPE-RII-34743S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.530	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	65	Female
Russia/SPE-RII-34728S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	29	Male
Russia/SPE-RII-34514S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	30	Male
Russia/SPE-RII-35046S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	63	Female
Russia/SPE-RII-34720S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	53	Female
Russia/SPE-RII-MH18155S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	21	Male
Russia/SPE-RII-MH18154S/2021		0.01	0.05	0.06	0.07	O	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	18	Male
Germany/BE-ChVir-LB-210604-83852/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Germany	Germany	Germany	Berlin	Human		Labor Berlin Charité Vivantes GmbH / Institut für Virologie	B.1.617.2	Europe	Europe	Charité Universitätsmedizin Berlin, Institut für Virologie/Labor Berlin		2021-05-26	Peter Menzel et al	[object Object]		
Russia/SPE-RII-35364S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-25	Andrey Komissarov et al A	[object Object]	42	Male
Russia/SPE-RII-MH17835S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	36	Female
Russia/SPE-RII-35371S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-25	Andrey Komissarov et al A	[object Object]	76	Female
Russia/SPE-RII-35372S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-25	Andrey Komissarov et al A	[object Object]	82	Male
Russia/SPE-RII-34882S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	30	Female
Russia/SPE-RII-34905S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-20	Andrey Komissarov et al A	[object Object]	38	Female
Russia/SPE-RII-35088S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	30	Male
Denmark/DCGC-104354/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Denmark	Denmark	Denmark	Hovedstaden	Human		Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark	B.1.617.1	Europe	Europe	Statens Serum Institut Bioinformatics and Microbial Genomics		2021-05-17	Danish Covid-19 Genome Consortium et al	[object Object]		
Russia/SPE-RII-35129S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-22	Andrey Komissarov et al A	[object Object]	50	Male
Russia/SPE-RII-35394S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	A	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-25	Andrey Komissarov et al A	[object Object]	89	Female
Russia/SPE-RII-35400S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-26	Andrey Komissarov et al A	[object Object]	52	
Russia/SPE-RII-35167S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-23	Andrey Komissarov et al A	[object Object]	40	Female
Russia/SPE-RII-35141S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-22	Andrey Komissarov et al A	[object Object]	38	Male
Russia/SPE-RII-34730S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	71	Female
Russia/SPE-RII-35320S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-25	Andrey Komissarov et al A	[object Object]	26	Female
Russia/SPE-RII-MH17386S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-10	Andrey Komissarov et al A	[object Object]	32	Male
Russia/SPE-RII-MH18132S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-16	Andrey Komissarov et al A	[object Object]	20	Male
Russia/SPE-RII-35114S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	54	Female
Russia/SPE-RII-34908S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-20	Andrey Komissarov et al A	[object Object]	33	Female
Switzerland/GE-33896105/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Switzerland	Switzerland	Switzerland	Geneva	Human		University Hospitals of Geneva, Laboratory of Virology	B.1.617.2	Europe	Europe	HUG, Laboratory of Virology and the Health2030 Genome Center		2021-04-17	Samuel Cordey et al	[object Object]		
Russia/SPE-RII-MH18451S/2021		0.01	0.05	0.06	0.07	G	9.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	2	Female
Russia/SPE-RII-35123S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	73	Male
Russia/SPE-RII-35515S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-26	Andrey Komissarov et al A	[object Object]	32	Female
Russia/SPE-RII-35710S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-27	Andrey Komissarov et al A	[object Object]	32	Female
Russia/SPE-RII-MH17235S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-28	Andrey Komissarov et al A	[object Object]	40	Male
Russia/SPE-RII-MH17291S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-03	Andrey Komissarov et al A	[object Object]	56	Female
Russia/SPE-RII-35627S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-26	Andrey Komissarov et al A	[object Object]	47	Female
Russia/SPE-RII-34640S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	59	Female
Russia/SPE-RII-35257S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]	43	Female
Russia/SPE-RII-35155S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]	56	Female
Russia/SPE-RII-34961S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	21	Female
NorthernIreland/MILK-15B0948/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	United Kingdom	United Kingdom	United Kingdom	Northern Ireland	Human		Lighthouse Lab in Milton Keynes	B.1.617.2	Europe	Europe	Wellcome Sanger Institute for the COVID-19 Genomics UK (COG-UK) Consortium		2021-05-23	The Lighthouse Lab in Milton Keynes et al	[object Object]		
Russia/SPE-RII-34624S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	33	Female
Russia/SPE-RII-MH17836S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	88	Female
Russia/SPE-RII-34745S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	26	Male
Russia/SPE-RII-34884S/2021		0.01	0.05	0.06	0.07	G	8.00	21A (Delta)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.617.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	60	Female
Nigeria/Lagos01/2020						GR	1.00	20B	Africa	Italy	Africa	Italy	Human	Africa	Centre for Human and Zoonotic Virology (CHAZVY), College of Medicine University of Lagos/Lagos University Teaching Hospital (LUTH), part of the Laboratory Network of the Nigeria Centre for Disease Control (NCDC)	B.1.1	Africa	Europe	African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria		2020-02-27	Oluniyi P.E. et al C (https://virological.org/t/first-african-sars-cov-2-genome-sequence-from-nigerian-covid-19-case/421)	[object Object]	44	Male
Oman/C-16516/2020						GR	1.00	20B	Asia	Oman	Asia	Buraimi	Human	Asia	Oman-National Influenza Center	B.1.1	Asia	Asia	Biotechnology & OMICs Laboratory		2020-05-09	Abdul Latif Khan et al	[object Object]	40	Female
HongKong/HKU-200723-064/2020						GR	1.00	20B	Asia	Hong Kong	Asia	Hong Kong	Human	Asia	Department of Microbiology, The University of Hong Kong	B.1.1	Asia	Asia	Department of Microbiology, The University of Hong Kong		2020-03-13	Kelvin K.W. To et al	[object Object]		
Russia/Perm-82707/2020						GR	1.00	20B	Russia	Russia	Perm Krai	Perm Krai	Human	Perm	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-24	Sergey A. Bodnev et al	[object Object]	36	Female
Germany/HE-Cento-37777865/2020						GR	2.00	20B	Germany	Germany	Germany	Hesse	Human	Wiesbaden	Centogene	B.1.1	Europe	Europe	Centogene		2020-09-27	Peter Bauer et al	[object Object]	46	Male
Russia/StPetersburg-RII4307V/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-03-24	Andrey Komissarov et al B (https://dx.doi.org/10.1101/2020.07.14.20150979)	[object Object]	28	Female
Canada/QC-JUS-V5272136/2020						GR	1.00	20B	North America	Canada	North America	Quebec	Human	North America	Laboratoire de santé publique du Québec	B.1.1.176	North America	North America	Laboratoire de santé publique du Québec		2020-03-26	Sandrine Moreira et al	[object Object]	87	Male
Norway/3924/2021						GR	3.00	20B	Norway	Norway	Norway	Nordland	Human		Hospital of Southern Norway - Kristiansand, Department of Medical Microbiology	B.1.1.333	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-02-09	Kathrine Stene-Johansen et al	[object Object]		
Belgium/LL-0328341/2020						GR	1.00	20B	Belgium	Belgium	Belgium	Aalst	Human	Geraardsbergen	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.1.200	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-03-28	Tony Wawina-Bokalanga et al	[object Object]	85	Male
Russia/CU-RII-MH16169S/2021						GR	2.00	20B	Russia	Russia	Chuvash Republic	Chuvash Republic	Human	Kanash	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-05	Andrey Komissarov et al A	[object Object]	32	Female
Germany/BW-FR0095/2020		0.01	0.22	0.05	0.07	GR	3.00	20B	Germany	Germany	Germany	Baden-Wuerttemberg	Human	Freiburg	Institute of Virology, Medical Center, University of Freiburg, Freiburg, Germany	B.1.1	Europe	Europe	Institute of Virology, Clinial Virus Genomics, Medical Center, University of Freiburg, Freiburg, Germany		2020-08-10	Jonas Fuchs et al	[object Object]	59	Male
Russia/Krasnodar-63401/2020						GR	1.00	20B	Russia	Russia	Krasnodar	Krasnodar	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-11	Oleg V. Pyankov et al	[object Object]	62	Male
Russia/Lipetsk-62707/2020						GR	1.00	20B	Russia	Russia	Lipetsk	Lipetsk	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-11	Oleg V. Pyankov et al	[object Object]	45	Male
Russia/AST-RII-MH14417S/2020						GR	1.00	20B	Russia	Russia	Astrakhan Region	Astrakhan Region	Human	Multanovo	Pathogenic Microorganisms Variability Laboratory	B.1.1.220	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-05	Andrey Komissarov et al A	[object Object]	55	Male
Russia/SAR-RARI-3573/2020						GR	1.00	20B	Russia	Russia	Saratov	Saratov	Human		Mikrobiologie, RARI	B.1.1.424	Europe	Europe	Mikrobiologie, RARI		2020-05-02	Krasnov et al	[object Object]		
Russia/KAM-RII-MH12281S/2020						GR	1.00	20B	Russia	Russia	Kamchatka Krai	Kamchatka Krai	Human	Petropavlovsk-Kamchatsky	Kamchatka Regional Children's Infectious Diseases Hospital	B.1.1.424	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-15	Andrey Komissarov et al A	[object Object]	37	Female
Norway/2439/2020						GR	2.00	20B	Norway	Norway	Norway	Rogaland	Human		Dept. of Medical Microbiology, Stavanger University Hospital, Helse Stavanger HF	B.1.1.189	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2020-04-14	Kathrine Stene-Johansen et al	[object Object]		
Poland/NIPH-NIH_ECDC-043/2021		0.01	0.01		0.02	GR	4.00	20B	Poland	Poland	Poland	Mazowieckie	Human	Warszawa	National Institute of Public Health - National Institute of Hygiene	B.1.1.351	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-01-28	Wołkowicz Tomasz et al	[object Object]	36	Female
Russia/AST-RII-MH4466S/2020						GR	1.00	20B	Russia	Russia	Astrakhan Region	Astrakhan Region	Human	Astrakhan	Pathogenic Microorganisms Variability Laboratory	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-10	Andrey Komissarov et al A	[object Object]	23	Female
Russia/Moscow_PMVL-27/2020						GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Influenza etiology and epidemiology laboratory	B.1.1	Europe	Europe	Pathogenic Microorganisms Variability Laboratory		2020-08-20	Alexey Shchetinin et al	[object Object]		Male
Croatia/14412_Koprivnica/2020						GR	1.00	20B	Croatia	Croatia	Croatia	Koprivnica	Human		Croatian Institute of Public Health	B.1.1	Europe	Europe	University of Zagreb, Centre for research and knowledge transfer in biotechnology		2020-04-21	Irena Tabain et al	[object Object]	68	Male
Ireland/DL-NVRL-20G45120/2020						GR	1.00	20B	Ireland	Ireland	Ireland	Donegal	Human		National Virus Reference Lab (NVRL)	B.1.1.10	Europe	Europe	Irish Coronavirus Sequencing Consortium-Teagasc Grange		2020-04-02	Matthew McCabe et al	[object Object]		Male
Nigeria/NCDC-08/2020						GR	1.00	20B	Africa	Nigeria	Africa	Federal Capital Territory	Human	Africa	National Reference Laboratory, Nigeria Centre for Disease Control.	L.3	Africa	Africa	National Reference Laboratory, Nigeria Centre for Disease Control, Gaduwa,Abuja, Nigeria		2020-08-21	Dr Ndodo Nnaemeka et al	[object Object]	22	Female
Lithuania/MR-LUHS-Eilnr422/2020						GR	1.00	20B	Lithuania	Lithuania	Lithuania	Kauno Apskritis	Human		Lithuanian University of Health Sciences Hospital, Department of Laboratory Medicine	B.1.1.10	Europe	Europe	Lithuanian University of Health Sciences, Molecular cardiology lab.		2020-09-03	Lukas Zemaitis et al	[object Object]	21	Female
Netherlands/ZH-EMC-253/2020						GR	2.00	20B	Netherlands	Netherlands	Netherlands	South Holland	Human		Dutch COVID-19 response team	L.2	Europe	Europe	Erasmus Medical Center		2020-06-29	Bas Oude Munnink et al	[object Object]		
Brazil/SP-L9-CD121/2020						GR	1.00	20B	South America	Brazil	South America	São Paulo	Human	South America	Hospital da Clínicas da Faculdade de Medicina da Universidade de São Paulo	B.1.1.28	South America	South America	Instituto de Medicina Tropical da Univesidade de São Paulo		2020-03-17	Samples: Ingra Morales Claro et al (https://dx.doi.org/10.1126/science.abd2161)	[object Object]		
Russia/YAR-RII-MH3382S/2020						GR	1.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human	Yaroslavl	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	44	Female
Russia/KL-RII-MH5356S/2020						GR	1.00	20B	Russia	Russia	Kalmykia	Kalmykia	Human	Elista	WHO National Influenza Centre Russian Federation	B.1.1.184	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-23	Andrey Komissarov et al A	[object Object]	57	Female
Paraguay/33620/2020						G	1.00	20B	South America	Paraguay	South America	Paraguay	Human	South America	Departamento de Virologia, Laboratorio Central de Salud Pública, Avenida Venezuela y Teniente Escurra, Asunción, Paraguay	B.1	South America	South America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-07-06	Paola Resende et al	[object Object]		
Paraguay/PY7/2020						GR	1.00	20B	South America	Paraguay	South America	Paraguay	Human	South America	Laboratorio Central de Salud Publica de Paraguay	B.1.1.28	South America	South America	Laboratorio Central de Salud Publica de Paraguay		2020-12-15	Marta Giovanetti et al	[object Object]	80	Male
Brazil/SP-L19-CD395/2020						GR	1.00	20B	South America	Brazil	South America	São Paulo	Human	South America	DB Diagnósticos do Brasil	B.1.1.28	South America	South America	Instituto de Medicina Tropical da Univesidade de São Paulo		2020-04-03	Samples: Nelson Gaburo Jr et al (https://dx.doi.org/10.1126/science.abd2161)	[object Object]		
Paraguay/33622/2020						GR	1.00	20B	South America	Paraguay	South America	Paraguay	Human	South America	Departamento de Virologia, Laboratorio Central de Salud Pública, Avenida Venezuela y Teniente Escurra, Asunción, Paraguay	B.1.1.28	South America	South America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-09-08	Paola Resende et al	[object Object]		
Qatar/QA-QU_07-1-A8/2020						GR	1.00	20B	Asia	Qatar	Asia	Doha	Human	Asia	Ministry of Public Health / Hamad Medical Corporation	B.1.1.28	Asia	Asia	Biomedical Research Center (BRC), Qatar University / Qatar Genome Project (QGP)		2020-06-14	BRC: Fatiha M. Benslimane et al	[object Object]	56	Male
Brazil/BA-00753/2021						GR	2.00	20B	South America	Brazil	South America	Bahia	Human	South America	LAFEM/UESC	B.1.1.28	South America	South America	Bioinformatics Laboratory / LNCC		2021-02-03	Alessandra P Lamarca et al	[object Object]	51	Female
Netherlands/GE-EMC-293/2020						GR	1.00	20B	Netherlands	Netherlands	Netherlands	Gelderland	Human		Dutch COVID-19 response team	B.1.1.70	Europe	Europe	Erasmus Medical Center		2020-07-07	Bas Oude Munnink et al	[object Object]		
Slovenia/08-079912-MB/2020						GR	1.00	20B	Slovenia	Slovenia	Slovenia	Podravska	Human		National Laboratory for Health, Environment and Food, OMM, Maribor	AP.1	Europe	Europe	CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2020-10-31	Jernej Kovač et al	[object Object]	32	Male
Norway/2970/2020						GR	1.00	20B	Norway	Norway	Norway	More Og Romsdal	Human		Ostfold Hospital Trust - Kalnes, Centre for Laboratory Medicine, Section for gene technology and infection serology	B.1.1.70	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2020-07-22	Kathrine Stene-Johansen et al	[object Object]		
Ireland/LH-NVRL-71IRL81038/2020						GR	2.00	20B	Ireland	Ireland	Ireland	Louth	Human		National Virus Reference Laboratory	B.1.1.70	Europe	Europe	National Virus Reference Laboratory		2020-07-24	Michael Carr et al	[object Object]		Female
Sweden/20-52883/2020		0.01	0.01		0.01	GR	3.00	20B	Sweden	Sweden	Sweden	Halland	Human		Halmstad klinisk mikrobiologi	B.1.1.70	Europe	Europe	The Public Health Agency of Sweden		2020-09-14	Anna-Malin Linde et al	[object Object]	50	Female
NorthMacedonia/31392/2021						GR	2.00	20B	North Macedonia	North Macedonia	North Macedonia	Vardar	Human	Veles	General Hospital - Veles	B.1.1.70	Europe	Europe	Research Center for Genetic Engineering and Biotechnology "Georgi D. Efremov” , Macedonian Academy of Sciences and Arts		2021-01-13	Aleksandar J. Dimovski et al	[object Object]	84	Male
NorthMacedonia/8817/2020						GR	2.00	20B	North Macedonia	North Macedonia	North Macedonia	Southwestern Region	Human	Struga	General Hospital - Struga	B.1.1.70	Europe	Europe	Research Center for Genetic Engineering and Biotechnology "Georgi D. Efremov” , Macedonian Academy of Sciences and Arts		2020-07-29	RCGEB - MASA et al	[object Object]	78	Female
NorthMacedonia/5324/2021						GR	2.00	20B	North Macedonia	North Macedonia	North Macedonia	Vardar	Human	Veles	Laboratory of Virology and Molecular Diagnostics	B.1.1.70	Europe	Europe	Institute of Public Health of Republic of North Macedonia Laboratory of Virology and Molecular Diagnostics		2021-01-25	M. Kuzmanovska et al	[object Object]	58	Female
Serbia/NoviPazar-00391007/2020						GR	1.00	20B	Serbia	Serbia	Serbia	Raška District	Human	Novi Pazar	Veterinary Specialized Institute "Kraljevo", Serbia	B.1.1.70	Europe	Europe	Veterinary Specialized Institute "Kraljevo", Serbia		2020-07-09	Vidanovic et al	[object Object]		
Croatia/Zagreb-5/2020						GR	1.00	20B	Croatia	Croatia	Croatia	Zagreb	Human		University Hospital Dubrava	B.1.1.70	Europe	Europe	Ruđer Boškovic Institute; Forensic Science Centre Ivan Vučetić; University of Zagreb Faculty of Science		2020-10-02	Robert Belužić et al	[object Object]	60	Male
NorthMacedonia/18568/2020						GR	1.00	20B	North Macedonia	North Macedonia	North Macedonia	Tetovo	Human		General Hospital - Tetovo	B.1.1.70	Europe	Europe	Research Center for Genetic Engineering and Biotechnology "Georgi D. Efremov” , Macedonian Academy of Sciences and Arts		2020-11-03	RCGEB - MASA et al	[object Object]	66	Male
Serbia/NoviSad-111681105/2020						GR	1.00	20B	Serbia	Serbia	Serbia	South Bačka District	Human	Novi Sad	Scientific Veterinary Institute Novi Sad	B.1.1.70	Europe	Europe	Veterinary Specialized Institute "Kraljevo", Serbia		2020-05-10	Vidanovic et al	[object Object]		
Switzerland/AG-HUG-7120/2020						GR	1.00	20B	Switzerland	Switzerland	Switzerland	Aargau	Human		University Hospitals of Geneva Laboratory of Virology	B.1.1	Europe	Europe	University Hospitals of Geneva Laboratory of Virology		2020-02-29	Laubscher F. et al	[object Object]	30	
Brazil/GO-HLAGYN-1013302_R1/2021						GR	1.00	20B	South America	Brazil	South America	Goiás	Human	South America	HLAGYN - Laboratorio de Imunologia de Transplantes de Goias	B.1.1.33	South America	South America	HLAGYN - Laboratorio de Imunologia de Transplantes de Goias		2020-08-14	Fernando Antonio Vinhal dos Santos et al	[object Object]	30	Female
Argentina/PAIS-A0058/2020						GR	1.00	20B	South America	Argentina	South America	Buenos Aires	Human	South America	Laboratorio de Virología del Hospital de Niños Dr. Ricardo Gutierrez	N.3	South America	South America	Área de Secuenciación del Laboratorio de Virología del Hospital de Niños Dr. Ricardo Gutierrez on behalf of 'Proyecto Argentino Interinstitucional de genomica de SARS-CoV-2' (PAIS Consortium)		2020-05-02	Nabaes Jodar et al	[object Object]	33	Female
HongKong/HKPU-05353/2020						GR	2.00	20B	Asia	Hong Kong	Asia	Hong Kong	Human	Asia	Department of Health Technology and Informatics, The Hong Kong Polytechnic University	N.3	Asia	Asia	Department of Health Technology and Informatics, The Hong Kong Polytechnic University		2020-11-05	Gilman Kit-Hang Siu et al	[object Object]	23	Male
Brazil/RJ-FIOCRUZ-3956/2020						GR	1.00	20B	South America	Brazil	South America	Rio de Janeiro	Human	South America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ	B.1.1.33	South America	South America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-05-15	Paola Resende et al	[object Object]	24	Female
Chile/NB-32567/2021						GR	1.00	20B	South America	Chile	South America	Ñuble	Human	South America	Genetica Molecular and Subdepartamento de Virologia ISP Chile	B.1.1.33	South America	South America	Instituto de Salud Publica de Chile		2021-02-10	Javier Tognarelli et al	[object Object]	51	Male
Uruguay/TYT-M91/2020						GR	1.00	20B	South America	Uruguay	South America	Treinta y Tres	Human	South America	Sanatorio Americano	N.7	South America	South America	Institut Pasteur de Montevideo		2020-06-25	Daiana Mir et al	[object Object]		
Uruguay/TYT-M93/2020						GR	1.00	20B	South America	Uruguay	South America	Treinta y Tres	Human	South America	Sanatorio Americano	N.7	South America	South America	Institut Pasteur de Montevideo		2020-06-25	Daiana Mir et al	[object Object]		
Argentina/PAIS-G0208/2021		0.01	0.01		0.01	GR	2.00	20B	South America	Argentina	South America	Cordoba AR	Human	South America	Laboratorio Central, Ministerio de Salud Córdoba	N.5	South America	South America	Instituto de Patologia Vegetal (CIAP-INTA) on behalf of 'Proyecto Argentino Interinstitucional de genomica de SARS-CoV-2' (PAIS Consortium)		2021-02-04	Fernández et al	[object Object]	63	Male
Brazil/RS-FIOCRUZ-6208/2020						GR	1.00	20B	South America	Brazil	South America	Rio Grande do Sul	Human	South America	Laboratório Central de Saúde Pública do Estado do Rio Grande do Sul (LACEN-RS)	B.1.1.33	South America	South America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-05-19	Paola Resende et al	[object Object]	35	Male
Brazil/AM-L77-CD2307/2021						GR	1.00	20B	South America	Brazil	South America	Amazonas BR	Human	South America	CDL Laboratorio Santos e Vidal LTDA.	B.1.1.33	South America	South America	Instituto de Medicina Tropical de Sao Paulo		2021-01-04	Brazil-UK Centre for Arbovirus Discovery Diagnosis Genomics et al	[object Object]		
Chile/AT-CMM-ATAC20/2020						GR	1.00	20B	South America	Chile	South America	Atacama	Human	South America	Laboratorio de Biología Molecular, Facultad de Medicina, Universidad de Atacama, Copiapo, Chile/ FONDAP CRG, Universidad Andrés Bello, Santiago, Chile	N.4	South America	South America	Center for Mathematical Modeling and Center for Genome Regulation. Santiago, Chile		2020-07-26	Echeverría C et al	[object Object]		Male
Chile/RM-127424/2020						GR	1.00	20B	South America	Chile	South America	Region Metropolitana de Santiago	Human	South America	Genetica Molecular and Subdepartamento de Virologia ISP Chile	N.4	South America	South America	Instituto de Salud Publica de Chile		2020-07-18	Javier Tognarelli et al	[object Object]	77	Male
Morocco/RMPS-12/2020						GR	1.00	20B	Africa	Morocco	Africa	Morocco	Human	Africa	LNR National Reference Laboratory, Mohammed VI University of Health Sciences	B.1.1	Africa	Africa	Medical Biotechnology Laboratory, Rabat Medical and Pharmacy School, Mohammed The Vth University in Rabat		2020-05-08	Meriem LAAMARTI et al B	[object Object]		Male
Switzerland/ZH-UZH-1000477377/2020						GR	1.00	20B	Switzerland	Switzerland	Switzerland	Zürich	Human		Department of Internal Medicine, Triemli Hospital	B.1.1	Europe	Europe	Institute of Medical Virology, University of Zurich		2020-02-27	Stefan Schmutz et al (https://virological.org/t/phylodynamic-analyses-based-on-11-genomes-from-the-italian-outbreak/426)	[object Object]	37	Male
France/OCC-SC463/2020						GR	1.00	20B	France	France	France	Occitanie	Human	Montpellier	CHU Montpellier	B.1.1	Europe	Europe	CNR Virus des Infections Respiratoires - France SUD		2020-02-26	Antonin Bal et al	[object Object]	32	Male
Gambia/0278/2020						GR	1.00	20B	Africa	Gambia	Africa	Kombo	Human	Africa	MRCG at LSHTM Genomics lab	B.1.1	Africa	Africa	MRCG at LSHTM Genomics lab		2020-03-20	Sesay et al	[object Object]	28	Female
Belgium/VAJ-0328370/2020						GR	1.00	20B	Belgium	Belgium	Belgium	Oudenaarde	Human	Bevere	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.1	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-03-28	Tony Wawina-Bokalanga et al	[object Object]	54	Female
Gambia/NPHL-1224/2020						GR	1.00	20B	Africa	Gambia	Africa	Kombo	Human	Africa	MRCG at LSHTM Genomics lab	B.1.1	Africa	Africa	MRCG at LSHTM Genomics lab		2020-06-30	Abdul Karim sesay et al	[object Object]	50	Male
mink/Poland/Pomorskie_76/2020						GR	2.00	20B	Poland	Poland	Poland	Pomorskie	Mink		Department of Tropical Parasitology	B.1.1	Europe	Europe	Laboratory of Recombinant Vaccines		2020-11-17	Lukasz Rabalski et al	[object Object]		
Germany/HH-hpi-p2457/2020						GR	1.00	20B	Germany	Germany	Germany	Hamburg	Human		University Medical Center Hamburg Eppendorf	B.1.1	Europe	Europe	Heinrich Pette Institute, Leibniz Institute for Experimental Virology		2020-05-31	Alexis Robitaille et al	[object Object]		
Belgium/rega-0801770/2020						GR	1.00	20B	Belgium	Belgium	Belgium	Brussels	Human	Evere	UZ Leuven, National Reference Laboratory for Coronaviruses, Laboratory Medicine, Leuven, Belgium	B.1.1	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-08-01	Tony Wawina-Bokalanga et al	[object Object]	30	Female
Germany/HE-ChVir-W1553-8207/2020						GR	1.00	20B	Germany	Germany	Germany	Hesse	Human		Charité Universitätsmedizin Berlin, Institut für Virologie/Labor Berlin	B.1.1	Europe	Europe	Charité Universitätsmedizin Berlin, Institut für Virologie		2020-06-17	Victor M Corman et al	[object Object]		
Russia/KK-RII-MH2759S/2020						GR	1.00	20B	Russia	Russia	Khakassia	Khakassia	Human	Abakan	HELIX LLC	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-25	Andrey Komissarov et al A	[object Object]	56	Female
Russia/ROS-RII-MH3377S/2020						GR	2.00	20B	Russia	Russia	Rostov	Rostov	Human	Zernograd	HELIX LLC	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	67	Male
Russia/KDA-RII-MH4727S/2020						GR	1.00	20B	Russia	Russia	Krasnodar	Krasnodar	Human	Krasnodar	WHO National Influenza Centre Russian Federation	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-11	Andrey Komissarov et al A	[object Object]	41	Female
Russia/DA-RII-MH2741S/2020						GR	2.00	20B	Russia	Russia	Dagestan	Dagestan	Human	Derbent	HELIX LLC	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-26	Andrey Komissarov et al A	[object Object]	64	Male
Russia/KK-RII-MH2758S/2020						GR	3.00	20B	Russia	Russia	Khakassia	Khakassia	Human	Abakan	HELIX LLC	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-25	Andrey Komissarov et al A	[object Object]	54	Female
Russia/SPE-RII-6981S/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-06	Andrey Komissarov et al A	[object Object]	35	Female
Russia/MOW-RSMU-GC-SAR046/2020						GR	1.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	FSBI «NATIONAL MEDICAL RESEARCH CENTER FOR OBSTETRICS, GYNECOLOGY AND PERINATOLOGY NAMED AFTER ACADEMICIAN V.I.KULAKOV» MINISTRY OF HEALTHCARE OF THE RUSSIAN FEDERATION	B.1.1.294	Europe	Europe	Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Medical University, Moscow, Russian Federation		2020-05-29	Yegor Botsmanov et al	[object Object]		
Russia/RYA-RII-MH9318S/2020						GR	3.00	20B	Russia	Russia	Ryazan	Ryazan	Human	Ryazan	HELIX LLC	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-11	Andrey Komissarov et al A	[object Object]	31	Female
Russia/TA-KFU_46/2020						GR	1.00	20B	Russia	Russia	Tatarstan	Tatarstan	Human	Kazan	Kazan Federal University, Academic Consortium	B.1.1.294	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-09-08	Vladislav Babenko et al	[object Object]	68	Male
Russia/LEN-RII-MH14721S/2021						GR	2.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Tosno	HELIX LLC	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-21	Andrey Komissarov et al A	[object Object]	45	Female
Russia/MOW-5COV_078/2020						GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		City Clinical Hospital named after S.I. Spasokukotsky of Moscow Healthcare Department, Academic Consortium	M.3	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-11-13	Vladislav Babenko et al	[object Object]	72	Female
Russia/SPE-RII-32307S/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-08-31	Andrey Komissarov et al A	[object Object]	22	Male
Russia/ORE-RII-MH9335S/2020						GR	2.00	20B	Russia	Russia	Orenburg	Orenburg	Human	Orsk	HELIX LLC	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-13	Andrey Komissarov et al A	[object Object]	51	Female
Russia/TAM-RII-MH3383S/2020						GR	2.00	20B	Russia	Russia	Tambov Region	Tambov Region	Human	Tambov	HELIX LLC	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	36	Male
Russia/NGR-RII-MH14269S/2021						GR	3.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Veliky Novgorod	HELIX LLC	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-01-12	Andrey Komissarov et al A	[object Object]	54	Female
Russia/NGR-RII-MH14367S/2021						GR	3.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Veliky Novgorod	HELIX LLC	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-01-12	Andrey Komissarov et al A	[object Object]	32	Female
Russia/TVE-RII-MH15885S/2021						GR	3.00	20B	Russia	Russia	Tver	Tver	Human	Tver	HELIX LLC	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-02	Andrey Komissarov et al A	[object Object]	46	Male
Russia/MOS-CRIE-L189D3434b/2021	1.00	0.12	0.01		0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-08	Samojlov A.E. et al	[object Object]	21	Male
Russia/MOS-CRIE-L106D0729b/2021						GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.371	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-07	Samojlov A.E. et al	[object Object]	18	Female
Russia/MOW-CRIE-L192P0043/2021						GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-23	Samojlov A.E. et al	[object Object]	40	Male
Russia/KHM-RII-MH16104S/2021						GR	4.00	20B	Russia	Russia	Khanty-Mansi	Khanty-Mansi	Human	Surgut	HELIX LLC	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-10	Andrey Komissarov et al A	[object Object]	35	Female
Russia/SPE-RII-MH15663S/2021						GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	59	Female
Russia/SPE-RII-34408S/2021	1.00	0.07	0.01	0.01	0.04	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-14	Andrey Komissarov et al A	[object Object]	62	Female
Russia/SPE-RII-MH15709S/2021		0.01	0.01		0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	26	Female
Russia/DA-RII-MH16100S/2021						GR	4.00	20B	Russia	Russia	Dagestan	Dagestan	Human	Makhachkala	HELIX LLC	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-01	Andrey Komissarov et al A	[object Object]	35	Male
Russia/SPE-RII-MH16292S/2021						GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.294	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-15	Andrey Komissarov et al A	[object Object]	35	Male
Russia/SPE-RII-MH17318S/2021		0.01	0.05	0.06	0.07	G	6.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-06	Andrey Komissarov et al A	[object Object]	45	Female
Russia/SPE-RII-32122S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-15	Andrey Komissarov et al A	[object Object]	58	Female
Russia/PSK-RII-MH17301S/2021		0.04	0.34		0.24	GR	3.00	20B	Russia	Russia	Pskov Oblast	Pskov Oblast	Human	Pskov	HELIX LLC	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-27	Andrey Komissarov et al A	[object Object]	50	Female
Russia/SPE-RII-MH16267S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-15	Andrey Komissarov et al A	[object Object]	29	Female
Russia/PSK-16/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Pskov Oblast	Pskov Oblast	Human		Group for molecular genetics of pathogens	AT.1	Europe	Europe	Group for molecular genetics of pathogens		2021-01-18	Anna S. Gladkikh et al	[object Object]	32	Male
Russia/MOW-RII-MH16061S/2021		0.04	0.34		0.24	GR	6.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-02	Andrey Komissarov et al A	[object Object]	47	Male
Russia/SPE-RII-MH17363S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-06	Andrey Komissarov et al A	[object Object]	54	Male
Russia/SPE-RII-MH15699S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	60	Male
Russia/SPE-RII-MH17348S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-27	Andrey Komissarov et al A	[object Object]	29	Female
Russia/SPE-RII-MH15656S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-18	Andrey Komissarov et al A	[object Object]	42	Male
Russia/LEN-RII-MH14792S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Sosnovyi Bor	HELIX LLC	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]	35	Female
Russia/LEN-RII-MH14832S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Sosnovyi Bor	HELIX LLC	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-13	Andrey Komissarov et al A	[object Object]	24	Male
Russia/NGR-RII-MH17791S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Grigorovo	WHO National Influenza Centre Russian Federation	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-13	Andrey Komissarov et al A	[object Object]	30	Female
Russia/SPE-RII-34989S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-20	Andrey Komissarov et al A	[object Object]	71	Female
Russia/SPE-RII-35621S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-26	Andrey Komissarov et al A	[object Object]	81	Male
Russia/MOW-CRIE-L188K0257hu/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Infectious Diseases Hospital № 2	AT.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-11	Samoilov AE et al	[object Object]	79	Male
Russia/SPE-RII-33847S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-11	Andrey Komissarov et al A	[object Object]	30	Female
Russia/MOW-CRIE-L188K0259u/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	AT.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-12	Samoilov AE et al	[object Object]	72	Female
Russia/MOW-CRIE-L188K0298u/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	AT.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-08	Samoilov AE et al	[object Object]	77	Male
Russia/MOW-CRIE-L188K0243u/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	AT.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-13	Samoilov AE et al	[object Object]	35	Female
Russia/SPE-RII-34455S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-15	Andrey Komissarov et al A	[object Object]	72	Female
Russia/SPE-RII-34510S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	82	Female
Russia/SPE-RII-32651S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-21	Andrey Komissarov et al A	[object Object]	62	Male
Russia/SPE-RII-32827S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-23	Andrey Komissarov et al A	[object Object]	52	Male
Russia/SPE-RII-MH17818S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	10	Female
Russia/SPE-RII-MH17293S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-27	Andrey Komissarov et al A	[object Object]	45	Female
Russia/SPE-RII-MH15731S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-14	Andrey Komissarov et al A	[object Object]	31	Male
Russia/SPE-RII-MH17347S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-23	Andrey Komissarov et al A	[object Object]	45	Male
Russia/SPE-RII-34297S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-13	Andrey Komissarov et al A	[object Object]	72	Male
Russia/LEN-RII-MH17786S/2021		0.04	0.34		0.24	GR	6.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Pikkolovo	WHO National Influenza Centre Russian Federation	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-13	Andrey Komissarov et al A	[object Object]	38	Female
Russia/BEL-RII-MH17738S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-10	Andrey Komissarov et al A	[object Object]	33	
Russia/SPE-RII-MH17292S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-29	Andrey Komissarov et al A	[object Object]	28	Male
Russia/SPE-RII-MH18162S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	59	Male
Russia/SPE-RII-34744S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	48	Female
Russia/SPE-RII-34977S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-20	Andrey Komissarov et al A	[object Object]	44	Female
Russia/SPE-RII-MH17232S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-23	Andrey Komissarov et al A	[object Object]	44	Female
Russia/SPE-RII-MH17288S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-27	Andrey Komissarov et al A	[object Object]	45	Female
Russia/SPE-RII-32882S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-25	Andrey Komissarov et al A	[object Object]	93	Female
Russia/SPE-RII-MH16463S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-26	Andrey Komissarov et al A	[object Object]	18	Female
Russia/BEL-RII-MH17539S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-19	Andrey Komissarov et al A	[object Object]	55	
Russia/SPE-RII-35116S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	64	Male
Russia/NGR-RII-MH17245S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Veliky Novgorod	HELIX LLC	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-27	Andrey Komissarov et al A	[object Object]	28	Male
Russia/SPE-RII-MH18142S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	41	Female
Russia/SPE-RII-MH16307S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	AT.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-18	Andrey Komissarov et al A	[object Object]	73	
Uganda/UG007/2020						GR	2.00	20B	Africa	Uganda	Africa	Uganda	Human	Africa	Uganda Virus Research Institute	B.1.1.369	Africa	Africa	MRC/UVRI & LSHTM Uganda Research Unit		2020-03-30	Dan Lule Bugembe et al (https://dx.doi.org/10.3201/eid2610.202575)	[object Object]		
Russia/IRK-RII-MH15599S/2020						GR	1.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human	Irkutsk	Department of Experimental Modeling and Pathogenesis of Infectious Diseases	B.1.1.372	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-22	Andrey Komissarov et al A	[object Object]		
Russia/IRK-RII-MH15605S/2020						GR	1.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human	Irkutsk	Department of Experimental Modeling and Pathogenesis of Infectious Diseases	B.1.1.369	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-08	Andrey Komissarov et al A	[object Object]		
Russia/SPE-RII-8811S/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.372	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-11	Andrey Komissarov et al A	[object Object]	73	Female
Russia/KGD-RII-MH7185S/2020						GR	1.00	20B	Russia	Russia	Kaliningrad Region	Kaliningrad Region	Human	Kaliningrad	WHO National Influenza Centre Russian Federation	B.1.1.372	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-23	Andrey Komissarov et al A	[object Object]	78	Male
Russia/SAK-CRIE-L188Z0027/2020						GR	2.00	20B	Russia	Russia	Sakhalin	Sakhalin	Human		Laboratory of Extremely Dangerous Infections of Federal Budget Health Care Instute "Center of Hygiene and Epidemiology in Sakhalin region"	B.1.1.372	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2020-12-20	Samoilov AE et al	[object Object]	71	Female
Russia/SAK-CRIE-L188Z0034/2020						GR	1.00	20B	Russia	Russia	Sakhalin	Sakhalin	Human		Laboratory of Extremely Dangerous Infections of Federal Budget Health Care Instute "Center of Hygiene and Epidemiology in Sakhalin region"	B.1.1.372	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2020-12-25	Samoilov AE et al	[object Object]	0	Female
Peru/LIM-INS-001/2020						GR	1.00	20D	South America	Peru	South America	Lima	Human	South America	Laboratorio de Infecciones Respiratorias Agudas. Centro Nacional de Salud Publica,Instituto Nacional de Salud	B.1.1.1	South America	South America	Laboratorio de Infecciones Respiratorias Agudas. Centro Nacional de Salud Publica,Instituto Nacional de Salud		2020-04-01	Juscamayta et al	[object Object]		
Cameroon/CV411/2020						GR	2.00	20D	Africa	Cameroon	Africa	Yaoundé	Human	Africa	National Public Health Laboratory, Cameroon	B.1.1.1	Africa	Africa	African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University		2020-06-16	Oluniyi P.E. et al B	[object Object]	34	Male
Russia/Khabarovsk-88201/2020						GR	1.00	20D	Russia	Russia	Khabarovsk	Khabarovsk	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1.1.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-31	Oleg V. Pyankov et al	[object Object]	56	Female
Russia/MOW-Moscow_S/2021						GR	3.00	20D	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		State collection of viruses, N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation	B.1.1.1	Europe	Europe	Laboratory of genome analysis, N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation		2021-02-17	Olga Voronina et al	[object Object]	47	Male
Egypt/CUNCI-HGC8I031/2020						GR	2.00	20D	Africa	Egypt	Africa	Egypt	Human	Africa	Cancer Biology Department, National Cancer Institute	C.36	Africa	Africa	Cancer Biology Department, National Cancer Institute		2020-12-25	Zekri et al	[object Object]		
Egypt/PHARCO-ARMY-23/2021						GR	2.00	20D	Africa	Egypt	Africa	Cairo	Human	Africa	Main Chemical Laboratories Egypt Army	C.36	Africa	Africa	Main Chemical Laboratories Egypt Army		2021-02-12	Sherine Helmy et al	[object Object]		
Norway/13247/2021		0.01	0.05	0.05	0.06	GR	3.00	20D	Norway	Norway	Norway	More Og Romsdal	Human		Ostfold Hospital Trust - Kalnes, Centre for Laboratory Medicine, Section for gene technology and infection serology	C.36	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-05-25	Kathrine Stene-Johansen et al	[object Object]		
Belgium/AZDelta-15028-2122R/2021		0.01	0.06	0.17	0.08	GR	6.00	20D	Belgium	Belgium	Belgium	Tielt	Human	Pittem	AZDelta	C.36.3	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-06-07	Geert Martens et al	[object Object]		
Australia/NT219/2021		0.01	0.06	0.17	0.08	GR	6.00	20D	Oceania	Australia	Oceania	Northern Territory	Human	Oceania	Royal Darwin Hospital Pathology	C.36.3	Oceania	Oceania	MDU-PHL		2021-05-25	Meumann et al	[object Object]		
Austria/CeMM9653/2021		0.01	0.06	0.17	0.08	GR	6.00	20D	Austria	Austria	Austria	Salzburg	Human		Austrian Agency for Health and Food Safety (AGES)	C.36.3	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-05-21	Lukas Endler et al	[object Object]	6	Female
Ireland/MN-NVRL-30IRL70375/2021		0.01	0.06	0.17	0.08	GR	6.00	20D	Ireland	Ireland	Ireland	Monaghan	Human		National Virus Reference Laboratory	C.36.3	Europe	Europe	National Virus Reference Laboratory		2021-05-24	Zoe Yandle et al	[object Object]		Female
Ireland/MN-NVRL-30IRL70347/2021		0.01	0.06	0.17	0.08	GR	6.00	20D	Ireland	Ireland	Ireland	Monaghan	Human		National Virus Reference Laboratory	C.36.3	Europe	Europe	National Virus Reference Laboratory		2021-05-24	Zoe Yandle et al	[object Object]		Female
Ireland/KK-NVRL-30IRL23015/2021		0.01	0.06	0.17	0.08	GR	6.00	20D	Ireland	Ireland	Ireland	Kilkenny	Human		National Virus Reference Laboratory	C.36.3	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Male
Austria/CeMM9654/2021		0.01	0.06	0.17	0.08	GR	6.00	20D	Austria	Austria	Austria	Salzburg	Human		Austrian Agency for Health and Food Safety (AGES)	C.36.3	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-05-23	Lukas Endler et al	[object Object]	44	Male
Norway/13292/2021		0.01	0.06	0.17	0.08	GR	6.00	20D	Norway	Norway	Norway	Vestfold Og Telemark	Human		Unilabs Laboratory Medicine	C.36.3	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-05-19	Kathrine Stene-Johansen et al	[object Object]		
Egypt/NRC-287/2021		0.01	0.06	0.17	0.08	GR	7.00	20D	Africa	Egypt	Africa	Egypt	Human	Africa	Center of Scientific Excellence for Influenza Viruses (CSEIV), National Research Centre	C.36.3	Africa	Africa	Center of Scientific Excellence for Influenza Viruses (CSEIV), National Research Centre		2021-03-07	Ahmed E Kayed et al	[object Object]		Female
Germany/NI-RKI-I-173643/2021		0.01	0.06	0.17	0.08	GR	7.00	20D	Germany	Germany	Germany	Niedersachsen	Human		MVZ Medizinisches Labor Hannover GmbH	C.36.3	Europe	Europe	Robert Koch Institute		2021-06-05	?	[object Object]		
Egypt/NRC-295/2021		0.01	0.06	0.17	0.08	GR	6.00	20D	Africa	Egypt	Africa	Egypt	Human	Africa	Center of Scientific Excellence for Influenza Viruses (CSEIV), National Research Centre	C.36.3	Africa	Africa	Center of Scientific Excellence for Influenza Viruses (CSEIV), National Research Centre		2021-03-08	Ahmed E Kayed et al	[object Object]		Female
Italy/FVG-UD-64028634/2021		0.01	0.06	0.17	0.08	GR	6.00	20D	Italy	Italy	Italy	Friuli Venezia Giulia	Human	Udine	SC (UCO) Igiene e Sanità Pubblica, ASUGI, Trieste and SOC Igiene ed Epidemiologia Clinica, laboratorio di Virologia ,ASUFC, Udine	C.36.3	Europe	Europe	ARGO Laboratorio Genomica ed Epigenomica		2021-05-18	Licastro D et al	[object Object]	48	Male
Germany/un-ChVir-LB-210528-5735/2021		0.02	0.07	0.17	0.09	GR	8.00	20D	Germany	Germany	Germany	Germany	Human		Labor Berlin Charité Vivantes GmbH / Institut für Virologie	C.36.3.1	Europe	Europe	Charité Universitätsmedizin Berlin, Institut für Virologie/Labor Berlin		2021-05-17	Peter Menzel et al	[object Object]		
Belgium/AZDelta/18606-2115R/2021		0.02	0.07	0.17	0.09	GR	7.00	20D	Belgium	Belgium	Belgium	Ieper	Human	Wervik	AZDelta	C.36.3.1	Europe	Europe	AZDelta		2021-04-14	Geert Martens et al	[object Object]		
Belgium/AZDelta/11729-2116R/2021		0.02	0.07	0.17	0.09	GR	7.00	20D	Belgium	Belgium	Belgium	Tielt	Human		AZDelta	C.36.3.1	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-04-20	Geert Martens et al	[object Object]		
Belgium/AZDelta-03554-2121R/2021		0.02	0.07	0.17	0.09	GR	7.00	20D	Belgium	Belgium	Belgium	Diksmuide	Human	Koekelare	AZDelta	C.36.3.1	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-05-30	Geert Martens et al	[object Object]		
Belgium/AZDelta-10248-2119R/2021		0.02	0.07	0.17	0.09	GR	7.00	20D	Belgium	Belgium	Belgium	Diksmuide	Human	Koekelare	AZDelta	C.36.3.1	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-05-18	Geert Martens et al	[object Object]		
Belgium/rega-0517522/2020						GR	1.00	20D	Belgium	Belgium	Belgium	Leuven	Human	Kortenberg	UZ Leuven, National Reference Laboratory for Coronaviruses, Laboratory Medicine, Leuven, Belgium	B.1.1.1	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-04-17	Tony Wawina-Bokalanga et al	[object Object]	85	Male
Chile/RM-153915/2020						GR	1.00	20D	South America	Chile	South America	Region Metropolitana de Santiago	Human	South America	Genetica Molecular and Subdepartamento de Virologia ISP Chile	C.26	South America	South America	Instituto de Salud Publica de Chile		2020-08-18	Javier Tognarelli et al	[object Object]	33	Female
Chile/RM-1150/2021						GR	2.00	20D	South America	Chile	South America	Region Metropolitana de Santiago	Human	South America	Genetica Molecular and Subdepartamento de Virologia ISP Chile	C.26	South America	South America	Instituto de Salud Publica de Chile		2021-01-03	Javier Tognarelli et al	[object Object]	17	Male
Angola/KRISP-K009705/2020						GR	1.00	20D	Africa	Angola	Africa	Luanda	Human	Africa	Instituto Nacional de Investigação em Saúde	C.16	Africa	Africa	KRISP, KZN Research Innovation and Sequencing Platform		2020-06-26	Morais J et al	[object Object]	24	Male
SouthAfrica/KRISP-K002827/2020						GR	1.00	20D	Africa	South Africa	Africa	KwaZulu-Natal	Human	Africa	NHLS-IALCH	C.9	Africa	Africa	KRISP, KZN Research Innovation and Sequencing Platform		2020-09-01	Giandhari J et al	[object Object]	69	Male
SouthAfrica/KRISP-K002845/2020						GR	2.00	20D	Africa	South Africa	Africa	KwaZulu-Natal	Human	Africa	NHLS-IALCH	C.9	Africa	Africa	KRISP, KZN Research Innovation and Sequencing Platform		2020-08-31	Giandhari J et al	[object Object]	37	Male
Italy/VEN-SI_140/2020						GR	1.00	20D	Italy	Italy	Italy	Veneto	Human		Microbiology and Virology Unit,Azienda Ospedale Padova,Padova,Italy	B.1.1.1	Europe	Europe	Department of Molecular Medicine,Computational Medicine Group,Univeresity of Padova,Padova,Italy		2020-07-07	Elisa Franchin et al	[object Object]		Male
Serbia/Novi_Sad-NIVNS610111/2020						GR	1.00	20D	Serbia	Serbia	Serbia	South Bačka District	Human	Novi Sad	Scientific Veterinary Institute Novi Sad	C.35	Europe	Europe	Veterinary Specialized Institute "Kraljevo", Serbia		2020-11-01	Vidanovic et al	[object Object]		
Croatia/HRV000_25/2021						GR	1.00	20D	Croatia	Croatia	Croatia	Brod-Posavina County	Human		Croatian Institute of Public Health	C.35	Europe	Europe	Croatian Institute of Public Health		2021-01-29	Irena Tabain et al	[object Object]	15	Female
Aruba/AW-RIVM-11734/2021	1.00	0.07	0.01	0.01	0.04	GR	2.00	20D	South America	Aruba	South America	Aruba	Human	South America	Dutch COVID-19 response team	C.2.1	South America	South America	National Institute for Public Health and the Environment (RIVM)		2021-02-01	Adam Meijer et al	[object Object]		
Togo/BMC-92-20/2021						GR	1.00	20D	Africa	Togo	Africa	Golfe	Human	Africa	Institut National d’Hygiène (INH)	C.11	Africa	Africa	Unité Mixte Internationale TransVIHMI (UMI 233 IRD – U1175 INSERM - Université de Montpellier)IRD (Institut de recherche pour le développement)		2021-03-20	Mounerou SALOU et al	[object Object]		Male
Peru/LIM-INS-099/2020						GR	1.00	20D	South America	Peru	South America	Lima	Human	South America	Instituto Nacional de Salud	C.32	South America	South America	Laboratorio de Infecciones Respiratorias Agudas		2020-07-04	Eduardo Juscamayta Lopez et al	[object Object]	42	Female
Mozambique/INS-K007920/2020		0.01			0.01	GR	2.00	20D	Africa	Mozambique	Africa	Maputo	Human	Africa	Instituto Nacional de Saude (INS), Mozambique	C.1.1	Africa	Africa	KRISP, KZN Research Innovation and Sequencing Platform		2020-12-27	Nalia Ismael et al	[object Object]	23	Female
Ecuador/UEES-INTERLAB-6660310/2021		0.01	0.05	0.06	0.07	GR	3.00	20D	South America	Ecuador	South America	El Oro	Human	South America	INTERLAB	B.1.1.372	South America	South America	Omics Sciences Laboratory		2021-05-27	Derly Andrade Molina et al	[object Object]		Female
Peru/LIM-UPCH-0468/2021		0.01	0.26	0.10	0.13	GR	7.00	20D	South America	Peru	South America	Lima	Human	South America	Instituto de Medicina Tropical Alexander Von Humboldt, Universidad Peruana Cayetano Heredia	C.37	South America	South America	Laboratorio de Genómica Microbiana, Universidad Peruana Cayetano Heredia		2021-03-08	Lenin Maturrano et al	[object Object]		
Peru/LIM-UPCH-0467/2021		0.01	0.26	0.10	0.13	GR	8.00	20D	South America	Peru	South America	Lima	Human	South America	Instituto de Medicina Tropical Alexander Von Humboldt, Universidad Peruana Cayetano Heredia	C.37	South America	South America	Laboratorio de Genómica Microbiana, Universidad Peruana Cayetano Heredia		2021-03-10	Lenin Maturrano et al	[object Object]		
Italy/EMR-UOM-PVS_9374647501/2021		0.02	0.27	0.14	0.15	GR	8.00	20D	Italy	Italy	Italy	Emilia-Romagna	Human		U.O. Microbiologia Laboratorio Unico Centro Servizi AUSL della Romagna	C.37	Europe	Europe	U.O. Microbiologia Laboratorio Unico Centro Servizi AUSL della Romagna		2021-06-03	Giorgio Dirani et al	[object Object]	68	Male
Italy/EMR-UOM-PVS_9374647401/2021		0.02	0.27	0.14	0.15	GR	8.00	20D	Italy	Italy	Italy	Emilia-Romagna	Human		U.O. Microbiologia Laboratorio Unico Centro Servizi AUSL della Romagna	C.37	Europe	Europe	U.O. Microbiologia Laboratorio Unico Centro Servizi AUSL della Romagna		2021-06-03	Giorgio Dirani et al	[object Object]	68	Female
Ecuador/USFQ-1441/2021		0.01	0.26	0.10	0.13	GR	7.00	20D	South America	Ecuador	South America	Pichincha	Human	South America	Institute of Microbiology, Universidad San Francisco de Quito	C.37	South America	South America	Institute of Microbiology, Universidad San Francisco de Quito		2021-05-17	Belén Prado-Vivar et al	[object Object]	67	Male
Ecuador/USFQ-1121/2021		0.01	0.26	0.10	0.13	GR	8.00	20D	South America	Ecuador	South America	El Oro	Human	South America	Institute of Microbiology, Universidad San Francisco de Quito	C.37	South America	South America	Institute of Microbiology, Universidad San Francisco de Quito		2021-04-14	Sully Márquez et al	[object Object]		Male
Ecuador/UEES-INTERLAB-6660161/2021		0.01	0.26	0.10	0.13	GR	8.00	20D	South America	Ecuador	South America	Azuay	Human	South America	INTERLAB	C.37	South America	South America	Omics Sciences Laboratory		2021-05-27	Derly Andrade Molina et al	[object Object]	47	Male
Switzerland/GE-HUG-0199/2020						GR	1.00	20B	Switzerland	Switzerland	Switzerland	Geneva	Human		University Hospitals of Geneva Laboratory of Virology	B.1.1	Europe	Europe	University Hospitals of Geneva Laboratory of Virology		2020-02-28	Laubscher F. et al	[object Object]	24	
Turkey/HSGM-2002082/2020						GR	2.00	20B	Turkey	Turkey	Turkey	Turkey	Human		Ministry of Health Turkey	B.1.1.521	Europe	Europe	Ministry of Health Turkey		2020-08-04	Fatma Bayrakdar et al B	[object Object]		
Austria/CeMM0380/2020						GR	1.00	20B	Austria	Austria	Austria	Tyrol	Human	Mayrhofen	Institut für Virologie am Department für Hygiene, Mikrobiologie und Public Health	B.1.1.5	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2020-03-31	Alexandra Popa et al (https://dx.doi.org/10.1101/2020.07.15.204339v1)	[object Object]	41	Female
Ireland/MN-NVRL-20IRL22150/2020						GR	3.00	20B	Ireland	Ireland	Ireland	Monaghan	Human		National Virus Reference Laboratory	B.1.1.5	Europe	Europe	National Virus Reference Laboratory		2020-05-22	Michael Carr et al	[object Object]		Female
Belgium/RMO-0329386/2020						GR	1.00	20B	Belgium	Belgium	Belgium	Dendermonde	Human	Kalken	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.1.75	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-03-29	Tony Wawina-Bokalanga et al	[object Object]	87	Male
Russia/SAR-RARI-3663/2020						GR	1.00	20B	Russia	Russia	Saratov	Saratov	Human		Mikrobiologie, RARI	B.1.1	Europe	Europe	Mikrobiologie, RARI		2020-05-03	Krasnov et al	[object Object]		
Romania/B-53601/2020						GR	2.00	20B	Romania	Romania	Romania	Bucharest	Human		National Institute of Infectious Diseases-Prof. Dr. Matei Bals Molecular Diagnostics Laboratory	B.1.1	Europe	Europe	National Institute of Infectious Diseases-Prof. Dr. Matei Bals Molecular Diagnostics Laboratory		2020-08-10	Leontina Banica et al	[object Object]	41	Male
Russia/OMS-ORINFI-1612S/2020						GR	1.00	20B	Russia	Russia	Omsk	Omsk	Human	Omsk	Omsk Research Institute of Natural Focal Infections	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-07-06	Artem Fadeev et al	[object Object]	70	Female
Russia/KC-RII-MH3381S/2020		0.01	0.01	0.08	0.03	GR	4.00	20B	Russia	Russia	Karachay-Cherkess	Karachay-Cherkess	Human	Zelenchukskaya	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-06	Andrey Komissarov et al A	[object Object]	16	Male
Russia/NIZ-RII-MH1682S/2020						GR	1.00	20B	Russia	Russia	Nizhny Novgorod	Nizhny Novgorod	Human	Nizhny Novgorod	HELIX LCC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-02	Andrey Komissarov et al A	[object Object]	64	Male
Russia/PER-RII-MH1915S/2020						GR	1.00	20B	Russia	Russia	Perm Krai	Perm Krai	Human	Perm	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-16	Andrey Komissarov et al A	[object Object]	52	Male
Russia/MAG-RII-MH13981S/2020						GR	1.00	20B	Russia	Russia	Magadan	Magadan	Human	Magadan	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-25	Andrey Komissarov et al A	[object Object]	72	Male
Russia/BA-RII-MH9355S/2020						GR	1.00	20B	Russia	Russia	Bashkortostan	Bashkortostan	Human	Ufa	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-13	Andrey Komissarov et al A	[object Object]	59	Male
Russia/KO-RII-MH9290S/2020						GR	1.00	20B	Russia	Russia	Komi	Komi	Human	Ukhta	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-15	Andrey Komissarov et al A	[object Object]	30	Male
Russia/RYA-RII-MH9253S/2020						GR	1.00	20B	Russia	Russia	Ryazan	Ryazan	Human	Ryazan	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-11	Andrey Komissarov et al A	[object Object]	58	Female
Russia/RYA-RII-MH9366S/2020						GR	1.00	20B	Russia	Russia	Ryazan	Ryazan	Human	Ryazan	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-11	Andrey Komissarov et al A	[object Object]	59	Female
Russia/SAR-RARI-2666/2020						GR	1.00	20B	Russia	Russia	Saratov	Saratov	Human		Mikrobiologie, RARI	B.1.1.317	Europe	Europe	Mikrobiologie, RARI		2020-04-29	Krasnov et al	[object Object]		
Russia/AD-RII-MH1684S/2020						GR	1.00	20B	Russia	Russia	Adygea	Adygea	Human	Maykop	HELIX LCC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-09	Andrey Komissarov et al A	[object Object]	63	Male
Russia/VOR-RII-MH9263S/2020						GR	1.00	20B	Russia	Russia	Voronezh	Voronezh	Human	Voronezh	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-14	Andrey Komissarov et al A	[object Object]	39	Female
Russia/VOR-RII-MH3416S/2020						GR	1.00	20B	Russia	Russia	Voronezh	Voronezh	Human	Voronezh	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	38	Female
Russia/IRK-RII-MH15608S/2020						GR	1.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human	Irkutsk	Department of Experimental Modeling and Pathogenesis of Infectious Diseases	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-17	Andrey Komissarov et al A	[object Object]		
env/Liaoning/Dalian-IVDC-Pollock-30-05/2020						GR	1.00	20B	Asia	China	Asia	Liaoning	Environment	Asia	National Institute for Viral Disease Control and Prevention, China CDC	B.1.1.317	Asia	Asia	National Institute for Viral Disease Control and Prevention, China CDC		2020-05-30	Huilai Ma1& et al	[object Object]		
Lu-an/5053/2021						GR	1.00	20B	Asia	China	Asia	Anhui	Human	Asia	Microbiology Department, Lu`an Center for Disease Control and Prevention	B.1.1.317	Asia	Asia	Microbiology Department, Lu`an Center for Disease Control and Prevention		2021-05-13	Chen Zhichao et al	[object Object]	33	Female
Lu-an/5031Y/2021						GR	1.00	20B	Asia	China	Asia	Anhui	Human	Asia	Microbiology Department, Lu`an Center for Disease Control and Prevention	B.1.1.317	Asia	Asia	Microbiology Department, Lu`an Center for Disease Control and Prevention		2021-05-13	Chen Zhichao et al	[object Object]	20	Male
Lu-an/5073Y/2021						GR	1.00	20B	Asia	China	Asia	Anhui	Human	Asia	Microbiology Department, Lu`an Center for Disease Control and Prevention	B.1.1.317	Asia	Asia	Microbiology Department, Lu`an Center for Disease Control and Prevention		2021-05-13	Chen Zhichao et al	[object Object]	34	Male
Russia/AST-RII-MH4141S/2020						GR	1.00	20B	Russia	Russia	Astrakhan Region	Astrakhan Region	Human	Astrakhan	Pathogenic Microorganisms Variability Laboratory	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-07-30	Andrey Komissarov et al A	[object Object]	41	Female
Russia/CRIE5047007/2020						GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2020-07-16	Speranskaya AS et al	[object Object]	82	Female
Russia/VOR-RII-MH3414S/2020						GR	1.00	20B	Russia	Russia	Voronezh	Voronezh	Human	Voronezh	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	20	Male
Russia/SPE-RII-26454S/2021						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-11	Andrey Komissarov et al A	[object Object]	58	Male
Russia/ROS-RII-MH2820S/2020						GR	2.00	20B	Russia	Russia	Rostov	Rostov	Human	Kamensk-Shakhtinsky	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-24	Andrey Komissarov et al A	[object Object]	53	Female
Russia/ROS-RII-MH2821S/2020						GR	2.00	20B	Russia	Russia	Rostov	Rostov	Human	Kamensk-Shakhtinsky	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-24	Andrey Komissarov et al A	[object Object]	52	Male
Russia/AST-RII-MH14512S/2020						GR	1.00	20B	Russia	Russia	Astrakhan Region	Astrakhan Region	Human	Volodarskiy	Pathogenic Microorganisms Variability Laboratory	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-12	Andrey Komissarov et al A	[object Object]	83	Male
Russia/KR-RII-MH5672S/2020						GR	1.00	20B	Russia	Russia	Karelia	Karelia	Human	Petrozavodsk	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-14	Andrey Komissarov et al A	[object Object]	40	Female
Russia/NGR-RII-MH14370S/2021						GR	1.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Veliky Novgorod	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-01-05	Andrey Komissarov et al A	[object Object]	31	Female
Russia/STA-RII-MH3363S/2020						GR	3.00	20B	Russia	Russia	Stavropol	Stavropol	Human	Yessentuki	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	23	Male
Russia/AMU-RII-MH18320S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Tambovka	Tambov Hospital	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-25	Andrey Komissarov et al A	[object Object]	47	Female
Russia/AMU-RII-MH18321S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Tambovka	Tambov Hospital	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-25	Andrey Komissarov et al A	[object Object]	53	Female
Russia/MUR-RII-MH15685S/2021						GR	1.00	20B	Russia	Russia	Murmansk	Murmansk	Human	Severomorsk	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	24	Female
Russia/KDA-RII-MH4894S/2020						GR	1.00	20B	Russia	Russia	Krasnodar	Krasnodar	Human	Krasnodar	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-04	Andrey Komissarov et al A	[object Object]	65	Male
Russia/BEL-RII-MH12669S/2020						GR	1.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human	Belgorod	Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.319	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-01	Andrey Komissarov et al A	[object Object]	46	Male
Russia/BEL-RII-MH12655S/2020						GR	1.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human	Novy Oskol	Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.319	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-01	Andrey Komissarov et al A	[object Object]	64	Female
Russia/SVE-RII-MH15851S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Kushva	HELIX LLC	B.1.1.291	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-15	Andrey Komissarov et al A	[object Object]	62	Female
Russia/SPE-RII-MH15458S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	29	Male
Russia/BEL-RII-MH17405S/2021						GR	1.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-06	Andrey Komissarov et al A	[object Object]	59	
Russia/BEL-RII-MH17535S/2021						GR	1.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-16	Andrey Komissarov et al A	[object Object]	33	
Russia/STA-RII-MH2780S/2020						GR	1.00	20B	Russia	Russia	Stavropol	Stavropol	Human	Yessentuki	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-23	Andrey Komissarov et al A	[object Object]	45	Male
Russia/MUR-RII-MH5209S/2020						GR	1.00	20B	Russia	Russia	Murmansk	Murmansk	Human	Murmansk	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-01	Andrey Komissarov et al A	[object Object]	68	Female
Russia/ARK-CRIE-L188V0402/2020						GR	1.00	20B	Russia	Russia	Arkhangelsk Region	Arkhangelsk Region	Human		Laboratory of Virology of Federal Budget Health Care Institution "Center of Hygiene and Epidemiology in Arkhangelsk region"	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2020-12-26	Samoilov AE et al	[object Object]	24	Female
Russia/NIZ-63817/2020						GR	1.00	20B	Russia	Russia	Nizhny Novgorod	Nizhny Novgorod	Human		Federal State Budgetary Educational Institution of Higher Education В«Privolzhsky Research Medical UniversityВ» of the Ministry of Health of the Russian Federation, Academic Consortium	B.1.1.317	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-06-10	Vladislav Babenko et al	[object Object]	56	Female
Russia/IRK-RII-MH9281S/2020						GR	1.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human	Irkutsk	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-14	Andrey Komissarov et al A	[object Object]	38	Male
Russia/AMU-RII-MH10160S/2020						GR	1.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Blagoveshchensk	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-19	Andrey Komissarov et al A	[object Object]	25	Male
Turkey/HSGM-B10304/2021						GR	2.00	20B	Turkey	Turkey	Turkey	Turkey	Human		Ministry of Health Turkey	B.1.1.317	Europe	Europe	Ministry of Health Turkey		2021-04-28	Fatma Bayrakdar et al B	[object Object]		
Russia/KDA-RII-MH4871S/2020						GR	1.00	20B	Russia	Russia	Krasnodar	Krasnodar	Human	Krasnodar	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-21	Andrey Komissarov et al A	[object Object]	88	Female
Russia/ORL-RII-MH2815S/2020						GR	1.00	20B	Russia	Russia	Oryol	Oryol	Human	Oryol	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-28	Andrey Komissarov et al A	[object Object]	52	Female
Russia/STA-RII-MH3378S/2020						GR	1.00	20B	Russia	Russia	Stavropol	Stavropol	Human	Stavropol	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	55	Female
Russia/VGG-RII-MH9349S/2020						GR	2.00	20B	Russia	Russia	Volgograd Region	Volgograd Region	Human	Volgograd	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-14	Andrey Komissarov et al A	[object Object]	32	Female
Russia/STA-RII-MH2787S/2020		0.01	0.01		0.01	GR	4.00	20B	Russia	Russia	Stavropol	Stavropol	Human	Stavropol	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-19	Andrey Komissarov et al A	[object Object]	33	Female
Russia/YAR-RII-MH16107S/2021		0.01	0.01		0.01	GR	3.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human	Yaroslavl	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	71	Female
Russia/IVA-CRIE-L188E0260bh/2021		0.01	0.01		0.01	GR	3.00	20B	Russia	Russia	Ivanovo	Ivanovo	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-04	Samoilov A.E. et al	[object Object]	41	Female
Russia/PRI-RII-MH765S/2020						GR	2.00	20B	Russia	Russia	Primorsky	Primorsky	Human	Vladivostok	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-08-11	Andrey Komissarov et al A	[object Object]		Female
Russia/BEL-RII-MH12651S/2020						GR	2.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human	Belgorod	Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-30	Andrey Komissarov et al A	[object Object]	19	Female
Russia/IVA-CRIE-L188N0202/2021						GR	2.00	20B	Russia	Russia	Ivanovo	Ivanovo	Human		Federal Budget Health Care Institution "Center of Hygiene and Epidemiology in Ivanovo region"	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-13	Samoilov AE et al	[object Object]	67	Female
Russia/VGG-RII-MH9375S/2020						GR	2.00	20B	Russia	Russia	Volgograd Region	Volgograd Region	Human	Volgograd	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-10	Andrey Komissarov et al A	[object Object]	20	Male
Russia/SVE-RII-MH4666S/2020						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	UMMC-Health	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-08-31	Andrey Komissarov et al A	[object Object]	59	Female
Russia/SPE-RII-MH15756S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	27	Female
Russia/NVS-RII-MH2809S/2020						GR	2.00	20B	Russia	Russia	Novosibirsk	Novosibirsk	Human	Berdsk	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-25	Andrey Komissarov et al A	[object Object]	49	Female
Russia/NVS-RII-MH2810S/2020						GR	2.00	20B	Russia	Russia	Novosibirsk	Novosibirsk	Human	Berdsk	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-25	Andrey Komissarov et al A	[object Object]	42	Male
Russia/SVE-RII-MH15155S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Sredneuralsk	UMMC-Health	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-15	Andrey Komissarov et al A	[object Object]	68	Male
Russia/SVE-RII-MH16115S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Krasnoufimsk	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]	66	Male
Russia/IRK-RII-MH16241S/2021		0.01			0.01	GR	3.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human	Irkutsk	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	65	Female
Russia/SPE-RII-33811S/2021	1.00	0.01	0.01	0.02	0.03	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-10	Andrey Komissarov et al A	[object Object]	45	Male
Russia/NGR-RII-MH17273S/2021						GR	4.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Borovichi (Novgorod)	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-28	Andrey Komissarov et al A	[object Object]	43	Male
Russia/IVA-CRIE-L188E0261b/2021						GR	3.00	20B	Russia	Russia	Ivanovo	Ivanovo	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-01	Samoilov A.E. et al	[object Object]	65	Female
NewZealand/21CV0175/2021						GR	3.00	20B	Oceania	New Zealand	Oceania	Auckland	Human	Oceania	Middlemore Hospital	B.1.1.317	Oceania	Oceania	Institute of Environmental Science and Research (ESR)		2021-03-06	Rachel Boyle et al	[object Object]		Female
Russia/BEL-RII-MH12659S/2020		0.01			0.01	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human	Prokhorovka	Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-01	Andrey Komissarov et al A	[object Object]	36	Female
Russia/SPE-RII-MH14635S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-14	Andrey Komissarov et al A	[object Object]	39	Female
Russia/SPE-RII-MH14640S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-20	Andrey Komissarov et al A	[object Object]	52	Male
Russia/LEN-RII-MH14759S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Kirishi	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-12	Andrey Komissarov et al A	[object Object]	41	Male
Russia/SPE-RII-MH14798S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]	23	Female
Russia/MOW-RII-MH16124S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-19	Andrey Komissarov et al A	[object Object]	23	Female
Germany/BB-RKI-I-036487/2021		0.02	0.01	0.01	0.03	GR	6.00	20B	Germany	Germany	Germany	Brandenburg	Human		LADR MVZ Zweigpraxis Bernau	B.1.1.317	Europe	Europe	Robert Koch Institute		2021-02-27	?	[object Object]		
Russia/TAM-RII-MH16211S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Tambov Region	Tambov Region	Human	Morshansk	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-18	Andrey Komissarov et al A	[object Object]	29	Male
Russia/TVE-RII-23125S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Tver	Tver	Human	Torzhok	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-01-13	Andrey Komissarov et al A	[object Object]	18	Female
Russia/PSK-RII-MH14731S/2021		0.01			0.01	GR	6.00	20B	Russia	Russia	Pskov Oblast	Pskov Oblast	Human	Velikiye Luki	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-08	Andrey Komissarov et al A	[object Object]	36	Female
Russia/NGR-RII-MH14364S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Veliky Novgorod	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-01-05	Andrey Komissarov et al A	[object Object]	62	Male
Russia/SPE-RII-MH14685S/2021		0.01			0.01	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	52	Female
Russia/SPE-RII-MH14632S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-19	Andrey Komissarov et al A	[object Object]	33	Female
Russia/SPE-RII-MH14769S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]	37	Male
Russia/KR-RII-MH16419S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Karelia	Karelia	Human		Republican Infectious Diseases Hospital	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-24	Andrey Komissarov et al A	[object Object]	62	Male
Russia/SPE-RII-MH16514S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-22	Andrey Komissarov et al A	[object Object]	47	Male
Russia/KR-RII-MH16444S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Karelia	Karelia	Human		Republican Infectious Diseases Hospital	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-24	Andrey Komissarov et al A	[object Object]	51	Male
Russia/KR-RII-MH16448S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Karelia	Karelia	Human		Republican Infectious Diseases Hospital	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-23	Andrey Komissarov et al A	[object Object]		Female
Russia/KR-RII-MH16403S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Karelia	Karelia	Human		Republican Infectious Diseases Hospital	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-25	Andrey Komissarov et al A	[object Object]	44	Female
Russia/KR-RII-MH16441S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Karelia	Karelia	Human		Republican Infectious Diseases Hospital	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-24	Andrey Komissarov et al A	[object Object]	79	Female
Russia/KR-RII-12420S/2020		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Karelia	Karelia	Human	Porosoozero	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-18	Andrey Komissarov et al A	[object Object]	59	Female
Russia/ARK-CRIE-7602088512/2020		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Virology of Federal Budget Health Care Institution Center of Hygiene and Epidemiology in Arkhangelsk region	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2020-12-28	Samoilov AE et al	[object Object]	61	Female
Russia/MOW_2311/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Collection of WHO National Influenza Center, N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation	B.1.1.317	Europe	Europe	Laboratory of genome analysis, N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation		2021-02-08	Olga Voronina et al	[object Object]	44	Female
Russia/TAM-CRIE-L188K0233u/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Tambov Region	Tambov Region	Human		Federal Budget Health Care Institution "Center of Hygiene and Epidemiology in Tambov region"	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-11	Samoilov AE et al	[object Object]	58	Female
Germany/BY-RKI-I-038095/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Germany	Germany	Germany	Bavaria	Human		SYNLAB MVZ Weiden	B.1.1.317	Europe	Europe	Robert Koch Institute		2021-03-08	?	[object Object]		
Russia/TVE-CRIE-L188K0272/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Tver	Tver	Human		Federal Budget Health Care Institution "Center of Hygiene and Epidemiology in Tver region"	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-12	Samoilov AE et al	[object Object]	45	Male
Russia/MOS-CRIE-L106A0492b/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-01	Samojlov A.E. et al	[object Object]	76	Female
Austria/CeMM5006/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Austria	Austria	Austria	Tyrol	Human	Reutte	Department of Laboratory Medicine, Division of Clinical Virology, University of Medicine, Vienna	B.1.1.317	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-02-26	Lukas Endler et al	[object Object]	58	Female
Russia/MOW-RII-MH16155S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	26	Male
Russia/MOW-CRIE-L188K0291/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-12	Samoilov AE et al	[object Object]	90	Female
Russia/MOW-CRIE-L188K0287u/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-11	Samoilov AE et al	[object Object]	69	Male
Russia/KR-RII-MH16431S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Karelia	Karelia	Human		Republican Infectious Diseases Hospital	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-23	Andrey Komissarov et al A	[object Object]	60	Female
Russia/KR-RII-MH16402S/2021		0.01			0.01	GR	5.00	20B	Russia	Russia	Karelia	Karelia	Human		Republican Infectious Diseases Hospital	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-14	Andrey Komissarov et al A	[object Object]	85	Female
Russia/KR-RII-MH16398S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Karelia	Karelia	Human		Republican Infectious Diseases Hospital	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-19	Andrey Komissarov et al A	[object Object]	84	Female
Russia/SPE-RII-32644S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-21	Andrey Komissarov et al A	[object Object]	67	Female
Russia/SPE-RII-MH15744S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	32	Female
Russia/SPE-RII-MH14735S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-11	Andrey Komissarov et al A	[object Object]	29	Female
Russia/MOW-RII-MH15827S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	62	Female
Russia/TVE-RII-MH16044S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Tver	Tver	Human	Torzhok	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-18	Andrey Komissarov et al A	[object Object]	54	Female
Russia/SPE-RII-MH17276S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-26	Andrey Komissarov et al A	[object Object]	32	Female
Russia/SPE-RII-MH14615S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-20	Andrey Komissarov et al A	[object Object]	44	Male
Russia/NGR-RII-MH15684S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Veliky Novgorod	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	66	Female
Russia/MUR-RII-MH16481S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Murmansk	Murmansk	Human		WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-21	Andrey Komissarov et al A	[object Object]	20	Female
Russia/LEN-RII-MH17236S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Gatchina	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-27	Andrey Komissarov et al A	[object Object]	38	Female
Russia/CU-RII-MH16108S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Chuvash Republic	Chuvash Republic	Human	Cheboksary	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-10	Andrey Komissarov et al A	[object Object]	30	Male
Russia/MOW-CRIE-L188K0290u/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-08	Samoilov AE et al	[object Object]	90	Female
Germany/HH-RKI-I-032348/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Germany	Germany	Germany	Hamburg	Human		Sonic - Labor Lademannbogen MVZ GmbH	B.1.1.317	Europe	Europe	Robert Koch Institute		2021-02-25	?	[object Object]		
Russia/TVE-CRIE-L188F0168b/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Tver	Tver	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-08	Samoilov A.E. et al	[object Object]	65	Female
Russia/TVE-CRIE-L188D0213b/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Tver	Tver	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-02	Samojlov A.E. et al	[object Object]	59	Male
Russia/TVE-CRIE-L188S0144bh/2021		0.02	0.01	0.01	0.03	GR	4.00	20B	Russia	Russia	Tver	Tver	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-09	Samoilov A.E. et al	[object Object]	35	Female
Russia/MOW-CRIE-L188M0219/2021		0.02	0.01	0.01	0.03	GR	4.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-16	Samojlov A.E. et al	[object Object]	75	Female
Russia/TVE-CRIE-L188S0145b/2021		0.02	0.01	0.01	0.03	GR	6.00	20B	Russia	Russia	Tver	Tver	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-02-22	Samoilov A.E. et al	[object Object]		Male
Russia/TVE-CRIE-L188S0146bh/2021		0.02	0.01	0.01	0.03	GR	6.00	20B	Russia	Russia	Tver	Tver	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-11	Samoilov A.E. et al	[object Object]	35	Male
Russia/MOS-RII-MH16075S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Kubinka	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	16	Female
Russia/TAM-CRIE-L188K0234u/2021		0.02	0.01	0.01	0.03	G	5.00	20B	Russia	Russia	Tambov Region	Tambov Region	Human		Federal Budget Health Care Institution "Center of Hygiene and Epidemiology in Tambov region"	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-07	Samoilov AE et al	[object Object]	71	Female
Russia/NGR-RII-MH15719S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Veliky Novgorod	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	69	Female
Russia/KDA-RII-MH15916S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Krasnodar	Krasnodar	Human	Krasnodar	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-29	Andrey Komissarov et al A	[object Object]	32	Female
Russia/MOW-RII-MH16138S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-28	Andrey Komissarov et al A	[object Object]	29	Female
Russia/MOW-CRIE-L188A0905/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-30	Samoilov AE et al	[object Object]	67	Female
Russia/MOW-RII-MH16210S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	42	Female
Russia/MOW-RII-MH16116S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-10	Andrey Komissarov et al A	[object Object]	24	Male
Russia/SVE-RII-MH15241S/2021		0.01			0.01	GR	5.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	UMMC-Health	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-19	Andrey Komissarov et al A	[object Object]	38	Female
Russia/MOW-RII-MH16214S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	43	Female
Russia/MOS-RII-MH16041S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Balashikha	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-23	Andrey Komissarov et al A	[object Object]	37	Male
Russia/AMU-RII-MH18249S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Svobodny (Amur)	Svobodnensky Hospital	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-17	Andrey Komissarov et al A	[object Object]	71	Female
Russia/AMU-RII-MH18334S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Svobodny (Amur)	Svobodnensky Hospital	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-26	Andrey Komissarov et al A	[object Object]	69	Female
Russia/AMU-RII-MH18333S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Svobodny (Amur)	Svobodnensky Hospital	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-26	Andrey Komissarov et al A	[object Object]	61	Male
Russia/SPE-RII-MH17298S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-02	Andrey Komissarov et al A	[object Object]	24	Male
Russia/NGR-RII-MH17357S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Borovichi (Novgorod)	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-07	Andrey Komissarov et al A	[object Object]	53	Female
Russia/SPE-RII-MH14803S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-13	Andrey Komissarov et al A	[object Object]	33	Female
Russia/TAM-CRIE-L188L0279bh/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Tambov Region	Tambov Region	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-09	Samoilov A.E. et al	[object Object]	55	Female
Russia/KLU-RII-MH16106S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Kaluga	Kaluga	Human	Tovarkovo	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-22	Andrey Komissarov et al A	[object Object]	68	Female
Russia/BRY-RII-MH16101S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Bryansk Oblast	Bryansk Oblast	Human	Unecha	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-20	Andrey Komissarov et al A	[object Object]	74	Male
Russia/NIZ-RII-MH16131S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Nizhny Novgorod	Nizhny Novgorod	Human	Nizhny Novgorod	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-26	Andrey Komissarov et al A	[object Object]	19	Female
Russia/MOS-RII-MH16094S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-27	Andrey Komissarov et al A	[object Object]	18	Male
Russia/MOW-RII-MH16253S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-04	Andrey Komissarov et al A	[object Object]	70	Male
Russia/TVE-CRIE-L188F0169bh/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Tver	Tver	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-07	Samoilov A.E. et al	[object Object]	44	Male
Poland/NIPH-NIH_ECDC-1050/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Poland	Poland	Poland	Wielkopolskie	Human	Poznan	WSSE Laboratorium Mikrobiologii i Parazytologii	B.1.1.317	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-02-25	Wołkowicz Tomasz et al	[object Object]	74	Male
Poland/NIPH-NIH_ECDC-1156/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Poland	Poland	Poland	Opolskie	Human	Opole	LABORATORIUM BADAŃ KLINICZNYCH WSSE w OPOLU	B.1.1.317	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-03-04	Wołkowicz Tomasz et al	[object Object]	23	Female
Poland/NIPH-NIH_ECDC-1183/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Poland	Poland	Poland	Lubelskie	Human	Lublin	Laboratorium INNGEN	B.1.1.317	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-03-03	Wołkowicz Tomasz et al	[object Object]	59	Female
Russia/MOW-RII-MH16229S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-20	Andrey Komissarov et al A	[object Object]	53	Female
Russia/YAR-CRIE-L188K0007b/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-05	Samojlov A.E. et al	[object Object]	59	Male
Russia/YAR-CRIE-L188K0006b/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-05	Samojlov A.E. et al	[object Object]	85	Female
Russia/IVA-CRIE-L188E0259bu/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Ivanovo	Ivanovo	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-03	Samoilov A.E. et al	[object Object]	75	Male
Russia/VOR-RII-MH15855S/2021		0.02	0.01	0.01	0.03	GR	4.00	20B	Russia	Russia	Voronezh	Voronezh	Human	Voronezh	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	63	Female
Russia/MOW-CRIE-L106F0433u/2021		0.02	0.01	0.01	0.03	GR	4.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-10	Samojlov A.E. et al	[object Object]	33	Male
Russia/TVE-CRIE-L188D0215b/2021		0.02	0.01	0.01	0.03	GR	4.00	20B	Russia	Russia	Tver	Tver	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-05	Samojlov A.E. et al	[object Object]	32	Male
Russia/MOS-CRIE-L106A0727b/2021		0.02	0.01	0.01	0.03	GR	4.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-01	Samojlov A.E. et al	[object Object]	73	Female
Russia/BEL-RII-MH17477S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-13	Andrey Komissarov et al A	[object Object]	52	
Russia/BEL-RII-MH17651S/2021		0.02	0.01	0.01	0.03	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-28	Andrey Komissarov et al A	[object Object]	69	
Russia/RYA-CRIE-L188S0157bu/2021		0.02	0.01	0.01	0.03	GR	6.00	20B	Russia	Russia	Ryazan	Ryazan	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-20	Samoilov A.E. et al	[object Object]		Male
Russia/MOW-CRIE-L188M0200b/2021		0.02	0.01	0.01	0.03	GR	6.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-15	Samoilov A.E. et al	[object Object]	41	Male
Russia/YAR-CRIE-L188D0015b/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-05	Samojlov A.E. et al	[object Object]	45	Female
Russia/MOS-CRIE-L106D0128b/2021		0.02	0.01	0.01	0.03	GR	4.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-07	Samojlov A.E. et al	[object Object]	56	Female
Russia/SMO-CRIE-L188B0036b/2021		0.02	0.01	0.01	0.03	GR	6.00	20B	Russia	Russia	Smolensk Region	Smolensk Region	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-29	Samojlov A.E. et al	[object Object]	70	Male
Russia/YAR-RII-MH16128S/2021		0.02	0.01	0.01	0.03	GR	6.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human	Yaroslavl	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-28	Andrey Komissarov et al A	[object Object]	13	Female
Russia/YAR-CRIE-L188K0004b/2021		0.02	0.01	0.01	0.03	GR	6.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-08	Samojlov A.E. et al	[object Object]	82	Female
cat/Russia/RII-LEN-22246S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Felis catus	Vsevolozhsk	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-01-06	Andrey Komissarov et al A	[object Object]	3	Male
Russia/MOW-Moscow_2415/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		State collection of viruses, N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation	B.1.1.317	Europe	Europe	Laboratory of genome analysis, N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation		2021-02-17	Olga Voronina et al	[object Object]		Female
Russia/LEN-RII-MH14695S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Volkhov	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	50	Female
Russia/MOW-CRIE-L188K0297u/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-10	Samoilov AE et al	[object Object]	75	Male
Russia/SPE-RII-MH15725S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-28	Andrey Komissarov et al A	[object Object]	66	Female
Russia/SPE-RII-MH15768S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	69	Male
Lithuania/S21D27/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Lithuania	Lithuania	Lithuania	Klaipedos Apskritis	Human		Klaipeda University Hospital	B.1.1.317	Europe	Europe	Vilnius University Hospital Santaros Klinikos, Center of Laboratory Medicine		2021-03-21	Ingrida Olendraite et al	[object Object]	66	Female
Russia/KOS-CRIE-L188D0022b/2021		0.02	0.01	0.01	0.03	GR	6.00	20B	Russia	Russia	Kostroma Region	Kostroma Region	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-02	Samojlov A.E. et al	[object Object]	82	Female
Russia/MOW-RII-MH16225S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-08	Andrey Komissarov et al A	[object Object]	32	Male
Russia/RYA-CRIE-L188F0005bh/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Ryazan	Ryazan	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-11	Samoilov A.E. et al	[object Object]	70	Female
Russia/SPE-RII-27357S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	42	Male
Russia/SPE-RII-MH15689S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-04	Andrey Komissarov et al A	[object Object]	74	Male
Russia/SPE-RII-MH15647S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-03	Andrey Komissarov et al A	[object Object]	42	Male
Russia/SPE-RII-MH15710S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	21	Male
Russia/SPE-RII-34978S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-20	Andrey Komissarov et al A	[object Object]	34	Female
Russia/SPE-RII-MH15664S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	83	Male
Russia/SPE-RII-MH15673S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	35	Male
Russia/VGG-RII-MH16059S/2021		0.01			0.01	GR	5.00	20B	Russia	Russia	Volgograd Region	Volgograd Region	Human	Volgograd	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-31	Andrey Komissarov et al A	[object Object]	75	Male
Russia/KRS-RII-MH16222S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Kursk Region	Kursk Region	Human	Kursk	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-18	Andrey Komissarov et al A	[object Object]	39	Female
Russia/BEL-RII-MH17432S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-08	Andrey Komissarov et al A	[object Object]	23	
Russia/SPE-RII-MH15439S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	58	Female
Russia/KRS-RII-MH16245S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Kursk Region	Kursk Region	Human	Kursk	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-18	Andrey Komissarov et al A	[object Object]	46	Female
Russia/KRS-RII-MH16134S/2021		0.02	0.05	0.06	0.07	GR	5.00	20B	Russia	Russia	Kursk Region	Kursk Region	Human	Kursk	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	45	Male
Russia/BEL-RII-MH17559S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-21	Andrey Komissarov et al A	[object Object]	63	
Russia/BEL-RII-MH17663S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-29	Andrey Komissarov et al A	[object Object]	67	
Russia/BEL-RII-MH17571S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-22	Andrey Komissarov et al A	[object Object]	45	
Russia/LEN-RII-MH14833S/2021		0.01			0.01	GR	5.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Vyborg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]	16	Female
Russia/SPE-RII-31577S/2021		0.02	0.01	0.01	0.03	GR	6.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-08	Andrey Komissarov et al A	[object Object]	38	Female
Russia/SPE-RII-MH14762S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-09	Andrey Komissarov et al A	[object Object]	33	Male
Russia/SPE-RII-MH14794S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Sestroretsk	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-13	Andrey Komissarov et al A	[object Object]	40	Male
Russia/SPE-RII-MH15648S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	60	Female
Russia/LEN-RII-MH15745S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Tosno	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-15	Andrey Komissarov et al A	[object Object]	66	Female
Russia/SPE-RII-MH15445S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	54	Male
Russia/SPE-RII-MH14700S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-25	Andrey Komissarov et al A	[object Object]	80	Male
Russia/SPE-RII-MH14679S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-25	Andrey Komissarov et al A	[object Object]	49	Female
Russia/SPE-RII-MH14613S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-19	Andrey Komissarov et al A	[object Object]	65	Female
Russia/KR-RII-MH14748S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Karelia	Karelia	Human	Sortavala	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-11	Andrey Komissarov et al A	[object Object]	32	Male
Russia/SPE-RII-MH15753S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-26	Andrey Komissarov et al A	[object Object]	32	Female
Russia/SPE-RII-MH14672S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-14	Andrey Komissarov et al A	[object Object]	40	Female
Russia/MOW-RII-MH16065S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-23	Andrey Komissarov et al A	[object Object]	42	Male
Russia/MOW-RII-MH16102S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-19	Andrey Komissarov et al A	[object Object]	30	Female
Russia/SPE-RII-MH14780S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]	23	Male
Germany/HB-RKI-I-015976/2021		0.01			0.01	GR	4.00	20B	Germany	Germany	Germany	Bremen	Human		Labor Dr. Schumacher MVZ	B.1.1.317	Europe	Europe	Robert Koch Institute		2021-02-08	?	[object Object]		
Russia/NIZ-RII-MH16092S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Nizhny Novgorod	Nizhny Novgorod	Human	Nizhny Novgorod	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-19	Andrey Komissarov et al A	[object Object]	82	Female
Russia/SPE-RII-MH14658S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-25	Andrey Komissarov et al A	[object Object]	37	Female
Russia/MOS-RII-MH16081S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Ruza	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-26	Andrey Komissarov et al A	[object Object]	50	Male
Russia/SPE-RII-MH14616S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-14	Andrey Komissarov et al A	[object Object]	56	Male
Russia/SPE-RII-MH14775S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]	77	Male
Russia/SPE-RII-MH15737S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-04	Andrey Komissarov et al A	[object Object]	80	Female
Russia/SPE-RII-MH14804S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-13	Andrey Komissarov et al A	[object Object]	58	Female
Russia/LEN-RII-MH14622S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Kirovsk	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-14	Andrey Komissarov et al A	[object Object]	77	Female
Russia/RYA-RII-MH15789S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Ryazan	Ryazan	Human	Ryazan	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-26	Andrey Komissarov et al A	[object Object]	66	Male
Russia/RYA-RII-MH15840S/2021		0.02	0.01	0.01	0.03	GR	5.00	20B	Russia	Russia	Ryazan	Ryazan	Human	Ryazan	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-15	Andrey Komissarov et al A	[object Object]	69	Female
Russia/SPE-RII-34230S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-13	Andrey Komissarov et al A	[object Object]	42	Female
Russia/NIZ-RII-MH15794S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Nizhny Novgorod	Nizhny Novgorod	Human	Nizhny Novgorod	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-03	Andrey Komissarov et al A	[object Object]	64	Female
Russia/SPE-RII-MH14822S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-16	Andrey Komissarov et al A	[object Object]	22	Female
Russia/KR-RII-MH16426S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Karelia	Karelia	Human		Republican Infectious Diseases Hospital	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-23	Andrey Komissarov et al A	[object Object]	73	Male
Russia/SPE-RII-35137S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-22	Andrey Komissarov et al A	[object Object]	66	Female
Russia/SPE-RII-25392S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-04	Andrey Komissarov et al A	[object Object]	68	Male
Russia/SPE-RII-MH14711S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-13	Andrey Komissarov et al A	[object Object]	43	Male
Russia/SPE-RII-MH15661S/2021		0.01			0.01	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	47	Male
Russia/SPE-RII-MH15766S/2021		0.01			0.01	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	49	Female
Russia/LEN-RII-MH14668S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Vsevolozhsk	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-16	Andrey Komissarov et al A	[object Object]	30	Male
Russia/SPE-RII-34653S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	25	Male
Russia/SPE-RII-MH15683S/2021		0.01			0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	67	Male
Russia/SPE-RII-32279S/2021		0.02	0.01	0.01	0.03	GR	6.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-16	Andrey Komissarov et al A	[object Object]	70	Male
Russia/SPE-RII-33352S/2021		0.01			0.01	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-29	Andrey Komissarov et al A	[object Object]	23	Female
Russia/SPE-RII-32816S/2021		0.01			0.01	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-23	Andrey Komissarov et al A	[object Object]	22	Female
Russia/SPE-RII-30769V/2020	1.00	0.06	0.02	0.01	0.06	GR	6.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-08-20	Andrey Komissarov et al A	[object Object]	47	Female
Russia/ORE-RII-MH4423S/2020						GR	1.00	20B	Russia	Russia	Orenburg	Orenburg	Human	Orenburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-29	Andrey Komissarov et al A	[object Object]	75	Male
Russia/RYA-RII-MH2824S/2020						GR	5.00	20B	Russia	Russia	Ryazan	Ryazan	Human	Ryazan	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-26	Andrey Komissarov et al A	[object Object]	41	Female
Belgium/WLM-0406275/2020						GR	1.00	20B	Belgium	Belgium	Belgium	Waremme	Human	Hannut	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.1	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-04-06	Tony Wawina-Bokalanga et al	[object Object]	22	Male
Sweden/20-52638/2020						GR	2.00	20B	Sweden	Sweden	Sweden	Vasternorrland	Human		Laboratoriemedicin Vasternorrland	B.1.1.302	Europe	Europe	The Public Health Agency of Sweden		2020-08-19	Anna-Malin Linde et al	[object Object]	37	Male
Sweden/20-52830/2020						GR	1.00	20B	Sweden	Sweden	Sweden	Vastra Gotaland	Human		Skovde/Unilabs	B.1.1.302	Europe	Europe	The Public Health Agency of Sweden		2020-09-07	Anna-Malin Linde et al	[object Object]	81	Female
Spain/CT-IBV-005488/2020						GR	1.00	20B	Spain	Spain	Spain	Catalunya	Human	Badalona	Servicio de Microbiología, Laboratori Clínic Metropolitana Nord. Hospital Universitari Germans Trias i Pujol. Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP)	B.1.1	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2020-05-21	Elisa Martró et al	[object Object]	28	Male
Romania/RO_IOCN38/2020						GR	1.00	20B	Romania	Romania	Romania	Suceava	Human		The Oncology Institute "Prof. Dr. Ion Chiricuta" Cluj Napoca	B.1.1.347	Europe	Europe	"Stefan cel Mare" University Metagenomics Lab		2020-07-19	Lobiuc Andrei et al	[object Object]	71	Male
France/HDF-CERBA-0160-202011/2020						GR	1.00	20B	France	France	France	Hauts de France	Human		CERBA LAB	B.1.1	Europe	Europe	CERBA LAB		2020-06-03	Roquebert B et al	[object Object]	57	Male
Egypt/CCHE57357-A-13/2020						O	1.00	20B	Africa	Egypt	Africa	Egypt	Human	Africa	Genomics Program, Children Cancer Hospital	B.1.1	Africa	Africa	Genomics Program, Children Cancer Hospital		2020-04-29	Hatem et al	[object Object]		
BosniaandHerzegovina/01-Livno/2020						O	1.00	20B	Bosnia and Herzegovina	Bosnia and Herzegovina	Bosnia and Herzegovina	Livno	Human		University Clinical Hospital of Mostar	B.1.1	Europe	Europe	University of Sarajevo Veterinary Faculty		2020-05-27	Goletic et al (https://dx.doi.org/10.1101/2020.06.19.160606)	[object Object]	71	Female
Oman/520258569/2020						O	1.00	20B	Asia	Oman	Asia	Dakhiliyah	Human	Asia	Oman-National Influenza Center	B.1.1	Asia	Asia	Biotechnology & OMICs Laboratory		2020-09-17	Abdul Latif Khan et al	[object Object]	40	Male
Nigeria/EK025-CV58/2020						GR	1.00	20B	Africa	Nigeria	Africa	Ekiti State	Human	Africa	Nigeria Centre for Disease Control (NCDC)	B.1.1.487	Africa	Africa	African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria		2020-04-19	Oluniyi P.E. et al A (https://virological.org/t/new-sars-cov-2-genomes-from-nigeria-reveals-dominance-of-viruses-with-spike-protein-mutation-d614g-and-additional-virus-lineages-in-circulation/527)	[object Object]	45	Male
Mauritius/P-002337/2021		0.01	0.05	0.06	0.09	GR	4.00	20B	Africa	Mauritius	Africa	Grand Port	Human	Africa	Virology Department, Central Health Laboratory	B.1.1.487	Africa	Africa	The Francis Crick Institute		2021-01-06	Ramuth M et al	[object Object]	22	Female
Bangladesh/BCSIR-NILMRC-305/2020						GR	1.00	20B	Asia	Bangladesh	Asia	Sylhet	Human	Asia	National Institute of Laboratory Medicine and Referral Center	B.1.1	Asia	Asia	Genomic Research Lab, BCSIR		2020-07-18	Abu Sayeed Mohammad Mahmud et al	[object Object]	45	Male
Bangladesh/BCSIR-JU-25/2021		0.04	0.34		0.24	GR	6.00	20B	Asia	Bangladesh	Asia	Dhaka	Human	Asia	GRMDCR & JU	B.1.1.25	Asia	Asia	Genomic Research Lab, BCSIR		2021-02-14	Md. Murshed Hasan Sarkar et al	[object Object]	50	Male
Australia/VIC2326/2020		0.01			0.01	GR	2.00	20F	Oceania	Australia	Oceania	Victoria	Human	Oceania	Microbiological Diagnostic Unit - Public Health Laboratory (MDU-PHL)	D.2	Oceania	Oceania	MDU-PHL		2020-06-25	Seemann T. et al	[object Object]	51	
Australia/VIC6907/2020		0.01			0.01	GR	3.00	20F	Oceania	Australia	Oceania	Victoria	Human	Oceania	Microbiological Diagnostic Unit - Public Health Laboratory (MDU-PHL)	D.2	Oceania	Oceania	MDU-PHL		2020-07-21	Seemann et al	[object Object]	26	Male
Lithuania/LTU000_10160/2021						GR	1.00	20B	Lithuania	Lithuania	Lithuania	Utena Apskritis	Human		NVSPL	AD.2.1	Europe	Europe	National Public Health Surveillance Laboratory		2021-02-04	Lukas Zemaitis et al	[object Object]		
Bangladesh/GRMDRC-7/2020						GR	2.00	20B	Asia	Bangladesh	Asia	Dhaka	Human	Asia	Gonoshasthya-RNA Molecular Research Center	B.1.1.25	Asia	Asia	Gonoshasthya-RNA Molecular Research Center		2020-10-17	Mohd. Raeed Jamiruddin et al	[object Object]	35	Female
Bangladesh/GRBL_S11/2020						GR	2.00	20B	Asia	Bangladesh	Asia	Dhaka	Human	Asia	Gonoshasthaya-RNA Research Center, Gonoshasthaya-RNA Molecular Diagnostics and Research Center	B.1.1.25	Asia	Asia	Gonoshasthaya-RNA Research Center, Gonoshasthaya-RNA Molecular Diagnostics and Research Center		2020-09-05	Jamiruddin et al	[object Object]		
Austria/CeMM2603/2020						GR	1.00	20B	Austria	Austria	Austria	Tyrol	Human	Innsbruck	Institut für Virologie am Department für Hygiene, Mikrobiologie und Public Health	B.1.1	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2020-11-19	Lukas Endler et al	[object Object]	32	Male
Russia/CRIE4988935/2020						GR	1.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2020-07-16	Samoilov AE et al	[object Object]	20	Male
Russia/KHM-RII-MH3415S/2020						GR	1.00	20B	Russia	Russia	Khanty-Mansi	Khanty-Mansi	Human	Surgut	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-06	Andrey Komissarov et al A	[object Object]	31	Male
Armenia/UW-ARM10/2020						GR	1.00	20B	Asia	Armenia	Asia	Armenia	Human	Asia	National Center of Disease Control and Prevention of the Republic of Armenia	B.1.1	Asia	Asia	UW Virology Lab		2020-07-30	Pavitra Roychoudhury et al	[object Object]		
Russia/OMS-ORINFI-4761S/2020						O	1.00	20B	Russia	Russia	Omsk	Omsk	Human	Sedelnikovo	Omsk Research Institute of Natural Focal Infections	B.1.1.163	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-06-30	Artem Fadeev et al	[object Object]	68	Male
Russia/OMS-ORINFI-4822S/2020						GR	1.00	20B	Russia	Russia	Omsk	Omsk	Human	Azovo	Omsk Research Institute of Natural Focal Infections	B.1.1.163	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-07-10	Artem Fadeev et al	[object Object]	52	Male
Russia/IRK-ICOV_010/2020						GR	1.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human		Federal State Public Scientific Institution В«Scientific РЎentre for Family Health and Human Reproduction ProblemsВ», Academic Consortium	B.1.1.163	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-07-14	Vladislav Babenko et al	[object Object]	34	Male
Russia/STA-RII-MH16090S/2021						GR	4.00	20B	Russia	Russia	Stavropol	Stavropol	Human	Stavropol	HELIX LLC	B.1.1.163	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-25	Andrey Komissarov et al A	[object Object]	37	Male
Russia/PRI-RII-MH829S/2020						GR	1.00	20B	Russia	Russia	Primorsky	Primorsky	Human	Ussuriysk	WHO National Influenza Centre Russian Federation	B.1.1.163	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-08-07	Andrey Komissarov et al A	[object Object]	60	Male
Russia/SVE-RII-MH9000S/2020						GR	1.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Dvurechensk	UMMC-Health	B.1.1.163	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-01	Andrey Komissarov et al A	[object Object]	63	Female
Russia/DA-RII-MH2742S/2020						GR	2.00	20B	Russia	Russia	Dagestan	Dagestan	Human	Makhachkala	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-23	Andrey Komissarov et al A	[object Object]	52	Male
Russia/DA-RII-MH2744S/2020						GR	1.00	20B	Russia	Russia	Dagestan	Dagestan	Human	Makhachkala	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-25	Andrey Komissarov et al A	[object Object]	36	Female
Russia/SPE-RII-35106S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	40	Female
Russia/SPE-RII-19578V/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1.1.71	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-06-03	Andrey Komissarov et al A	[object Object]	58	Female
Russia/SPE-RII-21119V/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1.1.71	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-06-04	Andrey Komissarov et al A	[object Object]	61	Male
CzechRepublic/NRL-1631/2021						GR	1.00	20B	Czech Republic	Czech Republic	Czech Republic	Liberec Region	Human		National Institute of Public Health	B.1.1.153	Europe	Europe	State Veterinary Institute Prague		2021-01-05	Nagy et al	[object Object]	49	Female
Russia/MO-RII-MH3582S/2020						GR	2.00	20B	Russia	Russia	Republic of Mordovia	Republic of Mordovia	Human	Saransk	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-13	Andrey Komissarov et al A	[object Object]	36	Female
NewZealand/21CV0063/2021						GR	3.00	20B	Russia	Russia	Russia	Russia	Human		LabPLUS	B.1.1	Europe	Europe	Institute of Environmental Science and Research (ESR)		2021-01-06	Xiaoyun Ren et al	[object Object]		Female
Slovakia/UKBA-203/2020						GR	1.00	20B	Slovakia	United Kingdom	Slovakia	United Kingdom	Human	Zehra	Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava	B.1.1	Europe	Europe	Faculty of Natural Sciences, Comenius University, Bratislava		2020-04-06	Kristína Boršová et al	[object Object]	16	Male
Russia/ALT-RII-MH2765S/2020						GR	1.00	20B	Russia	Russia	Altai Krai	Altai Krai	Human	Barnaul	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-26	Andrey Komissarov et al A	[object Object]	49	Male
Russia/KDA-RII-MH2774S/2020						GR	1.00	20B	Russia	Russia	Krasnodar	Krasnodar	Human	Krasnodar	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-20	Andrey Komissarov et al A	[object Object]	33	Male
Tunisia/6895/2020						GR	1.00	20B	Africa	Tunisia	Africa	Tunis	Human	Africa	1-Laboratory of Microbiology, National Reference Lab, Charles Nicolle Hospital; 2-University of Tunis ElManar, Faculty of Medicine of Tunis, LR99ES09, Tunis, Tunisia	B.1.1	Africa	Africa	1-Clinical and Experimental Pharmacology Lab, LR16SP02, National Center of Pharmacovigilance, University of Tunis El Manar, Tunis, Tunisia. 2-Neurodegenerative diseases and psychiatric troubles, LR18SP03, Razi Hospital, University of Tunis El Manar, Tunis, Tunisia. 3- Ministry of Health, National Observatory of New and Emerging Diseases, 1006, Tunis, Tunisia		2020-04-01	Ilhem Boutiba-Ben Boubaker et al	[object Object]	60	Male
Togo/TGS4/2021						GR	3.00	20B	Africa	Togo	Africa	Golfe	Human	Africa	Institut National d'hygiène	B.1.1.404	Africa	Africa	Unité Mixte Internationale TransVIHMI (UMI 233 IRD – U1175 INSERM - Université de Montpellier) IRD (Institut de recherche pour le développement)		2020-11-20	Mounerou SALOU et al	[object Object]		
France/IDF-8761/2020						GR	1.00	20B	France	France	France	Ile de France	Human	Boulogne Billancourt	Hospital	B.1.1.406	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2020-07-16	Sylvie Behillil et al	[object Object]	31	Female
Greece/39139/2020						GR	1.00	20B	Greece	Greece	Greece	Epirus	Human		Central Public Health Laboratory, National Public Health Organization	B.1.1	Europe	Europe	Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)		2020-10-27	Emmanouil Athanasiadis et al	[object Object]		
Russia/DA-RII-MH2743S/2020		0.01	0.01		0.02	GR	2.00	20B	Russia	Russia	Dagestan	Dagestan	Human	Makhachkala	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-25	Andrey Komissarov et al A	[object Object]	36	Female
Ghana/WACCBIP-GS481/2020						GR	1.00	20B	Africa	Ghana	Africa	Eastern Region GH	Human	Africa	West African Centre for Cell Biology of Infectious Pathogen, University of Ghana, Legon	B.1.1	Africa	Africa	WACCBIP, University of Ghana, Volta Road, Legon, Accra		2020-09-03	Collins M. Morang'a et al	[object Object]	30	Male
Russia/IRK-ICOV_017/2020						GR	1.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human		Federal State Public Scientific Institution В«Scientific РЎentre for Family Health and Human Reproduction ProblemsВ», Academic Consortium	B.1.1	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-07-20	Vladislav Babenko et al	[object Object]	30	Male
Russia/Omsk202118_1707/2020						GR	1.00	20B	Russia	Russia	Omsk	Omsk	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-07-17	Sergey A. Bodnev et al	[object Object]	26	Female
Belgium/rega-0502900/2020						GR	1.00	20B	Belgium	Belgium	Belgium	Thuin	Human	Anderlues	UZ Leuven, National Reference Laboratory for Coronaviruses, Laboratory Medicine, Leuven, Belgium	B.1.1.436	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-05-02	Tony Wawina-Bokalanga et al	[object Object]	67	Female
Russia/AST-RII-MH4439S/2020						GR	2.00	20B	Russia	Russia	Astrakhan Region	Astrakhan Region	Human	Astrakhan	Pathogenic Microorganisms Variability Laboratory	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-08-15	Andrey Komissarov et al A	[object Object]	50	Male
Russia/AST-RII-MH4456S/2020						GR	2.00	20B	Russia	Russia	Astrakhan Region	Astrakhan Region	Human	Astrakhan	Pathogenic Microorganisms Variability Laboratory	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-08-15	Andrey Komissarov et al A	[object Object]	56	Male
Russia/Sakha-89702/2020						GR	1.00	20B	Russia	Russia	Republic of Sakha	Republic of Sakha	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-04-01	Oleg V. Pyankov et al	[object Object]	38	Male
Jordan/SR-055/2020						GR	1.00	20B	Asia	Jordan	Asia	Amman	Human	Asia	Biolab Diagnostic Laboratories	B.1.1	Asia	Asia	Andersen lab at Scripps Research		2020-04-02	Issa Abu-Dayyeh et al	[object Object]		
Russia/SPE-RII-17942V/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-05-27	Andrey Komissarov et al A	[object Object]	43	Male
Russia/KK-RII-MH1680S/2020						GR	1.00	20B	Russia	Russia	Khakassia	Khakassia	Human	Abakan	HELIX LCC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-03	Andrey Komissarov et al A	[object Object]	45	Female
Russia/KK-RII-MH1681S/2020						GR	1.00	20B	Russia	Russia	Khakassia	Khakassia	Human	Abakan	HELIX LCC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-03	Andrey Komissarov et al A	[object Object]	32	Female
CzechRepublic/NRL-7944/2020		0.01	0.01		0.02	GR	2.00	20B	Czech Republic	Czech Republic	Czech Republic	Olomouc Region	Human	Písařov	The National Institute of Public Health	B.1.1.266	Europe	Europe	State Veterinary Institute Prague		2020-07-28	Nagy et al	[object Object]	46	Female
CzechRepublic/IAB20_016_214/2020		0.01	0.01		0.02	GR	2.00	20B	Czech Republic	Czech Republic	Czech Republic	South Moravian Region	Human	Brno	The University Hospital Brno	B.1.1.266	Europe	Europe	Institute of Applied Biotechnologies a.s.		2020-07-13	Petr Klempt et al	[object Object]		
HongKong/HKU-201216-276/2020						GR	1.00	20B	Asia	Hong Kong	Asia	Hong Kong	Human	Asia	Department of Microbiology, The University of Hong Kong	B.1.1.241	Asia	Asia	Department of Microbiology, The University of Hong Kong		2020-09-15	Kelvin K.W. To et al	[object Object]		
Ireland/CN-NVRL-71IRL96106/2020						GR	1.00	20B	Ireland	Ireland	Ireland	Cavan	Human		National Virus Reference Laboratory	B.1.1.241	Europe	Europe	National Virus Reference Laboratory		2020-08-01	Michael Carr et al	[object Object]		Female
Russia/IRK-RII-MH15595S/2020						GR	1.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human	Irkutsk	Department of Experimental Modeling and Pathogenesis of Infectious Diseases	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-07-29	Andrey Komissarov et al A	[object Object]		
Russia/IRK-ICOV_012/2020						GR	1.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human		Federal State Public Scientific Institution В«Scientific РЎentre for Family Health and Human Reproduction ProblemsВ», Academic Consortium	B.1.1	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-07-16	Vladislav Babenko et al	[object Object]	72	Male
Russia/IRK-ICOV_006/2020						GR	1.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human		Federal State Public Scientific Institution В«Scientific РЎentre for Family Health and Human Reproduction ProblemsВ», Academic Consortium	B.1.1	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-07-14	Vladislav Babenko et al	[object Object]	59	Male
Russia/VOR-RII-MH2793S/2020						GR	1.00	20B	Russia	Russia	Voronezh	Voronezh	Human	Voronezh	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-28	Andrey Komissarov et al A	[object Object]	32	Male
Russia/KC-RII-MH2754S/2020						GR	1.00	20B	Russia	Russia	Karachay-Cherkess	Karachay-Cherkess	Human	Karachayevsk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-17	Andrey Komissarov et al A	[object Object]	2	Female
Russia/IN-RII-MH2745S/2020						G	1.00	20B	Russia	Russia	Ingushetia	Ingushetia	Human	Nazran	HELIX LLC	B.1.1.31	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-21	Andrey Komissarov et al A	[object Object]	43	Female
Russia/CE-RII-MH2649S/2020						GR	1.00	20B	Russia	Russia	Chechen Republic	Chechen Republic	Human	Grozny	WHO National Influenza Centre Russian Federation	B.1.1.31	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-11	Andrey Komissarov et al A	[object Object]	61	Female
Russia/SVE-RII-MH2025S/2020						GR	1.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	HELIX LLC	B.1.1.31	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-20	Andrey Komissarov et al A	[object Object]	37	Female
Russia/CE-RII-MH2636S/2020						GR	1.00	20B	Russia	Russia	Chechen Republic	Chechen Republic	Human	Grozny	WHO National Influenza Centre Russian Federation	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-11	Andrey Komissarov et al A	[object Object]	59	Male
Russia/KC-RII-MH2752S/2020						GR	1.00	20B	Russia	Russia	Karachay-Cherkess	Karachay-Cherkess	Human	Cherkessk	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-17	Andrey Komissarov et al A	[object Object]	61	Female
Russia/NVS-RII-MH1142S/2020						GR	3.00	20B	Russia	Russia	Novosibirsk	Novosibirsk	Human	Novosibirsk	WHO National Influenza Centre Russian Federation	B.1.1.31	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-08-09	Andrey Komissarov et al A	[object Object]	44	Female
Russia/ALT-RII-MH2761S/2020						GR	2.00	20B	Russia	Russia	Altai Krai	Altai Krai	Human	Barnaul	HELIX LLC	B.1.1.31	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-22	Andrey Komissarov et al A	[object Object]	32	Female
Russia/KDA-RII-MH2773S/2020						GR	2.00	20B	Russia	Russia	Krasnodar	Krasnodar	Human	Krasnodar	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-17	Andrey Komissarov et al A	[object Object]	28	Female
Russia/IRK-RII-MH15602S/2020						GR	2.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human	Irkutsk	Department of Experimental Modeling and Pathogenesis of Infectious Diseases	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-30	Andrey Komissarov et al A	[object Object]		
Kenya/NIC_569/2020						GR	1.00	20B	Africa	Kenya	Africa	Kenya	Human	Africa	National Public Health Laboratory	B.1.1	Africa	Africa	KEMRI-Wellcome Trust Research Programme/KEMRI-CGMR-C Kilifi		2020-03-29	Githinji G. et al 2020 et al (https://virological.org/t/introduction-and-local-transmission-of-sars-cov-2-cases-in-kenya/497)	[object Object]		Male
Russia/PSK-RII-MH2018S/2020						GR	1.00	20B	Russia	Russia	Pskov Oblast	Pskov Oblast	Human	Velikiye Luki	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-24	Andrey Komissarov et al A	[object Object]	37	Male
Russia/PSK-RII-MH6073S/2020						GR	1.00	20B	Russia	Russia	Pskov Oblast	Pskov Oblast	Human	Velikiye Luki	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-14	Andrey Komissarov et al A	[object Object]	31	Female
Russia/Primorskiy-79001/2020						GR	1.00	20B	Russia	Russia	Primorsky	Primorsky	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-22	Sergey A. Bodnev et al	[object Object]	31	Female
Russia/Ulan-Ude-RII4560S/2020						GR	1.00	20B	Russia	Russia	Buryatia	Buryatia	Human	Ulan-Ude	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-03-25	Andrey Komissarov et al B (https://dx.doi.org/10.1101/2020.07.14.20150979)	[object Object]	32	Male
Russia/AST-RII-MH4492S/2020						GR	1.00	20B	Russia	Russia	Astrakhan Region	Astrakhan Region	Human	Astrakhan	Pathogenic Microorganisms Variability Laboratory	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-03	Andrey Komissarov et al A	[object Object]	66	Female
Russia/AST-RII-MH14509S/2020						GR	1.00	20B	Russia	Russia	Astrakhan Region	Astrakhan Region	Human	Volodarskiy	Pathogenic Microorganisms Variability Laboratory	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-09	Andrey Komissarov et al A	[object Object]	59	Female
Chile/AR-253595/2020						GR	1.00	20B	South America	Chile	South America	Araucanía	Human	South America	Genetica Molecular and Subdepartamento de Virologia ISP Chile	B.1.1	South America	South America	Instituto de Salud Publica de Chile		2020-12-02	Javier Tognarelli et al	[object Object]	21	Male
Russia/CHE-RII-MH3117S/2020						O	2.00	20B	Russia	Russia	Chelyabinsk	Chelyabinsk	Human	Ozyorsk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-02	Andrey Komissarov et al A	[object Object]	49	Male
Russia/PNZ-RII-MH15795S/2021						GR	3.00	20B	Russia	Russia	Penza	Penza	Human	Penza	HELIX LLC	B.1.1.213	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	72	Female
Spain/GA-CHUVI-33371866/2020						GR	2.00	20B	Spain	Spain	Spain	Galicia	Human	Vigo	Microbiology Department. Complexo Hospitalario Universitario de Vigo	B.1.1.198	Europe	Europe	Microbiology Department. Complexo Hospitalario Universitario de Vigo		2020-08-09	Alfaya N et al	[object Object]	52	Male
Spain/GA-IBV-98006034/2020						GR	1.00	20B	Spain	Spain	Spain	Galicia	Human	Lousame	Hospital Clínico Universitario de Santiago de Compostela	B.1.1.198	Europe	Europe	SeqCOVID-SPAIN consortium/Institute of Biomedicine of Valencia, IBV-CSIC		2020-06-13	José Javier Costa Alcalde et al	[object Object]	59	Male
Luxembourg/LNS2350135/2020						GR	1.00	20B	Luxembourg	Luxembourg	Luxembourg	Luxembourg	Human		Laboratoire national de santé, Microbiology, Virology	B.1.1.198	Europe	Europe	Laboratoire national de santé, Microbiology, Microbial Genomics Platform		2020-07-10	Anke Wienecke-Baldacchino et al	[object Object]	56	Male
Luxembourg/LNS1963903/2020						GR	1.00	20B	Luxembourg	Luxembourg	Luxembourg	Luxembourg	Human		Laboratoire national de santé, Microbiology, Virology	B.1.1.198	Europe	Europe	Laboratoire national de santé, Microbiology, Microbial Genomics Platform		2020-07-03	Anke Wienecke-Baldacchino et al	[object Object]	30	Male
Russia/KDA-RII-MH4938S/2020						GR	2.00	20B	Russia	Russia	Krasnodar	Krasnodar	Human	Armavir	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-14	Andrey Komissarov et al A	[object Object]	83	Male
Russia/SPE-RII-MH6365S/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-12	Andrey Komissarov et al A	[object Object]	29	Male
Indonesia/JK-LIPI032/2020						GR	1.00	20B	Asia	Indonesia	Asia	Jakarta	Human	Asia	Klinik Apotik Dien, Jakarta	B.1.1	Asia	Asia	Biosafety Level-3 Laboratory, Indonesian Institute of Sciences (LIPI)		2020-09-18	Anik Budhi Dharmayanthi et al	[object Object]	38	Male
Russia/KR-RII-MH2076S/2020						GR	2.00	20B	Russia	Russia	Karelia	Karelia	Human	Petrozavodsk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-25	Andrey Komissarov et al A	[object Object]	39	Male
Russia/YAR-CRIE-L188D0012b/2021						GR	2.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.10	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-07	Samojlov A.E. et al	[object Object]	82	Female
Russia/YAR-CRIE-L188D0009b/2021						GR	2.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.10	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-02-13	Samojlov A.E. et al	[object Object]	66	Female
Russia/YAR-CRIE-L188D0010b/2021						GR	2.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.10	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-02-13	Samojlov A.E. et al	[object Object]	66	Female
Russia/AST-RII-MH4453S/2020						GR	1.00	20B	Russia	Russia	Astrakhan Region	Astrakhan Region	Human	Astrakhan	Pathogenic Microorganisms Variability Laboratory	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-14	Andrey Komissarov et al A	[object Object]	65	Female
Chile/RM-153333/2020						GR	1.00	20B	South America	Chile	South America	Region Metropolitana de Santiago	Human	South America	Genetica Molecular and Subdepartamento de Virologia ISP Chile	B.1.1.324	South America	South America	Instituto de Salud Publica de Chile		2020-08-17	Javier Tognarelli et al	[object Object]	24	Male
Vietnam/VNHN_4868/2020						GR	1.00	20B	Asia	Vietnam	Asia	Red River Delta	Human	Asia	National Hospital of Tropical Diseases	B.1.1	Asia	Asia	Oxford University Clinical Research Unit, Hanoi, Vietnam		2020-04-09	Nguyen Thi Tam et al	[object Object]	51	Male
Ireland/CE-UHL101/2020						GR	1.00	20B	Ireland	Ireland	Ireland	Clare	Human		University Hospital Limerick	B.1.1	Europe	Europe	Irish Coronavirus Sequencing Consortium - Teagasc Moorepark		2020-05-21	Paul Cotter et al	[object Object]		Male
Ireland/CE-UHL96/2020						GR	1.00	20B	Ireland	Ireland	Ireland	Clare	Human		University Hospital Limerick	B.1.1	Europe	Europe	Irish Coronavirus Sequencing Consortium - Teagasc Moorepark		2020-05-19	Paul Cotter et al	[object Object]		Female
Russia/NIZ-86756/2020						GR	1.00	20B	Russia	Russia	Nizhny Novgorod	Nizhny Novgorod	Human		Federal State Budgetary Educational Institution of Higher Education В«Privolzhsky Research Medical UniversityВ» of the Ministry of Health of the Russian Federation, Academic Consortium	B.1.1.54	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-06-26	Vladislav Babenko et al	[object Object]	30	Female
Russia/NIZ-92127/2020						GR	1.00	20B	Russia	Russia	Nizhny Novgorod	Nizhny Novgorod	Human		Federal State Budgetary Educational Institution of Higher Education В«Privolzhsky Research Medical UniversityВ» of the Ministry of Health of the Russian Federation, Academic Consortium	B.1.1.54	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-07-02	Vladislav Babenko et al	[object Object]	59	Female
Russia/SVE-RII-MH9113S/2020						GR	1.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Verkhnyaya Pyshma	UMMC-Health	B.1.1.83	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-01	Andrey Komissarov et al A	[object Object]	62	Female
Norway/3828/2020						GR	2.00	20B	Norway	Norway	Norway	Vestfold Og Telemark	Human		Unilabs Laboratory Medicine	K.3	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2020-09-24	Kathrine Stene-Johansen et al	[object Object]		
Norway/3463/2021						GR	3.00	20B	Norway	Norway	Norway	More Og Romsdal	Human		Department of Medical Microbiology - section Molde, Molde Hospital	B.1.1.277	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-02-03	Kathrine Stene-Johansen et al	[object Object]		
Poland/IHG-PAS-8-30/2020						GR	2.00	20B	Poland	Poland	Poland	Wielkopolskie	Human		Institute of Human Genetics, Polish Academy of Sciences	B.1.1.277	Europe	Europe	Institute of Human Genetics, Polish Academy of Sciences		2020-09-05	Szymon Hryhorowicz et al	[object Object]	38	Male
Italy/BAS-IZSPB_298PT/2020						GR	2.00	20B	Italy	Italy	Italy	Basilicata	Human	Matera	I.R.C.C.S. "S. De Bellis" - Ente Ospedaliero	B.1.1.277	Europe	Europe	Istituto Zooprofilattico Sperimentale della Puglia e della Basilicata		2020-11-03	Parisi A. et al	[object Object]	37	Male
Russia/AMU-RII-MH10147S/2020						GR	1.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Poyarkovo	WHO National Influenza Centre Russian Federation	K.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-19	Andrey Komissarov et al A	[object Object]	43	Male
Russia/KO-RII-MH3409S/2020						GR	1.00	20B	Russia	Russia	Komi	Komi	Human	Ukhta	HELIX LLC	K.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-06	Andrey Komissarov et al A	[object Object]	43	Female
Russia/TUL-RII-MH3372S/2020						GR	2.00	20B	Russia	Russia	Tula Region	Tula Region	Human	Novomoskovsk	HELIX LLC	K.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	31	Female
Russia/IVA-RII-MH11889S/2020						GR	2.00	20B	Russia	Russia	Ivanovo	Ivanovo	Human	Ivanovo	WHO National Influenza Centre Russian Federation	K.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-14	Andrey Komissarov et al A	[object Object]	57	Female
Russia/PRI-RII-MH795S/2020						GR	1.00	20B	Russia	Russia	Primorsky	Primorsky	Human	Ussuriysk	WHO National Influenza Centre Russian Federation	K.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-07-26	Andrey Komissarov et al A	[object Object]	65	Female
Russia/ROS-RII-MH3369S/2020						GR	1.00	20B	Russia	Russia	Rostov	Rostov	Human	Kamensk-Shakhtinsky	HELIX LLC	K.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-06	Andrey Komissarov et al A	[object Object]	56	Male
Russia/KHM-RII-MH3413S/2020						GR	1.00	20B	Russia	Russia	Khanty-Mansi	Khanty-Mansi	Human	Surgut	HELIX LLC	K.2	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-06	Andrey Komissarov et al A	[object Object]	44	Male
Russia/ROS-RII-MH3379S/2020						GR	1.00	20B	Russia	Russia	Rostov	Rostov	Human	Kamensk-Shakhtinsky	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-06	Andrey Komissarov et al A	[object Object]	31	Male
Russia/Kipen-RII6907V/2020						GR	1.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Kipen	WHO National Influenza Centre Russian Federation	B.1.1.162	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-04-19	Andrey Komissarov et al B (https://dx.doi.org/10.1101/2020.07.14.20150979)	[object Object]	46	Female
Russia/CRIE168693/2020						GR	1.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2020-03-31	Speranskaya AS et al	[object Object]	48	Female
Georgia/Tb-RNGS001/2021						GR	2.00	20B	Asia	Georgia	Asia	Tbilisi	Human	Asia	Department for Virology, Molecular Biology and Genome Research, R. G. Lugar Center for Public Health Research, National Center for Disease Control and Public Health (NCDC) of Georgia.	B.1.1	Asia	Asia	Department for Virology, Molecular Biology and Genome Research, R. G. Lugar Center for Public Health Research, National Center for Disease Control and Public Health (NCDC) of Georgia.		2020-11-14	Giorgi Tomashvili et al	[object Object]		Male
Georgia/Tb-RNGS003/2021						GR	2.00	20B	Asia	Georgia	Asia	Tbilisi	Human	Asia	Department for Virology, Molecular Biology and Genome Research, R. G. Lugar Center for Public Health Research, National Center for Disease Control and Public Health (NCDC) of Georgia.	B.1.1	Asia	Asia	Department for Virology, Molecular Biology and Genome Research, R. G. Lugar Center for Public Health Research, National Center for Disease Control and Public Health (NCDC) of Georgia.		2020-10-10	Meri Pantsulaia et al	[object Object]		Male
India/MH-ACTREC-305/2020						GR	1.00	20B	Asia	India	Asia	Maharashtra	Human	Asia	Hematopathology Laboratory, ACTREC, TMC	B.1.1.306	Asia	Asia	Hematopathology Laboratory, ACTREC, TMC		2020-07-15	Hematopathology Laboratory et al	[object Object]	26	Male
Zambia/ZMB-24503/2020						GR	1.00	20B	Africa	Zambia	Africa	Copperbelt	Human	Africa	University of Zambia, School of Veterinary Medicine	AE.1	Africa	Africa	UNZAVET and PATH		2020-06-04	Mulenga Mwenda-Chimfwembe et al	[object Object]	27	Male
Bahrain/340864186/2020						GR	1.00	20B	Asia	Bahrain	Asia	Bahrain	Human	Asia	Communicable Disease Laboratory, Public Health Directorate	AE.2	Asia	Asia	Communicable Disease Laboratory, Public Health Directorate		2020-10-14	AlTaif et al	[object Object]		
Bahrain/920457301_S8/2020						GR	1.00	20B	Asia	Bahrain	Asia	Bahrain	Human	Asia	Communicable Disease Laboratory, Public Health Directorate	AE.2	Asia	Asia	Communicable Disease Laboratory, Public Health Directorate		2020-10-14	AlAbbas et al	[object Object]		
India/MH-ACTREC-362/2020						GR	2.00	20B	Asia	India	Asia	Maharashtra	Human	Asia	Hematopathology Laboratory, ACTREC, TMC	B.1.1.306	Asia	Asia	Hematopathology Laboratory, ACTREC, TMC		2020-07-23	Hematopathology Laboratory et al	[object Object]	54	Male
Bahrain/250182770_S11_L001/2020						GR	1.00	20B	Asia	Bahrain	Asia	Bahrain	Human	Asia	Communicable Disease Laboratory, Public Health Directorate	AE.6	Asia	Asia	Communicable Disease Laboratory, Public Health Directorate		2020-11-21	Alwasti et al	[object Object]		
Bahrain/341063898_S19_L001/2020						GR	1.00	20B	Asia	Bahrain	Asia	Bahrain	Human	Asia	Communicable Disease Laboratory, Public Health Directorate	AE.6	Asia	Asia	Communicable Disease Laboratory, Public Health Directorate		2020-11-12	Alwasti et al	[object Object]		
NorthMacedonia/9360/2020						GR	1.00	20B	North Macedonia	North Macedonia	North Macedonia	Southwestern Region	Human	Ohrid	General Hospital - Ohrid	B.1.1	Europe	Europe	Research Center for Genetic Engineering and Biotechnology "Georgi D. Efremov” , Macedonian Academy of Sciences and Arts		2020-08-05	RCGEB - MASA et al	[object Object]	75	Male
Greece/16034_HPI/2020						GR	1.00	20B	Greece	Greece	Greece	Central Greece	Human	Livadeia	Hellenic Pasteur Institute, Public Health Laboratories	B.1.1	Europe	Europe	Hellenic Pasteur Institute, National Influenza Reference laboratory of Southern Greece & Unit of Bioinformatics and Applied Genomics		2020-04-24	Vasiliki Pogka et al	[object Object]	79	Female
Japan/PG-10308/2020						GR	1.00	20B	Asia	Japan	Asia	Japan	Human	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases	B.1.1.214	Asia	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases		2020-10-19	Tsuyoshi Sekizuka et al B	[object Object]		
Japan/PG-31345/2021						GR	2.00	20B	Asia	Japan	Asia	Japan	Human	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases	B.1.1.214	Asia	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases		2021-02-03	Tsuyoshi Sekizuka et al B	[object Object]		
Japan/PG-26574/2021						GR	1.00	20B	Asia	Japan	Asia	Japan	Human	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases	B.1.1.214	Asia	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases		2021-01-18	Tsuyoshi Sekizuka et al B	[object Object]		
Japan/PG-15656/2020						GR	1.00	20B	Asia	Japan	Asia	Japan	Human	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases	B.1.1.214	Asia	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases		2020-10-02	Tsuyoshi Sekizuka et al B	[object Object]		
Japan/PG-27582/2021						GR	2.00	20B	Asia	Japan	Asia	Fukuoka	Human	Asia	Fukuoka Institute of Health and Environmental Sciences	B.1.1.214	Asia	Asia	Fukuoka Institute of Health and Environmental Sciences		2021-02-06	Takayuki Kobayashi et al	[object Object]		
Japan/YCH0124/2021						GR	1.00	20B	Asia	Japan	Asia	Yamanashi	Human	Asia	Genome Analysis Center, Yamanashi Central Hospital	B.1.1.214	Asia	Asia	Genome Analysis Center, Yamanashi Central Hospital		2021-02-07	Yosuke Hirotsu et al	[object Object]	86	Female
Russia/SMO-RII-MH16117S/2021						GR	1.00	20B	Russia	Russia	Smolensk Region	Smolensk Region	Human	Smolensk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	60	Male
Russia/OMS-ORINFI-7132S/2020						GR	1.00	20B	Russia	Russia	Omsk	Omsk	Human	Omsk	Omsk Research Institute of Natural Focal Infections	B.1.1.506	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-05-14	Artem Fadeev et al	[object Object]	63	Female
Russia/OMS-RII-MH2812S/2020						GR	1.00	20B	Russia	Russia	Omsk	Omsk	Human	Omsk	HELIX LLC	B.1.1.506	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-23	Andrey Komissarov et al A	[object Object]	47	Female
Russia/OMS-ORINFI-9815S/2020						GR	1.00	20B	Russia	Russia	Omsk	Omsk	Human	Omsk	Omsk Research Institute of Natural Focal Infections	B.1.1.506	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-05-21	Artem Fadeev et al	[object Object]	64	Male
Russia/KO-RII-MH2080S/2020						GR	1.00	20B	Russia	Russia	Komi	Komi	Human	Ukhta	HELIX LLC	B.1.1.506	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-21	Andrey Komissarov et al A	[object Object]	38	Female
Russia/RYA-RII-MH3360S/2020						GR	1.00	20B	Russia	Russia	Ryazan	Ryazan	Human	Ryazan	HELIX LLC	B.1.1.506	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	70	Male
Russia/VLA-RII-MH3422S/2020						GR	1.00	20B	Russia	Russia	Vladimir Region	Vladimir Region	Human	Vladimir	HELIX LLC	B.1.1.506	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	44	Female
Russia/MOW-RII-MH15829S/2021						GR	1.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.506	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	80	Male
Russia/Moscow_PMVL-14/2020						GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Pathogenic Microorganisms Variability Laboratory	B.1.1	Europe	Europe	Pathogenic Microorganisms Variability Laboratory		2020-05-25	Alexey Shchetinin et al	[object Object]	48	Male
Ireland/MN-NVRL-20IRL22531/2020						GR	1.00	20B	Ireland	Ireland	Ireland	Monaghan	Human		National Virus Reference Laboratory	B.1	Europe	Europe	National Virus Reference Laboratory		2020-05-25	Michael Carr et al	[object Object]		Male
Gambia/3115G/2021						GR	1.00	20B	Africa	Gambia	Africa	Kombo	Human	Africa	MRCG at LSHTM Genomics lab	B.1.1	Africa	Africa	MRCG at LSHTM Genomics lab		2020-10-19	Abdul Karim sesay et al	[object Object]	88	Male
Senegal/SN-MBO-201666/2020		0.01	0.01	0.04	0.02	O	5.00	20B	Africa	Senegal	Africa	Dakar	Human	Africa	Iressef Genomics lab	B.1.1.420	Africa	Africa	L'institut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF)		2020-12-30	Souleymane MBOUP et al	[object Object]	74	Male
Senegal/SN-IR6-002324/2020		0.01	0.01	0.04	0.02	GR	3.00	20B	Africa	Senegal	Africa	Dakar	Human	Africa	Institute for Health Research, Epidemiological Surveillance and Training (IRESSEF)	B.1.1.420	Africa	Africa	Abbott Laboratories		2020-12-31	Souleymane Mboup et al	[object Object]	70	Female
Philippines/PH-RITM-0028/2020						GR	1.00	20B	Asia	Philippines	Asia	Calabarzon	Human	Asia	Batangas City Health Office	B.1.1.63	Asia	Asia	Research Institute for Tropical Medicine		2020-09-26	Hannah Leah Morito et al	[object Object]	34	Female
Philippines/PH-PGC-00394/2020						GR	1.00	20B	Asia	Philippines	Asia	Manila	Human	Asia	South Super Highway Molecular Diagnostic Laboratory	B.1.1.63	Asia	Asia	Philippine Genome Center		2020-12-05	Francis A. Tablizo et al	[object Object]	30	Male
Iran/Q0275/2021		0.01			0.01	GR	4.00	20B	Asia	Iran	Asia	Arak	Human	Asia	COVID-19 National Reference Laboratory, Pasteur Institute of Iran	B.1.1.413	Asia	Asia	Genetics Research Center, University of Social Welfare and Rehabilitation Sciences		2021-02-20	Zohreh Fattahi et al	[object Object]	35	Female
Sweden/20-09852/2020		0.02	0.01	0.01	0.03	GR	4.00	20B	Sweden	Sweden	Sweden	Halland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1	Europe	Europe	The Public Health Agency of Sweden		2020-10-19	Maximilian Riess et al	[object Object]	61	Female
Russia/MOW-RII-MH15896/2021		0.01			0.01	GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Pathogenic Microorganisms Variability Laboratory	B.1.1.220	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-19	Andrey Komissarov et al A	[object Object]	64	Female
Russia/TVE-RII-MH2860S/2020		0.01			0.01	GR	2.00	20B	Russia	Russia	Tver	Tver	Human	Torzhok	HELIX LLC	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-25	Andrey Komissarov et al A	[object Object]	34	Female
Russia/SPE-RII-MH14659S/2021		0.01			0.01	GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-11	Andrey Komissarov et al A	[object Object]	30	Female
Russia/IVA-RII-MH11884S/2020		0.01			0.01	GR	2.00	20B	Russia	Russia	Ivanovo	Ivanovo	Human	Kineshma	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-15	Andrey Komissarov et al A	[object Object]	61	Female
env/Beijing/IVDC-03-06/2020						GR	1.00	20B	Asia	China	Asia	Beijing	Environment	Asia	National Institute for Viral Disease Control and Prevention, China CDC	B.1.1	Asia	Asia	National Institute for Viral Disease Control and Prevention, China CDC		2020-06-11	Xiang Zhao et al	[object Object]		
Georgia/Tb-171516/2020						GR	3.00	20B	Asia	Georgia	Asia	Tbilisi	Human	Asia	Department for Virology, Molecular Biology and Genome Research, R. G. Lugar Center for Public Health Research, National Center for Disease Control and Public Health (NCDC) of Georgia.	B.1.1.10	Asia	Asia	Department for Virology, Molecular Biology and Genome Research, R. G. Lugar Center for Public Health Research, National Center for Disease Control and Public Health (NCDC) of Georgia.		2020-12-21	Giorgi Tomashvili et al	[object Object]		Male
Russia/STA-RII-MH3374S/2020						GR	1.00	20B	Russia	Russia	Stavropol	Stavropol	Human	Yessentuki	HELIX LLC	B.1.1.220	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	23	Female
Russia/SVE-RII-MH15294S/2021		0.01	0.06	0.07	0.05	GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Verkhnyaya Pyshma	UMMC-Health	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-20	Andrey Komissarov et al A	[object Object]	51	Female
Russia/SVE-RII-MH15295S/2021		0.01	0.06	0.07	0.05	GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Verkhnyaya Pyshma	UMMC-Health	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-20	Andrey Komissarov et al A	[object Object]	54	Male
Russia/AMU-RII-MH18287S/2021						GR	3.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Poyarkovo	Amur Region Mikhailovsky Hospital	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-23	Andrey Komissarov et al A	[object Object]	60	Female
Russia/SPE-RII-32044S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-07	Andrey Komissarov et al A	[object Object]	64	Female
Russia/SPE-RII-MH17269S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-03	Andrey Komissarov et al A	[object Object]	55	Male
Russia/AMU-RII-MH10166S/2020						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Blagoveshchensk	WHO National Influenza Centre Russian Federation	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-23	Andrey Komissarov et al A	[object Object]	44	Female
Russia/SPE-RII-MH14694S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-14	Andrey Komissarov et al A	[object Object]	53	Male
Russia/AMU-RII-MH18353S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Blagoveshchensk	Amur Regional Infectious Diseases Hospital	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-30	Andrey Komissarov et al A	[object Object]	16	Female
Russia/AMU-RII-MH18342S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Novokiyevsky Uval	Mazanovsky Hospital	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-27	Andrey Komissarov et al A	[object Object]	67	Female
Russia/AMU-RII-MH18293S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Novokiyevsky Uval	Mazanovsky Hospital	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-23	Andrey Komissarov et al A	[object Object]	79	Female
Russia/AMU-RII-MH18291S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Novokiyevsky Uval	Mazanovsky Hospital	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-23	Andrey Komissarov et al A	[object Object]	79	Female
Russia/AMU-RII-MH18311S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Novokiyevsky Uval	Mazanovsky Hospital	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-25	Andrey Komissarov et al A	[object Object]	72	Female
Russia/AMU-RII-MH18317S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Novokiyevsky Uval	Mazanovsky Hospital	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-25	Andrey Komissarov et al A	[object Object]	65	Male
Russia/AMU-RII-MH18312S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Novokiyevsky Uval	Mazanovsky Hospital	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-25	Andrey Komissarov et al A	[object Object]	59	Female
Russia/MOW-CRIE-L188D0049b/2021		0.01	0.01		0.03	GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.141	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-07	Samojlov A.E. et al	[object Object]		Male
Russia/PRI-RII-MH750S/2020		0.01	0.01		0.03	GR	3.00	20B	Russia	Russia	Primorsky	Primorsky	Human	Vladivostok	WHO National Influenza Centre Russian Federation	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-08-08	Andrey Komissarov et al A	[object Object]	60	Male
Russia/SPE-RII-27359S/2021		0.01	0.01		0.03	GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	40	Male
Russia/BEL-RII-MH17555S/2021		0.01	0.01		0.03	GR	3.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-20	Andrey Komissarov et al A	[object Object]	79	
Russia/MOW_1410/2020		0.01	0.01		0.03	GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Collection of WHO National Influenza Center, N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation	B.1.1.141	Europe	Europe	Laboratory of genome analysis, N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation		2020-12-02	Olga Voronina et al	[object Object]	62	Female
Russia/SPE-RII-MH14621S/2021		0.01	0.01		0.03	GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-14	Andrey Komissarov et al A	[object Object]	26	Male
Russia/MOW-RII-MH16144S/2021		0.01	0.01		0.03	GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-11	Andrey Komissarov et al A	[object Object]	36	Female
Russia/TVE-CRIE-L188D0216b/2021		0.01	0.01		0.03	GR	3.00	20B	Russia	Russia	Tver	Tver	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.141	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-05	Samojlov A.E. et al	[object Object]	64	Male
Russia/KR-RII-12754S/2020		0.01	0.01		0.03	GR	4.00	20B	Russia	Russia	Karelia	Karelia	Human	Podporozhye	WHO National Influenza Centre Russian Federation	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-16	Andrey Komissarov et al A	[object Object]	56	Female
Russia/YAR-CRIE-L188D0013b/2021		0.01	0.01		0.03	GR	4.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-03	Samojlov A.E. et al	[object Object]	80	Female
Russia/YAR-CRIE-L188K0005b/2021		0.01	0.01		0.03	GR	5.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-06	Samojlov A.E. et al	[object Object]	79	Male
Russia/YAR-CRIE-L188D0016b/2021						GR	4.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-07	Samojlov A.E. et al	[object Object]	69	Female
Russia/YAR-CRIE-L188D0017b/2021						GR	4.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-31	Samojlov A.E. et al	[object Object]	81	Male
Russia/SPE-RII-MH15774S/2021		0.01	0.01		0.03	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-27	Andrey Komissarov et al A	[object Object]	33	Male
Russia/BEL-RII-MH17443S/2021		0.05	0.35	0.01	0.27	GR	5.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-09	Andrey Komissarov et al A	[object Object]	79	
Russia/YAR-RII-MH16231S/2021		0.01	0.01		0.03	GR	4.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human	Yaroslavl	HELIX LLC	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-04	Andrey Komissarov et al A	[object Object]	49	Male
Russia/KR-RII-MH16435S/2021		0.01	0.01		0.03	GR	4.00	20B	Russia	Russia	Karelia	Karelia	Human		Republican Infectious Diseases Hospital	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-22	Andrey Komissarov et al A	[object Object]	61	Male
Russia/KR-RII-MH16450S/2021		0.01	0.01		0.03	GR	4.00	20B	Russia	Russia	Karelia	Karelia	Human		Republican Infectious Diseases Hospital	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-22	Andrey Komissarov et al A	[object Object]	61	Male
Russia/BEL-RII-MH17578S/2021		0.01	0.01		0.03	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-22	Andrey Komissarov et al A	[object Object]	68	
Russia/KR-RII-MH16415S/2021		0.01	0.01		0.03	GR	4.00	20B	Russia	Russia	Karelia	Karelia	Human		Republican Infectious Diseases Hospital	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-24	Andrey Komissarov et al A	[object Object]	52	Female
Russia/SPE-RII-MH16551S/2021		0.01	0.01		0.03	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-27	Andrey Komissarov et al A	[object Object]	84	Male
Russia/SPE-RII-MH18101S/2021		0.01	0.01		0.03	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-16	Andrey Komissarov et al A	[object Object]	33	Male
Russia/SPE-RII-MH18151S/2021		0.01	0.01		0.03	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	62	Female
Russia/SPE-RII-MH18023S/2021		0.01	0.01		0.03	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-12	Andrey Komissarov et al A	[object Object]	71	Male
CostaRica/INC-0230/2021						GR	1.00	20B	North America	Costa Rica	North America	Guanacaste	Human	North America	HOSPITAL MEXICO	B.1.1.389	North America	North America	Inciensa, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud		2021-01-12	Francisco Duarte et al	[object Object]	28	Female
CostaRica/HNN-0344/2020						GR	1.00	20B	North America	Costa Rica	North America	San Jose	Human	North America	Inciensa, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud	B.1.1.389	North America	North America	Inciensa, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud		2020-12-21	Cristian Peréz-Corrales et al	[object Object]	0	Female
CostaRica/HNN-0378/2020						GR	2.00	20B	North America	Costa Rica	North America	Limon	Human	North America	Inciensa, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud	B.1.1.389	North America	North America	Inciensa, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud		2020-12-30	Cristian Peréz-Corrales et al	[object Object]	45	Female
Russia/SPE-RII-33740S/2021	1.00	0.01	0.01	0.02	0.03	GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-07	Andrey Komissarov et al A	[object Object]	68	Male
Russia/SPE-RII-31441S/2021	1.00	0.01	0.01	0.02	0.03	GR	6.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-07	Andrey Komissarov et al A	[object Object]	39	Male
Russia/SPE-RII-MH18181S/2021	1.00	0.01	0.01	0.02	0.03	GR	6.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	34	Female
Russia/SPE-RII-34490S/2021	1.00	0.01	0.01	0.02	0.03	GR	7.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-16	Andrey Komissarov et al A	[object Object]	52	Female
Russia/SPE-RII-33883S/2021	1.00	0.01	0.01	0.02	0.03	GR	6.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-10	Andrey Komissarov et al A	[object Object]	52	Female
Brazil/RN-FIOCRUZ-34127/2020						GR	1.00	20B	South America	Brazil	South America	Rio Grande do Norte	Human	South America	Laboratório de Biologia Molecular de Doenças Infecciosas e do Câncer (LADIC - UFRN)	B.1.1	South America	South America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-10-01	Paola Resende et al	[object Object]		Female
Russia/TA-KFU_28/2020						GR	1.00	20B	Russia	Russia	Tatarstan	Tatarstan	Human	Kazan	Kazan Federal University, Academic Consortium	B.1.1	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-07-23	Vladislav Babenko et al	[object Object]	48	Male
Russia/SAR-RARI-3083/2020						GR	2.00	20B	Russia	Russia	Saratov	Saratov	Human		Mikrobiologie, RARI	B.1.1	Europe	Europe	Mikrobiologie, RARI		2020-07-30	Krasnov et al	[object Object]		
Poland/Masovia-4249/2020						GR	1.00	20B	Poland	Poland	Poland	Masovia	Human		Laboratory Diagnostics and Clinical Immunology of Developmental Age, Medical University of Warsaw	B.1.1	Europe	Europe	genXone SA, Research & Development Laboratory; The Faculty of Mathematics, Informatics and Mechanics of the University of Warsaw		2020-05-26	Maciej Sykulski et al	[object Object]		
Ukraine/ChVir23535_79/2021						GR	2.00	20B	Ukraine	Ukraine	Ukraine	Ukraine	Human		Public Health Center of Ukraine	B.1.1.243	Europe	Europe	Charité Universitätsmedizin Berlin, Institute of Virology		2021-01-09	Victor M Corman et al	[object Object]		
Russia/NGR-RII-MH15734S/2021						GR	2.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Borovichi (Novgorod)	HELIX LLC	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-26	Andrey Komissarov et al A	[object Object]	5	Male
Russia/RYA-CRIE-L188A1671b/2021						GR	2.00	20B	Russia	Russia	Ryazan	Ryazan	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-28	Samojlov A.E. et al	[object Object]		Female
Russia/PSK-RII-MH2017S/2020		0.01	0.01	0.01	0.02	GR	2.00	20B	Russia	Russia	Pskov Oblast	Pskov Oblast	Human	Velikiye Luki	HELIX LLC	B.1.1.407	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-23	Andrey Komissarov et al A	[object Object]	47	Male
Russia/PER-RII-MH1647S/2020						GR	1.00	20B	Russia	Russia	Perm Krai	Perm Krai	Human	Perm	HELIX LLC	B.1.1.452	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-10	Andrey Komissarov et al A	[object Object]	29	Male
Senegal/45436/2020						GR	1.00	20B	Africa	Senegal	Africa	Dakar	Human	Africa	Institut Pasteur de Dakar	B.1.1	Africa	Africa	Institut Pasteur de Dakar		2020-05-27	Ndongo Dia et al	[object Object]	63	Male
Gambia/12759/2021						GR	1.00	20B	Africa	Gambia	Africa	Kombo	Human	Africa	MRCG at LSHTM Genomics lab	B.1.1	Africa	Africa	MRCG at LSHTM Genomics lab		2021-02-15	Abdul Karim sesay et al	[object Object]	58	Female
Russia/Sverdlovsk-86704/2020						GR	1.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-30	Sergey A. Bodnev et al	[object Object]	60	Female
Russia/STA-RII-MH2782S/2020						GR	2.00	20B	Russia	Russia	Stavropol	Stavropol	Human	Stavropol	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-23	Andrey Komissarov et al A	[object Object]	20	Female
Russia/AMU-RII-MH18261S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Zavitinsk	Zavitinsk Hospital	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-18	Andrey Komissarov et al A	[object Object]	48	Female
Russia/CRIE155506/2020						GR	1.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2020-03-30	Speranskaya AS et al	[object Object]	57	Male
Russia/KO-RII-MH2755S/2020						GR	1.00	20B	Russia	Russia	Komi	Komi	Human	Sosnogorsk	HELIX LLC	B.1.1.129	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-17	Andrey Komissarov et al A	[object Object]	59	Female
Russia/SPE-RII-34660S/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1.1.129	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-18	Andrey Komissarov et al A	[object Object]	45	Female
Russia/SPE-RII-21358V/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1.1.129	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-06-05	Andrey Komissarov et al A	[object Object]		Female
Russia/SPE-RII-22266V/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1.1.129	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-06-08	Andrey Komissarov et al A	[object Object]	46	Male
Ghana/WACCBIP-GS462/2020						GR	2.00	20B	Africa	Ghana	Africa	Western Region	Human	Africa	West African Centre for Cell Biology of Infectious Pathogen, University of Ghana, Legon	B.1.1	Africa	Africa	WACCBIP, University of Ghana, Volta Road, Legon, Accra		2020-07-08	Collins M. Morang'a et al	[object Object]	36	Female
Russia/BEL-RII-MH17670S/2021						GR	2.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.41	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-29	Andrey Komissarov et al A	[object Object]	43	
Russia/BEL-RII-MH17705S/2021						GR	2.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.41	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-07	Andrey Komissarov et al A	[object Object]	63	
Henan/HN07/2020						GR	1.00	20B	Asia	China	Asia	Henan	Human	Asia	Department of Infectious Disease Prevention and Control, Henan Provincial Center for Disease Control and Prevention	B.1.1	Asia	Asia	Department of Infectious Disease Prevention and Control, Henan Provincial Center for Disease Control and Prevention		2020-04-02	Li et al	[object Object]		
Sweden/20-14071/2020						GR	1.00	20B	Sweden	Sweden	Sweden	Jamtland	Human		Follinge Halsocentral	B.1.1.261	Europe	Europe	The Public Health Agency of Sweden		2020-04-28	Oskar Karlsson Lindsjo et al	[object Object]	68	Male
Sweden/20-52079/2020						GR	1.00	20B	Sweden	Sweden	Sweden	Ostergotland	Human		Klinsisk mikrobiologi Linkoping	B.1.1.261	Europe	Europe	The Public Health Agency of Sweden		2020-06-15	Oskar Karlsson Lindsjo et al	[object Object]	29	Male
Sweden/20-08931/2020						GR	1.00	20B	Sweden	Sweden	Sweden	Ostergotland	Human		Universitetssjukhuset i Linkoping	B.1.1.261	Europe	Europe	The Public Health Agency of Sweden		2020-07-11	Anna-Malin Linde et al	[object Object]	41	Female
Russia/STA-RII-MH2784S/2020						GR	1.00	20B	Russia	Russia	Stavropol	Stavropol	Human	Stavropol	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-19	Andrey Komissarov et al A	[object Object]	33	Female
Russia/MO-RII-MH3571S/2020						GR	1.00	20B	Russia	Russia	Republic of Mordovia	Republic of Mordovia	Human	Saransk	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-13	Andrey Komissarov et al A	[object Object]	34	Female
Armenia/UW-ARM15/2020		0.07	0.01		0.02	GR	3.00	20B	Asia	Armenia	Asia	Armenia	Human	Asia	National Center of Disease Control and Prevention of the Republic of Armenia	B.1.1.10	Asia	Asia	UW Virology Lab		2020-08-03	Pavitra Roychoudhury et al	[object Object]		
Armenia/UW-ARM35/2020		0.07	0.01		0.02	GR	2.00	20B	Asia	Armenia	Asia	Armenia	Human	Asia	National Center of Disease Control and Prevention of the Republic of Armenia	B.1.1	Asia	Asia	UW Virology Lab		2020-08-28	Pavitra Roychoudhury et al	[object Object]		
Armenia/UW-ARM30/2020		0.07	0.01		0.02	GR	2.00	20B	Asia	Armenia	Asia	Armenia	Human	Asia	National Center of Disease Control and Prevention of the Republic of Armenia	B.1.1	Asia	Asia	UW Virology Lab		2020-08-20	Pavitra Roychoudhury et al	[object Object]		
Latvia/034/2020						GR	1.00	20B	Latvia	Latvia	Latvia	Riga	Human		Centrala laboratorija	B.1.1	Europe	Europe	Latvian Biomedical Research and Study Centre		2020-05-08	Ivars Silamiķelis et al	[object Object]		
Russia/ARK-CRIE-7602095950/2020						GR	1.00	20B	Russia	Russia	Arkhangelsk Region	Arkhangelsk Region	Human		Laboratory of Virology of Federal Budget Health Care Institution "Center of Hygiene and Epidemiology in Arkhangelsk region"	B.1.1.435	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2020-12-26	Samoilov AE et al	[object Object]	62	Male
Russia/KOS-CRIE-L188D0023b/2021						GR	1.00	20B	Russia	Russia	Kostroma Region	Kostroma Region	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.435	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-04	Samojlov A.E. et al	[object Object]	81	Female
Russia/Buryatia-87106/2020						GR	1.00	20B	Russia	Russia	Buryatia	Buryatia	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-30	Sergey A. Bodnev et al	[object Object]	16	Male
Russia/Buryatia-87104/2020						GR	1.00	20B	Russia	Russia	Buryatia	Buryatia	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-30	Oleg V. Pyankov et al	[object Object]	66	Female
Russia/NGR-RII-MH2019S/2020						GR	2.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Veliky Novgorod	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-26	Andrey Komissarov et al A	[object Object]	48	Female
Russia/KO-RII-MH3432S/2020						GR	2.00	20B	Russia	Russia	Komi	Komi	Human	Sosnogorsk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-06	Andrey Komissarov et al A	[object Object]	35	Male
Ghana/WACCBIP-GS29/2020						GR	1.00	20B	Africa	Ghana	Africa	Ghana	Human	Africa	Department of Biochemistry, Cell and Molecular Biology, West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana	B.1.1	Africa	Africa	Department of Biochemistry, Cell and Molecular Biology, West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana		2020-07-21	Ngoi et al	[object Object]		
Russia/PRI-RII-MH755S/2020						GR	1.00	20B	Russia	Russia	Primorsky	Primorsky	Human	Vladivostok	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-08-09	Andrey Komissarov et al A	[object Object]		Male
Tunisia/11-MHT_10/2020						GR	1.00	20B	Africa	Tunisia	Africa	Tunis	Human	Africa	Department of Virology, Principal Military Hospital of Instruction of Tunis	B.1.1	Africa	Africa	Bundeswehr Institute of Microbiology		2020-09-13	Susann Handrick et al	[object Object]	83	Female
Russia/LEN-RII-MH2021S/2020						GR	1.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Vsevolozhsk	HELIX LLC	B.1.1.373	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-24	Andrey Komissarov et al A	[object Object]	41	Female
Russia/SVE-RII-MH16170S/2021						GR	1.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Nizhny Tagil	HELIX LLC	B.1.1.373	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	26	Female
Russia/SPE-RII-29032S/2021						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.373	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-11	Andrey Komissarov et al A	[object Object]	58	Female
Russia/PSK-RII-MH6324S/2020						GR	1.00	20B	Russia	Russia	Pskov Oblast	Pskov Oblast	Human	Velikiye Luki	HELIX LLC	B.1.1.373	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-12	Andrey Komissarov et al A	[object Object]	55	Female
Russia/LEN-RII-MH5740S/2020						GR	1.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Gatchina	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-09	Andrey Komissarov et al A	[object Object]	25	Male
Russia/AST-RII-MH4496S/2020						GR	1.00	20B	Russia	Russia	Astrakhan Region	Astrakhan Region	Human	Kharabali	Pathogenic Microorganisms Variability Laboratory	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-01	Andrey Komissarov et al A	[object Object]	10	Male
Russia/TA-KFU_29/2020						GR	1.00	20B	Russia	Russia	Tatarstan	Tatarstan	Human	Kazan	Kazan Federal University, Academic Consortium	B.1.1	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-07-27	Vladislav Babenko et al	[object Object]	46	Male
Norway/4633/2020						GR	2.00	20B	Norway	Norway	Norway	Vestland	Human		Ostfold Hospital Trust - Kalnes, Centre for Laboratory Medicine, Section for gene technology and infection serology	B.1.1.37	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2020-10-18	Kathrine Stene-Johansen et al	[object Object]		
Russia/OMS-ORINFI-3401S/2020						GR	1.00	20B	Russia	Russia	Omsk	Omsk	Human	Cherlak	Omsk Research Institute of Natural Focal Infections	B.1.1.37	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-04-20	Artem Fadeev et al	[object Object]	48	Male
Russia/SVE-RII-MH15256S/2021						GR	1.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-20	Andrey Komissarov et al A	[object Object]	61	Male
Russia/STA-RII-MH16096S/2021						GR	2.00	20B	Russia	Russia	Stavropol	Stavropol	Human	Zelenokumsk	HELIX LLC	B.1.1.274	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-19	Andrey Komissarov et al A	[object Object]	56	Female
Crimea/RII-MH3437S/2020						GR	2.00	20B	Ukraine	Ukraine	Ukraine	Crimea	Human	Simpheropol	HELIX LLC	B.1.1.274	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	56	Male
Russia/BEL-RII-MH17472S/2021						GR	2.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.274	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-12	Andrey Komissarov et al A	[object Object]	4	
Russia/BEL-RII-MH17417S/2021						GR	2.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.274	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-07	Andrey Komissarov et al A	[object Object]	60	
Russia/BEL-RII-MH17486S/2021						GR	2.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.274	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-13	Andrey Komissarov et al A	[object Object]	67	
Russia/BEL-RII-MH17471S/2021						GR	2.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.274	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-12	Andrey Komissarov et al A	[object Object]	36	
Russia/ALT-RII-MH2764S/2020						GR	2.00	20B	Russia	Russia	Altai Krai	Altai Krai	Human	Barnaul	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-25	Andrey Komissarov et al A	[object Object]	32	Female
Russia/KRS-RII-MH16212S/2021						GR	3.00	20B	Russia	Russia	Krasnoyarsk	Krasnoyarsk	Human	Zheleznogorsk	HELIX LLC	B.1.1.10	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-18	Andrey Komissarov et al A	[object Object]	63	Male
Russia/SVE-RII-MH15806S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Revda	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	40	Female
Russia/PSK-RII-MH13295S/2020						GR	4.00	20B	Russia	Russia	Pskov Oblast	Pskov Oblast	Human	Velikiye Luki	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-23	Andrey Komissarov et al A	[object Object]	52	Male
Russia/SPE-RII-MH14725S/2021		0.01	0.06	0.07	0.05	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.135	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-21	Andrey Komissarov et al A	[object Object]	42	Male
Russia/SVE-RII-MH15815S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Kamyshlov	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	61	Female
Russia/OMS-ORINFI-MH10289M/2020						GR	3.00	20B	Russia	Russia	Omsk	Omsk	Human	Tara	Omsk Research Institute of Natural Focal Infections	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-12	Andrey Komissarov et al A	[object Object]	65	Female
Russia/IVA-RII-MH9268S/2020						GR	2.00	20B	Russia	Russia	Ivanovo	Ivanovo	Human	Ivanovo	HELIX LLC	B.1.1.396	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-14	Andrey Komissarov et al A	[object Object]	47	Female
Russia/KC-RII-MH2751S/2020						GR	2.00	20B	Russia	Russia	Karachay-Cherkess	Karachay-Cherkess	Human	Zelenchukskaya	HELIX LLC	B.1.1.396	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-21	Andrey Komissarov et al A	[object Object]	41	Female
Russia/SPE-RII-30850S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.396	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-31	Andrey Komissarov et al A	[object Object]	39	Female
Russia/NVS-RII-MH1137S/2020						GR	2.00	20B	Russia	Russia	Novosibirsk	Novosibirsk	Human	Novosibirsk	WHO National Influenza Centre Russian Federation	B.1.1.396	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-07-30	Andrey Komissarov et al A	[object Object]	58	Female
Russia/NVS-RII-MH1159V/2020						GR	2.00	20B	Russia	Russia	Novosibirsk	Novosibirsk	Human	Novosibirsk	WHO National Influenza Centre Russian Federation	B.1.1.396	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-08-04	Andrey Komissarov et al A	[object Object]	72	Male
Russia/MOW-RII-MH16072S/2021						GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-28	Andrey Komissarov et al A	[object Object]	47	Male
Russia/RYA-CRIE-L188S0154bh/2021						GR	3.00	20B	Russia	Russia	Ryazan	Ryazan	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.451	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-25	Samoilov A.E. et al	[object Object]	35	Female
Russia/SVE-RII-MH16258S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-25	Andrey Komissarov et al A	[object Object]	89	Female
Russia/SVE-RII-MH15805S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Kamyshlov	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	60	Female
Russia/SVE-RII-MH16249S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Nizhny Tagil	HELIX LLC	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	65	Male
Russia/SVE-RII-MH15231S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Verkhnyaya Pyshma	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-18	Andrey Komissarov et al A	[object Object]	36	Female
Russia/SVE-RII-MH16078S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Nizhny Tagil	HELIX LLC	B.1.1.396	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-10	Andrey Komissarov et al A	[object Object]	9	Male
Russia/SVE-RII-MH16206S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Nizhny Tagil	HELIX LLC	B.1.1.396	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	8	Female
Mauritius/N4272/2021		0.04	0.34		0.24	GR	5.00	20B	Africa	Mauritius	Africa	Plaine-Wilhems	Human	Africa	Central Health Laboratory	B.1.1	Africa	Africa	National Institute for Communicable Diseases of the National Health Laboratory Service		2021-03-11	Ramuth M et al	[object Object]	66	Female
Mauritius/N4267/2021		0.04	0.34		0.24	GR	5.00	20B	Africa	Mauritius	Africa	Plaine-Wilhems	Human	Africa	Central Health Laboratory	B.1.1	Africa	Africa	National Institute for Communicable Diseases of the National Health Laboratory Service		2021-03-10	Ramuth M et al	[object Object]	57	Female
Mauritius/N4273/2021		0.04	0.34		0.24	GR	5.00	20B	Africa	Mauritius	Africa	Plaine-Wilhems	Human	Africa	Central Health Laboratory	B.1.1	Africa	Africa	National Institute for Communicable Diseases of the National Health Laboratory Service		2021-03-11	Ramuth M et al	[object Object]	29	Male
Antigua/52171/2021		0.04	0.34		0.24	GR	5.00	20B	South America	Antigua	South America	Antigua	Human	South America	The Caribbean Public Health Agency	B.1.1.318	South America	South America	Carrington Lab, Department of PreClinical Sciences, Faculty of Medical Sciences, The University of the West Indies		2021-01-26	Nikita S. D. Sahadeo et al	[object Object]		
Gabon/CERMEL-DD0590/2021		0.04	0.34		0.24	GR	5.00	20B	Africa	Gabon	Africa	Lambarene	Human	Africa	Centre de Recherches Médicales de Lambaréné (CERMEL)	B.1.1.318	Africa	Africa	Centre de Recherches Médicales de Lambaréné (CERMEL)		2021-05-12	Gédéon Prince Manouana et al	[object Object]	20	Male
Belgium/AZDelta/12219-2121R/2021		0.04	0.34		0.24	GR	5.00	20B	Belgium	Belgium	Belgium	Kortrijk	Human	Menen	AZDelta	B.1.1.318	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-06-01	Geert Martens et al	[object Object]		
Italy/FVG-TS-36728676/2021		0.04	0.34		0.24	GR	6.00	20B	Italy	Italy	Italy	Friuli Venezia Giulia	Human	Trieste	SC (UCO) Igiene e Sanità Pubblica, ASUGI, Trieste	B.1.1.318	Europe	Europe	ARGO Laboratorio Genomica ed Epigenomica		2021-04-27	Licastro D et al	[object Object]	22	Male
Italy/FVG-TS-36728795/2021		0.04	0.34		0.24	GR	5.00	20B	Italy	Italy	Italy	Friuli Venezia Giulia	Human	Trieste	SC (UCO) Igiene e Sanità Pubblica, ASUGI, Trieste	B.1.1.318	Europe	Europe	ARGO Laboratorio Genomica ed Epigenomica		2021-04-27	Licastro D et al	[object Object]	22	Male
Greece/KEDY_11910/2021		0.04	0.34		0.24	GR	5.00	20B	Greece	Greece	Greece	Greece	Human		Central Public Health Lab, National Public Health Organization	B.1.1.318	Europe	Europe	Central Public Health Lab, National Public Health Organization		2021-05-23	Kyriaki Tryfinopoulou et al	[object Object]	8	Male
Greece/KEDY_11927/2021		0.04	0.34		0.24	GR	5.00	20B	Greece	Greece	Greece	Greece	Human		Central Public Health Lab, National Public Health Organization	B.1.1.7	Europe	Europe	Central Public Health Lab, National Public Health Organization		2021-05-23	Kyriaki Tryfinopoulou et al	[object Object]	20	Male
Greece/81101/2021		0.04	0.34		0.24	GR	5.00	20B	Greece	Greece	Greece	Epirus	Human		Clinical and Basic Functional Sciences, Department of Microbiology	B.1.1.318	Europe	Europe	Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)		2021-05-19	Emmanouil Athanasiadis et al	[object Object]		
Greece/81586/2021		0.04	0.34		0.24	GR	5.00	20B	Greece	Greece	Greece	Epirus	Human		Clinical and Basic Functional Sciences, Department of Microbiology	B.1.1.318	Europe	Europe	Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)		2021-05-19	Emmanouil Athanasiadis et al	[object Object]		
Greece/KEDY_11575/2021		0.04	0.34		0.24	GR	5.00	20B	Greece	Greece	Greece	Korinthia	Human		Central Public Health Lab, National Public Health Organization	B.1.1.318	Europe	Europe	Central Public Health Lab, National Public Health Organization		2021-05-20	Kyriaki Tryfinopoulou et al	[object Object]	56	Male
Greece/KEDY_11578/2021		0.04	0.34		0.24	GR	5.00	20B	Greece	Greece	Greece	Korinthia	Human		Central Public Health Lab, National Public Health Organization	B.1.1.318	Europe	Europe	Central Public Health Lab, National Public Health Organization		2021-05-20	Kyriaki Tryfinopoulou et al	[object Object]	17	Male
Japan/IC-1269/2021	1.00	0.11	0.35	0.01	0.28	GR	7.00	21E (Theta)	Asia	Philippines	Asia	Philippines	Human	Asia	SARS-CoV-2 testing team, National Institute of Infectious Diseases	P.3	Asia	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases		2021-05-13	Tsuyoshi Sekizuka et al B	[object Object]		
Chile/RM-26542/2021		0.04	0.34		0.24	GR	2.00	20B	South America	Chile	South America	Region Metropolitana de Santiago	Human	South America	Genetica Molecular and Subdepartamento de Virologia ISP Chile	P.2	South America	South America	Instituto de Salud Publica de Chile		2021-02-02	Javier Tognarelli et al	[object Object]	49	Male
Suriname/SR-97/2020		0.04	0.34		0.24	GR	2.00	20B	South America	Suriname	South America	Suriname	Human	South America	Central Laboratory, Bureau of Public Health (BOG) and Academic Hospital Paramaribo	P.2	South America	South America	Erasmus Medical Center		2020-12-13	Bas B Oude Munnink et al	[object Object]		
Brazil/SP-2431/2021		0.04	0.34		0.24	GR	2.00	20B	South America	Brazil	South America	São Paulo	Human	South America	Instituto Adolfo Lutz - Regional de Marilia	P.2	South America	South America	Instituto Adolfo Lutz, Interdiciplinary Procedures Center, Strategic Laboratory		2021-02-05	Claudio Tavares Sacchi et al	[object Object]	84	Female
Argentina/INEI099626/2021		0.04	0.34		0.24	GR	2.00	20B	South America	Brazil	South America	Brazil	Human	South America	Servicio Virosis Respiratorias-Departamento Virología-INEI	P.2	South America	South America	Instituto Nacional Enfermedades Infecciosas C.G.Malbran		2021-01-07	Baumeister E. et al	[object Object]	25	Male
Brazil/AM-FIOCRUZ-20142973ES/2020		0.04	0.34		0.24	GR	2.00	20B	South America	Brazil	South America	Amazonas BR	Human	South America	Laboratorio de Ecologia de Doencas Transmissiveis na Amazonia, Instituto Leonidas e Maria Deane - Fiocruz Amazonia	P.2	South America	South America	Laboratorio de Ecologia de Doencas Transmissiveis na Amazonia, Instituto Leonidas e Maria Deane - Fiocruz Amazonia		2020-12-10	Valdinete Nascimento et al	[object Object]	36	Female
Italy/SIC-CQRC-21049594/2021						O	6.00	20B	Italy	Italy	Italy	Sicily	Human	Palermo	CQRC_QUALITY CONTROL CHEMICAL BIOLOGICAL RISK_AOOR Villa Sofia Cervello Palermo	B.1.153	Europe	Europe	CQRC_QUALITY CONTROL CHEMICAL BIOLOGICAL RISK_AOOR Villa Sofia Cervello Palermo		2021-05-18	Di Gaudio et al	[object Object]	11	Male
Chile/RM-0263-04951853/2021	2.00	0.23	0.36	0.01	0.31	GR	9.00	20B	South America	Chile	South America	Region Metropolitana de Santiago	Human	South America	Clinica INDISA	P.1	South America	South America	"Facultad de Ciencias de la Vida, UNAB"		2021-04-29	"Claudio Meneses et al	[object Object]	39	Male
Bolivia/21739/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	South America	Bolivia	South America	Bolivia	Human	South America	Centro Nacional de Enfermidades Tropicales (CENETROP)	P.1	South America	South America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2021-03-25	Paola Resende et al	[object Object]	56	unkown
Paraguay/iics_12700/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	South America	Paraguay	South America	Central	Human	South America	IICS-UNA	P.1	South America	South America	IICS-UNA		2021-05-01	Magaly Martinez et al	[object Object]	47	Female
Norway/6128/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	Norway	Norway	Norway	Norway	Human		Furst Medical Laboratory	P.1	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-02-24	Kathrine Stene-Johansen et al	[object Object]		
FrenchGuiana/IPG2021460/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	France	France	France	French Guiana	Human	Matoury	CNR Institut Pasteur de la Guyane	P.1	Europe	Europe	Institut Pasteur de la Guyane		2021-05-21	Anne Lavergne et al	[object Object]	39	Female
Belgium/UZA-UA-CV2206864275/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	Belgium	Belgium	Belgium	Halle-Vilvoorde	Human	Halle	Platform BIS UZA/UAntwerpen	P.1	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-17	Marie Le Mercier et al	[object Object]	31	Male
Colombia/AMA-INS-VG-1112/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	South America	Colombia	South America	Departamento de Amazonas	Human	South America	Laboratorio de Salud Publica de Cauca	P.1	South America	South America	Instituto Nacional de Salud- Dirección de Investigación en Salud Pública		2021-02-02	Katherine Laiton-Donato et al	[object Object]	91	Male
Colombia/AMA-INS-VG-1166/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	South America	Colombia	South America	Departamento de Amazonas	Human	South America	CLINICA COLSANITAS CENTRAL DE REFERENCIA	P.4	South America	South America	Instituto Nacional de Salud- Dirección de Investigación en Salud Pública		2021-02-18	Katherine Laiton-Donato et al	[object Object]	54	Female
Chile/RM-0263-04949794/2021	2.00	0.23	0.36	0.01	0.31	GR	11.00	20J (Gamma, V3)	South America	Chile	South America	Region Metropolitana de Santiago	Human	South America	Clinica INDISA	P.1	South America	South America	"Facultad de Ciencias de la Vida, UNAB"		2021-04-29	"Claudio Meneses et al	[object Object]	45	Female
Italy/TUS-Siena-13/2021	2.00	0.23	0.36	0.01	0.31	GR	11.00	20J (Gamma, V3)	Italy	Italy	Italy	Tuscany	Human		UOC Microbiologia e Virologia, Azienda Ospedaliera Universitaria Senese, Siena, Italy	P.1.1	Europe	Europe	Dipartimento di Biotecnologie Mediche		2021-03-15	Maria Grazia Cusi et al	[object Object]		
USA/OR-OSPHL00874/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	North America	USA	North America	Oregon	Human	North America	Oregon State Public Health Laboratory	P.1	North America	North America	Oregon State Public Health Laboratory		2021-06-02	Rafia Razzaque et al	[object Object]	30	Male
USA/OR-OSPHL00875/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	North America	USA	North America	Oregon	Human	North America	Oregon State Public Health Laboratory	P.1	North America	North America	Oregon State Public Health Laboratory		2021-06-03	Rafia Razzaque et al	[object Object]	34	Male
Suriname/SR-RIVM-22510/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	South America	Suriname	South America	Suriname	Human	South America	Dutch COVID-19 response team	P.1	South America	South America	National Institute for Public Health and the Environment (RIVM)		2021-02-22	Adam Meijer et al	[object Object]	25	
USA/IL-S21WGS2069/2021	2.00	0.23	0.36	0.01	0.31	GR	11.00	20J (Gamma, V3)	North America	USA	North America	Illinois	Human	North America	Illinois Department of Public Health - Springfield Lab	P.1	North America	North America	Illinois Department of Public Health - Springfield Lab		2021-06-01	Bryan Sim et al	[object Object]	48	Female
USA/MO-MSPHL-002307/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	North America	USA	North America	Missouri	Human	North America	Missouri State Public Health Laboratory	P.1	North America	North America	Missouri State Public Health Laboratory		2021-05-21	Matthew Sinn et al	[object Object]		
Paraguay/iics_11777/2021	2.00	0.23	0.36	0.01	0.31	GR	12.00	20J (Gamma, V3)	South America	Paraguay	South America	Central	Human	South America	IICS-UNA	P.1.2	South America	South America	IICS-UNA		2021-03-30	Magaly Martinez et al	[object Object]	28	Female
Paraguay/iics_12552/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	South America	Paraguay	South America	Central	Human	South America	IICS-UNA	P.1.2	South America	South America	IICS-UNA		2021-05-02	Magaly Martinez et al	[object Object]	33	Female
Ireland/WW-NVRL-21IRL63003/2021	2.00	0.23	0.36	0.01	0.31	GR	11.00	20J (Gamma, V3)	Ireland	Ireland	Ireland	Wicklow	Human		National Virus Reference Laboratory	P.1.2	Europe	Europe	National Virus Reference Laboratory		2021-05-27	Zoe Yandle et al	[object Object]		Female
USA/KY-CDC-LC0064951/2021	2.00	0.23	0.36	0.01	0.31	GR	11.00	20J (Gamma, V3)	North America	USA	North America	Kentucky	Human	North America	Laboratory Corporation of America	B.1.1	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-18	Dakota Howard et al	[object Object]	27	Female
Ecuador/NIC-INSPI-322757/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	South America	Ecuador	South America	Chimborazo	Human	South America	INSPI-CRN DE INFLUENZA Y OTROS VIRUS RESPIRATORIOS	P.1	South America	South America	NIC-INSPI		2021-05-21	Alfredo Bruno et al	[object Object]	55	Female
Colombia/DC-INS-H-5863/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	South America	Colombia	South America	Bogota	Human	South America	Instituto Nacional de Salud	P.1	South America	South America	Instituto Nacional de Salud- Dirección de Investigación en Salud Pública		2021-05-20	Katherine Laiton-Donato et al	[object Object]		Female
Spain/CM-HGUCR-21-658003/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	Spain	Spain	Spain	Castilla la Mancha	Human		Servicio de Microbiología, Hospital General Universitario de Ciudad Real	P.1	Europe	Europe	Servicio de Microbiología, Hospital General Universitario de Ciudad Real		2021-05-04	Jose Martinez Alarcon et al	[object Object]	49	Female
Mexico/SIN-InDRE_FB16078_S2510/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	North America	Mexico	North America	Sinaloa	Human	North America	LESP Sinaloa	P.1	North America	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)		2021-05-17	Claudia Wong-Arambula et al	[object Object]	19	Male
CostaRica/INC-0664/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	North America	Costa Rica	North America	Heredia	Human	North America	HOSPITAL SAN JUAN DE DIOS	P.1	North America	North America	Inciensa, Instituto Costarricense de InvestigaciOn y Enseñanza en NutriciOn y Salud		2021-05-20	Francisco Duarte et al	[object Object]	28	Female
Italy/FVG-TS-64028356/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	Italy	Italy	Italy	Friuli Venezia Giulia	Human	Trieste	SC (UCO) Igiene e Sanità Pubblica, ASUGI, Trieste	P.1.1	Europe	Europe	ARGO Laboratorio Genomica ed Epigenomica		2021-05-07	Licastro D et al	[object Object]	29	Male
Italy/ABR-IZSGC-275354/2021	2.00	0.23	0.36	0.01	0.31	G	11.00	20J (Gamma, V3)	Italy	Italy	Italy	Abruzzo	Human		SIESP DIPARTIMENTO DI PREVENZIONE TERAMO	P.1.1	Europe	Europe	Istituto Zooprofilattico Sperimentale dell’Abruzzo e Molise “G. Caporale”		2021-05-19	Lorusso A et al	[object Object]	13	Female
Italy/CAL-AOCatanzaro-05081179/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	Italy	Italy	Italy	Calabria	Human		Azienda Ospedaliera Pugliese Ciaccio di Catanzaro SOC Microbiologia e Virologia	P.1.1	Europe	Europe	Azienda Ospedaliera Pugliese Ciaccio di Catanzaro SOC Microbiologia e Virologia		2021-05-08	Rossana Tallerico Federica Pasceri Marco De Fazio Ilenia Talotta Giuseppina Panduri Pasquale Minchella et al	[object Object]	24	Female
Italy/ABR-IZSGC-273997/2021	2.00	0.23	0.36	0.01	0.31	G	10.00	20J (Gamma, V3)	Italy	Italy	Italy	Abruzzo	Human		SIESP DIPARTIMENTO DI PREVENZIONE TERAMO	P.1.1	Europe	Europe	Istituto Zooprofilattico Sperimentale dell’Abruzzo e Molise “G. Caporale”		2021-05-18	Lorusso A et al	[object Object]	17	Male
Italy/MOL-21051810048/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	Italy	Italy	Italy	Molise	Human		Laboratorio Microbiologia PO Cardarelli	P.1.1	Europe	Europe	Laboratorio Microbiologia PO Cardarelli		2021-05-23	Felice V. et al	[object Object]	1	Female
Italy/MOL-21051810047/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	Italy	Italy	Italy	Molise	Human		Laboratorio Microbiologia PO Cardarelli	P.1.1	Europe	Europe	Laboratorio Microbiologia PO Cardarelli		2021-05-23	Felice V. et al	[object Object]	44	Male
Italy/MOL-21051896175/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	Italy	Italy	Italy	Molise	Human		Laboratorio Microbiologia PO Cardarelli	P.1.1	Europe	Europe	Laboratorio Microbiologia PO Cardarelli		2021-05-23	Felice V. et al	[object Object]	36	Female
Haiti/27713/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	North America	Haiti	North America	Haiti	Human	North America	Laboratoire National de Santé Publique – LNSP (HAITI - LNSP)	P.1	North America	North America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2021-05-20	Paola Resende et al	[object Object]	64	
USA/DC-CDC-LC0065625/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	North America	USA	North America	Washington DC	Human	North America	Laboratory Corporation of America	P.1	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-06-01	Dakota Howard et al	[object Object]	2	Male
USA/TN-CDC-ASC210106369/2021	2.00	0.24	0.36	0.02	0.33	GR	11.00	20J (Gamma, V3)	North America	USA	North America	Tennessee	Human	North America	Aegis Sciences Corporation	P.1	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-06-01	Dakota Howard et al	[object Object]	30	Female
Taiwan/CGMH-CGU-56/2021	2.00	0.23	0.36	0.01	0.31	GR	11.00	20J (Gamma, V3)	Asia	Taiwan	Asia	Taiwan	Human	Asia	Laboratory Medicine	P.1	Asia	Asia	Department of Laboratory Medicine, Lin-Kou Chang Gung Memorial Hospital, Taoyuan, Taiwan		2021-01-28	Kuo-Chien Tsao et al B	[object Object]		Female
FrenchGuiana/IPG2021487/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	France	France	France	French Guiana	Human	Cayenne GF	CNR Institut Pasteur de la Guyane	P.1	Europe	Europe	Institut Pasteur de la Guyane		2021-05-28	Anne Lavergne et al	[object Object]	8	Male
USA/NE-NCOV21-22598/2021	2.00	0.23	0.36	0.01	0.31	GR	11.00	20J (Gamma, V3)	North America	USA	North America	Nebraska	Human	North America	Nebraska Public Health Laboratory	P.1	North America	North America	NPHL COVID-19 Response Team		2021-06-07	NPHL COVID-19 Response Team et al	[object Object]		
Uruguay/LAS-M530/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	South America	Uruguay	South America	Rocha	Human	South America	Institut Pasteur de Montevideo	P.1	South America	South America	Institut Pasteur de Montevideo		2021-02-23	Daiana Mir et al	[object Object]		
Peru/un-CDC-2-4069938/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	South America	Peru	South America	Peru	Human	South America	NAMRU-6	P.1	South America	South America	Pathogen Discovery, Respiratory Viruses Branch, Division of Viral Diseases, Centers for Disease Control and Prevention		2021-02-22	Yan Li et al	[object Object]		
USA/AZ-ASU6457/2021	2.00	0.24	0.36	0.02	0.32	GR	11.00	20J (Gamma, V3)	North America	USA	North America	Arizona	Human	North America	Arizona State University	P.1	North America	North America	Arizona State University		2021-06-02	Peter T. Skidmore et al	[object Object]		
Mexico/YUC-InDRE_FB15983_S2560/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	North America	Mexico	North America	Yucatan	Human	North America	LESP Yucatan	P.1	North America	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)		2021-05-17	Claudia Wong-Arambula et al	[object Object]	15	Female
Argentina/INEI104409/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	South America	Argentina	South America	Buenos Aires	Human	South America	Servicio Virosis Respiratorias-Departamento Virología-INEI	P.1	South America	South America	Instituto Nacional Enfermedades Infecciosas C.G.Malbran		2021-04-16	Baumeister E. et al	[object Object]	64	Female
Suriname/SR-238/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	South America	Suriname	South America	Suriname	Human	South America	Central Laboratory, Bureau of Public Health (BOG) and Academic Hospital Paramaribo	P.1	South America	South America	Erasmus Medical Center		2021-04-29	Bas B Oude Munnink et al	[object Object]		
Suriname/SR-289/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	South America	Suriname	South America	Suriname	Human	South America	Central Laboratory, Bureau of Public Health (BOG) and Academic Hospital Paramaribo	P.1	South America	South America	Erasmus Medical Center		2021-05-17	Bas B Oude Munnink et al	[object Object]		
Argentina/PAIS-A0519/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	South America	Brazil	South America	Brazil	Human	South America	Hospital de Clínicas "José de San Martín"	P.1	South America	South America	Área de Secuenciación del Laboratorio de Virología del Hospital de Niños Dr. Ricardo Gutierrez on behalf of 'Proyecto Argentino Interinstitucional de genomica de SARS-CoV-2' (PAIS Consortium)		2021-02-09	Marcelo Rodríguez Fermepin et al	[object Object]		
Suriname/SR-295/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	South America	Suriname	South America	Suriname	Human	South America	Central Laboratory, Bureau of Public Health (BOG) and Academic Hospital Paramaribo	P.1.1	South America	South America	Erasmus Medical Center		2021-05-19	Bas B Oude Munnink et al	[object Object]		
Belgium/rega-6316/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	Belgium	Belgium	Belgium	Tournai-Mouscron	Human	Tournai	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	P.1	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2021-03-15	Tony Wawina-Bokalanga et al	[object Object]	17	Male
Belgium/SJ4328099/2021	2.00	0.23	0.36	0.01	0.31	G	10.00	20J (Gamma, V3)	Belgium	Belgium	Belgium	Brugge	Human	Knokke-Heist	AZ Zeno Knokke-Blankenberge	P.1	Europe	Europe	AZ Sint Jan		2021-05-17	Marijke Reynders et al	[object Object]	50	Male
Belgium/Aalst-OLVZ-8022147/2021	2.00	0.23	0.36	0.01	0.31	GR	11.00	20J (Gamma, V3)	Belgium	Belgium	Belgium	Dendermonde	Human	Lebbeke	OLVZ Aalst	P.1	Europe	Europe	OLVZ Aalst		2021-03-15	Astrid Holderbeke et al	[object Object]	16	Male
Belgium/AZSL_2102-30973/2021	2.00	0.23	0.36	0.01	0.31	GR	11.00	20J (Gamma, V3)	Belgium	Belgium	Belgium	Aalst	Human	Lede	AZ Sint-Lucas Gent	P.1	Europe	Europe	AZ Sint-Lucas Gent		2021-02-24	Jos Van Acker et al	[object Object]	68	Male
Belgium/SJ4296853/2021	2.00	0.24	0.36	0.02	0.32	GR	11.00	20J (Gamma, V3)	Belgium	Belgium	Belgium	Oostende	Human		AZ St.Jan Brugge-Oostende	P.1	Europe	Europe	AZ SINT-JAN BRUGGE		2021-04-21	Marijke Reynders et al	[object Object]	21	V
Belgium/UZA-UA-TIH315/2021	2.00	0.24	0.36	0.02	0.32	GR	11.00	20J (Gamma, V3)	Belgium	Belgium	Belgium	Soignies	Human	Braine-le-Comte	LHUB-ULB	P.1	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-20	Marie Le Mercier et al	[object Object]	40	Female
Belgium/UZA-UA-TKE422/2021	2.00	0.23	0.36	0.01	0.31	GR	11.00	20J (Gamma, V3)	Belgium	Belgium	Belgium	Halle-Vilvoorde	Human	Relegem	LHUB-ULB	P.1	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-17	Marie Le Mercier et al	[object Object]	48	Female
Belgium/UZA-UA-CV2184195678/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	Belgium	Belgium	Belgium	Gent	Human		Platform BIS UZA/UAntwerpen	P.1	Europe	Europe	Labo Klinische Biologie, UZA		2021-06-05	Jasmine Coppens et al	[object Object]	35	Male
Belgium/ULG-16357/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	Belgium	Belgium	Belgium	Brabant Wallon	Human		SYNLAB	P.1	Europe	Europe	GIGA Medical Genomics		2021-06-04	Keith Durkin et al	[object Object]	46	Male
Belgium/UZA-UA-CV2269986017/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	Belgium	Belgium	Belgium	Halle-Vilvoorde	Human	Halle	Platform BIS UZA/UAntwerpen	P.1	Europe	Europe	Labo Klinische Biologie, UZA		2021-06-04	Jasmine Coppens et al	[object Object]	45	Female
Belgium/ULG-16073/2021	2.00	0.23	0.36	0.01	0.31	GR	11.00	20J (Gamma, V3)	Belgium	Belgium	Belgium	Oost-Vlaanderen	Human		University of Liège COVID-19 testing center	P.1	Europe	Europe	GIGA Medical Genomics		2021-05-24	Keith Durkin et al	[object Object]	22	Male
Belgium/rega-5025/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	Belgium	Belgium	Belgium	Philippeville	Human	Walcourt	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	P.1	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2021-02-28	Tony Wawina-Bokalanga et al	[object Object]	93	Male
Belgium/rega-4227/2021	2.00	0.23	0.36	0.01	0.31	GR	10.00	20J (Gamma, V3)	Belgium	Belgium	Belgium	La Louvière	Human	Houdeng-Goegnies	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	P.1	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2021-02-26	Tony Wawina-Bokalanga et al	[object Object]	67	Male
Russia/MOW-RII-MH15902/2021		0.04	0.34		0.24	GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Pathogenic Microorganisms Variability Laboratory	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-25	Andrey Komissarov et al A	[object Object]	66	Female
Russia/ARK-CRIE-7602087210/2020		0.04	0.34		0.24	GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Virology of Federal Budget Health Care Institution Center of Hygiene and Epidemiology in Arkhangelsk region	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2020-12-28	Samoilov AE et al	[object Object]	71	Male
Russia/YAR-RII-MH16079S/2021		0.04	0.34		0.24	GR	2.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human	Yaroslavl	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	37	Male
Russia/YAR-CRIE-L188N0197/2021		0.04	0.34		0.24	GR	2.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-01	Samoilov AE et al	[object Object]		Female
Russia/BEL-RII-MH17634S/2021		0.01			0.02	GR	5.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-28	Andrey Komissarov et al A	[object Object]	82	
Russia/SPE-RII-MH15680S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	35	Male
Russia/SPE-RII-MH15678S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	73	Female
Russia/BEL-RII-MH17700S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-06	Andrey Komissarov et al A	[object Object]	66	
Russia/KRS-RII-MH16151S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Kursk Region	Kursk Region	Human	Kursk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-08	Andrey Komissarov et al A	[object Object]	66	Female
Russia/VOR-RII-MH16113S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Voronezh	Voronezh	Human	Voronezh	HELIX LLC	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-25	Andrey Komissarov et al A	[object Object]	25	Female
Russia/AMU-RII-MH18263S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Arkhara	Arkhara Hospital	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-18	Andrey Komissarov et al A	[object Object]	58	Female
Russia/SPE-RII-MH14651S/2021		0.05	0.39	0.04	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-15	Andrey Komissarov et al A	[object Object]	57	Female
Russia/SPE-RII-MH15784S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-15	Andrey Komissarov et al A	[object Object]	36	Male
Russia/PSK-RII-MH14686S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Pskov Oblast	Pskov Oblast	Human	Velikiye Luki	HELIX LLC	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]	67	Male
Russia/ORL-RII-MH15809S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Oryol	Oryol	Human	Oryol	HELIX LLC	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	86	Female
Russia/KR-RII-MH16428S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Karelia	Karelia	Human		Republican Infectious Diseases Hospital	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-25	Andrey Komissarov et al A	[object Object]	51	Male
Russia/SPE-RII-MH14824S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-21	Andrey Komissarov et al A	[object Object]	37	Female
Russia/ORL-RII-MH16111S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Oryol	Oryol	Human	Oryol	HELIX LLC	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	40	Male
Russia/BEL-RII-MH17392S/2021	1.00	0.17	0.35	0.01	0.27	GR	5.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-06	Andrey Komissarov et al A	[object Object]	15	
Russia/MOW-RII-MH16207S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-25	Andrey Komissarov et al A	[object Object]	38	Female
Russia/MOS-RII-MH16056S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Zvenigorod	HELIX LLC	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-23	Andrey Komissarov et al A	[object Object]	32	Male
Russia/ORL-RII-MH16175S/2021		0.05	0.35	0.01	0.26	GR	5.00	20B	Russia	Russia	Oryol	Oryol	Human	Oryol	HELIX LLC	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	29	Female
Russia/BEL-RII-MH17524S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-15	Andrey Komissarov et al A	[object Object]	72	
Russia/KRS-RII-MH16174S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Krasnoyarsk	Krasnoyarsk	Human	Zheleznogorsk	HELIX LLC	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	49	Female
Russia/MOW-PMVL-47/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Pathogenic Microorganisms Variability Laboratory	B.1.351	Europe	Europe	Pathogenic Microorganisms Variability Laboratory		2021-02-18	Alexey Shchetinin et al	[object Object]	50	Female
Russia/SVE-RII-MH15894S/2021		0.04	0.34		0.24	GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Krasnoufimsk	HELIX LLC	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-27	Andrey Komissarov et al A	[object Object]		Female
Russia/BRY-RII-MH15914S/2021		0.04	0.34		0.24	GR	5.00	20B	Russia	Russia	Bryansk Oblast	Bryansk Oblast	Human	Bryansk	WHO National Influenza Centre Russian Federation	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-28	Andrey Komissarov et al A	[object Object]	34	Male
Russia/BEL-RII-MH17412S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-07	Andrey Komissarov et al A	[object Object]	60	
Russia/SPE-RII-MH17281S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-06	Andrey Komissarov et al A	[object Object]	60	Female
Russia/MOW_2833/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Collection of WHO National Influenza Center, N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation	B.1.351	Europe	Europe	Laboratory of genome analysis, N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation		2021-03-29	Olga Voronina et al	[object Object]	101	Female
Russia/BEL-RII-MH17426S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-08	Andrey Komissarov et al A	[object Object]	94	
Russia/BEL-RII-MH17529S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-16	Andrey Komissarov et al A	[object Object]	13	
Russia/BEL-RII-MH17440S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-09	Andrey Komissarov et al A	[object Object]	40	
Russia/BEL-RII-MH17521S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-15	Andrey Komissarov et al A	[object Object]	43	
Russia/BEL-RII-MH17747S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-10	Andrey Komissarov et al A	[object Object]	19	
Russia/MOW-RII-MH16073S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-02	Andrey Komissarov et al A	[object Object]	49	Male
Russia/KLU-RII-MH16223S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Kaluga	Kaluga	Human	Tovarkovo	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	58	Female
Russia/BEL-RII-MH17657S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-28	Andrey Komissarov et al A	[object Object]	56	
Russia/BEL-RII-MH17718S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-07	Andrey Komissarov et al A	[object Object]	57	
Russia/BEL-RII-MH17725S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-07	Andrey Komissarov et al A	[object Object]	38	
Russia/BEL-RII-MH17726S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.351	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-07	Andrey Komissarov et al A	[object Object]	18	
Russia/BEL-RII-MH17463S/2021		0.01	0.01		0.01	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.34	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-12	Andrey Komissarov et al A	[object Object]	83	
Russia/BEL-RII-MH17540S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.345	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-19	Andrey Komissarov et al A	[object Object]	63	
Russia/BEL-RII-MH17678S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.345	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-30	Andrey Komissarov et al A	[object Object]	69	
Russia/BEL-RII-MH17586S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.345	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-26	Andrey Komissarov et al A	[object Object]	76	
Russia/BEL-RII-MH17587S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.345	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-26	Andrey Komissarov et al A	[object Object]	87	
Russia/BEL-RII-MH17716S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.345	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-07	Andrey Komissarov et al A	[object Object]	81	
Russia/BEL-RII-MH17577S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.345	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-22	Andrey Komissarov et al A	[object Object]	88	
Russia/SPE-RII-MH15455S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	AV.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	76	Male
Russia/SVE-RII-MH16067S/2021		0.06	0.35	0.01	0.26	O	5.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Revda	HELIX LLC	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-03	Andrey Komissarov et al A	[object Object]	66	Male
Russia/SVE-RII-MH16215S/2021		0.04	0.34		0.24	GR	4.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Revda	HELIX LLC	AV.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-10	Andrey Komissarov et al A	[object Object]	48	Male
Russia/SPE-RII-MH15679S/2021		0.05	0.40	0.07	0.29	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	40	Female
Russia/STA-RII-MH16062S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Stavropol	Stavropol	Human	Pyatigorsk	HELIX LLC	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-25	Andrey Komissarov et al A	[object Object]	40	Male
Russia/BEL-RII-MH17715S/2021		0.05	0.40	0.07	0.29	GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-07	Andrey Komissarov et al A	[object Object]	38	
Russia/SPE-RII-MH17332S/2021						GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.451	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-23	Andrey Komissarov et al A	[object Object]	33	Male
Russia/SPE-RII-35291S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.318	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]	58	Male
Switzerland/AG-ETHZ-550306/2020		0.05	0.40	0.07	0.29	GR	5.00	20B	Switzerland	Switzerland	Switzerland	Aargau	Human		Viollier AG	B.1.1.523	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-03-25	Christian Beisel et al	[object Object]		
Russia/MOW-CRIE-D186B0041/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-02-02	Samoilov A.E. et al	[object Object]	66	Male
Russia/MOW-CRIE-L188K0246/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-11	Samoilov AE et al	[object Object]	85	Female
Russia/BEL-RII-MH17562S/2021		0.05	0.40	0.07	0.29	GR	6.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-21	Andrey Komissarov et al A	[object Object]	7	
Russia/SPE-RII-35617S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.318	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-26	Andrey Komissarov et al A	[object Object]	24	Male
Russia/MOW-CRIE-L188A0887/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-31	Samoilov AE et al	[object Object]	65	Female
Russia/MOW-RII-MH16168S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-10	Andrey Komissarov et al A	[object Object]	48	Female
Russia/MOW-CRIE-L188K0261/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-12	Samoilov AE et al	[object Object]	85	Female
Russia/MOW_3051/2021		0.05	0.40	0.07	0.29	GR	6.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Collection of WHO National Influenza Center, N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation	B.1.1.523	Europe	Europe	N.F. Gamaleya Research Center for Epidemiology and Microbiology		2021-04-09	Olga Voronina et al	[object Object]	84	Male
France/IDF-IPP09759/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	France	France	France	Ile de France	Human	Pontoise	Hospital	B.1.1.523	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2021-04-12	Marion Barbet et al	[object Object]	28	Male
France/IDF-IPP13031/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	France	France	France	Ile de France	Human	Villejuif	Hospital	B.1.1.523	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2021-05-24	Marion Barbet et al	[object Object]	83	Female
Russia/SPE-RII-34904S/2021		0.05	0.40	0.07	0.29	GR	6.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	34	Female
Russia/MOW-CRIE-L188K0258u/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-11	Samoilov AE et al	[object Object]	60	Male
Russia/MOW-CRIE-L188A1319/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-31	Samoilov AE et al	[object Object]	81	Female
Russia/TAM-CRIE-L188K0232u/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Tambov Region	Tambov Region	Human		Federal Budget Health Care Institution "Center of Hygiene and Epidemiology in Tambov region"	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-15	Samoilov AE et al	[object Object]	46	Male
Russia/MOW-RII-MH16132S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	24	Female
Russia/SPE-RII-34894S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	63	Male
Russia/MOW-CRIE-L188A0896/2021		0.05	0.40	0.07	0.29	GR	6.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-29	Samoilov AE et al	[object Object]	45	Male
Russia/MOW-CRIE-L188A0883/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center (Laboratory Testing Center) of Moscow Health Department "	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-29	Samoilov AE et al	[object Object]	63	Female
Russia/MOW-CRIE-L188K0292u/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-08	Samoilov AE et al	[object Object]	85	Female
Russia/SPE-RII-MH16281S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-15	Andrey Komissarov et al A	[object Object]	35	Female
Russia/SPE-RII-MH16354S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1.1.89	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-22	Andrey Komissarov et al A	[object Object]	66	
Russia/SPE-RII-34888S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	65	Female
Russia/TAM-CRIE-L188F0166/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Tambov Region	Tambov Region	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-05	Samojlov A.E. et al	[object Object]	60	Female
Russia/MOW-CRIE-D187L0056b/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-13	Samoilov A.E. et al	[object Object]	47	Female
Germany/BB-RKI-I-153554/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Germany	Germany	Germany	Brandenburg	Human		Klinikum Ernst von Bergmann gemeinnützige GmbH - stationärer Bereich	B.1.1.523	Europe	Europe	Robert Koch Institute		2021-05-17	?	[object Object]		
Russia/VLA-RII-MH18406S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Vladimir Region	Vladimir Region	Human	Kovrov	HELIX LLC	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-11	Andrey Komissarov et al A	[object Object]	80	Female
Russia/SPE-RII-MH15668S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	53	Male
Russia/BEL-RII-MH17482S/2021		0.05	0.40	0.07	0.29	GR	6.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-13	Andrey Komissarov et al A	[object Object]	35	
Russia/BEL-RII-MH17483S/2021		0.05	0.40	0.07	0.29	GR	6.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-13	Andrey Komissarov et al A	[object Object]	65	
Russia/KR-RII-MH17365S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Karelia	Karelia	Human	Petrozavodsk	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-07	Andrey Komissarov et al A	[object Object]	56	Male
Russia/MOW-CRIE-L188A1317/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-31	Samoilov AE et al	[object Object]	82	Male
Russia/LIP-CRIE-L188H0265b/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Lipetsk	Lipetsk	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-03	Samojlov A.E. et al	[object Object]	82	Female
France/PDL-CHUN-0059/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	France	France	France	Pays de la Loire	Human	Vendee	CH La Roche sur Yon	B.1.1.523	Europe	Europe	CHU Nantes Virology		2021-04-04	Celine Bressollette-Bodin et al	[object Object]	61	Male
Russia/SPE-RII-MH17284S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-12	Andrey Komissarov et al A	[object Object]	40	Female
Russia/SPE-RII-34994S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-20	Andrey Komissarov et al A	[object Object]	45	Female
Russia/SPE-RII-34656S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	55	Female
Russia/SPE-RII-34919S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	32	Female
Switzerland/ZH-UZH-IMV-456f7033/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Switzerland	Switzerland	Switzerland	Zürich	Human		UniversitätsSpital Zürich 009	B.1.1.523	Europe	Europe	Institute of Medical Virology		2021-05-20	Verena Kufner et al	[object Object]		
Switzerland/ZH-UZH-IMV-3ba49aea/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Switzerland	Switzerland	Switzerland	Zürich	Human		UniversitätsSpital Zürich	B.1.1.523	Europe	Europe	Institute of Medical Virology		2021-05-27	Verena Kufner et al	[object Object]		
Russia/SPE-RII-MH17272S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-13	Andrey Komissarov et al A	[object Object]	57	Male
Russia/VLA-RII-MH18393S/2021						GR	3.00	20B	Russia	Russia	Vladimir Region	Vladimir Region	Human	Pokrov	HELIX LLC	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-13	Andrey Komissarov et al A	[object Object]	82	Female
Russia/MOW-CRIE-L188K0303/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-10	Samoilov AE et al	[object Object]	41	Male
Russia/SPE-RII-MH17390S/2021		0.05	0.40	0.07	0.29	GR	6.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-10	Andrey Komissarov et al A	[object Object]	45	Male
Germany/NW-RKI-I-172499/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Germany	Germany	Germany	North Rhine Westphalia	Human		Labor Mönchengladbach MVZ Dr. Stein + Kollegen GbR	B.1.1.523	Europe	Europe	Robert Koch Institute		2021-05-29	?	[object Object]		
Russia/SPE-RII-35097S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	47	Female
Russia/SPE-RII-35280S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]	46	Male
Russia/MOW-CRIE-L188K0251u/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-11	Samoilov AE et al	[object Object]	36	Female
Russia/MOW-CRIE-L188K0256u/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-13	Samoilov AE et al	[object Object]	29	Male
Russia/MOW-CRIE-L188A0889/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-31	Samoilov AE et al	[object Object]	82	Male
Russia/MOW-CRIE-L188M0201b/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-17	Samoilov A.E. et al	[object Object]	23	Female
Russia/SPE-RII-34731S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	40	Female
Russia/SPE-RII-MH17381S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-11	Andrey Komissarov et al A	[object Object]	39	Female
Russia/SPE-RII-35286S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]	62	Female
Belgium/Jessa_11-2121-004742/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Belgium	Belgium	Belgium	Limburg BE	Human		Jessa	B.1.1.523	Europe	Europe	Jessa		2021-05-27	Berden et al. on behalf of the Jessa_cmdLab et al	[object Object]	50	Female
Belgium/Jessa_11-2120-001055/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Belgium	Belgium	Belgium	Belgium	Human		Jessa	B.1.1.523	Europe	Europe	Jessa		2021-05-17	Raymaekers et al. on behalf of the Jessa_cmdLab et al	[object Object]	29	Female
Belgium/Jessa_55-2120-000259/2021		0.05	0.40	0.07	0.29	O	5.00	20B	Belgium	Belgium	Belgium	Limburg BE	Human		Jessa	B.1.1.523	Europe	Europe	Jessa		2021-05-18	Berden et al. on behalf of the Jessa_cmdLab et al	[object Object]	46	Male
Poland/WGS-CoV_PZH-LUM-0976/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Poland	Poland	Poland	Pomorskie	Human		Cell-T	B.1.1.523	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland 2. Biobank Lab, University of Lodz 3. Laboratory of Respiratory Viruses, Teaching and Clinical Center of the Medical University of Lodz		2021-05-11	Dominik Strapagiel et al	[object Object]	40	Female
Russia/SPE-RII-MH15692S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-11	Andrey Komissarov et al A	[object Object]	50	Male
Russia/SPE-RII-MH17831S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	27	Female
Russia/RYA-CRIE-L188K0278/2021		0.05	0.40	0.07	0.29	GR	6.00	20B	Russia	Russia	Ryazan	Ryazan	Human		Federal Budget Health Care Institution "Center of Hygiene and Epidemiology in Ryazan region"	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-15	Samoilov AE et al	[object Object]	50	Female
Russia/SVE-RII-MH18439S/2021		0.05	0.40	0.07	0.29	GR	6.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-20	Andrey Komissarov et al A	[object Object]	27	Female
Russia/BEL-RII-MH17575S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-22	Andrey Komissarov et al A	[object Object]	72	
Russia/SPE-RII-MH17256S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-23	Andrey Komissarov et al A	[object Object]	50	Female
Russia/SPE-RII-MH16274S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-19	Andrey Komissarov et al A	[object Object]	38	Female
Russia/MOW-RII-MH16139S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-23	Andrey Komissarov et al A	[object Object]	69	Female
Russia/MOW-CRIE-L188A0888/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-28	Samoilov AE et al	[object Object]	31	Female
Sweden/SUS0001828/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Sweden	Sweden	Sweden	Skane	Human		Clinical Microbiology, Infection Prevention and Control	B.1.1.523	Europe	Europe	Section for Molecular Diagnostics		2021-05-01	Björn Hallström et al	[object Object]	77	Female
Russia/BEL-RII-MH17699S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-06	Andrey Komissarov et al A	[object Object]	1	
Sweden/SE00455066/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Sweden	Sweden	Sweden	Skane	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.523	Europe	Europe	The Public Health Agency of Sweden		2021-04-26	Maximilian Riess et al	[object Object]		
Russia/BEL-RII-MH17614S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-28	Andrey Komissarov et al A	[object Object]	35	
Russia/KR-RII-MH17355S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Karelia	Karelia	Human	Petrozavodsk	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-05	Andrey Komissarov et al A	[object Object]	38	Female
Russia/MOW-CRIE-L188A0895/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-30	Samoilov AE et al	[object Object]	38	Male
Russia/SPE-RII-MH18141S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	56	Male
Germany/NW-HHU-7133/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Germany	Germany	Germany	North Rhine Westphalia	Human	Duesseldorf	ZOTZ KLIMAS MVZ Düsseldorf-Centrum GbR ÜBAG für Labormedizin, Genetik, Zytologie, Pathologie	B.1.1.523	Europe	Europe	Center of Medical Microbiology, Virology, and Hospital Hygiene, University of Duesseldorf		2021-05-24	Maximilian Damagnez et al	[object Object]		
Russia/MOW-CRIE-L188A0899/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-28	Samoilov AE et al	[object Object]	29	Female
Russia/SPE-RII-MH16263S/2021	1.00	0.12	0.40	0.08	0.33	GR	6.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-14	Andrey Komissarov et al A	[object Object]	37	Female
Russia/SPE-RII-34467S/2021	1.00	0.12	0.40	0.08	0.33	GR	6.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-15	Andrey Komissarov et al A	[object Object]	35	Male
Israel/CVL-13562/2021		0.05	0.40	0.07	0.29	GR	6.00	20B	Asia	Israel	Asia	Jerusalem District	Human	Asia	Israel Central Virology laboratory	B.1.1.523	Asia	Asia	Israel National Consortium for SARS-CoV-2 sequencing		2021-05-10	Neta Zuckerman et al	[object Object]		
Russia/RYA-RII-MH16160S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Ryazan	Ryazan	Human	Ryazan	HELIX LLC	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-04	Andrey Komissarov et al A	[object Object]	59	Male
Russia/MOW-CRIE-L188K0264u/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-11	Samoilov AE et al	[object Object]	31	Female
Russia/MOW-CRIE-L188K0241/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-12	Samoilov AE et al	[object Object]	16	Male
Russia/MOW-CRIE-D186A0018b/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-30	Samoilov A.E. et al	[object Object]	66	Male
Russia/MOS-RII-MH16244S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Kubinka	HELIX LLC	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-04	Andrey Komissarov et al A	[object Object]	41	Female
Russia/MOW-CRIE-L188K0249u/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-12	Samoilov AE et al	[object Object]	62	Male
Germany/NI-RKI-I-164965/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Germany	Germany	Germany	Niedersachsen	Human		Laborarztpraxis Osnabrück	B.1.1.523	Europe	Europe	Robert Koch Institute		2021-05-23	?	[object Object]		
Russia/SVE-RII-MH15253S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	UMMC-Health	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-19	Andrey Komissarov et al A	[object Object]	37	Male
Russia/MOW-CRIE-L188K0265/2021		0.05	0.40	0.07	0.29	O	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-11	Samoilov AE et al	[object Object]	75	Female
Russia/BEL-RII-MH17523S/2021		0.05	0.40	0.08	0.31	GR	6.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-15	Andrey Komissarov et al A	[object Object]	48	
Russia/IVA-CRIE-L188N0206u/2021		0.05	0.40	0.07	0.29	G	5.00	20B	Russia	Russia	Ivanovo	Ivanovo	Human		Federal Budget Health Care Institution "Center of Hygiene and Epidemiology in Ivanovo region"	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-19	Samoilov AE et al	[object Object]	37	Female
Russia/SPE-RII-32819S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-23	Andrey Komissarov et al A	[object Object]	88	Female
Russia/SPE-RII-MH15739S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	41	Female
Switzerland/BE-ETHZ-620386/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Switzerland	Switzerland	Switzerland	Bern	Human		Viollier AG	B.1.1.523	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-05-10	Chaoran Chen et al	[object Object]		
Germany/BW-RKI-I-161516/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Germany	Germany	Germany	Baden-Wuerttemberg	Human		SYNLAB MVZ Leinfelden-Echterdingen	B.1.1.523	Europe	Europe	Robert Koch Institute		2021-05-18	?	[object Object]		
Germany/BE-ChVir-LB-210528-4533/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Germany	Germany	Germany	Berlin	Human		Labor Berlin Charité Vivantes GmbH / Institut für Virologie	B.1.1.523	Europe	Europe	Charité Universitätsmedizin Berlin, Institut für Virologie/Labor Berlin		2021-05-19	Peter Menzel et al	[object Object]		
Russia/SPE-RII-34970S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-20	Andrey Komissarov et al A	[object Object]	-8	Male
Russia/MOW-CRIE-L188A0900/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-29	Samoilov AE et al	[object Object]	43	Female
Russia/MOW-CRIE-L188K0302/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.523	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-10	Samoilov AE et al	[object Object]	49	Male
Russia/SPE-RII-MH17295S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-13	Andrey Komissarov et al A	[object Object]	43	Male
Russia/SPE-RII-35002S/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.523	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-20	Andrey Komissarov et al A	[object Object]	72	Female
CzechRepublic/NRL_7779/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Czech Republic	Czech Republic	Czech Republic	Prague	Human		National Institute of Public Health	B.1.1.523	Europe	Europe	State Veterinary Institute Prague		2021-05-17	Nagy et al	[object Object]	24	Female
UnitedArabEmirates/4204/2020						GR	1.00	20B	Asia	United Arab Emirates	Asia	Abu Dhabi	Human	Asia	BTC, Khalifa University	B.1.1.263	Asia	Asia	BTC, Khalifa University		2020-05-06	Al Safar et al	[object Object]	39	Female
Poland/IHG_PAS_4_67/2020						GR	1.00	20B	Poland	Poland	Poland	Opolskie	Human		Institute of Human Genetics, Polish Academy of Sciences	B.1.1	Europe	Europe	Institute of Human Genetics, Polish Academy of Sciences		2020-06-01	Szymon Hryhorowicz et al	[object Object]	34	Female
Russia/NGR-RII-MH1702S/2020						GR	1.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Veliky Novgorod	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-18	Andrey Komissarov et al A	[object Object]	38	Female
Russia/NGR-RII-MH6330S/2020						GR	1.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Veliky Novgorod	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-12	Andrey Komissarov et al A	[object Object]	66	Female
Ecuador/EC-G-5369/2020						GR	1.00	20B	South America	Ecuador	South America	Guayas	Human	South America	INSPI-CRN DE INFLUENZA Y OTROS VIRUS RESPIRATORIOS	B.1.1	South America	South America	Instituto de Salud Publica de Chile		2020-03-30	Javier Tognarelli et al	[object Object]	28	Male
Russia/SPE-RII-MH13406S/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-24	Andrey Komissarov et al A	[object Object]	24	Female
Mexico/DUR_INER_IMSS_00680/2021						GR	2.00	20B	North America	Mexico	North America	Durango	Human	North America	Centro de Investigación Biomédica del Noreste (CIBIN)	B.1.1.432	North America	North America	Centro de Investigación en Enfermedades Infecciosas (CIENI), Instituto Nacional de Enfermedades Respiratorias (INER)		2021-02-11	Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex). Authors (in alphabetical order): Julio Elias Alvarado-Yaah et al	[object Object]	29	Male
Russia/LIP-CRIE-L188E0266bh/2021						GR	1.00	20B	Russia	Russia	Lipetsk	Lipetsk	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.83	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-04	Samoilov A.E. et al	[object Object]		Female
Peru/AMA-INS-773/2020						GR	2.00	20B	South America	Peru	South America	Amazonas PE	Human	South America	Laboratorio de Referencia Nacional de Virus Respiratorio. Instituto Nacional de Salud Perú	B.1.1.16	South America	South America	Laboratorio de Referencia Nacional de Biotecnología y Biología Molecular. Instituto Nacional de Salud Perú		2020-09-09	Carlos Padilla Rojas et al	[object Object]	18	Male
Mexico/CMX-InDRE-07/2020						GR	1.00	20B	North America	Italy	North America	Lombardy	Human	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)	B.1.1	North America	Europe	Instituto de diagnóstico y Referencia Epidemiologicos (INDRE)		2020-02-28	Ramirez-Gonzalez Ernesto et al	[object Object]	45	Male
Russia/BRY-RII-MH2790S/2020		0.01	0.01		0.01	GR	2.00	20B	Russia	Russia	Bryansk Oblast	Bryansk Oblast	Human	Bryansk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-17	Andrey Komissarov et al A	[object Object]	56	Female
Russia/KLU-RII-MH2795S/2020		0.01	0.01		0.01	GR	2.00	20B	Russia	Russia	Kaluga	Kaluga	Human	Tovarkovo	HELIX LLC	B.1.1.372	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-16	Andrey Komissarov et al A	[object Object]	66	Female
Russia/KEM-RII-MH2796S/2020		0.01	0.01		0.01	GR	3.00	20B	Russia	Russia	Kemerovo	Kemerovo	Human	Kemerovo	HELIX LLC	B.1.1.372	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-25	Andrey Komissarov et al A	[object Object]	43	Female
Lebanon/S4_761/2020						GR	1.00	20B	Asia	United Kingdom	Asia	United Kingdom	Human	Asia	Rafik Hariri University Hospital	B.1.1	Asia	Europe	Rafik Hariri University Hospital		2020-03-04	Rita Feghali et al	[object Object]	33	Female
Peru/LIM-INS-100/2020						GR	1.00	20B	South America	Peru	South America	Lima	Human	South America	Instituto Nacional de Salud	B.1.1	South America	South America	Laboratorio de Infecciones Respiratorias Agudas		2020-07-04	Eduardo Juscamayta Lopez et al	[object Object]	32	Female
Russia/SE-RII-MH3356S/2020						GR	2.00	20B	Russia	Russia	Republic of North Ossetia-Alania	Republic of North Ossetia-Alania	Human	Vladikavkaz	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	41	Female
BurkinaFaso/7990/2021		0.01	0.06	0.07	0.05	GR	5.00	20B	Africa	Burkina Faso	Africa	Dandé	Human	Africa	Laboratoire de Microbiologie CHU Souro Sanou	B.1.1	Africa	Africa	Laboratoire bacteriologie virologie CHUSS		2021-02-05	Yacouba Sawadogo et al	[object Object]	38	Male
Poland/2142277439_gx1/2021						GR	3.00	20B	Poland	Poland	Poland	Lubuskie	Human	Dabrowka (Lubuskie)	genXone SA, Molecular Diagnostics Laboratory / NZOZ	B.1.1	Europe	Europe	genXone SA, Research & Development Laboratory		2021-02-15	Maciej Sykulski et al	[object Object]	11	Male
Russia/AST-RII-MH4136S/2020						GR	1.00	20B	Russia	Russia	Astrakhan Region	Astrakhan Region	Human	Astrakhan	Pathogenic Microorganisms Variability Laboratory	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-07-29	Andrey Komissarov et al A	[object Object]	28	Male
Mozambique/INS-K007974/2020	1.00	0.12	0.01		0.03	O	2.00	20B	Africa	Mozambique	Africa	Sofala	Human	Africa	Instituto Nacional de Saude (INS), Mozambique	B.1.1.161	Africa	Africa	KRISP, KZN Research Innovation and Sequencing Platform		2020-08-24	Nalia Ismael et al	[object Object]	34	Male
Russia/MOW-PMVL-37/2021						GR	1.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Pathogenic Microorganisms Variability Laboratory	B.1.1	Europe	Europe	Pathogenic Microorganisms Variability Laboratory		2021-01-18	Alexey Shchetinin et al	[object Object]	61	Female
Russia/OMS-ORINFI-MH10294S/2020						GR	1.00	20B	Russia	Russia	Omsk	Omsk	Human	Tara	Omsk Research Institute of Natural Focal Infections	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-17	Andrey Komissarov et al A	[object Object]	56	Male
Russia/PER-RII-MH2816S/2020						GR	1.00	20B	Russia	Russia	Perm Krai	Perm Krai	Human	Perm	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-24	Andrey Komissarov et al A	[object Object]	33	Male
Russia/TA-KFU_35/2020						GR	1.00	20B	Russia	Russia	Tatarstan	Tatarstan	Human	Kazan	Kazan Federal University, Academic Consortium	B.1.1	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-07-24	Vladislav Babenko et al	[object Object]	45	Female
Russia/TA-KFU_127/2020						GR	2.00	20B	Russia	Russia	Tatarstan	Tatarstan	Human	Kazan	Kazan Federal University, Academic Consortium	B.1.1	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-09-02	Vladislav Babenko et al	[object Object]	64	Female
Russia/TA-KFU_77/2020						GR	1.00	20B	Russia	Russia	Tatarstan	Tatarstan	Human	Kazan	Kazan Federal University, Academic Consortium	B.1.1	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-08-17	Vladislav Babenko et al	[object Object]	33	Female
Bangladesh/BCSIR-NILMRC-359/2020						GR	2.00	20B	Asia	Bangladesh	Asia	Chattogram	Human	Asia	National Institute of Laboratory Medicine and Referral Center	B.1.1.25	Asia	Asia	Genomic Research Lab, BCSIR		2020-07-24	Md. Murshed Hasan Sarkar et al	[object Object]	28	Male
Brazil/PB-FIOCRUZ-29631/2020						GR	2.00	20B	South America	Brazil	South America	Paraiba	Human	South America	Laboratório Central de Saúde Pública do Estado da Paraíba (LACEN-PB)	B.1.1	South America	South America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-09-30	Paola Resende et al	[object Object]		
Bulgaria/16/2020						GR	2.00	20B	Bulgaria	Bulgaria	Bulgaria	Vidin	Human		National Reference Laboratory "Influenza and acute respiratory diseases"	B.1.1	Europe	Europe	NRL-HIV		2020-04-26	Ivan Ivanov et al	[object Object]	80	Male
Chile/RM-13685/2021						GR	1.00	20B	South America	Chile	South America	Region Metropolitana de Santiago	Human	South America	Genetica Molecular and Subdepartamento de Virologia ISP Chile	B.1.1.348	South America	South America	Instituto de Salud Publica de Chile		2021-01-14	Javier Tognarelli et al	[object Object]	73	Female
Colombia/COR-U11/2020						GR	2.00	20B	South America	Colombia	South America	Cordoba CO	Human	South America	Universidad de Cordoba, Montería, Colombia	B.1.1.348	South America	South America	Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia		2020-07-09	Salim Mattar et al	[object Object]	47	Male
Bolivia/Potosi-1/2021						GR	1.00	20B	South America	Bolivia	South America	Potosi	Human	South America	Laboratorio de Biologia Molecular, SEDES-Potosi	B.1.1.348	South America	South America	Molecular Genetics Laboratory, Instituto de Investigaciones Químicas, Universidad Mayor de San Andrés		2021-02-05	Oscar M. Rollano-Peñaloza et al	[object Object]		
Peru/LIM-INS-439/2021						GR	1.00	20B	South America	Peru	South America	Lima	Human	South America	Laboratorio de Referencia Nacional de Virus Respiratorio. Instituto Nacional de Salud Perú	B.1.1.348	South America	South America	Laboratorio de Referencia Nacional de Enteropatógenos. Instituto Nacional de Salud del Perú		2021-01-17	Ronnie Gavilan Chavez et al	[object Object]		
Bolivia/LPZ-3/2021		0.01	0.02	0.12	0.03	GR	3.00	20B	South America	Bolivia	South America	La Paz	Human	South America	Clin & Gen Lab	B.1.1	South America	South America	Molecular Genetics Laboratory, Instituto de Investigaciones Químicas, Universidad Mayor de San Andrés		2021-01-28	Oscar M. Rollano-Peñaloza et al	[object Object]		
Zimbabwe/ZW-36225/2020						GR	1.00	20B	Africa	Zimbabwe	Africa	Zimbabwe	Human	Africa	National Microbiology Reference Laboratory	B.1.1	Africa	Africa	Quadram Institute Bioscience		2020-11-07	Tapfumanei Mashe et al	[object Object]	66	Female
Russia/KDA-RII-MH1685S/2020		0.05	0.35	0.01	0.26	GR	3.00	20B	Russia	Russia	Krasnodar	Krasnodar	Human	Sochi	HELIX LCC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-04	Andrey Komissarov et al A	[object Object]	65	Male
Belgium/rega-0620851/2020						GR	1.00	20B	Belgium	Belgium	Belgium	Antwerpen	Human		UZ Leuven, National Reference Laboratory for Coronaviruses, Laboratory Medicine, Leuven, Belgium	B.1.1.218	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-06-20	Tony Wawina-Bokalanga et al	[object Object]	13	Female
Russia/OMS-ORINFI-3807S/2020						GR	1.00	20B	Russia	Russia	Omsk	Omsk	Human	Omsk	Omsk Research Institute of Natural Focal Infections	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-05-13	Artem Fadeev et al	[object Object]	62	Male
Russia/ME-RII-MH2757S/2020						GR	2.00	20B	Russia	Russia	Mari El	Mari El	Human	Kozmodemyansk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-23	Andrey Komissarov et al A	[object Object]	42	Female
Russia/TAM-RII-MH2855S/2020						GR	1.00	20B	Russia	Russia	Tambov Region	Tambov Region	Human	Morshansk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-21	Andrey Komissarov et al A	[object Object]	44	Female
Russia/LEN-RII-MH3120S/2020						GR	1.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Kirovsk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-30	Andrey Komissarov et al A	[object Object]	22	Male
Jordan/SEARCH-5474/2020						GR	1.00	20B	Asia	Jordan	Asia	Amman	Human	Asia	Biolab Diagnostic Laboratories	B.1.1.312	Asia	Asia	Andersen lab at Scripps Research		2020-08-29	Issa Abu-Dayyeh et al	[object Object]		
Ireland/D-CFS8-230852/2020						GR	1.00	20B	Ireland	Ireland	Ireland	Dublin	Human		Mater Misericordiae University Hospital Dublin	B.1.1	Europe	Europe	University College Dublin, CFS, School of Public Health		2020-06-04	Maureen Lynch et al	[object Object]		Female
Russia/SVE-RII-MH199S/2020		0.03	0.03	0.03	0.08	GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-07-16	Andrey Komissarov et al A	[object Object]	27	Female
Russia/STA-RII-MH3407S/2020						GR	1.00	20B	Russia	Russia	Stavropol	Stavropol	Human	Stavropol	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	44	Female
Russia/KDA-RII-MH4744S/2020						GR	1.00	20B	Russia	Russia	Krasnodar	Krasnodar	Human	Krasnodar	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-20	Andrey Komissarov et al A	[object Object]	14	Female
Russia/MOW-PMU-0417/2020						GR	1.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Pirogov Russian National Research Medical University	B.1.1	Europe	Europe	Pirogov Russian National Research Medical University, Research and Development		2020-04-17	Blagodatskikh et al	[object Object]		
Algeria/G35155-8850/2020						GR	1.00	20B	Africa	Algeria	Africa	Bouira	Human	Africa	NIC Viral Respiratory Unit - Institut Pasteur of Algeria	B.1.1	Africa	Africa	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2020-07-15	Mélanie Albert et al	[object Object]	62	Male
Russia/STA-RII-MH2783S/2020						GR	2.00	20B	Russia	Russia	Stavropol	Stavropol	Human	Yessentuki	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-28	Andrey Komissarov et al A	[object Object]	42	Male
Russia/VOR-RII-MH3357S/2020						GR	2.00	20B	Russia	Russia	Voronezh	Voronezh	Human	Voronezh	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	45	Male
Russia/NVS-RII-MH15584S/2020						GR	1.00	20B	Russia	Russia	Novosibirsk	Novosibirsk	Human	Novosibirsk	Department of Experimental Modeling and Pathogenesis of Infectious Diseases	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-15	Andrey Komissarov et al A	[object Object]		
Russia/MUR-RII-MH2062S/2020						GR	2.00	20B	Russia	Russia	Murmansk	Murmansk	Human	Murmansk	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-21	Andrey Komissarov et al A	[object Object]	55	Male
Russia/VLA-RII-MH15891S/2021						GR	2.00	20B	Russia	Russia	Vladimir Region	Vladimir Region	Human	Kovrov	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	27	Female
Russia/BRY-RII-MH3408S/2020						GR	1.00	20B	Russia	Russia	Bryansk Oblast	Bryansk Oblast	Human	Bryansk	HELIX LLC	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	35	Female
Russia/TAM-CRIE-L188F0163b/2021						GR	1.00	20B	Russia	Russia	Tambov Region	Tambov Region	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-04	Samoilov A.E. et al	[object Object]	59	Female
Russia/TAM-CRIE-L188L0283b/2021						GR	1.00	20B	Russia	Russia	Tambov Region	Tambov Region	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.317	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-11	Samoilov A.E. et al	[object Object]	59	Male
Coted-Ivoire/COV-BKE1422/bc62/2020						O	3.00	20B	Africa	Côte d'Ivoire	Africa	Niakara	Human	Africa	Molecular diagnostic unit for viral haemorrhagic fevers and emerging viruses, Bouaké CHU Laboratory	B	Africa	Africa	Molecular diagnostic unit for viral haemorrhagic fevers and emerging viruses, Bouaké CHU Laboratory		2020-12-22	Chantal Akoua-Koffi et al	[object Object]	43	Female
Philippines/PH-PGC-02411/2021		0.04	0.34		0.24	GR	3.00	20B	Asia	Philippines	Asia	Manila	Human	Asia	Philippine Red Cross - Port Area	R.1	Asia	Asia	Philippine Genome Center		2021-01-07	Francis A. Tablizo et al	[object Object]	25	Female
TrinidadandTobago/55455/2021		0.04	0.34		0.24	GR	3.00	20B	South America	Trinidad and Tobago	South America	Trinidad and Tobago	Human	South America	Caribbean Public Health Agency	R.1	South America	South America	Carrington Lab, Department of PreClinical Sciences, Faculty of Medical Sciences, The University of the West Indies		2021-02-18	Nikita S. D. Sahadeo et al	[object Object]		
Austria/CeMM5962/2021		0.04	0.34		0.24	GR	3.00	20B	Austria	Austria	Austria	Austria	Human		Elling group, Institute of Molecular Biotechnology (IMBA)	R.1	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-02-03	Lukas Endler et al	[object Object]		
Japan/YCH0223/2021		0.04	0.34		0.24	GR	3.00	20B	Asia	Japan	Asia	Yamanashi	Human	Asia	Genome Analysis Center, Yamanashi Central Hospital	R.1	Asia	Asia	Genome Analysis Center, Yamanashi Central Hospital		2021-05-17	Yosuke Hirotsu et al	[object Object]	41	Female
Curacao/CW-RIVM-15641/2021		0.01	0.01		0.01	GR	3.00	20B	South America	Curacao	South America	Curacao	Human	South America	Dutch COVID-19 response team	B.1.1.519	South America	South America	National Institute for Public Health and the Environment (RIVM)		2021-02-21	Adam Meijer et al	[object Object]	70	
Mexico/GRO-InDRE_FB16218_S2683/2021		0.01	0.01		0.01	GR	3.00	20B	North America	Mexico	North America	Guerrero	Human	North America	LESP Guerrero	B.1.1.519	North America	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)		2021-05-20	Claudia Wong-Arambula et al	[object Object]	26	Male
Martinique/HCL021023920301/2021		0.01	0.01		0.01	GR	3.00	20B	France	France	France	Martinique	Human	Fort-de-France	HOPITAL UNIVERSITAIRE DE FORT DE FRANCE	B.1.1.519	Europe	Europe	CNR Virus des Infections Respiratoires - France SUD		2021-02-01	Antonin Bal et al	[object Object]	38	Female
Mexico/CMX-INMEGEN-02-03-23/2021		0.01	0.01		0.01	GR	3.00	20B	North America	Mexico	North America	Mexico City	Human	North America	Instituto Nacional de Medicina Genomica	B.1.1.519	North America	North America	Instituto Nacional de Medicina Genomica		2021-02-03	Hidalgo-Miranda A et al	[object Object]	49	Male
USA/AZ-ASU6490/2021		0.01	0.01		0.01	GR	4.00	20B	North America	USA	North America	Arizona	Human	North America	Arizona State University	B.1.1.519	North America	North America	Arizona State University		2021-06-02	Peter T. Skidmore et al	[object Object]		
Curacao/CW-RIVM-13575/2021		0.01	0.01		0.01	GR	3.00	20B	South America	Curacao	South America	Curacao	Human	South America	Dutch COVID-19 response team	B.1.1.519	South America	South America	National Institute for Public Health and the Environment (RIVM)		2021-02-08	Adam Meijer et al	[object Object]	21	
Mexico/MOR-InDRE_FB16233_S2586/2021		0.01	0.01		0.01	GR	3.00	20B	North America	Mexico	North America	Morelos	Human	North America	LESP Morelos	B.1.1.519	North America	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)		2021-05-18	Claudia Wong-Arambula et al	[object Object]	49	Female
Mexico/ZAC-InDRE_FB16085_S2667/2021		0.01	0.01		0.01	GR	3.00	20B	North America	Mexico	North America	Zacatecas	Human	North America	LESP Zacatecas	B.1.1.519	North America	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)		2021-05-17	Claudia Wong-Arambula et al	[object Object]	17	Male
Mexico/ZAC-InDRE_FB16086_S2668/2021		0.01	0.01		0.01	GR	3.00	20B	North America	Mexico	North America	Zacatecas	Human	North America	LESP Zacatecas	B.1.1.519	North America	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)		2021-05-17	Claudia Wong-Arambula et al	[object Object]	20	Female
Nigeria/S20/2020						GR	2.00	20B	Africa	Nigeria	Africa	Lagos	Human	Africa	Centre for Human Virology and Genomics, Microbiology Department, Nigerian Institute of Medical Research	B.1.1	Africa	Africa	Central Research Laboratory, Nigerian Institute of Medical Research		2020-10-12	Chika Kingsley Onwuamah et al	[object Object]	45	Male
Russia/LIP-CRIE-L188D0003b/2021						GR	2.00	20B	Russia	Russia	Lipetsk	Lipetsk	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-18	Samojlov A.E. et al	[object Object]	83	Male
Russia/SPE-RII-MH14667S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-14	Andrey Komissarov et al A	[object Object]	40	Male
Russia/MOW-RII-MH16146S/2021						GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	42	Male
Russia/MOW-CRIE-L106B1427b/2021						GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-02	Samojlov A.E. et al	[object Object]	64	Female
Russia/LIP-CRIE-L188E0263bhu/2021						GR	3.00	20B	Russia	Russia	Lipetsk	Lipetsk	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-04	Samoilov A.E. et al	[object Object]		Female
Russia/LIP-CRIE-L188H0261b/2021						GR	4.00	20B	Russia	Russia	Lipetsk	Lipetsk	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-08	Samojlov A.E. et al	[object Object]	66	Female
Poland/AODPiGM-104650/2021						GR	3.00	20B	Poland	Poland	Poland	Podlaskie	Human	Sokółka	Academic Center for Pathomorphological and Genetic-Molecular Diagnostics ltd, Bialystok, Poland	B.1.1	Europe	Europe	Academic Center for Pathomorphological and Genetic-Molecular Diagnostics ltd, Bialystok, Poland		2021-01-28	Radoslaw Charkiewicz et al	[object Object]	69	Female
Poland/NIPH-NIH_ECDC-2201/2021						GR	3.00	20B	Poland	Poland	Poland	Podlaskie	Human	Białystok	Regionalne Centrum Krwiodawstwa i Krwiolecznictwa w Białymstoku Pracownia Diagnostyki Molekularnej wirusa SARS-CoV-2	B.1.1	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-03-08	Wołkowicz Tomasz et al	[object Object]	35	Male
Germany/BW-RKI-I-042356/2021						GR	2.00	20B	Germany	Germany	Germany	Baden-Wuerttemberg	Human		MVZ Labor Dr. Limbach & Kollegen GbR	B.1.1.336	Europe	Europe	Robert Koch Institute		2021-02-15	?	[object Object]		
Russia/SVE-RII-MH15090S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Verkhnyaya Pyshma	UMMC-Health	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-15	Andrey Komissarov et al A	[object Object]	24	Female
Russia/SVE-RII-MH15291S/2021		0.03	0.01		0.02	GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Rezh	UMMC-Health	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-20	Andrey Komissarov et al A	[object Object]	69	Female
Russia/MOW-CRIE-L188K0300/2021						GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.336	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-11	Samoilov AE et al	[object Object]	23	Female
Russia/SPE-RII-MH6358S/2020						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.336	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-10	Andrey Komissarov et al A	[object Object]	53	Female
Russia/SPE-RII-MH15456S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Pushkin	HELIX LLC	B.1.1.336	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	31	Male
Russia/LEN-RII-MH14741S/2021						GR	2.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Gatchina	HELIX LLC	B.1.1.336	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-13	Andrey Komissarov et al A	[object Object]	74	Male
Russia/PSK-RII-MH14671S/2021						GR	2.00	20B	Russia	Russia	Pskov Oblast	Pskov Oblast	Human	Velikiye Luki	HELIX LLC	B.1.1.336	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-16	Andrey Komissarov et al A	[object Object]	27	Female
Russia/RYA-CRIE-L188M0001b/2021						GR	2.00	20B	Russia	Russia	Ryazan	Ryazan	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-17	Samoilov A.E. et al	[object Object]		Male
Russia/SPE-RII-30111S/2021						O	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.336	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-19	Andrey Komissarov et al A	[object Object]	70	Female
Russia/SPE-RII-34703S/2021						GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.336	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	24	Male
Russia/LEN-RII-MH14664S/2021						GR	2.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Sertolovo	HELIX LLC	B.1.1.336	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-14	Andrey Komissarov et al A	[object Object]	48	Female
Russia/TVE-CRIE-L106D1930b/2021						GR	3.00	20B	Russia	Russia	Tver	Tver	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-08	Samojlov A.E. et al	[object Object]	61	Male
Russia/MOW-CRIE-L188K0288h/2021						GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Infectious Diseases Hospital № 2	B.1.1.336	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-13	Samoilov AE et al	[object Object]	60	Female
Russia/MOW-CRIE-L188K0255u/2021						GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.336	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-13	Samoilov AE et al	[object Object]	85	Female
Russia/KOS-CRIE-L188K0008b/2021						GR	2.00	20B	Russia	Russia	Kostroma Region	Kostroma Region	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.336	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-10	Samojlov A.E. et al	[object Object]	69	Male
Russia/KOS-CRIE-L188K0009b/2021						GR	2.00	20B	Russia	Russia	Kostroma Region	Kostroma Region	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.336	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-11	Samojlov A.E. et al	[object Object]	80	Male
SouthKorea/KDCA1383/2020						GR	1.00	20B	Asia	Russia	Asia	Russia	Human	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency	B.1.1	Asia	Europe	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency		2020-10-16	Ae Kyung Park et al	[object Object]	62	Female
Russia/NGR-RII-MH14761S/2021						GR	3.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Veliky Novgorod	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-13	Andrey Komissarov et al A	[object Object]	62	Male
Russia/Novosibirsk-84101/2020						GR	1.00	20B	Russia	Russia	Novosibirsk	Novosibirsk	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-27	Sergey A. Bodnev et al	[object Object]	23	Female
Russia/AD-RII-MH2738S/2020						GR	3.00	20B	Russia	Russia	Adygea	Adygea	Human	Maykop	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-17	Andrey Komissarov et al A	[object Object]	46	Female
Russia/KR-RII-12691S/2020						GR	4.00	20B	Russia	Russia	Karelia	Karelia	Human	Kondopoga	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-18	Andrey Komissarov et al A	[object Object]	49	Male
Russia/IRK-RII-MH15603S/2020						GR	2.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human	Irkutsk	Department of Experimental Modeling and Pathogenesis of Infectious Diseases	B.1.1.317	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-01	Andrey Komissarov et al A	[object Object]		
Russia/SVE-RII-MH2840S/2020						GR	1.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Nizhny Tagil	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-24	Andrey Komissarov et al A	[object Object]	56	Female
Russia/StPetersburg-RII15221S/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-05-12	Andrey Komissarov et al A	[object Object]		Female
Russia/TA-KFU_154/2020						GR	1.00	20B	Russia	Russia	Tatarstan	Tatarstan	Human	Kazan	Kazan Federal University, Academic Consortium	B.1.1	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-09-10	Vladislav Babenko et al	[object Object]	47	Female
Russia/ROS-Cento-32316789/2020						GR	1.00	20B	Russia	Russia	Rostov	Rostov	Human	Rostov-On-Don	Centogene	B.1.1	Europe	Europe	Centogene		2020-07-22	Peter Bauer et al	[object Object]	21	Female
Russia/ROS-Cento-34968130/2020						GR	1.00	20B	Russia	Russia	Rostov	Rostov	Human	Rostov-On-Don	Centogene	B.1.1	Europe	Europe	Centogene		2020-07-22	Peter Bauer et al	[object Object]	23	Male
SierraLeone/KGH-G-8549/2020						GR	1.00	20B	Africa	Sierra Leone	Africa	Sierra Leone	Human	Africa	Kenema Government Hospital, Ministry of Health and Sanitation	B.1.1	Africa	Africa	Kenema Government Hospital, Ministry of Health and Sanitation		2020-03-31	Goba et al	[object Object]		
Netherlands/LI-MUMC-12/2020						GR	1.00	20B	Belgium	Belgium	Belgium	Tongeren	Human	Lanaken	Dutch COVID-19 response team	B.1.1	Europe	Europe	Medical Microbiology, Maastricht University Medical Centre		2020-04-06	Jozef Dingemans* et al	[object Object]	30	Female
Russia/SAR-RII-MH4702S/2020						GR	1.00	20B	Russia	Russia	Saratov	Saratov	Human	Balakovo	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-11	Andrey Komissarov et al A	[object Object]	57	Female
Russia/STA-RII-MH2786S/2020						GR	1.00	20B	Russia	Russia	Stavropol	Stavropol	Human	Stavropol	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-19	Andrey Komissarov et al A	[object Object]	29	Male
Russia/LEN-RII-MH6145S/2020						GR	2.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Volkhov	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-06	Andrey Komissarov et al A	[object Object]	37	Male
Russia/OMS-ORINFI-4764S/2020						GR	1.00	20B	Russia	Russia	Omsk	Omsk	Human	Omsk	Omsk Research Institute of Natural Focal Infections	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-05-02	Artem Fadeev et al	[object Object]	82	Female
Bangladesh/DNAS-CPH-isl-428/2020						GR	1.00	20B	Asia	Bangladesh	Asia	Bangladesh	Human	Asia	NGS Lab, DNA SOLUTION LTD.	B.1.1	Asia	Asia	NGS Lab, DNA SOLUTION LTD.		2020-04-29	Khan et al	[object Object]		
France/GES-42467870/2020						GR	2.00	20B	France	France	France	Grand Est	Human	Vieux Ferette	University Hospital Basel, Clinical Virology	B.1.160	Europe	Europe	University Hospital Basel, Clinical Bacteriology		2020-10-03	Tim Roloff et al	[object Object]		Female
Russia/ORE-RII-MH3441S/2020						GR	1.00	20B	Russia	Russia	Orenburg	Orenburg	Human	Orenburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	25	Male
Russia/IVA-RII-MH2794S/2020						GR	1.00	20B	Russia	Russia	Ivanovo	Ivanovo	Human	Ivanovo	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-23	Andrey Komissarov et al A	[object Object]	46	Male
Russia/SVE-RII-MH15822S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	HELIX LLC	B.1.1.83	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	39	Male
Russia/SVE-RII-MH15823S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Kachkanar	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-26	Andrey Komissarov et al A	[object Object]	80	Male
Russia/SVE-RII-MH16257S/2021						GR	1.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Kachkanar	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-02	Andrey Komissarov et al A	[object Object]	71	Female
Chile/RM-214978/2020						GR	1.00	20B	South America	Chile	South America	Region Metropolitana de Santiago	Human	South America	Genetica Molecular and Subdepartamento de Virologia ISP Chile	B.1.1	South America	South America	Instituto de Salud Publica de Chile		2020-10-25	Javier Tognarelli et al	[object Object]	28	Female
Oman/520258565/2020						GR	1.00	20B	Asia	Oman	Asia	Dakhiliyah	Human	Asia	Oman-National Influenza Center	B.1.1.27	Asia	Asia	Biotechnology & OMICs Laboratory		2020-09-15	Abdul Latif Khan et al	[object Object]	30	Female
Italy/APU-IZSPB_311PT/2020						GR	1.00	20B	Italy	Italy	Italy	Apulia	Human	Bari	I.R.C.C.S. "S. De Bellis" - Ente Ospedaliero	B.1.1.229	Europe	Europe	Istituto Zooprofilattico Sperimentale della Puglia e della Basilicata		2020-11-03	Parisi A. et al	[object Object]	20	Female
Russia/KLU-RII-MH3421S/2020						GR	1.00	20B	Russia	Russia	Kaluga	Kaluga	Human	Tovarkovo	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-06	Andrey Komissarov et al A	[object Object]	78	Female
Germany/BW-Cento-33129068/2020						GR	1.00	20B	Germany	Germany	Germany	Baden-Wuerttemberg	Human	Mannheim	Centogene	B.1.1	Europe	Europe	Centogene		2020-09-26	Peter Bauer et al	[object Object]	30	Male
Russia/MUR-RII-MH2065S/2020						GR	1.00	20B	Russia	Russia	Murmansk	Murmansk	Human	Murmansk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-24	Andrey Komissarov et al A	[object Object]	39	Female
Russia/MOS-CRIE-L106D0705b/2021						GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.74	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-07	Samojlov A.E. et al	[object Object]	74	Female
Russia/MOW-CRIE-L189P0301bh/2021	1.00	0.01	0.01	0.02	0.03	GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.34	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-22	Samoilov A.E. et al	[object Object]	35	Female
Russia/SPE-RII-MH15783S/2021	1.00	0.01	0.01	0.02	0.03	GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.74	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-20	Andrey Komissarov et al A	[object Object]	18	Female
Russia/MOW-CRIE-L188A1326/2021	1.00	0.01	0.01	0.02	0.03	GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.74	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-31	Samoilov AE et al	[object Object]	86	Female
Russia/ROS-RII-MH15918S/2021	1.00	0.01	0.01	0.02	0.03	GR	3.00	20B	Russia	Russia	Rostov	Rostov	Human	Rostov-On-Don	WHO National Influenza Centre Russian Federation	B.1.1.74	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-29	Andrey Komissarov et al A	[object Object]	38	Male
Russia/MOW-RII-MH16147S/2021	1.00	0.01	0.01	0.02	0.03	GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.74	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-28	Andrey Komissarov et al A	[object Object]	61	Female
Russia/VOR-RII-MH16190S/2021	1.00	0.01	0.01	0.02	0.03	GR	4.00	20B	Russia	Russia	Voronezh	Voronezh	Human	Voronezh	HELIX LLC	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-25	Andrey Komissarov et al A	[object Object]	69	Female
Switzerland/VS-33737146/2021	1.00	0.01	0.01	0.02	0.03	GR	3.00	20B	Switzerland	Switzerland	Switzerland	Valais	Human		University Hospitals of Geneva, Laboratory of Virology	B.1.1.74	Europe	Europe	HUG, Laboratory of Virology and the Health2030 Genome Center		2021-03-30	Samuel Cordey et al	[object Object]		
Russia/MOW-RII-MH16129S/2021	1.00	0.01	0.01	0.02	0.03	GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.74	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-02	Andrey Komissarov et al A	[object Object]	68	Female
Russia/SPE-RII-34524S/2021	1.00	0.01	0.01	0.02	0.03	GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.74	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	34	Male
Russia/ORE-RII-MH16166S/2021	1.00	0.01	0.01	0.02	0.03	GR	3.00	20B	Russia	Russia	Orenburg	Orenburg	Human	Orsk	HELIX LLC	B.1.1.98	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-03	Andrey Komissarov et al A	[object Object]	41	Male
Russia/ORE-RII-MH16123S/2021	1.00	0.01	0.01	0.02	0.03	GR	4.00	20B	Russia	Russia	Orenburg	Orenburg	Human	Orenburg	HELIX LLC	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-27	Andrey Komissarov et al A	[object Object]	56	Female
Russia/LEN-RII-MH15665S/2021	1.00	0.01	0.01	0.02	0.03	GR	4.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Sertolovo	HELIX LLC	B.1.1.74	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-15	Andrey Komissarov et al A	[object Object]	46	Female
Russia/KC-RII-MH18408S/2021	1.00	0.01	0.01	0.02	0.03	GR	4.00	20B	Russia	Russia	Karachay-Cherkess	Karachay-Cherkess	Human	Cherkessk	HELIX LLC	B.1.1.74	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-11	Andrey Komissarov et al A	[object Object]	61	Female
Russia/SPE-RII-MH15711S/2021	1.00	0.01	0.01	0.02	0.03	GR	4.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Veliky Novgorod	HELIX LLC	B.1.1.74	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	60	Male
Russia/NGR-RII-MH17353S/2021	1.00	0.01	0.01	0.02	0.03	GR	4.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Veliky Novgorod	WHO National Influenza Centre Russian Federation	B.1.1.74	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-06	Andrey Komissarov et al A	[object Object]	33	Female
Russia/SPE-RII-MH15681S/2021	1.00	0.01	0.01	0.02	0.03	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.74	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	44	Female
Russia/SPE-RII-26830S/2021	1.00	0.01	0.01	0.02	0.03	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.74	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]		Female
Russia/SPE-RII-MH14765S/2021	1.00	0.01	0.01	0.02	0.03	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.74	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-16	Andrey Komissarov et al A	[object Object]	42	Female
Russia/SPE-RII-MH14825S/2021	1.00	0.01	0.01	0.02	0.03	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]	27	Female
Russia/SPE-RII-MH16352S/2021	1.00	0.01	0.01	0.02	0.03	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-22	Andrey Komissarov et al A	[object Object]	46	
Russia/SPE-RII-MH15669S/2021	1.00	0.01	0.01	0.02	0.03	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	39	Female
Russia/SPE-RII-MH17828S/2021	1.00	0.01	0.01	0.02	0.03	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	44	Female
Georgia/Tb-1679/2020						GR	1.00	20B	Asia	Georgia	Asia	Tbilisi	Human	Asia	Department for Virology, Molecular Biology and Genome Research, R. G. Lugar Center for Public Health Research, National Center for Disease Control and Public Health (NCDC) of Georgia.	B.1.1	Asia	Asia	Department for Virology, Molecular Biology and Genome Research, R. G. Lugar Center for Public Health Research, National Center for Disease Control and Public Health (NCDC) of Georgia.		2020-04-01	Gvantsa Chanturia et al	[object Object]	49	Female
Russia/Buryatia-88903/2020						GR	1.00	20B	Russia	Russia	Buryatia	Buryatia	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-04-01	Oleg V. Pyankov et al	[object Object]	25	Male
Russia/un-IAIRAS-42/2020						GR	1.00	20B	Russia	Russia	Russia	Russia	Human		Department of Methods and Devices of Biotechnology and Medicine, Institute for Analytical Instrumentation RAS (IAI RAS)	B.1.1	Europe	Europe	Department of Methods and Devices of Biotechnology and Medicine, Institute for Analytical Instrumentation RAS (IAI RAS)		2020-04-21	Bocharova et al	[object Object]		
Denmark/DCGC-16743/2020	1.00	0.06	0.01		0.04	GR	2.00	20B	Denmark	Denmark	Denmark	Nordjylland	Human		Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark	B.1.1.298	Europe	Europe	Albertsen Lab, Department of Chemistry and Bioscience, Aalborg University, Denmark		2020-06-15	Danish Covid-19 Genome Consortium et al	[object Object]		
Russia/MOW-RSMU-GC-SAR053/2020						GR	1.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	FSBI «NATIONAL MEDICAL RESEARCH CENTER FOR OBSTETRICS, GYNECOLOGY AND PERINATOLOGY NAMED AFTER ACADEMICIAN V.I.KULAKOV» MINISTRY OF HEALTHCARE OF THE RUSSIAN FEDERATION	B.1.1	Europe	Europe	Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Medical University, Moscow, Russian Federation		2020-06-14	Yegor Botsmanov et al	[object Object]		
Sweden/20-21508/2020						GR	2.00	20B	Sweden	Sweden	Sweden	Uppsala	Human		Uppsala klinisk mikrobiologi	B.1.1	Europe	Europe	The Public Health Agency of Sweden		2020-07-10	Department of Microbiology et al	[object Object]	22	Female
Russia/BEL-RII-MH12660S/2020						GR	1.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human	Prokhorovka	Center of Hygiene and Epidemiology in Belgorod Region	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-01	Andrey Komissarov et al A	[object Object]	34	Female
Russia/KHM-RII-MH2930S/2020						GR	2.00	20B	Russia	Russia	Khanty-Mansi	Khanty-Mansi	Human	Nizhnevartovsk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-17	Andrey Komissarov et al A	[object Object]	40	Female
Russia/SPE-RII-MH6884S/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-06	Andrey Komissarov et al A	[object Object]	44	Female
Russia/NGR-RII-MH1404S/2020						GR	1.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Borovichi (Novgorod)	HELIX LCC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-10	Andrey Komissarov et al A	[object Object]	33	Female
Russia/NGR-RII-MH4539S/2020						GR	1.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Veliky Novgorod	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-29	Andrey Komissarov et al A	[object Object]	57	Female
Russia/YAR-RII-MH2862S/2020						GR	1.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human	Yaroslavl	HELIX LLC	B.1.1.427	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-27	Andrey Komissarov et al A	[object Object]	27	Male
Madagascar/IPM-01498/2021						G	2.00	20B	Africa	Madagascar	Africa	Haute Matsiatra	Human	Africa	Virology Unit, Institut Pasteur de Madagascar	B.1	Africa	Africa	Virology Unit, Institut Pasteur de Madagascar		2021-02-01	Christian Ranaivoson et al	[object Object]	24	Male
Russia/SVE-RII-MH2844S/2020						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Svobodny (Sverdlovsk)	HELIX LLC	B.1.1.274	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-26	Andrey Komissarov et al A	[object Object]	12	Female
Russia/TAM-RII-MH2858S/2020						GR	2.00	20B	Russia	Russia	Tambov Region	Tambov Region	Human	Morshansk	HELIX LLC	B.1.1.274	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-26	Andrey Komissarov et al A	[object Object]	20	Male
Chile/AT-CMM-00063/2020						GR	1.00	20B	South America	Chile	South America	Atacama	Human	South America	Laboratorio de Biologia Molecular, Facultad de Medicina, Universidad de Atacama	B.1.1	South America	South America	Center for Mathematical Modeling and Center for Genome Regulation. Santiago, Chile		2020-05-01	Gaete A et al	[object Object]	16	Female
Chile/AR-36001/2021						GR	3.00	20B	South America	Chile	South America	Araucanía	Human	South America	Genetica Molecular and Subdepartamento de Virologia ISP Chile	N.6	South America	South America	Instituto de Salud Publica de Chile		2021-02-03	Javier Tognarelli et al	[object Object]	55	Female
Russia/BEL-RII-MH17419S/2021						GR	1.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-07	Andrey Komissarov et al A	[object Object]		
Russia/un-IAIRAS-41/2020						GR	1.00	20B	Russia	Russia	Russia	Russia	Human		Department of Methods and Devices of Biotechnology and Medicine, Institute for Analytical Instrumentation RAS (IAI RAS)	B.1.1	Europe	Europe	Department of Methods and Devices of Biotechnology and Medicine, Institute for Analytical Instrumentation RAS (IAI RAS)		2020-04-21	Bocharova et al	[object Object]		
Russia/SAM-RARI-1011/2020						GR	1.00	20B	Russia	Russia	Samara	Samara	Human		Mikrobiologie, RARI	B.1.1	Europe	Europe	Mikrobiologie, RARI		2020-04-11	Krasnov et al	[object Object]		
Peru/LIM-INS-828/2020						GR	3.00	20B	South America	Peru	South America	Lima	Human	South America	Laboratorio de Referencia Nacional de Virus Respiratorio. Instituto Nacional de Salud Perú	B.1.1	South America	South America	Laboratorio de Referencia Nacional de Biotecnología y Biología Molecular. Instituto Nacional de Salud Perú		2020-11-18	Carlos Padilla Rojas et al	[object Object]	45	Female
Croatia/HRV000_228/2021						GR	1.00	20B	Croatia	Croatia	Croatia	Virovitica-Podravina County	Human		Public Health Institute of Virovitica-Podravina County	B.1.1.428	Europe	Europe	Croatian Institute of Public Health		2021-02-10	Irena Tabain et al	[object Object]	28	Female
Croatia/HRV000_229/2021						GR	1.00	20B	Croatia	Croatia	Croatia	Virovitica-Podravina County	Human		Public Health Institute of Osijek-Baranja County	B.1.1.428	Europe	Europe	Croatian Institute of Public Health		2021-02-10	Irena Tabain et al	[object Object]	31	Male
India/DL-NCDC-809143/2020						GR	2.00	20B	Asia	India	Asia	Delhi	Human	Asia	National Centre for Disease Control (NCDC) Biotechnology Division, Delhi	B.1.1.216	Asia	Asia	NCDC Delhi, Biotechnology Division INSACOG		2020-12-03	Manoj K Singh et al	[object Object]	56	Male
India/RJ-NCDC-1809303/2020						GR	1.00	20B	Asia	India	Asia	Rajasthan	Human	Asia	National Centre for Disease Control (NCDC) Biotechnology Division, Delhi	B.1.1.216	Asia	Asia	NCDC Delhi, Biotechnology Division INSACOG		2020-10-13	Kalaiarasan Ponnusamy et al	[object Object]	58	Male
Russia/OMS-ORINFI-2166S/2020						GR	1.00	20B	Russia	Russia	Omsk	Omsk	Human	Omsk	Omsk Research Institute of Natural Focal Infections	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-07-02	Artem Fadeev et al	[object Object]	74	Female
Russia/OMS-ORINFI-1322S/2020						GR	1.00	20B	Russia	Russia	Omsk	Omsk	Human	Omsk	Omsk Research Institute of Natural Focal Infections	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-02	Artem Fadeev et al	[object Object]	45	Female
Russia/CHE-RII-MH2861S/2020						GR	1.00	20B	Russia	Russia	Chelyabinsk	Chelyabinsk	Human	Ozyorsk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-23	Andrey Komissarov et al A	[object Object]	59	Female
Russia/SVE-RII-MH15195S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Verkhnyaya Pyshma	UMMC-Health	B.1.1.405	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-18	Andrey Komissarov et al A	[object Object]	49	Female
Algeria/G35014-8856/2020						GR	1.00	20B	Africa	Algeria	Africa	El Oued	Human	Africa	NIC Viral Respiratory Unit - Institut Pasteur of Algeria	B.1.1	Africa	Africa	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2020-06-09	Mélanie Albert et al	[object Object]	70	Male
Russia/SVE-RII-MH15813S/2021						GR	1.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Krasnoufimsk	HELIX LLC	B.1.1.387	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	59	Male
Russia/SVE-RII-MH16127S/2021						GR	1.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Kamyshlov	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-02	Andrey Komissarov et al A	[object Object]	60	Male
India/TG-CCMB-BA982/2020						GR	2.00	20B	Asia	India	Asia	Telangana	Human	Asia	CSIR-Centre for Cellular and Molecular Biology	B.1.1	Asia	Asia	CSIR-Centre for Cellular and Molecular Biology-INSACOG		2020-12-22	Payel Mukherjee et al	[object Object]	80	Female
India/DL-NCDC-809223/2020						GR	1.00	20B	Asia	India	Asia	Delhi	Human	Asia	National Centre for Disease Control (NCDC) Biotechnology Division, Delhi	B.1.1	Asia	Asia	NCDC Delhi, Biotechnology Division INSACOG		2020-11-25	Radhakrishnan V. S et al	[object Object]	65	Male
Malaysia/IMR-WI203/2020						GR	1.00	20B	Asia	Malaysia	Asia	Malaysia	Human	Asia	Institute for Medical Research, Infectious Disease Research Centre, National Institutes of Health, Ministry of Health Malaysia	B.1.1.354	Asia	Asia	Institute for Medical Research, Infectious Disease Research Centre, National Institutes of Health, Ministry of Health Malaysia		2020-09-29	Suppiah J et al	[object Object]	26	Male
Belgium/ULG-15277/2021		0.01			0.01	GR	3.00	20B	Belgium	Belgium	Belgium	Brussels	Human		SYNLAB	B.1.1.354	Europe	Europe	GIGA Medical Genomics		2021-04-30	Keith Durkin et al	[object Object]	35	Female
Russia/IRK-ICOV_014/2020						GR	2.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human		Federal State Public Scientific Institution В«Scientific РЎentre for Family Health and Human Reproduction ProblemsВ», Academic Consortium	B.1.1	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-07-18	Vladislav Babenko et al	[object Object]	21	Male
Russia/VOR-RII-MH2792S/2020						GR	1.00	20B	Russia	Russia	Voronezh	Voronezh	Human	Voronezh	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-26	Andrey Komissarov et al A	[object Object]	56	Female
Iran/Gilan-NICS1-58/2020						GR	1.00	20B	Asia	Iran	Asia	Gilan	Human	Asia	National Influenza Center, Virology Department	B.1.1	Asia	Asia	National Influenza Center		2020-08-22	NZ Shafiei Jandaghi et al	[object Object]		Male
Russia/KHM-RII-MH9266S/2020						GR	1.00	20B	Russia	Russia	Khanty-Mansi	Khanty-Mansi	Human	Nizhnevartovsk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-10	Andrey Komissarov et al A	[object Object]	48	Male
Russia/SVE-RII-MH16250S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Krasnoufimsk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-25	Andrey Komissarov et al A	[object Object]	70	Male
Russia/SVE-RII-MH16097S/2021						GR	1.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Krasnoufimsk	HELIX LLC	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-25	Andrey Komissarov et al A	[object Object]	66	Male
Russia/SVE-RII-MH16066S/2021						GR	1.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Krasnoufimsk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	62	Female
Russia/SVE-RII-MH15884S/2021						GR	1.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Krasnoufimsk	HELIX LLC	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-14	Andrey Komissarov et al A	[object Object]	61	Female
Russia/KDA-RII-MH15622S/2020						GR	1.00	20B	Russia	Russia	Krasnodar	Krasnodar	Human	Sochi	Department of Experimental Modeling and Pathogenesis of Infectious Diseases	B.1.1.16	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-10	Andrey Komissarov et al A	[object Object]		
Russia/MOS-RII-MH2807S/2020						GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Lapino	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-27	Andrey Komissarov et al A	[object Object]	37	Male
Russia/AMU-RII-MH18229S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Svobodny (Amur)	Svobodnensky Hospital	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-15	Andrey Komissarov et al A	[object Object]	70	Female
Russia/AMU-RII-MH18241S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Raychikhinsk	Raychikhinsk City Hospital	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-16	Andrey Komissarov et al A	[object Object]	69	Male
Russia/KHA-CRIE-L188V0245/2020						GR	2.00	20B	Russia	Russia	Khabarovsk	Khabarovsk	Human		Virological laboratory FBIH "The Center for Hygiene and Epidemiology in the Khabarovsk Region"	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2020-12-14	Samoilov AE et al	[object Object]	30	Male
Russia/SPE-RII-MH14354S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-01-15	Andrey Komissarov et al A	[object Object]	14	Male
Russia/AMU-RII-MH18255S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Zeya	Zeya Hospital	B.1.1.506	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-18	Andrey Komissarov et al A	[object Object]	65	Male
Russia/AMU-RII-MH18192S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Belogorsk	Belgorod Hospital	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-16	Andrey Komissarov et al A	[object Object]	80	Female
Russia/AMU-RII-MH18360S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Belogorsk	Belgorod Hospital	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-30	Andrey Komissarov et al A	[object Object]	19	Female
Russia/AMU-RII-MH18244S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Blagoveshchensk	Amur Region Children's City Clinical Hospital	B.1.1.506	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-17	Andrey Komissarov et al A	[object Object]	78	Male
Russia/AMU-RII-MH18356S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Tambovka	Tambov Hospital	B.1.1.506	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-30	Andrey Komissarov et al A	[object Object]	66	Male
Russia/SVE-RII-MH2964S/2020						GR	1.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	HELIX LLC	B.1.1.364	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-02	Andrey Komissarov et al A	[object Object]	37	Female
Russia/TYU-RII-MH3116S/2020						GR	1.00	20B	Russia	Russia	Tyumen Region	Tyumen Region	Human	Tyumen	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-03	Andrey Komissarov et al A	[object Object]	38	Male
Russia/LEN-RII-MH3119S/2020						GR	1.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Gatchina	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-01	Andrey Komissarov et al A	[object Object]	42	Male
Russia/MOW-RII-MH16157S/2021						GR	1.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-23	Andrey Komissarov et al A	[object Object]	33	Female
Russia/PER-RII-MH1950S/2020						GR	1.00	20B	Russia	Russia	Perm Krai	Perm Krai	Human	Perm	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-16	Andrey Komissarov et al A	[object Object]	36	Male
Russia/KLU-RII-MH3423S/2020						GR	2.00	20B	Russia	Russia	Kaluga	Kaluga	Human	Tovarkovo	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-06	Andrey Komissarov et al A	[object Object]	90	Female
Russia/ROS-Cento-37159082/2020						GR	1.00	20B	Russia	Russia	Rostov	Rostov	Human	Rostov-On-Don	Centogene	B.1.1	Europe	Europe	Centogene		2020-07-22	Peter Bauer et al	[object Object]	43	Female
Russia/ROS-Cento-37463019/2020						GR	1.00	20B	Russia	Russia	Rostov	Rostov	Human	Rostov-On-Don	Centogene	B.1.1	Europe	Europe	Centogene		2020-07-22	Peter Bauer et al	[object Object]	62	Male
Russia/NGR-RII-MH1705S/2020						GR	1.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Veliky Novgorod	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-19	Andrey Komissarov et al A	[object Object]	35	Male
Russia/RYA-CRIE-L188S0155bh/2021		0.01			0.01	GR	3.00	20B	Russia	Russia	Ryazan	Ryazan	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.349	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-24	Samoilov A.E. et al	[object Object]	35	Male
Mongolia/2742/2020						GR	1.00	20B	Asia	Mongolia	Asia	Mongolia	Human	Asia	National Center for Communicable Diseases (NCCD) National Influenza Center	B.1.1.349	Asia	Asia	National Center for Communicable Diseases (NCCD) National Influenza Center		2020-11-24	Naranzul Ts et al	[object Object]	14	Male
Russia/PRI-RII-MH931S/2020						GR	1.00	20B	Russia	Russia	Primorsky	Primorsky	Human	Vladivostok	WHO National Influenza Centre Russian Federation	B.1.1.349	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-08-12	Andrey Komissarov et al A	[object Object]	60	Female
Russia/SVE-RII-MH15791S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human		HELIX LLC	B.1.1.349	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	55	Male
Russia/VGG-RII-MH16242S/2021						GR	1.00	20B	Russia	Russia	Volgograd Region	Volgograd Region	Human	Novoanninsky	HELIX LLC	B.1.1.349	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-18	Andrey Komissarov et al A	[object Object]	25	Male
Russia/StPetersburg-RII11168S/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-05-02	Andrey Komissarov et al A	[object Object]	39	Female
Russia/MOW-FCOV_016/2020						GR	1.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Biomedical Agency of the Russian Federation, Academic Consortium	B.1.1	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-06-14	Vladislav Babenko et al	[object Object]	68	Female
Russia/SVE-RII-MH182S/2020						GR	1.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-06-26	Andrey Komissarov et al A	[object Object]	52	Female
Russia/STA-RII-MH2785S/2020						GR	2.00	20B	Russia	Russia	Stavropol	Stavropol	Human	Yessentuki	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-20	Andrey Komissarov et al A	[object Object]	86	Male
Russia/OMS-ORINFI-1141S/2020						GR	1.00	20B	Russia	Russia	Omsk	Omsk	Human	Omsk	Omsk Research Institute of Natural Focal Infections	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-08-18	Artem Fadeev et al	[object Object]	62	Female
Russia/NGR-RII-MH2939S/2020						GR	1.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Chudovo	HELIX LLC	B.1.1.481	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-30	Andrey Komissarov et al A	[object Object]	55	Female
Russia/LEN-RII-MH3121S/2020						GR	1.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Vsevolozhsk	HELIX LLC	B.1.1.481	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-01	Andrey Komissarov et al A	[object Object]	59	Male
Russia/SAR-RARI-9895/2020						GR	1.00	20B	Russia	Russia	Saratov	Saratov	Human		Mikrobiologie, RARI	B.1.1	Europe	Europe	Mikrobiologie, RARI		2020-07-22	Krasnov et al	[object Object]		
Russia/YAR-RII-MH2864S/2020						GR	1.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human	Yaroslavl	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-24	Andrey Komissarov et al A	[object Object]	56	Male
Sweden/20-53054/2020						GR	1.00	20B	Sweden	Sweden	Sweden	Gavleborgs Lan	Human		Gavle klinisk mikrobiologi	B.1.1	Europe	Europe	The Public Health Agency of Sweden		2020-09-21	Department of Microbiology et al	[object Object]	85	Male
Russia/SPE-RII-22207V/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-06-08	Andrey Komissarov et al A	[object Object]	55	Female
Zimbabwe/ZW-28983/2020						GR	1.00	20B	Africa	Zimbabwe	Africa	Zimbabwe	Human	Africa	National Microbiology Reference Laboratory	B.1	Africa	Africa	Quadram Institute Bioscience		2020-09-01	Tapfumanei Mashe et al	[object Object]	36	Male
Zimbabwe/ZW-34550/2020						GR	1.00	20B	Africa	Zimbabwe	Africa	Zimbabwe	Human	Africa	National Microbiology Reference Laboratory	B.1.1	Africa	Africa	Quadram Institute Bioscience		2020-10-19	Tapfumanei Mashe et al	[object Object]	46	Female
Russia/OMS-ORINFI-3970S/2020						GR	1.00	20B	Russia	Russia	Omsk	Omsk	Human	Novovarshavka	Omsk Research Institute of Natural Focal Infections	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-07-08	Artem Fadeev et al	[object Object]	50	Female
Zimbabwe/ZW-25731/2020						GR	1.00	20B	Africa	Zimbabwe	Africa	Zimbabwe	Human	Africa	National Microbiology Reference Laboratory	B.1	Africa	Africa	Quadram Institute Bioscience		2020-08-17	Tapfumanei Mashe et al	[object Object]	65	Male
Russia/SPE-RII-MH15652S/2021	1.00	0.07	0.01	0.01	0.04	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-26	Andrey Komissarov et al A	[object Object]	29	Male
Russia/SPE-RII-MH15705S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-16	Andrey Komissarov et al A	[object Object]	30	Male
Russia/SPE-RII-29158S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-08	Andrey Komissarov et al A	[object Object]	84	Female
Russia/SPE-RII-MH15466S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	27	Male
Russia/SPE-RII-30103S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-16	Andrey Komissarov et al A	[object Object]	63	Female
Madagascar/IPM-40265/2020						GR	2.00	20B	Africa	Madagascar	Africa	Analamanga	Human	Africa	Virology Unit, Institut Pasteur de Madagascar	B.1.1	Africa	Africa	Virology Unit, Institut Pasteur de Madagascar		2020-12-23	Christian Ranaivoson et al	[object Object]	85	Female
Madagascar/IPM-00648/2021						GR	2.00	20B	Africa	Madagascar	Africa	Analamanga	Human	Africa	Virology Unit, Institut Pasteur de Madagascar	B.1.1	Africa	Africa	Virology Unit, Institut Pasteur de Madagascar		2021-01-11	Marion Barbet et al	[object Object]	44	Female
Turkey/26_Ankara_GUMV_50546/2020						GR	1.00	20B	Turkey	Turkey	Turkey	Ankara	Human		Gazi University Faculty of Medicine, Medical Virology Laboratory	B.1.1	Europe	Europe	Gazi University Faculty of Medicine, Medical Virology Laboratory		2020-11-20	Erdem Şahin et al	[object Object]		
Turkey/HSGM-202605/2020						GR	1.00	20B	Turkey	Turkey	Turkey	Turkey	Human		Ministry of Health Turkey	B.1.1	Europe	Europe	Ministry of Health Turkey		2020-12-28	Fatma Bayrakdar et al B	[object Object]		
Peru/LIM-INS-524/2020						GR	1.00	20B	South America	Peru	South America	Lima	Human	South America	Laboratorio de Referencia Nacional de Enteropatógenos. Instituto Nacional de Salud del Perú	B.1.1	South America	South America	Laboratorio de Referencia Nacional de Enteropatógenos. Instituto Nacional de Salud del Perú		2020-08-19	Ronnie Gavilan Chavez et al	[object Object]		
Lithuania/MR-LUHS-Eilnr442/2020						GR	2.00	20B	Lithuania	Lithuania	Lithuania	Taurages Apskritis	Human		Lithuanian University of Health Sciences Hospital, Department of Laboratory Medicine	B.1.1.280	Europe	Europe	Lithuanian University of Health Sciences, Molecular cardiology lab.		2020-09-06	Lukas Zemaitis et al	[object Object]	34	Female
Russia/KEM-RII-MH9291S/2020						GR	2.00	20B	Russia	Russia	Kemerovo	Kemerovo	Human	Kemerovo	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-12	Andrey Komissarov et al A	[object Object]	37	Male
Russia/KEM-RII-MH9345S/2020						GR	2.00	20B	Russia	Russia	Kemerovo	Kemerovo	Human	Novokuznetsk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-12	Andrey Komissarov et al A	[object Object]	32	Female
Russia/LEN-RII-MH2053S/2020						GR	2.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Kirovsk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-28	Andrey Komissarov et al A	[object Object]	36	Female
Russia/SVE-RII-MH8829S/2020						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Ivdel	UMMC-Health	B.1.1.452	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-01	Andrey Komissarov et al A	[object Object]	36	Female
Russia/LEN-RII-MH5654S/2020						GR	2.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Yanino-1	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-09	Andrey Komissarov et al A	[object Object]	54	Female
Russia/KYA-RII-MH10332S/2020						GR	2.00	20B	Russia	Russia	Krasnoyarsk	Krasnoyarsk	Human	Krasnoyarsk	Krasnoyarsk Regional Clinical Hospital	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-21	Andrey Komissarov et al A	[object Object]	66	Female
Russia/PSK-RII-MH6331S/2020						GR	2.00	20B	Russia	Russia	Pskov Oblast	Pskov Oblast	Human	Velikiye Luki	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-09	Andrey Komissarov et al A	[object Object]	51	Female
Russia/IRK-RII-MH15597S/2020						GR	2.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human	Irkutsk	Department of Experimental Modeling and Pathogenesis of Infectious Diseases	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-22	Andrey Komissarov et al A	[object Object]		
Russia/SPE-RII-MH5893S/2020						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-06	Andrey Komissarov et al A	[object Object]	55	Male
Russia/BEL-RII-MH12811S/2020						GR	2.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human	Stary Oskol	Center of Hygiene and Epidemiology in Belgorod Region	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-30	Andrey Komissarov et al A	[object Object]	53	Female
Russia/SVE-RII-MH15238S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Sysert	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-19	Andrey Komissarov et al A	[object Object]	31	Male
Russia/SVE-RII-MH15205S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Sysert	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-18	Andrey Komissarov et al A	[object Object]	60	Female
Russia/NVS-RII-MH1087V/2020						GR	2.00	20B	Russia	Russia	Novosibirsk	Novosibirsk	Human	Novosibirsk	WHO National Influenza Centre Russian Federation	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-07-22	Andrey Komissarov et al A	[object Object]	47	Male
Russia/RYA-RII-MH3361S/2020						GR	2.00	20B	Russia	Russia	Ryazan	Ryazan	Human	Ryazan	HELIX LLC	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	33	Female
Russia/MOW-RII-MH16082S/2021						GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	31	Female
Russia/LEN-RII-MH14844S/2021						GR	2.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Kirovsk	HELIX LLC	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-21	Andrey Komissarov et al A	[object Object]	44	Female
Russia/MAG-RII-MH13951S/2020						GR	2.00	20B	Russia	Russia	Magadan	Magadan	Human	Magadan	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-18	Andrey Komissarov et al A	[object Object]	75	Male
Russia/IRK-RII-MH15604S/2020						GR	2.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human	Irkutsk	Department of Experimental Modeling and Pathogenesis of Infectious Diseases	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-09	Andrey Komissarov et al A	[object Object]		
Russia/KR-RII-12119S/2020						GR	2.00	20B	Russia	Russia	Karelia	Karelia	Human	Petrozavodsk	WHO National Influenza Centre Russian Federation	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-17	Andrey Komissarov et al A	[object Object]	59	Female
Russia/MOS-CRIE-13380178/2020						GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.141	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2020-11-06	Samoilov AE et al	[object Object]	39	Male
Russia/SVE-RII-MH16248S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	HELIX LLC	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-25	Andrey Komissarov et al A	[object Object]	63	Male
Russia/CU-RII-MH18398S/2021						GR	4.00	20B	Russia	Russia	Chuvash Republic	Chuvash Republic	Human	Cheboksary	HELIX LLC	B.1.1.282	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-18	Andrey Komissarov et al A	[object Object]	39	Female
Russia/MOW-RII-MH15899/2021		0.01	0.01		0.02	GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Zelenograd	Pathogenic Microorganisms Variability Laboratory	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-19	Andrey Komissarov et al A	[object Object]	83	Female
Russia/SVE-RII-MH15218S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	UMMC-Health	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-19	Andrey Komissarov et al A	[object Object]	23	Female
Russia/MOS-RII-MH16181S/2021						GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Khimki	HELIX LLC	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-19	Andrey Komissarov et al A	[object Object]	37	Male
Russia/SPE-RII-MH18153S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	74	Male
Russia/SVE-RII-MH15243S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Verkhnyaya Pyshma	UMMC-Health	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-19	Andrey Komissarov et al A	[object Object]	64	Male
Russia/SVE-RII-MH15277S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Verkhnyaya Pyshma	UMMC-Health	B.1.1.141	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-19	Andrey Komissarov et al A	[object Object]	57	Female
Russia/MOW-CRIE-D187L0035bu/2021						GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-16	Samoilov A.E. et al	[object Object]	36	Female
Russia/YAR-CRIE-L188D0014b/2021						GR	2.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-03	Samojlov A.E. et al	[object Object]	73	Female
Russia/YAR-CRIE-L188D0021b/2021						GR	3.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-02	Samojlov A.E. et al	[object Object]	86	Female
Russia/SVE-RII-MH15244S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Verkhnyaya Pyshma	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-19	Andrey Komissarov et al A	[object Object]	74	Male
Russia/IRK-RII-MH15607S/2020						GR	2.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human	Irkutsk	Department of Experimental Modeling and Pathogenesis of Infectious Diseases	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-09	Andrey Komissarov et al A	[object Object]		
Russia/AMU-RII-MH18330S/2021						GR	2.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Blagoveshchensk	RZD Medicine	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-26	Andrey Komissarov et al A	[object Object]	33	Female
Russia/KK-RII-MH9337S/2020						GR	2.00	20B	Russia	Russia	Khakassia	Khakassia	Human	Abakan	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-10	Andrey Komissarov et al A	[object Object]	37	Male
Russia/AST-RII-MH14483S/2020						GR	2.00	20B	Russia	Russia	Astrakhan Region	Astrakhan Region	Human	Kamyzyak	Pathogenic Microorganisms Variability Laboratory	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-13	Andrey Komissarov et al A	[object Object]	81	Female
Russia/STA-RII-MH16240S/2021						GR	3.00	20B	Russia	Russia	Stavropol	Stavropol	Human	Pyatigorsk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-19	Andrey Komissarov et al A	[object Object]	68	Female
Kazakhstan/115579/2020						GR	3.00	20B	Asia	Kazakhstan	Asia	Almaty	Human	Asia	Laboratory of virology, National center of expertise	B.1.1	Asia	Asia	RSE "National Center for Biotechnology" and RSE "National Center of Expertise"		2020-11-17	Shevtsov Alexandr et al	[object Object]	13	
Russia/SPE-RII-MH14611S/2021						GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-14	Andrey Komissarov et al A	[object Object]	23	Female
Russia/BEL-RII-MH12678S/2020						GR	2.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human	Valuyki	Center of Hygiene and Epidemiology in Belgorod Region	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-02	Andrey Komissarov et al A	[object Object]	20	Male
Russia/OMS-ORINFI-MH10270S/2020						GR	2.00	20B	Russia	Russia	Omsk	Omsk	Human	Omsk	Omsk Research Institute of Natural Focal Infections	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-02	Andrey Komissarov et al A	[object Object]	63	Female
Russia/SPE-RII-MH14653S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-14	Andrey Komissarov et al A	[object Object]	26	Female
Russia/SPE-RII-30159S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-17	Andrey Komissarov et al A	[object Object]	6	Female
Russia/KK-RII-MH2760S/2020						GR	2.00	20B	Russia	Russia	Khakassia	Khakassia	Human	Abakan	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-18	Andrey Komissarov et al A	[object Object]	26	Male
Russia/SVE-RII-MH15293S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Verkhnyaya Pyshma	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-20	Andrey Komissarov et al A	[object Object]	30	Female
Russia/MUR-RII-MH6041S/2020						GR	2.00	20B	Russia	Russia	Murmansk	Murmansk	Human	Murmansk	HELIX LLC	B.1.1.485	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-12	Andrey Komissarov et al A	[object Object]	36	Male
Russia/MOW-RII-MH16125S/2021						GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-20	Andrey Komissarov et al A	[object Object]	39	Female
Russia/MOS-RII-MH16213S/2021						GR	2.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Podolsk	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-18	Andrey Komissarov et al A	[object Object]	53	Male
Russia/SPE-RII-MH14758S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-16	Andrey Komissarov et al A	[object Object]	29	Female
Russia/SPE-RII-MH14652S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.51	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-14	Andrey Komissarov et al A	[object Object]	37	Male
Russia/SPE-RII-MH14733S/2021						GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.51	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-13	Andrey Komissarov et al A	[object Object]	68	Female
Russia/IRK-RII-MH15596S/2020						GR	2.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human	Irkutsk	Department of Experimental Modeling and Pathogenesis of Infectious Diseases	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-21	Andrey Komissarov et al A	[object Object]		
Russia/SVE-RII-MH16120S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Nizhny Tagil	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-18	Andrey Komissarov et al A	[object Object]	70	Female
Russia/KDA-RII-MH5076S/2020						GR	3.00	20B	Russia	Russia	Krasnodar	Krasnodar	Human	Novorossiysk	WHO National Influenza Centre Russian Federation	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-05	Andrey Komissarov et al A	[object Object]	71	Male
Russia/BEL-RII-MH17754S/2021						O	2.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-11	Andrey Komissarov et al A	[object Object]	47	
Russia/TA-2KFU_COV_25/2020						GR	3.00	20B	Russia	Russia	Tatarstan	Tatarstan	Human	Kazan	Kazan Federal University, Academic Consortium	B.1.1	Europe	Europe	FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL-CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY, Academic Consortium		2020-11-17	Vladislav Babenko et al	[object Object]	61	Male
Russia/SVE-RII-MH15821S/2021						GR	4.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Berezovsky	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	36	Male
Russia/SVE-RII-MH16182S/2021						GR	4.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-04	Andrey Komissarov et al A	[object Object]	69	Male
Russia/PER-RII-MH15890S/2021						GR	3.00	20B	Russia	Russia	Perm Krai	Perm Krai	Human	Perm	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-04	Andrey Komissarov et al A	[object Object]	53	Male
Russia/SVE-RII-MH14941S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Sredneuralsk	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-11	Andrey Komissarov et al A	[object Object]	37	Female
Russia/SVE-RII-MH15048S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Verkhnyaya Pyshma	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-11	Andrey Komissarov et al A	[object Object]	50	Male
Russia/SVE-RII-MH15130S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-16	Andrey Komissarov et al A	[object Object]	64	Female
Russia/SVE-RII-MH15127S/2021						GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-16	Andrey Komissarov et al A	[object Object]	58	Male
Russia/KDA-RII-MH2766S/2020						GR	3.00	20B	Russia	Russia	Krasnodar	Krasnodar	Human	Krasnodar	HELIX LLC	B.1.1.31	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-22	Andrey Komissarov et al A	[object Object]	27	Female
Russia/LIP-CRIE-L188E0265bh/2021						GR	2.00	20B	Russia	Russia	Lipetsk	Lipetsk	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-04	Samoilov A.E. et al	[object Object]		Female
Russia/SVE-RII-MH15204S/2021						O	4.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-18	Andrey Komissarov et al A	[object Object]	31	Male
Russia/TAM-CRIE-L188K0231u/2021						GR	3.00	20B	Russia	Russia	Tambov Region	Tambov Region	Human		Federal Budget Health Care Institution "Center of Hygiene and Epidemiology in Tambov region"	B.1.1.117	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-07	Samoilov AE et al	[object Object]	78	Male
Russia/MOW-RII-MH16135S/2021						GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	48	Female
Russia/MOW-RII-MH16089S/2021						GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-25	Andrey Komissarov et al A	[object Object]	44	Female
Russia/NIZ-RII-MH16057S/2021						GR	3.00	20B	Russia	Russia	Nizhny Novgorod	Nizhny Novgorod	Human	Nizhny Novgorod	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-19	Andrey Komissarov et al A	[object Object]	61	Male
Russia/NIZ-RII-MH16224S/2021						GR	3.00	20B	Russia	Russia	Nizhny Novgorod	Nizhny Novgorod	Human	Nizhny Novgorod	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-04	Andrey Komissarov et al A	[object Object]	2	Male
Russia/MOW-CRIE-L188A1328/2021						GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-31	Samoilov AE et al	[object Object]	72	Female
Russia/SPE-RII-MH15782S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	33	Female
Russia/SVE-RII-MH15288S/2021						GR	4.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-21	Andrey Komissarov et al A	[object Object]	57	Female
Russia/SVE-RII-MH15082S/2021						GR	4.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-15	Andrey Komissarov et al A	[object Object]	37	Male
Russia/SVE-RII-MH15266S/2021						GR	4.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-20	Andrey Komissarov et al A	[object Object]	2	Male
Russia/RYA-CRIE-L188K0277u/2021						GR	3.00	20B	Russia	Russia	Ryazan	Ryazan	Human		Federal Budget Health Care Institution "Center of Hygiene and Epidemiology in Ryazan region"	B.1.1.54	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-12	Samoilov AE et al	[object Object]	61	Female
Russia/STA-RII-MH15807S/2021						GR	3.00	20B	Russia	Russia	Stavropol	Stavropol	Human	Yessentuki	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	41	Female
Russia/MOW-CRIE-L189P0475u/2021						GR	4.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-22	Samojlov A.E. et al	[object Object]	68	Female
Russia/SMO-CRIE-L188B0037b/2021						GR	3.00	20B	Russia	Russia	Smolensk Region	Smolensk Region	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-23	Samojlov A.E. et al	[object Object]	60	Female
Russia/MOW-CRIE-L188K0301hu/2021						GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Infectious Diseases Hospital № 2	B.1.526	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-10	Samoilov AE et al	[object Object]	27	Male
Russia/SVE-RII-MH15119S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Verkhnyaya Pyshma	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-15	Andrey Komissarov et al A	[object Object]	41	Female
Russia/AMU-RII-MH18298S/2021						GR	3.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Tambovka	Tambov Hospital	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-23	Andrey Komissarov et al A	[object Object]	55	Female
Russia/SPE-RII-31084S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-29	Andrey Komissarov et al A	[object Object]	67	Female
Russia/SPE-RII-MH14696S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	57	Male
Russia/SPE-RII-29160S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-08	Andrey Komissarov et al A	[object Object]	82	Female
Russia/LEN-RII-MH14317S/2021						GR	3.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Sosnovyi Bor	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-01-05	Andrey Komissarov et al A	[object Object]	60	Female
Russia/SPE-RII-MH14628S/2021						GR	5.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.132	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-14	Andrey Komissarov et al A	[object Object]	30	Female
Russia/SPE-RII-MH15695S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	73	Female
Russia/SE-RII-MH16205S/2021						GR	3.00	20B	Russia	Russia	Republic of North Ossetia-Alania	Republic of North Ossetia-Alania	Human	Digora	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-27	Andrey Komissarov et al A	[object Object]	60	Male
Russia/SPE-RII-MH14830S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]	33	Female
Russia/BEL-RII-MH17394S/2021						GR	3.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-06	Andrey Komissarov et al A	[object Object]	29	
Russia/AMU-RII-MH18254S/2021						GR	4.00	20B	Russia	Russia	Amur Region	Amur Region	Human	Zeya	Zeya Hospital	B.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-18	Andrey Komissarov et al A	[object Object]	49	Male
Russia/LEN-RII-MH14656S/2021						GR	3.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Lomonosov	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-11	Andrey Komissarov et al A	[object Object]	30	Female
Russia/SPE-RII-MH14323S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-01-13	Andrey Komissarov et al A	[object Object]	38	Female
Russia/SPE-RII-MH14782S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-12	Andrey Komissarov et al A	[object Object]	30	Female
Russia/SPE-RII-MH14704S/2021						GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-10	Andrey Komissarov et al A	[object Object]	44	Female
Russia/SPE-RII-MH15447S/2021						GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	60	Female
Russia/KR-RII-MH16400S/2021						GR	3.00	20B	Russia	Russia	Karelia	Karelia	Human		Republican Infectious Diseases Hospital	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-28	Andrey Komissarov et al A	[object Object]	66	Female
Russia/KR-RII-MH16416S/2021						GR	3.00	20B	Russia	Russia	Karelia	Karelia	Human		Republican Infectious Diseases Hospital	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-24	Andrey Komissarov et al A	[object Object]	68	Female
Russia/SPE-RII-MH15671S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-15	Andrey Komissarov et al A	[object Object]	23	Female
Russia/SPE-RII-MH17338S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-23	Andrey Komissarov et al A	[object Object]	34	Male
Russia/SPE-RII-MH15662S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	47	Female
Russia/SPE-RII-MH15761S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-11	Andrey Komissarov et al A	[object Object]	33	Female
Russia/SPE-RII-MH15676S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	63	Male
Russia/IRK-RII-MH15600S/2020						GR	3.00	20B	Russia	Russia	Irkutsk Region	Irkutsk Region	Human	Irkutsk	Department of Experimental Modeling and Pathogenesis of Infectious Diseases	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-30	Andrey Komissarov et al A	[object Object]		
Russia/SPE-RII-MH16270S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-19	Andrey Komissarov et al A	[object Object]	32	Female
Russia/IVA-RII-MH11765S/2020						GR	3.00	20B	Russia	Russia	Ivanovo	Ivanovo	Human	Kineshma	WHO National Influenza Centre Russian Federation	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-06	Andrey Komissarov et al A	[object Object]	69	Male
Russia/TAM-RII-MH2856S/2020		0.01	0.05	0.05	0.06	GR	4.00	20B	Russia	Russia	Tambov Region	Tambov Region	Human	Morshansk	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-26	Andrey Komissarov et al A	[object Object]	32	Female
Russia/NGR-RII-MH14660S/2021						GR	3.00	20B	Russia	Russia	Novgorod	Novgorod	Human	Veliky Novgorod	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]	30	Male
Russia/LEN-RII-MH14325S/2021						GR	3.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Tosno	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-01-05	Andrey Komissarov et al A	[object Object]	65	Male
Russia/SPE-RII-MH14681S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-14	Andrey Komissarov et al A	[object Object]	63	Female
Russia/LEN-RII-MH14740S/2021						GR	3.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Roshchino	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]	66	Male
Russia/SPE-RII-32838S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-24	Andrey Komissarov et al A	[object Object]	30	Male
Russia/SVE-RII-MH16243S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-25	Andrey Komissarov et al A	[object Object]	71	Female
Russia/SPE-RII-MH15448S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	40	Female
Russia/SVE-RII-MH15050S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Verkhnyaya Pyshma	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-13	Andrey Komissarov et al A	[object Object]	42	Female
Russia/SVE-RII-MH15157S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Sredneuralsk	UMMC-Health	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-15	Andrey Komissarov et al A	[object Object]	47	Female
Russia/SVE-RII-MH15227S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Sredneuralsk	UMMC-Health	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-18	Andrey Komissarov et al A	[object Object]	40	Female
Russia/SVE-RII-MH15258S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Sredneuralsk	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-18	Andrey Komissarov et al A	[object Object]	62	Female
Russia/SVE-RII-MH15158S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Sredneuralsk	UMMC-Health	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-16	Andrey Komissarov et al A	[object Object]	37	Male
Russia/SVE-RII-MH15110S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Sredneuralsk	UMMC-Health	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-15	Andrey Komissarov et al A	[object Object]	43	Female
Russia/SVE-RII-MH15300S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Sredneuralsk	UMMC-Health	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-18	Andrey Komissarov et al A	[object Object]	66	Female
Russia/SVE-RII-MH15228S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Sredneuralsk	UMMC-Health	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-18	Andrey Komissarov et al A	[object Object]	37	Male
Russia/KGD-RII-MH7049S/2020						GR	3.00	20B	Russia	Russia	Kaliningrad Region	Kaliningrad Region	Human	Kaliningrad	WHO National Influenza Centre Russian Federation	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-26	Andrey Komissarov et al A	[object Object]	43	Male
Russia/KR-RII-12884S/2020						GR	3.00	20B	Russia	Russia	Karelia	Karelia	Human	Derevyanka	WHO National Influenza Centre Russian Federation	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-18	Andrey Komissarov et al A	[object Object]	80	Female
Russia/SPE-RII-MH14742S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]	83	Male
Russia/VLA-RII-MH16255S/2021						GR	3.00	20B	Russia	Russia	Vladimir Region	Vladimir Region	Human	Kovrov	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-26	Andrey Komissarov et al A	[object Object]	88	Male
Russia/MOW-CRIE-L189B0937b/2021						GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-02	Samojlov A.E. et al	[object Object]	45	Female
Russia/LIP-CRIE-L188E0262b/2021						GR	2.00	20B	Russia	Russia	Lipetsk	Lipetsk	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-04	Samoilov A.E. et al	[object Object]		Male
Russia/BEL-RII-MH17519S/2021						GR	4.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-15	Andrey Komissarov et al A	[object Object]	70	
Russia/MOW-RII-MH16219S/2021						GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	37	Male
Russia/SPE-RII-MH14722S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]	33	Female
Russia/SPE-RII-MH15675S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	67	Female
Russia/SPE-RII-MH15693S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	88	Female
Russia/SPE-RII-MH15733S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	48	Male
Russia/SVE-RII-MH15834S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Kamyshlov	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	53	Female
Russia/SVE-RII-MH15833S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Kamyshlov	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	48	Female
Russia/SVE-RII-MH16234S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-21	Andrey Komissarov et al A	[object Object]	18	Female
Russia/SVE-RII-MH15270S/2021						GR	4.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Verkhnyaya Pyshma	UMMC-Health	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-19	Andrey Komissarov et al A	[object Object]	57	Female
Russia/SVE-RII-MH15276S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Verkhnyaya Pyshma	UMMC-Health	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-18	Andrey Komissarov et al A	[object Object]	60	Female
Russia/SVE-RII-MH15281S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Olhovka	UMMC-Health	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-20	Andrey Komissarov et al A	[object Object]	82	Female
Russia/SVE-RII-MH15122S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Verkhnyaya Pyshma	UMMC-Health	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-15	Andrey Komissarov et al A	[object Object]	27	Female
Russia/STA-RII-MH16060S/2021						GR	3.00	20B	Russia	Russia	Stavropol	Stavropol	Human	Pyatigorsk	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	48	Male
Russia/NVS-RII-MH15586S/2020						GR	3.00	20B	Russia	Russia	Novosibirsk	Novosibirsk	Human	Novosibirsk	Department of Experimental Modeling and Pathogenesis of Infectious Diseases	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-28	Andrey Komissarov et al A	[object Object]		
Russia/RYA-RII-MH16197S/2021						GR	3.00	20B	Russia	Russia	Ryazan	Ryazan	Human	Ryazan	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-25	Andrey Komissarov et al A	[object Object]	69	Male
Russia/SPE-RII-MH14791S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-21	Andrey Komissarov et al A	[object Object]	67	Male
Russia/TUL-RII-MH16178S/2021						GR	3.00	20B	Russia	Russia	Tula Region	Tula Region	Human	Novomoskovsk	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-20	Andrey Komissarov et al A	[object Object]	80	Female
Russia/SPE-RII-MH14645S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-11	Andrey Komissarov et al A	[object Object]	36	Male
Russia/SPE-RII-MH14719S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]	59	Male
Russia/BEL-RII-MH12792S/2020						GR	3.00	20B	Russia	Russia	Belgorod Region	Belgorod Region	Human	Stary Oskol	Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.8	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-30	Andrey Komissarov et al A	[object Object]	57	Female
Russia/KDA-RII-MH9365S/2020						GR	3.00	20B	Russia	Russia	Krasnodar	Krasnodar	Human	Anapa	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-14	Andrey Komissarov et al A	[object Object]	4	Female
Russia/KLU-RII-MH3358S/2020						GR	3.00	20B	Russia	Russia	Kaluga	Kaluga	Human	Tovarkovo	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-06	Andrey Komissarov et al A	[object Object]	50	Male
Russia/TVE-RII-MH16188S/2021						GR	3.00	20B	Russia	Russia	Tver	Tver	Human	Rzhev	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-22	Andrey Komissarov et al A	[object Object]	66	Male
Russia/KDA-RII-MH4734S/2020						GR	3.00	20B	Russia	Russia	Krasnodar	Krasnodar	Human	Krasnodar	WHO National Influenza Centre Russian Federation	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-15	Andrey Komissarov et al A	[object Object]	0	Male
Russia/SPE-RII-MH14778S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-13	Andrey Komissarov et al A	[object Object]	37	Female
Russia/SPE-RII-MH14823S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-17	Andrey Komissarov et al A	[object Object]	38	Female
Russia/SVE-RII-MH16235S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Arti	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	35	Female
Russia/SVE-RII-MH16239S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Arti	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	41	Female
Russia/MOW-RII-MH16152S/2021						GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.354	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-08	Andrey Komissarov et al A	[object Object]	25	Male
Russia/MAG-RII-MH14019S/2021						GR	3.00	20B	Russia	Russia	Magadan	Magadan	Human	Magadan	WHO National Influenza Centre Russian Federation	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-01-07	Andrey Komissarov et al A	[object Object]	70	Male
Russia/SVE-RII-MH15889S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Asbest	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	59	Male
Russia/YAR-CRIE-L188D0020b/2021		0.01	0.01		0.03	GR	4.00	20B	Russia	Russia	Yaroslavl	Yaroslavl	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.397	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-30	Samojlov A.E. et al	[object Object]	71	Female
Russia/SPE-RII-29769S/2021						GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-19	Andrey Komissarov et al A	[object Object]	43	Male
Russia/MAG-RII-MH13968S/2020						GR	3.00	20B	Russia	Russia	Magadan	Magadan	Human	Magadan	WHO National Influenza Centre Russian Federation	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-22	Andrey Komissarov et al A	[object Object]	83	Male
Russia/LEN-RII-MH14755S/2021						GR	2.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Gatchina	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-13	Andrey Komissarov et al A	[object Object]	33	Female
Russia/SPE-RII-MH14693S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-15	Andrey Komissarov et al A	[object Object]	33	Male
Russia/MAG-RII-MH14021S/2021						GR	4.00	20B	Russia	Russia	Magadan	Magadan	Human	Magadan	WHO National Influenza Centre Russian Federation	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-01-09	Andrey Komissarov et al A	[object Object]	63	Male
Russia/ARK-CRIE-7602077417/2020						GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Virology of Federal Budget Health Care Institution Center of Hygiene and Epidemiology in Arkhangelsk region	B.1.1.397	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2020-12-28	Samoilov AE et al	[object Object]	34	Male
Russia/MOW-RII-MH13929S/2020						GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	Pathogenic Microorganisms Variability Laboratory	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-29	Andrey Komissarov et al A	[object Object]	46	
Russia/SPE-RII-MH15773S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-26	Andrey Komissarov et al A	[object Object]	72	Female
Russia/SPE-RII-MH15441S/2021			0.01		0.01	GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-11	Andrey Komissarov et al A	[object Object]	58	Female
Russia/KAM-RII-MH12161S/2020						GR	3.00	20B	Russia	Russia	Kamchatka Krai	Kamchatka Krai	Human	Petropavlovsk-Kamchatsky	WHO National Influenza Centre Russian Federation	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-14	Andrey Komissarov et al A	[object Object]	52	Male
Russia/SPE-RII-MH13404S/2020						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-24	Andrey Komissarov et al A	[object Object]	32	Female
Russia/MUR-RII-MH6337S/2020						GR	3.00	20B	Russia	Russia	Murmansk	Murmansk	Human	Severomorsk	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-11	Andrey Komissarov et al A	[object Object]	31	Female
Russia/MUR-RII-MH14643S/2021						GR	3.00	20B	Russia	Russia	Murmansk	Murmansk	Human	Severomorsk	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-16	Andrey Komissarov et al A	[object Object]	63	Female
Russia/MUR-RII-MH6076S/2020						GR	3.00	20B	Russia	Russia	Murmansk	Murmansk	Human	Severomorsk	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-11-13	Andrey Komissarov et al A	[object Object]	26	Male
Russia/IVA-RII-MH11802S/2020						GR	4.00	20B	Russia	Russia	Ivanovo	Ivanovo	Human	Ivanovo	WHO National Influenza Centre Russian Federation	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-09	Andrey Komissarov et al A	[object Object]	60	Female
Russia/SPE-RII-MH14701S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	25	Female
Russia/SPE-RII-MH15457S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-11	Andrey Komissarov et al A	[object Object]	36	Female
Russia/SPE-RII-MH14783S/2021						GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-13	Andrey Komissarov et al A	[object Object]	34	Male
Russia/SPE-RII-MH14814S/2021						GR	4.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-20	Andrey Komissarov et al A	[object Object]	41	Male
Russia/SPE-RII-MH13834S/2021						GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-01-03	Andrey Komissarov et al A	[object Object]	63	Female
Russia/UA43-CRIE-L189B0546b/2021						GR	2.00	20B	Ukraine	Ukraine	Ukraine	Crimea	Human	Crimea	Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-02	Samojlov A.E. et al	[object Object]	28	Male
Russia/SVE-RII-MH16086S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Nizhny Tagil	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-27	Andrey Komissarov et al A	[object Object]	68	Female
Russia/BA-RII-MH15923S/2021						GR	3.00	20B	Russia	Russia	Bashkortostan	Bashkortostan	Human	Ufa	WHO National Influenza Centre Russian Federation	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-29	Andrey Komissarov et al A	[object Object]	25	Female
Russia/SVE-RII-MH15799S/2021						GR	3.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Pokrovskoe	HELIX LLC	B.1.1.397	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	64	Female
France/OCC-119/2020						GR	2.00	20B	France	France	France	Occitanie	Human		CHU Purpan - Laboratoire de Virologie - Institut Fédératif de Biologie	B.1.1.189	Europe	Europe	CHU Purpan - Laboratoire de Virologie - Institut Fédératif de Biologie		2020-09-12	Latour J. et al	[object Object]	25	Female
Russia/KGD-RII-MH6909S/2020						GR	1.00	20B	Russia	Russia	Kaliningrad Region	Kaliningrad Region	Human	Kaliningrad	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-02	Andrey Komissarov et al A	[object Object]	37	Female
Russia/KGD-RII-MH7067S/2020						GR	1.00	20B	Russia	Russia	Kaliningrad Region	Kaliningrad Region	Human	Kaliningrad	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-02	Andrey Komissarov et al A	[object Object]	51	Female
Bolivia/Sucre-2/2021						GR	1.00	20B	South America	Bolivia	South America	Chuquisaca	Human	South America	Laboratorio de Biologia Molecular, Hospital San Pedro Claver	B.1.1.274	South America	South America	Molecular Genetics Laboratory, Instituto de Investigaciones Químicas, Universidad Mayor de San Andrés		2021-02-18	Oscar M. Rollano-Peñaloza et al	[object Object]		
Russia/SPE-RII-MH14723S/2021		0.01	0.05	0.05	0.06	GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.200	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-13	Andrey Komissarov et al A	[object Object]	43	Male
Russia/StPetersburg-RII5654S/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-04-14	Andrey Komissarov et al B (https://dx.doi.org/10.1101/2020.07.14.20150979)	[object Object]	84	Female
Russia/StPetersburg-RII4972S/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-04-10	Andrey Komissarov et al B (https://dx.doi.org/10.1101/2020.07.14.20150979)	[object Object]	72	Female
Ireland/CW-NVRL-MPA64650/2020						GR	1.00	20B	Ireland	Ireland	Ireland	Carlow	Human		National Virus Reference Laboratory	B.59	Europe	Europe	Irish Coronavirus Sequencing Consortium - Teagasc Moorepark		2020-04-11	Calum Walsh et al	[object Object]		Female
Russia/KK-RII-MH9348S/2020						GR	2.00	20B	Russia	Russia	Khakassia	Khakassia	Human	Abakan	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-10	Andrey Komissarov et al A	[object Object]	27	Male
Japan/PG-10621/2020						GR	1.00	20B	Asia	Japan	Asia	Japan	Human	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases	B.1.1	Asia	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases		2020-04-01	Tsuyoshi Sekizuka et al B	[object Object]		
Russia/Samara-73403/2020						GR	1.00	20B	Russia	Russia	Samara	Samara	Human		State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms	B.1.1	Europe	Europe	State Research Center of Virology and Biotechnology VECTOR, Department of Collection of Microorganisms		2020-03-20	Oleg V. Pyankov et al	[object Object]	44	Male
Japan/PG-8802/2020						GR	1.00	20B	Asia	Japan	Asia	Japan	Human	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases	B.1.1.284	Asia	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases		2020-08-14	Tsuyoshi Sekizuka et al B	[object Object]		
Cambodia/171609/2020						G	2.00	20B	Asia	Cambodia	Asia	Cambodia	Human	Asia	Virology Unit, Institut Pasteur du Cambodge	B.1	Asia	Asia	Virology Unit, Institut Pasteur du Cambodge		2020-12-19	Sokhoun Yann et al	[object Object]	29	Female
Botswana/BOT2624/2020						GR	1.00	20B	Africa	Botswana	Africa	Gaborone	Human	Africa	National Health Laboratory	B.1.1	Africa	Africa	Botswana Institute for Technology Research and Innovation		2020-04-05	Kefentse Arnold Tumedi et al	[object Object]	43	Male
Russia/ORE-RII-MH4312S/2020						GR	1.00	20B	Russia	Russia	Orenburg	Orenburg	Human	Orenburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-09-08	Andrey Komissarov et al A	[object Object]	47	Male
NorthMacedonia/15613/2020						GR	1.00	20B	North Macedonia	North Macedonia	North Macedonia	Vardar	Human	Veles	General Hospital - Veles	B.1.1.430	Europe	Europe	Research Center for Genetic Engineering and Biotechnology "Georgi D. Efremov” , Macedonian Academy of Sciences and Arts		2020-10-19	RCGEB - MASA et al	[object Object]	86	Female
Palestine/68/2020						GR	1.00	20B	Asia	Palestine	Asia	Nablus	Human	Asia	Palestinian Ministry of Health	B.1.1.50	Asia	Asia	Molecular Genetics Lab		2020-07-09	Nouar Qutob et al	[object Object]		
Palestine/AAS24/2020						GR	2.00	20B	Asia	Palestine	Asia	Qalqilya	Human	Asia	Al-Quds Nutrition and Health Research Institute, Al-Quds University	B.1.1.50	Asia	Asia	Al-Quds Nutrition and Health Research Institute, Al-Quds University		2020-11-29	Nasereddin et al	[object Object]		Male
Israel/CVL-n25924/2020						GR	1.00	20B	Asia	Israel	Asia	Jerusalem District	Human	Asia	Israel Central Virology laboratory	B.1.1.50	Asia	Asia	Israel Central Virology laboratory		2020-07-20	Neta Zuckerman et al	[object Object]		
Israel/CVL-2611/2021						GR	1.00	20B	Asia	Israel	Asia	Israel	Human	Asia	Israel Central Virology laboratory	B.1.1.50	Asia	Asia	Israel National Consortium for SARS-CoV-2 sequencing		2021-01-17	Neta Zuckerman et al	[object Object]		
Palestine/AAS23/2020						GR	3.00	20B	Asia	Palestine	Asia	Nablus	Human	Asia	Biochemistry and Molecular Biology Department-Faculty of Medicine, Al-Quds University	B.1.1.50	Asia	Asia	Biochemistry and Molecular Biology Department-Faculty of Medicine, Al-Quds University		2020-11-30	Ereqat et al	[object Object]	57	Male
Russia/SPE-RII-29894S/2020						GR	1.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human		WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-08-02	Andrey Komissarov et al A	[object Object]	29	Female
Russia/KC-RII-MH3376S/2020						GR	1.00	20B	Russia	Russia	Karachay-Cherkess	Karachay-Cherkess	Human	Zelenchukskaya	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	8	Male
Belgium/rega-0801786/2020						GR	1.00	20B	Belgium	Belgium	Belgium	Mechelen	Human	Duffel	UZ Leuven, National Reference Laboratory for Coronaviruses, Laboratory Medicine, Leuven, Belgium	B.1.1.232	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2020-08-01	Tony Wawina-Bokalanga et al	[object Object]	42	Female
Bahamas/33826/2020						GR	1.00	20B	North America	Bahamas	North America	Bahamas	Human	North America	Reference Laboratory of the Ministry of Health	B.1.1.192	North America	North America	Laboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, FIOCRUZ		2020-07-28	Paola Resende et al	[object Object]		
Peru/LIM-INS-315/2020						GR	1.00	20B	South America	Peru	South America	Lima	Human	South America	Laboratorio de Referencia Nacional de Virus Respiratorio. Instituto Nacional de Salud Perú	B.1.1	South America	South America	Laboratorio de Referencia Nacional de Enteropatógenos. Instituto Nacional de Salud del Perú		2020-04-01	Ronnie Gavilan Chavez et al	[object Object]		
Russia/MOS-RII-MH3424S/2020						GR	1.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Zvenigorod	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-10-07	Andrey Komissarov et al A	[object Object]	37	Male
Russia/SVE-RII-MH16233S/2021		0.01			0.01	GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Yekaterinburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-03	Andrey Komissarov et al A	[object Object]	46	Male
Russia/IVA-RII-MH11867S/2020		0.01			0.01	GR	2.00	20B	Russia	Russia	Ivanovo	Ivanovo	Human	Kineshma	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2020-12-12	Andrey Komissarov et al A	[object Object]	58	Male
Russia/SPE-RII-MH14726S/2021		0.01			0.01	GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-21	Andrey Komissarov et al A	[object Object]	43	Male
Russia/SVE-RII-MH15163S/2021		0.01			0.01	GR	2.00	20B	Russia	Russia	Sverdlovsk	Sverdlovsk	Human	Bobrovsky	UMMC-Health	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-16	Andrey Komissarov et al A	[object Object]	66	Male
Russia/LEN-RII-MH15688S/2021		0.01			0.01	O	2.00	20B	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Kirovsk	HELIX LLC	B.1.1.464	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	48	Male
Russia/SPE-RII-MH16511S/2021		0.01			0.01	GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-23	Andrey Komissarov et al A	[object Object]	75	Male
Russia/SPE-RII-MH15751S/2021		0.01			0.01	GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	26	Male
Russia/SPE-RII-MH15772S/2021		0.01			0.01	GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-10	Andrey Komissarov et al A	[object Object]	34	Male
Russia/SPE-RII-MH15746S/2021		0.01			0.01	GR	2.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	83	Female
Russia/SPE-RII-MH15467S/2021		0.01			0.01	GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	46	Male
Russia/SPE-RII-35098S/2021		0.01			0.01	GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	80	Female
Russia/SPE-RII-MH16342S/2021		0.01			0.01	GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-22	Andrey Komissarov et al A	[object Object]	69	
Russia/SPE-RII-35102S/2021		0.01			0.01	GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	50	Male
Russia/SPE-RII-MH17300S/2021		0.01			0.01	GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-06	Andrey Komissarov et al A	[object Object]	21	Male
Russia/SPE-RII-MH17258S/2021		0.01			0.01	GR	3.00	20B	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-20	Andrey Komissarov et al A	[object Object]	21	Male
Switzerland/SH-ETHZ-331378/2020						GR	2.00	20B	Switzerland	Switzerland	Switzerland	Schaffhausen	Human		Viollier AG	B.1.1	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2020-10-21	Christian Beisel et al	[object Object]		
Russia/MOW-RII-MH15906/2021	1.00	0.01	0.01	0.02	0.03	GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Zelenograd	Pathogenic Microorganisms Variability Laboratory	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	68	Female
Russia/MOW-RII-MH15907/2021		0.05	0.40	0.07	0.29	GR	5.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Pathogenic Microorganisms Variability Laboratory	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-18	Andrey Komissarov et al A	[object Object]	50	Male
Russia/MOW-RII-MH15905/2021		0.01	0.01		0.01	GR	3.00	20B	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Zelenograd	Pathogenic Microorganisms Variability Laboratory	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-08	Andrey Komissarov et al A	[object Object]	85	Male
Mexico/PUE-InDRE_FB16508_S2474/2021	1.00	0.07	0.01	0.01	0.04	GR	3.00	20B	North America	Mexico	North America	Puebla	Human	North America	LESP Puebla	B.1.1	North America	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)		2021-05-22	Claudia Wong-Arambula et al	[object Object]	66	Male
Turkey/HSGM-D65/2021	1.00	0.07	0.01	0.01	0.04	GR	3.00	20B	Turkey	Turkey	Turkey	Turkey	Human		Ministry of Health Turkey	B.1.1	Europe	Europe	Ministry of Health Turkey		2021-02-08	Fatma Bayrakdar et al B	[object Object]		
SouthKorea/KDCA3873/2021	1.00	0.07	0.01	0.01	0.04	GRY	5.00	20B	Asia	United Arab Emirates	Asia	United Arab Emirates	Human	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency	B.1.1.7	Asia	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency		2021-02-17	Ae Kyung Park et al	[object Object]	50	Male
Italy/TAA-1900552428/2021	1.00	0.07	0.01	0.01	0.04	O	6.00	20B	Italy	Italy	Italy	Trentino-Alto Adige	Human	South Tyrol	Laboratorio Aziendale di Microbiologia e Virologia, Azienda Sanitaria dell'Alto Adige	B.1.1.7	Europe	Europe	Laboratorio Aziendale di Microbiologia e Virologia, Azienda Sanitaria dell'Alto Adige		2021-04-01	Irene Bianconi et al	[object Object]	38	Female
Belgium/Jessa_11-2123-001309ZOL/2021						O	6.00	20B	Belgium	Belgium	Belgium	Limburg BE	Human		ZOL	B.1.1.7	Europe	Europe	Jessa		2021-06-07	Berden et al. on behalf of the Jessa_cmdLab et al	[object Object]	59	Male
USA/MI-CDC-LC0068148/2021	2.00	0.23	0.36	0.01	0.31	GRY	11.00	20B	North America	USA	North America	Michigan	Human	North America	Laboratory Corporation of America	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-26	Dakota Howard et al	[object Object]	84	Female
Russia/BEL-RII-MH17648S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-28	Andrey Komissarov et al A	[object Object]	61	
Switzerland/GL-ETHZ-640279/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Glarus	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-05-21	Chaoran Chen et al	[object Object]		
SouthKorea/KDCA4309/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	South Korea	Asia	South Korea	Human	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency	B.1.1.7	Asia	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency		2021-05-17	Ae Kyung Park et al	[object Object]	53	Female
Ireland/MO-NVRL-ec85IRL45075/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Mayo	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-02-09	Zoe Yandle et al	[object Object]		Male
Slovenia/90-024913-NM/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Jugovzhodna	Human		National Laboratory for Health, Environment and Food, OMM, Novo mesto	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-05-17	Sandra Janezic et al	[object Object]	43	Male
Italy/CAM-TIGEM-IZSM-COLLI-8359/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Russia	Russia	Human		Università Federico II - Dipartimento di scienze mediche traslazionali - Napoli	B.1.1.7	Europe	Europe	Telethon Institute of Genetics and Medicine (TIGEM)		2021-02-19	Antonio Grimaldi Patrizia Annunziata Francesco Panariello Teresa Giuliano Michele Cennamo Valentina Bouche Chiara Colantuono Lucio Di Filippo Mariano Fiorenza Anna Manfredi Marcello Salvi Giuseppe Portella Andrea Ballabio Davide Cacchiarelli et al	[object Object]	37	Female
Argentina/INEI103043/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	South America	Argentina	South America	Santa Fe	Human	South America	Servicio Virosis Respiratorias-Departamento Virología-INEI	B.1.1.7	South America	South America	Instituto Nacional Enfermedades Infecciosas C.G.Malbran		2021-03-18	Baumeister E. et al	[object Object]	74	Female
Denmark/DCGC-42220/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Denmark	Denmark	Denmark	Sjaelland	Human		Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark	B.1.1.7	Europe	Europe	Aalborg University		2021-02-08	Danish Covid-19 Genome Consortium et al	[object Object]		
Bulgaria/21BG-EU_001289_Pl13/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bulgaria	Bulgaria	Bulgaria	Pernik	Human		National Center of Infectious and Parasitic Diseases	B.1.1.7	Europe	Europe	National Center of Infectious and Parasitic Diseases		2021-03-07	Alexiev et al	[object Object]	20	Female
Bulgaria/21BG-EU_001291_Pl13/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bulgaria	Bulgaria	Bulgaria	Blagoevgrad	Human		National Center of Infectious and Parasitic Diseases	B.1.1.7	Europe	Europe	National Center of Infectious and Parasitic Diseases		2021-03-08	Alexiev et al	[object Object]	52	Male
Greece/V978/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Greece	Greece	Greece	Florina	Human		Laboratory of Molecular Biology, Mamatsio General Hospital of Kozani	B.1.1.7	Europe	Europe	Institute of Applied Biosciences, Centre for Research and Technology Hellas		2021-04-26	Anastasia Chatzidimitriou et al.	[object Object]		Male
Greece/KEDY_11861/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Greece	Greece	Greece	Ionian Islands	Human	Corfu	Central Public Health Lab, National Public Health Organization	B.1.1.7	Europe	Europe	Central Public Health Lab, National Public Health Organization		2021-05-20	Kyriaki Tryfinopoulou et al	[object Object]	47	Female
Italy/LOM-UniMI25/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Italy	Italy	Italy	Lombardy	Human		Laboratory of Infectious Diseases, Department of Biomedical and Clinical Sciences L. Sacco, University of Milan	B.1.1.7	Europe	Europe	Laboratory of Infectious Diseases, Department of Biomedical and Clinical Sciences L. Sacco, University of Milan		2021-02-23	Alessia Lai et al	[object Object]	77	Male
Russia/BEL-RII-MH17551S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-20	Andrey Komissarov et al A	[object Object]	66	
Belgium/UZA-UA-CV2147966279/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Hasselt	Human	Binderveld	Platform BIS UZA/UAntwerpen	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-19	Marie Le Mercier et al	[object Object]	27	Male
Switzerland/LU-HUG-SNRCI-34365404/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Lucerne	Human		University Hospitals of Geneva, Laboratory of Virology	B.1.1.7	Europe	Europe	HUG, Laboratory of Virology and the Health2030 Genome Center		2021-06-02	Samuel Cordey et al	[object Object]		
Ireland/MO-NVRL-e87IRL70682/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Mayo	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-03-21	Zoe Yandle et al	[object Object]		Male
Netherlands/ZH-RIVM-37890/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	South Holland	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-24	Adam Meijer et al	[object Object]	3	
Netherlands/GR-RIVM-37171/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Groningen	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-23	Adam Meijer et al	[object Object]	43	
Netherlands/ZE-RIVM-32250/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Zeeland	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-04-30	Adam Meijer et al	[object Object]	47	
Bonaire/BQ-RIVM-25812/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	South America	Bonaire	South America	Bonaire	Human	South America	Dutch COVID-19 response team	B.1.1.7	South America	South America	National Institute for Public Health and the Environment (RIVM)		2021-04-02	Adam Meijer et al	[object Object]	60	
Bonaire/BQ-RIVM-25778/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	South America	Bonaire	South America	Bonaire	Human	South America	Dutch COVID-19 response team	B.1.1.7	South America	South America	National Institute for Public Health and the Environment (RIVM)		2021-04-06	Adam Meijer et al	[object Object]	56	
Belgium/ULG-13832/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Liège	Human		University of Liège COVID-19 testing center	B.1.1.7	Europe	Europe	GIGA Medical Genomics		2021-03-29	Keith Durkin et al	[object Object]	20	Male
Poland/NIPH-NIH_ECDC-3136/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Podlaskie	Human	Białystok	Regionalne Centrum Krwiodawstwa i Krwiolecznictwa w Białymstoku Pracownia Diagnostyki Molekularnej wirusa SARS-CoV-2	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-03-22	Wołkowicz Tomasz et al	[object Object]	17	Female
Slovakia/UKBA-1653/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovakia	Slovakia	Slovakia	Zilina	Human	Rabca	Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava	B.1.1.7	Europe	Europe	Faculty of Natural Sciences, Comenius University, Bratislava		2021-02-20	Broňa Brejová et al	[object Object]	37	Male
Poland/NIPH-NIH_ECDC-4794/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Swietokrzyskie	Human	Kielce	Zakład Mikrobiologii WSZZ	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-04-24	Wołkowicz Tomasz et al	[object Object]	41	Female
Slovakia/UKBA-3359/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovakia	Slovakia	Slovakia	Chtelnica	Human		Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava	B.1.1.7	Europe	Europe	Faculty of Natural Sciences, Comenius University, Bratislava		2021-05-28	Brona Brejova et al	[object Object]	70	Male
Austria/CeMM9678/2021	1.00	0.08	0.01	0.01	0.05	GRY	7.00	20I (Alpha, V1)	Austria	Austria	Austria	Burgenland	Human	Eisenstadt	Austrian Agency for Health and Food Safety (AGES)	B.1.1.7	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-05-20	Lukas Endler et al	[object Object]	13	Female
USA/WI-CDC-FG-036618/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	Wisconsin	Human	North America	Fulgent Genetics	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-06-01	Dakota Howard et al	[object Object]	23	Female
Lithuania/LTU000_KUL_5148298/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Taurages Apskritis	Human		Viesoji istaiga Klaipedos universitetine ligonine	B.1.1.7	Europe	Europe	National Public Health Surveillance Laboratory		2021-05-13	Lukas Zemaitis et al	[object Object]	55	Female
Italy/PIE-ISS-7261/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Italy	Italy	Italy	Piedmont	Human		Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy; Azienda Sanitaria Locale TO5, Torino, Italy	B.1.1.7	Europe	Europe	Istituto Superiore di Sanità (ISS)		2021-02-08	Paola Stefanelli et al	[object Object]		
Italy/BAS-22/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Italy	Italy	Italy	Basilicata	Human		Laboratorio di Genetica Medica, Matera, Italy	B.1.1.7	Europe	Europe	Laboratorio di Genetica Medica, Matera, Italy		2021-05-18	Domenico Dell'Edera et al	[object Object]	9	Male
Brazil/SP-833836/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	South America	Brazil	South America	São Paulo	Human	South America	LABORATORIO DE FRANCA	B.1.1.7	South America	South America	Instituto Butantan / ESALQ-Piracicaba		2021-03-22	Instituto Butantan: Alexander Roberto Precioso et al	[object Object]		
Brazil/SP-IB_100922/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	South America	Brazil	South America	São Paulo	Human	South America	LABORATORIO DE FRANCA	B.1.1.7	South America	South America	Instituto Butantan / ESALQ-USP (Piracicaba)		2021-04-05	Instituto Butantan: Dimas Tadeu Covas et al	[object Object]		
Sweden/21-53922/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Sormland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-18	Maximilian Riess et al	[object Object]		Female
Thailand/CU-SI2106275-NT/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Portugal	Asia	Portugal	Human	Asia	Thai Red Cross Emerging Infectious Diseases Health Science Centre, Chulalongkorn Hospital, Faculty of Medicine, Chulalongkorn University	B.1.1.7	Asia	Europe	Thai Red Cross Emerging Infectious Diseases Center and Faculty of Medicine, Chulalongkorn University		2021-02-04	Rome Buathong et al	[object Object]	40	Female
GuineaBissau/JPLNSP0036/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Africa	Guinea Bissau	Africa	Guinea Bissau	Human	Africa	Reitor da Universidade Jean Piaget Guine-Bissau	B.1.1.7	Africa	Africa	MRCG at LSHTM, Genomics lab		2021-02-04	Aladje Balde et al	[object Object]	35	Male
Belgium/rega-3812/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Charleroi	Human	Gerpinnes	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.1.7	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2021-02-22	Tony Wawina-Bokalanga et al	[object Object]	72	Male
Belgium/ULG-16345/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Namur	Human		University of Liège COVID-19 testing center	B.1.1.7	Europe	Europe	GIGA Medical Genomics		2021-06-01	Keith Durkin et al	[object Object]	45	Male
Russia/SPE-RII-35131S/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-22	Andrey Komissarov et al A	[object Object]	68	Female
Malaysia/IMR_WC86762/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Malaysia	Asia	Malaysia	Human	Asia	Institute for Medical Research, Infectious Disease Research Centre, National Institutes of Health, Ministry of Health Malaysia	B.1.1.7	Asia	Asia	Institute for Medical Research, Infectious Disease Research Centre, National Institutes of Health, Ministry of Health Malaysia		2021-02-08	Suppiah J et al	[object Object]	33	Female
Lithuania/S21F53/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Alytaus Apskritis	Human		UAB Diagnostikos laboratorija	B.1.1.7	Europe	Europe	Vilnius University Hospital Santaros Klinikos, Center of Laboratory Medicine		2021-05-25	Ligita Raugaite et al	[object Object]	54	Female
Norway/12165/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Norway	Norway	Norway	Innlandet	Human		Innlandet Hospital Trust, Division Lillehammer, Department for Medical Microbiology	B.1.1.7	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-05-05	Kathrine Stene-Johansen et al	[object Object]		
Poland/PZH-LUM-1286/2021	1.00	0.07	0.01	0.01	0.04	O	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Lubuskie	Human		105 Kresowy Szpital Wojskowy SP ZOZ w Żarach Filia w Żaganiu	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland 2. Biobank Lab, University of Lodz 3. Laboratory of Respiratory Viruses, Teaching and Clinical Center of the Medical University of Lodz		2021-05-18	Dominik Strapagiel et al	[object Object]	47	Male
Sweden/4050919664/2021	1.00	0.11	0.35	0.01	0.28	GRY	7.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Sormland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1	Europe	Europe	The Public Health Agency of Sweden		2021-05-04	Maximilian Riess et al	[object Object]		
Switzerland/VS-ETHZ-500546/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Valais	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-02-12	Christian Beisel et al	[object Object]		
Netherlands/UT-RIVM-21240/2021	1.00	0.07	0.01	0.01	0.04	GRY	5.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Utrecht	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-03-21	Adam Meijer et al	[object Object]	50	
Romania/Breaza_420639/2021	1.00	0.07	0.01	0.01	0.04	GRY	4.00	20I (Alpha, V1)	Romania	Romania	Romania	Prahova	Human	Breaza	Laboratory for Respiratory Viruses, Cantacuzino National Military-Medical Institute for Research and Development	B.1.1.7	Europe	Europe	Cantacuzino Institute Virology		2021-02-08	Luiza Ustea et al	[object Object]	17	Male
Romania/Covasna_430356/2021	1.00	0.07	0.01	0.01	0.04	GRY	4.00	20I (Alpha, V1)	Romania	Romania	Romania	Covasna	Human		Laboratory for Respiratory Viruses, Cantacuzino National Military-Medical Institute for Research and Development	B.1.1.7	Europe	Europe	Cantacuzino Institute Virology		2021-02-23	Luiza Ustea et al	[object Object]	65	Female
Romania/Bihor_435286/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Romania	Romania	Romania	Bihor	Human		Laboratory for Respiratory Viruses, Cantacuzino National Military-Medical Institute for Research and Development	B.1.1.7	Europe	Europe	Cantacuzino Institute Virology		2021-03-10	Luiza Ustea et al	[object Object]	88	Female
Switzerland/NE-ETHZ-610175/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Neuchâtel	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-05-01	Christian Beisel et al	[object Object]		
Slovenia/5C-012902-KP/2021						GR	4.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Primorskonotranjska	Human		National Laboratory for Health, Environment and Food, OMM, Koper	B.1.1	Europe	Europe	CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-02-26	Jernej Kovač et al	[object Object]	43	Male
Switzerland/BE-ETHZ-510805/2021	1.00	0.01	0.01	0.02	0.03	GR	2.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Bern	Human		Viollier AG	B.1.1	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-02-25	Christian Beisel et al	[object Object]		
Lithuania/MR-LUHS-10-35/2021						GR	2.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Panevezio Apskritis	Human		UAB Medicina practica laboratorija	B.1.177	Europe	Europe	Lithuanian University of Health Sciences		2021-05-18	Daniel Naumovas et al	[object Object]	57	Female
Russia/PSK-RII-MH15464S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Pskov Oblast	Pskov Oblast	Human	Velikiye Luki	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	61	Male
Finland/TRE24386_2/2021	1.00	0.07	0.01	0.01	0.04	GRY	5.00	20I (Alpha, V1)	Finland	Finland	Finland	Keski-Suomi	Human		Fimlab Laboratories	B.1.1.7	Europe	Europe	Fimlab Laboratories		2021-04-08	Minna Paloniemi et al	[object Object]		Female
Finland/TRE26521_11/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Finland	Finland	Finland	Kanta-Häme	Human		Fimlab Laboratories	B.1.1.7	Europe	Europe	Fimlab Laboratories		2021-05-21	Minna Paloniemi et al	[object Object]	75	Male
Finland/TRE26444_2/2021	1.00	0.07	0.01	0.01	0.04	GRY	5.00	20I (Alpha, V1)	Finland	Finland	Finland	Päijät-Häme	Human		Fimlab Laboratories	B.1.1.7	Europe	Europe	Fimlab Laboratories		2021-05-19	Minna Paloniemi et al	[object Object]	27	Male
Finland/TRE26444_4/2021	1.00	0.07	0.01	0.01	0.04	GRY	5.00	20I (Alpha, V1)	Finland	Finland	Finland	Kanta-Häme	Human		Fimlab Laboratories	B.1.1.7	Europe	Europe	Fimlab Laboratories		2021-05-17	Minna Paloniemi et al	[object Object]	40	Female
Romania/GR-93715/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Romania	Romania	Romania	Giurgiu	Human		National Institute of Infectious Diseases-Prof. Dr. Matei Bals Molecular Diagnostics Laboratory	B.1.1.7	Europe	Europe	National Institute of Infectious Diseases-Prof. Dr. Matei Bals Molecular Diagnostics Laboratory		2021-01-04	Leontina Banica et al	[object Object]	27	Female
Spain/GA-ISCIII-210066/2020	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Spain	Spain	Spain	Galicia	Human		Complejo Hospitalario Universitario de Santiago	B.1.1.7	Europe	Europe	Instituto de Salud Carlos III		2020-12-31	Iglesias-Caballero et al	[object Object]	42	Male
Ireland/SO-NVRL-e84IRL55476/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Sligo	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-01-26	Zoe Yandle et al	[object Object]		Female
Ireland/MO-NVRL-e87IRL90218/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Mayo	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-03-24	Zoe Yandle et al	[object Object]		Female
Ireland/CN-NVRL-30IRL22977/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Cavan	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Male
Ireland/CN-NVRL-30IRL22983/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Cavan	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Female
Switzerland/UR-32271536/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Uri	Human		Viollier AG	B.1.1.7	Europe	Europe	Viollier AG		2021-03-27	Andrea Patrizia Salzmann et al	[object Object]	24	Female
Switzerland/OW-UHB-42864961/2021	1.00	0.07	0.01	0.01	0.04	GRY	9.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Obwalden	Human		Synlab Suisse SA	B.1.1.7	Europe	Europe	Clinical Bacteriology		2021-05-25	Tim Roloff et al	[object Object]		
Germany/RP-RKI-I-173614/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Rheinland-Pfalz	Human		MVZ für Laboratoriumsmedizin und Mikrobiologie Koblenz-Mittelrhein (Labor Koblenz)	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-06-01	?	[object Object]		
Slovenia/08-123044-MB/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Pomurska	Human		National Laboratory for Health, Environment and Food, OMM, Maribor	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-05-23	Sandra Janezic et al	[object Object]	36	Female
Belgium/ULG-12155/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Vlaams-Brabant	Human		Synlab	B.1.1.7	Europe	Europe	GIGA Medical Genomics		2021-01-30	Keith Durkin et al	[object Object]	29	Male
Germany/SN-RKI-I-173619/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Saxony	Human		MVZ Labor Dr. Reising-Ackermann und Kollegen	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-06-03	?	[object Object]		
Spain/GA-CHUVI-19358751/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Spain	Spain	Spain	Galicia	Human	Vigo	Microbiology Department. Complexo Hospitalario Universitario de Vigo	B.1.1.7	Europe	Europe	Microbiology Department. Complexo Hospitalario Universitario de Vigo		2021-06-01	Alfaya N et al	[object Object]	27	Male
Belgium/ULG-12798/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Hainaut	Human		SYNLAB	B.1.1.7	Europe	Europe	GIGA Medical Genomics		2021-02-24	Keith Durkin et al	[object Object]	71	Male
Sweden/461847152982/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Orebro	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-03-17	Swedish national genomic surveillance program of SARS-CoV-2 et al	[object Object]		
Sweden/20148322P/2021	1.00	0.07	0.01	0.01	0.05	GRY	7.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Uppsala	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-03	Maximilian Riess et al	[object Object]		
Sweden/SE00292240/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Gavleborgs Lan	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-02-25	Swedish national genomic surveillance program of SARS-CoV-2 et al	[object Object]		
Sweden/SE00332216/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Vastmanland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-03-06	Swedish national genomic surveillance program of SARS-CoV-2 et al	[object Object]		
Mexico/SLP-InDRE_FB16030_S2429/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	North America	Mexico	North America	San Luis Potosi	Human	North America	LESP San Luis Potosi	B.1.1.7	North America	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)		2021-05-17	Claudia Wong-Arambula et al	[object Object]	32	Female
Oman/182621/2020	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Oman	Asia	Muscat	Human	Asia	Oman-National Influenza Center	B.1.1.7	Asia	Asia	Oman-National Influenza Center		2020-12-22	Samiha Al-Kharusi et al	[object Object]	53	Male
Lithuania/LTU000_KNS_ANT_04_21_109/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Kauno Apskritis	Human		UAB Diagnostikos laboratorija	B.1.1.7	Europe	Europe	National Public Health Surveillance Laboratory		2021-04-16	Lukas Zemaitis et al	[object Object]	32	Male
Bulgaria/21BG-EU_002140_Pl20/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bulgaria	Bulgaria	Bulgaria	Vidin	Human		National Center of Infectious and Parasitic Diseases	B.1.1.7	Europe	Europe	National Center of Infectious and Parasitic Diseases		2021-04-02	Alexiev et al	[object Object]	72	Male
Sweden/DC107098901/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Halland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-02-08	Swedish national genomic surveillance program of SARS-CoV-2 et al	[object Object]		
Poland/PL_P41/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Pomorskie	Human	Lubkowo	1. Wojewódzka Stacja Sanitarno - Epidemiologiczna w Katowicach (WSSE Katowice); 2. Wojewódzka Stacja Sanitarno - Epidemiologiczna w Kielcach (WSSE Kielce); 3. Wojewódzka Stacja Sanitarno - Epidemiologiczna w Szczecinie (WSSE Szczecin); 4. Wojewódzka Stacja Sanitarno - Epidemiologiczna w Lublinie (WSSE Lublin); 5. Wojewódzka Stacja Sanitarno - Epidemiologiczna w Gorzowie Wielkopolskim (WSSE Gorzów Wielkopolski); 6. Wojewódzka Stacja Sanitarno-Epidemiologiczna w Gdańsku (WSSE Gdańsk); 7. Wojewódzka Stacja Sanitarno-Epidemiologiczna w Poznaniu (WSSE Poznań); 8. Wojewódzka Stacja Sanitarno-Epidemiologiczna w Opolu (WSSE Opole); 9. Wojewódzka Stacja Sanitarno-Epidemiologiczna we Wrocławiu (WSSE Wrocław); 10. Wojewódzka Stacja Sanitarno-Epidemiologiczna w Krakowie (WSSE Kraków); 11. Wojewódzka Stacja Sanitarno-Epidemiologiczna w Olsztynie (WSSE Olsztyn); 12. Wojewódzka Stacja Sanitarno-Epidemiologiczna w Bydgoszczy (WSSE Bydgoszcz); 13. Wojewódzka Stacja Sanitarno-Epidemiologiczna w Rzeszowie (WSSE Rzeszów); 14. Wojewódzka Stacja Sanitarno-Epidemiologiczna w Białymstoku (WSSE Białystok);	B.1.1.7	Europe	Europe	1. ViroGenetics - BSL3 Laboratory of Virology, Małopolska Centre of Biotechnology, Jagiellonian University; 2. Human Genome Variation Research Group, Malopolska Centre of Biotechnology, Jagiellonian University;		2021-01-12	Klajmon et al	[object Object]	49	Female
Poland/NIPH-NIH_ECDC-6268/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Zachodniopomorskie	Human	Szczecin	NZOZ Meditest Diagnostyka Medyczna	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-05-18	Wołkowicz Tomasz et al	[object Object]	36	Male
Russia/MOS-CRIE-L106A0347b/2021		0.01			0.01	GR	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-01	Samojlov A.E. et al	[object Object]	37	Male
Russia/MOS-CRIE-L106D1523b/2021	1.00	0.07	0.01	0.01	0.04	GR	7.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-07	Samojlov A.E. et al	[object Object]	62	Male
USA/WY-WYPHL21038402/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	Wyoming	Human	North America	Wyoming Public Health Laboratory	B.1.1.7	North America	North America	Wyoming Public Health Laboratory		2021-06-01	Jim Mildenberger et al	[object Object]	36	Female
Russia/SPE-RII-34642S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	73	Female
CzechRepublic/NRL-4412/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Southern Bohemia Region	Human		National Institute of Public Health	B.1.1.7	Europe	Europe	National Institute of Public Health		2021-03-09	Helena Jirincova et al	[object Object]	50	Female
USA/DC-DFS-PHL-0624/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	North America	USA	North America	Washington DC	Human	North America	DC Public Health Lab/ Dept. of Forensic Sciences	B.1.1.7	North America	North America	DC Public Health Lab/ Dept. of Forensic Sciences		2021-06-03	Janis Doss et al	[object Object]	64	Female
Russia/SPE-RII-MH15677S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-11	Andrey Komissarov et al A	[object Object]	48	Female
Bulgaria/21BG-EU_000120_Pl2/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bulgaria	Bulgaria	Bulgaria	Pazardzhik	Human		National Center for Infectious and Parasitic Diseases (NCIPD)	B.1.1.7	Europe	Europe	National Center for Infectious and Parasitic Diseases (NCIPD)		2021-01-22	Alexiev et al	[object Object]	38	Male
Russia/MOS-RII-MH16110S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Ramenskoye	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-19	Andrey Komissarov et al A	[object Object]	33	Female
Russia/RYA-CRIE-L188S0158u/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Russia	Russia	Ryazan	Ryazan	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-22	Samojlov A.E. et al	[object Object]		Male
Russia/BEL-RII-MH17556S/2021	1.00	0.07	0.01	0.01	0.05	GRY	7.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-20	Andrey Komissarov et al A	[object Object]	38	
Russia/MOW-CRIE-L188K0284/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-08	Samoilov AE et al	[object Object]	81	Female
Russia/SPE-RII-MH15776S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	33	Male
Russia/MOW-CRIE-L188K0289u/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-10	Samoilov AE et al	[object Object]	75	Female
Guadeloupe/IPP12975/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	Guadeloupe	North America	Les Abymes	Human	North America	Hospital	B.1.1.7	North America	North America	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2021-05-10	Marion Barbet et al	[object Object]	71	Male
Switzerland/NE-PMI-2105-6831/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Neuchâtel	Human		ADMED Microbiologie	B.1.1.7	Europe	Europe	Genomics and Transcriptomics, Philip Morris International		2021-02-07	Reto Lienhard et al	[object Object]		Male
Russia/SPE-RII-MH15700S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	32	Female
Belarus/MI-RRCEM-Sars_Cov_Vis_68/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Belarus	Belarus	Belarus	Minsk	Human		Laboratory for HIV and opportunistic infections diagnosis The Republican Research and Practical Center for Epidemiology and Microbiology (RRPCEM)	B.1.1.7	Europe	Europe	Laboratory for HIV and opportunistic infections diagnosis The Republican Research and Practical Center for Epidemiology and Microbiology (RRPCEM)		2021-02-23	Elena Gasich et al	[object Object]	13	Male
Russia/MOW-CRIE-D187M53/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-02-18	Samoilov AE et al	[object Object]	55	Female
Russia/SPE-RII-34509S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	63	Male
Guadeloupe/IPP11460/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	Guadeloupe	North America	Pointe-A-Pitre	Human	North America	Hospital	B.1.1.7	North America	North America	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2021-04-27	Marion Barbet et al	[object Object]	54	Male
Switzerland/UR-32755812/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Uri	Human		Viollier AG	B.1.1.7	Europe	Europe	Viollier AG		2021-05-03	Andrea Patrizia Salzmann et al	[object Object]	80	Female
USA/VI-CDC-ASC210106235/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	Virgin Islands	Human	North America	Aegis Sciences Corporation	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-30	Dakota Howard et al	[object Object]	17	Female
Iraq/Samawa-3/2020	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Iraq	Asia	Al-Muthanna Province	Human	Asia	Biology Department, College of Science, Al Muthanna University and Public Health Laboratory, Al-Muthanna Health Directorate	B.1.1.7	Asia	Asia	Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland		2020-12-27	Nihad Al-Rashedi et al	[object Object]	38	Male
Switzerland/VD-CHUV-GEN2896/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Vaud	Human		CHUV	B.1.1.7	Europe	Europe	Laboratory of genomics and metagenomics		2021-02-05	Trestan Pillonel et al	[object Object]		
Switzerland/GR-UHB-4183130301/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Graubünden	Human		Labormedizinisches Zentrum Dr Risch	B.1.1.7	Europe	Europe	Clinical Bacteriology		2021-02-04	Tim Roloff et al	[object Object]		
NewZealand/21CV0011/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Oceania	United Kingdom	Oceania	United Kingdom	Human	Oceania	LabPLUS	B.1.1.7	Oceania	Europe	Institute of Environmental Science and Research (ESR)		2021-01-01	Xiaoyun Ren et al	[object Object]		Male
Belgium/ULG-15941/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Liège	Human		C.H.C MontLégia	B.1.1.7	Europe	Europe	GIGA Medical Genomics		2021-05-12	Keith Durkin et al	[object Object]	34	Female
Ireland/MH-NVRL-30IRL15877/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Meath	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Female
Norway/12611/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Norway	Norway	Norway	Innlandet	Human		Akershus University Hospital, Department for Microbiology and Infectious Disease Control	B.1.1.7	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-05-18	Kathrine Stene-Johansen et al	[object Object]		
USA/TN-CDC-ASC210106362/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	Tennessee	Human	North America	Aegis Sciences Corporation	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-06-01	Dakota Howard et al	[object Object]	59	Male
Netherlands/FR-RIVM-27894/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Friesland	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-04-13	Adam Meijer et al	[object Object]	71	
Netherlands/ZH-RIVM-35557/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	South Holland	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-17	Adam Meijer et al	[object Object]	11	
Netherlands/NH-RIVM-37202/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	North Holland	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-23	Adam Meijer et al	[object Object]	37	
Spain/MC-ISCIII-210711/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Spain	Spain	Spain	Murcia	Human		HOSPITAL J.M. MORALES MESEGUER	B.1.1.7	Europe	Europe	Instituto de Salud Carlos III		2021-01-12	Vázquez-Morón et al	[object Object]	83	Female
Russia/MOW-CRIE-L189P2997/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-24	Samojlov A.E. et al	[object Object]	24	Male
Russia/LEN-RII-MH15657S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Fedorovskoe	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-04	Andrey Komissarov et al A	[object Object]	25	Female
Belgium/AZDelta/05162-2122R/2021	1.00	0.08	0.01	0.01	0.05	GR	7.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Veurne	Human		AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-06-02	Geert Martens et al	[object Object]		
USA/IA-GMF-B00892/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	North America	USA	North America	Iowa	Human	North America	Gundersen Clinical Microbiology Laboratory	B.1.1.7	North America	North America	Kabara Cancer Research Institute		2021-06-03	Craig S. Richmond et al	[object Object]		
Switzerland/BE-ETHZ-510237/2021	1.00	0.07	0.01	0.01	0.04	G	8.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Bern	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-02-19	Chaoran Chen et al	[object Object]		
Greece/196283/2021	1.00	0.07	0.01	0.01	0.07	GR	9.00	20I (Alpha, V1)	Greece	Greece	Greece	Peloponnese	Human		ETHNIKO KENTRO AIMODOSIAS E.KE.A.	B.1.1.7	Europe	Europe	Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)		2021-04-29	Emmanouil Athanasiadis et al	[object Object]		
Greece/196299/2021	1.00	0.07	0.01	0.01	0.07	GRY	9.00	20I (Alpha, V1)	Greece	Greece	Greece	Peloponnese	Human		ETHNIKO KENTRO AIMODOSIAS E.KE.A.	B.1.1.7	Europe	Europe	Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)		2021-04-29	Emmanouil Athanasiadis et al	[object Object]		
Ireland/LD-NVRL-90IRL59083/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Longford	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-06	Zoe Yandle et al	[object Object]		Male
Switzerland/SH-ETHZ-581027/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Schaffhausen	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-04-15	Chaoran Chen et al	[object Object]		
Switzerland/SH-ETHZ-640124/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Schaffhausen	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-05-27	Christian Beisel et al	[object Object]		
Belgium/rega-5158/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Ath	Human		KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.1.7	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2021-02-01	Tony Wawina-Bokalanga et al	[object Object]	33	Male
Belgium/AZDelta-13089/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Ieper	Human	Wervik	AZDelta	B.1.1.7	Europe	Europe	AZDelta		2021-02-11	Geert Martens et al	[object Object]	10	Female
Belgium/AZDelta-03637-2110R/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Brugge	Human	Zedelgem	AZDelta	B.1.1.7	Europe	Europe	AZDelta		2021-03-08	Geert Martens et al	[object Object]		
Greece/KEDY_11726/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Greece	Greece	Greece	Kefalonia	Human		Central Public Health Lab, National Public Health Organization	B.1.1.7	Europe	Europe	Central Public Health Lab, National Public Health Organization		2021-05-21	Kyriaki Tryfinopoulou et al	[object Object]	11	Male
Russia/MOW-CRIE-D186A0005/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-02-26	Samoilov AE et al	[object Object]	19	Male
Russia/MOS-CRIE-L106D0115b/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-07	Samojlov A.E. et al	[object Object]	1	Male
Russia/MOS-CRIE-L106D0106b/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-07	Samojlov A.E. et al	[object Object]	32	Female
Russia/MOW-CRIE-L189B2503b/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-04	Samojlov A.E. et al	[object Object]	65	Female
Russia/MOW-CRIE-L191C0036b/2021	1.00	0.07	0.01	0.01	0.04	GR	7.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-05	Samojlov A.E. et al	[object Object]	20	Male
Ireland/G-NVRL-21IRL42431/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Galway	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-02-22	Zoe Yandle et al	[object Object]		Male
Ireland/WD-NVRL-90IRL34340/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Waterford	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-02	Zoe Yandle et al	[object Object]		Female
Ireland/MH-NVRL-30IRL10551/2021	1.00	0.07	0.01	0.01	0.05	GRY	7.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Meath	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-16	Zoe Yandle et al	[object Object]		Female
Ireland/WD-NVRL-23IRL22750/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Waterford	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-22	Zoe Yandle et al	[object Object]		Female
Ireland/RN-NVRL-30IRL21659/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Roscommon	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Male
Ireland/RN-NVRL-21IRL63008/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Roscommon	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-27	Zoe Yandle et al	[object Object]		Female
Ireland/RN-NVRL-21IRL63005/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Roscommon	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-27	Zoe Yandle et al	[object Object]		Male
Belgium/AZDelta-9201/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Tielt	Human		AZDelta	B.1.1.7	Europe	Europe	AZDelta		2021-02-10	Geert Martens et al	[object Object]	22	Male
Russia/BEL-RII-MH17711S/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-07	Andrey Komissarov et al A	[object Object]	49	
Kuwait/KU-5862/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Kuwait	Asia	Hawalli	Human	Asia	Mubarak Al-Kabeer Hospital	B.1.1.7	Asia	Asia	Virology Unit, Department of Microbiology, Faculty of Medicine, Kuwait University		2021-02-02	Nada Madi et al	[object Object]	21	Female
Kuwait/MadiN/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Kuwait	Asia	Hawalli	Human	Asia	Mubarak Al-Kabeer Hospital	B.1.1.7	Asia	Asia	Virology Unit, Department of Microbiology, Faculty of Medicine, Kuwait University		2021-01-21	Nada Madi et al	[object Object]	11	Female
Switzerland/BL-ETHZ-550992/2020	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Basel-Land	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-03-21	Chaoran Chen et al	[object Object]		
Switzerland/BL-ETHZ-550991/2020	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Basel-Land	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-03-21	Chaoran Chen et al	[object Object]		
Switzerland/SO-ETHZ-550866/2020	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Solothurn	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-03-19	Chaoran Chen et al	[object Object]		
Ireland/WD-NVRL-21IRL48932/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Waterford	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-02-25	Zoe Yandle et al	[object Object]		Female
Ireland/CN-NVRL-30IRL22931/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Cavan	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Male
Ireland/CN-NVRL-30IRL30718/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Cavan	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-18	Zoe Yandle et al	[object Object]		Female
Russia/MOW-CRIE-D186P0130/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-02-23	Samoilov AE et al	[object Object]	57	Female
Ireland/C-NVRL-e85IRL45859/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Cork	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-02-08	Zoe Yandle et al	[object Object]		Male
Ireland/OY-NVRL-e85IRL53698/2021	1.00	0.07	0.01	0.01	0.04	G	7.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Offaly	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-02-10	Zoe Yandle et al	[object Object]		Male
Ireland/RN-NVRL-30IRL22606/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Roscommon	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Male
Ireland/MN-NVRL-ec21IRL29936/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Monaghan	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-02-15	Zoe Yandle et al	[object Object]		Male
Ireland/OY-NVRL-e84IRL89977/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Offaly	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-02-01	Zoe Yandle et al	[object Object]		Male
Ireland/WD-NVRL-89IRL24858/2021	2.00	0.12	0.04	0.09	0.14	GRY	8.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Waterford	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-04-13	Zoe Yandle et al	[object Object]		Male
CzechRepublic/NRL_5175_21/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Central Bohemian Region	Human		National Institute of Public Health	B.1.1.7	Europe	Europe	National Institute of Public Health		2021-02-22	Helena Jirincova et al	[object Object]	52	Male
Russia/MOW-RII-MH15908/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Pathogenic Microorganisms Variability Laboratory	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-05	Andrey Komissarov et al A	[object Object]	65	Female
NorthernIreland/RAND-1592618/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	United Kingdom	United Kingdom	United Kingdom	Northern Ireland	Human		Randox Laboratories	B.1.1.7	Europe	Europe	Wellcome Sanger Institute for the COVID-19 Genomics UK (COG-UK) Consortium		2021-05-17	Randox Laboratories et al	[object Object]		
Ireland/LH-NVRL-30IRL17174/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Louth	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Male
Ireland/WH-NVRL-ec86IRL27891/2021	1.00	0.07	0.01	0.01	0.04	G	7.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Westmeath	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-02-23	Zoe Yandle et al	[object Object]		Female
Ireland/WH-NVRL-30IRL43079/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Westmeath	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-20	Zoe Yandle et al	[object Object]		Male
Ireland/MH-NVRL-30IRL28616/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Meath	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-18	Zoe Yandle et al	[object Object]		Female
Ireland/WH-NVRL-30IRL43086/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Westmeath	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-20	Zoe Yandle et al	[object Object]		Male
Norway/13297/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Norway	Norway	Norway	Agder	Human		Unilabs Laboratory Medicine	B.1.1.7	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-05-19	Kathrine Stene-Johansen et al	[object Object]		
USA/NM-NMDOH-2021115620/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	North America	USA	North America	New Mexico	Human	North America	New Mexico Department of Health Scientific Laboratory	B.1.1.7	North America	North America	New Mexico Department of Health Scientific Laboratory		2021-05-17	Ellie Johnson et al	[object Object]	60	Female
Ireland/TA-NVRL-t21IRL35260/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Tipperary	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-02-16	Zoe Yandle et al	[object Object]		Female
Ireland/RN-NVRL-21IRL54866/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Roscommon	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-02-28	Zoe Yandle et al	[object Object]		Female
Ireland/WX-NVRL-ec21IRL50910/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Wexford	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-02-25	Zoe Yandle et al	[object Object]		Female
Ireland/DL-NVRL-30IRL24376/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Donegal	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Female
Ireland/DL-NVRL-30IRL40970/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Donegal	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-19	Zoe Yandle et al	[object Object]		Male
Sweden/20271342P/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Varmland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-18	Maximilian Riess et al	[object Object]		
Sweden/21-51485/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Jamtland	Human		Klinisk mikrobiologi	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-02-15	Anna-Malin Linde et al	[object Object]	19	Female
Sweden/21-53948/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Uppsala	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-25	Maximilian Riess et al	[object Object]		Male
Greece/EKAR_89017/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Greece	Greece	Greece	Aegean Islands	Human	Kalymnos	National Reference Centre for Retroviruses	B.1.1.7	Europe	Europe	Central Public Health Laboratory		2021-04-04	Gkikas Magiorkinis et al	[object Object]	16	Female
Ireland/LK-NVRL-e87IRL73759/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Limerick	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-03-21	Zoe Yandle et al	[object Object]		Male
Belgium/AZDelta/04258-2122R/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Oudenaarde	Human		AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-06-02	Geert Martens et al	[object Object]		
Bulgaria/21BG-NC_A000129/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bulgaria	Bulgaria	Bulgaria	Kyustendil	Human		National Center of Infectious and Parasitic Diseases	B.1.1.7	Europe	Europe	National Center of Infectious and Parasitic Diseases		2021-02-02	Alexiev et al	[object Object]	48	Male
Iraq/Samawa-77/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Asia	Iraq	Asia	Al-Muthanna Province	Human	Asia	Biology Department, College of Science, Al Muthanna University and Public Health Laboratory, Al-Muthanna Health Directorate	B.1.1.7	Asia	Asia	Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland		2021-02-11	Nihad Al-Rashedi et al	[object Object]	31	Male
Finland/HEL-16-335/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Finland	Finland	Finland	Uusimaa	Human		Department of Virology and Immunology, University of Helsinki and Helsinki University Hospital, Huslab Finland	B.1.1.7	Europe	Europe	Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland		2021-01-18	Teemu Smura et al	[object Object]	32	Male
Romania/B-14299/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Romania	Romania	Romania	Bucharest	Human		National Institute of Infectious Diseases-Prof. Dr. Matei Bals Molecular Diagnostics Laboratory	B.1.1.7	Europe	Europe	National Institute of Infectious Diseases-Prof. Dr. Matei Bals Molecular Diagnostics Laboratory		2021-05-17	Corina Casangiu et al	[object Object]	62	Female
Gabon/JE08/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Africa	Gabon	Africa	Libreville	Human	Africa	Centre Hospitalier Universitaire Mère-Enfant, Fondation Jeanne Ebori (CHUMEFJE)	B.1.1.7	Africa	Africa	Centre de recherches médicales de Lambaréné (CERMEL)		2021-01-12	Haruka Abe et al	[object Object]		
Russia/MOW-CRIE-L189C1877b/2021	1.00	0.07	0.01	0.01	0.04	GR	5.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-05	Samojlov A.E. et al	[object Object]	37	Male
Qatar/QA-QU_17-H4/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Qatar	Asia	Doha	Human	Asia	Ministry of Public Health / Hamad Medical Corporation	B.1.1.7	Asia	Asia	Biomedical Research Center (BRC), Qatar University / Qatar Genome Project (QGP)		2021-01-05	BRC: Fatiha M. Benslimane et al	[object Object]	11	Female
Switzerland/GR-ETHZ-480420/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Graubünden	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-02-01	Chaoran Chen et al	[object Object]		
Poland/NIPH-NIH_ECDC-4253/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Poland	Poland	Poland	Swietokrzyskie	Human	Kielce	WSSE Kielce	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-04-19	Wołkowicz Tomasz et al	[object Object]	60	Male
Poland/NIPH-NIH_ECDC-6127/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Poland	Poland	Poland	Podlaskie	Human	Białystok	WSSE Białystok	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-05-20	Wołkowicz Tomasz et al	[object Object]	61	Female
Ireland/KK-NVRL-t21IRL42494/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Kilkenny	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-02-23	Fiona Crispie et al	[object Object]		Male
Sweden/20258404P/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Jamtland Harjedalen	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-17	Maximilian Riess et al	[object Object]		
Sweden/20238035P/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Gavleborgs Lan	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-17	Maximilian Riess et al	[object Object]		
Sweden/20264251P/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Jamtland Harjedalen	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-17	Maximilian Riess et al	[object Object]		
Sweden/20262388P/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Jamtland Harjedalen	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-17	Maximilian Riess et al	[object Object]		
Sweden/20271356P/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Jamtland Harjedalen	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-18	Maximilian Riess et al	[object Object]		
Sweden/SE00276880/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Skane	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-02-19	Swedish national genomic surveillance program of SARS-CoV-2 et al	[object Object]		
Sweden/DC111182831/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Halland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-17	Maximilian Riess et al	[object Object]		
SaintLucia/59981/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	South America	Saint Lucia	South America	Saint Lucia	Human	South America	The Caribbean Public Health Agency	B.1.1.7	South America	South America	Carrington Lab, Department of PreClinical Sciences, Faculty of Medical Sciences, The University of the West Indies		2021-03-15	Nikita S. D. Sahadeo et al	[object Object]		
SaintLucia/59979/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	South America	Saint Lucia	South America	Saint Lucia	Human	South America	The Caribbean Public Health Agency	B.1.1.7	South America	South America	Carrington Lab, Department of PreClinical Sciences, Faculty of Medical Sciences, The University of the West Indies		2021-03-14	Nikita S. D. Sahadeo et al	[object Object]		
Belgium/AZDelta/22695-2113R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Roeselare	Human		AZDelta	B.1.1.7	Europe	Europe	AZDelta		2021-04-02	Geert Martens et al	[object Object]		
Ireland/G-NVRL-30IRL15181/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Galway	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Female
Ireland/G-NVRL-30IRL13497/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Galway	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Female
Ireland/CE-NVRL-30IRL21976/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Clare	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Male
Ireland/CE-NVRL-30IRL14303/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Clare	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Male
Russia/MOW-CRIE-D187S0065b/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-03	Samojlov A.E. et al	[object Object]	58	Male
Japan/IC-1325/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	USA	Asia	USA	Human	Asia	SARS-CoV-2 testing team, National Institute of Infectious Diseases	B.1.1.7	Asia	North America	Pathogen Genomics Center, National Institute of Infectious Diseases		2021-06-01	Tsuyoshi Sekizuka et al B	[object Object]		
Russia/MOW-RII-MH15912/2021	1.00	0.07	0.01	0.01	0.04	G	5.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Pathogenic Microorganisms Variability Laboratory	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	70	Female
Russia/MOW-PMVL-48/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Pathogenic Microorganisms Variability Laboratory	B.1.1.7	Europe	Europe	Pathogenic Microorganisms Variability Laboratory		2021-02-24	Alexey Shchetinin et al	[object Object]	70	Female
Aruba/AW-RIVM-16766/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	South America	Aruba	South America	Aruba	Human	South America	Dutch COVID-19 response team	B.1.1.7	South America	South America	National Institute for Public Health and the Environment (RIVM)		2021-02-28	Adam Meijer et al	[object Object]	63	
USA/VT-CDCBI-CRSP_UCY5JWKYEMHWCKCI/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	Vermont	Human	North America	Broad Institute Clinical Research Sequencing Platform	B.1.1.7	North America	North America	Infectious Disease Program, Broad Institute of Harvard and MIT		2021-05-19	Siddle et al	[object Object]		
USA/VT-CDC-QDX25249571/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	Vermont	Human	North America	Quest Diagnostics Incorporated	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-22	Dakota Howard et al	[object Object]	60	Male
USA/NY-PRL-2021_0603_00B04/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	New York	Human	North America	Pandemic Response Lab - NYC	B.1.1.7	North America	North America	Pandemic Response Lab, R&D		2021-06-01	Henry Lee et al	[object Object]	30	Female
Russia/MOW-CRIE-L189D0391b/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-07	Samojlov A.E. et al	[object Object]	57	Female
USA/NC-CDC-LC0065639/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	North Carolina	Human	North America	Laboratory Corporation of America	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-06-01	Dakota Howard et al	[object Object]	71	Female
USA/MT-CDC-ASC210064460/2021						GR	5.00	20I (Alpha, V1)	North America	USA	North America	Montana	Human	North America	Aegis Sciences Corporation	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-17	Dakota Howard et al	[object Object]	28	Male
USA/KY-CDC-LC0064575/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	North America	USA	North America	Kentucky	Human	North America	Laboratory Corporation of America	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-20	Dakota Howard et al	[object Object]	24	Male
USA/OH-CDC-FG-036629/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	North America	USA	North America	Ohio	Human	North America	Fulgent Genetics	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-06-01	Dakota Howard et al	[object Object]	22	Female
USA/OH-CDC-FG-036624/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	North America	USA	North America	Ohio	Human	North America	Fulgent Genetics	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-06-01	Dakota Howard et al	[object Object]	40	
Bermuda/51485/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	South America	Bermuda	South America	Bermuda	Human	South America	The Caribbean Public Health Agency	B.1.1.7	South America	South America	Carrington Lab, Department of PreClinical Sciences, Faculty of Medical Sciences, The University of the West Indies		2021-01-05	Nikita S. D. Sahadeo et al	[object Object]		
USA/SD-CDC-2-4449299/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	South Dakota	Human	North America	SD Public Health Laboratory	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-17	Mili Sheth et al	[object Object]	37	Female
Norway/13641/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Norway	Norway	Norway	Trondelag	Human		Department of Medical Microbiology, St. Olavs hospital	B.1.1.7	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-05-22	Kathrine Stene-Johansen et al	[object Object]		
Norway/11164/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Norway	Norway	Norway	Agder	Human		Hospital of Southern Norway - Kristiansand, Department of Medical Microbiology	B.1.1.7	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-04-23	Kathrine Stene-Johansen et al	[object Object]		
Norway/13314/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Norway	Norway	Norway	Rogaland	Human		Haugesund Hospital, laboratory for Medical Microbiology	B.1.1.7	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-05-21	Kathrine Stene-Johansen et al	[object Object]		
Russia/MOW-CRIE-L188K0285u/2021	1.00	0.07	0.01	0.01	0.04	G	7.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-08	Samoilov AE et al	[object Object]	42	Male
Russia/MOW-RII-MH15897/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Pathogenic Microorganisms Variability Laboratory	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-25	Andrey Komissarov et al A	[object Object]	59	Female
Russia/MOW-CRIE-L189P2389/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-23	Samojlov A.E. et al	[object Object]	38	Female
Russia/MOW-CRIE-D187S0070/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-02-24	Samoilov AE et al	[object Object]	40	Female
Russia/MOW-CRIE-D186A0041/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-02-27	Samoilov AE et al	[object Object]	46	Male
Russia/MOW-CRIE-D186A0064/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-02-28	Samoilov AE et al	[object Object]	55	Female
Russia/SPE-RII-MH17384S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-10	Andrey Komissarov et al A	[object Object]	34	Male
Russia/VGG-RII-MH18401S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Volgograd Region	Volgograd Region	Human	Volgograd	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-11	Andrey Komissarov et al A	[object Object]	50	Female
Russia/SPE-RII-MH15728S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-03	Andrey Komissarov et al A	[object Object]	35	Male
Sweden/101560476/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Kronoberg	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-17	Maximilian Riess et al	[object Object]		
Sweden/SUS0002385/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Skane	Human		Clinical Microbiology, Infection Prevention and Control	B.1.1.7	Europe	Europe	Section for Molecular Diagnostics		2021-06-04	Björn Hallström et al	[object Object]	25	Female
Sweden/SUS0002359/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Skane	Human		Clinical Microbiology, Infection Prevention and Control	B.1.1.7	Europe	Europe	Section for Molecular Diagnostics		2021-06-01	Björn Hallström et al	[object Object]	58	Female
Italy/VDA-35343-1/2021						GR	4.00	20I (Alpha, V1)	Italy	Italy	Italy	Valle D'Aosta	Human		Azienda USL Valle d'Aosta	B.1.1.7	Europe	Europe	U.O. Genomics, S.S. Genetics and Advanced Omics Techniques, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta		2021-04-03	Chiara Beltramo et al	[object Object]	39	Female
Greece/194133/2021	1.00	0.07	0.01	0.01	0.05	GRY	7.00	20I (Alpha, V1)	Greece	Greece	Greece	Attica	Human		Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)	B.1.1.7	Europe	Europe	Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)		2021-04-28	Emmanouil Athanasiadis et al	[object Object]		
Belgium/UZA-UA-189KFJ/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	La Louvière	Human	Carnières	LHUB-ULB	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-20	Marie Le Mercier et al	[object Object]	25	Female
Belgium/CHUNamur13180905/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	West-Vlaanderen	Human		Plateforme de testing Namuroise	B.1.1.7	Europe	Europe	Plateforme de testing Namuroise		2021-02-19	Céline Maschietto et al	[object Object]	41	Female
Belgium/UZA-UA-586KEJ/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Nivelles	Human	Baulers	LHUB-ULB	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-19	Marie Le Mercier et al	[object Object]	44	Female
Belgium/UZA-UA-975KIJ/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Nivelles	Human	Baulers	LHUB-ULB	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-26	Marie Le Mercier et al	[object Object]	44	Female
Spain/ML-ISCIII-213613/2021	1.00	0.07	0.01	0.01	0.04	GR	5.00	20I (Alpha, V1)	Spain	Spain	Spain	Melilla	Human		HOSPITAL COMARCAL DE MELILLA	B.1.1.7	Europe	Europe	Instituto de Salud Carlos III		2021-04-05	Iglesias-Caballero et al	[object Object]	60	Male
Russia/SPE-RII-35288S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]	64	Female
Switzerland/ZG-ETHZ-640109/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Zug	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-05-27	Christian Beisel et al	[object Object]		
Belgium/rega-6594/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Eeklo	Human		KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.1.7	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2021-04-04	Tony Wawina-Bokalanga et al	[object Object]	84	Female
Norway/13082/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Norway	Norway	Norway	Vestfold Og Telemark	Human		Vestfold Hospital, Toensberg Department of Microbiology	B.1.1.7	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-05-24	Kathrine Stene-Johansen et al	[object Object]		
Norway/13254/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Norway	Norway	Norway	Innlandet	Human		Innlandet Hospital Trust, Division Lillehammer, Department for Medical Microbiology	B.1.1.7	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-05-23	Kathrine Stene-Johansen et al	[object Object]		
Norway/13545/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Norway	Norway	Norway	Vestfold Og Telemark	Human		Vestfold Hospital, Toensberg Department of Microbiology	B.1.1.7	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-05-26	Kathrine Stene-Johansen et al	[object Object]		
Norway/13093/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Norway	Norway	Norway	Vestfold Og Telemark	Human		Vestfold Hospital, Toensberg Department of Microbiology	B.1.1.7	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-05-24	Kathrine Stene-Johansen et al	[object Object]		
Russia/SPE-RII-34635S/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-17	Andrey Komissarov et al A	[object Object]	79	Male
Germany/NI-RKI-I-035704/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Niedersachsen	Human		amedes Göttingen	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-02-19	?	[object Object]		
Germany/TH-RKI-I-051799/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Thuringia	Human		SYNLAB Jena Oncoscreen	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-03-18	?	[object Object]		
Germany/TH-RKI-I-163553/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Thuringia	Human		amedes MVZ Jena	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-05-20	?	[object Object]		
Germany/TH-RKI-I-167198/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Thuringia	Human		Thüringer Landesamtes für Verbraucherschutz	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-05-18	?	[object Object]		
Germany/HE-RKI-I-055833/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Hesse	Human		IMD Labor Frankfurt	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-03-18	?	[object Object]		
Germany/TH-RKI-I-152143/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Thuringia	Human		SYNLAB Jena Oncoscreen	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-05-07	?	[object Object]		
Germany/ST-MD2676/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Saxony-Anhalt	Human		Institute of Medical Microbiology and Hospital Hygiene	B.1.1.7	Europe	Europe	Institute of Medical Microbiology and Hospital Hygiene		2021-04-16	Prof. Dr. Achim Kaasch et al	[object Object]	59	Female
Germany/HB-RKI-I-055366/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Bremen	Human		Labor Dr. Schumacher MVZ	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-03-18	?	[object Object]		
Sweden/21-52163/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Jonkoping	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-03-25	Maximilian Riess et al	[object Object]	68	Male
Spain/MD-ISCIII-212001/2021	1.00	0.07	0.01	0.01	0.04	GR	5.00	20I (Alpha, V1)	Spain	Spain	Spain	Madrid	Human		CENTRO MILITAR DE VETERINARIA	B.1.1.7	Europe	Europe	Instituto de Salud Carlos III		2021-02-18	Iglesias-Caballero et al	[object Object]	30	Male
Italy/LAZ-IZSLT-21066784/2021	1.00	0.07	0.01	0.01	0.04	GR	7.00	20I (Alpha, V1)	Italy	Italy	Italy	Lazio	Human	Rome	Department of Virology, Istituto Zooprofilattico Sperimentale del Lazio e della Toscana (IZSLT)	B.1.1.7	Europe	Europe	Department of General Diagnostics; Department of Virology; Istituto Zooprofilattico Sperimentale del Lazio e della Toscana (IZSLT)		2021-05-18	Patricia Alba et al	[object Object]	14	Female
Mexico/CMX-InDRE_FD64253_S2063/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	North America	Mexico	North America	Mexico City	Human	North America	LESP Ciudad de Mexico	B.1.1.7	North America	North America	Instituto de Diagnostico y Referencia Epidemiologicos (INDRE)		2021-03-05	Claudia Wong-Arambula et al	[object Object]	22	Female
USA/MI-CDC-ASC210065349/2021	1.00	0.07	0.01	0.01	0.04	GR	7.00	20I (Alpha, V1)	North America	USA	North America	Michigan	Human	North America	Aegis Sciences Corporation	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-18	Dakota Howard et al	[object Object]	14	Male
Spain/RI-IBV-99027073/2021	1.00	0.07	0.01	0.01	0.05	G	8.00	20I (Alpha, V1)	Spain	Spain	Spain	La Rioja ES	Human	Calahorra	Centro de Investigación Biomédica de La Rioja - Hospital San Pedro Logroño	B.1.1.7	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2021-03-19	María de Toro et al	[object Object]	35	Female
Spain/AN-IBV-99023171/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Spain	Spain	Spain	Andalusia	Human	Viator	Hospital General Universitario Gregorio Marañón	B.1.1.7	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2021-02-14	Darío García de Viedma et al	[object Object]	85	Male
Spain/AN-IBV-99023164/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	Spain	Spain	Spain	Andalusia	Human	Viator	Hospital General Universitario Gregorio Marañón	B.1.1.7	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2021-02-17	Darío García de Viedma et al	[object Object]	68	Female
Sweden/14510147P/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Öland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-02-19	Swedish national genomic surveillance program of SARS-CoV-2 et al	[object Object]		
Greece/201409/2021	1.00	0.07	0.01	0.01	0.07	GR	7.00	20I (Alpha, V1)	Greece	Greece	Greece	Western Greece	Human		Hellenic National Blood Transfusion Center - EKEA	B.1.1.7	Europe	Europe	Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)		2021-05-09	Emmanouil Athanasiadis et al	[object Object]		
Greece/210145/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Greece	Greece	Greece	Crete	Human		Laboratory of Clinical Virology	B.1.1.7	Europe	Europe	Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)		2021-05-20	Emmanouil Athanasiadis et al	[object Object]		
Italy/SAR-2764/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Italy	Italy	Italy	Sardinia	Human		Laboratorio Biologia Molecolare Sars Cov2 - UOC Laboratorio Analisi - Servizio Medicina di Laboratorio, Ospedale "San Francesco" - ATS-ASSL Nuoro	B.1.1.7	Europe	Europe	Laboratorio specialistico UOC Ematologia - Ospedale "San Francesco" - ATS-ASSL Nuoro		2021-06-02	Asproni Rosanna et al	[object Object]	20	Male
Italy/APU-IZSPB-1015PT/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Italy	Italy	Italy	Apulia	Human	Taranto	Ospedale Santissima Annunziata	B.1.1.7	Europe	Europe	Istituto Zooprofilattico Sperimentale della Puglia e della Basilicata		2021-03-18	Parisi A. et al	[object Object]	56	Male
Greece/210139/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Greece	Greece	Greece	Peloponnese	Human		Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)	B.1.1.7	Europe	Europe	Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)		2021-05-20	Emmanouil Athanasiadis et al	[object Object]		
Germany/NI-RKI-I-010915/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Niedersachsen	Human		amedes MVZ Hannover	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-01-18	?	[object Object]		
Croatia/2178/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Croatia	Croatia	Croatia	Dubrovnik-Neretva County	Human		Institute of Public health Dubrovnik-Neretva County	B.1.1.7	Europe	Europe	Croatian Institute of Public Health		2021-03-23	Irena Tabain et al	[object Object]	17	Female
SriLanka/CMC111167/2021						O	5.00	20I (Alpha, V1)	Asia	Sri Lanka	Asia	Sabaragamuwa Province	Human	Asia	Centre for Dengue Research and AICBU, Department of Immunology and Molecular Medicine	B.1.1.7	Asia	Asia	Centre for Dengue Research and AICBU, Department of Immunology and Molecular Medicine		2021-05-25	Chandima Jeewandara et al B	[object Object]	27	Male
Italy/VDA-36943-6/2021						GR	4.00	20I (Alpha, V1)	Italy	Italy	Italy	Valle D'Aosta	Human		Azienda USL Valle d'Aosta	B.1.1.7	Europe	Europe	U.O. Genomics, S.S. Genetics and Advanced Omics Techniques, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta		2021-04-20	Chiara Beltramo et al	[object Object]	55	Female
Russia/SPE-RII-MH17299S/2021		0.01	0.05	0.06	0.07	GR	7.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-28	Andrey Komissarov et al A	[object Object]	36	Female
Lithuania/S21E1178/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Alytaus Apskritis	Human		Viesoji istaiga Vilniaus universiteto ligonine Santaros klinikos	B.1.1.7	Europe	Europe	Vilnius University Hospital Santaros Klinikos, Center of Laboratory Medicine		2021-05-20	Ligita Raugaite et al	[object Object]	53	Female
Greece/146304/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Greece	Greece	Greece	Crete	Human		Laboratory of Clinical Virology	B.1.1.7	Europe	Europe	Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)		2021-03-09	Emmanouil Athanasiadis et al	[object Object]		
Ghana/WACCBIP-GS703/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Africa	Ghana	Africa	Eastern Region GH	Human	Africa	West African Centre for Cell Biology of Infectious Pathogen, University of Ghana, Legon	B.1.1.7	Africa	Africa	WACCBIP, University of Ghana, Volta Road, Legon, Accra		2021-04-24	Collins M. Morang'a et al	[object Object]	16	Female
Canada/AB-ABPHL-17129/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	Canada	North America	Alberta	Human	North America	Edmonton Provincial Lab	B.1.1.7	North America	North America	Public Health Agency of Canada (PHAC) National Microbiology Laboratory		2021-04-12	Buss et al	[object Object]		
Norway/11322/2021	1.00	0.08	0.22	0.05	0.11	GRY	8.00	20I (Alpha, V1)	Norway	Norway	Norway	Agder	Human		Hospital of Southern Norway - Kristiansand, Department of Medical Microbiology	B.1.1.7	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-04-27	'Kathrine Stene-Johansen et al	[object Object]		
Belgium/UZA-UA-CV2112591995/2021	1.00	0.08	0.01	0.01	0.05	GRY	7.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Mechelen	Human	Beerzel	Platform BIS UZA/UAntwerpen	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-06-02	Marie Le Mercier et al	[object Object]	7	Male
Belgium/UMONS-P01-82099-01/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Hainaut	Human		National Platform bis UMONS/Jolimont	B.1.1.7	Europe	Europe	National Platform bis UMONS/Jolimont		2021-05-19	François Dufrasne et al	[object Object]	63	Male
Sweden/Orebro-19813950/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Orebro	Human		Orebro University Hospital, Dept Laboratory Medicine, Clinical Microbiology	B.1.1.7	Europe	Europe	Orebro University Hospital		2021-05-21	Sundqvist M et al	[object Object]	51	Male
Belgium/AZDelta-17733-2120R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Veurne	Human		AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-05-26	Geert Martens et al	[object Object]		
Italy/LIG-TIGEM-IZSM-COLLI-9892/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Italy	Italy	Italy	Liguria	Human		UOC laboratorio di analisi Istituto Giannina Gaslini	B.1.1.7	Europe	Europe	TIGEM		2021-03-02	Antonio Grimaldi Patrizia Annunziata Francesco Panariello Teresa Giuliano Valentina Bouche Chiara Colantuono Lucio Di Filippo Anna Manfredi Marcello Salvi Andrea Ballabio Davide Cacchiarelli et al	[object Object]	51	Male
Russia/MOW-CRIE-L189C2000b/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-05	Samojlov A.E. et al	[object Object]	25	Female
Russia/BEL-RII-MH17509S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-14	Andrey Komissarov et al A	[object Object]	50	
Greece/E_845/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Greece	Greece	Greece	Central Macedonia	Human		National Influenza Centre for Northern Greece, Aristotle University of Thessaloniki	B.1.1.7	Europe	Europe	Central Public Health Laboratory, National Public Health Organization		2021-03-03	Anna Papa et al	[object Object]		
Greece/V975/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Greece	Greece	Greece	Chalkidiki	Human		Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece	B.1.1.7	Europe	Europe	Institute of Applied Biosciences, Centre for Research and Technology Hellas		2021-04-26	Anastasia Chatzidimitriou et al.	[object Object]		Female
Greece/V979/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Greece	Greece	Greece	Amyntaio	Human		Laboratory of Molecular Biology, Mamatsio General Hospital of Kozani	B.1.1.7	Europe	Europe	Institute of Applied Biosciences, Centre for Research and Technology Hellas		2021-04-26	Anastasia Chatzidimitriou et al.	[object Object]		Female
Belgium/UZA-UA-CV2236636003/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Veurne	Human	Beveren	Platform BIS UZA/UAntwerpen	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-06-03	Jasmine Coppens et al	[object Object]	14	Female
NorthMacedonia/35054/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North Macedonia	North Macedonia	North Macedonia	Skopje	Human		Research Center for Genetic Engineering and Biotechnology "Georgi D. Efremov” , Macedonian Academy of Sciences and Arts	B.1.1.7	Europe	Europe	Research Center for Genetic Engineering and Biotechnology "Georgi D. Efremov” , Macedonian Academy of Sciences and Arts		2021-03-31	Aleksandar J. Dimovski et al	[object Object]	73	Male
Bulgaria/21BG-EU_002225_Pl21/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bulgaria	Bulgaria	Bulgaria	Gabrovo	Human		National Center of Infectious and Parasitic Diseases	B.1.1.7	Europe	Europe	National Center of Infectious and Parasitic Diseases		2021-04-05	Alexiev et al	[object Object]	92	Female
Russia/SPE-RII-MH15654S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	65	Male
Russia/LEN-RII-MH15759S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Fedorovskoe	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	58	Female
Russia/SPE-RII-33326S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-29	Andrey Komissarov et al A	[object Object]	70	Female
Russia/SPE-RII-MH14710S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-11	Andrey Komissarov et al A	[object Object]	44	Male
Lithuania/LSMULKKGMMK4C41/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Vilkaviskis	Human		Medicina practica laboratorija	B.1.1.7	Europe	Europe	Lithuanian University of Health Sciences Hospital, Department of Genetics and Molecular Medicine		2021-02-10	Rasa Ugenskiene et al	[object Object]		
Lithuania/LTU000_NMVRI_2021_03_22_200/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Marijampoles Apskritis	Human		Diagnostikos laboratorija	B.1.1.7	Europe	Europe	National Public Health Surveillance Laboratory		2021-03-15	Lukas Zemaitis et al	[object Object]	57	Female
Russia/SPE-RII-34719S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	49	Male
Russia/SPE-RII-MH15698S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-28	Andrey Komissarov et al A	[object Object]	31	Female
Lithuania/LTU000_MP_Pr71/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Marijampoles Apskritis	Human		UAB Medicina practica laboratorija	B.1.1.7	Europe	Europe	National Public Health Surveillance Laboratory		2021-05-04	Lukas Zemaitis et al	[object Object]	23	Male
Russia/PSK-RII-MH15748S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Pskov Oblast	Pskov Oblast	Human	Velikiye Luki	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	53	Female
Sweden/16440737P/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Dalarna	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-04-12	Maximilian Riess et al	[object Object]		
Switzerland/BE-IFIK-1295-6094/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Bern	Human		Institute for Infectious Diseases, University of Bern, Switzerland	B.1.1.7	Europe	Europe	Institute for Infectious Diseases, University of Bern, Switzerland		2021-05-22	Stefan Neuenschwander et al	[object Object]		
Switzerland/SO-ETHZ-630261/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Solothurn	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-05-17	Christian Beisel et al	[object Object]		
Russia/MOW-CRIE-L189S1896/2021	1.00	0.07	0.01	0.01	0.04	GR	4.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-25	Samojlov A.E. et al	[object Object]	37	Female
Russia/MOW-CRIE-L189C0102b/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-04	Samojlov A.E. et al	[object Object]	38	Male
Gambia/20197/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Africa	Gambia	Africa	Kombo	Human	Africa	MRCG at LSHTM Genomics lab	B.1.1.7	Africa	Africa	MRCG at LSHTM Genomics lab		2021-03-10	Abdul Karim sesay et al	[object Object]	52	Female
Greece/196471/2021	1.00	0.07	0.01	0.01	0.04	GR	8.00	20I (Alpha, V1)	Greece	Greece	Greece	Western Greece	Human		Hellenic National Blood Transfusion Center - EKEA	B.1.1.7	Europe	Europe	Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)		2021-02-05	Emmanouil Athanasiadis et al	[object Object]		
France/OCC-HMN-21042200448/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	France	France	France	Occitanie	Human		Laboratoire du CH Narbonne	B.1.1.7	Europe	Europe	Department of Virology, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Université Paris-Est Créteil, INSERM U955		2021-04-13	Christophe Rodriguez et al	[object Object]	56	Female
Romania/un-USAFSAM-S2819/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Romania	Romania	Romania	Romania	Human		US Air Force School of Aerospace Medicine	B.1.1.7	Europe	Europe	US Air Force School of Aerospace Medicine		2021-04-16	Anthony Fries et al	[object Object]	20	Male
DRC/867/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Africa	Democratic Republic of the Congo	Africa	Lualaba	Human	Africa	Viral Respiratory Lab, National Institute for Biomedical Research (INRB)	B.1.1.7	Africa	Africa	Pathogen Sequencing Lab, National Institute for Biomedical Research (INRB)		2021-01-30	Placide Mbala-Kingebeni et al A	[object Object]	71	Female
Sweden/21-53884/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Vastra Gotaland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-20	Maximilian Riess et al	[object Object]		Female
Sweden/101539896/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Kronoberg	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-04-30	Maximilian Riess et al	[object Object]		
Sweden/101557641/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Kronoberg	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-17	Maximilian Riess et al	[object Object]		
Switzerland/LU-UHB-42866956/2021	1.00	0.07	0.01	0.01	0.04	GR	5.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Lucerne	Human		Synlab Suisse SA	B.1.1.7	Europe	Europe	Clinical Bacteriology		2021-05-26	Tim Roloff et al	[object Object]		
NorthMacedonia/9257-k/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North Macedonia	North Macedonia	North Macedonia	Pelagonia	Human	Prilep	General Hospital - Prilep	B.1.1.7	Europe	Europe	Laboratory of virology and molecular diagnostics, Institute of Public Health		2021-03-11	Kuzmanovska M et al	[object Object]	37	Female
NorthMacedonia/22013/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North Macedonia	North Macedonia	North Macedonia	Gevgelija	Human		Laboratory of virology and molecular diagnostics, Institute of Public Health	B.1.1.7	Europe	Europe	Laboratory of virology and molecular diagnostics, Institute of Public Health		2021-03-17	Kuzmanovska M et al	[object Object]	43	Male
Greece/V1145/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Greece	Greece	Greece	Giannitsa	Human		Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece	B.1.1.7	Europe	Europe	Institute of Applied Biosciences, Centre for Research and Technology Hellas		2021-05-07	Anastasia Chatzidimitriou et al.	[object Object]		
Greece/KEDY_6947/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Greece	Greece	Greece	Aegean Islands	Human	Lesvos	Central Public Health Laboratory	B.1.1.7	Europe	Europe	Central Public Health Laboratory		2021-05-05	Kyriaki Tryfinopoulou et al	[object Object]	43	Female
Greece/KEDY_11243/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Greece	Greece	Greece	Western Greece	Human	Aetolia Acarnania	Central Public Health Lab, National Public Health Organization	B.1.1.7	Europe	Europe	Central Public Health Lab, National Public Health Organization		2021-05-18	Kyriaki Tryfinopoulou et al	[object Object]	41	Female
Bulgaria/21BG_COV_EU_001796_Pl17/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bulgaria	Bulgaria	Bulgaria	Haskovo	Human		National Center of Infectious and Parasitic Diseases	B.1.1.7	Europe	Europe	National Center of Infectious and Parasitic Diseases		2021-03-22	Alexiev et al	[object Object]	69	Female
Bulgaria/21BG-EU_002368_Pl22/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bulgaria	Bulgaria	Bulgaria	Montana BG	Human		National Center of Infectious and Parasitic Diseases	B.1.1.7	Europe	Europe	National Center of Infectious and Parasitic Diseases		2021-04-01	Alexiev et al	[object Object]	74	Male
Bulgaria/21BG-EU_002664_Pl24/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bulgaria	Bulgaria	Bulgaria	Smolyan	Human		National Center of Infectious and Parasitic Diseases	B.1.1.7	Europe	Europe	National Center of Infectious and Parasitic Diseases		2021-04-16	Alexiev et al	[object Object]	42	Male
Belgium/rega-4317/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Hasselt	Human	Zonhoven	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.1.7	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2021-03-05	Tony Wawina-Bokalanga et al	[object Object]	20	Female
Belgium/UZA-UA-24914366/2021	1.00	0.07	0.01	0.01	0.04	GR	4.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Brussels	Human	Schaerbeek	LHUB-ULB	B.1.1.7	Europe	Europe	UAntwerp, Laboratory of Medical Microbiology		2021-03-16	Basil Britto Xavier et al	[object Object]	67	Male
Belgium/rega-4662/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Maaseik	Human	Houthalen-Helchteren	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.1.7	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2021-03-09	Tony Wawina-Bokalanga et al	[object Object]	44	Male
Belgium/rega-6023/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Tongeren	Human	Maasmechelen	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.1.7	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2021-03-30	Tony Wawina-Bokalanga et al	[object Object]	35	Female
Belgium/rega-6705/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Hasselt	Human	Heusden-Zolder	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.1.7	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2021-04-12	Tony Wawina-Bokalanga et al	[object Object]	62	Male
Belgium/rega-6157/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Turnhout	Human	Retie	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.1.7	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2021-03-30	Tony Wawina-Bokalanga et al	[object Object]	33	Male
Belgium/Jessa-55-2112-000036/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Tongeren	Human	Alken	Jessa	B.1.1.7	Europe	Europe	Jessa		2021-03-22	Cruys et al. on behalf of the Jessa_cmdLab et al	[object Object]	17	Male
Russia/MOS-CRIE-L106A2225b/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-01	Samojlov A.E. et al	[object Object]	23	Female
Russia/TVE-CRIE-L188D0214b/2021	1.00	0.07	0.01	0.01	0.04	GR	5.00	20I (Alpha, V1)	Russia	Russia	Tver	Tver	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-02	Samojlov A.E. et al	[object Object]	19	Male
Russia/MOW-CRIE-L188K0296tu/2021	1.00	0.08	0.01	0.01	0.05	GRY	7.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Laboratory of Polymerase Chain Reaction of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-11	Samoilov AE et al	[object Object]	80	Male
Ireland/WX-NVRL-23IRL11404/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Wexford	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Female
Romania/MS-4188/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Romania	Romania	Romania	Mures	Human	Targu Mures	County Emergency Clinical Hospital of Tg. Mures	B.1.1.7	Europe	Europe	National Institute of Infectious Diseases-Prof. Dr. Matei Bals Molecular Diagnostics Laboratory		2021-02-22	Leontina Banica et al	[object Object]	38	Male
Romania/Vrancea_442775/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Romania	Romania	Romania	Vrancea	Human		Viral Respiratory Infections Laboratory, Cantacuzino National Military-Medical Institute	B.1.1.7	Europe	Europe	Cantacuzino Institute Virology		2021-04-06	Luiza Ustea et al	[object Object]	34	Male
Switzerland/AR-32559331/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Appenzell Ausserrhoden	Human		Viollier AG	B.1.1.7	Europe	Europe	Viollier AG		2021-04-20	Andrea Patrizia Salzmann et al	[object Object]		
France/BFC-HMN-21032170530/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	France	France	France	Bourgogne-France-Comté	Human		SELAS BC-LAB	B.1.1.7	Europe	Europe	Department of Virology, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Université Paris-Est Créteil, INSERM U955		2021-03-15	Christophe Rodriguez et al	[object Object]	46	Male
France/BRE-B116-59/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	France	France	France	Bretagne	Human		Biology Lab, HIA CLERMONT-TONNERRE	B.1.1.7	Europe	Europe	IRBA, 2MI		2021-03-08	GORGE O. et al	[object Object]	24	Male
France/GES-IPP11644/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	France	France	France	Grand Est	Human	Troyes	Hospital	B.1.1.7	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2021-03-12	Marion Barbet et al	[object Object]	43	Female
Belgium/CHUNamur13351479/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Namur	Human		Plateforme de testing Namuroise	B.1.1.7	Europe	Europe	Plateforme de testing Namuroise		2021-05-04	Lesly Nyinkeu Kemamen et al	[object Object]	78	Male
Germany/BW-RKI-I-170462/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Baden-Wuerttemberg	Human		Limbach - MVZ Humangenetik Ulm	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-06-01	?	[object Object]		
Switzerland/BL-ETHZ-640335/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Basel-Land	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-05-24	Chaoran Chen et al	[object Object]		
Russia/MOW-CRIE-L188S0136/2021	1.00	0.07	0.01	0.01	0.04	GR	4.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-22	Samojlov A.E. et al	[object Object]	18	Male
Pakistan/UHS-PAK-S12/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Asia	Pakistan	Asia	Lahore	Human	Asia	University of Health Sciences	B.1.1.7	Asia	Asia	Quadram Institute Bioscience		2021-04-09	Muhammad Bilal Sarwar et al	[object Object]	34	Male
Pakistan/UHS-PAK-S54/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Asia	Pakistan	Asia	Sargodha	Human	Asia	University of Health Sciences	B.1.1.7	Asia	Asia	Quadram Institute Bioscience		2021-04-10	Muhammad Bilal Sarwar et al	[object Object]	56	Male
Switzerland/VD-ETHZ-571105/2021	1.00	0.07	0.01	0.01	0.04	GR	7.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Vaud	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zurich		2021-04-07	Chaoran Chen et al	[object Object]		
Croatia/990/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Croatia	Croatia	Croatia	Split-Dalmatia County	Human		Teaching Institute for Public Health of Split-Dalmatia County	B.1.1.7	Europe	Europe	Croatian Institute of Public Health		2021-02-24	Irena Tabain et al	[object Object]	62	Male
Sweden/20269523P/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Varmland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-18	Maximilian Riess et al	[object Object]		
Bangladesh/ideSHi-B-100402007/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Bangladesh	Asia	Dhaka	Human	Asia	Institute of Epidemiology, Disease Control and Research (IEDCR)	B.1.1.7	Asia	Asia	Institute for Developing Science and Health Initiatives (ideSHi)		2021-02-04	Hassan Afrad et al	[object Object]	33	Male
Philippines/PH-PGC-13302/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Asia	Philippines	Asia	Cordillera Administrative Region	Human	Asia	Baguio General Hospital Medical Center (BGHMC)	B.1.1.7	Asia	Asia	Philippine Genome Center		2021-03-07	Francis A. Tablizo et al	[object Object]	23	Male
Philippines/PH-PGC-13297/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Asia	Philippines	Asia	Cordillera Administrative Region	Human	Asia	Baguio General Hospital Medical Center (BGHMC)	B.1.1.7	Asia	Asia	Philippine Genome Center		2021-03-03	Francis A. Tablizo et al	[object Object]	21	Female
Ireland/WW-NVRL-AIIDV1617/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Wicklow	Human		AIID	B.1.1.7	Europe	Europe	Irish Coronavirus Sequencing Consortium-Teagasc Grange		2021-01-15	Matthew McCabe et al	[object Object]	69	Female
Ireland/D-NVRL-ec21IRL67125/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Dublin	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-03-08	Zoe Yandle et al	[object Object]		Female
Ireland/OY-NVRL-ec87IRL50710/2021	1.00	0.07	0.01	0.01	0.04	GR	5.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Offaly	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-03-18	Zoe Yandle et al	[object Object]		Female
Ireland/CE-NVRL-e87IRL31091/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Clare	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-03-14	Zoe Yandle et al	[object Object]		Male
Ireland/KE-NVRL-ec86IRL26663/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Kildare	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-02-22	Zoe Yandle et al	[object Object]		Male
Romania/GJ-5330/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Romania	Romania	Romania	Gorj	Human		Gorj County Directorate of Public Health	B.1.1.7	Europe	Europe	National Institute of Infectious Diseases-Prof. Dr. Matei Bals Molecular Diagnostics Laboratory		2021-02-22	Corina Casangiu et al	[object Object]	54	Female
Ireland/TA-NVRL-t21IRL41915/2021	1.00	0.07	0.01	0.01	0.06	GRY	8.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Tipperary	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-02-23	Fiona Crispie et al	[object Object]		Female
Russia/SPE-RII-MH14609S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-14	Andrey Komissarov et al A	[object Object]	27	Female
Austria/CeMM8399/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Austria	Austria	Austria	Styria	Human	Liezen	Department of Laboratory Medicine, Division of Clinical Virology, University of Medicine, Vienna	B.1.1.7	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-04-28	Lukas Endler et al	[object Object]	37	Female
Belgium/UMONS-P02-02337-01/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Hainaut	Human		National Platform bis UMONS/Jolimont	B.1.1.7	Europe	Europe	National Platform bis UMONS/Jolimont		2021-06-02	François Dufrasne et al	[object Object]	42	Female
Belgium/ULG-16367/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Hainaut	Human		University of Liège COVID-19 testing center	B.1.1.7	Europe	Europe	GIGA Medical Genomics		2021-06-04	Keith Durkin et al	[object Object]	17	Male
Belgium/AZDelta-02580-2120R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Roeselare	Human	Lichtervelde	AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-05-21	Geert Martens et al	[object Object]		
Poland/NIPH-NIH_ECDC-3806/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	Poland	Poland	Poland	Wielkopolskie	Human	Poznan	WSSE Laboratorium Mikrobiologii i Parazytologii	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-04-09	Wołkowicz Tomasz et al	[object Object]	1	Male
Switzerland/LU-ETHZ-640091/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Lucerne	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-05-26	Christian Beisel et al	[object Object]		
Russia/KR-RII-MH17377S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Karelia	Karelia	Human	Petrozavodsk	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-09	Andrey Komissarov et al A	[object Object]	53	Male
Ireland/WW-NVRL-23IRL09095/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Wicklow	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-16	Zoe Yandle et al	[object Object]		Female
WallisandFutuna/HCL021099336701/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Oceania	Wallis and Futuna	Oceania	Wallis	Human	Oceania	HOPITAL DE SIA/WALLIS	B.1.1.7	Oceania	Oceania	CNR Virus des Infections Respiratoires - France SUD		2021-03-08	Antonin Bal et al	[object Object]	44	Female
WallisandFutuna/HCL021099329301/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Oceania	Wallis and Futuna	Oceania	Wallis	Human	Oceania	HOPITAL DE SIA/WALLIS	B.1.1.7	Oceania	Oceania	CNR Virus des Infections Respiratoires - France SUD		2021-03-11	Antonin Bal et al	[object Object]	75	Male
Russia/KR-RII-MH16496S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Karelia	Karelia	Human	Petrozavodsk	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-20	Andrey Komissarov et al A	[object Object]	49	Male
Guadeloupe/IPP11462/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	North America	Guadeloupe	North America	Pointe-A-Pitre	Human	North America	Hospital	B.1.1.7	North America	North America	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2021-04-27	Marion Barbet et al	[object Object]	54	Male
Poland/NIPH-NIH_ECDC-2033/2021	1.00	0.07	0.01	0.01	0.04	GR	7.00	20I (Alpha, V1)	Poland	Poland	Poland	Swietokrzyskie	Human	Kielce	WSSE Kielce	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-03-12	Wołkowicz Tomasz et al	[object Object]	62	Female
Russia/MOW-RII-MH16232S/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-10	Andrey Komissarov et al A	[object Object]	33	Male
Russia/MOW-CRIE-D187S0005/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-02-18	Samoilov AE et al	[object Object]	44	Male
Russia/MOW-CRIE-D187S0006/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-02-18	Samoilov AE et al	[object Object]	40	Female
Belgium/UZA-UA-TKQ221/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Soignies	Human	Braine-le-Comte	Brussels Academic Hospital Lab (LHUB-ULB)	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-04-02	Jasmine Coppens et al	[object Object]	64	Female
Russia/MOW-RII-MH15910/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Pathogenic Microorganisms Variability Laboratory	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-24	Andrey Komissarov et al A	[object Object]	50	Male
Greece/V964/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Greece	Greece	Greece	Katerini	Human		Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece	B.1.1.7	Europe	Europe	Institute of Applied Biosciences, Centre for Research and Technology Hellas		2021-04-30	Anastasia Chatzidimitriou et al.	[object Object]		Male
Russia/MOS-CRIE-L106D1223b/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-05	Samojlov A.E. et al	[object Object]	59	Male
Russia/MOW-CRIE-D187S0044b/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-16	Samojlov A.E. et al	[object Object]	35	Male
Russia/MOW-CRIE-D187L0069b/2021	1.00	0.07	0.01	0.01	0.04	GR	4.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-15	Samoilov A.E. et al	[object Object]	52	Female
Russia/MOW-RII-MH15901/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Pathogenic Microorganisms Variability Laboratory	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-03	Andrey Komissarov et al A	[object Object]	84	Female
Russia/MOS-CRIE-L106B0388b/2021	1.00	0.07	0.01	0.01	0.04	GR	5.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-02	Samojlov A.E. et al	[object Object]	40	Male
Russia/MOW-CRIE-D187M0065/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-02-17	Samoilov AE et al	[object Object]	35	Female
Russia/MOW_3269/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Collection of WHO National Influenza Center, N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation	B.1.1.7	Europe	Europe	Laboratory of genome analysis, N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation		2021-04-27	Olga Voronina et al	[object Object]	68	Male
Russia/MOW-CRIE-L188M0196b/2021	1.00	0.07	0.01	0.01	0.04	GR	4.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-15	Samojlov A.E. et al	[object Object]	48	Male
Slovenia/17-058104-CE/2020	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Savinjska	Human		National Laboratory for Health, Environment and Food, OMM, Celje	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2020-11-30	Sandra Janezic et al	[object Object]	15	Female
Belgium/UZA-UA-TIH472/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Ath	Human	Enghien	LHUB-ULB	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-27	Marie Le Mercier et al	[object Object]	35	Female
Lithuania/S21E1188/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Utena Apskritis	Human		Viesoji istaiga Vilniaus universiteto ligonine Santaros klinikos	B.1.1.7	Europe	Europe	Vilnius University Hospital Santaros Klinikos, Center of Laboratory Medicine		2021-05-21	Ligita Raugaite et al	[object Object]	59	Female
Lithuania/S21F45/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Alytaus Apskritis	Human		UAB Diagnostikos laboratorija	B.1.1.7	Europe	Europe	Vilnius University Hospital Santaros Klinikos, Center of Laboratory Medicine		2021-05-25	Ligita Raugaite et al	[object Object]	36	Female
Bulgaria/21BG-EU_000332_Pl4/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bulgaria	Bulgaria	Bulgaria	Sliven	Human		National Center for Infectious and Parasitic Diseases (NCIPD)	B.1.1.7	Europe	Europe	National Center for Infectious and Parasitic Diseases (NCIPD)		2021-02-02	Alexiev et al	[object Object]	65	Female
Poland/PZH-GUM-1382/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Poland	Poland	Poland	Wielkopolskie	Human		UM im. Karola Marcinkowskiego w Poznaniu Laboratorium UCA_Covid-19 Centrum Biologii Medycznej	B.1.1.7	Europe	Europe	1. Tricity SARS-CoV-2 sequencing consortium: University of Gdansk, Medical University of Gdansk, Vaxican Ltd., Invicta Ltd. 2. National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland		2021-05-18	Maciej Kosinski et al	[object Object]	48	Female
Bulgaria/21BG-EU_000300_Pl4/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bulgaria	Bulgaria	Bulgaria	Sliven	Human		National Center for Infectious and Parasitic Diseases (NCIPD)	B.1.1.7	Europe	Europe	National Center for Infectious and Parasitic Diseases (NCIPD)		2021-01-29	Alexiev et al	[object Object]	65	Female
Taiwan/3445/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Taiwan	Asia	Taiwan	Human	Asia	Centers for Disease Control, R.O.C. (Taiwan)	B.1.1.7	Asia	Asia	Centers for Disease Control, R.O.C. (Taiwan)		2021-05-26	Ji-Rong Yang et al	[object Object]	50	Female
France/IPP-00158i/2020	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	France	France	France	Centre-Val de Loire	Human	Tours	hôpital	B.1.1.7	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2020-12-21	Marion Barbet et al	[object Object]	34	Male
Russia/SPE-RII-MH15717S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-09	Andrey Komissarov et al A	[object Object]	35	Female
Russia/SVE-RII-MH15817S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Karachay-Cherkess	Karachay-Cherkess	Human	Karachayevsk	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-15	Andrey Komissarov et al A	[object Object]	48	Female
Lithuania/S21E1197/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Vilniaus Apskritis	Human		Viesoji istaiga Vilniaus universiteto ligonine Santaros klinikos	B.1.1.7	Europe	Europe	Vilnius University Hospital Santaros Klinikos, Center of Laboratory Medicine		2021-05-17	Ligita Raugaite et al	[object Object]	34	Male
Russia/BEL-RII-MH17560S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-21	Andrey Komissarov et al A	[object Object]	55	
Belgium/SJ4294309/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Veurne	Human	De Panne	AZ St.Jan Brugge-Oostende	B.1.1.7	Europe	Europe	AZ SINT-JAN BRUGGE		2021-04-19	Marijke Reynders et al	[object Object]	69	Female
Bulgaria/21BG-NC_002711_R11/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bulgaria	Bulgaria	Bulgaria	Varna	Human		National Center of Infectious and Parasitic Diseases	B.1.1.7	Europe	Europe	National Center of Infectious and Parasitic Diseases		2021-03-18	Alexiev et al	[object Object]	49	Male
Russia/MOW-CRIE-D187S0097/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-02-10	Samoilov AE et al	[object Object]	19	Female
Japan/YCH0214/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Japan	Asia	Yamanashi	Human	Asia	Genome Analysis Center, Yamanashi Central Hospital	B.1.1.7	Asia	Asia	Genome Analysis Center, Yamanashi Central Hospital		2021-06-04	Yosuke Hirotsu et al	[object Object]	19	Female
Japan/YCH0215/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Japan	Asia	Yamanashi	Human	Asia	Genome Analysis Center, Yamanashi Central Hospital	B.1.1.7	Asia	Asia	Genome Analysis Center, Yamanashi Central Hospital		2021-06-04	Yosuke Hirotsu et al	[object Object]	42	Male
Austria/CeMM9652/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Austria	Austria	Austria	Salzburg	Human		Austrian Agency for Health and Food Safety (AGES)	B.1.1.7	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-05-21	Lukas Endler et al	[object Object]	16	Male
Bulgaria/21BG-EU_001433_Pl14/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bulgaria	Bulgaria	Bulgaria	Stara Zagora	Human		National Center of Infectious and Parasitic Diseases	B.1.1.7	Europe	Europe	National Center of Infectious and Parasitic Diseases		2021-02-23	Alexiev et al	[object Object]	68	Male
Russia/MOS-RII-MH16122S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Ramenskoye	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-19	Andrey Komissarov et al A	[object Object]	40	Male
Russia/SPE-RII-32804S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-23	Andrey Komissarov et al A	[object Object]	33	Male
Russia/BEL-RII-MH17530S/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-16	Andrey Komissarov et al A	[object Object]	78	
Greece/V982/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Greece	Greece	Greece	Grevena	Human		Laboratory of Molecular Biology, Mamatsio General Hospital of Kozani	B.1.1.7	Europe	Europe	Institute of Applied Biosciences, Centre for Research and Technology Hellas		2021-04-27	Anastasia Chatzidimitriou et al.	[object Object]		Female
Russia/BEL-RII-MH17696S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-06	Andrey Komissarov et al A	[object Object]	30	
Russia/BEL-RII-MH17708S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-07	Andrey Komissarov et al A	[object Object]	33	
Belgium/AZDelta-20742-2120R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Veurne	Human	Koksijde	AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-05-30	Geert Martens et al	[object Object]		
NewZealand/21CH0030/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Oceania	New Zealand	Oceania	Canterbury	Human	Oceania	Canterbury Health Laboratories	B.1.1.7	Oceania	Oceania	Institute of Environmental Science and Research (ESR)		2021-05-23	Paula scholes et al	[object Object]		Male
Poland/PL-P911/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Poland	Poland	Poland	Swietokrzyskie	Human	Oksa	1. Glowny Inspektorat Sanitarny. 2. Diagnostyka. Laboratoria Medyczne.	B.1.1.7	Europe	Europe	1. ViroGenetics - BSL3 Laboratory of Virology, Małopolska Centre of Biotechnology, Jagiellonian University; 2. genXone SA, Research & Development Laboratory		2021-03-21	Mazur-Panasiuk et al	[object Object]	69	Female
Germany/HB-RKI-I-137212/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Bremen	Human		Labor Dr. Schumacher MVZ	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-04-14	?	[object Object]		
Poland/NIPH-NIH_ECDC-4030/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Poland	Poland	Poland	Warminsko-Mazurskie	Human	Ostrodzki	Laboratorium Medyczne BIOLAB	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-04-13	Wołkowicz Tomasz et al	[object Object]	20	Female
Slovenia/22-6391/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Posavska	Human		Department of Public Health Microbiology Ljubljana, National Laboratory for Health, Environment and Food	B.1.1.7	Europe	Europe	Department of Public Health Microbiology Ljubljana, National Laboratory for Health, Environment and Food		2021-04-30	Tom Koritnik et al	[object Object]	47	Female
Poland/PZH-UMB-1468/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Łódzkie	Human	Piotrkow Trybunalski	Centrum Medycyny Klinicznej dr n.med. Karol Majewski - DiMedical	B.1.1.7	Europe	Europe	1. Academic Center for Pathomorphological and Genetic-Molecular Diagnostics ltd, Bialystok, Poland 2. National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland		2021-05-20	Radosław Charkiewicz et al	[object Object]	40	Female
Luxembourg/LNS4863399/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Luxembourg	Luxembourg	Luxembourg	Luxembourg	Human		Laboratoires d'analyses medicales - Ketterthill	B.1.1.7	Europe	Europe	Laboratoire national de sante, Microbiology, Microbial Genomics Platform		2021-02-24	Anke Wienecke-Baldacchino et al	[object Object]	58	Female
FaroeIslands/HFS-201/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Denmark	Denmark	Denmark	Faroe Islands	Human		Sp/f Thetis	B.1.1.7	Europe	Europe	Faroese National Reference Laboratory for Fish and Animal Diseases		2021-03-08	Arnfinnur Kallsberg et al	[object Object]		
Russia/SPE-RII-MH16486S/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-21	Andrey Komissarov et al A	[object Object]	48	Male
Belgium/ULG-12338/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Liège	Human		CHR de La Citadelle	B.1.1.7	Europe	Europe	GIGA Medical Genomics		2021-02-08	Keith Durkin et al	[object Object]	33	Male
Sweden/1991301811/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Vasterbotten	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-02-16	Swedish national genomic surveillance program of SARS-CoV-2 et al	[object Object]		
Sweden/21-52387/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Vasterbotten	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-04-07	Maximilian Riess et al	[object Object]	84	Female
Sweden/2774949115/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Vasterbotten	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-03-23	Maximilian Riess et al	[object Object]		
Italy/EMR-173643-005-01/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Italy	Italy	Italy	Emilia-Romagna	Human		Azienda Sanitaria Locale di Piacenza - Presidio Ospedaliero - Laboratorio di Microbiologia	B.1.1.7	Europe	Europe	Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER), Risk Analysis and Genomic Epidemiology Unit		2021-05-18	Lo Cascio Giuliana et al	[object Object]	40	Male
Italy/VEN-IZSVe-21RS592-31_PD/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Italy	Italy	Italy	Veneto	Human	Padova	Microbiologia e Virologia	B.1.1.7	Europe	Europe	Istituto Zooprofilattico Sperimentale delle Venezie		2021-03-15	Adelaide Milani et al	[object Object]	46	Female
Italy/ABR-IZSGC-213949/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Italy	Italy	Italy	Abruzzo	Human		DIP. PREV. AVEZZANO SERVIZIO DI IGIENE EPIDEMIOLOGIA E SANITA' PUBBLICA	B.1.1.7	Europe	Europe	Istituto Zooprofilattico Sperimentale dell’Abruzzo e Molise “G. Caporale”		2021-04-13	Lorusso A et al	[object Object]	75	Male
Italy/VEN-IZSVe-21RS1306-3_VI/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Italy	Italy	Italy	Veneto	Human	Vicenza	ULSS 8 Berica	B.1.1.7	Europe	Europe	Istituto Zooprofilattico Sperimentale delle Venezie		2021-05-18	Adelaide Milani et al	[object Object]	56	Male
Cambodia/VIR2115974/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Cambodia	Asia	Cambodia	Human	Asia	Cambodian National Public Health Laboratory, National Institute of Public Health	B.1.1.7	Asia	Asia	Virology Unit, Institut Pasteur du Cambodge		2021-02-03	Sokhoun Yann et al	[object Object]		
Russia/SPE-RII-MH15667S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-01	Andrey Komissarov et al A	[object Object]	24	Female
Australia/VIC18157/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Oceania	Australia	Oceania	Victoria	Human	Oceania	Microbiological Diagnostic Unit - Public Health Laboratory (MDU-PHL)	B.1.1.7	Oceania	Oceania	MDU-PHL		2021-01-18	Seemann T. et al	[object Object]	44	Male
Greece/V1144/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Greece	Greece	Greece	Chalkidiki	Human		Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece	B.1.1.7	Europe	Europe	Institute of Applied Biosciences, Centre for Research and Technology Hellas		2021-05-07	Anastasia Chatzidimitriou et al.	[object Object]		
Greece/210217/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Greece	Greece	Greece	Crete	Human		Laboratory of Clinical Virology	B.1.1.7	Europe	Europe	Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)		2021-05-17	Emmanouil Athanasiadis et al	[object Object]		
Sweden/RVFOI21-01144/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Vasterbotten	Human		Klinisk mikrobiologi, Region Västerbotten	B.1.1.7	Europe	Europe	CBRN Defence and Security, Swedish Defence Research Agency		2021-05-20	Caroline Öhrman et al	[object Object]	26	Male
Sweden/20272287P/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Dalarna	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-18	Maximilian Riess et al	[object Object]		
Sweden/47632110X5/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Dalarna	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-18	Maximilian Riess et al	[object Object]		
Sweden/16810403P/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Gavleborgs Lan	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-04-21	Maximilian Riess et al	[object Object]		
Sweden/13167511PL/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Gavleborgs Lan	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-04-20	Maximilian Riess et al	[object Object]		
Belgium/rega-4748/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Brussels	Human	Saint-Gilles BE	KU Leuven, Rega Institute, Clinical and Epidemiological Virology	B.1.1.7	Europe	Europe	KU Leuven, Rega Institute, Clinical and Epidemiological Virology		2021-02-24	Tony Wawina-Bokalanga et al	[object Object]	26	Female
Belgium/UZA-UA-CV2067391918/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Eeklo	Human	Middelburg BE	Platform BIS UZA/UAntwerpen	B.1.1.7	Europe	Europe	UAntwerp, Laboratory of Medical Microbiology		2021-03-27	Basil Britto Xavier et al	[object Object]	50	Male
Belgium/UZA-UA-CV2184974409/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Maaseik	Human	Dilsen	Platform BIS UZA/UAntwerpen	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-20	Marie Le Mercier et al	[object Object]	18	Male
Netherlands/ZE-RIVM-35267/2021	1.00	0.07	0.01	0.01	0.04	G	7.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Zeeland	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-17	Adam Meijer et al	[object Object]	30	
Belgium/AZDelta/17746-2120R/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Diksmuide	Human		AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-06-01	Geert Martens et al	[object Object]		
Switzerland/NE-PMI-2117-1731/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Neuchâtel	Human		ADMED Microbiologie	B.1.1.7	Europe	Europe	Genomics and Transcriptomics, Philip Morris International		2021-04-24	Reto Lienhard et al	[object Object]	90	Female
Switzerland/NE-PMI-2118-3072/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Neuchâtel	Human		ADMED Microbiologie	B.1.1.7	Europe	Europe	Genomics and Transcriptomics, Philip Morris International		2021-05-05	Reto Lienhard et al	[object Object]	90	Female
USA/KS-KHEL-2235/2021	1.00	0.07	0.01	0.01	0.04	G	7.00	20I (Alpha, V1)	North America	USA	North America	Kansas	Human	North America	Kansas Health and Environmental Lab	B.1.1.7	North America	North America	Kansas Health and Environmental Lab		2021-06-02	Katherine Wiggins et al	[object Object]	38	Female
USA/GA-CDC-LC0065333/2021	1.00	0.07	0.01	0.01	0.04	GRY	9.00	20I (Alpha, V1)	North America	USA	North America	Georgia	Human	North America	Laboratory Corporation of America	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-24	Dakota Howard et al	[object Object]	47	Female
USA/WY-WPHL-21020258/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	Wyoming	Human	North America	Wyoming Public Health Laboratory	B.1.1.7	North America	North America	Wyoming Public Health Laboratory		2021-03-09	Jim Mildenberger et al	[object Object]	9	Male
USA/CO-CDPHE-2100592965/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	Colorado	Human	North America	Colorado Department of Public Health and Environment	B.1.1.7	North America	North America	Colorado Department of Public Health and Environment		2021-03-09	Laura Bankers et al	[object Object]		
USA/FL-CDC-ASC210065556/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	Florida	Human	North America	Aegis Sciences Corporation	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-21	Dakota Howard et al	[object Object]	42	Male
Russia/MOW-CRIE-L106P2624b/2021	1.00	0.07	0.01	0.01	0.04	GR	5.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-22	Samojlov A.E. et al	[object Object]	62	Male
Armenia/IMB3-4/2021	1.00	0.07	0.06	0.01	0.07	G	7.00	20I (Alpha, V1)	Asia	Armenia	Asia	Armenia	Human	Asia	National Center of Disease Control and Prevention of the Republic of Armenia	B.1.1.7	Asia	Asia	Institute of Molecular Biology NAS RA, Republic of Armenia, Department of Bioengineering, BioinformaticsInstitute and Molecular Biology IBMPh RAU, Republic of Armenia		2021-03-18	Arsen Arakelyan et al	[object Object]		
SriLanka/CDR98/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Asia	Sri Lanka	Asia	North Western Province	Human	Asia	Centre for Dengue Research and AICBU, Department of Immunology and Molecular Medicine	B.1.1.7	Asia	Asia	Centre for Dengue Research and AICBU, Department of Immunology and Molecular Medicine		2021-04-28	Chandima Jeewandara et al B	[object Object]	52	Male
India/PB-NCDC-14091/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Asia	India	Asia	Punjab IN	Human	Asia	National Centre for Disease Control (NCDC) Biotechnology Division, Delhi	B.1.1.7	Asia	Asia	NCDC Delhi, Biotechnology Division INSACOG		2021-02-25	Uma Sharma et al	[object Object]	28	Male
env/Austria/CeMM6440/2021	1.00	0.07	0.01	0.01	0.04	G	5.00	20I (Alpha, V1)	Austria	Austria	Austria	Lower Austria	Environment		Institute for Water Quality and Resource Management, Technical University Vienna	B.1.1.7	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-03-21	Lukas Endler et al	[object Object]		
Germany/MV-RKI-I-027763/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Mecklenburg-Vorpommern	Human		IMD - Medizinisches Labor Rostock	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-02-17	?	[object Object]		
Belgium/Jessa_11-2117-008020/2021	1.00	0.07	0.01	0.01	0.04	O	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Hasselt	Human		Jessa	B.1.1.7	Europe	Europe	Jessa		2021-05-02	Berden et al. on behalf of the Jessa_cmdLab et al	[object Object]	76	Female
Guatemala/ASI03001/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	Guatemala	North America	Guatemala	Human	North America	Hospital Herrera Llerandi	B.1.1.7	North America	North America	Asociación de Salud Integral/Clínica Familiar Luis Ángel García		2021-04-07	Eduardo Arathoon et al	[object Object]	68	Male
NorthMacedonia/29541/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	North Macedonia	North Macedonia	North Macedonia	Eastern Region MK	Human	Shtip	Laboratory of virology and molecular diagnostics, Institute of Public Health	B.1.1.7	Europe	Europe	Laboratory of virology and molecular diagnostics, Institute of Public Health		2021-04-05	Kuzmanovska M et al	[object Object]	45	Male
Switzerland/BS-UHB-42855246/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Basel-Stadt	Human		Clinical Virology	B.1.1.7	Europe	Europe	Clinical Bacteriology		2021-05-19	Tim Roloff et al	[object Object]		
Switzerland/AG-ETHZ-620101/2021	1.00	0.07	0.01	0.01	0.04	G	7.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Aargau	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-05-07	Christian Beisel et al	[object Object]		
Switzerland/GR-ETHZ-640277/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Graubünden	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-05-21	Chaoran Chen et al	[object Object]		
Switzerland/VD-CHUV-GEN5093/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Vaud	Human		CHUV	B.1.1.7	Europe	Europe	Laboratory of genomics and metagenomics		2021-05-28	Trestan Pillonel et al	[object Object]		
Switzerland/SH-ETHZ-580213/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Schaffhausen	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-04-10	Christian Beisel et al	[object Object]		
Switzerland/VD-CHUV-GEN4979/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Vaud	Human		CHUV	B.1.1.7	Europe	Europe	Laboratory of genomics and metagenomics		2021-05-22	Trestan Pillonel et al	[object Object]		
Sweden/SUS0002233/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Skane	Human		Clinical Microbiology, Infection Prevention and Control	B.1.1.7	Europe	Europe	Section for Molecular Diagnostics		2021-05-21	Björn Hallström et al	[object Object]	61	Male
Slovenia/90-025087-NM/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Jugovzhodna	Human		National Laboratory for Health, Environment and Food, OMM, Novo mesto	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-05-17	Sandra Janezic et al	[object Object]	30	Female
Slovenia/90-025652-NM/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Posavska	Human		National Laboratory for Health, Environment and Food, OMM, Novo mesto	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-05-20	Sandra Janezic et al	[object Object]	72	Female
Croatia/1912/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Croatia	Croatia	Croatia	Split-Dalmatia County	Human		Institute of Public Health Split-Dalmatia County	B.1.1.7	Europe	Europe	Croatian Institute of Public Health		2021-03-09	Irena Tabain et al	[object Object]	16	Female
Croatia/2261/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Croatia	Croatia	Croatia	Split-Dalmatia County	Human		Institute of Public Health Split-Dalmatia County	B.1.1.7	Europe	Europe	Croatian Institute of Public Health		2021-03-17	Irena Tabain et al	[object Object]	52	Female
Slovenia/17-055005-CE/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Savinjska	Human		National Laboratory for Health, Environment and Food, OMM, Celje	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-05-18	Sandra Janezic et al	[object Object]	40	Male
Slovenia/5C-026068-KP/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Obalnokraska	Human		National Laboratory for Health, Environment and Food, OMM, Koper	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-05-18	Sandra Janezic et al	[object Object]	25	Male
Slovenia/08-119292-MB/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Koroska	Human		National Laboratory for Health, Environment and Food, OMM, Maribor	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-05-17	Sandra Janezic et al	[object Object]	54	Male
Croatia/694/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Croatia	Croatia	Croatia	Osijek-Baranja County	Human		University Hospital for Infectious Diseases	B.1.1.7	Europe	Europe	Croatian Institute of Public Health		2021-02-25	Irena Tabain et al	[object Object]	26	Male
Ireland/LS-NVRL-30IRL14583/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Laois	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Female
Ireland/LS-NVRL-30IRL14617/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Laois	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Male
Ireland/LS-NVRL-30IRL14615/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Laois	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Female
Ireland/OY-NVRL-30IRL13429/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Offaly	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Female
Spain/CL-COV00974/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Spain	Spain	Spain	Castilla y Leon	Human		SARS-CoV-2 Sequencing Castilla y Leon-Spain Consortium	B.1.1.7	Europe	Europe	SARS-CoV-2 Sequencing Castilla y Leon-Spain Consortium		2021-02-23	Antonio Orduña-Domingo et al	[object Object]		Female
Spain/CL-COV01087/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Spain	Spain	Spain	Castilla y Leon	Human		SARS-CoV-2 Sequencing Castilla y Leon-Spain Consortium	B.1.1.7	Europe	Europe	SARS-CoV-2 Sequencing Castilla y Leon-Spain Consortium		2021-02-24	Antonio Orduña-Domingo et al	[object Object]		Male
Romania/B-14392/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Romania	Romania	Romania	Bucharest	Human		Department of Public Health Bucharest	B.1.1.7	Europe	Europe	National Institute of Infectious Diseases-Prof. Dr. Matei Bals Molecular Diagnostics Laboratory		2021-05-17	Corina Casangiu et al	[object Object]	67	Male
Romania/B-14397/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Romania	Romania	Romania	Bucharest	Human		Department of Public Health Bucharest	B.1.1.7	Europe	Europe	National Institute of Infectious Diseases-Prof. Dr. Matei Bals Molecular Diagnostics Laboratory		2021-05-17	Corina Casangiu et al	[object Object]	45	Male
Switzerland/UR-ETHZ-571427/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Uri	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zurich		2021-04-08	Chaoran Chen et al	[object Object]		
Switzerland/GR-ETHZ-510460/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Graubünden	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-02-22	Chaoran Chen et al	[object Object]		
Switzerland/SZ-ETHZ-620112/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Schwyz	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-05-07	Christian Beisel et al	[object Object]		
Austria/CeMM10879/2021	1.00	0.07	0.01	0.01	0.04	G	7.00	20I (Alpha, V1)	Austria	Austria	Austria	Vorarlberg	Human	Feldkirch	Austrian Agency for Health and Food Safety (AGES)	B.1.1.7	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-05-24	Lukas Endler et al	[object Object]	58	Female
env/Austria/CeMM9739/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Austria	Austria	Austria	Vorarlberg	Environment		Universität Innsbruck, Institut für Mikrobiologie	B.1.1.7	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-05-21	Lukas Endler et al	[object Object]		
Germany/BE-RKI-I-015759/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Berlin	Human		Labor 28 MVZ GmbH	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-01-30	?	[object Object]		
Poland/PZH-UMB-1526/2021	1.00	0.07	0.01	0.01	0.04	GR	7.00	20I (Alpha, V1)	Poland	Poland	Poland	Malopolskie	Human	Nowy Sacz	Vitomed Sp. z o.o.	B.1.1.7	Europe	Europe	1. Academic Center for Pathomorphological and Genetic-Molecular Diagnostics ltd, Bialystok, Poland 2. National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland		2021-05-18	Radosław Charkiewicz et al	[object Object]	54	Male
USA/KY-CDC-ASC210065306/2021						G	5.00	20I (Alpha, V1)	North America	USA	North America	Kentucky	Human	North America	Aegis Sciences Corporation	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-20	Dakota Howard et al	[object Object]	17	Female
Lithuania/REZUS04_08_54/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Siauliu Apskritis	Human		RezusLT	B.1.1.7	Europe	Europe	National Public Health Surveillance Laboratory		2021-04-08	Lukas Zemaitis et al	[object Object]	29	Female
Greece/V986/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Greece	Greece	Greece	Kozani	Human		Laboratory of Molecular Biology, Mamatsio General Hospital of Kozani	B.1.1.7	Europe	Europe	Institute of Applied Biosciences, Centre for Research and Technology Hellas		2021-04-29	Anastasia Chatzidimitriou et al.	[object Object]		Male
Italy/ABR-IZSGC-267232/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Italy	Italy	Italy	Abruzzo	Human		SIESP DIPARTIMENTO DI PREVENZIONE CHIETI	B.1.1.7	Europe	Europe	Istituto Zooprofilattico Sperimentale dell’Abruzzo e Molise “G. Caporale”		2021-05-11	Lorusso A et al	[object Object]	28	Male
Germany/MV-RKI-I-172819/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	Germany	Germany	Germany	Mecklenburg-Vorpommern	Human		IMD - MVZ Labor Greifswald	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-05-25	?	[object Object]		
Belgium/AZDelta-18942-2119R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Oostende	Human	Oudenburg	AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-05-21	Geert Martens et al	[object Object]		
Belgium/IPG-372/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Wallonia	Human		CHWAPI - SITE NOTRE DAME	B.1.1.7	Europe	Europe	Institut de Pathologie et Genetique (IPG)		2021-05-14	Pascale Hilbert et al	[object Object]	26	Male
Belgium/AZDelta-08900-2118R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Tournai-Mouscron	Human	Comines-Warneton	AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-05-12	Geert Martens et al	[object Object]		
Belgium/12105527701/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Oost-Vlaanderen	Human		Imeda Hospital	B.1.1.7	Europe	Europe	Imelda Hospital		2021-03-28	Johan Frans et al	[object Object]	36	Male
Belgium/UGent-4162/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Gent	Human		Lab voor klinische biologie	B.1.1.7	Europe	Europe	Lab voor klinische biologie		2021-03-15	Marija Janevska et al	[object Object]	49	Female
Belgium/UGent-6410/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Gent	Human		Lab voor klinische biologie	B.1.1.7	Europe	Europe	Lab voor klinische biologie		2021-05-06	Marija Janevska et al	[object Object]	77	Male
Belgium/MBLG132942/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Brussels	Human		Cliniques universitaires Saint-Luc	B.1.1.7	Europe	Europe	UCLouvain/IREC/MBLG		2021-05-21	Jean Ruelle et al	[object Object]	7	Female
Belgium/UGent-6868/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Gent	Human		Lab voor klinische biologie	B.1.1.7	Europe	Europe	Lab voor klinische biologie		2021-05-19	Marija Janevska et al	[object Object]	23	Male
UnitedArabEmirates/4257/2020	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	United Arab Emirates	Asia	Abu Dhabi	Human	Asia	BTC, Khalifa University	B.1.1.7	Asia	Asia	BTC, Khalifa University		2020-12-29	Al Safar et al	[object Object]	14	Female
Belgium/ULG-12325/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Luxembourg BE	Human		University of Liège COVID-19 testing center	B.1.1.7	Europe	Europe	GIGA Medical Genomics		2021-02-15	Keith Durkin et al	[object Object]	85	Female
Russia/SVE-CRIE-L188T0152/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	United Arab Emirates	Sverdlovsk	Dubai	Human		Laboratory of Extremely Dangerous Infections of Federal Budget Health Care Instute "Center of Hygiene and Epidemiology in Sverdlovsk region"	B.1.1.7	Europe	Asia	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-01-21	Samoilov AE et al	[object Object]	33	Female
Philippines/PH-PGC-06927/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Philippines	Asia	Manila	Human	Asia	Valenzuela Hope Molecular Laboratory	B.1.1.7	Asia	Asia	Philippine Genome Center		2021-02-06	Francis A. Tablizo et al	[object Object]	6	Female
Philippines/PH-PGC-16756/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Philippines	Asia	Manila	Human	Asia	The Medical City	B.1.1.7	Asia	Asia	Philippine Genome Center		2021-03-19	Francis A. Tablizo et al	[object Object]	51	Female
HongKong/HKPU-00147/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Hong Kong	Asia	Hong Kong	Human	Asia	Department of Health Technology and Informatics, The Hong Kong Polytechnic University	B.1.1.7	Asia	Asia	Department of Health Technology and Informatics, The Hong Kong Polytechnic University		2021-03-21	Siu et al	[object Object]		
Malta/MDxMDH474/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Malta	Malta	Malta	Malta	Human		Molecular Diagnostics Pathology Department Mater Dei Hospital Malta	B.1.1.7	Europe	Europe	Molecular Diagnostics Pathology Department Mater Dei Hospital Malta		2021-05-26	G Zahra et al	[object Object]		Female
Ireland/C-NVRL-30IRL12487/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Cork	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-16	Zoe Yandle et al	[object Object]		Male
Italy/LAZ-INMI-857/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Italy	Italy	Italy	Lazio	Human		Ospedale Sandro Pertini ASL Roma 2	B.1.1.7	Europe	Europe	INMI Lazzaro Spallanzani IRCCS		2021-05-18	O Butera et al	[object Object]	59	Female
SaudiArabia/KFSHRC8/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Saudi Arabia	Asia	Saudi Arabia	Human	Asia	Infectious Diseases, King Faisal Hospital Research Center	B.1.1.7	Asia	Asia	Infectious Diseases, King Faisal Hospital Research Center		2021-04-15	Alhamlan F et al	[object Object]		
Israel/CVL-6772/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Israel	Asia	Jerusalem District	Human	Asia	Israel Central Virology laboratory	B.1.1.7	Asia	Asia	Israel National Consortium for SARS-CoV-2 sequencing		2021-02-16	Neta Zuckerman et al	[object Object]		
Sweden/20268209P/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Blekinge	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-18	Maximilian Riess et al	[object Object]		
Sweden/SUS0002362/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Skane	Human		Clinical Microbiology, Infection Prevention and Control	B.1.1.7	Europe	Europe	Section for Molecular Diagnostics		2021-06-01	Björn Hallström et al	[object Object]	77	Male
France/OCC-CHU-TLS-210691273001/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	France	France	France	Occitanie	Human	Haute-Garonne	CHU Purpan - Laboratoire de Virologie - Institut Fédératif de Biologie	B.1.1.7	Europe	Europe	CHU Purpan - Laboratoire de Virologie - Institut Fédératif de Biologie		2021-03-10	Latour J. et al	[object Object]	52	Female
France/NAQ-HCL021065192901/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	France	France	France	Nouvelle-Aquitaine	Human	Agen	AGEN	B.1.1.7	Europe	Europe	CNR Virus des Infections Respiratoires - France SUD		2021-04-08	Antonin Bal et al	[object Object]	21	Male
France/NAQ-HCL021091514001/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	France	France	France	Nouvelle-Aquitaine	Human	Agen	CENTRE HOSPITALIER AGEN	B.1.1.7	Europe	Europe	CNR Virus des Infections Respiratoires - France SUD		2021-05-18	Antonin Bal et al	[object Object]	50	Female
Russia/SPE-RII-MH15650S/2021	1.00	0.07	0.01	0.01	0.04	GR	5.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-11	Andrey Komissarov et al A	[object Object]	25	Female
Russia/SPE-RII-MH15701S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-02	Andrey Komissarov et al A	[object Object]	42	Male
Russia/SPE-RII-MH15750S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-04	Andrey Komissarov et al A	[object Object]	45	Female
Russia/SPE-RII-34973S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-20	Andrey Komissarov et al A	[object Object]	25	Female
Russia/SPE-RII-35365S/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-25	Andrey Komissarov et al A	[object Object]	39	Female
Russia/MOW-CRIE-D186K0015b/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-03-07	Samoilov A.E. et al	[object Object]	30	Male
Russia/MOW-CRIE-D187S0091b/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-19	Samojlov A.E. et al	[object Object]	51	Male
Russia/MOS-CRIE-L106B0088b/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-01	Samojlov A.E. et al	[object Object]	24	Female
Russia/MOW-CRIE-L189B3633b/2021	1.00	0.07	0.01	0.01	0.04	GR	4.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-04	Samojlov A.E. et al	[object Object]	38	Female
Russia/MOW-CRIE-L189B3530b/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-04	Samojlov A.E. et al	[object Object]	2	Female
Russia/KR-RII-MH16432S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Karelia	Karelia	Human		Republican Infectious Diseases Hospital	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-23	Andrey Komissarov et al A	[object Object]	58	Male
Russia/BEL-RII-MH17761S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-11	Andrey Komissarov et al A	[object Object]	54	
Russia/KR-RII-MH16411S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Karelia	Karelia	Human		Republican Infectious Diseases Hospital	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-25	Andrey Komissarov et al A	[object Object]	58	Male
Cambodia/VIR21273431/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Cambodia	Asia	Cambodia	Human	Asia	Cambodian National Public Health Laboratory, National Institute of Public Health	B.1.1.7	Asia	Asia	Virology Unit, Institut Pasteur du Cambodge		2021-05-03	Jurre Y Siegers et al	[object Object]		
Cambodia/512774/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Cambodia	Asia	Cambodia	Human	Asia	Virology Unit, Institut Pasteur du Cambodge	B.1.1.7	Asia	Asia	Virology Unit, Institut Pasteur du Cambodge		2021-05-22	Jurre Y Siegers et al	[object Object]		
Cambodia/298905/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Cambodia	Asia	Cambodia	Human	Asia	Virology Unit, Institut Pasteur du Cambodge	B.1.1.7	Asia	Asia	Virology Unit, Institut Pasteur du Cambodge		2021-03-08	Sokhoun Yann et al	[object Object]		
Cambodia/254856/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Cambodia	Asia	Cambodia	Human	Asia	Virology Unit, Institut Pasteur du Cambodge	B.1.1.7	Asia	Asia	Virology Unit, Institut Pasteur du Cambodge		2021-02-21	Sokhoun Yann et al	[object Object]		
Cambodia/302100/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Cambodia	Asia	Cambodia	Human	Asia	Virology Unit, Institut Pasteur du Cambodge	B.1.1.7	Asia	Asia	Virology Unit, Institut Pasteur du Cambodge		2021-03-09	Sokhoun Yann et al	[object Object]		
SouthKorea/KDCA1937/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	United Arab Emirates	Asia	United Arab Emirates	Human	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency	B.1.1.7	Asia	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency		2021-02-24	Ae Kyung Park et al	[object Object]	42	Male
Thailand/DMSc-00301/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Thailand	Asia	Bangkok	Human	Asia	Public Health Centre 36	B.1.1.7	Asia	Asia	Division of Genomic Medicine and Innovation support,Department of Medical Sciences, Ministry of Public Health, Thailand		2021-05-06	Surakameth Mahasirimongkol et al	[object Object]		Female
Thailand/DMSc-00048/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Thailand	Asia	Samut Sakhon	Human	Asia	Ekachai Hospital	B.1.1.7	Asia	Asia	Division of Genomic Medicine and Innovation support,Department of Medical Sciences, Ministry of Public Health, Thailand		2021-04-03	Surakameth Mahasirimongkol et al	[object Object]		Female
Thailand/DMSc-00544/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Thailand	Asia	Phitsanulok	Human	Asia	Naresuan University Hospital	B.1.1.7	Asia	Asia	Division of Genomic Medicine and Innovation support,Department of Medical Sciences, Ministry of Public Health, Thailand		2021-05-17	Surakameth Mahasirimongkol et al	[object Object]	53	Female
Thailand/DMSc-00466/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Thailand	Asia	Bangkok	Human	Asia	Medical Correctional Hospital	B.1.1.7	Asia	Asia	Division of Genomic Medicine and Innovation support,Department of Medical Sciences, Ministry of Public Health, Thailand		2021-05-16	Surakameth Mahasirimongkol et al	[object Object]		Male
Thailand/DMSc-00613/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Thailand	Asia	Trang	Human	Asia	Trang Hospital	B.1.1.7	Asia	Asia	Division of Genomic Medicine and Innovation support,Department of Medical Sciences, Ministry of Public Health, Thailand		2021-05-20	Surakameth Mahasirimongkol et al	[object Object]		Female
Thailand/DMSc-00617/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Thailand	Asia	Chiang Rai	Human	Asia	Regional Medical Sciences Center 1/1 Chiangrai	B.1.1.7	Asia	Asia	Division of Genomic Medicine and Innovation support,Department of Medical Sciences, Ministry of Public Health, Thailand		2021-05-20	Surakameth Mahasirimongkol et al	[object Object]		Male
Thailand/DMSc-00631/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Thailand	Asia	Chiang Rai	Human	Asia	Regional Medical Sciences Center 1/1 Chiangrai	B.1.1.7	Asia	Asia	Division of Genomic Medicine and Innovation support,Department of Medical Sciences, Ministry of Public Health, Thailand		2021-05-20	Surakameth Mahasirimongkol et al	[object Object]		Female
SouthKorea/KDCA4162/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Thailand	Asia	Thailand	Human	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency	B.1.1.7	Asia	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency		2021-05-03	Ae Kyung Park et al	[object Object]	30	Male
Japan/IC-0979/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Thailand	Asia	Thailand	Human	Asia	SARS-CoV-2 testing team, National Institute of Infectious Diseases	B.1.1.7	Asia	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases		2021-04-08	Tsuyoshi Sekizuka et al B	[object Object]		
Thailand/DMSc-00568/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Thailand	Asia	Tak	Human	Asia	Taksin King the Great Hospital	B.1.1.7	Asia	Asia	Division of Genomic Medicine and Innovation support,Department of Medical Sciences, Ministry of Public Health, Thailand		2021-05-17	Surakameth Mahasirimongkol et al	[object Object]		Female
Norway/Ahus-527/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Norway	Norway	Norway	Viken	Human		Dept. of Microbiology and Infection Control, Akershus University Hospital HF	B.1.1.7	Europe	Europe	Dept. of Microbiology and Infection Control, Akershus University Hospital HF		2021-05-18	Hege Vangstein Aamot et al	[object Object]		
Germany/SH-ChVir25607_09/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Schleswig-Holstein	Human		A. Krumbholz, Labor Dr. Krause und Kollegen MVZ GmbH, Kiel	B.1.1.7	Europe	Europe	Charité Universitätsmedizin Berlin, Institut für Virologie		2021-05-24	Victor M Corman et al	[object Object]		
Germany/HH-RKI-I-169548/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Hamburg	Human		Sonic - Labor Dr. von Froreich GmbH	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-05-28	?	[object Object]		
Thailand/DMSc-00495/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Thailand	Asia	Yala	Human	Asia	Yala Hospital	B.1.1.7	Asia	Asia	Division of Genomic Medicine and Innovation support,Department of Medical Sciences, Ministry of Public Health, Thailand		2021-05-24	Surakameth Mahasirimongkol et al	[object Object]		Female
Thailand/Bangkok-CONI-0650/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Thailand	Asia	Bangkok	Human	Asia	Institute for Urban Disease Control and Prevention	B.1.1.7	Asia	Asia	COVID-19 Network Investigations (CONI) Alliance		2021-04-03	Elizabeth Batty et al	[object Object]		
Thailand/DMSc-00324/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Thailand	Asia	Pattani	Human	Asia	Pattani Hoapital	B.1.1.7	Asia	Asia	Division of Genomic Medicine and Innovation support,Department of Medical Sciences, Ministry of Public Health, Thailand		2021-05-22	Surakameth Mahasirimongkol et al	[object Object]	25	Female
Thailand/DMSc-00325/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Thailand	Asia	Pattani	Human	Asia	Pattani Hoapital	B.1.1.7	Asia	Asia	Division of Genomic Medicine and Innovation support,Department of Medical Sciences, Ministry of Public Health, Thailand		2021-05-23	Surakameth Mahasirimongkol et al	[object Object]	27	Male
Singapore/229/2021	1.00	0.08	0.01	0.15	0.07	GR	8.00	20I (Alpha, V1)	Asia	Singapore	Asia	Singapore	Human	Asia	National Public Health Laboratory, National Centre for Infectious Diseases	B.1.1.7	Asia	Asia	National Public Health Laboratory, National Centre for Infectious Diseases		2021-02-22	Tze Minn Mak et al	[object Object]	35	Female
Norway/3423/2021	1.00	0.07	0.01	0.01	0.04	GR	7.00	20I (Alpha, V1)	Norway	Norway	Norway	Viken	Human		Akershus University Hospital, Department for Microbiology and Infectious Disease Control	B.1.1.7	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-02-08	Kathrine Stene-Johansen et al	[object Object]		
Bulgaria/21BG-EU_000699_Pl7/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bulgaria	Bulgaria	Bulgaria	Pazardzhik	Human		National Center of Infectious and Parasitic Diseases	B.1.1.7	Europe	Europe	National Center of Infectious and Parasitic Diseases		2021-03-01	Alexiev et al	[object Object]	51	Male
Bulgaria/21BG-EU_001302_Pl13/2021	1.00	0.07	0.01	0.01	0.04	GR	7.00	20I (Alpha, V1)	Bulgaria	Bulgaria	Bulgaria	Sofia	Human		National Center of Infectious and Parasitic Diseases	B.1.1.7	Europe	Europe	National Center of Infectious and Parasitic Diseases		2021-03-15	Alexiev et al	[object Object]	45	Male
Switzerland/VS-ETHZ-510263/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Valais	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-02-21	Chaoran Chen et al	[object Object]		
Russia/MOS-RII-MH16196S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Lyubertsy	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-02-22	Andrey Komissarov et al A	[object Object]	40	Female
England/QEUH-12E57DA/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	United Kingdom	United Kingdom	United Kingdom	England	Human		Lighthouse Lab in Glasgow	B.1.1.7	Europe	Europe	Wellcome Sanger Institute for the COVID-19 Genomics UK (COG-UK) Consortium		2021-02-20	Harper VanSteenhouse et al	[object Object]		
Belgium/AZDelta-05819-2112R/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Ieper	Human	Wervik	AZDelta	B.1.1.7	Europe	Europe	AZDelta		2021-03-23	Geert Martens et al	[object Object]		
Poland/PZH-LUM-1246/2021	1.00	0.07	0.01	0.01	0.04	O	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Mazowieckie	Human		Laboratorium Analiz Lekarskich ALAB Mazowiecki Szpital Wojewódzki im. w. Jana Pawła II Sp. z o.o.	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland 2. Biobank Lab, University of Lodz 3. Laboratory of Respiratory Viruses, Teaching and Clinical Center of the Medical University of Lodz		2021-05-23	Dominik Strapagiel et al	[object Object]	29	Female
Sweden/21-53785/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Uppsala	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-19	Maximilian Riess et al	[object Object]		Male
Netherlands/OV-RIVM-37866/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Overijssel	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-26	Adam Meijer et al	[object Object]	8	
Poland/NIPH-NIH_ECDC-6349/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Kujawsko-Pomorskie	Human	Bydgoszcz	Zakład Diagnostyki Mikrobiologicznej, Kujawsko-Pomorskie Centrum Pulmonologii	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-05-17	Wołkowicz Tomasz et al	[object Object]	32	Female
Poland/NIPH-NIH_ECDC-6348/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Kujawsko-Pomorskie	Human	Bydgoszcz	Zakład Diagnostyki Mikrobiologicznej, Kujawsko-Pomorskie Centrum Pulmonologii	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-05-17	Wołkowicz Tomasz et al	[object Object]	30	Male
Belgium/IPG-375/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Wallonia	Human		CHWAPI - SITE NOTRE DAME	B.1.1.7	Europe	Europe	Institut de Pathologie et Genetique (IPG)		2021-05-17	Pascale Hilbert et al	[object Object]	27	Female
Belgium/AZDelta-00879-2119R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Tielt	Human	Meulebeke	AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-05-14	Geert Martens et al	[object Object]		
Belgium/AZDelta-15860-2120R/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Tielt	Human	Meulebeke	AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-05-26	Geert Martens et al	[object Object]		
Belgium/AZDelta-13672-2120R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Ieper	Human	Vlamertinge	AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-05-26	Geert Martens et al	[object Object]		
Belgium/AZDelta-13687-2120R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Ieper	Human	Vlamertinge	AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-05-26	Geert Martens et al	[object Object]		
Belgium/AZDelta/05128-2122R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Ieper	Human	Poperinge	AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-06-02	Geert Martens et al	[object Object]		
Morocco/FMP-172/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Africa	Morocco	Africa	Casablanca	Human	Africa	Institut National d'Hygiène	B.1.1.7	Africa	Africa	Laboratoire de Biotechnologie		2021-02-06	Mouna Ouadghiri et al	[object Object]		
Georgia/Tb-SNGS049/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Georgia	Asia	Tbilisi	Human	Asia	Department for Virology, Molecular Biology and Genome Research, R. G. Lugar Center for Public Health Research, National Center for Disease Control and Public Health (NCDC) of Georgia.	B.1.1.7	Asia	Asia	Department for Virology, Molecular Biology and Genome Research, R. G. Lugar Center for Public Health Research, National Center for Disease Control and Public Health (NCDC) of Georgia.		2021-03-03	Giorgi Gogoladze et al	[object Object]		Male
Bulgaria/21BG-EU_001288_Pl13/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bulgaria	Bulgaria	Bulgaria	Vratsa	Human		National Center of Infectious and Parasitic Diseases	B.1.1.7	Europe	Europe	National Center of Infectious and Parasitic Diseases		2021-03-15	Alexiev et al	[object Object]	43	Male
France/COR-HCL021097659701/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	France	France	France	Corse	Human	Bastia	LABORATOIRE DE BIOLOGIE MEDICALE	B.1.1.7	Europe	Europe	CNR Virus des Infections Respiratoires - France SUD		2021-05-25	Antonin Bal et al	[object Object]	58	Male
Belgium/ULG-15831/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Hainaut	Human		SYNLAB	B.1.1.7	Europe	Europe	GIGA Medical Genomics		2021-05-14	Keith Durkin et al	[object Object]	54	Female
Russia/MOW-NMRCOGP-6525-1098896F/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of Russian Federation	B.1.1.7	Europe	Europe	National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of Russian Federation		2021-03-02	Jekaterina Shubina et al	[object Object]	40	Female
Russia/MOW-CRIE-D186K0034/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-02-08	Samoilov AE et al	[object Object]	20	Male
Russia/ORL-RII-MH16069S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Oryol	Oryol	Human	Oryol	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-25	Andrey Komissarov et al A	[object Object]	21	Male
Russia/ORL-RII-MH16126S/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Russia	Russia	Oryol	Oryol	Human	Oryol	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-25	Andrey Komissarov et al A	[object Object]	48	Female
Sweden/DC107328631/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Kalmar	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-02-16	Swedish national genomic surveillance program of SARS-CoV-2 et al	[object Object]		
Sweden/DC111182471/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Halland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-17	Maximilian Riess et al	[object Object]		
Switzerland/VD-CHUV-GEN5251/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Vaud	Human		CHUV	B.1.1.7	Europe	Europe	Laboratory of genomics and metagenomics		2021-06-05	Trestan Pillonel et al	[object Object]		
Russia/SPE-RII-MH15459S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	49	Male
Lebanon/MDC_LAU_12/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Lebanon	Asia	Tyr	Human	Asia	Mashrek Medical Diagnostic Center	B.1.1.7	Asia	Asia	Microbial Pathogenomics Lab - LAU		2021-04-19	Jad Koweyes et al	[object Object]	27	Female
Iraq/Erbil3/2021	1.00	0.07	0.01	0.01	0.04	GR	5.00	20I (Alpha, V1)	Asia	Iraq	Asia	Erbil	Human	Asia	Biology, Gaziantep University	B.1.1.7	Asia	Asia	Biology, Gaziantep University		2021-03-09	Ozaslan et al	[object Object]		
Sweden/101462737/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Kronoberg	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-02-10	Maximilian Riess et al	[object Object]		
Russia/MOS-CRIE-L106B0155b/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-02	Samojlov A.E. et al	[object Object]	55	Male
Russia/MOW-CRIE-L106P2208bu/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-21	Samojlov A.E. et al	[object Object]	54	Female
Russia/MOW-CRIE-L189A4872b/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-04-02	Samojlov A.E. et al	[object Object]	55	Male
Lebanon/MDC_LAU_16/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Asia	Lebanon	Asia	Tyr	Human	Asia	Mashrek Medical Diagnostic Center	B.1.1.7	Asia	Asia	Microbial Pathogenomics Lab - LAU		2021-04-19	Jad Koweyes et al	[object Object]	81	Male
USA/GA-GPHL-0453/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	Georgia	Human	North America	GA Department of Public Health	B.1.1.7	North America	North America	GA Department of Public Health		2021-06-09	Stacy Reeves et al	[object Object]		
USA/AZ-ASU6451/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	Arizona	Human	North America	Arizona State University	B.1.1.7	North America	North America	Arizona State University		2021-06-01	Peter T. Skidmore et al	[object Object]		
Denmark/DCGC-109909/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Denmark	Denmark	Denmark	Midtjylland	Human		Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark	B.1.1.7	Europe	Europe	Statens Serum Institut Bioinformatics and Microbial Genomics		2021-05-24	Danish Covid-19 Genome Consortium et al	[object Object]		
Belgium/UZA-UA-UGS112/2021	1.00	0.08	0.01	0.01	0.05	GRY	7.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Ath	Human	Ellezelles	LHUB-ULB	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-04-15	Marie Le Mercier et al	[object Object]	84	Male
Russia/SPE-RII-35343S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-25	Andrey Komissarov et al A	[object Object]	27	Female
Lebanon/BI_MEIH1/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Lebanon	Asia	Beirut	Human	Asia	Middle East Institute of Health University Hospital	B.1.1.7	Asia	Asia	Microbial Pathogenomics Lab - LAU		2021-05-03	Georgi Merhi et al	[object Object]		
Sweden/21-52001/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Kronoberg	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-03-19	Maximilian Riess et al	[object Object]	78	Female
Sweden/21-52002/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Kronoberg	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-03-19	Maximilian Riess et al	[object Object]	71	Female
Norway/13226/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Norway	Norway	Norway	Agder	Human		Hospital of Southern Norway - Kristiansand, Department of Medical Microbiology	B.1.1.7	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-05-23	Kathrine Stene-Johansen et al	[object Object]		
Norway/13551/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Norway	Norway	Norway	Vestfold Og Telemark	Human		Vestfold Hospital, Toensberg Department of Microbiology	B.1.1.7	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-05-27	Kathrine Stene-Johansen et al	[object Object]		
Greece/210141/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Greece	Greece	Greece	Peloponnese	Human		Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)	B.1.1.7	Europe	Europe	Greek Genome Center, Biomedical Research Foundation of the Academy of Athens (BRFAA)		2021-05-20	Emmanouil Athanasiadis et al	[object Object]		
Russia/SPE-RII-MH17359S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-07	Andrey Komissarov et al A	[object Object]	22	Female
Russia/SPE-RII-34983S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-20	Andrey Komissarov et al A	[object Object]	56	Male
Germany/NI-RKI-I-155667/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Niedersachsen	Human		nordlab - Partnerschaftspraxis für Laboratoriumsmedizin	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-05-17	?	[object Object]		
Ireland/D-NVRL-30IRL15856/2021	1.00	0.08	0.01	0.01	0.05	GRY	7.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Dublin	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Male
NewZealand/21MV0400/2021	1.00	0.07	0.01	0.01	0.04	GR	7.00	20I (Alpha, V1)	Oceania	New Zealand	Oceania	Auckland	Human	Oceania	LabPLUS	B.1.1.7	Oceania	Oceania	Institute of Environmental Science and Research (ESR)		2021-05-02	Rachel Boyle et al	[object Object]		Male
Lithuania/S21C480/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Vilnius	Human		National Food and Veterinary Risk Assessment Institute	B.1.1.7	Europe	Europe	Vilnius University Hospital Santaros Klinikos, Center of Laboratory Medicine		2021-02-22	Gytis Dudas et al	[object Object]	53	Female
Lithuania/MR-LUHS-11-41/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Panevezio Apskritis	Human		UAB Medicina practica laboratorija	B.1.1.7	Europe	Europe	Lithuanian University of Health Sciences		2021-05-25	Arnoldas Pautienius et al	[object Object]	54	Female
Slovenia/90-015611-NM/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Posavska	Human		National Laboratory for Health, Environment and Food, OMM, Novo mesto	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-03-25	Sandra Janezic et al	[object Object]	56	Female
Slovenia/90-025640-NM/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Jugovzhodna	Human		National Laboratory for Health, Environment and Food, OMM, Novo mesto	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-05-20	Sandra Janezic et al	[object Object]	15	Female
Slovenia/90-024977-NM/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Jugovzhodna	Human		National Laboratory for Health, Environment and Food, OMM, Novo mesto	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-05-17	Sandra Janezic et al	[object Object]	59	Female
Bulgaria/21BG_COV_EU_001834_Pl18/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bulgaria	Bulgaria	Bulgaria	Gabrovo	Human		National Center of Infectious and Parasitic Diseases	B.1.1.7	Europe	Europe	National Center of Infectious and Parasitic Diseases		2021-03-25	Alexiev et al	[object Object]	66	Female
BosniaandHerzegovina/KCUS28523/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bosnia and Herzegovina	Bosnia and Herzegovina	Bosnia and Herzegovina	Gorazde	Human		Clinical Center, University of Sarajevo; Unit for Clinical Microbiology	B.1.1.7	Europe	Europe	Clinical Center, University of Sarajevo; Unit for Clinical Microbiology		2021-03-08	Irma Salimović-Bešić et al	[object Object]	85	Female
Switzerland/GE-HUG-34257920/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Geneva	Human		University Hospitals of Geneva, Laboratory of Virology	B.1.1.7	Europe	Europe	HUG, Laboratory of Virology and the Health2030 Genome Center		2021-05-23	Samuel Cordey et al	[object Object]		
Poland/NIPH-NIH_ECDC-2796/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Lubuskie	Human	Zielona Gora	Szpital Uniwersytecki im. Karola Marcinkowskiego	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-03-23	Wołkowicz Tomasz et al	[object Object]	10	Female
Poland/NIPH-NIH_ECDC-4679/2021	1.00	0.07	0.06	0.01	0.07	GRY	7.00	20I (Alpha, V1)	Poland	Poland	Poland	Warminsko-Mazurskie	Human	Olsztyn	Laboratorium Medyczne GEN LAB	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-04-21	Wołkowicz Tomasz et al	[object Object]	65	Male
Poland/NIPH-NIH_ECDC-6213/2021	1.00	0.07	0.06	0.01	0.07	GRY	7.00	20I (Alpha, V1)	Poland	Poland	Poland	Podkarpackie	Human	Rzeszow	Centrum Medyczne MEDYK Sp. z o.o. ,Sp.k. Zakład Diagnostyki Medycznej	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-05-18	Wołkowicz Tomasz et al	[object Object]	58	Male
Switzerland/FL-UHB-4181115401/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Fuerstentum Liechtenstein	Human		Labormedizinisches Zentrum Dr Risch	B.1.1.7	Europe	Europe	Clinical Bacteriology		2021-01-26	Tim Roloff et al	[object Object]		
Russia/SPE-RII-MH17387S/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-11	Andrey Komissarov et al A	[object Object]	42	Female
Sweden/14467814P/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Öland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-02-18	Swedish national genomic surveillance program of SARS-CoV-2 et al	[object Object]		
Russia/SPE-RII-MH16334S/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	City Hospital No 40	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-22	Andrey Komissarov et al A	[object Object]	59	
Russia/LEN-RII-MH17264S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Leningrad Oblast	Leningrad Oblast	Human	Kirovsk	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-02	Andrey Komissarov et al A	[object Object]	28	Female
SriLanka/CDR141/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Asia	Sri Lanka	Asia	Gampaha	Human	Asia	Centre for Dengue Research and AICBU, Department of Immunology and Molecular Medicine	B.1.1.7	Asia	Asia	Centre for Dengue Research and AICBU, Department of Immunology and Molecular Medicine		2021-05-18	Chandima Jeewandara et al B	[object Object]		
Ireland/C-NVRL-30IRL20034/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Cork	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Female
Croatia/2385/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Croatia	Croatia	Croatia	Sibenik-Knin County	Human		Institute of Public Health Sibenik-Knin County	B.1.1.7	Europe	Europe	Croatian Institute of Public Health		2021-03-25	Irena Tabain et al	[object Object]	38	Female
Sweden/6A17349530099/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Norrbotten	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-17	Maximilian Riess et al	[object Object]		
Sweden/RVFOI21-00152/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Vasterbotten	Human		Klinisk mikrobiologi, Region Västerbotten	B.1.1.7	Europe	Europe	CBRN Defence and Security, Swedish Defence Research Agency		2021-02-03	Andreas Sjödin et al	[object Object]	47	Male
Slovenia/08-120290-MB/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Koroska	Human		National Laboratory for Health, Environment and Food, OMM, Maribor	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-05-18	Sandra Janezic et al	[object Object]	41	Male
Slovenia/17-032669-KR/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Gorenjska	Human		National Laboratory for Health, Environment and Food, OMM, Kranj	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-05-17	Sandra Janezic et al	[object Object]	65	Male
Slovenia/90-025651-NM/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Posavska	Human		National Laboratory for Health, Environment and Food, OMM, Novo mesto	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-05-20	Sandra Janezic et al	[object Object]	37	Female
Russia/MOW-CRIE-L189C0358b/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-05-05	Samojlov A.E. et al	[object Object]	53	Female
Lithuania/LTU000_40609/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Vilniaus Apskritis	Human		NMVRVI	B.1.1.7	Europe	Europe	National Public Health Surveillance Laboratory		2021-02-26	Lukas Zemaitis et al	[object Object]	62	Male
Russia/MOW-CRIE-D187T0003b/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-26	Samojlov A.E. et al	[object Object]	15	Male
Russia/MOW-CRIE-L188S0129/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Molecular diagnostic laboratory of Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemilology		2021-03-22	Samojlov A.E. et al	[object Object]	32	Female
Russia/SPE-RII-MH17310S/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-03	Andrey Komissarov et al A	[object Object]	35	Male
Russia/SPE-RII-35283S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-25	Andrey Komissarov et al A	[object Object]	31	Female
Russia/MOW-CRIE-L188K0247u/2021	1.00	0.11	0.35	0.01	0.28	GRY	7.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human		Public Institution of Health Care "Diagnostic Center ( Laboratory Testing Center) of Moscow Health Department "	B.1.1.7	Europe	Europe	Group of Genomics and Postgenomic Technologies of Central Research Institute of Epidemiology		2021-04-13	Samoilov AE et al	[object Object]	82	Female
EquatorialGuinea/93096/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Africa	Equatorial Guinea	Africa	Equatorial Guinea	Human	Africa	Laboratorio de Investigaciones de Baney	B.1.1.7	Africa	Africa	Swiss Tropical and Public Health Institute		2021-02-09	Salome Hosch et al	[object Object]		
Slovenia/5C-025939-KP/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Obalnokraska	Human		National Laboratory for Health, Environment and Food, OMM, Koper	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-05-17	Sandra Janezic et al	[object Object]	48	Female
Lithuania/MR-LUHS-10-11/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Panevezio Apskritis	Human		UAB Medicina practica laboratorija	B.1.1.7	Europe	Europe	Lithuanian University of Health Sciences		2021-05-18	Daniel Naumovas et al	[object Object]	20	Female
Norway/10847/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Norway	Norway	Norway	Vestland	Human		Haukeland University Hospital, Dept. of Microbiology	B.1.1.7	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-04-23	Kathrine Stene-Johansen et al	[object Object]		
Sweden/DC111185521/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Halland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-17	Maximilian Riess et al	[object Object]		
Belgium/AZDelta/17757-2120R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Veurne	Human	De Panne	AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-06-01	Geert Martens et al	[object Object]		
Belgium/AZDelta/05201-2122R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Veurne	Human		AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-06-02	Geert Martens et al	[object Object]		
Belgium/AZDelta/18260-2120T/2021	1.00	0.07	0.01	0.01	0.04	GR	7.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Oostende	Human	Ichtegem	AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-06-01	Geert Martens et al	[object Object]		
Poland/NIPH-NIH_ECDC-6149/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Poland	Poland	Poland	Lubelskie	Human	Lublin	Laboratorium Diagnostyczne Centrum Medycznego Luxmed	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-05-17	Wołkowicz Tomasz et al	[object Object]	25	Female
Norway/09594/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Norway	Norway	Norway	Rogaland	Human		Dept. of Medical Microbiology, Stavanger University Hospital, Helse Stavanger HF	B.1.1.7	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-04-06	Kathrine Stene-Johansen et al	[object Object]		
Russia/BEL-RII-MH17434S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-08	Andrey Komissarov et al A	[object Object]	63	
Russia/BEL-RII-MH17740S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-10	Andrey Komissarov et al A	[object Object]	60	
Jordan/Biolab024/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Jordan	Asia	Amman	Human	Asia	Biolab Diagnostic Laboratories	B.1.1.7	Asia	Asia	Biolab Diagnostic Laboratories		2021-02-09	Issa Abu-Dayyeh et al	[object Object]		
Spain/VC-IBV-99028790/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Spain	Spain	Spain	Comunitat Valenciana	Human	Valencia ES	Servicio de Microbiología. Consorcio Hospital General Universitario de Valencia	B.1.1.7	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2021-04-29	María Dolores Ocete et al	[object Object]	19	Male
Spain/VC-IBV-98028792/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Spain	Spain	Spain	Comunitat Valenciana	Human	Valencia ES	Servicio de Microbiología. Hospital Clínico Universitario de Valencia	B.1.1.7	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2021-05-21	David Navarro Ortega et al	[object Object]	57	Male
Sweden/6033565364/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Vasterbotten	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-01-31	Swedish national genomic surveillance program of SARS-CoV-2 et al	[object Object]		
Sweden/ZN0106411687/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Norrbotten	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-01-21	Maximilian Riess et al	[object Object]		
Sweden/461847171383/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Orebro	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-04-02	Maximilian Riess et al	[object Object]		
Sweden/3926100263/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Vastra Gotaland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-02-24	Maximilian Riess et al	[object Object]		
Portugal/PT5773/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Portugal	Portugal	Portugal	Portugal	Human			B.1.1.7	Europe	Europe	Instituto Nacional de Saude (INSA)		2021-04-08	Borges et al	[object Object]		
Sweden/16445435P/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Vasternorrland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-04-12	Maximilian Riess et al	[object Object]		
Portugal/PT7315/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Portugal	Portugal	Portugal	Portugal	Human			B.1.1.7	Europe	Europe	Instituto Nacional de Saude (INSA)		2021-05-07	Borges et al	[object Object]		
Spain/CT-HUVH-E95318/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Spain	Spain	Spain	Catalunya	Human		Hospital Universitari Vall d'Hebron - Vall d'Hebron Institut de Recerca	B.1.1.7	Europe	Europe	Hospital Universitari Vall d'Hebron - Vall d'Hebron Institut de Recerca		2021-06-03	Cristina Andrés et al	[object Object]	24	Male
Lithuania/S21E1221/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Utena Apskritis	Human		Viesoji istaiga Vilniaus universiteto ligonine Santaros klinikos	B.1.1.7	Europe	Europe	Vilnius University Hospital Santaros Klinikos, Center of Laboratory Medicine		2021-05-18	Ligita Raugaite et al	[object Object]	33	Female
Mexico/HID-INMEGEN-05-05-71/2021	1.00	0.07	0.01	0.01	0.04	G	7.00	20I (Alpha, V1)	North America	Mexico	North America	Hidalgo	Human	North America	Salud Digna	B.1.1.7	North America	North America	Instituto Nacional de Medicina Genomica		2021-05-23	Hidalgo-Miranda A et al	[object Object]	60	Male
BosniaandHerzegovina/KCUS5Z-2264/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Bosnia and Herzegovina	Bosnia and Herzegovina	Bosnia and Herzegovina	Zavidovici	Human		Cantonal Hospital Zenica; Department of Microbiological Diagnostics	B.1.1.7	Europe	Europe	Clinical Center, University of Sarajevo; Unit for Clinical Microbiology		2021-03-04	Irma Salimović-Bešić et al	[object Object]		Female
Slovenia/5C-025950-KP/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Primorskonotranjska	Human		National Laboratory for Health, Environment and Food, OMM, Koper	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-05-17	Sandra Janezic et al	[object Object]	39	Male
Sweden/20116512P/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Varmland	Human		Swedish national genomic surveillance program of SARS-CoV-2	B.1.1.7	Europe	Europe	The Public Health Agency of Sweden		2021-05-01	Maximilian Riess et al	[object Object]		
Romania/B-12942/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Romania	Romania	Romania	Bucharest	Human		Department of Public Health Bucharest	B.1.1.7	Europe	Europe	National Institute of Infectious Diseases-Prof. Dr. Matei Bals Molecular Diagnostics Laboratory		2021-05-04	Corina Casangiu et al	[object Object]	56	Female
Italy/EMR-176077-014-01/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Italy	Italy	Italy	Emilia-Romagna	Human		Università di Parma, Laboratorio di Igiene e Sanità Pubblica	B.1.1.7	Europe	Europe	Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER), Risk Analysis and Genomic Epidemiology Unit		2021-05-18	Maria Eugenia Colucci et al	[object Object]	54	Male
Poland/NIPH-NIH_ECDC-6235/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Podkarpackie	Human	Rzeszow	Centrum Medyczne MEDYK Sp. z o.o. ,Sp.k. Zakład Diagnostyki Medycznej	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-05-21	Wołkowicz Tomasz et al	[object Object]	75	Male
Poland/PL-P954/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Slaskie	Human	Siemianowice Slaskie	1. Glowny Inspektorat Sanitarny. 2. Diagnostyka. Laboratoria Medyczne.	B.1.1.7	Europe	Europe	1. ViroGenetics - BSL3 Laboratory of Virology, Małopolska Centre of Biotechnology, Jagiellonian University; 2. genXone SA, Research & Development Laboratory		2021-03-22	Mazur-Panasiuk et al	[object Object]	42	Male
Poland/PL-P987/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Slaskie	Human	Siemianowice Slaskie	1. Glowny Inspektorat Sanitarny. 2. Diagnostyka. Laboratoria Medyczne.	B.1.1.7	Europe	Europe	1. ViroGenetics - BSL3 Laboratory of Virology, Małopolska Centre of Biotechnology, Jagiellonian University; 2. genXone SA, Research & Development Laboratory		2021-03-22	Mazur-Panasiuk et al	[object Object]	48	Male
Bahrain/341709279/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Asia	Bahrain	Asia	Bahrain	Human	Asia	Communicable Disease Laboratory, Public Health Directorate	B.1.1.7	Asia	Asia	Communicable Disease Laboratory, Public Health Directorate		2021-03-19	Alwasti et al	[object Object]		
Congo/ROC-ITM-069-6277/2021	1.00	0.07	0.01	0.01	0.04	GR	7.00	20I (Alpha, V1)	Africa	Republic of the Congo	Africa	Brazzaville	Human	Africa	Fondation Congolaise pour la recherche medicale (FCRM), Francine Ntoumi	B.1.1.7	Africa	Africa	Institute of Tropical Medicine		2021-03-05	Prof. Francine Ntoumi et al	[object Object]	62	Male
USA/LA-CDC-LC0062559/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	Louisiana	Human	North America	Laboratory Corporation of America	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-21	Dakota Howard et al	[object Object]	31	Male
India/WB-1930400357660/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	India	Asia	West Bengal	Human	Asia	INSACOG-WB	B.1.1.7	Asia	Asia	National Institute of Biomedical Genomics – INSACOG		2021-02-19	Arindam Maitra et al	[object Object]	58	Female
Wales/PHWC-4D6DBD/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	United Kingdom	United Kingdom	United Kingdom	Wales	Human		Originating lab: Wales Specialist Virology Centre Sequencing lab: Pathogen Genomics Unit	B.1.1.7	Europe	Europe	Public Health Wales Microbiology Cardiff Wales Specialist Virology Centre		2021-02-25	Catherine Moore et al B	[object Object]		
Philippines/PH-PGC-06383/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Asia	Philippines	Asia	Manila	Human	Asia	Philippine Red Cross - Port Area	B.1.1.7	Asia	Asia	Philippine Genome Center		2021-02-16	Francis A. Tablizo et al	[object Object]	52	Female
USA/GA-GPHL-0448/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	Georgia	Human	North America	GA Department of Public Health	B.1.1.7	North America	North America	GA Department of Public Health		2021-06-09	Stacy Reeves et al	[object Object]		
USA/WV-CDC-LC0068585/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	West Virginia	Human	North America	Laboratory Corporation of America	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-25	Dakota Howard et al	[object Object]	22	Male
USA/WV-CDC-LC0068370/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	West Virginia	Human	North America	Laboratory Corporation of America	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-24	Dakota Howard et al	[object Object]	17	Male
Ireland/WH-NVRL-88IRL81556/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Westmeath	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-04-05	Zoe Yandle et al	[object Object]		Male
Belgium/UGent-5063/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Gent	Human		Lab voor klinische biologie	B.1.1.7	Europe	Europe	Lab voor klinische biologie		2021-04-04	Marija Janevska et al	[object Object]	41	Female
Canada/ABPHL-07132/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	Canada	North America	Alberta	Human	North America	Alberta Precision Labs (APL)	B.1.1.7	North America	North America	Public Health Agency of Canada (PHAC) National Microbiology Laboratory		2021-03-02	Buss et al	[object Object]		
Wales/PHWC-PYDWEH/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	United Kingdom	United Kingdom	United Kingdom	Wales	Human		Wales Specialist Virology Centre Sequencing lab: Pathogen Genomics Unit	B.1.1.7	Europe	Europe	Public Health Wales Microbiology Cardiff Wales Specialist Virology Centre		2021-04-07	Catherine Moore et al B	[object Object]		
Netherlands/ZH-RIVM-34164/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	South Holland	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-03	Adam Meijer et al	[object Object]		
Japan/IC-0831/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	United Arab Emirates	Asia	United Arab Emirates	Human	Asia	SARS-CoV-2 testing team, National Institute of Infectious Diseases	B.1.1.7	Asia	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases		2021-02-26	Tsuyoshi Sekizuka et al B	[object Object]		
Netherlands/LI-MUMC-1726/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Limburg	Human	Stein	Dutch COVID-19 response team	B.1.1.7	Europe	Europe	Medical Microbiology, Maastricht University Medical Centre		2021-03-29	Jozef Dingemans* et al	[object Object]	33	Female
Netherlands/LI-MUMC-1761/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Limburg	Human	Beekdaelen	Dutch COVID-19 response team	B.1.1.7	Europe	Europe	Medical Microbiology, Maastricht University Medical Centre		2021-03-30	Jozef Dingemans* et al	[object Object]	38	Female
Netherlands/LI-MUMC-2338/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Limburg	Human	Stein	Dutch COVID-19 response team	B.1.1.7	Europe	Europe	Medical Microbiology, Maastricht University Medical Centre		2021-04-28	Jozef Dingemans* et al	[object Object]	27	Female
Belgium/UZA-UA-CV2186089404/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Antwerpen	Human	Schoten	Platform BIS UZA/UAntwerpen	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-02	Jasmine Coppens et al	[object Object]	32	Female
Belgium/UZA-UA-CV2234505639/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Antwerpen	Human		Platform BIS UZA/UAntwerpen	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-30	Marie Le Mercier et al	[object Object]	12	Female
Belgium/UZA-UA-815311350/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Turnhout	Human	Retie	CENTRUM VOOR MEDISCHE ANALYSE	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-27	Marie Le Mercier et al	[object Object]	42	Male
Belgium/UZA-UA-CV2265622431/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Antwerpen	Human	Wilrijk	Platform BIS UZA/UAntwerpen	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-06-05	Jasmine Coppens et al	[object Object]	30	Female
Belgium/UZA-UA-CV2273731833/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Turnhout	Human	Geel	Platform BIS UZA/UAntwerpen	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-29	Marie Le Mercier et al	[object Object]	23	Male
Belgium/UZA-UA-815311340/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Belgium	Human		CENTRUM VOOR MEDISCHE ANALYSE	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-26	Marie Le Mercier et al	[object Object]	43	Female
Belgium/UZA-UA-CV2265560995/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Antwerpen	Human		Platform BIS UZA/UAntwerpen	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-06-04	Jasmine Coppens et al	[object Object]	80	Female
Belgium/UZA-UA-CV2278297503/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Turnhout	Human	Geel	Platform BIS UZA/UAntwerpen	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-06-03	Jasmine Coppens et al	[object Object]	58	Male
Japan/IC-1302/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Sri Lanka	Asia	Sri Lanka	Human	Asia	SARS-CoV-2 testing team, National Institute of Infectious Diseases	B.1.1.7	Asia	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases		2021-05-24	Tsuyoshi Sekizuka et al B	[object Object]		
Japan/IC-1311/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Sri Lanka	Asia	Sri Lanka	Human	Asia	SARS-CoV-2 testing team, National Institute of Infectious Diseases	B.1.1.7	Asia	Asia	Pathogen Genomics Center, National Institute of Infectious Diseases		2021-05-27	Tsuyoshi Sekizuka et al B	[object Object]		
Sweden/SUS0002224/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Skane	Human		Clinical Microbiology, Infection Prevention and Control	B.1.1.7	Europe	Europe	Section for Molecular Diagnostics		2021-05-19	Björn Hallström et al	[object Object]	43	Female
USA/TN-CDC-ASC210065246/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	North America	USA	North America	Tennessee	Human	North America	Aegis Sciences Corporation	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-18	Dakota Howard et al	[object Object]	70	Female
Italy/EMR-175896-027-01/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Italy	Italy	Italy	Emilia-Romagna	Human		Azienda Ospedaliero - Universitaria di Modena Policlinico - Virologia e Microbiologia Molecolare	B.1.1.7	Europe	Europe	Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER), Risk Analysis and Genomic Epidemiology Unit		2021-05-18	Monica Pecorari et al	[object Object]	6	Male
Russia/SPE-RII-35242S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-24	Andrey Komissarov et al A	[object Object]	48	Male
Germany/HE-RKI-I-083578/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Hesse	Human		IMD Labor Frankfurt	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-04-09	?	[object Object]		
Luxembourg/LNS2979892/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Luxembourg	Luxembourg	Luxembourg	Luxembourg	Human		Laboratoire national de sante, Microbiology, Virology	B.1.1.7	Europe	Europe	Laboratoire national de sante, Microbiology, Microbial Genomics Platform		2021-04-24	Anke Wienecke-Baldacchino et al	[object Object]	44	Female
Luxembourg/LNS1087022/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Luxembourg	Luxembourg	Luxembourg	Luxembourg	Human		BioneXt Lab	B.1.1.7	Europe	Europe	Laboratoire national de sante, Microbiology, Microbial Genomics Platform		2021-04-28	Anke Wienecke-Baldacchino et al	[object Object]	47	Female
Netherlands/ZH-RIVM-37870/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	South Holland	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-24	Adam Meijer et al	[object Object]	7	
Spain/NC-CHN-01001442/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Spain	Spain	Spain	Navarra	Human		Servicio de Microbiología Clínica (Complejo Hospitalario de Navarra, Pamplona)	B.1.1.7	Europe	Europe	Centro de Secuenciación NASERTIC		2021-03-24	Carmen Ezpeleta Baquedano et al	[object Object]	20	Male
USA/FL-CDC-ASC210106286/2021	2.00	0.18	0.06	0.01	0.10	GRY	7.00	20I (Alpha, V1)	North America	USA	North America	Florida	Human	North America	Aegis Sciences Corporation	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-29	Dakota Howard et al	[object Object]	47	Female
Palestine/AAS78/2021	1.00	0.07	0.01	0.01	0.04	GR	5.00	20I (Alpha, V1)	Asia	Palestine	Asia	Tubas	Human	Asia	Medical Laboratory Sciences, Arab American University	B.1.1.7	Asia	Asia	Medical Laboratory Sciences, Arab American University		2021-04-09	Al-Jawabreh et al	[object Object]	78	Female
USA/NC-CDC-ASC210106094/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	North America	USA	North America	North Carolina	Human	North America	Aegis Sciences Corporation	B.1.1.7	North America	North America	Centers for Disease Control and Prevention Division of Viral Diseases, Pathogen Discovery		2021-05-28	Dakota Howard et al	[object Object]	56	Female
Belgium/ULG-16341/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Vlaams-Brabant	Human		University of Liège COVID-19 testing center	B.1.1.7	Europe	Europe	GIGA Medical Genomics		2021-06-01	Keith Durkin et al	[object Object]	25	Female
Belgium/ULG-15766/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Liège	Human		Department of Clinical Microbiology	B.1.1.7	Europe	Europe	GIGA Medical Genomics		2021-05-17	Keith Durkin et al	[object Object]	69	Male
France/BRE-IPP13150/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	France	France	France	Bretagne	Human	Vannes	Hospital	B.1.1.7	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2021-05-25	Marion Barbet et al	[object Object]	40	Male
France/BRE-IPP13152/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	France	France	France	Bretagne	Human	Vannes	Hospital	B.1.1.7	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2021-05-25	Marion Barbet et al	[object Object]	32	Female
France/ARA-CFD210033431101/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	France	France	France	Auvergne-Rhône-Alpes	Human	Saugues	Centre Hospitalier Universitaire Clermont-Ferrand	B.1.1.7	Europe	Europe	CHU Clermont-Ferrand, service de virologie		2021-06-01	Bisseux Maxime et al	[object Object]	58	Female
France/ARA-CFD210033384301/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	France	France	France	Auvergne-Rhône-Alpes	Human	Clermont-Ferrand	Centre Hospitalier Universitaire Clermont-Ferrand	B.1.1.7	Europe	Europe	CHU Clermont-Ferrand, service de virologie		2021-06-01	Bisseux Maxime et al	[object Object]	33	Male
Slovakia/UVZ_PL1_E2/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Slovakia	Slovakia	Slovakia	Trenčín	Human	Prievidza	Public Health Authority of the Slovak Republic	B.1.1.7	Europe	Europe	Laboratory of Genomics and Bioinformatics, Comenius University Science Park		2021-02-26	Tatiana Sedláčková et al	[object Object]	63	Male
Slovakia/UVZ_PL9_E11_8061/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Slovakia	Slovakia	Slovakia	Prešov	Human	Kezmarok	Public Health Authority of the Slovak Republic	B.1.1.7	Europe	Europe	Laboratory of Genomics and Bioinformatics, Comenius University Science Park		2021-04-01	Tatiana Sedláčková et al	[object Object]	56	Female
Germany/HE-RKI-I-172064/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Hesse	Human		CENTOGENE Frankfurt Laboratory: Niederlassung Industriepark Höchst	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-06-01	?	[object Object]		
Belgium/AZDelta-20343-2120R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Oostende	Human	Ichtegem	AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-05-30	Geert Martens et al	[object Object]		
CzechRepublic/NRL_2160_21/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Stredocesky Region	Human		National Institute of Public Health	B.1.1.7	Europe	Europe	National Reference Laboratory for Influenza and Respiratory Viruses CZE		2021-02-05	Helena Jirincova et al	[object Object]	47	Female
CzechRepublic/IAB20_016_partD_24/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Uhlirske Janovice	Human		Motol University Hospital	B.1.1.7	Europe	Europe	Institute of Applied Biotechnologies a.s.		2021-01-29	Petr Klempt et al	[object Object]	1	Male
CzechRepublic/IAB20_016_partD_11/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Slavetin	Human		Motol University Hospital	B.1.1.7	Europe	Europe	Institute of Applied Biotechnologies a.s.		2021-02-04	Petr Klempt et al	[object Object]	52	Female
env/Austria/CeMM4516/2021	1.00	0.07	0.01	0.01	0.04	GR	5.00	20I (Alpha, V1)	Austria	Austria	Austria	Burgenland	Environment		Institute for Water Quality and Resource Management, Technical University Vienna	B.1.1.7	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-02-19	Lukas Endler et al	[object Object]		
Lithuania/S21C189/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Alytaus Apskritis	Human		Vilnius University Hospital Santaros Klinikos, Center of Laboratory Medicine	B.1.1.7	Europe	Europe	Vilnius University Hospital Santaros Klinikos, Center of Laboratory Medicine		2021-02-24	Daniel Naumovas et al	[object Object]		
CzechRepublic/VIR-582/2021	1.00	0.07	0.01	0.01	0.04	O	7.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	South Moravian Region	Human	Brno	CMBG FN Brno	B.1.1.7	Europe	Europe	CMBG FN Brno		2021-03-12	Bezdicek M. et al	[object Object]	72	Male
env/Austria/CeMM5049/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Austria	Austria	Austria	Salzburg	Environment		Department of Microbiology, University Innsbruck	B.1.1.7	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-02-24	Lukas Endler et al	[object Object]		
Belgium/AZDelta/05287-2115R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Roeselare	Human		AZDelta	B.1.1.7	Europe	Europe	AZDelta		2021-04-14	Geert Martens et al	[object Object]		
CzechRepublic/UKDD-U116468/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Czech Republic	Human		Oddělení klinické mikrobiologie	B.1.1.7	Europe	Europe	Institute of Medical Microbiology and Virology, University Hospital Carl Gustav Carus, TU Dresden		2021-03-16	Marlena Stadtmüller et al	[object Object]	8	Female
Slovakia/UKBA-3165/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Slovakia	Slovakia	Slovakia	Zilina	Human	Oravska Jasenica	Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava	B.1.1.7	Europe	Europe	Faculty of Natural Sciences, Comenius University, Bratislava		2021-05-18	Brona Brejova et al	[object Object]	21	Male
Germany/TH-RKI-I-173674/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Thuringia	Human		Limbach - MVZ Gemeinschaftslabor Suhl	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-06-02	?	[object Object]		
CzechRepublic/162989-21w/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Czech Republic	Human		Bioptická laboratoř s.r.o.	B.1.1.7	Europe	Europe	Bioptická laboratoř s.r.o.		2021-03-04	Petr Šteiner et al	[object Object]	31	Male
Lithuania/S21E1167/2021	2.00	0.11	0.01	0.07	0.10	GRY	8.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Klaipedos Apskritis	Human		UAB Diagnostikos laboratorija	B.1.1.7	Europe	Europe	Vilnius University Hospital Santaros Klinikos, Center of Laboratory Medicine		2021-05-17	Ligita Raugaite et al	[object Object]	25	Female
CzechRepublic/NRL_6886_21/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Plzeň Region	Human		National Institute of Public Health	B.1.1.7	Europe	Europe	National Institute of Public Health		2021-04-22	Helena Jirincova et al	[object Object]	13	Female
Austria/CeMM9675/2021	1.00	0.11	0.35	0.01	0.28	GRY	7.00	20I (Alpha, V1)	Austria	Austria	Austria	Burgenland	Human	Güssing	Austrian Agency for Health and Food Safety (AGES)	B.1.1.7	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-05-20	Lukas Endler et al	[object Object]	65	Female
SriLanka/CMC111317/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Sri Lanka	Asia	Colombo	Human	Asia	Centre for Dengue Research and AICBU, Department of Immunology and Molecular Medicine	B.1.1.7	Asia	Asia	Centre for Dengue Research and AICBU, Department of Immunology and Molecular Medicine		2021-06-01	Chandima Jeewandara et al B	[object Object]	59	Male
Switzerland/BL-UHB-42716769/2021						G	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Basel-Land	Human		Rothen Medizinische Laboratorien AG	B.1.1.7	Europe	Europe	Clinical Bacteriology		2021-02-27	Tim Roloff et al	[object Object]		
Spain/RI-IBV-99027069/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Spain	Spain	Spain	La Rioja ES	Human	Arnedo	Centro de Investigación Biomédica de La Rioja - Hospital San Pedro Logroño	B.1.1.7	Europe	Europe	SeqCOVID-SPAIN consortium/IBV(CSIC)		2021-02-25	María de Toro et al	[object Object]	5	Female
Switzerland/VD-CHUV-GEN5240/2021	1.00	0.07	0.01	0.01	0.05	GRY	7.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Vaud	Human		CHUV	B.1.1.7	Europe	Europe	Laboratory of genomics and metagenomics		2021-06-03	Trestan Pillonel et al	[object Object]		
Latvia/2288/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Latvia	Latvia	Latvia	Latvia	Human		Centrala Laboratorija	B.1.1.7	Europe	Europe	Latvian Biomedical Research and Study Centre		2021-04-15	Janis Pjalkovskis et al	[object Object]		
Lithuania/LTU000_VLN_ANT_05_10_6/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Panevezio Apskritis	Human		UAB Diagnostikos laboratorija	B.1.1.7	Europe	Europe	National Public Health Surveillance Laboratory		2021-05-07	Lukas Zemaitis et al	[object Object]	16	Female
Switzerland/VS-ICH-2210560865/2021	1.00	0.07	0.01	0.01	0.04	GR	8.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Valais	Human		Valais Hospital, Central Institute	B.1.1.7	Europe	Europe	Valais Hospital, Central Institute		2021-05-21	Alexis Dumoulin et al	[object Object]		
Switzerland/NE-ETHZ-640293/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Neuchâtel	Human		Viollier AG	B.1.1.7	Europe	Europe	Department of Biosystems Science and Engineering, ETH Zürich		2021-05-22	Chaoran Chen et al	[object Object]		
Switzerland/LU-UHB-42870191/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Lucerne	Human		Synlab Suisse SA	B.1.1.7	Europe	Europe	Clinical Bacteriology		2021-05-24	Tim Roloff et al	[object Object]		
Belgium/UGent-6820/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Gent	Human		Lab voor klinische biologie	B.1.1.7	Europe	Europe	Lab voor klinische biologie		2021-05-17	Marija Janevska et al	[object Object]	66	Female
Russia/BEL-RII-MH17572S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-22	Andrey Komissarov et al A	[object Object]	45	
Lithuania/IBT-LSC-VU_r11_24/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Kauno Apskritis	Human		UAB "Baltic Medics"	B.1.1.7	Europe	Europe	Institute of Biotechnology, Life Sciences Center, Vilnius University		2021-05-19	Daniel Naumovas et al	[object Object]	57	Female
Lithuania/IBT-LSC-VU_r11_45/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Kauno Apskritis	Human		UAB "Baltic Medics"	B.1.1.7	Europe	Europe	Institute of Biotechnology, Life Sciences Center, Vilnius University		2021-05-19	Daniel Naumovas et al	[object Object]	49	Female
SouthKorea/KDCA1745/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Hungary	Asia	Hungary	Human	Asia	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency	B.1.1.7	Asia	Europe	Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency		2021-01-26	Ae Kyung Park et al	[object Object]	21	Male
Hungary/7224_7/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Hungary	Hungary	Hungary	Nógrád	Human		National Public Health Center, COVID Laboratory	B.1.1.7	Europe	Europe	National Public Health Center, National Biosafety Laboratory		2021-02-06	Bernadett Pályi et al	[object Object]	66	Female
Switzerland/VD-CHUV-GEN5238/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Vaud	Human		CHUV	B.1.1.7	Europe	Europe	Laboratory of genomics and metagenomics		2021-06-03	Trestan Pillonel et al	[object Object]		
Netherlands/ZE-RIVM-35347/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Zeeland	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-21	Adam Meijer et al	[object Object]	44	
Croatia/2093/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Croatia	Croatia	Croatia	Karlovac County	Human		University Hospital for Infectious Diseases Dr. Fran Mihaljevic	B.1.1.7	Europe	Europe	Croatian Institute of Public Health		2021-03-19	Irena Tabain et al	[object Object]	46	Female
Netherlands/DR-RIVM-19010/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Drenthe	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-02-17	Adam Meijer et al	[object Object]		
CzechRepublic/UMTM218747/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Olomouc Region	Human		Institute of Molecular and Translational Medicine / Laboratory of Experimental Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc	B.1.1.7	Europe	Europe	Institute of Molecular and Translational Medicine / Laboratory of Experimental Medicine, Faculty of Medicine and Dentistry, Palacky University		2021-05-17	Rastislav Slavkovský et al	[object Object]	29	Female
Poland/PZH-GUM-1341/2021	1.00	0.07	0.01	0.01	0.04	GRY	9.00	20I (Alpha, V1)	Poland	Poland	Poland	Opolskie	Human		LABORATORIUM BADAŃ KLINICZNYCH WSSE w OPOLU	B.1.1.7	Europe	Europe	1. Tricity SARS-CoV-2 sequencing consortium: University of Gdansk, Medical University of Gdansk, Vaxican Ltd., Invicta Ltd. 2. National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland		2021-05-21	Maciej Kosinski et al	[object Object]	68	Female
CzechRepublic/NRL-3702/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Zlín Region	Human		National Institute of Public Health	B.1.1.7	Europe	Europe	State Veterinary Institute Prague		2021-02-23	Nagy et al	[object Object]	40	Female
CzechRepublic/NRL_5399/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Vysocina Region	Human		National Institute of Public Health	B.1.1.7	Europe	Europe	State Veterinary Institute Prague		2021-03-30	Nagy et al	[object Object]	44	Male
Slovakia/UKBA-3207/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Slovakia	Slovakia	Slovakia	Kosice	Human		Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava	B.1.1.7	Europe	Europe	Faculty of Natural Sciences, Comenius University, Bratislava		2021-05-20	Viktoria Cabanova et al	[object Object]	32	Male
Slovakia/UKBA-3040/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	Slovakia	Slovakia	Slovakia	Banska Bystrica	Human	Velky Krtis	Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava	B.1.1.7	Europe	Europe	Faculty of Natural Sciences, Comenius University, Bratislava		2021-04-14	Kristina Borsova et al	[object Object]	34	Male
Austria/CeMM5349/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Austria	Austria	Austria	Burgenland	Human		Austrian Agency for Health and Food Safety (AGES)	B.1.1.7	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-03-03	Lukas Endler et al	[object Object]	64	Male
Switzerland/SG-UHB-729776700/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Sankt Gallen	Human		Labormedizinisches Zentrum Dr Risch	B.1.1.7	Europe	Europe	Clinical Bacteriology		2021-02-09	Tim Roloff et al	[object Object]		
Austria/CeMM6611/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Austria	Austria	Austria	Carinthia	Human		Austrian Agency for Health and Food Safety (AGES)	B.1.1.7	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-03-21	Lukas Endler et al	[object Object]	26	Male
Slovenia/5C-023783-KP/2021	1.00	0.07	0.01	0.01	0.07	GRY	7.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Primorskonotranjska	Human		National Laboratory for Health, Environment and Food, OMM, Koper	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-04-28	Sandra Janezic et al	[object Object]	12	Male
Germany/HE-RKI-I-163396/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Hesse	Human		CENTOGENE Frankfurt Laboratory: Niederlassung Industriepark Höchst	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-05-19	?	[object Object]		
Germany/RP-RKI-I-157538/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Rheinland-Pfalz	Human		SYNLAB MVZ Trier	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-05-19	?	[object Object]		
Netherlands/FR-RIVM-23263/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Friesland	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-03-27	Adam Meijer et al	[object Object]	52	
Georgia/Tb-SNGS072/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Asia	Georgia	Asia	Tbilisi	Human	Asia	Department for Virology, Molecular Biology and Genome Research, R. G. Lugar Center for Public Health Research, National Center for Disease Control and Public Health (NCDC) of Georgia.	B.1.1.7	Asia	Asia	Department for Virology, Molecular Biology and Genome Research, R. G. Lugar Center for Public Health Research, National Center for Disease Control and Public Health (NCDC) of Georgia.		2021-04-06	Meri Pantsulaia et al	[object Object]		Male
Poland/PZH-LUM-1285/2021	1.00	0.07	0.01	0.01	0.04	O	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Lubuskie	Human		105 Kresowy Szpital Wojskowy SP ZOZ w Żarach Filia w Żaganiu	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland 2. Biobank Lab, University of Lodz 3. Laboratory of Respiratory Viruses, Teaching and Clinical Center of the Medical University of Lodz		2021-05-18	Dominik Strapagiel et al	[object Object]	43	Male
Germany/BW-RKI-I-173086/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	Germany	Germany	Germany	Baden-Wuerttemberg	Human		SYNLAB MVZ Leinfelden-Echterdingen	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-06-02	?	[object Object]		
Russia/CU-RII-MH16098S/2021	1.00	0.07	0.01	0.01	0.04	GRY	9.00	20I (Alpha, V1)	Russia	Russia	Chuvash Republic	Chuvash Republic	Human	Cheboksary	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-09	Andrey Komissarov et al A	[object Object]	45	Female
CzechRepublic/NRL_2919_21/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Carlsbad	Human		National Institute of Public Health	B.1.1.7	Europe	Europe	National Reference Laboratory for Influenza and Respiratory Viruses CZE		2021-02-17	Helena Jirincova et al	[object Object]	43	Female
Poland/NIPH-NIH_ECDC-4579/2021	1.00	0.07	0.01	0.01	0.04	GRY	8.00	20I (Alpha, V1)	Poland	Poland	Poland	Lubuskie	Human	Zielona Gora	Szpital Uniwersytecki im. Karola Marcinkowskiego	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-04-22	Wołkowicz Tomasz et al	[object Object]	71	Female
CzechRepublic/NRL_4447/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Usti nad Labem	Human		National Institute of Public Health	B.1.1.7	Europe	Europe	Charles University, Faculty of Science, BIOCEV, OMICS Genomics		2021-03-11	Vladimír Hampl et al	[object Object]	49	Female
CzechRepublic/NRL_2779/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Usti nad Labem	Human		National Institute of Public Health	B.1.1.7	Europe	Europe	Charles University, Faculty of Science, BIOCEV, OMICS Genomics		2021-02-08	Vladimír Hampl et al	[object Object]	28	Female
CzechRepublic/174440/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Olomouc Region	Human		Institute of Molecular and Translational Medicine / Laboratory of Experimental Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc	B.1.1.7	Europe	Europe	Institute of Molecular and Translational Medicine / Laboratory of Experimental Medicine, Faculty of Medicine and Dentistry, Palacky University		2021-03-16	Rastislav Slavkovský et al	[object Object]	55	Male
Netherlands/FR-RIVM-34555/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Friesland	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-14	Adam Meijer et al	[object Object]	37	
Ireland/CW-NVRL-30IRL20966/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Carlow	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-17	Zoe Yandle et al	[object Object]		Male
Ireland/WD-NVRL-23IRL12648/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Waterford	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-18	Zoe Yandle et al	[object Object]		Female
Denmark/DCGC-99859/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Denmark	Denmark	Denmark	Syddanmark	Human		Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark	B.1.1.7	Europe	Europe	Aalborg University		2021-05-17	Danish Covid-19 Genome Consortium et al	[object Object]		
Denmark/DCGC-109064/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Denmark	Denmark	Denmark	Syddanmark	Human		Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark	B.1.1.7	Europe	Europe	Statens Serum Institut Bioinformatics and Microbial Genomics		2021-05-24	Danish Covid-19 Genome Consortium et al	[object Object]		
CzechRepublic/MOTOL-C2102-18288/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Hradec Králové Region	Human	Rychnov nad Kněžnou	Department of Microbiology, University Hospital Motol	B.1.1.7	Europe	Europe	Department of Microbiology, University Hospital Motol		2021-02-25	Klara Krivankova et al	[object Object]	30	Male
Croatia/HRV000_208/2021	1.00	0.07	0.01	0.01	0.04	GR	5.00	20I (Alpha, V1)	Croatia	Croatia	Croatia	Pozega-Slavonia County	Human		Croatian Institute of Public Health	B.1.1.7	Europe	Europe	Croatian Institute of Public Health		2021-01-20	Irena Tabain et al	[object Object]	65	Male
CzechRepublic/NRL_5000/2021	1.00	0.08	0.22	0.05	0.11	GRY	7.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Plzeň Region	Human		National Institute of Public Health	B.1.1.7	Europe	Europe	National Institute of Public Health		2021-03-17	Helena Jirincova et al	[object Object]	40	Male
Croatia/2175/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Croatia	Croatia	Croatia	Dubrovnik-Neretva County	Human		Institute of Public health Dubrovnik-Neretva County	B.1.1.7	Europe	Europe	Croatian Institute of Public Health		2021-03-23	Irena Tabain et al	[object Object]	40	Female
Croatia/2214/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Croatia	Croatia	Croatia	Zadar County	Human		Institute of Public health Zadar County	B.1.1.7	Europe	Europe	Croatian Institute of Public Health		2021-03-25	Irena Tabain et al	[object Object]	35	Female
Austria/CeMM8692/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Austria	Austria	Austria	Carinthia	Human		Austrian Agency for Health and Food Safety (AGES)	B.1.1.7	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-05-02	Lukas Endler et al	[object Object]	40	Female
Poland/PZH-UMB-1456/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Łódzkie	Human	Sieradz	LABORATORIUM DIAGNOSTYKA	B.1.1.7	Europe	Europe	1. Academic Center for Pathomorphological and Genetic-Molecular Diagnostics ltd, Bialystok, Poland 2. National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland		2021-05-17	Radosław Charkiewicz et al	[object Object]	20	Male
Germany/BB-RKI-I-172775/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Brandenburg	Human		Klinikum Ernst von Bergmann gemeinnützige GmbH - stationärer Bereich	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-06-02	?	[object Object]		
Switzerland/VS-32937058/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Valais	Human		Viollier AG	B.1.1.7	Europe	Europe	Viollier AG		2021-05-21	Andrea Patrizia Salzmann et al	[object Object]		
Russia/BEL-RII-MH17421S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-07	Andrey Komissarov et al A	[object Object]	66	
Russia/BEL-RII-MH17707S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-07	Andrey Komissarov et al A	[object Object]	64	
Russia/BEL-RII-MH17712S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-07	Andrey Komissarov et al A	[object Object]	38	
Russia/BEL-RII-MH17713S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-07	Andrey Komissarov et al A	[object Object]	35	
Slovakia/UKBA-3370/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovakia	Slovakia	Slovakia	Trnava	Human	Hradište pod Vrátnom	Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava	B.1.1.7	Europe	Europe	Faculty of Natural Sciences, Comenius University, Bratislava		2021-05-27	Viktoria Cabanova et al	[object Object]	41	Male
Belgium/AZDelta-18505-2121R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Roeselare	Human		AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-06-07	Geert Martens et al	[object Object]		
Poland/NIPH-NIH_ECDC-6193/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Dolnośląskie	Human	Wroclaw	Labolatorium Biologi Molekularnej USK	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-05-23	Wołkowicz Tomasz et al	[object Object]	64	Female
Netherlands/FL-RIVM-36814/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Flevoland	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-23	Adam Meijer et al	[object Object]	25	
Netherlands/FL-RIVM-36841/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Flevoland	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-25	Adam Meijer et al	[object Object]	55	
Belgium/AZDelta-21710-2118R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Roeselare	Human		AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-05-14	Geert Martens et al	[object Object]		
Belgium/AZDelta-01502-2121R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Ieper	Human	Zonnebeke	AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-05-30	Geert Martens et al	[object Object]		
Netherlands/FR-RIVM-35157/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Friesland	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-17	Adam Meijer et al	[object Object]	45	
Netherlands/GR-UMCG-MMB_2011/2021	1.00	0.08	0.02	0.12	0.05	GRY	7.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Groningen	Human		UMC Groningen, Clinical Virology, Department of Medical Microbiology and Infection Prevention	B.1.1.7	Europe	Europe	UMC Groningen, Clinical Virology, Department of Medical Microbiology and Infection Prevention		2021-05-30	Hubert Niesters et al	[object Object]	74	Male
Netherlands/OV-RIVM-37070/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Overijssel	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-19	Adam Meijer et al	[object Object]	36	
Netherlands/DR-RIVM-37743/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Drenthe	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-29	Adam Meijer et al	[object Object]	28	
Netherlands/DR-UMCG-MMB_2026/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Drenthe	Human		UMC Groningen, Clinical Virology, Department of Medical Microbiology and Infection Prevention	B.1.1.7	Europe	Europe	UMC Groningen, Clinical Virology, Department of Medical Microbiology and Infection Prevention		2021-05-28	Hubert Niesters et al	[object Object]	41	Female
Netherlands/FR-RIVM-36859/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Friesland	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-24	Adam Meijer et al	[object Object]	3	
Netherlands/FR-RIVM-36871/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Friesland	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-24	Adam Meijer et al	[object Object]	39	
Austria/CeMM9651/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Austria	Austria	Austria	Salzburg	Human		Austrian Agency for Health and Food Safety (AGES)	B.1.1.7	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-05-21	Lukas Endler et al	[object Object]	7	Female
Slovakia/UKBA-3120/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovakia	Slovakia	Slovakia	Bratislava	Human		Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava	B.1.1.7	Europe	Europe	Faculty of Natural Sciences, Comenius University, Bratislava		2021-05-19	Brona Brejova et al	[object Object]	47	Female
Slovakia/UKBA-3311/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovakia	Slovakia	Slovakia	Bratislava	Human	Senec	Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava	B.1.1.7	Europe	Europe	Faculty of Natural Sciences, Comenius University, Bratislava		2021-05-27	Viktoria Cabanova et al	[object Object]	38	Male
Austria/CeMM9604/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Austria	Austria	Austria	Lower Austria	Human	Sankt Pölten	Austrian Agency for Health and Food Safety (AGES)	B.1.1.7	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-05-19	Lukas Endler et al	[object Object]	50	Female
Germany/un-RKI-I-140086/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Germany	Human		SYNLAB Jena Oncoscreen	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-05-05	?	[object Object]		
Ireland/C-NVRL-30IRL52767/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Ireland	Ireland	Ireland	Cork	Human		National Virus Reference Laboratory	B.1.1.7	Europe	Europe	National Virus Reference Laboratory		2021-05-21	Zoe Yandle et al	[object Object]		Female
Poland/PZH-LUM-1280/2021	1.00	0.07	0.01	0.01	0.04	O	4.00	20I (Alpha, V1)	Poland	Poland	Poland	Lubuskie	Human		Szpital Uniwersytecki im. Karola Marcinkowskiego	B.1.1	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland 2. Biobank Lab, University of Lodz 3. Laboratory of Respiratory Viruses, Teaching and Clinical Center of the Medical University of Lodz		2021-05-20	Dominik Strapagiel et al	[object Object]	75	Male
France/CVL-IPP13206/2021	1.00	0.11	0.35	0.01	0.28	GRY	7.00	20I (Alpha, V1)	France	France	France	Centre-Val de Loire	Human	Chambrey Les Tours	Labo Analyses Med	B.1.1.7	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2021-05-25	Marion Barbet et al	[object Object]	26	Female
Angola/KRISP-K010853/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Africa	Angola	Africa	Luanda	Human	Africa	Instituto Nacional de Investigação em Saúde	B.1.1.7	Africa	Africa	KRISP, KZN Research Innovation and Sequencing Platform		2021-02-22	Morais J et al	[object Object]	52	Male
France/ARA-HCL021064205801/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	France	France	France	Auvergne-Rhône-Alpes	Human	Bourg-en-Bresse	CENTRE HOSPITALIER DE BOURG EN BRESSE	B.1.1.7	Europe	Europe	CNR Virus des Infections Respiratoires - France SUD		2021-04-02	Antonin Bal et al	[object Object]	75	Male
Switzerland/SG-CLM-9128/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Sankt Gallen	Human	Niederuzwil	Center for Laboratory Medicine St. Gallen	B.1.1.7	Europe	Europe	Center for Laboratory Medicine St. Gallen		2021-03-30	Yannick Gerth et al	[object Object]		
France/BRE-IPP10643/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	France	France	France	Bretagne	Human	Brest	Labo Analyses Med	B.1.1.7	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2021-04-26	Marion Barbet et al	[object Object]	18	Female
France/ARA-HCL021096919201/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	France	France	France	Auvergne-Rhône-Alpes	Human	Saint-Etienne	CHU ST ETIENNE HOPITAL NORD	B.1.1.7	Europe	Europe	CNR Virus des Infections Respiratoires - France SUD		2021-05-25	Antonin Bal et al	[object Object]	83	Female
France/ARA-HCL021099906001/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	France	France	France	Auvergne-Rhône-Alpes	Human	Saint-Etienne	CHU ST ETIENNE HOPITAL NORD	B.1.1.7	Europe	Europe	CNR Virus des Infections Respiratoires - France SUD		2021-05-25	Antonin Bal et al	[object Object]	72	Female
Poland/NIPH-NIH_ECDC-1738/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Podlaskie	Human	Białystok	Regionalne Centrum Krwiodawstwa i Krwiolecznictwa w Białymstoku Pracownia Diagnostyki Molekularnej wirusa SARS-CoV-2	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-03-01	Wołkowicz Tomasz et al	[object Object]	6	Male
Poland/PZH-UMB-1474/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Łódzkie	Human	Lodz	Centrum Medycyny Klinicznej dr n.med. Karol Majewski - DiMedical	B.1.1.7	Europe	Europe	1. Academic Center for Pathomorphological and Genetic-Molecular Diagnostics ltd, Bialystok, Poland 2. National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland		2021-05-21	Radosław Charkiewicz et al	[object Object]	23	Male
Belgium/UMONS-CV2150877491/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Hainaut	Human		National Platform bis UMONS/Jolimont	B.1.1.7	Europe	Europe	National Platform bis UMONS/Jolimont		2021-04-29	François Dufrasne et al	[object Object]	17	Male
Luxembourg/LNS8961434/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Luxembourg	Luxembourg	Luxembourg	Luxembourg	Human		BioneXt Lab	B.1.1.7	Europe	Europe	Laboratoire national de sante, Microbiology, Microbial Genomics Platform		2021-02-04	Anke Wienecke-Baldacchino et al	[object Object]	6	
Slovakia/UKBA-3344/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovakia	Slovakia	Slovakia	Moravany nad Vahom	Human		Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava	B.1.1.7	Europe	Europe	Faculty of Natural Sciences, Comenius University, Bratislava		2021-05-26	Kristina Borsova et al	[object Object]	39	Female
Switzerland/TG-UZH-IMV-3ba49ab6/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Thurgau	Human		Amt für Gesundheit	B.1.1.7	Europe	Europe	Institute of Medical Virology		2021-05-27	Verena Kufner et al	[object Object]		
Russia/MOW-NMRCOGP-240-1073106F/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of Russian Federation	B.1.1.7	Europe	Europe	National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of Russian Federation		2021-03-10	Jekaterina Shubina et al	[object Object]	53	Female
Russia/MOW-NMRCOGP-2766-26308W/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of Russian Federation	B.1.1.7	Europe	Europe	National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of Russian Federation		2021-03-16	Jekaterina Shubina et al	[object Object]	85	Female
Switzerland/un-HUG-34191200/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Switzerland	Human		University Hospitals of Geneva, Laboratory of Virology	B.1.1.7	Europe	Europe	HUG, Laboratory of Virology and the Health2030 Genome Center		2021-05-17	Samuel Cordey et al	[object Object]		
Switzerland/GE-HUG-34348086/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Geneva	Human		University Hospitals of Geneva, Laboratory of Virology	B.1.1.7	Europe	Europe	HUG, Laboratory of Virology and the Health2030 Genome Center		2021-06-01	Samuel Cordey et al	[object Object]		
Switzerland/un-HUG-34224210/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Switzerland	Human		University Hospitals of Geneva, Laboratory of Virology	B.1.1.7	Europe	Europe	HUG, Laboratory of Virology and the Health2030 Genome Center		2021-05-19	Samuel Cordey et al	[object Object]		
Switzerland/un-HUG-34217303/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Switzerland	Switzerland	Switzerland	Switzerland	Human		University Hospitals of Geneva, Laboratory of Virology	B.1.1.7	Europe	Europe	HUG, Laboratory of Virology and the Health2030 Genome Center		2021-05-19	Samuel Cordey et al	[object Object]		
Poland/PZH-GUM-1362/2021	1.00	0.07	0.01	0.01	0.04	GR	7.00	20I (Alpha, V1)	Poland	Poland	Poland	Wielkopolskie	Human		UM im. Karola Marcinkowskiego w Poznaniu Laboratorium UCA_Covid-19 Centrum Biologii Medycznej	B.1.1.7	Europe	Europe	1. Tricity SARS-CoV-2 sequencing consortium: University of Gdansk, Medical University of Gdansk, Vaxican Ltd., Invicta Ltd. 2. National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland		2021-05-17	Maciej Kosinski et al	[object Object]	64	Female
Germany/MV-RKI-I-124585/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Mecklenburg-Vorpommern	Human		IMD - Medizinisches Labor Rostock	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-04-21	?	[object Object]		
Denmark/DCGC-96921/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Denmark	Denmark	Denmark	Syddanmark	Human		Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark	B.1.1.7	Europe	Europe	Aalborg University		2021-05-03	Danish Covid-19 Genome Consortium et al	[object Object]		
Slovakia/UVZ_PL15_H10_9931/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Slovakia	Slovakia	Slovakia	Trenčín	Human	Myjava	Public Health Authority of the Slovak Republic	B.1.1.7	Europe	Europe	Laboratory of Genomics and Bioinformatics, Comenius University Science Park		2021-05-03	Tatiana Sedláčková et al	[object Object]	23	Male
Slovakia/UKBA-3262/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovakia	Slovakia	Slovakia	Banska Bystrica	Human	Kruzno	Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava	B.1.1.7	Europe	Europe	Faculty of Natural Sciences, Comenius University, Bratislava		2021-05-21	Brona Brejova et al	[object Object]	9	Male
Lithuania/IBT-LSC-VU_r11_32/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Siauliu Apskritis	Human		Viesoji istaiga Respublikine Siauliu ligonine	B.1.1.7	Europe	Europe	Institute of Biotechnology, Life Sciences Center, Vilnius University		2021-05-16	Daniel Naumovas et al	[object Object]	65	Female
Russia/MOW-RII-MH16133S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Moscow Oblast	Moscow Oblast	Human	Moscow	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-10	Andrey Komissarov et al A	[object Object]	27	Female
Slovakia/UVZ_PL2_B7/2021	1.00	0.07	0.01	0.01	0.04	G	6.00	20I (Alpha, V1)	Slovakia	Slovakia	Slovakia	Kosice	Human		Public Health Authority of the Slovak Republic	B.1.1.7	Europe	Europe	Laboratory of Genomics and Bioinformatics, Comenius University Science Park		2021-03-03	Tatiana Sedláčková et al	[object Object]	31	Male
Germany/ST-MD3776/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Saxony-Anhalt	Human		Landesamt für Verbraucherschutz Sachsen Anhalt, Magdeburg	B.1.1.7	Europe	Europe	Institute of Medical Microbiology and Hospital Hygiene		2021-05-18	Prof. Dr. Achim Kaasch et al	[object Object]	24	Male
Russia/SPE-RII-34042S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-11	Andrey Komissarov et al A	[object Object]	60	Female
Russia/SPE-RII-MH15735S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-03-12	Andrey Komissarov et al A	[object Object]	26	Female
Russia/SPE-RII-35616S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-26	Andrey Komissarov et al A	[object Object]	77	Female
Russia/SPE-RII-34645S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-18	Andrey Komissarov et al A	[object Object]	45	Male
CzechRepublic/NRL_2567_21/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Cheb	Human		National Institute of Public Health	B.1.1.7	Europe	Europe	National Reference Laboratory for Influenza and Respiratory Viruses CZE		2021-02-08	Helena Jirincova et al	[object Object]	34	Female
France/PDL-IPP13160/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	France	France	France	Pays de la Loire	Human	La Roche-sur-Yon	Labo Analyses Med	B.1.1.7	Europe	Europe	National Reference Center for Viruses of Respiratory Infections, Institut Pasteur, Paris		2021-05-25	Marion Barbet et al	[object Object]	81	Male
Poland/NIPH-NIH_ECDC-2080/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Dolnośląskie	Human	Jelenia Gora	Dział Diagnostyki Laboratoryjnej SPZOZ	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-03-17	Wołkowicz Tomasz et al	[object Object]	22	Male
Slovakia/UKBA-3166/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Slovakia	Slovakia	Slovakia	Trnava	Human	Skalica	Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava	B.1.1.7	Europe	Europe	Faculty of Natural Sciences, Comenius University, Bratislava		2021-05-18	Brona Brejova et al	[object Object]	74	Female
CzechRepublic/UMTM205823/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Olomouc Region	Human		Institute of Molecular and Translational Medicine / Laboratory of Experimental Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc	B.1.1.7	Europe	Europe	Institute of Molecular and Translational Medicine / Laboratory of Experimental Medicine, Faculty of Medicine and Dentistry, Palacky University		2021-04-26	Rastislav Slavkovský et al	[object Object]	6	Male
CzechRepublic/NRL_6702/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Ustecky Region	Human		National Institute of Public Health	B.1.1.7	Europe	Europe	State Veterinary Institute Prague		2021-04-26	Nagy et al	[object Object]	84	Female
CzechRepublic/NRL_7616_21/2021	1.00	0.07	0.01	0.01	0.04	GR	7.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Plzeň Region	Human		National Institute of Public Health	B.1.1.7	Europe	Europe	National Institute of Public Health		2021-05-01	Helena Jirincova et al	[object Object]	59	Male
Austria/CeMM4262/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Austria	Austria	Austria	Burgenland	Human		Austrian Agency for Health and Food Safety (AGES)	B.1.1.7	Europe	Europe	Bergthaler laboratory, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences		2021-02-14	Lukas Endler et al	[object Object]		
Slovakia/UKBA-3324/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovakia	Slovakia	Slovakia	Rumanova	Human		Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava	B.1.1.7	Europe	Europe	Faculty of Natural Sciences, Comenius University, Bratislava		2021-05-08	Brona Brejova et al	[object Object]	15	Female
Lithuania/REZUS04_12_33/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Lithuania	Lithuania	Lithuania	Siauliu Apskritis	Human		RezusLT	B.1.1.7	Europe	Europe	National Public Health Surveillance Laboratory		2021-04-12	Lukas Zemaitis et al	[object Object]	28	Male
Poland/NIPH-NIH_ECDC-4001/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Podlaskie	Human	Białystok	Regionalne Centrum Krwiodawstwa i Krwiolecznictwa w Białymstoku Pracownia Diagnostyki Molekularnej wirusa SARS-CoV-2	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-04-07	Wołkowicz Tomasz et al	[object Object]	28	Female
Belgium/UZA-UA-24982416/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Halle-Vilvoorde	Human	Diegem	LHUB-ULB	B.1.1.7	Europe	Europe	Labo Klinische Biologie, UZA		2021-05-20	Marie Le Mercier et al	[object Object]	13	Male
Belgium/AZDelta/04324-2122R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Kortrijk	Human	Sint-Eloois-Vijve	AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-06-02	Geert Martens et al	[object Object]		
Poland/NIPH-NIH_ECDC-6138/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Lubelskie	Human	Lublin	Laboratorium Badawczo-Rozwojowe Vitagenum	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-05-18	Wołkowicz Tomasz et al	[object Object]	36	Male
Belgium/AZDelta/17763-2120R/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Belgium	Belgium	Belgium	Veurne	Human	Koksijde	AZDelta	B.1.1.7	Europe	Europe	AZ Delta Medical Laboratories in Roeselare, Belgium		2021-06-01	Geert Martens et al	[object Object]		
Netherlands/GE-RIVM-33634/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Netherlands	Netherlands	Netherlands	Gelderland	Human		Dutch COVID-19 response team	B.1.1.7	Europe	Europe	National Institute for Public Health and the Environment (RIVM)		2021-05-10	Adam Meijer et al	[object Object]	82	
Slovakia/UKBA-1122/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Slovakia	Slovakia	Slovakia	Banska Bystrica	Human	Velky Krtis	Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava	B.1.1.7	Europe	Europe	Faculty of Natural Sciences, Comenius University, Bratislava		2021-01-26	Kristína Boršová et al	[object Object]	29	Male
Denmark/DCGC-68343/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Denmark	Denmark	Denmark	Hovedstaden	Human		Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark	B.1.1.7	Europe	Europe	Aalborg University		2021-04-19	Danish Covid-19 Genome Consortium et al	[object Object]		
Denmark/DCGC-99722/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Denmark	Denmark	Denmark	Syddanmark	Human		Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark	B.1.1.7	Europe	Europe	Aalborg University		2021-05-17	Danish Covid-19 Genome Consortium et al	[object Object]		
CzechRepublic/MOTOL-C2102-18608/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Karlovy Vary	Human		Department of Microbiology, University Hospital Motol	B.1.1.7	Europe	Europe	Department of Microbiology, University Hospital Motol		2021-02-26	Klara Krivankova et al	[object Object]	30	Female
Germany/TH-RKI-I-163162/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Thuringia	Human		Dianovis GmbH Greiz	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-05-21	?	[object Object]		
Russia/SPE-RII-34957S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	61	Female
CzechRepublic/NRL-2585/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Trutnov District	Human		National Institute of Public Health	B.1.1.7	Europe	Europe	State Veterinary Institute Prague		2021-01-24	Nagy et al	[object Object]	54	Male
Norway/12248/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Norway	Norway	Norway	Nordland	Human		University Hospital of Northern Norway, Department for Microbiology and Infectious Disease Control	B.1.1.7	Europe	Europe	Norwegian Institute of Public Health, Department of Virology		2021-05-03	Kathrine Stene-Johansen et al	[object Object]		
CzechRepublic/MOTOL-V2103-2611/2021	1.00	0.07	0.01	0.01	0.04	GRY	7.00	20I (Alpha, V1)	Czech Republic	Czech Republic	Czech Republic	Hostivice	Human		Department of Genetics and Department of Microbiology, University Hospital Motol	B.1.1.7	Europe	Europe	Department of Microbiology, University Hospital Motol		2021-03-08	Malgorzata Libik et al	[object Object]	52	Female
Russia/BEL-RII-MH17552S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Belgorod Region	Belgorod Region	Human		Center of Hygiene and Epidemiology in Belgorod Region	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-20	Andrey Komissarov et al A	[object Object]	61	
Russia/SPE-RII-MH17252S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	HELIX LLC	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-27	Andrey Komissarov et al A	[object Object]	70	Male
Poland/NIPH-NIH_ECDC-3888/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Dolnośląskie	Human	Wroclaw	Labolatorium Biologi Molekularnej USK	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-04-06	Wołkowicz Tomasz et al	[object Object]	45	Female
Poland/PZH-GUM-1508/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Pomorskie	Human		Diagnostyka	B.1.1.7	Europe	Europe	1. Tricity SARS-CoV-2 sequencing consortium: University of Gdansk, Medical University of Gdansk, Vaxican Ltd., Invicta Ltd. 2. National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland		2021-05-21	Maciej Kosinski et al	[object Object]	61	Female
Poland/PZH-UMB-1227/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Dolnośląskie	Human	Dzierzoniow	Diagnostyka Sp. Z o.o.	B.1.1.7	Europe	Europe	1. Academic Center for Pathomorphological and Genetic-Molecular Diagnostics ltd, Bialystok, Poland 2. National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland		2021-05-05	Radosław Charkiewicz et al	[object Object]	60	Female
Germany/RP-RKI-I-172258/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Germany	Germany	Germany	Rheinland-Pfalz	Human		MVZ für Laboratoriumsmedizin und Mikrobiologie Koblenz-Mittelrhein (Labor Koblenz)	B.1.1.7	Europe	Europe	Robert Koch Institute		2021-05-29	?	[object Object]		
Poland/NIPH-NIH_ECDC-6224/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Poland	Poland	Poland	Podkarpackie	Human	Rzeszow	Centrum Medyczne MEDYK Sp. z o.o. ,Sp.k. Zakład Diagnostyki Medycznej	B.1.1.7	Europe	Europe	1. National Institute of Public Health - National Institute of Hygiene; 2. Eurofins Genomics Europe Sequencing GmbH		2021-05-19	Wołkowicz Tomasz et al	[object Object]	67	Female
Sweden/Orebro-48531571/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Sweden	Sweden	Sweden	Orebro	Human		Orebro University Hospital, Dept Laboratory Medicine, Clinical Microbiology	B.1.1.7	Europe	Europe	Orebro University Hospital		2021-05-19	Sundqvist M et al	[object Object]	22	Male
Slovenia/17-054462-CE/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Slovenia	Slovenia	Slovenia	Savinjska	Human		National Laboratory for Health, Environment and Food, OMM, Celje	B.1.1.7	Europe	Europe	NLZOH (National Laboratory for Health, Environment and Food) / CISLD (Clinical Institute of Special Laboratory Diagnostics), University Children's Hospital, University Medical Center Ljubljana		2021-05-17	Sandra Janezic et al	[object Object]	33	Female
Russia/SPE-RII-34896S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-19	Andrey Komissarov et al A	[object Object]	48	Female
Russia/SPE-RII-33346S/2021	1.00	0.07	0.01	0.01	0.04	GR	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-29	Andrey Komissarov et al A	[object Object]	62	Female
Russia/SPE-RII-MH16261S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-04-15	Andrey Komissarov et al A	[object Object]	35	Male
Russia/SPE-RII-35056S/2021	1.00	0.07	0.01	0.01	0.04	GRY	6.00	20I (Alpha, V1)	Russia	Russia	Saint-Petersburg	Saint-Petersburg	Human	Saint-Petersburg	WHO National Influenza Centre Russian Federation	B.1.1.7	Europe	Europe	WHO National Influenza Centre Russian Federation		2021-05-21	Andrey Komissarov et al A	[object Object]	46	Male